Citrus Sinensis ID: 010149
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RY65 | 635 | Protein NSP-INTERACTING K | yes | no | 0.953 | 0.776 | 0.779 | 0.0 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.998 | 0.808 | 0.732 | 0.0 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.957 | 0.780 | 0.658 | 0.0 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.959 | 0.765 | 0.660 | 0.0 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.974 | 0.797 | 0.636 | 1e-176 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.936 | 0.788 | 0.587 | 1e-158 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.988 | 0.817 | 0.542 | 1e-140 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.893 | 0.745 | 0.539 | 1e-133 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.916 | 0.770 | 0.484 | 1e-129 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.947 | 0.799 | 0.492 | 1e-127 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/494 (77%), Positives = 429/494 (86%), Gaps = 1/494 (0%)
Query: 24 LSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNL 83
L+ KGVN+EV AL+GIK SL DPH VL NWD+ +VDPCSW ++TCSDG V L APSQNL
Sbjct: 34 LTDKGVNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCSDGFVIRLEAPSQNL 93
Query: 84 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 143
SGTLSSSIGNLTNLQ VLLQNN I+G+IP EIGKL KL TLDLS N FTG IP T+S+ +
Sbjct: 94 SGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSK 153
Query: 144 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATG 203
LQYLR+NNNSLTG IP SL+NM+QL FLDLSYNNLSGPVP AKTFN+ GNS IC TG
Sbjct: 154 NLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTG 213
Query: 204 AEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQ 263
E+DC GT P P+S LN+S N G K +KIA+ G SL C+ LLI+GFGFLLWWR+
Sbjct: 214 TEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRR 273
Query: 264 RHNQQI-FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD 322
RHN+Q+ FFD+NEQ +EE+CLGNL+RF+FKELQSATSNFSSKNLVGKGGFGNVYKG L D
Sbjct: 274 RHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHD 333
Query: 323 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382
G+++AVKRLKD N GGE+QFQTE+EMISLAVHRNLLRL GFC T++ERLLVYPYMSNGS
Sbjct: 334 GSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGS 393
Query: 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442
VASRLKAKP LDW TRKRIALGA RGLLYLHEQCDPKIIHRDVKAANILLD+Y+EAVVGD
Sbjct: 394 VASRLKAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGD 453
Query: 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502
FGLAKLLDH +SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI+GLRALEF
Sbjct: 454 FGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEF 513
Query: 503 GKTANQKGAMLDWV 516
GK ANQ+GA+LDWV
Sbjct: 514 GKAANQRGAILDWV 527
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/519 (73%), Positives = 430/519 (82%), Gaps = 3/519 (0%)
Query: 1 MRREEAVFCFVALFGLWTCAC-GLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVD 59
M + FCF+ L + GLLSPKGVN+EVQALM IK SLHDPH VL+NWD ++VD
Sbjct: 9 MMITRSFFCFLGFLCLLCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVD 68
Query: 60 PCSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKL 118
PCSW +VTCS + V GLG PSQNLSGTLS SI NLTNL++VLLQNNNI G IP EIG+L
Sbjct: 69 PCSWTMVTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRL 128
Query: 119 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN 178
++L TLDLS+NFF G IP +V +L++LQYLRLNNNSL+G P SLSNM+QLAFLDLSYNN
Sbjct: 129 TRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNN 188
Query: 179 LSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIA 238
LSGPVP F AKTF+I GN LIC TG E DC GT +P+S LN + +G + K+A
Sbjct: 189 LSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMA 248
Query: 239 LALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNE-QRREEVCLGNLKRFHFKELQSA 297
+A+GSS+G +SL+ + G LWWRQRHNQ FFDV + EEV LGNL+RF F+ELQ A
Sbjct: 249 IAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIA 308
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
T+NFSSKNL+GKGG+GNVYKG L D TVVAVKRLKDG A+GGEIQFQTEVEMISLAVHRN
Sbjct: 309 TNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRN 368
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 417
LLRL GFC+T TE+LLVYPYMSNGSVASR+KAKP LDW+ RKRIA+GAARGL+YLHEQCD
Sbjct: 369 LLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHEQCD 428
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
PKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQS
Sbjct: 429 PKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQS 488
Query: 478 SEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
SEKTDVFGFGILLLEL++G RA EFGK ANQKG MLDWV
Sbjct: 489 SEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWV 527
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/513 (65%), Positives = 399/513 (77%), Gaps = 18/513 (3%)
Query: 7 VFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALV 66
+ CF TC+ LS + N EV+AL+ IK+ LHDPH V NWDE SVDPCSW ++
Sbjct: 17 LLCFFV-----TCS---LSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMI 68
Query: 67 TCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLD 125
+CS D LV GLGAPSQ+LSGTLS SIGNLTNL+ V LQNNNISG IP EI L KL TLD
Sbjct: 69 SCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLD 128
Query: 126 LSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
LSNN F+G IP +V+ L LQYLRLNNNSL+G P SLS + L+FLDLSYNNL GPVP
Sbjct: 129 LSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPK 188
Query: 186 FHAKTFNITGNSLICATGAEEDCFGT-APMPLSFALNNSPNSKPSGMPKGQKIALALGSS 244
F A+TFN+ GN LIC E C G+ + PLS +L +S + + +A+ALG S
Sbjct: 189 FPARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRTN------ILAVALGVS 242
Query: 245 LGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSS 303
LG +IL GF+ W+R++ + +++++ E + LGNL+ F F+EL AT FSS
Sbjct: 243 LGFAVSVILSLGFI-WYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSS 301
Query: 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
K+++G GGFGNVY+G DGTVVAVKRLKD N G QF+TE+EMISLAVHRNLLRLIG
Sbjct: 302 KSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIG 361
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+C +++ERLLVYPYMSNGSVASRLKAKP+LDW TRK+IA+GAARGL YLHEQCDPKIIHR
Sbjct: 362 YCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHR 421
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
DVKAANILLDEY+EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV
Sbjct: 422 DVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 481
Query: 484 FGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
FGFGILLLELI+G+RALEFGK+ +QKGAML+WV
Sbjct: 482 FGFGILLLELITGMRALEFGKSVSQKGAMLEWV 514
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/504 (66%), Positives = 396/504 (78%), Gaps = 8/504 (1%)
Query: 16 LWTCACGL-LSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS-DGLV 73
L+ C L LS + N EV+AL+ I+++LHDPH LNNWDE SVDPCSWA++TCS D LV
Sbjct: 20 LFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDNLV 79
Query: 74 TGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG 133
GLGAPSQ+LSG LS SIGNLTNL+ V LQNNNISG IP E+G L KL TLDLSNN F+G
Sbjct: 80 IGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSG 139
Query: 134 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNI 193
IP ++ L +LQYLRLNNNSL+G P SLS + L+FLDLSYNNLSGPVP F A+TFN+
Sbjct: 140 DIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNV 199
Query: 194 TGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLIL 253
GN LIC + E C G+ A S + S + ++A+AL SLG + +L+L
Sbjct: 200 AGNPLICRSNPPEICSGSIN-----ASPLSVSLSSSSGRRSNRLAIALSVSLGSVVILVL 254
Query: 254 GFGFLLWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSSKNLVGKGGF 312
G W+R++ + + ++N+++ E + LGNL+ F F+EL T FSSKN++G GGF
Sbjct: 255 ALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGF 314
Query: 313 GNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372
GNVY+G L DGT+VAVKRLKD N G+ QF+ E+EMISLAVH+NLLRLIG+C T+ ERL
Sbjct: 315 GNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERL 374
Query: 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432
LVYPYM NGSVAS+LK+KP+LDW RKRIA+GAARGLLYLHEQCDPKIIHRDVKAANILL
Sbjct: 375 LVYPYMPNGSVASKLKSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILL 434
Query: 433 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 492
DE +EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE
Sbjct: 435 DECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 494
Query: 493 LISGLRALEFGKTANQKGAMLDWV 516
LI+GLRALEFGKT +QKGAML+WV
Sbjct: 495 LITGLRALEFGKTVSQKGAMLEWV 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1597), Expect = e-176, Method: Compositional matrix adjust.
Identities = 325/511 (63%), Positives = 389/511 (76%), Gaps = 7/511 (1%)
Query: 10 FVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS 69
F+ + + LSP GVNYEV AL+ +K+ L+DP+ VL NWD NSVDPCSW +V+C+
Sbjct: 13 FLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT 72
Query: 70 DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 129
DG V+ L PSQ+LSGTLS IGNLT LQ V+LQNN I+G IP IG+L KL +LDLSNN
Sbjct: 73 DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNN 132
Query: 130 FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK 189
FTG IP+++ L+ L YLRLNNNSL G P SLS + L +D+SYNNLSG +P A+
Sbjct: 133 SFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSAR 192
Query: 190 TFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCIS 249
TF + GN+LIC A +C P PL+ + S G +ALA +S
Sbjct: 193 TFKVIGNALICGPKAVSNC-SAVPEPLTLPQDGPDES--GTRTNGHHVALAFAASFSAAF 249
Query: 250 LLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGK 309
+ G LWWR R N+QIFFDVNEQ EV LG+LKR+ FKEL+SAT++F+SKN++G+
Sbjct: 250 FVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGR 309
Query: 310 GGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 369
GG+G VYKG+L DGT+VAVKRLKD N GGE+QFQTEVE ISLA+HRNLLRL GFC +
Sbjct: 310 GGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQ 369
Query: 370 ERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
ER+LVYPYM NGSVASRLK +P+LDW+ RK+IA+G ARGL+YLHEQCDPKIIHRDV
Sbjct: 370 ERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDV 429
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485
KAANILLDE +EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG
Sbjct: 430 KAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 489
Query: 486 FGILLLELISGLRALEFGKTANQKGAMLDWV 516
FGILLLELI+G +AL+FG++A+QKG MLDWV
Sbjct: 490 FGILLLELITGQKALDFGRSAHQKGVMLDWV 520
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 293/499 (58%), Positives = 368/499 (73%), Gaps = 15/499 (3%)
Query: 23 LLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS-DGLVTGLGAPSQ 81
LLSPKGVNYEV ALM +K+ + D +VL+ WD NSVDPC+W +V CS +G V L S+
Sbjct: 30 LLSPKGVNYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSSEGFVVSLEMASK 89
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
LSG LS+SIG LT+L +LLQNN ++G IP+E+G+LS+L TLDLS N F+G IP+++
Sbjct: 90 GLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGF 149
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICA 201
L L YLRL+ N L+G +P ++ +S L+FLDLS+NNLSGP P+ AK + I GN+ +C
Sbjct: 150 LTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFLCG 209
Query: 202 TGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLWW 261
++E C P+ + L+ NSK + ++ A G + I L+ F ++LW
Sbjct: 210 PASQELCSDATPVRNATGLSEKDNSKHHSL----VLSFAFGIVVAFIISLMFLFFWVLWH 265
Query: 262 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ 321
R R ++ + Q+ E +G+LKRF F+E+Q+ATSNFS KN++G+GGFG VYKGYL
Sbjct: 266 RSRLSRS-----HVQQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLP 320
Query: 322 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381
+GTVVAVKRLKD GE+QFQTEVEMI LAVHRNLLRL GFCMT ER+LVYPYM NG
Sbjct: 321 NGTVVAVKRLKD-PIYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNG 379
Query: 382 SVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437
SVA RL+ KPSLDW R IALGAARGL+YLHEQC+PKIIHRDVKAANILLDE +E
Sbjct: 380 SVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFE 439
Query: 438 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
A+VGDFGLAKLLD DSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELI+G
Sbjct: 440 AIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGH 499
Query: 498 RALEFGKTANQKGAMLDWV 516
+ ++ G +KG +L WV
Sbjct: 500 KMIDQGNGQVRKGMILSWV 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 499 bits (1285), Expect = e-140, Method: Compositional matrix adjust.
Identities = 286/527 (54%), Positives = 353/527 (66%), Gaps = 16/527 (3%)
Query: 1 MRREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
M VF ++L L + L S N E AL ++ +L DP++VL +WD V+P
Sbjct: 1 MESSYVVFILLSLILLPNHSLWLAS---ANLEGDALHTLRVTLVDPNNVLQSWDPTLVNP 57
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119
C+W VTC+ + V + + LSG L +G L NLQ + L +NNI+G IP+ +G L+
Sbjct: 58 CTWFHVTCNNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLT 117
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
L++LDL N F+GPIP ++ L L++LRLNNNSLTG+IP SL+N++ L LDLS N L
Sbjct: 118 NLVSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRL 177
Query: 180 SGPVP---SFHAKT-FNITGNSLICA-TGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKG 234
SG VP SF T + N +C + P + P S PSG G
Sbjct: 178 SGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGY--G 235
Query: 235 QKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKEL 294
A+A G + G L WWR+R IFFDV + EV LG LKRF +EL
Sbjct: 236 ITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLREL 295
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
Q A+ FS+KN++G+GGFG VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+AV
Sbjct: 296 QVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAV 355
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVAS----RLKAKPSLDWATRKRIALGAARGLL 410
HRNLLRL GFCMT TERLLVYPYM+NGSVAS R ++P LDW TRKRIALG+ARGL
Sbjct: 356 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLS 415
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLAKL+D+ D+HVTTAVRGT+GHIAPE
Sbjct: 416 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 475
Query: 471 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM-LDWV 516
YLSTG+SSEKTDVFG+GI+LLELI+G RA + + AN M LDWV
Sbjct: 476 YLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 522
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 476 bits (1224), Expect = e-133, Method: Compositional matrix adjust.
Identities = 275/510 (53%), Positives = 340/510 (66%), Gaps = 48/510 (9%)
Query: 30 NYEVQALMGIKDSLH--DP-HDVLNNWDENSVDPCSWALVTCS-DGLVTGLGAPSQNLSG 85
N E AL +K+SL DP ++VL +WD V PC+W VTC+ + VT + + LSG
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
L +G L NLQ + L +NNI+G IP E+G L +L++LDL N +GPIPS++ L L
Sbjct: 90 KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149
Query: 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN-SLICATGA 204
++LRLNNNSL+G IP +L+++ QL LD+S N LSG +P + G+ SL
Sbjct: 150 RFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIP--------VNGSFSLFT---- 196
Query: 205 EEDCFGTAPMPLSFALNNSPNSKPSGMPK-----------GQKIALALGSSLGCISLL-- 251
P+SFA NNS P P GQ A G +LL
Sbjct: 197 ----------PISFA-NNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFA 245
Query: 252 ILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGG 311
+ F WW +R Q FFDV + EV LG LKRF +EL AT NFS+KN++G+GG
Sbjct: 246 VPAIAFA-WWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGG 304
Query: 312 FGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371
FG VYKG L DG +VAVKRLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TER
Sbjct: 305 FGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 364
Query: 372 LLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 427
LLVYPYM+NGSVAS L+ +P +LDW RK IALG+ARGL YLH+ CD KIIHRDVKA
Sbjct: 365 LLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKA 424
Query: 428 ANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 487
ANILLDE +EAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 425 ANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 484
Query: 488 ILLLELISGLRALEFGKTANQKGAM-LDWV 516
++LLELI+G +A + + AN M LDWV
Sbjct: 485 VMLLELITGQKAFDLARLANDDDIMLLDWV 514
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 462 bits (1188), Expect = e-129, Method: Compositional matrix adjust.
Identities = 268/553 (48%), Positives = 340/553 (61%), Gaps = 79/553 (14%)
Query: 1 MRREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
M R + CF L L+ N E AL +K+SL DP+ VL +WD V P
Sbjct: 1 MERRLMIPCFFWLI----LVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTP 56
Query: 61 CSWALVTC-SDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119
C+W VTC SD VT + + NLSG L +G L NLQ + L +NNI+G IP ++G L+
Sbjct: 57 CTWFHVTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLT 116
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
+L++LDL N +GPIPS +L + +L FL L+ N+L
Sbjct: 117 ELVSLDLYLNNLSGPIPS------------------------TLGRLKKLRFLRLNNNSL 152
Query: 180 SGPVPS-----FHAKTFNITGNSLICATGAEEDCFGTAPM--------PLSFALNNSPNS 226
SG +P + +++ N L G P+ P+SFA N+
Sbjct: 153 SGEIPRSLTAVLTLQVLDLSNNPLT----------GDIPVNGSFSLFTPISFA-----NT 197
Query: 227 KPSGMPK---------------GQKIALALGSSLGCISLLILGFGF--LLWWRQRHNQQI 269
K + +P +I A+ + + L+ L WWR++ Q
Sbjct: 198 KLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDH 257
Query: 270 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVK 329
FFDV + EV LG LKRF +ELQ A+ NFS+KN++G+GGFG VYKG L DGT+VAVK
Sbjct: 258 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 317
Query: 330 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS---- 385
RLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS
Sbjct: 318 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 377
Query: 386 RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 445
R +++P LDW R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGL
Sbjct: 378 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 437
Query: 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505
AKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G RA + +
Sbjct: 438 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 497
Query: 506 ANQKGAM-LDWVS 517
AN M LDWV
Sbjct: 498 ANDDDVMLLDWVK 510
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 256/520 (49%), Positives = 336/520 (64%), Gaps = 30/520 (5%)
Query: 4 EEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSW 63
++ F LF + C C +SP + + AL ++ SL + L++W++N V+PC+W
Sbjct: 7 QKMAMAFTLLF--FACLCSFVSP---DAQGDALFALRISLRALPNQLSDWNQNQVNPCTW 61
Query: 64 ALVTCSD-GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLL 122
+ V C D VT L N SGTLSS +G L NL+ + L+ N I+G IP + G L+ L
Sbjct: 62 SQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLT 121
Query: 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182
+LDL +N TG IPST+ +L+ LQ+L L+ N L G IP SL+ + L L L N+LSG
Sbjct: 122 SLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQ 181
Query: 183 VPS--FHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALA 240
+P F +N T N+L +C G P P A+ +S +S PK IA
Sbjct: 182 IPQSLFEIPKYNFTSNNL--------NCGGRQPHPCVSAVAHSGDSSK---PKTGIIAGV 230
Query: 241 LGSSLGCISLLILGFGFLLWWRQRHN---QQIFFDVNEQRREEVCLGNLKRFHFKELQSA 297
+ ++++ G L+ + RH + +F DV + + G LKRF ++ELQ A
Sbjct: 231 VAGV----TVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLA 286
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
T NFS KN++G+GGFG VYKG L D T VAVKRL D + GG+ FQ EVEMIS+AVHRN
Sbjct: 287 TDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 346
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLH 413
LLRLIGFC T TERLLVYP+M N S+A RL+ P LDW TRKRIALGAARG YLH
Sbjct: 347 LLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLH 406
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
E C+PKIIHRDVKAAN+LLDE +EAVVGDFGLAKL+D ++VTT VRGT+GHIAPEYLS
Sbjct: 407 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLS 466
Query: 474 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 513
TG+SSE+TDVFG+GI+LLEL++G RA++F + + +L
Sbjct: 467 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 506
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | ||||||
| 224099221 | 622 | predicted protein [Populus trichocarpa] | 0.988 | 0.821 | 0.813 | 0.0 | |
| 225425033 | 625 | PREDICTED: protein NSP-INTERACTING KINAS | 0.994 | 0.822 | 0.819 | 0.0 | |
| 110432095 | 622 | leucine-rich repeat receptor-like kinase | 0.988 | 0.821 | 0.802 | 0.0 | |
| 224108601 | 627 | predicted protein [Populus trichocarpa] | 0.990 | 0.816 | 0.795 | 0.0 | |
| 225451885 | 624 | PREDICTED: protein NSP-INTERACTING KINAS | 0.998 | 0.826 | 0.791 | 0.0 | |
| 298204417 | 622 | unnamed protein product [Vitis vinifera] | 0.998 | 0.829 | 0.791 | 0.0 | |
| 356498122 | 621 | PREDICTED: protein NSP-INTERACTING KINAS | 0.990 | 0.824 | 0.794 | 0.0 | |
| 356502688 | 770 | PREDICTED: protein NSP-INTERACTING KINAS | 0.982 | 0.659 | 0.800 | 0.0 | |
| 449434692 | 623 | PREDICTED: protein NSP-INTERACTING KINAS | 0.974 | 0.808 | 0.787 | 0.0 | |
| 255584308 | 624 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.998 | 0.826 | 0.773 | 0.0 |
| >gi|224099221|ref|XP_002311408.1| predicted protein [Populus trichocarpa] gi|222851228|gb|EEE88775.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/516 (81%), Positives = 458/516 (88%), Gaps = 5/516 (0%)
Query: 3 REEAVFCFVA-LFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPC 61
++ A+FC VA L LWT A G L+ GVNYEV+ALMGIK+SLHDPH++LN WDE++VDPC
Sbjct: 5 KKNALFCCVASLICLWTTAYGELTAAGVNYEVEALMGIKNSLHDPHNILN-WDEHAVDPC 63
Query: 62 SWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSK 120
SWA+VTCS D VT LGAPSQ LSGTLS SIGNLTNLQ +LLQ+NNISGHIP+E+G+LSK
Sbjct: 64 SWAMVTCSPDNFVTSLGAPSQRLSGTLSPSIGNLTNLQSLLLQDNNISGHIPSELGRLSK 123
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L T+DLS+N F+G IPS +S+L +LQYLRLNNNSL GAIP SL NM+QL FLDLSYN+LS
Sbjct: 124 LKTIDLSSNNFSGQIPSALSNLNSLQYLRLNNNSLDGAIPASLVNMTQLTFLDLSYNDLS 183
Query: 181 GPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALA 240
PVP HAKTFNI GN LIC G E+ C GT P+P S ALNNS NS+PSG K KIALA
Sbjct: 184 TPVPPVHAKTFNIVGNPLIC--GTEQGCAGTTPVPQSVALNNSQNSQPSGNNKSHKIALA 241
Query: 241 LGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSN 300
GSSLGCI LL+LGFGF+LWWRQRHNQQIFFDVNEQ EE+ LGNL+ F FKELQ AT+N
Sbjct: 242 FGSSLGCICLLVLGFGFILWWRQRHNQQIFFDVNEQHNEELNLGNLRSFQFKELQVATNN 301
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
FSSKNL+GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR
Sbjct: 302 FSSKNLIGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 361
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
L GFCMTTTERLLVYPYMSNGSVA+RLKAKP+LDW TRKRIALGAARGLLYLHEQCDPKI
Sbjct: 362 LYGFCMTTTERLLVYPYMSNGSVATRLKAKPALDWGTRKRIALGAARGLLYLHEQCDPKI 421
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
IHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEK
Sbjct: 422 IHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
Query: 481 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
TDVFGFGILLLELISGLRALEFGK+ NQKGA+LDWV
Sbjct: 482 TDVFGFGILLLELISGLRALEFGKSTNQKGALLDWV 517
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425033|ref|XP_002269902.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera] gi|297738231|emb|CBI27432.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/516 (81%), Positives = 460/516 (89%), Gaps = 2/516 (0%)
Query: 3 REEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCS 62
R EAV CFVA LW A LLSPKGVN+EVQALM IK+SL DP VL NWD+++VDPCS
Sbjct: 5 RREAVLCFVAFLCLWNSASSLLSPKGVNFEVQALMSIKNSLIDPRSVLENWDKDAVDPCS 64
Query: 63 WALVTCSDG-LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKL 121
W ++TCSD LV LG PSQNLSGTLS SIGNLTNLQ VLLQ+N+ISG IP+E+GKLSKL
Sbjct: 65 WNMITCSDDKLVISLGTPSQNLSGTLSPSIGNLTNLQTVLLQDNSISGPIPSELGKLSKL 124
Query: 122 LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
LDLSNNFF G IP+++SHL++LQYLRLNNNSL+GAIP SL+NM+ LAFLD+SYNNLSG
Sbjct: 125 HLLDLSNNFFNGEIPTSLSHLKSLQYLRLNNNSLSGAIPSSLANMTHLAFLDMSYNNLSG 184
Query: 182 PVPSFHAKTFNITGNSLICATGAEEDCFGT-APMPLSFALNNSPNSKPSGMPKGQKIALA 240
PVP F A+TFNI GN LIC TG E+DCFG P+P+S ++NNS +S+PS PK K+ALA
Sbjct: 185 PVPGFAARTFNIVGNPLICPTGTEKDCFGRPTPLPVSISMNNSQSSQPSARPKSHKVALA 244
Query: 241 LGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSN 300
GSSLGCI LLILGFGFLLWWRQRHNQQIFFDVNEQ REEVCLGNL+RF FKELQ AT+N
Sbjct: 245 FGSSLGCICLLILGFGFLLWWRQRHNQQIFFDVNEQYREEVCLGNLRRFPFKELQIATNN 304
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
FSSKN++GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG IQFQTEVEMISLAVHRNLLR
Sbjct: 305 FSSKNILGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGVIQFQTEVEMISLAVHRNLLR 364
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
L GFCMTTTERLLVYPYMSNGSVA RLKAKP+LDW+TRKRIALGAARGLLYLHEQCDPKI
Sbjct: 365 LYGFCMTTTERLLVYPYMSNGSVAYRLKAKPALDWSTRKRIALGAARGLLYLHEQCDPKI 424
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
IHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEK
Sbjct: 425 IHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 484
Query: 481 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
TDVFGFGILLLELI+G RALEFGK ANQKGAMLDWV
Sbjct: 485 TDVFGFGILLLELITGQRALEFGKAANQKGAMLDWV 520
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110432095|gb|ABG73621.1| leucine-rich repeat receptor-like kinase [Populus tomentosa] | Back alignment and taxonomy information |
|---|
Score = 836 bits (2159), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/516 (80%), Positives = 452/516 (87%), Gaps = 5/516 (0%)
Query: 3 REEAVFCFVA-LFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPC 61
++ ++FC VA L LWT A G L+ GVNYEV+ALMG K+SLHDPH++LN WDE++VDPC
Sbjct: 5 KKNSLFCCVASLICLWTTAYGELTAAGVNYEVEALMGFKNSLHDPHNILN-WDEHAVDPC 63
Query: 62 SWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSK 120
SWA+VTCS D VT LGAPSQ LSGTLS IGNLTNLQ +LLQ+NNISGHIP+E+G+L K
Sbjct: 64 SWAMVTCSPDNFVTSLGAPSQRLSGTLSPYIGNLTNLQSLLLQDNNISGHIPSELGRLPK 123
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L T+DLS+N F+G IPS +S+L LQYLRLNNNSL GAIP SL NM+QL FLDLSYN+LS
Sbjct: 124 LKTIDLSSNNFSGQIPSALSNLNNLQYLRLNNNSLDGAIPASLVNMTQLTFLDLSYNDLS 183
Query: 181 GPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALA 240
PVP HAKTFNI GN IC G E+ C GT P+P S ALNNS NS+PSG K KIALA
Sbjct: 184 TPVPPVHAKTFNIVGNPQIC--GTEQGCAGTTPVPQSVALNNSQNSQPSGNNKSHKIALA 241
Query: 241 LGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSN 300
GSSLGCI LL+LGFGF+LWWRQRHNQQIFFDVNEQ EE+ LGNL+ F FKELQ AT+N
Sbjct: 242 FGSSLGCICLLVLGFGFILWWRQRHNQQIFFDVNEQHNEELSLGNLRSFQFKELQVATNN 301
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
FSSKNL+GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG IQFQTEVEMISLAVHRNLLR
Sbjct: 302 FSSKNLIGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGVIQFQTEVEMISLAVHRNLLR 361
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
L GFCMTTTERLLVYPYMSNGSVA+RLKAKP+LDW TRKRIALGAARGLLYLHEQCDPKI
Sbjct: 362 LHGFCMTTTERLLVYPYMSNGSVATRLKAKPALDWGTRKRIALGAARGLLYLHEQCDPKI 421
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
IHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEK
Sbjct: 422 IHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 481
Query: 481 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
TDVFGFGILLLELISGLRALEFGK+ NQKGA+LDWV
Sbjct: 482 TDVFGFGILLLELISGLRALEFGKSTNQKGALLDWV 517
|
Source: Populus tomentosa Species: Populus tomentosa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108601|ref|XP_002314905.1| predicted protein [Populus trichocarpa] gi|222863945|gb|EEF01076.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/522 (79%), Positives = 454/522 (86%), Gaps = 10/522 (1%)
Query: 2 RREEAVFCFVALF-GLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
R++ A+FC V L LW A G L+ GVN+EV+ALMGIK SLHDPHDVL WDE+SVDP
Sbjct: 4 RKKNALFCCVGLLICLWNTAYGELTATGVNFEVEALMGIKASLHDPHDVLK-WDEHSVDP 62
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119
CSW +VTCS DG VT LGAPSQ+LSGTLS SIGNLTNLQ +LLQ+NNISGHIP E+GKL
Sbjct: 63 CSWIMVTCSTDGFVTTLGAPSQSLSGTLSPSIGNLTNLQSLLLQDNNISGHIPAELGKLP 122
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYL-----RLNNNSLTGAIPPSLSNMSQLAFLDL 174
KL T+DLS+N F+G IPST+S+L +L YL RLNNNSL GAIP SL+NM+QL FLDL
Sbjct: 123 KLKTIDLSSNNFSGQIPSTLSNLNSLHYLGIWIRRLNNNSLNGAIPASLANMTQLTFLDL 182
Query: 175 SYNNLSGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKG 234
SYNNL+ PVP HAKTFNI GN+LIC G E+ C GT P+P S A++NS NS+PSG K
Sbjct: 183 SYNNLNTPVPPVHAKTFNIVGNTLIC--GTEQGCAGTTPVPQSLAVHNSQNSQPSGNSKS 240
Query: 235 QKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKEL 294
KIALA GSSLGCI LL+LGFGF+LWWRQRHNQQIFFD+NEQ EE+ LGNL+RF FKEL
Sbjct: 241 HKIALAFGSSLGCICLLVLGFGFILWWRQRHNQQIFFDINEQHHEELNLGNLRRFQFKEL 300
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
Q ATSNFSSKNL+GKGGFGNVYKG+LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV
Sbjct: 301 QIATSNFSSKNLIGKGGFGNVYKGHLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 360
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
HRNLLRL G CMTTTERLLVYPYMSNGSVA+RLKAKP LDW TRKR+ALGA RGLLYLHE
Sbjct: 361 HRNLLRLYGLCMTTTERLLVYPYMSNGSVATRLKAKPVLDWGTRKRVALGAGRGLLYLHE 420
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
QCDPKIIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLST
Sbjct: 421 QCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLST 480
Query: 475 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
GQSSEKTDVFGFGILLLELISGLRALEFGK+ NQKGA+LDWV
Sbjct: 481 GQSSEKTDVFGFGILLLELISGLRALEFGKSTNQKGALLDWV 522
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225451885|ref|XP_002278965.1| PREDICTED: protein NSP-INTERACTING KINASE 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2127), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/517 (79%), Positives = 448/517 (86%), Gaps = 1/517 (0%)
Query: 1 MRREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
MR F FV WT A GLLSPKGVN+EVQALMGIK L DPH VL+NWD ++VDP
Sbjct: 3 MRSRVIAFWFVPFLWFWTSANGLLSPKGVNFEVQALMGIKAFLVDPHGVLDNWDGDAVDP 62
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119
CSW +VTCS D LV GLG PSQNLSGTLS SIGNLTNLQ+VLLQNNNI+G IP E+G+LS
Sbjct: 63 CSWTMVTCSTDSLVVGLGTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPQELGRLS 122
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
KL TLDLSNNFFT +PS++ HL +LQYLRLNNNSL+G P SL+NM+QLAFLDLS+NNL
Sbjct: 123 KLHTLDLSNNFFTDEVPSSLGHLTSLQYLRLNNNSLSGPFPVSLANMTQLAFLDLSFNNL 182
Query: 180 SGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIAL 239
SGPVP F AKTFNI GN LICATG+E++C+GT MP+S LN+S + P+ K K+AL
Sbjct: 183 SGPVPRFPAKTFNIVGNPLICATGSEQECYGTTLMPMSMTLNSSQTALPTRRSKNHKLAL 242
Query: 240 ALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATS 299
A G+SLGCI LLI G G LLWWRQRHNQQ+FFDVN++ EEV LGNLKRF F+ELQ AT
Sbjct: 243 AFGTSLGCICLLIFGGGLLLWWRQRHNQQMFFDVNDRHHEEVSLGNLKRFQFRELQIATD 302
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
NFSSKN++GKGGFGNVYKGYLQDGT+VAVKRLKDGNA+GGEIQFQTEVEMISLAVHRNLL
Sbjct: 303 NFSSKNILGKGGFGNVYKGYLQDGTIVAVKRLKDGNAVGGEIQFQTEVEMISLAVHRNLL 362
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
RL GFC+TT+ERLLVYPYMSNGSVASRLK KP LDW TRKRIALGAARGLLYLHEQCDPK
Sbjct: 363 RLYGFCITTSERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPK 422
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 423 IIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 482
Query: 480 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
KTDVFGFGILLLELI+G RALEFGK ANQKGAMLDWV
Sbjct: 483 KTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWV 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204417|emb|CBI16897.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2126), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/517 (79%), Positives = 448/517 (86%), Gaps = 1/517 (0%)
Query: 1 MRREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
MR F FV WT A GLLSPKGVN+EVQALMGIK L DPH VL+NWD ++VDP
Sbjct: 1 MRSRVIAFWFVPFLWFWTSANGLLSPKGVNFEVQALMGIKAFLVDPHGVLDNWDGDAVDP 60
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119
CSW +VTCS D LV GLG PSQNLSGTLS SIGNLTNLQ+VLLQNNNI+G IP E+G+LS
Sbjct: 61 CSWTMVTCSTDSLVVGLGTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPQELGRLS 120
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
KL TLDLSNNFFT +PS++ HL +LQYLRLNNNSL+G P SL+NM+QLAFLDLS+NNL
Sbjct: 121 KLHTLDLSNNFFTDEVPSSLGHLTSLQYLRLNNNSLSGPFPVSLANMTQLAFLDLSFNNL 180
Query: 180 SGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIAL 239
SGPVP F AKTFNI GN LICATG+E++C+GT MP+S LN+S + P+ K K+AL
Sbjct: 181 SGPVPRFPAKTFNIVGNPLICATGSEQECYGTTLMPMSMTLNSSQTALPTRRSKNHKLAL 240
Query: 240 ALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATS 299
A G+SLGCI LLI G G LLWWRQRHNQQ+FFDVN++ EEV LGNLKRF F+ELQ AT
Sbjct: 241 AFGTSLGCICLLIFGGGLLLWWRQRHNQQMFFDVNDRHHEEVSLGNLKRFQFRELQIATD 300
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
NFSSKN++GKGGFGNVYKGYLQDGT+VAVKRLKDGNA+GGEIQFQTEVEMISLAVHRNLL
Sbjct: 301 NFSSKNILGKGGFGNVYKGYLQDGTIVAVKRLKDGNAVGGEIQFQTEVEMISLAVHRNLL 360
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
RL GFC+TT+ERLLVYPYMSNGSVASRLK KP LDW TRKRIALGAARGLLYLHEQCDPK
Sbjct: 361 RLYGFCITTSERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPK 420
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 421 IIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 480
Query: 480 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
KTDVFGFGILLLELI+G RALEFGK ANQKGAMLDWV
Sbjct: 481 KTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWV 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498122|ref|XP_003517902.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 821 bits (2120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/516 (79%), Positives = 451/516 (87%), Gaps = 4/516 (0%)
Query: 2 RREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPC 61
RR+ A+FC +ALF LWT LLSPKGVNYEVQALMGI++SL DPH VLNNWD ++VDPC
Sbjct: 4 RRDVALFC-LALFFLWTSVAALLSPKGVNYEVQALMGIRNSLADPHSVLNNWDPDAVDPC 62
Query: 62 SWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSK 120
+WA+VTCS D V LG PSQN+SGTLS SIGNLTNLQ VLLQ+NNI+G IP+EIG+L K
Sbjct: 63 NWAMVTCSSDHFVIALGIPSQNISGTLSPSIGNLTNLQTVLLQDNNITGPIPSEIGRLQK 122
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L TLDLS+NFFTG +P ++SH++ L YLRLNNNSLTG IP SL+NM+QLAFLD+SYNNLS
Sbjct: 123 LQTLDLSDNFFTGQLPDSLSHMKGLHYLRLNNNSLTGPIPSSLANMTQLAFLDISYNNLS 182
Query: 181 GPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALA 240
PVP +AKTFNI GN IC TG E++C T +P A NNS +S+ + PK K+ALA
Sbjct: 183 EPVPRINAKTFNIVGNPQICVTGVEKNCSRTTSIP--SAPNNSQDSQSTKRPKSHKVALA 240
Query: 241 LGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSN 300
SSL CI LLILG GFL+WWRQR+N+QIFF VNEQ REEVCLGNLK+FHF+ELQ AT+N
Sbjct: 241 FASSLSCICLLILGLGFLIWWRQRYNKQIFFVVNEQHREEVCLGNLKKFHFRELQLATNN 300
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
FSSKNL+GKGGFGNVYKGYLQDGTV+AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR
Sbjct: 301 FSSKNLIGKGGFGNVYKGYLQDGTVIAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
L GFCMT TERLLVYPYMSNGSVASRLKAKP+LDW TRKRIALGA RGLLYLHEQCDPKI
Sbjct: 361 LYGFCMTATERLLVYPYMSNGSVASRLKAKPALDWPTRKRIALGAGRGLLYLHEQCDPKI 420
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
IHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEK
Sbjct: 421 IHRDVKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
Query: 481 TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
TDVFGFGILLLELISG RALEFGK ANQKGAMLDWV
Sbjct: 481 TDVFGFGILLLELISGQRALEFGKAANQKGAMLDWV 516
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502688|ref|XP_003520149.1| PREDICTED: protein NSP-INTERACTING KINASE 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/512 (80%), Positives = 449/512 (87%), Gaps = 4/512 (0%)
Query: 6 AVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWAL 65
A+FC +ALF LWT LLSPKGVNYEVQALM IK+SL DPH VLNNWD ++VDPC+WA+
Sbjct: 157 ALFC-LALFFLWTSVAALLSPKGVNYEVQALMSIKNSLVDPHSVLNNWDTDAVDPCNWAM 215
Query: 66 VTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTL 124
VTCS D V LG PSQ++SGTLS SIGNLTNLQ VLLQ+NNI+G IP EIG+L KL TL
Sbjct: 216 VTCSSDHFVIALGIPSQSISGTLSPSIGNLTNLQTVLLQDNNITGPIPFEIGRLQKLQTL 275
Query: 125 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
DLS+NFFTG +P T+S+++ L YLRLNNNSLTG IP SL+NM+QLAFLD+SYNNLS PVP
Sbjct: 276 DLSDNFFTGQLPDTLSYMKGLHYLRLNNNSLTGPIPSSLANMTQLAFLDISYNNLSEPVP 335
Query: 185 SFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSS 244
+AKTFNI GN ICATG E++CF T +P A NNS +S+ + PK K ALA SS
Sbjct: 336 RINAKTFNIIGNPQICATGVEKNCFRTTSIP--SAPNNSQDSQSTKRPKSHKFALAFASS 393
Query: 245 LGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSK 304
L CI LLILG GFL+WWRQR+N+QIFFDVNEQ REEVCLGNLK+FHF+ELQ AT+NFSSK
Sbjct: 394 LSCICLLILGLGFLIWWRQRYNKQIFFDVNEQHREEVCLGNLKKFHFRELQLATNNFSSK 453
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
NL+GKGGFGNVYKGY+QDGTV+AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL GF
Sbjct: 454 NLIGKGGFGNVYKGYVQDGTVIAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLYGF 513
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
CMT TERLLVYPYMSNGSVASRLKAKP+LDWATRKRIALGA RGLLYLHEQCDPKIIHRD
Sbjct: 514 CMTATERLLVYPYMSNGSVASRLKAKPALDWATRKRIALGAGRGLLYLHEQCDPKIIHRD 573
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 484
VKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF
Sbjct: 574 VKAANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 633
Query: 485 GFGILLLELISGLRALEFGKTANQKGAMLDWV 516
GFGILLLELISG RALEFGK ANQKGAMLDWV
Sbjct: 634 GFGILLLELISGQRALEFGKAANQKGAMLDWV 665
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434692|ref|XP_004135130.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus] gi|449478323|ref|XP_004155284.1| PREDICTED: protein NSP-INTERACTING KINASE 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/509 (78%), Positives = 447/509 (87%), Gaps = 5/509 (0%)
Query: 11 VALFGLWT-CACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS 69
+ L LW GLL+ KGVNYEVQALM IK +L DPH VLN WDEN+VDPCSW+++TCS
Sbjct: 12 IFLLLLWNFSGNGLLTEKGVNYEVQALMAIKAALKDPHSVLN-WDENAVDPCSWSMITCS 70
Query: 70 -DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128
+ V LGAPSQNLSG+LS SIGNLTNLQ VLLQ+NNISG IP E+G + L TLDLS+
Sbjct: 71 SEKFVISLGAPSQNLSGSLSPSIGNLTNLQSVLLQDNNISGTIPMELGNIPSLDTLDLSS 130
Query: 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 188
N F G IP+++SHL++LQYLRLNNNSL+GAIP SL+NM+QLA LDLS+NNLSGP+P A
Sbjct: 131 NGFHGEIPTSLSHLKSLQYLRLNNNSLSGAIPSSLANMTQLALLDLSFNNLSGPLPRLLA 190
Query: 189 KTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCI 248
KT+N+ GNSLIC+ G+E C GTAP PL FA+N S NS+PSG KG K+ALA GSSLGC+
Sbjct: 191 KTYNLAGNSLICSPGSEHSCNGTAP-PLLFAVNTSQNSQPSGRSKGHKLALAFGSSLGCV 249
Query: 249 SLLILGFGFLLWWRQRHNQQIFFDVN-EQRREEVCLGNLKRFHFKELQSATSNFSSKNLV 307
LL +GFGF +WWRQRHNQQIFFDVN +QR EEVCLGNL+ F F+ELQ+AT+NFSSKNLV
Sbjct: 250 FLLTIGFGFFIWWRQRHNQQIFFDVNNDQRFEEVCLGNLRIFQFRELQAATNNFSSKNLV 309
Query: 308 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367
GKGGFGNVYKGYLQDGT++AVKRLKDGNA+ GEIQFQTEVEMISLAVHRNLLRL GFCMT
Sbjct: 310 GKGGFGNVYKGYLQDGTIIAVKRLKDGNAMRGEIQFQTEVEMISLAVHRNLLRLYGFCMT 369
Query: 368 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 427
TTERLLVYPYMSNGSVASRLKAKP+LDW+TRKRIALGAARGLLYLHEQCDPKIIHRDVKA
Sbjct: 370 TTERLLVYPYMSNGSVASRLKAKPALDWSTRKRIALGAARGLLYLHEQCDPKIIHRDVKA 429
Query: 428 ANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 487
ANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG+G
Sbjct: 430 ANILLDDYCEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGYG 489
Query: 488 ILLLELISGLRALEFGKTANQKGAMLDWV 516
ILLLELI+G RALEFGK NQKGAMLDWV
Sbjct: 490 ILLLELITGQRALEFGKAVNQKGAMLDWV 518
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584308|ref|XP_002532890.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223527350|gb|EEF29495.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2096), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/517 (77%), Positives = 445/517 (86%), Gaps = 1/517 (0%)
Query: 1 MRREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
M+R F F+ L + A GLLSPKGVN+EVQALMGIK SLHDPH VL+NWD ++VDP
Sbjct: 3 MKRRVVAFAFICLLWFCSTANGLLSPKGVNFEVQALMGIKASLHDPHGVLDNWDGDAVDP 62
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119
CSW +VTCS + LV GLG PSQNLSGTLS SIGNLTNLQ+VLLQNNNI+G IP E+G+L
Sbjct: 63 CSWTMVTCSPESLVIGLGTPSQNLSGTLSPSIGNLTNLQIVLLQNNNITGPIPAELGRLR 122
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
KL TLDLSNNFFTG +PS++ HL LQY+RLNNNSL+G P SL+NM+QL FLDLSYNNL
Sbjct: 123 KLQTLDLSNNFFTGDVPSSLGHLRNLQYMRLNNNSLSGIFPMSLANMTQLVFLDLSYNNL 182
Query: 180 SGPVPSFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIAL 239
SGPVP F AKTFNI GN LIC TG+E +CFGTA MP+S LN++ + PSG P+ KIAL
Sbjct: 183 SGPVPRFPAKTFNIVGNPLICPTGSEPECFGTALMPMSMNLNSTQTALPSGRPRNHKIAL 242
Query: 240 ALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATS 299
A GSS+G +S++IL GFLLWWRQR NQ FFDV ++ EEV LGNL+RF F+ELQ AT+
Sbjct: 243 AFGSSVGTVSIIILILGFLLWWRQRRNQPTFFDVKDRHHEEVSLGNLRRFQFRELQVATN 302
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
NFS+KN++GKGGFGNVYKG L DG++VAVKRLKDGNA GGEIQFQTEVEMISLAVHRNLL
Sbjct: 303 NFSNKNILGKGGFGNVYKGILHDGSIVAVKRLKDGNAAGGEIQFQTEVEMISLAVHRNLL 362
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
RL GFC+T+TERLLVYPYMSNGSVASRLK KP LDW TRKRIALGAARGLLYLHEQCDPK
Sbjct: 363 RLYGFCITSTERLLVYPYMSNGSVASRLKGKPVLDWGTRKRIALGAARGLLYLHEQCDPK 422
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IIHRDVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSE
Sbjct: 423 IIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSE 482
Query: 480 KTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
KTDVFGFGILLLELI+G RALEFGK ANQKGAMLDWV
Sbjct: 483 KTDVFGFGILLLELITGQRALEFGKAANQKGAMLDWV 519
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | ||||||
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.982 | 0.796 | 0.697 | 2.4e-186 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.974 | 0.797 | 0.604 | 1.5e-161 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.957 | 0.763 | 0.627 | 1.1e-160 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.945 | 0.771 | 0.631 | 5.9e-160 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.936 | 0.788 | 0.559 | 1.9e-138 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.986 | 0.816 | 0.526 | 1.2e-129 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.984 | 0.810 | 0.514 | 5.3e-127 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.953 | 0.795 | 0.516 | 7.4e-121 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.943 | 0.796 | 0.475 | 7.3e-114 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.781 | 0.672 | 0.519 | 3.1e-99 |
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1807 (641.2 bits), Expect = 2.4e-186, P = 2.4e-186
Identities = 358/513 (69%), Positives = 399/513 (77%)
Query: 8 FCFVALFGLWTCAC--GLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWAL 65
FCF+ L C+ GLLSPKGVN+EVQALM IK SLHDPH VL+NWD ++VDPCSW +
Sbjct: 16 FCFLGFLCL-LCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTM 74
Query: 66 VTCS-DGLVTGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTL 124
VTCS + V GLG PSQNLSGTLS SI I G IP EIG+L++L TL
Sbjct: 75 VTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETL 134
Query: 125 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
DLS+NFF G IP +V +L++LQYLRLNNNSL+G P SLSNM+QLAFLDLSYNNLSGPVP
Sbjct: 135 DLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP 194
Query: 185 SFHAKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXX 244
F AKTF+I GN LIC TG E DC GT +P+S LN + +G + K+
Sbjct: 195 RFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSS 254
Query: 245 XXXXXXXXXXXXXXXWWRQRHNQQIFFDVNE-QRREEVCLGNLKRFHFKELQSATSNFSS 303
WWRQRHNQ FFDV + EEV LGNL+RF F+ELQ AT+NFSS
Sbjct: 255 VGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSS 314
Query: 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
KNL+GKGG+GNVYKG L D TVVAVKRLKDG A+GGEIQFQTEVEMISLAVHRNLLRL G
Sbjct: 315 KNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYG 374
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
FC+T TE+LLVYPYMSNGSVASR+KAKP LDW+ RKRIA+GAARGL+YLHEQCDPKIIHR
Sbjct: 375 FCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHR 434
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
DVKAANILLD+Y EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV
Sbjct: 435 DVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 494
Query: 484 FGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
FGFGILLLEL++G RA EFGK ANQKG MLDWV
Sbjct: 495 FGFGILLLELVTGQRAFEFGKAANQKGVMLDWV 527
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1573 (558.8 bits), Expect = 1.5e-161, P = 1.5e-161
Identities = 309/511 (60%), Positives = 372/511 (72%)
Query: 10 FVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS 69
F+ + + LSP GVNYEV AL+ +K+ L+DP+ VL NWD NSVDPCSW +V+C+
Sbjct: 13 FLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT 72
Query: 70 DGLVTGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNN 129
DG V+ L PSQ+LSGTLS IG I+G IP IG+L KL +LDLSNN
Sbjct: 73 DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNN 132
Query: 130 FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK 189
FTG IP+++ L+ L YLRLNNNSL G P SLS + L +D+SYNNLSG +P A+
Sbjct: 133 SFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSAR 192
Query: 190 TFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXX 249
TF + GN+LIC A +C P PL+ + P+ + G +
Sbjct: 193 TFKVIGNALICGPKAVSNC-SAVPEPLTLP-QDGPDESGT-RTNGHHVALAFAASFSAAF 249
Query: 250 XXXXXXXXXXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGK 309
WWR R N+QIFFDVNEQ EV LG+LKR+ FKEL+SAT++F+SKN++G+
Sbjct: 250 FVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGR 309
Query: 310 GGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 369
GG+G VYKG+L DGT+VAVKRLKD N GGE+QFQTEVE ISLA+HRNLLRL GFC +
Sbjct: 310 GGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQ 369
Query: 370 ERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
ER+LVYPYM NGSVASRLK +P+LDW+ RK+IA+G ARGL+YLHEQCDPKIIHRDV
Sbjct: 370 ERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDV 429
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485
KAANILLDE +EAVVGDFGLAKLLDH DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG
Sbjct: 430 KAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 489
Query: 486 FGILLLELISGLRALEFGKTANQKGAMLDWV 516
FGILLLELI+G +AL+FG++A+QKG MLDWV
Sbjct: 490 FGILLLELITGQKALDFGRSAHQKGVMLDWV 520
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1565 (556.0 bits), Expect = 1.1e-160, P = 1.1e-160
Identities = 317/505 (62%), Positives = 377/505 (74%)
Query: 16 LWTCACGL-LSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS-DGLV 73
L+ C L LS + N EV+AL+ I+++LHDPH LNNWDE SVDPCSWA++TCS D LV
Sbjct: 20 LFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPDNLV 79
Query: 74 TGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTG 133
GLGAPSQ+LSG LS SIG ISG IP E+G L KL TLDLSNN F+G
Sbjct: 80 IGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNRFSG 139
Query: 134 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNI 193
IP ++ L +LQYLRLNNNSL+G P SLS + L+FLDLSYNNLSGPVP F A+TFN+
Sbjct: 140 DIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPARTFNV 199
Query: 194 TGNSLICATGAEEDCFGTA-PMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXX 252
GN LIC + E C G+ PLS +L++S SG + ++
Sbjct: 200 AGNPLICRSNPPEICSGSINASPLSVSLSSS-----SGR-RSNRLAIALSVSLGSVVILV 253
Query: 253 XXXXXXXWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSSKNLVGKGG 311
W+R++ + + ++N+++ E + LGNL+ F F+EL T FSSKN++G GG
Sbjct: 254 LALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGG 313
Query: 312 FGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371
FGNVY+G L DGT+VAVKRLKD N G+ QF+ E+EMISLAVH+NLLRLIG+C T+ ER
Sbjct: 314 FGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGER 373
Query: 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 431
LLVYPYM NGSVAS+LK+KP+LDW RKRIA+GAARGLLYLHEQCDPKIIHRDVKAANIL
Sbjct: 374 LLVYPYMPNGSVASKLKSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANIL 433
Query: 432 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 491
LDE +EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL
Sbjct: 434 LDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 493
Query: 492 ELISGLRALEFGKTANQKGAMLDWV 516
ELI+GLRALEFGKT +QKGAML+WV
Sbjct: 494 ELITGLRALEFGKTVSQKGAMLEWV 518
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1558 (553.5 bits), Expect = 5.9e-160, P = 5.9e-160
Identities = 317/502 (63%), Positives = 371/502 (73%)
Query: 18 TCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS-DGLVTGL 76
TC+ LS + N EV+AL+ IK+ LHDPH V NWDE SVDPCSW +++CS D LV GL
Sbjct: 23 TCS---LSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSDNLVIGL 79
Query: 77 GAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIP 136
GAPSQ+LSGTLS SIG ISG IP EI L KL TLDLSNN F+G IP
Sbjct: 80 GAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNRFSGEIP 139
Query: 137 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGN 196
+V+ L LQYLRLNNNSL+G P SLS + L+FLDLSYNNL GPVP F A+TFN+ GN
Sbjct: 140 GSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKFPARTFNVAGN 199
Query: 197 SLICATGAEEDCFGT-APMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXX 255
LIC E C G+ + PLS +L +S SG + I
Sbjct: 200 PLICKNSLPEICSGSISASPLSVSLRSS-----SG--RRTNILAVALGVSLGFAVSVILS 252
Query: 256 XXXXWWRQRHNQQIFFDVNEQRREEVC-LGNLKRFHFKELQSATSNFSSKNLVGKGGFGN 314
W+R++ + +++++ E + LGNL+ F F+EL AT FSSK+++G GGFGN
Sbjct: 253 LGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGN 312
Query: 315 VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374
VY+G DGTVVAVKRLKD N G QF+TE+EMISLAVHRNLLRLIG+C +++ERLLV
Sbjct: 313 VYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLV 372
Query: 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 434
YPYMSNGSVASRLKAKP+LDW TRK+IA+GAARGL YLHEQCDPKIIHRDVKAANILLDE
Sbjct: 373 YPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDE 432
Query: 435 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 494
Y+EAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI
Sbjct: 433 YFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 492
Query: 495 SGLRALEFGKTANQKGAMLDWV 516
+G+RALEFGK+ +QKGAML+WV
Sbjct: 493 TGMRALEFGKSVSQKGAMLEWV 514
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
Identities = 279/499 (55%), Positives = 347/499 (69%)
Query: 23 LLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCS-DGLVTGLGAPSQ 81
LLSPKGVNYEV ALM +K+ + D +VL+ WD NSVDPC+W +V CS +G V L S+
Sbjct: 30 LLSPKGVNYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSSEGFVVSLEMASK 89
Query: 82 NLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
LSG LS+SIG ++G IP+E+G+LS+L TLDLS N F+G IP+++
Sbjct: 90 GLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGF 149
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICA 201
L L YLRL+ N L+G +P ++ +S L+FLDLS+NNLSGP P+ AK + I GN+ +C
Sbjct: 150 LTHLNYLRLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISAKDYRIVGNAFLCG 209
Query: 202 TGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWW 261
++E C P+ + L+ NSK + + W
Sbjct: 210 PASQELCSDATPVRNATGLSEKDNSKHHSLV----LSFAFGIVVAFIISLMFLFFWVLWH 265
Query: 262 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQ 321
R R ++ + Q+ E +G+LKRF F+E+Q+ATSNFS KN++G+GGFG VYKGYL
Sbjct: 266 RSRLSRS-----HVQQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLP 320
Query: 322 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381
+GTVVAVKRLKD GE+QFQTEVEMI LAVHRNLLRL GFCMT ER+LVYPYM NG
Sbjct: 321 NGTVVAVKRLKDP-IYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNG 379
Query: 382 SVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437
SVA RL+ KPSLDW R IALGAARGL+YLHEQC+PKIIHRDVKAANILLDE +E
Sbjct: 380 SVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFE 439
Query: 438 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
A+VGDFGLAKLLD DSHVTTAVRGT+GHIAPEYLSTGQSSEKTDVFGFG+L+LELI+G
Sbjct: 440 AIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELITGH 499
Query: 498 RALEFGKTANQKGAMLDWV 516
+ ++ G +KG +L WV
Sbjct: 500 KMIDQGNGQVRKGMILSWV 518
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
Identities = 278/528 (52%), Positives = 342/528 (64%)
Query: 1 MRREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDP 60
M VF ++L L + L S N E AL ++ +L DP++VL +WD V+P
Sbjct: 1 MESSYVVFILLSLILLPNHSLWLAS---ANLEGDALHTLRVTLVDPNNVLQSWDPTLVNP 57
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLS 119
C+W VTC+ + V + + LSG L +G I+G IP+ +G L+
Sbjct: 58 CTWFHVTCNNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLT 117
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
L++LDL N F+GPIP ++ L L++LRLNNNSLTG+IP SL+N++ L LDLS N L
Sbjct: 118 NLVSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRL 177
Query: 180 SGPVP---SFHAKT-FNITGNSLICATGAEEDCFGTAPM--PLSFALNNSPNSKPSGMPK 233
SG VP SF T + N +C C G+ P P F + P S PSG
Sbjct: 178 SGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPF-IQPPPVSTPSGY-- 234
Query: 234 GQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKE 293
G WWR+R IFFDV + EV LG LKRF +E
Sbjct: 235 GITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRE 294
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
LQ A+ FS+KN++G+GGFG VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+A
Sbjct: 295 LQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMA 354
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGL 409
VHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ ++P LDW TRKRIALG+ARGL
Sbjct: 355 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGL 414
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469
YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLAKL+D+ D+HVTTAVRGT+GHIAP
Sbjct: 415 SYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 474
Query: 470 EYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWV 516
EYLSTG+SSEKTDVFG+GI+LLELI+G RA + + AN ML DWV
Sbjct: 475 EYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 522
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1247 (444.0 bits), Expect = 5.3e-127, P = 5.3e-127
Identities = 272/529 (51%), Positives = 339/529 (64%)
Query: 2 RREEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPC 61
R++ F FV L L L N E AL ++ +L DP++VL +WD V+PC
Sbjct: 3 RKKFEAFGFVCLISLLLLFNSLWLASS-NMEGDALHSLRANLVDPNNVLQSWDPTLVNPC 61
Query: 62 SWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSK 120
+W VTC+ + V + + +LSG L +G I+G +P+++G L+
Sbjct: 62 TWFHVTCNNENSVIRVDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTN 121
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L++LDL N FTGPIP ++ L L++LRLNNNSLTG IP SL+N+ L LDLS N LS
Sbjct: 122 LVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLS 181
Query: 181 GPVP---SFHAKT-FNITGNSLICATGAEEDCFGTAPM--PLSFALNNSPNSKPSGMPKG 234
G VP SF T + N +C C G+ P P F P P+ P G
Sbjct: 182 GSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPPPPFI---PPPIVPT--PGG 236
Query: 235 QKIXXXXXXXXXXXXXXXXXX--XXXXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFK 292
WWR+R Q+ FFDV + EV LG LKRF +
Sbjct: 237 YSATGAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLR 296
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
ELQ AT +FS+KN++G+GGFG VYKG L DGT+VAVKRLK+ GGE+QFQTEVEMIS+
Sbjct: 297 ELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISM 356
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----LDWATRKRIALGAARG 408
AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +P L W+ R++IALG+ARG
Sbjct: 357 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARG 416
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
L YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGLA+L+D+ D+HVTTAVRGT+GHIA
Sbjct: 417 LSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIA 476
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWV 516
PEYLSTG+SSEKTDVFG+GI+LLELI+G RA + + AN ML DWV
Sbjct: 477 PEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 525
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
Identities = 272/527 (51%), Positives = 337/527 (63%)
Query: 4 EEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLH--DP-HDVLNNWDENSVDP 60
+ ++ CF+ L L+ L G N E AL +K+SL DP ++VL +WD V P
Sbjct: 8 QRSLLCFLYLLLLFNFT---LRVAG-NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTP 63
Query: 61 CSWALVTCS-DGLVTGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLS 119
C+W VTC+ + VT + + LSG L +G I+G IP E+G L
Sbjct: 64 CTWFHVTCNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLV 123
Query: 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
+L++LDL N +GPIPS++ L L++LRLNNNSL+G IP +L+++ QL LD+S N L
Sbjct: 124 ELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRL 182
Query: 180 SGPVP---SFHAKT-FNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQ 235
SG +P SF T + NSL T E P P S + P PSG GQ
Sbjct: 183 SGDIPVNGSFSLFTPISFANNSL---TDLPE------PPPTSTSPTPPP---PSG---GQ 227
Query: 236 KIXXXXXXXXXXXXXXXXX-XXXXXWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKEL 294
WW +R Q FFDV + EV LG LKRF +EL
Sbjct: 228 MTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLREL 287
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
AT NFS+KN++G+GGFG VYKG L DG +VAVKRLK+ GGE+QFQTEVEMIS+AV
Sbjct: 288 LVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAV 347
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLL 410
HRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +P +LDW RK IALG+ARGL
Sbjct: 348 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLA 407
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
YLH+ CD KIIHRDVKAANILLDE +EAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPE
Sbjct: 408 YLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPE 467
Query: 471 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWV 516
YLSTG+SSEKTDVFG+G++LLELI+G +A + + AN ML DWV
Sbjct: 468 YLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 514
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
Identities = 248/522 (47%), Positives = 322/522 (61%)
Query: 4 EEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSW 63
++ F LF + C C +SP + AL ++ SL + L++W++N V+PC+W
Sbjct: 7 QKMAMAFTLLF--FACLCSFVSPDA---QGDALFALRISLRALPNQLSDWNQNQVNPCTW 61
Query: 64 ALVTCSD-GLVTGLGAPSQNLSGTLSSSIGXXXXXXXXXXXXXXISGHIPTEIGKLSKLL 122
+ V C D VT L N SGTLSS +G I+G IP + G L+ L
Sbjct: 62 SQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLT 121
Query: 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182
+LDL +N TG IPST+ +L+ LQ+L L+ N L G IP SL+ + L L L N+LSG
Sbjct: 122 SLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQ 181
Query: 183 VPS--FHAKTFNITGNSLICATGAEEDCFGTAPMP-LSFALNNSPNSKP-SGMPKGQKIX 238
+P F +N T N+L +C G P P +S ++ +SKP +G+ G
Sbjct: 182 IPQSLFEIPKYNFTSNNL--------NCGGRQPHPCVSAVAHSGDSSKPKTGIIAG---- 229
Query: 239 XXXXXXXXXXXXXXXXXXXXXWWRQRHN---QQIFFDVNEQRREEVCLGNLKRFHFKELQ 295
+ + RH + +F DV + + G LKRF ++ELQ
Sbjct: 230 -----VVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQ 284
Query: 296 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 355
AT NFS KN++G+GGFG VYKG L D T VAVKRL D + GG+ FQ EVEMIS+AVH
Sbjct: 285 LATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 344
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLY 411
RNLLRLIGFC T TERLLVYP+M N S+A RL+ P LDW TRKRIALGAARG Y
Sbjct: 345 RNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEY 404
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
LHE C+PKIIHRDVKAAN+LLDE +EAVVGDFGLAKL+D ++VTT VRGT+GHIAPEY
Sbjct: 405 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEY 464
Query: 472 LSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 513
LSTG+SSE+TDVFG+GI+LLEL++G RA++F + + +L
Sbjct: 465 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 506
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 218/420 (51%), Positives = 268/420 (63%)
Query: 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
+SG + ++ +L L L+L NN TG IP + L L L L N+++G IP SL +
Sbjct: 82 LSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKL 141
Query: 167 SQLAFLDLSYNNLSGPVP-SFHAKTFNIT--GNSLICATGAEEDCFGTAPMPLSFALNN- 222
+L FL L N+LSG +P S A ++ N+ + F +SFA N
Sbjct: 142 GKLRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGSFSQFTS-MSFANNKL 200
Query: 223 SPN-SKPSGMPKGQKIXXXXXXXXXXXXXXXXXXXXXXWWRQRHNQQIFFDVNEQRREEV 281
P + PS P G WW +R Q F DV + EV
Sbjct: 201 RPRPASPSPSPSG-----TSAAIVVGVAAGAALLFALAWWLRRKLQGHFLDVPAEEDPEV 255
Query: 282 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI 341
LG KRF +EL AT FS +N++GKG FG +YKG L D T+VAVKRL + GGE+
Sbjct: 256 YLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGEL 315
Query: 342 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP----SLDWAT 397
QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L+ +P +LDW
Sbjct: 316 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPK 375
Query: 398 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457
RK IALG+ARGL YLH+ CD KIIH DVKAANILLDE +EAVVGDFGLAKL+++ DSHVT
Sbjct: 376 RKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVT 435
Query: 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML-DWV 516
TAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G +A + + AN ML DWV
Sbjct: 436 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 495
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RY65 | NIK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7793 | 0.9535 | 0.7763 | yes | no |
| Q9LFS4 | NIK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7321 | 0.9980 | 0.8087 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 517 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-47
Identities = 67/191 (35%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+GGFG VY + G VA+K +K ++ + E+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
LV Y GS+ LK L RI L GL YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 425 VKAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTD 482
+K NILLD + + DFGL+KLL D + + GT ++APE L SEK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 483 VFGFGILLLEL 493
++ G++L EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-44
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 6/197 (3%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+ +G+G FG VY + G +VA+K +K + E++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
RL + LV Y G + LK + L + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
I+HRD+K NILLDE + DFGLA+ LD +TT V GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 480 KTDVFGFGILLLELISG 496
D++ G++L EL++G
Sbjct: 176 AVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 1e-43
Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 308 GKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G+G FG VYKG L+ VAVK LK+ + +F E ++ H N+++L+
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G C +V YM G + S L+ +P L + AL ARG+ YL + I
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFI 124
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
HRD+ A N L+ E + DFGL++ L D + + + +APE L G+ + K+
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKS 184
Query: 482 DVFGFGILLLELIS 495
DV+ FG+LL E+ +
Sbjct: 185 DVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 72/193 (37%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRL-KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G G FG VYK + G +VAVK L K + + E+ ++ H N++RLI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
LV Y G + L L K+IAL RGL YLH IIHRD
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRD 123
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDV 483
+K NILLDE + DFGLAK L S T GT ++APE L G K DV
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 484 FGFGILLLELISG 496
+ G++L EL++G
Sbjct: 183 WSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 308 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G+G FG VYKG L+ VAVK LK+ + +F E ++ H N+++L+
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G C ++V YM G + L+ L + AL ARG+ YL +
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NF 124
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
IHRD+ A N L+ E + DFGL++ L D + + + +APE L G+ + K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184
Query: 481 TDVFGFGILLLELIS 495
+DV+ FG+LL E+ +
Sbjct: 185 SDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 305 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G FG VYKG L+ T VAVK LK+ + F E M L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKA---------KPSLDWATRKRIALGAARGLL 410
RL+G C LV YM G + L+ K +L A+ A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI--- 467
YL + K +HRD+ A N L+ E + DFGL++ + D + G I
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWM 174
Query: 468 APEYLSTGQSSEKTDVFGFGILLLELIS 495
APE L G + K+DV+ FG+LL E+ +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 308 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G+G FG VYKG L T VAVK LK+G + +F E ++ H N++RL+
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G C +V YM G + L+ L ++AL A+G+ YL + +
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---NFV 124
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 476
HRD+ A N L+ E + DFGL++ + D + ++ APE L G+
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESLKDGK 180
Query: 477 SSEKTDVFGFGILLLELISG 496
+ K+DV+ FG+LL E+ +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 8e-40
Identities = 127/436 (29%), Positives = 213/436 (48%), Gaps = 45/436 (10%)
Query: 82 NLSGTLSSSIG--NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
G L S G L NL L N SG +P ++G LS+L+ L LS N +G IP +
Sbjct: 463 KFFGGLPDSFGSKRLENLDL---SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITG-NSL 198
S + L L L++N L+G IP S S M L+ LDLS N LSG +P N+ SL
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK------NLGNVESL 573
Query: 199 ICATGAEEDCFGTAPMPLSF-ALNNSP---------NSKPSGMPKGQKIA------LALG 242
+ + G+ P +F A+N S SG+P +++ +
Sbjct: 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633
Query: 243 SSLGC-ISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNF 301
+LG + L ++ FGF ++ R R+N ++ NE E+ + K + S+
Sbjct: 634 CTLGAFLVLALVAFGF-VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692
Query: 302 SSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+N++ +G G YKG +++G VK + D N+I +E+ + H N+++
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVK 747
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
LIG C + L++ Y+ +++ L+ +L W R++IA+G A+ L +LH +C P +
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
+ ++ I++D E + L LL C T + ++APE T +EK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL-RLSLPGLL--C---TDTKCFISSAYVAPETRETKDITEK 858
Query: 481 TDVFGFGILLLELISG 496
+D++GFG++L+EL++G
Sbjct: 859 SDIYGFGLILIELLTG 874
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 305 NLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLI 362
L+G+G FG+VY +D G ++AVK ++ E+ + E+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 363 GFCMTTTER-LLVY-PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G + L ++ Y+S GS++S LK L ++ GL YLH I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GI 122
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
+HRD+K ANIL+D + DFG AK L D T +VRGT +APE + +
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 480 KTDVFGFGILLLELISG 496
D++ G ++E+ +G
Sbjct: 183 AADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 68/199 (34%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKD-GNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+GKG FG+V G + G VAVK LKD A F E +++ H NL++L+
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66
Query: 363 GFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G + +V YM+ GS+ R + + + A + AL G+ YL E+
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
+HRD+ A N+L+ E A V DFGLAK + + + V APE L + S K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQ--DSGKLPVKWTAPEALREKKFSTK 179
Query: 481 TDVFGFGILLLELISGLRA 499
+DV+ FGILL E+ S R
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 8e-30
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 301 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAV 354
F +GKGGFG VYK + + G VA+K +K I EIQ + +
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------ 55
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 413
H N+++ G + E +V + S GS+ LK+ +L + + +GL YLH
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYL 472
IIHRD+KAANILL E + DFGL+ L D + GT +APE +
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI 169
Query: 473 STGQSSEKTDVFGFGILLLELISG 496
+ K D++ GI +EL G
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 6/199 (3%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 357
N+ +L+G+G FG VYKG L+ G VA+K++ ++ E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 417
+++ IG T+ ++ Y NGS+ +K + +GL YLHEQ
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
+IHRD+KAANIL + + DFG+A L+ S +V GT +APE + +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 478 SEKTDVFGFGILLLELISG 496
S +D++ G ++EL++G
Sbjct: 177 STASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-27
Identities = 64/156 (41%), Positives = 93/156 (59%), Gaps = 7/156 (4%)
Query: 32 EVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSD-GLVTGLGAPSQNLSGTLSSS 90
E++ L+ K S++DP L+NW+ +S D C W +TC++ V + +N+SG +SS+
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 91 IGNLTNLQLVLLQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPIPS-TVSHLETLQYL 148
I L +Q + L NN +SG IP +I S L L+LSNN FTG IP ++ +LETL
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLD-- 146
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
L+NN L+G IP + + S L LDL N L G +P
Sbjct: 147 -LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 7/199 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
F+ + +G G FG V++G ++ VA+K LK + + + FQ EV+ + H++L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHL 64
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQC 416
+ L C ++ M GS+ + L++ L A+ +A A G+ YL EQ
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
IHRD+ A NIL+ E V DFGLA+L+ D ++++ + APE S G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASHGT 180
Query: 477 SSEKTDVFGFGILLLELIS 495
S K+DV+ FGILL E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 306 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+GKG FG+VYKG L+ T VAVK + + +F E E++ H N+++LIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 366 MTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
+ +V + GS+ + L K K L +++L AA G+ YL + IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT----VGHIAPEYLSTGQSSEK 480
+ A N L+ E + DFG+++ + + T G + APE L+ G+ + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 481 TDVFGFGILLLELISG 496
+DV+ +GILL E S
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 305 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++GKG FG VY G L D AVK L + QF E ++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 361 LIGFCMTTT-ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG--AARGLLYLHEQCD 417
L+G C+ + L+V PYM +G + + ++ + + + I G A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYLASK-- 117
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLD--HCDSHVTTAVRGTVGHIAPEYLST 474
K +HRD+ A N +LDE + V DFGLA+ + D + H T + V +A E L T
Sbjct: 118 -KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 475 GQSSEKTDVFGFGILLLELIS 495
+ + K+DV+ FG+LL EL++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 20/233 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI--QFQTEVE-MISLAVHR 356
++ +G+G FG VY D +VA+K L + +F E++ + SL
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLH 413
N+++L F LV Y+ GS+ LK L + I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 414 EQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSHV-----TTAVRGTVGHI 467
+ IIHRD+K NILLD + DFGLAKLL S + GT G++
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 468 APEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVS 517
APE L S +S +D++ GI L EL++GL E K ++ L +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228
|
Length = 384 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 72/246 (29%), Positives = 104/246 (42%), Gaps = 56/246 (22%)
Query: 32 EVQALMGIKDSLHDPHDVLNNWDENSVDPCS-----WALVTC------SDGLVTGLGAPS 80
EV AL +K SL P W+ DPC W+ C + GLG +
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
Q L G + + I L +LQ + L N+I G+IP +G ++ L LDLS N F G IP ++
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 200
L +L+ L LN NSL+G +P +L G H +FN T N+ +C
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAAL-----------------GGRL-LHRASFNFTDNAGLC 529
Query: 201 ATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGFLLW 260
C + G KI +A G S+ + L+I + W
Sbjct: 530 GIPGLRAC-------------------GPHLSVGAKIGIAFGVSVAFLFLVICA---MCW 567
Query: 261 WRQRHN 266
W++R N
Sbjct: 568 WKRRQN 573
|
Length = 623 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 69/194 (35%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 306 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
L+GKG FG V+KG L+D T VAVK K+ +I+F +E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 366 MTTTERLLVYPYM---SNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
T+R +Y M G S L K K L + AL AA G+ YL + I
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
HRD+ A N L+ E + DFG+++ D + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 482 DVFGFGILLLELIS 495
DV+ +GILL E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 305 NLVGKGGFGNVYKGY---LQDGT--VVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHR 356
+G+G FG V L D T VAVK L N G E F+ E+E++ H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 357 NLLRLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLH 413
N+++ G C R L+ Y+ +GS+ L + + ++ + +G+ YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEY 471
Q + IHRD+ A NIL++ + DFGLAK+L + G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 472 LSTGQSSEKTDVFGFGILLLELIS 495
L T + S +DV+ FG+ L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY T VA+K LK G+ F E ++ H L+RL + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 367 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 423
T E + ++ YM NGS+ LK + K I + A A G+ ++ + IHR
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D++AANIL+ E + DFGLA+L++ + + + APE ++ G + K+DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 484 FGFGILLLELIS 495
+ FGILL E+++
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 65/193 (33%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 308 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367
G G FG V+ G T VAVK LK G F E +++ H L++L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 368 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRDV 425
+V YMS GS+ LK+ + + + A A G+ YL + IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSSEKTD 482
A NIL+ E + DFGLA+L++ D TA G + APE + G+ + K+D
Sbjct: 130 AARNILVGENLVCKIADFGLARLIE--DDEY-TAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 483 VFGFGILLLELIS 495
V+ FGILL E+++
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ GY + VA+K +++G E F E +++ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 367 TTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+ LV+ +M +G ++ L+A+ T + L G+ YL +IHRD+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485
A N L+ E V DFG+ + + +T + V +PE S + S K+DV+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 486 FGILLLELIS 495
FG+L+ E+ S
Sbjct: 187 FGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 305 NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G G FG V +G L+ VA+K LK G++ + F TE ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPK 419
L G + +++ YM NGS+ L+ + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLST 474
+HRD+ A NIL++ V DFGL++ L+ ++ TT +R T APE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 475 GQSSEKTDVFGFGILLLELIS 495
+ + +DV+ FGI++ E++S
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 50/113 (44%), Positives = 70/113 (61%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
NL+G + SS+GNL NLQ + L N +SG IP I L KL++LDLS+N +G IP V
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 194
L+ L+ L L +N+ TG IP +L+++ +L L L N SG +P K N+T
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 51/114 (44%), Positives = 72/114 (63%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S L G + +G + +L+ + L NN+SG IP EIG L+ L LDL N TGPIPS++
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNI 193
+L+ LQYL L N L+G IPPS+ ++ +L LDLS N+LSG +P + N+
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 2e-22
Identities = 63/198 (31%), Positives = 87/198 (43%), Gaps = 15/198 (7%)
Query: 307 VGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLR 360
+GKG FG V K G + A+K LK I TE ++S H +++
Sbjct: 1 LGKGSFGKVLLVRKK---DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 361 LIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
L + T E+L LV Y G + S L + + A L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---G 113
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
II+RD+K NILLD + DFGLAK L S T GT ++APE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 480 KTDVFGFGILLLELISGL 497
D + G+LL E+++G
Sbjct: 173 AVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG V+ GY + T VAVK LK G +Q F E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 423
++ YM+ GS+ LK+ K I A A G+ Y+ + IHR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D++AAN+L+ E + DFGLA++++ + + + APE ++ G + K+DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 484 FGFGILLLELIS 495
+ FGILL E+++
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGYLQ--DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+G G FG+V KG G VAVK LK + G+ +F E +++ H ++RLI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
G C +LV G + LK + + + K +A A G+ YL + +H
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVH 118
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTGQSSEK 480
RD+ A N+LL ++A + DFG+++ L + TTA R + APE ++ G+ S K
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 481 TDVFGFGILLLELIS 495
+DV+ +G+ L E S
Sbjct: 179 SDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 301 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR--LKDGNAIGGEIQF-QTEVEMISLAVHR 356
F+ +GKG FG VYK + VVA+K L++ EI+ Q E++ +S
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED---EIEDIQQEIQFLSQCRSP 59
Query: 357 NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
+ + G +L ++ Y GS LK LD I GL YLHE+
Sbjct: 60 YITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEE 117
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
IHRD+KAANILL E + + DFG++ L S T V GT +APE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 476 QSSEKTDVFGFGILLLELISG 496
EK D++ GI +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 360
N +G G FG VY L G ++AVK R++D + EI E++++ L H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA--DEMKVLELLKHPNLVK 63
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G + + + Y S G++ L+ LD + L GL YLH I
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------GTVGHIAPEYLST 474
+HRD+K ANI LD +GDFG A L ++ TT GT ++APE ++
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 475 GQSSEK---TDVFGFGILLLELISGLR 498
G+ D++ G ++LE+ +G R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 306 LVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGE-IQFQTEVEMI-SLAVHRN 357
+G+G FG V K + VAVK LKD +A + +E+EM+ + H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--------KPSLDWATRKRI-------- 401
++ L+G C +V Y ++G++ L+A P + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 460
A ARG+ +L + K IHRD+ A N+L+ E + + DFGLA+ + H D + TT
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R V +APE L + ++DV+ FG+LL E+ +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 308 GKGGFGNVYKGY-LQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G G FG VYKG + +G VA+K L++ + + E +++ H +++RL+
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 363 GFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
G C+++ L+ M G + + ++ L+W + A+G+ YL E+
Sbjct: 76 GICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLST 474
+++HRD+ A N+L+ + DFGLAKLLD + + + +A E +
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 475 GQSSEKTDVFGFGILLLELISGLRALEFGK 504
+ K+DV+ +G+ + EL + FG
Sbjct: 186 RIYTHKSDVWSYGVTVWEL------MTFGA 209
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 59/191 (30%), Positives = 88/191 (46%), Gaps = 7/191 (3%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V++G + T VAVK LK G F E +++ H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 367 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHRD 424
+V M GS+ L+ + I + A A G+ YL Q IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 484
+ A N+L+ E V DFGLA+++ + + APE + S K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 485 GFGILLLELIS 495
FGILL E+++
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 308 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG-FC 365
G+G G VYK + G + A+K++ Q E++ + +++ G F
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+ V YM GS+A LK + IA +GL YLH IIHRD+
Sbjct: 70 KEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDI 126
Query: 426 KAANILLDEYYEAVVGDFGLAKLL----DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
K +N+L++ E + DFG++K+L D C++ V GTV +++PE + S
Sbjct: 127 KPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGESYSYAA 181
Query: 482 DVFGFGILLLELISG 496
D++ G+ LLE G
Sbjct: 182 DIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 5e-21
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 304 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRL 361
+GKG FG VY DG + +K + N E + EV+++ H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------LDWATRKRIALGAARGLLY 411
+ +V Y G ++ ++K + LDW + + L L Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKY 118
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
LH + KI+HRD+K NI L +GDFG++K+L T V GT +++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173
Query: 472 LSTGQS-SEKTDVFGFGILLLEL 493
L + + K+D++ G +L EL
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYEL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 301 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 358
F +G+G +G+VYK + + G VVA+K + + ++Q E+ ++ +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYI 60
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 417
++ G T+ +V Y GSV+ +K +L I +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN-- 118
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV-G---HIAPEYLS 473
K IHRD+KA NILL+E +A + DFG++ L T A R TV G +APE +
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEVIQ 172
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
+ K D++ GI +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 7/206 (3%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G FG V+ G L+ D T VAVK ++ + +F E ++ H N++RLIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 366 MTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
+V + G + L+ + P L ++ AA G+ YL + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGHIAPEYLSTGQSSEKTDV 483
+ A N L+ E + DFG+++ + T ++ V APE L+ G+ S ++DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 484 FGFGILLLELISGLRALEFGKTANQK 509
+ FGILL E S L A+ + +NQ+
Sbjct: 180 WSFGILLWEAFS-LGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++ + K+ +G G +G VY+G + VAVK LK+ E F E ++ H N
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 63
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQ 415
L++L+G C ++ +M+ G++ L+ + ++ +A + + YL ++
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVGHIAPEYLST 474
IHRD+ A N L+ E + V DFGL++L+ D++ A + + APE L+
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAY 179
Query: 475 GQSSEKTDVFGFGILLLEL 493
+ S K+DV+ FG+LL E+
Sbjct: 180 NKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRL--------KDGNAIGGEIQ-FQTEVEMISLAVH 355
L+GKG +G VY + G ++AVK++ + + ++ ++E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
N+++ +GF T + Y+ GS+ S L+ + + GL YLH +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLST 474
I+HRD+KA N+L+D + DFG++K D D+ +++G+V +APE + +
Sbjct: 128 ---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 475 GQS--SEKTDVFGFGILLLELISGLR 498
S K D++ G ++LE+ +G R
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 58/205 (28%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
S+ + + ++G G FG V++G L+ VA+K LK G F +E ++
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYL 412
H N++RL G +++ YM NG++ L+ ++++ + + + G A G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYL 123
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 470
D +HRD+ A NIL++ E V DFGL+++L D ++ T+ + + APE
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 471 YLSTGQSSEKTDVFGFGILLLELIS 495
++ + + +DV+ FGI++ E++S
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 62/199 (31%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLIGF 364
+G G VY L + VA+KR+ D + + EV+ +S H N+++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKII 421
+ E LV PY+S GS+ +K+ IA +GL YLH I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQI 124
Query: 422 HRDVKAANILLDEYYEAVVGDFGL-AKLLDH--CDSHVTTAVRGTVGHIAPEYLSTGQS- 477
HRD+KA NILL E + DFG+ A L D V GT +APE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 478 SEKTDVFGFGILLLELISG 496
K D++ FGI +EL +G
Sbjct: 185 DFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEI--QFQTEVEMISLAVHRNLLR 360
L+G G FG+VY+G L DG AVK L D G E Q + E+ ++S H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 361 LIGFCMTTTERLLVY-PYMSNGSVASRLKAKPSLDWA-----TRKRIALGAARGLLYLHE 414
+G + L ++ + GS+A LK S TR+ + GL YLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-----AVRGTVGHIAP 469
+ +HRD+K ANIL+D + DFG+AK V + +G+ +AP
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAP 170
Query: 470 EYL-STGQSSEKTDVFGFGILLLELISG 496
E + G D++ G +LE+ +G
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRL---KDGNAIGGEI-QFQTEVEMISLAV 354
N+ L+G+G FG VY Y D G +AVK++ D E+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 355 HRNLLRLIGFCMTTTERLLVY-PYMSNGSVASRLKAKPSL-DWATRK--RIALGAARGLL 410
H +++ G C+ E L ++ YM GSV +LKA +L + TRK R L G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EGVE 118
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIA 468
YLH I+HRD+K ANIL D +GDFG +K L S T +V GT ++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELIS 495
PE +S K DV+ G ++E+++
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 307 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V+ G D +VAVK LK+ + F+ E E+++ H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKR-------------IALGAA 406
G C ++V+ YM +G + L++ P + IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--- 463
G++YL Q +HRD+ N L+ +GDFG+++ + D + V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTML 186
Query: 464 -VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504
+ + PE + + + ++DV+ FG++L E+ + +GK
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------YGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 306 LVGKGGFGNVYKGYL-QDGTV---VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLR 360
++G+G FG+V +G L QD VAVK +K EI+ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 361 LIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIALGAARG 408
LIG C + +++ P+M +G + SRL P L T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHI 467
+ YL + IHRD+ A N +L E V DFGL+K + D + + V I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 468 APEYLSTGQSSEKTDVFGFGILLLELIS 495
A E L+ + K+DV+ FG+ + E+ +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKR--LKDGNAIGGEIQF---QTEVEMISLAVHRNLL 359
++GKG +G VY G G ++AVK+ L N + E ++ Q EV+++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+ +G C+ + ++ GS++S L L + G+ YLH C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-----TAVRGTVGHIAPEYLST 474
++HRD+K N++L + DFG A+ L H T ++ GT +APE ++
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 475 GQSSEKTDVFGFGILLLELISG 496
K+D++ G + E+ +G
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ G + VA+K +++G E F E +++ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 367 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA----RGLLYLHEQCDPKIIH 422
+V YM+NG + + L+ + L + YL IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 423 RDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSS 478
RD+ A N L+ E V DFGLA+ +LD D + T+ +GT V PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 479 EKTDVFGFGILLLELISG 496
K+DV+ FG+L+ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLK------DGNAIGGEIQFQTEVEMISLAVHRNL 358
L+G+G +G VY+G + G VVA+K + D + I E+ ++ + + N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHE 414
+ G + ++ Y GSV + +KA P K I++ R +L Y+H+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISV-IIREVLVALKYIHK 119
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+IHRD+KAANIL+ + DFG+A LL+ S +T V GT +APE ++
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 475 GQSSE-KTDVFGFGILLLELISG 496
G+ + K D++ GI + E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 305 NLVGKGGFGNVYKGYLQD----GT---VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
N +G G FG VY+G D G+ VAVK L+ G + +F E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLL 410
+++L+G C+ + ++ M G + S L+ P L I L A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 411 YLHEQCDPKIIHRDVKAANILLDEY-YEA----VVGDFGLAKLLDHCDSHVTTAVRG--- 462
YL IHRD+ A N L+ E Y+A +GDFGLA+ + D + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 463 -TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V +APE L G+ + ++DV+ FG+L+ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHR 356
+F N +GKG FG V+K + D V A+K+ L N E E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP------SLDWATRKRIALGAARGLL 410
++R + + +V Y NG + LK + W R + GL
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+LH + KI+HRD+K+ N+ LD Y +GD G+AKLL + T V GT +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171
Query: 471 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 513
+EK+DV+ G++L E +G + AN +GA++
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G + T VA+K + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKRI---ALGAARGLL 410
L+G T L+V M+ G + S L+++ P L T ++ A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAP 469
YL + K +HRD+ A N ++ E +GDFG+ + + D + V +AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 470 EYLSTGQSSEKTDVFGFGILLLELIS 495
E L G + K+DV+ FG++L E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 20/197 (10%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G +G+VYK + G +VA+K +L+ G+ Q E+ M+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE---IIQQEISMLKECRHPNIVAYFG 67
Query: 364 FCMTTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+ + +V Y GS+ + L A R L +GL YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHET---G 121
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL---STGQ 476
IHRD+K ANILL E + + DFG++ L + + + GT +APE G
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGG 180
Query: 477 SSEKTDVFGFGILLLEL 493
K D++ GI +EL
Sbjct: 181 YDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 63/197 (31%), Positives = 91/197 (46%), Gaps = 6/197 (3%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 359
F+ +GKG FG VYKG V ++ D EI+ Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
R G + T+ ++ Y+ GS LK P L+ I +GL YLH + +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE---R 121
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 480 KTDVFGFGILLLELISG 496
K D++ GI +EL G
Sbjct: 181 KADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 306 LVGKGGFGNVYK-GY--LQDGT--VVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 359
+GKG FG+V Y LQD T VVAVK+L+ A ++ F+ E+E++ H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIV 68
Query: 360 RLIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 416
+ G C + R LV Y+ GS+ L K + LD A +G+ YL +
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLS 473
+ +HRD+ NIL++ +GDFGL K+L D V + APE L+
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAPESLT 184
Query: 474 TGQSSEKTDVFGFGILLLELIS 495
+ S +DV+ FG++L EL +
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 72/224 (32%), Positives = 99/224 (44%), Gaps = 21/224 (9%)
Query: 306 LVGKGGFGNVYKGYLQD--GTV--VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 360
+G G FG V +G G V VAVK LK F E M SL H NL+R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIR 60
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDP 418
L G +T ++V GS+ RL+ A +T A+ A G+ YL +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEYLSTGQ 476
+ IHRD+ A NILL + +GDFGL + L + H V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 477 SSEKTDVFGFGILLLELIS-------GLRALEFGKTANQKGAML 513
S +DV+ FG+ L E+ + GL + K +++G L
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL 220
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 18/197 (9%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G FG V +G Y G VAVK +K D A F E +++ H+NL+RL+G
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 365 CMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ +V MS G++ + R + + + + +L A G+ YL + K++H
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+ A NIL+ E A V DFGLA++ S + V APE L + S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179
Query: 483 VFGFGILLLELISGLRA 499
V+ +G+LL E+ S RA
Sbjct: 180 VWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G F E +++ H L++L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 367 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 423
+ E + +V YMS GS+ LK + + + + A A G+ Y+ +HR
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D++AANIL+ E V DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 484 FGFGILLLELISGLR 498
+ FGILL EL + R
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 6e-18
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G +G VYK + G +VA+K+++ + G I E++++ H N++RL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK-- 64
Query: 365 CMTTTERL----LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
+ T++ +V+ YM + + + K + K GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES--QIKCYMKQLLEGLQYLHSN--- 119
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQ 476
I+HRD+K +NIL++ + DFGLA+ +S T T+ + PE L +T +
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT-R 178
Query: 477 SSEKTDVFGFGILLLELISG 496
+ D++ G +L EL G
Sbjct: 179 YGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 306 LVGKGGFGNVYKG-YLQDGTVVAVKRLK-DGNAIGGEIQ-------FQTEVEMISLAVHR 356
L+G G FG+VY G G ++AVK+++ + + + E+ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
N+++ +G + + Y+ GSVA+ L + + + +GL YLH +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-----AVRGTVGHIAPEY 471
IIHRD+K ANIL+D + DFG++K L+ T +++G+V +APE
Sbjct: 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 472 LSTGQSSEKTDVFGFGILLLELISG 496
+ + K D++ G L++E+++G
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 7e-18
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLA 353
+N+ L+G+G FG VY Y D G +AVK+++ + E+ + E++++
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 354 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
+H +++ G ER L +M GS+ +LK+ +L ++ G+ Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAP 469
LH I+HRD+K ANIL D +GDFG +K L C S +V GT ++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 470 EYLSTGQSSEKTDVFGFGILLLELIS 495
E +S K D++ G ++E+++
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 358
F+ +GKG FG V+KG + VVA+K + D EI+ Q E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQC 416
+ G + T+ ++ Y+ GS L+A P AT + L +GL YLH +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE- 120
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
K IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA 177
Query: 477 SSEKTDVFGFGILLLELISG 496
K D++ GI +EL G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 8/198 (4%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLL 359
F+ +GKG FG V+KG V ++ D EI+ Q E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+ G + T+ ++ Y+ GS L+ P LD I +GL YLH + K
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE---K 121
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRGTVGHIAPEYLSTGQSS 478
IHRD+KAAN+LL E+ E + DFG+A L D+ + GT +APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 479 EKTDVFGFGILLLELISG 496
K D++ GI +EL G
Sbjct: 180 SKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 38/103 (36%), Positives = 65/103 (63%)
Query: 83 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
LSG + + IG+ ++L+++ L N + G IP + L+ L L L++N G IP + +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
++L+++ L N+L+G IP + ++ L LDL YNNL+GP+PS
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 42/102 (41%), Positives = 62/102 (60%)
Query: 83 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
L G + +S+ NLT+L+ + L +N + G IP E+G++ L + L N +G IP + L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
+L +L L N+LTG IP SL N+ L +L L N LSGP+P
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ T VAVK +K G+ F E ++ H L++L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKL--HAV 69
Query: 367 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 423
T E + ++ +M+ GS+ LK+ K I A A G+ ++ ++ IHR
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D++AANIL+ + DFGLA++++ + + + APE ++ G + K+DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 484 FGFGILLLELIS 495
+ FGILL+E+++
Sbjct: 187 WSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 307 VGKGGFGNVYKGYL-QDGTV--VAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 362
+G+G FG+V +G L QD ++ VAVK +K E++ F +E + H N++RLI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 363 GFCMTTTER------LLVYPYMSNGSVAS-----RLKAKPS-LDWATRKRIALGAARGLL 410
G C+ T E +++ P+M +G + S RL P L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAP 469
YL + IHRD+ A N +L+E V DFGL+K + + D + + + V IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 470 EYLSTGQSSEKTDVFGFGILLLEL 493
E L+ + K+DV+ FG+ + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 308 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQ--TEVEMISLAVHRNLLRLIGF 364
G G G V K + G ++AVK ++ I IQ Q E++++ ++ G
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 365 CMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+ + YM GS+ LK + + +IA+ +GL YLHE+ KIIHR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHR 125
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
DVK +NIL++ + + DFG++ L +S T V GT ++APE + S K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 484 FGFGILLLELISG 496
+ G+ L+EL +G
Sbjct: 183 WSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 307 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAVHRNLLRLIG- 363
+GKG FG V K DG ++ K + GN E Q +EV ++ H N++R
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 364 FCMTTTERL-LVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLH--EQC 416
+ + L +V Y G +A + K + ++ RI L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
++HRD+K ANI LD +GDFGLAK+L H S T V GT +++PE L+
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHMS 186
Query: 477 SSEKTDVFGFGILLLELISG 496
EK+D++ G L+ EL +
Sbjct: 187 YDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 64/193 (33%), Positives = 93/193 (48%), Gaps = 16/193 (8%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+GKG FG+V G + G VAVK +K D A F E +++ H NL++L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVI 68
Query: 366 MTTTERL-LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ L +V YM+ GS+ L+++ L + +L + YL +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+ A N+L+ E A V DFGL K V+ T APE L + S K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSD 181
Query: 483 VFGFGILLLELIS 495
V+ FGILL E+ S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 34/216 (15%)
Query: 307 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VYKG L T VA+K LK+ + +F+ E E++S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRL----------------KAKPSLDWATRKRIALG 404
L+G C +++ Y+++G + L K SLD + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHVTTA 459
A G+ YL +HRD+ A N L+ E + DFGL++ + D S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
VR + PE + G+ + ++D++ FG++L E+ S
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ G T VAVK LK G F E +++ H L++L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 367 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 423
+ E + +V YMS GS+ LK + + A A G+ Y+ IHR
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 126
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D+++ANIL+ + + DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 484 FGFGILLLELISGLR 498
+ FGILL EL++ R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 307 VGKGGFGNVYK----GYL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V++ G L + T+VAVK LK+ + + FQ E +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKA----------------------KPSLDWATR 398
L+G C L++ YM+ G + L+ L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 399 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK---LLDHCDSH 455
IA A G+ YL E+ K +HRD+ N L+ E + DFGL++ D+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
A+ + + PE + + + ++DV+ +G++L E+ S
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKG---YLQDGTV---VAVKRLKDGNAIGGEIQFQTEVE 348
+ + + +G G FG VY+G V VAVK L + + E F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKR------I 401
++S H+N++RLIG R ++ M+ G + S L+ +P + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHCDSHVTT 458
A A+G YL E IHRD+ A N LL A + DFG+A+ D + +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRAS 173
Query: 459 AVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R + + PE G + KTDV+ FG+LL E+ S
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K VAVK LKD +E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRI--- 401
++ L+G C ++ Y S G++ L+A+ P +D++ T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 460
A ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ + + D + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R V +APE L + ++DV+ FG+LL E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMIS-LAV 354
+F ++G+G F V + A+K L I + E E+++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 355 HRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 413
H +++L + E L V Y NG + ++ SLD + A L YLH
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------------ 461
+ IIHRD+K NILLD+ + DFG AK+LD S +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 462 -------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT +++PE L+ + + +D++ G ++ ++++G
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 45/105 (42%), Positives = 63/105 (60%), Gaps = 1/105 (0%)
Query: 81 QN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
QN LSG + SI +L L + L +N++SG IP + +L L L L +N FTG IP +
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
+ L LQ L+L +N +G IP +L + L LDLS NNL+G +P
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K ++ VAVK LKD +E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA-----------TRKRI--- 401
++ L+G C ++ Y S G++ L+A+ P ++++ T K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 460
ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ +++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R V +APE L + ++DV+ FG+L+ E+ +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 354
N+ L+G+G FG VY Y D G +AVK++ D E+ + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 355 HRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 412
H +++ G E+ L YM GS+ +LKA +L +R +G+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAPE 470
H I+HRD+K ANIL D +GDFG +K + C S +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 471 YLSTGQSSEKTDVFGFGILLLELIS 495
+S K DV+ ++E+++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 306 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEMISLAVHRNLLRL 361
+VG+G +G V K + G +VA+K+ K+ + E +T EV+++ H N++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKI 420
LV+ Y+ ++ L+A P L + + + Y H I
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYL-STGQS 477
IHRD+K NIL+ E + DFG A+ L S +T V T + APE L
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARAL-RARPASPLTDYV-ATRWYRAPELLVGDTNY 179
Query: 478 SEKTDVFGFGILLLELISG 496
+ DV+ G ++ EL+ G
Sbjct: 180 GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 306 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
++G G FG V +G L+ VA+K LK G F +E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPK 419
G + +++ +M NG++ S L+ + + + + G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---N 126
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGT--VGHIAPEYLSTG 475
+HRD+ A NIL++ V DFGL++ L D D T+++ G + APE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 476 QSSEKTDVFGFGILLLELIS 495
+ + +DV+ +GI++ E++S
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLK--DGNAIGGEIQFQT---EVEMISLAVHRNLL 359
+G G F + Y+ ++ GT++AVK++ + E + E+ +++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
R++G + L +M+ GSV+ L + A RGL YLHE +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---Q 123
Query: 420 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPEYL 472
IIHRDVK AN+L+D + + + DFG A L + T A + GT+ +APE L
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 473 STGQSSEKTDVFGFGILLLELISG 496
Q DV+ G +++E+ +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK---DGNAIGGEIQ-FQTEVEMISLAV 354
N+ L+G+G FG VY Y D G +A K+++ + E+ + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 355 HRNLLRLIGFCMTTTERLLV--YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 412
H +++ G E+ L YM GSV +LKA +L + ++ G+ YL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH-CDSHV-TTAVRGTVGHIAPE 470
H I+HRD+K ANIL D +GDFG +K L C S +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 471 YLSTGQSSEKTDVFGFGILLLELIS 495
+S K DV+ G ++E+++
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G+G FG V+ G T VA+K LK G + F E +++ H L+ L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE--AFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 367 TTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKIIHR 423
+ E + +V +M GS+ LK + + + A A G+ Y+ IHR
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D++AANIL+ + + DFGLA+L++ + + + APE G+ + K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 484 FGFGILLLELISGLR 498
+ FGILL EL++ R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-16
Identities = 42/103 (40%), Positives = 60/103 (58%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
NLSG + IG LT+L + L NN++G IP+ +G L L L L N +GPIP ++
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
L+ L L L++NSL+G IP + + L L L NN +G +P
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 306 LVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLRL 361
++GKG FG V L + G + AVK LK + I + + TE ++SLA + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 362 IGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
+ C T +RL V +++ G + ++ D A + A L++LH++ I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GI 117
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
I+RD+K N+LLD + DFG+ K + T+ GT +IAPE L
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 481 TDVFGFGILLLELISG 496
D + G+LL E++ G
Sbjct: 177 VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 301 FSSKNLV-----GKGGFGNVYK--GY-----LQDGTV-VAVKRLKDGNAIGGEIQFQTEV 347
F LV G+G FG V + Y D TV VAVK LKD +E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 348 EMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWA---TRK-- 399
E++ L H+N++ L+G C ++ Y + G++ L+A+ P D+ T+
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 400 ---------RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450
A ARG+ YL + + IHRD+ A N+L+ E + DFGLA+ +
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 451 HCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
D + T+ R V +APE L + ++DV+ FGIL+ E+ +
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V Y D G +VAVK LK ++ E+ ++ H N+++
Sbjct: 12 LGEGHFGKVSL-YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 361 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
G C + L+ Y+ GS+ L K L+ A A G+ YLH Q
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ--- 126
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST 474
IHRD+ A N+LLD +GDFGLAK + + H VR V A E L
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 475 GQSSEKTDVFGFGILLLELIS 495
+ S +DV+ FG+ L EL++
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGN----AIGGEIQFQTEVEMISL 352
+ + +G+G G VYK G VA+K+++ I EI M
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILI-----MKDC 72
Query: 353 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLL 410
H N++ + L +V YM GS+ + ++ + +GL
Sbjct: 73 -KHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
YLH Q +IHRD+K+ NILL + + DFG A L S + V GT +APE
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 471 YLSTGQSSEKTDVFGFGILLLELISG---------LRAL 500
+ K D++ GI+ +E+ G LRAL
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 66/196 (33%), Positives = 87/196 (44%), Gaps = 20/196 (10%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRL----KDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+G G FG VY ++ VVA+K++ K N +I EV + H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQQLRHPNTIEY 80
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G + LV Y GS + L+ K L I GA +GL YLH
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---R 136
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---LSTGQS 477
IHRD+KA NILL E + DFG A L+ +S V GT +APE + GQ
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQY 191
Query: 478 SEKTDVFGFGILLLEL 493
K DV+ GI +EL
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+GKGGFG V ++ G + A K+L K GE E +++ V + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK-VSSRFIVSLA 59
Query: 364 FCMTTTERL-LVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
+ T + L LV M+ G + + +P A A GL +LH++ +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
++RD+K N+LLD++ + D GLA ++ GT G++APE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 481 TDVFGFGILLLELISG 496
D F G L E+I+G
Sbjct: 175 VDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 31/207 (14%)
Query: 306 LVGKGGFGNVYKG-YLQDGTVV----AVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G G FG VYKG ++ +G V A+K L + ++F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 361 LIGFCMTTTERL----------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 410
L+G C++ T +L L Y + ++ S+L L+W + A+G++
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL----LNWCVQ------IAKGMM 123
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIA 468
YL E+ +++HRD+ A N+L+ + DFGLA+LL+ D A G + +A
Sbjct: 124 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG-DEKEYNADGGKMPIKWMA 179
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELIS 495
E + + + ++DV+ +G+ + EL++
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 307 VGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V K T VAVK LK+ + +E ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLK----------------AKPSLDWATRKRIALG 404
L G C LL+ Y GS+ S L+ LD + + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 405 --------AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456
+RG+ YL E K++HRD+ A N+L+ E + + DFGL++ + DS+V
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 457 TTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+ R V +A E L + ++DV+ FG+LL E+++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 307 VGKGGFGNVY--------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRN 357
+G+G FG V K T VAVK LK +E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRK--------------RI 401
++ L+G C ++ Y S G++ L+A+ P +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAV 460
A ARG+ YL + K IHRD+ A N+L+ E + DFGLA+ + H D + TT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R V +APE L + ++DV+ FG+LL E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
S + ++G G FG V G L+ VA+K LK G F +E ++
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYL 412
H N++ L G + ++V YM NGS+ + L+ K + + + + G A G+ YL
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 470
D +HRD+ A NIL++ V DFGL+++L D ++ T + + APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 471 YLSTGQSSEKTDVFGFGILLLELIS 495
++ + + +DV+ +GI++ E++S
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/212 (26%), Positives = 80/212 (37%), Gaps = 28/212 (13%)
Query: 300 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+F ++GKG FG V + A+K + Q VE S+ N
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----------YMNKQKCVEKGSVRNVLNE 50
Query: 359 LR---------LIGFCMTTTER---LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 406
R L+ + + LV + G + L K K
Sbjct: 51 RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIV 110
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
L YLH + IIHRD+K NILLDE + DF +A + +TT+ GT G+
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGY 165
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498
+APE L S D + G+ E + G R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 35/222 (15%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAV 354
++ ++++G+G FG V K + +DG + A+KR+K+ + F E+E++ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSV-----ASR-LKAKPSLDWATRKRIALGA--- 405
H N++ L+G C L Y +G++ SR L+ P+ A L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 406 -------ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458
ARG+ YL ++ + IHRD+ A NIL+ E Y A + DFGL++ +
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------V 176
Query: 459 AVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIS 495
V+ T+G + A E L+ + +DV+ +G+LL E++S
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 42/106 (39%), Positives = 57/106 (53%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N +G + ++ +L LQ++ L +N SG IP +GK + L LDLS N TG IP +
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L L L +NSL G IP SL L + L N+ SG +PS
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI 350
E + + ++GKG +G VY L +A+K + + ++ +Q E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALH 59
Query: 351 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--------PSLDWATRKRIA 402
S HRN+++ +G + + GS+++ L++K ++ + T++ +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL- 118
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVR 461
GL YLH+ +I+HRD+K N+L++ Y V + DFG +K L + T
Sbjct: 119 ----EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFT 170
Query: 462 GTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISG 496
GT+ ++APE + G D++ G ++E+ +G
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 307 VGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
+G+ FG +YKG+L +VA+K LKD N +FQ E +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRL-----------------KAKPSLDWATRKRIALG 404
+G +++ Y++ G + L K SLD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGT 463
A G+ YL +H+D+ A NIL+ E + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+ + PE + G+ S +D++ FG++L E+ S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 65/201 (32%), Positives = 88/201 (43%), Gaps = 28/201 (13%)
Query: 322 DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG-------FCMTTTE-RLL 373
V VK + G G EI ++ IS HR ++ LI CM + +
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433
++ Y+ R P T +R L A L YLH + IIHRDVK NI LD
Sbjct: 172 LFTYVD------RSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219
Query: 434 EYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 492
E AV+GDFG A KL H D+ GT+ +PE L+ KTD++ G++L E
Sbjct: 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
Query: 493 LISGLRALEFGKTANQKGAML 513
+ L FGK + L
Sbjct: 280 MSVKNVTL-FGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V G + VA+K +K+G+ E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 367 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+V YMSNG + + L+ + + G+ YL + + IHRD+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT---VGHIAPEYLSTGQSSEKTD 482
A N L+D+ V DFGL++ + D T++V G+ V PE L + S K+D
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 483 VFGFGILLLELIS 495
V+ FG+L+ E+ S
Sbjct: 184 VWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMI- 350
L T F ++G+G +G VYK + + G +VA+K + + I E + + E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILR 57
Query: 351 SLAVHRNLLRLIGFCMTTTERL------LVYPYMSNGSVASRLKAKPSLDWATRKR---- 400
+ H N+ G + LV GSV + L K R +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-TDL-VKGLRKKGKRLKEEWI 115
Query: 401 --IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458
I RGL YLHE K+IHRD+K NILL + E + DFG++ LD T
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 459 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELISG 496
+ GT +APE ++ + + + DV+ GI +EL G
Sbjct: 173 FI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 46/118 (38%), Positives = 62/118 (52%), Gaps = 1/118 (0%)
Query: 68 CSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLS 127
CS G + L S +L G + S+G +L+ V LQ+N+ SG +P+E KL + LD+S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 128 NNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
NN G I S + +LQ L L N G +P S +L LDLS N SG VP
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQFSGAVPR 493
|
Length = 968 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 37/179 (20%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL-----KDGNAIGGEIQFQTEVEM 349
S ++ +G+G FG VYK ++ G VVA+K++ KDG I E+++
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA----LREIKI 60
Query: 350 ISLAVHRNLLRLIGFCM-----TTTERLLVY---PYM--------SNGSVASRLKAKPSL 393
+ H N++ LI + + +R VY PYM N SV L
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--------KL 112
Query: 394 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452
+ K L G+ YLHE I+HRD+KAANIL+D + DFGLA+ D
Sbjct: 113 TESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 304 KNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
K +G+G FG V+ +D +VAVK LKD + FQ E E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEH 68
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRI 401
+++ G C ++V+ YM +G + L+A K L + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SHV 456
A A G++YL Q +HRD+ N L+ +GDFG+++ + D H
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+R + PE + + + ++DV+ FG++L E+ +
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 301 FSSKNLVGKGGFGNVYKGYL--QDGTV--VAVKRLK-DGNAIGGEIQFQTEVEMISLAVH 355
F+ ++GKG FG+V + L +DG+ VAVK LK D + +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 356 RNLLRLIGFCMTTTER------LLVYPYMSNGSV-----ASRLKAKP-SLDWATRKRIAL 403
N+++LIG + + + +++ P+M +G + SR+ +P +L T R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRG 462
A G+ YL + IHRD+ A N +L+E V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V +A E L+ + +DV+ FG+ + E+++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 306 LVGKGGFGNVYKG-YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVE-MISLAV--HRN 357
L+G G FG V+KG ++ +G VA+K ++D + G FQ + M+++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 416
++RL+G C + +L V GS+ + + + SLD + A+G+ YL E
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTG 475
++HR++ A NILL + DFG+A LL D + + + + +A E + G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 476 QSSEKTDVFGFGILLLELIS 495
+ + ++DV+ +G+ + E++S
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 307 VGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V+ QD +VAVK LK+ + FQ E E++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVR 71
Query: 361 LIGFCMTTTERLLVYPYMSNGSV---------------ASRLKAKPSLDWATRKRIALGA 405
G C L+V+ YM +G + A L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTV 464
A G++YL +HRD+ N L+ + +GDFG+++ + D + V +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+ PE + + + ++D++ FG++L E+ +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 300 NFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQ-TEVEMISLAVHRN 357
+F +GKG +G+VYK L D A+K + G+ E + E+ +++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 358 LLR-----LIGFCMTTTERL-LVYPYMSNGSVA----SRLKAKPSLDWATRKRIALGAAR 407
++ L G +L +V Y G ++ R K + + RI + R
Sbjct: 61 IISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
GL LHEQ KI+HRD+K+ANILL +GD G++K+L ++ GT ++
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYM 168
Query: 468 APEYLSTGQSSEKTDVFGFGILLLELISG 496
APE S K+D++ G LL E+ +
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
SN +G+G FG V+ + T+V VK L+ + +F+ E++M
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW-------ATRKRIALGA 405
H+N++RL+G C ++ Y G + L+A S D +T++++AL
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 406 --ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
A G+ +L + +HRD+ A N L+ E V L+K + + + +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+ +APE + S K+DV+ FG+L+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 300 NFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
N K +G+G FG V+ QD +VAVK LKD + F E E+++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNL 64
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-------------PSLDWATRKR 400
H ++++ G C+ ++V+ YM +G + L+A L +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-----SH 455
IA A G++YL Q +HRD+ N L+ E +GDFG+++ + D H
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+R + PE + + + ++DV+ G++L E+ +
Sbjct: 182 TMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 307 VGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY+G +D T VAVK + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKA------------KPSLDWATRKRIALGA--A 406
L+G L+V M++G + S L++ P+L ++ I + A A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL----QEMIQMAAEIA 129
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TV 464
G+ YL+ + K +HRD+ A N ++ + +GDFG+ + + D + +G V
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPV 185
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+APE L G + +D++ FG++L E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 356
FS +G G FG VY +++ VVA+K++ E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 415
N ++ G + LV Y GS + L+ K L + GA +GL YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 472
+IHRDVKA NILL E +GDFG A ++ + V GT +APE +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 473 STGQSSEKTDVFGFGILLLEL 493
GQ K DV+ GI +EL
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 308 GKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G+G G+V K L G + A+K + + Q E+E+ +++ G +
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 367 --TTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLLYLHEQCDPKI 420
+++ + Y GS+ S K + +IA +GL YLH + KI
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KI 126
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLA-KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IHRD+K +NILL + + DFG++ +L++ T GT ++APE + S
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGKPYSI 182
Query: 480 KTDVFGFGILLLELISG 496
+DV+ G+ LLE+
Sbjct: 183 TSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 307 VGKGGFGNVYKGYLQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG V G G A VK L+ ++ F EV+ H N+L+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSL-----DWATRKRIALGAARGLLYLHEQCDP 418
C+ + LLV + G + + L++ + +R+A A GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--HIAPEYLSTGQ 476
IH D+ N L +GD+GLA L + + + T V +APE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 477 S-------SEKTDVFGFGILLLEL 493
++K++++ G+ + EL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 35/216 (16%)
Query: 305 NLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLR 360
+++G+G FG V K ++ DG + A+KR+K+ + F E+E++ L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLD--------------WATRK--RIALG 404
L+G C L Y +G++ L+ L+ ++++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 464
ARG+ YL ++ + IHRD+ A NIL+ E Y A + DFGL++ + V+ T+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170
Query: 465 GHI-----APEYLSTGQSSEKTDVFGFGILLLELIS 495
G + A E L+ + +DV+ +G+LL E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 32/228 (14%)
Query: 284 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQ 342
G H E ++ K N D V VAVK L+ +
Sbjct: 16 GQFGEVHLCE------ADGLQDFSEKAFAENDNA----DAPVLVAVKVLRPDASDNARED 65
Query: 343 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-----------KP 391
F EV+++S N+ RL+G C ++ YM NG + L+
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 392 SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451
SL ++T +A A G+ YL +HRD+ N L+ + Y + DFG+++ L
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 452 CDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELIS 495
D + V+G I A E + G+ + K+DV+ FG+ L E+++
Sbjct: 183 SDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 35/217 (16%)
Query: 304 KNLVGKGGFGNVYKGYLQ-DGTVV--AVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLL 359
++++G+G FG V + ++ DG + A+K LK+ + F E+E++ L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLD--------------WATRK--RIAL 403
L+G C + Y G++ L+ L+ +++ + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
A G+ YL E+ + IHRD+ A N+L+ E + + DFGL++ + V+ T
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKT 176
Query: 464 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELIS 495
+G + A E L+ + K+DV+ FG+LL E++S
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLIG 363
+G+G G V+K + G VA+K++ GG I Q E++ + H +++L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQACQHPYVVKLLD 66
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ +LV YM ++ L+ + L A K +G+ Y+H I+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKT 481
RD+K AN+L+ + DFGLA+L + + + T + APE L +
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 482 DVFGFGILLLELISG 496
D++ G + EL++G
Sbjct: 183 DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 307 VGKGGFGNVY----KGYLQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG VY KG ++D T VA+K + + ++ I+F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGA---ARGLL 410
L+G L++ M+ G + S L++ P + K++ A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIA 468
YL+ K +HRD+ A N ++ E + +GDFG+ + + D + +G V ++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMS 189
Query: 469 PEYLSTGQSSEKTDVFGFGILLLEL 493
PE L G + +DV+ FG++L E+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAA 406
+ ++ RL+G C+T+T +L + M G + + ++ L+W + A
Sbjct: 67 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 119
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV-- 464
+G+ YL E+ +++HRD+ A N+L+ + DFGLAKLL D A G V
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-ADEKEYHAEGGKVPI 175
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+A E + + ++DV+ +G+ + EL++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 351
L+ F LVG G +G VYKG +++ G + A+K + + G E + + E+ M+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLK 57
Query: 352 -LAVHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIA 402
+ HRN+ G + + LV + GSV +K +L I
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462
RGL +LH+ K+IHRD+K N+LL E E + DFG++ LD T + G
Sbjct: 118 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 173
Query: 463 TVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG 496
T +APE ++ ++ + K+D++ GI +E+ G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 306 LVGKGGFGNVYKG-YLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G G FG VYKG ++ DG VA+K L++ + + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 361 LIGFCMTTTERLLVYPYMSNGSV-------ASRLKAKPSLDWATRKRIALGAARGLLYLH 413
L+G C+T+T +L V M G + R+ ++ L+W + A+G+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV--GHIAPEY 471
E +++HRD+ A N+L+ + DFGLA+LLD D A G V +A E
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALES 182
Query: 472 LSTGQSSEKTDVFGFGILLLELIS 495
+ + + ++DV+ +G+ + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 3e-13
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL---AVHR 356
+ +G+G +G VYK + G +VA+K+++ N G I T + ISL H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IP-STALREISLLKELKHP 58
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQ 415
N+++L+ T + LV+ Y + L +P L K I RGL Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSH--VTTAVRGTVGHIAPE 470
+I+HRD+K NIL++ + DFGLA+ +H VT R APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168
Query: 471 YL--STGQSSEKTDVFGFGILLLELISG 496
L S S+ D++ G + E+I+G
Sbjct: 169 ILLGSKHYSTA-VDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHR 356
F+ +G G FG VY ++ VVA+K++ E ++Q EV+ + H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVKFLQRIKHP 85
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 415
N + G + LV Y GS + L+ K L I GA +GL YLH
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---L 472
+IHRD+KA NILL E + + DFG A + +S V GT +APE +
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 473 STGQSSEKTDVFGFGILLLEL 493
GQ K DV+ GI +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 8/206 (3%)
Query: 300 NFSSKNLVGKGGFGNVY--KGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHR 356
+ +VG+G FG V+ + D +V +K++ + + Q E +++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
N++ + ++V Y G++A K I + LL LH
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLA-EYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 417 DPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
I+HRD+K NILLD++ V +GDFG++K+L S T V GT +I+PE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGK 176
Query: 476 QSSEKTDVFGFGILLLELISGLRALE 501
++K+D++ G +L EL S RA E
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 65/194 (33%), Positives = 85/194 (43%), Gaps = 16/194 (8%)
Query: 307 VGKGGFGNVY-KGYLQDGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIG 363
+G G FG VY VVAVK++ G + Q EV+ + H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ LV Y GS + L+ K L I GA +GL YLH +IH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY---LSTGQSSE 479
RD+KA NILL E + + DFG A +S V GT +APE + GQ
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDG 199
Query: 480 KTDVFGFGILLLEL 493
K DV+ GI +EL
Sbjct: 200 KVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 306 LVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
++GKG FG V KG + AVK LK + + T E LA+ L
Sbjct: 2 VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 362 IGF--CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
C T +RL V Y++ G + ++ D + A GL +LHE+
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
II+RD+K N+LLD + DFG+ K T+ GT +IAPE LS
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 479 EKTDVFGFGILLLELISG 496
D + G+LL E+++G
Sbjct: 175 PAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 301 FSSKNLV-----GKGGFGNVYK----GYLQDGTV--VAVKRLKDGNAIGGEIQ-FQTEVE 348
F NL G G FG V + G + V VAVK LK A E + +E++
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP-TAHSSEREALMSELK 90
Query: 349 MIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS--RLKAKPSLDWATRKRIALGA 405
++S L H N++ L+G C L++ Y G + + R K + L +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 406 ARGLLYL-HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT- 463
A+G+ +L + C IHRD+ A N+LL + DFGLA+ + + ++V V+G
Sbjct: 151 AKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNA 203
Query: 464 ---VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V +APE + + ++DV+ +GILL E+ S
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 349
+ L T + +GKG +G VYK +DG++ AVK L + + EI+ + + +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72
Query: 350 ISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASR----LKAKPSLDWATRKR 400
SL H N+++ G + + LV + GSV L LD A
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
I GA GL +LH +IIHRDVK NILL + DFG++ L T+V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 461 RGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG 496
GT +APE ++ Q + + DV+ GI +EL G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 307 VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG V KG + VA+K LK+ N + E E++ + ++R+IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKI 420
C +LV S G + L K D T + + G+ YL +
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPEYLSTGQSS 478
+HRD+ A N+LL + A + DFGL+K L DS+ +A + + APE ++ + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 479 EKTDVFGFGILLLELISGLRALEFGKTANQK 509
++DV+ +GI + E A +G+ +K
Sbjct: 177 SRSDVWSYGITMWE------AFSYGQKPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGYLQ---DGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+G G FG V KG + VAVK LK D N + + E ++ + ++R+I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
G C +LV G + L+ + + + G+ YL E +H
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVH 118
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSEK 480
RD+ A N+LL + A + DFGL+K L +++ G V APE ++ + S K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 481 TDVFGFGILLLELIS 495
+DV+ FG+L+ E S
Sbjct: 179 SDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 307 VGKGGFGNVY---KGYLQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLR 360
+ KG +G V+ K G + A+K +K + I + Q TE +++S A +++
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVK 57
Query: 361 LIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
L + ++ LV Y+ G +AS L+ SLD + L YLH
Sbjct: 58 L--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN--- 112
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKL---LDHCDSHVTTA----VRGTVGHIAPEY 471
IIHRD+K NIL+D + DFGL+K+ + + + GT +IAPE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 472 LSTGQSSEKT-DVFGFGILLLELISG 496
+ GQ KT D + G +L E + G
Sbjct: 173 I-LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 16/195 (8%)
Query: 308 GKGGFGNVYKG-YLQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
G G FG VYK + + G A K ++ + F E++++S H N++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE---DFMVEIDILSECKHPNIVGLYEA 70
Query: 365 CMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+ ++ + G++ S L+ + L + + L +LH K+IHR
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE---- 479
D+KA NILL + + DFG++ T + GT +APE ++ +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 480 -KTDVFGFGILLLEL 493
K D++ GI L+EL
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 30/222 (13%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHR 356
+G+G +G VYK L G VA+K+++ + G EI ++E H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 357 NLLRLIGFCMT-TTER----LLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGL 409
N++RL+ C T+R LV+ ++ +A+ L KP L T K + RG+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469
+LH I+HRD+K NIL+ + + DFGLA++ + +T+ V T+ + AP
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TLWYRAP 175
Query: 470 EYLSTGQSSEKT--DVFGFGILLLELISGLRALEFGKT-ANQ 508
E L QSS T D++ G + EL R L G + A+Q
Sbjct: 176 EVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQDGTV-----VAVKRLKDGNAIGGEIQ---FQTEVEMISL 352
+ +L+ +G FG ++ G L D V VK +KD + EIQ E ++
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQESCLLYG 64
Query: 353 AVHRNLLRLIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKR---------IA 402
H+N+L ++ C+ E V YPYM+ G++ L+ + L A + +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMA 123
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVR 461
+ A G+ YLH++ +IH+D+ A N ++DE + + D L++ L D H +
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V +A E L + S +DV+ FG+LL EL++
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 301 FSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNL 358
F +VG G +G VYKG +++ G + A+K + EI+ E+ M+ + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--EINMLKKYSHHRNI 75
Query: 359 LRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARG 408
G + + + LV + GSV +K DW I RG
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRG 133
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
L +LH K+IHRD+K N+LL E E + DFG++ LD T + GT +A
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 189
Query: 469 PEYLSTGQSSEKT-----DVFGFGILLLELISG 496
PE ++ ++ + T D++ GI +E+ G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 304 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+ ++G G G VYK Y L ++AVK + + + Q +E+E++ ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
G + +M GS L + RIA+ +GL YL KI+H
Sbjct: 66 GAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILH 118
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RDVK +N+L++ + + DFG++ L +S T V GT ++APE +S Q +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSD 175
Query: 483 VFGFGILLLELISG 496
V+ GI +EL G
Sbjct: 176 VWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 301 FSSKNL-----VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
F++++L +G+G FG V K + GT++AVKR++ + + +++++ +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 355 H-RNLLRLIG---------FCM----TTTERLLVYPYMS-NGSVASRLKAKPSLDWATRK 399
+++ G CM + ++ Y Y + + K
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--------- 111
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459
IA+ + L YL E + KIIHRDVK +NILLD + DFG++ L DS T
Sbjct: 112 -IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166
Query: 460 VRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELISG 496
G ++APE + ++DV+ GI L E+ +G
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 51/217 (23%)
Query: 308 GKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G+G +G V K ++ GT++AVKR++ ++ + LL + M
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIR---------------ATVNSQEQKRLLMDLDISM 54
Query: 367 TTTERLLVYPYM--------SNGSVASRLKA-KPSLDWATRK--------------RIAL 403
+ + PY G V ++ SLD +K +IA+
Sbjct: 55 RSVD----CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
+ L YLH + +IHRDVK +N+L++ + + DFG++ L DS T G
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGC 166
Query: 464 VGHIAPEYLSTGQSSE----KTDVFGFGILLLELISG 496
++APE ++ + + K+DV+ GI ++EL +G
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG V+ G + VA+K + +G E F E +++ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 367 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR----GLLYLHEQCDPKIIH 422
+V +M NG + + L+ + K + L + G+ YL IH
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 423 RDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTA-VRGTVGHIAPEYLSTGQSSEK 480
RD+ A N L+ V DFG+ + +LD D + +++ + V PE + + S K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 481 TDVFGFGILLLELISGLRALEFGKTAN 507
+DV+ FG+L+ E+ + + + F K +N
Sbjct: 182 SDVWSFGVLMWEVFTEGK-MPFEKKSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRL---KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+G+G +G V+K ++ G +VA+K+ +D I +I + E+ M+ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALR-EIRMLKQLKHPNLVNLI 66
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKII 421
+ LV+ Y + +V + L+ P + K+I + + + H+ I
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCI 122
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL-STGQSSEK 480
HRDVK NIL+ + + + DFG A++L T V T + APE L Q
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPP 181
Query: 481 TDVFGFGILLLELISG 496
DV+ G + EL++G
Sbjct: 182 VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 30/159 (18%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLA 353
+G+G + VYK + G +VA+K++K G EI+ E++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK----- 60
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARG 408
H N++ L+ + LV+ +M + L+ L A K L RG
Sbjct: 61 -HPNIIGLLDVFGHKSNINLVFEFME-----TDLEKVIKDKSIVLTPADIKSYMLMTLRG 114
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
L YLH I+HRD+K N+L+ + DFGLA+
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR----- 360
+GKG FG V + DG AVK L+ I + E + I RN+L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHI--MAERNVLLKNVKH 55
Query: 361 --LIG--FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
L+G + T ++L V Y++ G + L+ + S + A A L YLH
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIAPEYLST 474
II+RD+K NILLD V+ DFGL K ++H + T+ GT ++APE L
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
D + G +L E++ GL
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRL-----KDGNAIGG--EIQFQTEVEMI 350
+ F N +G+G +G VY+ G +VA+K++ +DG I EI +
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-- 64
Query: 351 SLAVHRNLLRLIGFCMTTTERL----LVYPYMSNGSVASRLKAKPS-LDWATRKRIALGA 405
H N++ L + + L LV Y +AS L P+ + K + L
Sbjct: 65 ----HPNIVELKE--VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQL 117
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
RGL YLHE IIHRD+K +N+LL + + DFGLA+ +T V T+
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLW 173
Query: 466 HIAPEYL--STGQSSEKTDVFGFGILLLELISG 496
+ APE L T + D++ G +L EL++
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 37/208 (17%)
Query: 308 GKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI----------SLA 353
G+G FG V YK G + A+K LK G+ I + EVE + +
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARD-----EVESLMCEKRIFETANSE 59
Query: 354 VHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---GL 409
H L+ L C T + + V Y + G + + D + R AA GL
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGL 114
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVRGTVGHIA 468
YLHE KI++RD+K N+LLD + DFGL K + D T+ GT +A
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLA 169
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISG 496
PE L+ + D +G G+L+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
GL YLH Q +IIHRDVK NI +++ + +GD G A+ + + GTV
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELIS 495
APE L+ + + K D++ GI+L E+++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 306 LVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVH 355
++GKG FG V L+ GT V A+K LK ++ Q TE +++LA
Sbjct: 2 VLGKGSFGKVMLAELK-GTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAK 54
Query: 356 RNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
L + C T +RL V Y++ G + +++ D + A L++LH
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+I+RD+K NILLD + DFG+ K + TT GT +IAPE L
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 475 GQSSEKTDVFGFGILLLELISG 496
+ D + G+L+ E+++G
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 306 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRL 361
++G+GGFG VY D G + A+K L D I GE E M+SL + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 362 IGFCMT----TTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
+ CM+ T ++L + M+ G + L A + A GL ++H +
Sbjct: 60 V--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
+++RD+K ANILLDE+ + D GLA H + GT G++APE L G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 477 SSEKT-DVFGFGILLLELISG 496
+ + + D F G +L +L+ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 304 KNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+G+G FG+VY+G VAVK K+ + +F E ++ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 418
+LIG T +V G + S L+ K SLD A+ + + L YL +
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK--- 126
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQ 476
+ +HRD+ A N+L+ +GDFGL++ L+ D A +G + +APE ++ +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE--DESYYKASKGKLPIKWMAPESINFRR 184
Query: 477 SSEKTDVFGFGILLLELIS 495
+ +DV+ FG+ + E++
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 307 VGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG V G + G V VK L+ ++ +++F E + H NLL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKP-----SLDWATRKRIALGAARGLLYLHEQCDP 418
C T LLV + G + L++ + D T +R+A A GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGHIAPEYLSTGQS 477
IH D+ N LL +GD+GL+ D +VT + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 478 -------SEKTDVFGFGILLLEL 493
+++++V+ G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 295 QSATSNFSS---KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 350
SA + S N +G G G VYK + G + A+K + + Q E+E++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 351 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGL 409
H N+++ E ++ +M GS+ + + + L R+ ++ G+
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----GI 181
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG----LAKLLDHCDSHVTTAVRGTVG 465
YLH + I+HRD+K +N+L++ + DFG LA+ +D C+S V GT+
Sbjct: 182 AYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIA 233
Query: 466 HIAPEYLSTGQSSEK-----TDVFGFGILLLELISGLRALEFGKTANQKGAMLDWVS 517
+++PE ++T + D++ G+ +LE G G+ DW S
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-------DWAS 283
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 307 VGKGGFGNVY------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G+G FG V +G G VAVK LK + + E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 361 LIGFCMTTTER--LLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCD 417
G C L+ ++ +GS+ L + K ++ + + A+ +G+ YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--VRGTVGHIAPEYLSTG 475
+ +HRD+ A N+L++ ++ +GDFGL K ++ + T + V APE L
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 476 QSSEKTDVFGFGILLLELIS 495
+ +DV+ FG+ L EL++
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 306 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLI 362
LVG+G +G V K ++ G +VA+K+ + + + +I + E+ M+ H NL+ LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKII 421
LV+ ++ + +V L+ P+ LD + ++ RG+ + H II
Sbjct: 67 EVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK- 480
HRD+K NIL+ + + DFG A+ L T V T + APE L +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRA 181
Query: 481 TDVFGFGILLLELISG 496
D++ G L+ E+++G
Sbjct: 182 VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 306 LVGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
++G+GGFG VY D G + A+K L K GE E M+SL + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 363 GFCMT----TTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 417
CMT T ++L + M+ G + L + A GL ++H +
Sbjct: 61 --CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
+++RD+K ANILLDE+ + D GLA H + GT G++APE L G +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 478 SEKT-DVFGFGILLLELISGLRALEFGKTANQ 508
+ + D F G +L +L+ G KT ++
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 357
F ++GKGGFG V ++ G + A KRL K GE E +++ V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE-KVNSQ 60
Query: 358 LLRLIGFCMTTTERL-LVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR---GLLY 411
+ + + T + L LV M+ G + + P + +R AA GL
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE---EERALFYAAEILCGLED 117
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
LH + ++RD+K NILLD+Y + D GLA + +S GTVG++APE
Sbjct: 118 LHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEV 172
Query: 472 LSTGQSSEKTDVFGFGILLLELISG 496
L+ + + D +G G L+ E+I G
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN- 357
+F+ ++GKG FG V + + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 358 -LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
L + C T +RL V Y++ G + ++ A + GL +LH +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLST 474
II+RD+K N++LD + DFG+ K +H VTT GT +IAPE ++
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 475 GQSSEKTDVFGFGILLLELISG 496
+ D + +G+LL E+++G
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVE--MISLAVH 355
+F+ ++GKG FG V + GT + A+K LK I + T VE +++L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 356 RNLLRLIGFCMTTTERL-LVYPYMSNGSV------ASRLKAKPSLDWATRKRIALGAARG 408
L + C T +RL V Y++ G + R K ++ +A I G
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------G 113
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
L +LH + II+RD+K N++LD + DFG+ K + D T GT +IA
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIA 169
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISG 496
PE ++ + D + FG+LL E+++G
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG VYK ++ V+A ++ D + + E+++++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 367 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
++ + + G+V A L+ + L + + L YLHE KIIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 426 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 479
KA NIL + + DFG++ + + DS + GT +APE + S +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 184
Query: 480 ---KTDVFGFGILLLEL 493
K DV+ GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKR-----LKDGNAIGGEIQFQTEVEMISL 352
+NF + +G+G F VY+ L DG VA+K+ L D A I+ E++++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 58
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 408
H N+++ + E +V G ++ + K K + T + +
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 465
L ++H + +++HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 507
+++PE + + K+D++ G LL E+ + L++ +G N
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 306 LVGKGGFGNVYKG-YLQDGTVVAVKRL-KDGNAIGGE-IQFQTEVEMISLAVHR--NLLR 360
+G G G VYK + + G V+AVK++ + GN + I +V + S H +++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVK 78
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQ 415
G+ +T ++ + MS + +L + P ++ + + L YL E+
Sbjct: 79 CYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPE---DILGKMTVAIVKALHYLKEK 133
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
+IHRDVK +NILLD + DFG++ L DS T G ++APE +
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPERIDPP 189
Query: 476 QSSEK----TDVFGFGILLLELISGL 497
+ K DV+ GI L+EL +G
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLK-DGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 362
++GKG FG V L+ G AVK LK D I +++ E +++LA L +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 363 GFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
T E L V +++ G + ++ K D A GL +LH + II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
+RD+K N++LD + DFG+ K D+ +T GT +IAPE L + +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177
Query: 482 DVFGFGILLLELISG 496
D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-11
Identities = 19/41 (46%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 30 NYEVQALMGIKDSL-HDPHDVLNNWDENSVDPCSWALVTCS 69
N + AL+ K SL DP L++W+ +S DPCSW VTC
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 8/195 (4%)
Query: 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE--MISLAVHRNLLRLI 362
++GKG FG V+ L+ A+K LK + + T VE ++SLA L +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 363 GFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
T E L V Y++ G + +++ D A GL +LH + I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
+RD+K NILLD + DFG+ K D+ T GT +IAPE L + +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSV 177
Query: 482 DVFGFGILLLELISG 496
D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 307 VGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---------- 354
+G+G +G V+K G VA+KR ++ QT E + L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR----------VRVQTGEEGMPLSTIREVAVLRHL 58
Query: 355 ----HRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALG 404
H N++RL C + T+ LV+ ++ K +P + T K +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 464
RGL +LH +++HRD+K NIL+ + + DFGLA++ T+V T+
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTL 173
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
+ APE L + D++ G + E+ +Q G +LD +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 21/200 (10%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISLAVHRNL 358
+G+G +G VYK G +VA+K++K G EI+ E+ H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPNI 60
Query: 359 LRLIGFCMTTTERLLVYPYM-SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCD 417
++L+ + LV+ +M ++ + + + L + K +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQ 476
I+HRD+K N+L++ + DFGLA+ T T + APE L
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 477 SSEKTDVFGFGILLLELISG 496
S D++ G + EL+S
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 38/102 (37%), Positives = 55/102 (53%)
Query: 83 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
LSG + + L NL+++ L +NN +G IP + L +L L L +N F+G IP +
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
L L L+ N+LTG IP L + L L L N+L G +P
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 34/114 (29%), Positives = 59/114 (51%)
Query: 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 132
+T L + NL+G + + + NL ++L +N++ G IP +G L + L +N F+
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 133 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
G +PS + L + +L ++NN+L G I +M L L L+ N G +P
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471
|
Length = 968 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 304 KNLVGKGGFGNVY-------KGYLQDGT--------VVAVKRLKDGNAIGGEIQFQTEVE 348
K +G+G FG V+ +L +G +VAVK L+ F E++
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------------PSLDWA 396
++S + N++RL+G C++ ++ YM NG + L + PS+ A
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 397 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456
+A+ A G+ YL +HRD+ N L+ +Y + DFG+++ L D +
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY- 185
Query: 457 TTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
++G + +A E + G+ + +DV+ FG+ L E+ +
Sbjct: 186 --RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
T+ + VG G FG V Q G VA+K++ F T E+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK--------PFSTPVLAKRTYREL 60
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 407
+++ H N++ L ++ E + + + L ++P L+ + R
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILR 119
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
GL Y+H ++HRD+K +NIL++E + + DFGLA++ D +T V T +
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYV-STRYYR 172
Query: 468 APEYLSTGQS-SEKTDVFGFGILLLELISG 496
APE + T Q + D++ G + E++ G
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 306 LVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
++G G FG + +G L+ VA+ L+ G + F E + H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G ++V YMSNG++ S L K + L + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GY 128
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIAPEYLSTGQSS 478
+H+ + A +L++ + F +L + + T + G V APE + S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 479 EKTDVFGFGILLLELIS 495
+DV+ FGI++ E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 307 VGKGGFGN--VYKGYLQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+GKG FG +Y+ +D ++V K L + E+ ++SL H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAYY 65
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL--GAARGLLYLHEQCDPKI 420
M L+ Y + G++ ++ + + + + Y+H+ I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
+HRD+K NI L + +GDFG++K+L S T V GT +++PE + + K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFK 181
Query: 481 TDVFGFGILLLELISGLRALE 501
+D++ G +L EL++ R +
Sbjct: 182 SDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 14/135 (10%)
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
I CM +M GS+ LK + +I++ RGL YL E+ KI+
Sbjct: 74 ISICME---------HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIM 122
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L + ++
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYTVQS 179
Query: 482 DVFGFGILLLELISG 496
D++ G+ L+E+ G
Sbjct: 180 DIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 46/227 (20%)
Query: 306 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLL 359
L+GKGG G VY Y D VA+K++++ + + +F E ++ + +H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 360 RLIGFCMTTTERLLVY---PYMSNGSVASRLKA---KPSLDWATRKRIALGA-------- 405
+ C ++ VY PY+ ++ S LK+ K SL ++ ++GA
Sbjct: 66 PVYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK--------LLD------- 450
+ Y+H + ++HRD+K NILL + E V+ D+G A LLD
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 451 HCDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
C S +T + GT ++APE L +SE TD++ G++L ++++
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 307 VGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGF 364
+GKG FG V + +D + A+K ++ + + T E LA V+ + + F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 365 CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+ E+L LV +++ G + L+ + D +R R A L L +I+R
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFD-LSRARFY--TAELLCALENLHKFNVIYR 117
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
D+K NILLD + DFGL K L+ D T GT ++APE L ++ D
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 484 FGFGILLLELISGL 497
+ G+LL E+++GL
Sbjct: 177 WTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMIS 351
NF + +GKG F VYK L DG VVA+K+++ D A ++ E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-----KAKPSLDWATRKRIALGAA 406
H N+++ + + E +V G + SR+ K K + T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG- 465
L ++H + +I+HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169
Query: 466 --HIAPEYLSTGQSSEKTDVFGFGILLLEL 493
+++PE + + K+D++ G LL E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 300 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISL-A 353
NF ++G G +G V+ G G + A+K LK + + T E L A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 354 VHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA-ARGLL 410
V R L+ L T T+ L+ Y++ G + + L + + R+ + L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLALD 119
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+LH+ II+RD+K NILLD V+ DFGL+K + + GT+ ++APE
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 471 YLSTGQS--SEKTDVFGFGILLLELISG 496
+ G + D + G+L EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 8/196 (4%)
Query: 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLI 362
++GKG FG V + DG AVK L+ + + Q E ++ V L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 363 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
+ TTE+L V +++ G + L+ + S + A A L YLH I+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIV 118
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
+RD+K NILLD V+ DFGL K S TT GT ++APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 482 DVFGFGILLLELISGL 497
D + G +L E++ GL
Sbjct: 178 DWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL-------KDGNAIG-GEIQFQTEVE--- 348
F ++GKGGFG V ++ G + A K+L + G A+ E Q +V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 349 MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLK--AKPSLDWATRKRIALGA 405
++SLA + T + L LV M+ G + + P D +R A
Sbjct: 62 VVSLA----------YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYA 108
Query: 406 AR---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462
A GL LH + +I++RD+K NILLD+Y + D GLA + + G
Sbjct: 109 AEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRVG 163
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
TVG++APE + + + D +G G L+ E+I G
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436
+M GS+ LK + ++++ RGL YL E+ +I+HRDVK +NIL++
Sbjct: 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRG 141
Query: 437 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
E + DFG++ L DS + V GT +++PE L S ++D++ G+ L+EL G
Sbjct: 142 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 304 KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLA 353
+G G +G V + G VA+K++ N F E++++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLLRHL 56
Query: 354 VHRNLLRLIGFCMTTTERL------LVYPYMSN--GSVASRLKAKPSLDWATRKRIALGA 405
H N++ L+ + +V M V +K+ L +
Sbjct: 57 RHENIIGLLDI-LRPPSPEDFNDVYIVTELMETDLHKV---IKSPQPLTDDHIQYFLYQI 112
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--------VT 457
RGL YLH +IHRD+K +NIL++ + + DFGLA+ +D + VT
Sbjct: 113 LRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 458 TAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 496
R APE LS+ + ++ D++ G + EL++
Sbjct: 170 RWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
+F+ ++GKG FG V + GT + A+K LK I + T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 358 --LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
L + C T +RL V Y++ G + ++ A A GL +LH
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLS 473
+ II+RD+K N++LD + DFG+ K ++ TT GT +IAPE ++
Sbjct: 120 K---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
+ D + FG+LL E+++G
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 21/197 (10%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
VG G +G+VYK L G + AVK +L+ G+ Q E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---LIQQEIFMVKECKHCNIVAYFG 73
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
++ + + Y GS+ L + +GL YLH + +HR
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHR 130
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLS---TGQ 476
D+K ANILL + + + DFG+A + T A R GT +APE + G
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 477 SSEKTDVFGFGILLLEL 493
++ D++ GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 6/196 (3%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G + VYKG + +G +VA+K ++ G E ++ H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
T LV+ Y+ K L K RGL Y+H++ I+HRD+
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDL 129
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 484
K N+L+ + E + DFGLA+ SH + T+ + P+ L + + S D++
Sbjct: 130 KPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMW 188
Query: 485 GFGILLLELISGLRAL 500
G G + +E+I G+ A
Sbjct: 189 GVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAV---HRNLLRL 361
+G G +G VYK G VA+K ++ N G + EV ++ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 362 IGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQ 415
+ C T+ T+ LV+ ++ K P L T K + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
C I+HRD+K NIL+ + + DFGLA++ C +T V T+ + APE L
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV-TLWYRAPEVLLQS 182
Query: 476 QSSEKTDVFGFGILLLEL 493
+ D++ G + E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 10/195 (5%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+GKGGFG V +++ G + A K+L K GE E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKII 421
+ T LV M+ G + + + I A G+L+LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIV 117
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
+RD+K N+LLD+ + D GLA L D T GT G++APE L S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 482 DVFGFGILLLELISG 496
D F G + E+++G
Sbjct: 176 DWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 306 LVGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRL 361
++GKG FG V L+ A+K LK + + T VE LA+ H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 362 IGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
FC T+ L V Y++ G + +++ D A + A GL +LH++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
II+RD+K N+LLD+ + DFG+ K + + +T GT +IAPE L + +E
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175
Query: 480 KTDVFGFGILLLELISG 496
D + FG+LL E++ G
Sbjct: 176 SVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 38/120 (31%), Positives = 65/120 (54%), Gaps = 5/120 (4%)
Query: 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436
+M GS+ K + +IA+ GL YL+ +I+HRD+K +NIL++
Sbjct: 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRG 141
Query: 437 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ + DFG++ L +S T V GT +++PE + G+ + K+DV+ GI ++EL G
Sbjct: 142 QIKLCDFGVSGEL--INSIADTFV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 306 LVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG V+ K D G + A+K LK + ++ + E ++++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
L T + L+ ++ G + +RL + K A L +LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GI 119
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
I+RD+K NILLDE + DFGL+K +DH + GTV ++APE ++ ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 480 KTDVFGFGILLLELISGLRALEF-GKTANQKGAML 513
D + FG+L+ E+++G +L F GK + M+
Sbjct: 178 SADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 357
F ++GKGGFG V ++ G + A K+L K GE E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 358 LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---GLLYLH 413
++ L + T + L LV M+ G + + + R AA GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDLH 119
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYL 472
++ +I++RD+K NILLD++ + D GLA H T R GTVG++APE +
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVV 173
Query: 473 STGQSSEKTDVFGFGILLLELISG 496
+ + D + G LL E+I+G
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
+G G FG VYK ++ +A ++ + + + E+E+++ H +++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 367 TTTERLLVYPYMSNGSV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+ ++ + G+V A L+ L + I L YLH KIIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 426 KAANILLDEYYEAVVGDFGLA----KLLDHCDSHVTTAVRGTVGHIAPEYL--STGQSSE 479
KA N+LL + + DFG++ K L DS + GT +APE + T + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191
Query: 480 ---KTDVFGFGILLLEL 493
K D++ GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF- 364
+GKG +G V+K ++G+ AVK L + I EI+ + + + +L+ H N+++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84
Query: 365 ----CMTTTERLLVYPYMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLHEQC 416
+ LV + GSV LK ++ I A GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
K IHRDVK NILL + DFG++ L T+V GT +APE ++ Q
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 477 S-----SEKTDVFGFGILLLELISG 496
+ DV+ GI +EL G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 17/199 (8%)
Query: 321 QDGTVVAVKRLKDGNAIGGEIQ---FQTEVEMISLAVHRNLLRLIGFCMTTTERLL-VYP 376
G VA+K L+ +A E Q F+ E + + H N++ L+ L V+
Sbjct: 1 MTGHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---D 433
Y+ ++ L A +L R+ L L H Q I+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 434 EYYEAVVGDFGLAKLL-DHCDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGFG 487
A V DFG+ LL D+ V T R GT + APE L + +D++ +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 488 ILLLELISGLRALEFGKTA 506
++ LE ++G R ++ A
Sbjct: 177 LIFLECLTGQRVVQGASVA 195
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---------EVEMI 350
+ + + VG G +G V + G VA+K+L FQ+ E+ ++
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR--------PFQSAIHAKRTYRELRLL 68
Query: 351 SLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIAL 403
H N++ L+ T L LV M G+ + + L + +
Sbjct: 69 KHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVY 125
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
RGL Y+H IIHRD+K +NI ++E E + DFGLA+ H D +T V T
Sbjct: 126 QILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV-AT 178
Query: 464 VGHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 496
+ APE L+ ++ D++ G ++ EL++G
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 329 KRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL--------IGFCMTTTERLLVYPYMSN 380
KR+K G+ IQ + E+ + H N+L++ + +T +Y +M +
Sbjct: 198 KRVKAGSRAA--IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 440
A K +P L TR I + Y+H D K+IHRD+K NI L+ + V+
Sbjct: 256 E--AFDWKDRPLL-KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308
Query: 441 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
GDFG A + GTV +PE L+ E TD++ G++LL+++S
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 49/212 (23%)
Query: 307 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLR---- 360
VGKG +G V + DG +K+L NA E + + E +++S H N++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 361 ----------LIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKRIA 402
++GFC G + +LK + ++W +
Sbjct: 68 WEGEDGLLYIVMGFC-------------EGGDLYHKLKEQKGKLLPENQVVEWFVQ---- 110
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVR 461
A L YLHE+ I+HRD+K N+ L VGD G+A++L+ CD + + +
Sbjct: 111 --IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLI 163
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 493
GT +++PE S + K+DV+ G + E+
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 306 LVGKGGFGNVYKGYLQDG--TVVAVKRLKDGNAIGGEIQFQ---------TEVEMISLAV 354
+G G FG VYK ++ ++A+K + N G+ + + +EV +I +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 355 -HRNLLRLIGFCMTTTERLLVYPYM------SNGSVASRLKAK-----PSLDWATRKRIA 402
H N++R + T E +Y M G + LK K W ++
Sbjct: 67 RHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462
L L YLH++ +I+HRD+ NI+L E + + DFGLAK +S +T+ V G
Sbjct: 124 LA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV-G 175
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 493
T+ + PE + EK DV+ FG +L ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 40/115 (34%), Positives = 60/115 (52%), Gaps = 4/115 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N +L S + NL NL+ + L N++S +P + LS L LDLS N + +P +
Sbjct: 148 SDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 194
L L+ L L+NNS+ + SLSN+ L+ L+LS NN +P N+
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLE 258
|
Length = 394 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 12/105 (11%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-----DHCDSHVTTAVR 461
RGL Y+H +IHRD+K +N+L++E E +GDFG+A+ L +H +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYV- 172
Query: 462 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505
T + APE LS + + D++ G + E++ G R L GK
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKN 216
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 59/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE---MISLAVHRNLLRL 361
++GKG FG V + DG+ AVK L+ + + Q E ++ H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 362 IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
+ T E+L V Y++ G + L+ + + A A + YLH I
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NI 117
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLSTGQSSE 479
I+RD+K NILLD V+ DFGL K + + TT+ GT ++APE L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 480 KTDVFGFGILLLELISGL 497
D + G +L E++ GL
Sbjct: 176 TVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 39/120 (32%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436
+M GS+ LK + ++++ +GL YL E+ KI+HRDVK +NIL++
Sbjct: 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 141
Query: 437 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
E + DFG++ L DS + V GT +++PE L S ++D++ G+ L+E+ G
Sbjct: 142 EIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 39/214 (18%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF-----------QTEVE 348
+ +G+G FG +Y +A + + + EI + EV
Sbjct: 1 RYEIIKKIGEGSFGKIY---------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI 51
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LDWATRKR 400
+++ H N++ +V Y G + R+ + L W +
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ-- 109
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTA 459
I+LG L ++H D KI+HRD+K+ NI L + A +GDFG+A+ L+ T
Sbjct: 110 ISLG----LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 493
V GT +++PE + KTD++ G +L EL
Sbjct: 163 V-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRN 357
F ++GKGGFG V ++ G + A K+L K GE E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 358 LLRLIGFCMTTTERL-LVYPYMSNGSVASRL--KAKPSLDWATRKRIALGAAR---GLLY 411
++ L + T + L LV M+ G + + P D +R AA GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLED 117
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
L + +I++RD+K NILLD+ + D GLA + + GTVG++APE
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGTVGYMAPEV 172
Query: 472 LSTGQSSEKTDVFGFGILLLELISG 496
++ + + D +G G L+ E+I G
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 27/204 (13%)
Query: 307 VGKGGFGNVY------KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VH-RNL 358
+GKGGFG V G L + KRLK G + VE LA VH R +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM-----VEKRILAKVHSRFI 55
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAAR---GLLY 411
+ L T T+ LV M+ G + + + P R A+ GL +
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEH 112
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
LH++ +II+RD+K N+LLD + D GLA L S T GT G +APE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPEL 168
Query: 472 LSTGQSSEKTDVFGFGILLLELIS 495
L + D F G+ L E+I+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIA 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQT--------EVE-MISLAVHR 356
+G G FG+VY + G +VA+K++K +F + EV+ + L H
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK--------KFYSWEECMNLREVKSLRKLNEHP 58
Query: 357 NLLRLIGFCMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGAARGLLYLH 413
N+++L E V+ YM + R K KP + + I +GL ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-KGKP-FSESVIRSIIYQILQGLAHIH 116
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL- 472
+ HRD+K N+L+ + DFGLA+ + + T V T + APE L
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILL 171
Query: 473 -STGQSSEKTDVFGFGILLLELISGLRAL 500
ST SS D++ G ++ EL + LR L
Sbjct: 172 RSTSYSS-PVDIWALGCIMAELYT-LRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 307 VGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G + VYKG L D +VA+K ++ + G EV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
T LV+ Y+ S++ K RGL Y H + K++HRD
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRD 129
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDV 483
+K N+L++E E + DFGLA+ + V T+ + P+ L + S + D+
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDM 188
Query: 484 FGFGILLLELISGLRALEFGKTANQK 509
+G G + E+ +G R L G T ++
Sbjct: 189 WGVGCIFYEMSTG-RPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 27/158 (17%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G FG V+K + + +VA+K++ N G I E++++ L H N++ LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 365 CMTTTERLLVYPYMSNGSVAS-------------RLKAKPSLDW--ATRKRIALGAARGL 409
C T N S L + ++ + + K++ GL
Sbjct: 80 CRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
Y+H KI+HRD+KAANIL+ + + DFGLA+
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 300 NFSSKNLVGKGGFGNVY-----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMIS 351
NF ++G G +G V+ G+ G + A+K LK + +TE +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 352 LAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 410
L + + T +L L+ Y++ G + + L + + + + + +L
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEIVL 116
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
L II+RD+K NILLD V+ DFGL+K + + GT+ ++AP+
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 471 YLSTGQS--SEKTDVFGFGILLLELISG 496
+ G + D + G+L+ EL++G
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 314 NVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373
NV KG +VAVK L+ F EV+++S N++RL+G C+ +
Sbjct: 40 NVRKGR---PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCM 96
Query: 374 VYPYMSNGSVASRLKAK-------------------PSLDWATRKRIALGAARGLLYLHE 414
+ YM NG + L + P++ +++ +AL A G+ YL
Sbjct: 97 ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG----TVGHIAPE 470
+HRD+ N L+ E + DFG+++ L D + ++G + +A E
Sbjct: 157 L---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWE 210
Query: 471 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 509
+ G+ + +DV+ FG+ L E++ + +G+ +++
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 34/88 (38%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHI 467
LL +H +IHRD+K+ANILL +GDFG +K+ S V GT ++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 468 APEYLSTGQSSEKTDVFGFGILLLELIS 495
APE S+K D+F G+LL EL++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 306 LVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLI 362
++GKG FG V + + AVK L+ + E +E ++ V L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 363 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
F T ++L V Y++ G + L+ + + A A L YLH I+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIV 118
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-GTVGHIAPEYLSTGQSSEK 480
+RD+K NILLD V+ DFGL K ++ + + TT+ GT ++APE L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 481 TDVFGFGILLLELISGL 497
D + G +L E++ GL
Sbjct: 177 VDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTE 346
E+ +T F + +G+ FG VYKG+L + VA+K LKD +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN----------------GSVASRLKAK 390
M S H N++ L+G +++ Y S+ GS K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 391 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450
+L+ A I A G+ +L ++H+D+ N+L+ + + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 451 HCDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
D + + G + ++PE + G+ S +D++ +G++L E+ S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 357
+ N + +G +G VY+ + G +VA+K+LK + G I E+ ++ H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 358 LLRLIGFCMTTTER--LLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLL 410
++ + + + +V Y+ + LK+ K + K + L G+
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+LH+ I+HRD+K +N+LL+ + DFGLA+ T V T+ + APE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 471 -YLSTGQSSEKTDVFGFGILLLELISG 496
L + S D++ G + EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
NF +G+G + VYKG + G +VA+K + G E+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLK-------AKPSLDWATRKRIALGAARGLLY 411
+RL T + +LV+ YM LK + +LD T K +G+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
HE +++HRD+K N+L+++ E + DFGLA+ + + V T+ + AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 472 LSTGQS-SEKTDVFGFGILLLELISGLRALEFGKTANQK 509
L ++ S D++ G ++ E+I+G R L G +
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQ 209
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 32/166 (19%)
Query: 307 VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA---VHRNLLR 360
+G+G +G VYK + DG A+K+ K I Q+ I+L H N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVS 66
Query: 361 LIGFCMTTTERL--LVYPYMSNGSVAS----------RLKAKPSLDWATRKRIALGAARG 408
L+ + ++ L++ Y A R + S+ + K + G
Sbjct: 67 LVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 409 LLYLHEQCDPKIIHRDVKAANILL--DEYYEAVV--GDFGLAKLLD 450
+ YLH ++HRD+K ANIL+ + VV GD GLA+L +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE------------IQFQT--EVEM 349
+G+G +G V K Y G +VA+K++K I + I F T E+++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKI-IEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 409
++ H N++ L+ + LV M+ + + K L + K I L GL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK------LLDHCDSHVTTAVRG- 462
LH+ +HRD+ ANI ++ + DFGLA+ D T R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 463 ------TVGHIAPEYL-STGQSSEKTDVFGFGILLLELISG 496
T+ + APE L + D++ G + EL++G
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 345 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL- 403
TE ++ H ++++L G L+ P R K A ++ IA+
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP---------RYKTDLYCYLAAKRNIAIC 182
Query: 404 -------GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456
R + YLHE +IIHRD+KA NI ++ + +GDFG A +++
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 500
GT+ APE L+ D++ GI+L E+ + +L
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-------HRNL 358
+G+G G VY + G VA+K++ +Q Q + E+I + H N+
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKHPNI 78
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
+ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 134
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 479 EKTDVFGFGILLLELISG---------LRAL 500
K D++ GI+ +E++ G LRAL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 8e-09
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 358
+G+G G VY + G VA+K++ +Q Q + E+I + V R N+
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKNPNI 78
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
+ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 479 EKTDVFGFGILLLELISG 496
K D++ GI+ +E++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 300 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISL 352
NF ++G G +G V+ G + A+K L+ + +TE ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 353 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
L + + T +L L+ Y+S G + + L + D + + + +L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILA 117
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
L I++RD+K NILLD V+ DFGL+K + T + GT+ ++APE
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 472 L-STGQSSEKTDVFGFGILLLELISG 496
+ G + D + GIL+ EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL 352
+NF + +G+G F VY+ L D VA+K+++ D A ++ E++++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQ 58
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARG 408
H N+++ + + E +V G ++ + K K + T + +
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG--- 465
+ ++H + +++HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLEL 493
+++PE + + K+D++ G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA 353
+ VG G FG V+ ++D A+K + I E E ++
Sbjct: 1 DDLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 354 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
H ++RL F +R L + Y+ G + S L+ +T A L Y
Sbjct: 59 SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPE 470
LH + +I++RD+K NILLD+ + DFG AK L D T + GT ++APE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPE 168
Query: 471 YLSTGQSSEKTDVFGFGILLLELISG 496
+ + ++ D + GIL+ E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G + V+KG + +VA+K ++ + G EV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 366 MTTTERLLVYPYMSN---------GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
T LV+ Y+ G++ S K L RGL Y H +
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAYCHRR- 123
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTG 475
K++HRD+K N+L++E E + DFGLA+ + V T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 476 QSSEKTDVFGFGILLLELISGLRALEFGKT 505
+ S + D++G G + E+ SG R L G T
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG-RPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLI 362
+ KG FG+VY + G A+K LK + I + E + + + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 363 GFCMTTTERL-LVYPYMSNGSVASRLKAKPSL--DWATRKRIALGAARGLLYLHEQCDPK 419
+ + + L LV Y++ G AS +K L DWA K+ G+ LH++
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLHQR---G 117
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IIHRD+K N+L+D+ + DFGL++ GT ++APE + +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDK 172
Query: 480 KTDVFGFGILLLELISGLRALE 501
+D + G ++ E + G
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 299 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISL 352
+F +G G FG V +K G A+K L + E ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLL 410
H L+ L G + LV Y+ G + S L+ + A AA+ +L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVL 112
Query: 411 ---YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
YLH I++RD+K N+LLD + DFG AK + T + GT ++
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYL 165
Query: 468 APEYLST---GQSSEKTDVFGFGILLLELISG 496
APE + + G++ D + GIL+ E+++G
Sbjct: 166 APEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GE------IQFQTEVEMIS-------L 352
+GKG FG VY ++D VA +RLK I GE +Q E +++S +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 353 AVHRNLLRLIGFCMTTT---ERLL---VYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 406
H + L FC+ T R L + G S + +W + +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV---CEWFIQLLL----- 117
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTAVRGTVG 465
G+ Y+H++ +I+HRD+KA NI L +GDFG+++LL CD + T GT
Sbjct: 118 -GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPY 170
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLEL 493
+++PE L K+D++ G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 52/226 (23%), Positives = 102/226 (45%), Gaps = 18/226 (7%)
Query: 272 DVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR 330
++ E+ R V +G+ K+ ++ +G+G G V+ + G VA+K+
Sbjct: 3 EIMEKLRTIVSIGDPKK-----------KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQ 51
Query: 331 LKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK 390
+ E+ + M L + N++ + + E +V Y++ GS+ + + +
Sbjct: 52 INLQKQPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSL-TDVVTE 109
Query: 391 PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450
+D A + + L +LH ++IHRD+K+ N+LL + DFG +
Sbjct: 110 TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
Query: 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
S +T V GT +APE ++ K D++ GI+ +E++ G
Sbjct: 167 PEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 7/155 (4%)
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIA 402
QTE + A L + C TT RL LV Y++ G + ++ + L + A
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA 102
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVR 461
L +LHE+ II+RD+K N+LLD + D+G+ K L D+ T+
Sbjct: 103 AEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFC 157
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT +IAPE L + D + G+L+ E+++G
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 37/115 (32%), Positives = 60/115 (52%), Gaps = 10/115 (8%)
Query: 393 LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452
LDW + I L L ++H D KI+HRD+K+ NI L + +GDFG+A++L+
Sbjct: 104 LDWFVQ--ICLA----LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154
Query: 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 507
T + GT +++PE + K+D++ G +L E+ + A E G N
Sbjct: 155 VELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAI--GGEIQFQTEVE 348
++LQ ++ ++G+G FG V + V A+K L I F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 349 MISLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLD-WATRKRIALGA 405
+++ A +++L FC ++ L V YM G + + + + WA
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYT 148
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAV 460
A +L L +IHRDVK N+LLD++ + DFG +D CD+ V
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV---- 204
Query: 461 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISG 496
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N L I L+ L+ + L NN+I + + + L L L+LSNN +P ++
Sbjct: 194 SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI 251
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+L L+ L L+NN ++ SL +++ L LDLS N+LS +P
Sbjct: 252 GNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPL 295
|
Length = 394 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR----- 360
+GKG FG VY+ +D + A+K L EI + EV RN+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVA--HTIGERNILVRTLLD 53
Query: 361 ----LIGF---CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 413
++G T ++ LV YMS G + L+ + R A +L L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALE 110
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
I++RD+K NILLD + DFGL+K + D+ T GT ++APE L
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 474 TGQSSEK-TDVFGFGILLLELISG 496
+ K D + G+L+ E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 7/205 (3%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G + V+KG + +VA+K ++ + G EV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
T LV+ Y+ + + K RGL Y H++ KI+HRD+
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDL 129
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 484
K N+L++E E + DFGLA+ + V T+ + P+ L + + S D++
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188
Query: 485 GFGILLLELISGLRALEFGKTANQK 509
G G +L E+ +G R + G T ++
Sbjct: 189 GVGCILYEMATG-RPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 14/196 (7%)
Query: 307 VGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLIG 363
+G GGFG V A+K +K + + Q +E E++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 364 FCMTTTERLLVY---PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
T ++ +Y Y G + + L+ + D T + YLH + I
Sbjct: 60 --RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
I+RD+K N+LLD + DFG AK L T GT ++APE +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 481 TDVFGFGILLLELISG 496
D + GILL EL++G
Sbjct: 173 VDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 52/224 (23%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 304 KNLVGKGGFGNVY----KGYLQ-------------DGTVVAVKRLKDGNAIGGEIQFQTE 346
K +G+G FG V+ +G + +VAVK L++ F E
Sbjct: 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV---ASRLKAK--------PSLDW 395
++++S N++RL+ C+T+ ++ YM NG + SR + + ++ +
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 396 ATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455
+T +A A G+ YL +HRD+ N L+ + Y + DFG+++ L D +
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 456 VTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
++G + ++ E + G+ + +DV+ FG+ L E+++
Sbjct: 187 ---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERLL-VYPYMSNGSVASRLKAKPSLDWATRKRIA 402
QTE + A + L + C T RL V Y++ G + ++ + L + +
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL-LDHCDSHVTTAVR 461
+ L YLHE+ II+RD+K N+LLD + D+G+ K L D+ T+
Sbjct: 103 AEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFC 157
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT +IAPE L D + G+L+ E+++G
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 29/86 (33%), Positives = 51/86 (59%), Gaps = 4/86 (4%)
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
G+ ++HE+ +++HRD+K+ NI L + + +GDFG A+LL ++ T V GT ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 468 APEYLSTGQSSEKTDVFGFGILLLEL 493
PE + K+D++ G +L EL
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 7/194 (3%)
Query: 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 363
L+GKG FG V + G A+K LK I + T E L R+ L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 364 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ T +RL V Y++ G + L + + L YLH KI++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVY 118
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+K N++LD+ + DFGL K D+ GT ++APE L D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 483 VFGFGILLLELISG 496
+G G+++ E++ G
Sbjct: 178 WWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 36/208 (17%)
Query: 307 VGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQT---------EVEMISLAVHR 356
VG G +G V + G VA+K+L FQ+ E+ ++ H
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHMKHE 74
Query: 357 NLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 409
N++ L+ T L LV P+M G+ +L L + + +GL
Sbjct: 75 NVIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469
Y+H IIHRD+K N+ ++E E + DFGLA+ DS +T V T + AP
Sbjct: 132 KYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAP 184
Query: 470 EY-LSTGQSSEKTDVFGFGILLLELISG 496
E L+ ++ D++ G ++ E+++G
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 307 VGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+G+G F ++KG ++ T V +K L + E F M+S H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE-SFFEAASMMSQLSHKHL 61
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY-LHEQCD 417
+ G C+ E ++V Y+ GS+ + LK +L + K L A+ L + LH D
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK---LEVAKQLAWALHFLED 118
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 474
+ H +V A N+LL + G+ KL D S + I PE +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 475 GQS-SEKTDVFGFGILLLELISG 496
Q+ S D + FG L E+ SG
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-08
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI--SLAVHR-----NL 358
+G+G G VY + G VA++++ +Q Q + E+I + V R N+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
+ + + E +V Y++ GS+ + + + +D + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 479 EKTDVFGFGILLLELISG 496
K D++ GI+ +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G +G+VYK + G + A+K +L+ G Q E+ M+ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---VVQQEIIMMKDCKHSNIVAYFG 73
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+ + + + GS+ L + ++ +GL YLH + +HR
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAPEYLST---GQ 476
D+K ANILL + + DFG++ + T A R GT +APE + G
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT-----ATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 477 SSEKTDVFGFGILLLEL 493
++ D++ GI +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
+ATS + + L G+G + VYKG + +G +VA+K + G E ++
Sbjct: 3 AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLH 413
H N++ L T V+ YM +A + P L + RGL Y+H
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD-HCDSHVTTAVRGTVGHIAPEYL 472
Q I+HRD+K N+L+ E + DFGLA+ ++ + V T+ + P+ L
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 473 --STGQSSEKTDVFGFGILLLELISG 496
+T SS D++G G + +E++ G
Sbjct: 176 LGATDYSSA-LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 301 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 358
F +G+G +G VYK +D G +VA+K+++ D G I E++++ HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 359 LRL----------IGFCMTTTERLLVYPYMSN---GSVASRLKAKPSLDWATRKRIALGA 405
+ L + F LV+ YM + G + S L + + L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-- 126
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
GL Y H++ +HRD+K +NILL+ + + DFGLA+L + +S T T+
Sbjct: 127 -EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 466 HIAPE-YLSTGQSSEKTDVFGFGILLLEL 493
+ PE L + DV+ G +L EL
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLK---DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+GKG +G+VYK + G +A+K ++ D + I E++++ AV ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65
Query: 363 GFCMTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
G + YM GS+ A + +RI +GL +L E+ +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG---HIAPEYLSTGQ 476
IIHRDVK N+L++ + + DFG++ L V + + +G ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 477 SSE------KTDVFGFGILLLELISG 496
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
L YLH +++RD+K N++LD+ + DFGL K D GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISG 496
PE L D +G G+++ E++ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 304 KNLVGKGGFGNVYKGYLQDGT----VVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHR 356
++GKGG+G V++ G + A+K LK + + + E ++ H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
++ LI T + L+ Y+S G + L+ + T + L +LH+Q
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ- 119
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
II+RD+K NILLD + DFGL K H + VT GT+ ++APE L
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSG 176
Query: 477 SSEKTDVFGFGILLLELISG 496
+ D + G L+ ++++G
Sbjct: 177 HGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
S + +G+G G V G VAVK++ E+ F EV ++ H N
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPN 77
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKRIALGAARGLLYL 412
++ + + E +V ++ G++ +R+ + + AT L A L +L
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQI--ATVCLAVLKA---LSFL 131
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV---RGTVGH--- 466
H Q +IHRD+K+ +ILL + DFG C + V+ V + VG
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF------C-AQVSKEVPRRKSLVGTPYW 181
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+APE +S + D++ GI+++E++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 357
NF +G+G +G VYK G VVA+K+++ D G E+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GL 409
+++L+ T + LV+ ++ K +D + I L + GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-------DLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469
+ H +++HRD+K N+L++ + DFGLA+ T V T+ + AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 470 E-YLSTGQSSEKTDVFGFGILLLELISGLRAL 500
E L S D++ G + E+++ RAL
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 464
ARG+ +L + K IHRD+ A NILL E + DFGLA+ + +V R +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+APE + + ++DV+ FG+LL E+ S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLI 362
+G+G +G VYKG + G +VA+K+++ + G T + ISL H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQ 65
Query: 363 GFCMTTTERLLVYPYMSNG--SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
M + L++ ++S L +D K +G+L+ H + ++
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SE 479
+HRD+K N+L+D + DFGLA+ V T T+ + APE L S
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 480 KTDVFGFGILLLELIS 495
D++ G + E+ +
Sbjct: 182 PVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 5/143 (3%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G +G V+K ++ +VA+KR++ D + G E+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
+ + LV+ Y +D K +GL + H ++HRD
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRD 124
Query: 425 VKAANILLDEYYEAVVGDFGLAK 447
+K N+L+++ E + DFGLA+
Sbjct: 125 LKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 32/86 (37%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
YLH D II+RD+K N+LLD V DFG AK + T + GT ++APE
Sbjct: 133 YLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185
Query: 471 YLSTGQSSEKTDVFGFGILLLELISG 496
+ + + D + G+LL E I+G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 300 NFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLA 353
+F K+LVG+G FG V K G + A+K +K + E F+ E +++S++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 354 VHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLY 411
+ +L + + L LV Y G + S L + + D A +L
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD---EDMAQFYLAELVLA 114
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
+H +HRD+K N+L+D + DFG A L + GT +IAPE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 472 LSTGQSSEKT------DVFGFGILLLELISGLRALEFGKTA 506
L+T K D + G++ E+I G G +A
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 45/191 (23%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G+G G V ++ G +VAVK++ E+ F EV ++ H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+ E +V ++ G++ + + ++ + L + L LH Q +IHRD+
Sbjct: 87 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDI 142
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485
K+ +ILL + DFG + + ++ GT +APE +S + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 486 FGILLLELISG 496
GI+++E++ G
Sbjct: 202 LGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 6/145 (4%)
Query: 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIG 363
+ +G FG VY G + + + AVK +K + I + Q + E +LA+ ++ ++ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+ LV Y+ G V S L D + A L YLH IIHR
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHR 128
Query: 424 DVKAANILLDEYYEAVVGDFGLAKL 448
D+K N+L+ + DFGL+K+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEV-------EMISL 352
++S VG G +G+V + G VA+K+L FQ+E+ E+ L
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR--------PFQSEIFAKRAYRELTLL 68
Query: 353 A--VHRNLLRLIGFCMTTT------ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 404
H N++ L+ + + LV PYM ++ P L + +
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHP-LSEDKVQYLVYQ 125
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 464
GL Y+H IIHRD+K N+ ++E E + DFGLA+ H D+ +T V T
Sbjct: 126 MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TR 178
Query: 465 GHIAPEY-LSTGQSSEKTDVFGFGILLLELISG 496
+ APE L+ ++ D++ G ++ E+++G
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 6/174 (3%)
Query: 323 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382
G VAVK++ E+ F EV ++ H N++ + + E +V ++ G+
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442
+ + + ++ + L R L YLH Q +IHRD+K+ +ILL + D
Sbjct: 106 L-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD 161
Query: 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
FG + + ++ GT +APE +S + D++ GI+++E+I G
Sbjct: 162 FGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 4/127 (3%)
Query: 372 LLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 429
LL+ Y S G + ++K K L + + + L + +L L E K++HRD+K+AN
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYE-VGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 430 ILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 488
I L +GDFG +K D V ++ GT ++APE + S+K D++ G+
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 489 LLLELIS 495
+L EL++
Sbjct: 260 ILYELLT 266
|
Length = 478 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 57/240 (23%), Positives = 91/240 (37%), Gaps = 45/240 (18%)
Query: 308 GKGGFGNVYKGYL-QDGTVVAVKRLKD--------GNAIGGEIQFQTEVEMISLAVHRNL 358
G+G F N+YKG L + V ++ G+ + F ++S H++L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-GAARGLLYLHEQCD 417
++L G C+ E ++V Y+ G + L + + K A L YL ++
Sbjct: 64 VKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK-- 120
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH----------I 467
K++H +V NIL+ Y G KL D + TV I
Sbjct: 121 -KLVHGNVCGKNILVAR-YGLNEGYVPFIKLSD-------PGIPITVLSREERVERIPWI 171
Query: 468 APEYLSTGQSS--EKTDVFGFGILLLELISG----------LRALEFGKTANQKGAMLDW 515
APE + GQ+S D + FG LLE+ S F + ++ M D
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL-PMPDC 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTT 458
R + A+G+ +L + IHRDV A N+LL + A + DFGLA+ +++ + V
Sbjct: 216 RFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R V +APE + + ++DV+ +GILL E+ S
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
RGL Y+H IIHRD+K +N+ ++E E + DFGLA+ H D +T V T +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 467 IAPE-YLSTGQSSEKTDVFGFGILLLELISG 496
APE L+ ++ D++ G ++ EL++G
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-AVRGTV 464
ARG+ +L + K IHRD+ A NILL E + DFGLA+ + +V + R +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+APE + + ++DV+ FG+LL E+ S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 5/154 (3%)
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIA 402
QTE + A + L + C T RL V ++S G + ++ + L + +
Sbjct: 43 QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS 102
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462
+ L +LHE+ II+RD+K N+LLD + D+G+ K T+ G
Sbjct: 103 AEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCG 158
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
T +IAPE L D + G+L+ E+++G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
RGL YLH I+HRD+K N+L++ + DFGLA++ + +S T T +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 467 IAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
APE L + + D++ G + EL+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 307 VGKGGFGNVYKGYLQDGTVVA---VKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG V + T VA VK LK + + +F + + + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR-------KRIALGAARGLLYLHEQC 416
C+ LLV+ Y G + S L + W R +R+A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKH- 118
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT------AVRGTVGHIAPE 470
+H D+ N L VGD+G+ + + ++ T +R APE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL----APE 171
Query: 471 YLSTGQ----SSEKT---DVFGFGILLLEL 493
+ ++E+T +V+ G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
+ N ++L T +L+ Y+ +G + LK + L A K+I L LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 415 QCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
IIH D+K N+L D + + + D+GL K++ + GT+ + +PE +
Sbjct: 128 H---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIK 179
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
D + G+L EL++G
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 38/160 (23%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLK-----DG---NAIGGEIQFQTEVEMISLAVHRN 357
+G+G +G VYK G +VA+K+++ +G AI EI E+ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELN------HPN 59
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA----------R 407
++RL+ + + LV+ ++ L K +D + L +
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLD-------LDLKKYMD--SSPLTGLDPPLIKSYLYQLLQ 110
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
G+ Y H +++HRD+K N+L+D + DFGLA+
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 20/199 (10%)
Query: 308 GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G+G + VYKG + G +VA+K ++ + G E ++ H N++ L
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH 73
Query: 367 TTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
T LV+ Y+ + + L + RGL Y H++ +++HRD+
Sbjct: 74 TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDL 129
Query: 426 KAANILLDEYYEAVVGDFGLAK---LLDHCDSH--VTTAVRGTVGHIAPEYL--STGQSS 478
K N+L+ E E + DFGLA+ + S+ VT R P+ L ST S+
Sbjct: 130 KPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGSTEYST 183
Query: 479 EKTDVFGFGILLLELISGL 497
D++G G + E+ +G
Sbjct: 184 S-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 54/239 (22%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVH 355
+F ++G+G FG V+ G V A+K L+ + I +I + E ++++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 356 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLD--WATRKRIA-LGAARGLLY 411
+++L + E L LV YM G + + L K A R IA L A L
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-RFYIAELVLA--LDS 116
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--------------------- 450
+H+ IHRD+K NIL+D + DFGL K ++
Sbjct: 117 VHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 451 ------------HCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
+S V GT +IAPE L G + D + G++L E++ G
Sbjct: 174 LVRRRDHKQRRVRANSTV-----GTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
VG+G +G+VYK +DG LK G + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 367 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 416
+ ++R L++ Y + AS+ KP L + K + G+ YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 417 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 470
++HRD+K ANIL+ E + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 471 YLSTGQSSEKT-DVFGFGILLLELIS 495
L + K D++ G + EL++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-06
Identities = 24/57 (42%), Positives = 30/57 (52%)
Query: 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
+LDLSNN T L L+ L L+ N+LT P + S + L LDLS NNL
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 39/207 (18%)
Query: 308 GKGGFGNVYKG-YLQDGTVVAVKRLKDG-------NAIGGEIQFQTEVEMISLAVHRNLL 359
G+G F V K + G A+K +K N + EIQ + L+ H N+L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQ-----ALRRLSPHPNIL 61
Query: 360 RLIGF-------CMTTTERLL---VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 409
RLI + L+ +Y + K L K + L
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDMNLYELIKG--------RKRPLPEKRVKSYMYQLLKSL 113
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469
++H I HRD+K NIL+ + + DFG + + T T + AP
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI--YSKPPYTEYISTRWYRAP 167
Query: 470 E-YLSTGQSSEKTDVFGFGILLLELIS 495
E L+ G K D++ G + E++S
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 363
L+GKG FG V + G A+K L+ I + T E L R+ L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 364 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA--ARGLLYLHEQCDPKI 420
+ T +RL V Y + G + L ++ + R R GA L YLH + +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSR---DV 116
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
++RD+K N++LD+ + DFGL K D GT ++APE L
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 481 TDVFGFGILLLELISG 496
D +G G+++ E++ G
Sbjct: 176 VDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 14/85 (16%)
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGTVGHIAPEYLST- 474
IHRDVK N+LLD+ + DFG +D CD TAV GT +I+PE L +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD----TAV-GTPDYISPEVLKSQ 218
Query: 475 ---GQSSEKTDVFGFGILLLELISG 496
G + D + G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 40/192 (20%), Positives = 82/192 (42%), Gaps = 19/192 (9%)
Query: 315 VYKGYLQDGTVVAVKRLK-DGNAIGGEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372
+YKG + V ++ K I + E++ + N+L++ GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 373 ----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAA 428
L+ Y + G + L + L + T+ +A+ +GL L++ ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSV 152
Query: 429 NILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAV---RGTVGHIAPEYLSTGQSSEKTDVF 484
+ L+ E Y+ + GL K+L +V V + I EY K D++
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT------IKDDIY 206
Query: 485 GFGILLLELISG 496
G++L E+ +G
Sbjct: 207 SLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 311 GFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
GF N+ YL GT+V V+ N ++ Q EV + H N++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68
Query: 366 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
T + ++ P+M+ GS S LK + A I GA RGL YLH+ IHR
Sbjct: 69 TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHR 125
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSE- 479
++KA++IL+ + +V GL+ H S V + V + P++ ++ S E
Sbjct: 126 NIKASHILISG--DGLVSLSGLS----HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 480 ----------KTDVFGFGILLLELISG 496
K+D++ GI EL +G
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
VG+G +G+VYK +DG LK G + E+ ++ H N++ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 367 TTTER--LLVYPYMSNG-------SVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 416
+ +R L++ Y + AS+ KP L K + G+ YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 417 DPKIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTVGHIAPE 470
++HRD+K ANIL+ E + D G A+L + + V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 471 YLSTGQSSEKT-DVFGFGILLLELIS 495
L + K D++ G + EL++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 6/174 (3%)
Query: 323 GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382
G VAVK + E+ F EV ++ H+N++ + + E ++ ++ G+
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442
+ + + ++ L+ + + L YLH Q +IHRD+K+ +ILL + D
Sbjct: 105 L-TDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSD 160
Query: 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
FG + D ++ GT +APE +S + D++ GI+++E++ G
Sbjct: 161 FGFCAQISK-DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD--HCDSHVTTAVRGTV 464
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H + T T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 465 GHIAPE-YLSTGQSSEKTDVFGFGILLLELISG 496
+ APE L++ ++ D++ G +L E++S
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 464
A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V R +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+APE + + ++DV+ FG+LL E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 38/207 (18%)
Query: 307 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQ--------TEVEMISLAVHRN 357
VG+GG+G V+ +D G +VA+KR+K + F+ TE ++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK------SLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 358 LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLD------WATRKRIALGAARGLL 410
L++L+ + E L L Y+ G + L L + A+ A
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA----- 116
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK-LLDHCDSHVTTAVRGTVGHIAP 469
LHE IHRD+K N L+D + DFGL+K ++ + +S V G+ ++AP
Sbjct: 117 -LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAP 167
Query: 470 EYLSTGQSSEKTDVFGFGILLLELISG 496
E L D + G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 6/194 (3%)
Query: 306 LVGKGGFGNV-YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIG 363
L+GKG FG V G A+K LK + + T E L R+ L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 364 FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ T +RL V Y + G + L + + L YLH + +++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+K N++LD+ + DFGL K D GT ++APE L D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 483 VFGFGILLLELISG 496
+G G+++ E++ G
Sbjct: 179 WWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 4/103 (3%)
Query: 79 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
PS S S ++ NL L + L N + +I +E+ +L+ L +LDL NN T IP
Sbjct: 77 PSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPL 134
Query: 139 VSHL-ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ L L+ L L++N + ++P L N+ L LDLS+N+LS
Sbjct: 135 IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 53/210 (25%), Positives = 82/210 (39%), Gaps = 39/210 (18%)
Query: 310 GGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHRNLLRLIGFCMTT 368
++ K + T+VAVK++ + +++ Q E+ H N+L
Sbjct: 13 LMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIV 70
Query: 369 TERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLLYLHEQCDPKIIHRD 424
L +V P M+ GS L + IA L Y+H + IHR
Sbjct: 71 DSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRS 126
Query: 425 VKAANILLDEYYEAVVGDFGLAKL--LDHCDSHVTTAVRGTVGH------------IAPE 470
VKA++ILL GD G L L + S + R V H ++PE
Sbjct: 127 VKASHILLS-------GD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 471 YLSTGQS----SEKTDVFGFGILLLELISG 496
L Q+ +EK+D++ GI EL +G
Sbjct: 179 VLQ--QNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
RGL Y+H IIHRD+K +N+ ++E E + DFGLA+ D +T V T +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYV-ATRWY 181
Query: 467 IAPE-YLSTGQSSEKTDVFGFGILLLELISG 496
APE L+ ++ D++ G ++ EL+ G
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 406 ARGLL----YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAV 460
AR LL Y+H + IIHRD+K N+L++ + +GDFG A + +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 492
GTV APE L+ + D++ G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 87 LSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
+ IG L NL+ + L +N I +P+ + L L LDLS N + +P +S+L L
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNL 188
Query: 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
L L+ N ++ +PP + +S L LDLS N++
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
RGL Y+H ++HRD+K AN+ ++ E +GDFGLA+++D SH G V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 466 --HIAPE-YLSTGQSSEKTDVFGFGILLLELISG 496
+ +P LS ++ D++ G + E+++G
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 307 VGKGGFGNVYKGYLQD---GTVVAVKRLK--------DGNAIGGEIQFQTEVEMISLAVH 355
+G+G +G VYK +D +A+K+++ AI EI E++ H
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ------H 60
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR--KRIALGAARGLLYLH 413
N++RL + LV+ Y+ + + + + P R K RG+ Y H
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE-Y 471
+++HRD+K N+L+D A+ + DFGLA+ T V T+ + APE
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 472 LSTGQSSEKTDVFGFGILLLELIS 495
L + S D++ G + E+++
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTV 464
A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V R V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+APE + + ++DV+ +GILL E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-- 463
ARG+ +L + +HRD+ A N+LL + + DFGLA+ + H ++V+ +G+
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 464 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V +APE + + +DV+ +GILL E+ S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEMISLAVHRNL 358
+GKG +G V+K + VVA+K++ D NA EI F E L H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE-----LGDHPNI 69
Query: 359 LRLIGFCMTTTER--LLVYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLH 413
++L+ ++ LV+ YM + L A L+ ++ I + L Y+H
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKALKYIH 124
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR----GTVGHIAP 469
+IHRD+K +NILL+ + DFGLA+ L + + V T + AP
Sbjct: 125 SG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 470 EYL--STGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
E L ST + ++ D++ G +L E++ G + L G T NQ
Sbjct: 182 EILLGST-RYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQ 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 9/91 (9%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
RGL Y+H ++HRD+K +N+LL+ + + DFGLA+ +T V T +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 467 IAPEYLSTGQSSEKT---DVFGFGILLLELI 494
APE L SE T DV+ G + EL+
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 23/61 (37%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 96 NLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
NL+ + L NN ++ IP L L LDLS N T P S L +L+ L L+ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 155 L 155
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 29/228 (12%)
Query: 299 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA 353
+F + L+ G +G VY K Q A+K++ N I +IQ Q VE L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQR---FAMKKINKQNLILRNQIQ-QVFVERDILT 56
Query: 354 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
N + FC T+R L V Y+ G A+ LK +L + L Y
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL------LDHCDSHVTTAVR---- 461
LH I+HRD+K N+L+ + DFGL+K+ + + H+ R
Sbjct: 117 LHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 462 ----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505
GT +IAPE + + D + GI+L E + G FG T
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
I++RD+K N+LLD+ + DFG AK++D T + GT +IAPE L +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGHGK 207
Query: 480 KTDVFGFGILLLELISG 496
D + GI + E++ G
Sbjct: 208 AADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 64/231 (27%), Positives = 92/231 (39%), Gaps = 50/231 (21%)
Query: 306 LVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGE---IQFQTEVEMISLAVHRNLLRL 361
L+GKG G V+ L+ G + A+K L D + + TE E+++ H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 413
T T LV Y G + L+ +P K ++ AR L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQP------GKCLSEEVARFYAAEVLLALEYLH 120
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------------ 461
I++RD+K NILL E ++ DF L+K D V+ A+R
Sbjct: 121 LL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 462 ----------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT +IAPE +S D + GILL E++ G
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 14/85 (16%)
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLD-----HCDSHVTTAVRGTVGHIAPEYLST- 474
IHRDVK N+LLD+ + DFG ++ CD+ V GT +I+PE L +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQ 218
Query: 475 ---GQSSEKTDVFGFGILLLELISG 496
G + D + G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 53/237 (22%), Positives = 91/237 (38%), Gaps = 46/237 (19%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+F S ++G+G FG V +D G V A+K L+ + + E E + V +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER-DILVEADS 60
Query: 359 LRLIGFCMTTTERL---LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
L ++ + ++L L+ ++ G + + L K +L T + A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL---TEEETQFYIAETVLAIDSI 117
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR-------------- 461
IHRD+K N+LLD + DFGL L +H T R
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFTFQN 175
Query: 462 ----------------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT +IAPE ++ D + G+++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
G+ +LH IIHRD+K +NI++ + DFGLA+ C + + T T +
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 468 APEYLSTGQSSEKTDVFGFGILLLELISG 496
APE + E D++ G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 48/202 (23%), Positives = 90/202 (44%), Gaps = 9/202 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYK-GYLQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVH 355
+ F +VG+G +G V K + + +VA+K+ KD E++ T E++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQ 59
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL-GAARGLLYLHE 414
N++ L + LV+ Y+ ++ L+ P+ + R + + + + H+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
I+HRD+K N+L+ + DFG A+ L + T T + +PE L
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 475 GQSSEKTDVFGFGILLLELISG 496
+ D++ G +L EL G
Sbjct: 176 APYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 29/126 (23%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433
+ + + P+L + + A G+ +L + +HRD+ A N+L+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273
Query: 434 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGIL 489
E + DFGLA+ + ++++ +G+ + +APE + + +DV+ FGIL
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 490 LLELIS 495
L E+ +
Sbjct: 331 LWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD----HCDSHVTTAVRG 462
GL Y+H ++HRD+K N+L++ E + DFGLA+ +T V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 463 TVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISG 496
T + APE + + QS K DV+ G +L EL+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 35/111 (31%), Positives = 47/111 (42%), Gaps = 9/111 (8%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
N L SIGNL+NL+ + L NN IS + +G L+ L LDLS N + +P
Sbjct: 242 NKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL- 298
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
L L L LN A+ L+ + L+ N LS S
Sbjct: 299 LLLLLELLLNLLLTLKALELKLN------SILLNNNILSNGETSSPEALSI 343
|
Length = 394 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 14/102 (13%)
Query: 421 IHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVRGTVGHIAPEYLST----- 474
+HRD+K NIL+D + DFG KL++ + AV GT +I+PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEDGK 182
Query: 475 GQSSEKTDVFGFGILLLELISGLRAL-------EFGKTANQK 509
G+ + D + G+ + E++ G +GK N K
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.5 bits (83), Expect = 0.002
Identities = 17/36 (47%), Positives = 24/36 (66%), Gaps = 2/36 (5%)
Query: 145 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ L L+NN +T +PP LSN+ L LDLS N ++
Sbjct: 3 LETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVRGTV 464
A +L +H +HRD+K N+LLD + DFG K+ + AV GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167
Query: 465 GHIAPEYLST-----GQSSEKTDVFGFGILLLELISG 496
+I+PE L G+ + D + G+ + E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 421 IHRDVKAANILLDEYYEAVVGDFG-LAKLLDHCDSHVTTAVR-GTVGHIAPEYL-----S 473
+HRD+K N+LLD+ + DFG +LL D V + V GT +I+PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
G+ + D + G+ + E++ G
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.89 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.41 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.28 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.16 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.84 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.83 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.65 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.64 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.63 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.55 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.55 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.54 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.54 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.47 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.47 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-55 Score=500.06 Aligned_cols=398 Identities=29% Similarity=0.492 Sum_probs=264.7
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
+++.|+|++|++++.+|..+.++++|+.|+|++|++.+.+|..+.++++|++|+|++|.++|.+|..+..+++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 45566666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCCCCCCCCCCCCCCcccccCCCCCCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPNSK 227 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~~~~~~~~~~~~p~~~~~~~~~~~~ 227 (517)
+|+++|.+|..+.++++|+.|++++|+++|.+|.... ....+.+|+..|+...... .| ...
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~------~~---------~c~ 620 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG------LP---------PCK 620 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC------CC---------CCc
Confidence 6666666666666666666666666666666664322 2334556665555321100 00 000
Q ss_pred CCCCCCcceeeeehhhhhHHHHHHHHHHHHHhhhhhcccccccccccchhhhhh--hc-CCCcccChHHHHHHhcCCCCC
Q 010149 228 PSGMPKGQKIALALGSSLGCISLLILGFGFLLWWRQRHNQQIFFDVNEQRREEV--CL-GNLKRFHFKELQSATSNFSSK 304 (517)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~~~~~~~~~ 304 (517)
. ........+++++++++++++++++++++++|+|+..+......+....+. .. .....+.++++ ...+...
T Consensus 621 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 695 (968)
T PLN00113 621 R--VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEE 695 (968)
T ss_pred c--ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcc
Confidence 0 001122233333333333333333333333333332211111000000000 00 00112223333 3457778
Q ss_pred CccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 305 NLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
++||+|+||.||+|+. .++..||||+++.... ...+|++.+++++|||||+++|++.+.+..++||||+++|+|
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 8999999999999996 5789999999864332 123568889999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecccc
Q 010149 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463 (517)
Q Consensus 384 ~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt 463 (517)
.++++ .++|..+..++.|+++||+|||+.++++|+||||||+||+++.++.+++. ||.+...... ....++
T Consensus 771 ~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t 841 (968)
T PLN00113 771 SEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFIS 841 (968)
T ss_pred HHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcccc
Confidence 99996 38999999999999999999997777799999999999999999988875 6655433211 122588
Q ss_pred ccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 464 ~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus 842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999999999999999999643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=401.29 Aligned_cols=230 Identities=54% Similarity=0.934 Sum_probs=201.1
Q ss_pred CCcccChHHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeee
Q 010149 285 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364 (517)
Q Consensus 285 ~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 364 (517)
....|++.++..+|++|+..+.||+|+||.||+|.+++|..||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999999999999886654432 5679999999999999999999999
Q ss_pred EecCC-cceEEEecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEc
Q 010149 365 CMTTT-ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 441 (517)
Q Consensus 365 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 441 (517)
|.+.+ +.+||||||++|+|.++++... .++|..|.+||.++|+||+|||+.+.|+|+||||||+|||+|+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 4999999999999999998654 89999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCccccccCcccccC
Q 010149 442 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516 (517)
Q Consensus 442 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~~~~~~~w~ 516 (517)
|||+|+.......+......||.+|+|||++..+..+.|+|||||||+++||+||++|.+...+..+.. .++|+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~-l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS-LVEWA 293 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc-HHHHH
Confidence 999997654312222211179999999999999999999999999999999999999998765322221 33774
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=360.67 Aligned_cols=203 Identities=27% Similarity=0.430 Sum_probs=182.3
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..+|...+.||+|+||+||+|+++ ++..||||.+.... .....+....|+.+++.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356788888999999999999965 68999999997654 2333445789999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC------CCeEEccccccccc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY------YEAVVGDFGLAKLL 449 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~ki~DFGla~~~ 449 (517)
|||.+|+|.++++..+.+++...+.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999999999999999999999999999999 99999999999999764 45899999999988
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.+ .....+.+|++-|||||++...+|+.|+|+||+|+|+|+|++|+.||+....
T Consensus 166 ~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 166 QP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred Cc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 74 3344567899999999999999999999999999999999999999985543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=340.63 Aligned_cols=198 Identities=29% Similarity=0.407 Sum_probs=180.7
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC-cceEEEecC
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~ 378 (517)
++..+.||+|..|+|||++++ +++.+|+|.+.......-.+++.+|+++++..+||+||+++|.|.... +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344688999999999999976 688999999976655556778999999999999999999999999988 599999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++|+|.+++...+.+++....+++.++++||.|||+. ++||||||||+|||++..|++||+|||.++.+.+. ...
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 9999999999888899999999999999999999963 29999999999999999999999999999877653 455
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+..||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 677999999999999999999999999999999999999999765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=339.91 Aligned_cols=205 Identities=28% Similarity=0.381 Sum_probs=186.0
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcc--hHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
..++|++.++||+|+||+||.++.+ +++.+|+|++++...... .+....|..++.+++||.||++...|.+.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3467899999999999999999954 689999999987654332 4568899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|+||+.||.|..+|++++.+++..++-++..|+.||.|||+. +||||||||+|||+|++|+++|+|||+++..-. .
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-D 178 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-C
Confidence 999999999999999999999999999999999999999999 999999999999999999999999999985432 3
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
...+.+.+||+.|||||++....|+..+|.||+|+++|||++|..||...+.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 3455668999999999999999999999999999999999999999987664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.14 Aligned_cols=199 Identities=37% Similarity=0.557 Sum_probs=174.9
Q ss_pred CCCccccccccceEEEEeCCCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCC-cceEEEecCcC
Q 010149 303 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYPYMSN 380 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~~~ 380 (517)
..+.+|+|+||+||+|.+.....||||++....... ...+|.+|+.++.+++|||||+++|+|.+.. ...+|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345699999999999999855559999997644222 2568999999999999999999999999988 78999999999
Q ss_pred CChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceEEcCCC-CeEEcccccccccCCCCCce
Q 010149 381 GSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 381 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~~~~ 456 (517)
|+|.++++. ...+++..+..++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 999999987 67899999999999999999999998 7 99999999999999997 99999999998765422 22
Q ss_pred eeeccccccccCccccc--cCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 457 TTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.....
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 23367999999999999 66999999999999999999999999986553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=350.73 Aligned_cols=203 Identities=28% Similarity=0.430 Sum_probs=186.6
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..|...++||+|+|+.+|.++. ..|+.||+|++.+.. .........+||++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 789999999997532 2334556889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+|++++|.++++..+.+++++++.++.||+.||.|||++ +|+|||||-.|++++++.++||+|||+|..+... .+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-GE 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-cc
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999988753 34
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
...+.+|||-|+|||++.....+..+||||+||++|-|++|++||+....
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 55678999999999999999999999999999999999999999998754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=335.91 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=178.6
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcc------hHHHHHHHHHHhccCCCcccceeeeEecCC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG------EIQFQTEVEMISLAVHRNLLRLIGFCMTTT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 369 (517)
..+.|.+.+.||+|+||.|-+|+. ++|+.||||++++...... ....++|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345677889999999999999994 5899999999986544331 223579999999999999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CCeEEcccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLA 446 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DFGla 446 (517)
..|+||||++||+|.+.+-.++.+.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999999999999999999999999999999999 99999999999999765 67999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCC---CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+... ......+.+||+.|.|||++.... +..++|+||+|||+|-+++|..||....
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 9876 345567789999999999997543 3348899999999999999999996543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=318.38 Aligned_cols=204 Identities=25% Similarity=0.373 Sum_probs=176.2
Q ss_pred cCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceee-eEecCCc-ceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIG-FCMTTTE-RLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~-~~~~~~~-~~lv 374 (517)
.+|.+.+.||+|.||+||++. ..+|..+|.|.++-.... ....+...|+.++++++|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 456778999999999999998 568999999998733322 22346789999999999999999999 4455555 7899
Q ss_pred EecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 375 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDP-KIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 375 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~-~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
|||+..|+|...++ +...+++..+++++.|+++||.++|+..++ -|+||||||.||+++.+|.+|++|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999886 456799999999999999999999995433 2889999999999999999999999999998
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... ......+|||.||+||.+....|+.|+||||+||++|||..-+.||...
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 7643 3345567999999999999999999999999999999999999999865
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.86 Aligned_cols=200 Identities=25% Similarity=0.367 Sum_probs=183.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+.... .+.+...+|..+++.+.||.++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999965 6899999999765432 23345789999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||.++|.|.+++++.+.+++..++-++.||+.|++|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999997653
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.+.+.+|||.|+|||.+....+..++|.|||||++|||+.|..||....+
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 36678999999999999999999999999999999999999999987665
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=334.96 Aligned_cols=197 Identities=32% Similarity=0.493 Sum_probs=176.2
Q ss_pred CCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 303 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
..+.||+|-||.||.|+++....||+|.++... -...+|.+|+++|++++|+|||+++|+|..++..+||||||+.|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 467899999999999999987899999997653 235689999999999999999999999999889999999999999
Q ss_pred hhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 383 VASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 383 L~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|.++|+. +..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...+.........
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 9999985 56799999999999999999999999 999999999999999999999999999996654444444444
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.-...|.|||.+..++++.|||||||||+||||+| |+.|++...
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 45679999999999999999999999999999999 888876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.33 Aligned_cols=206 Identities=27% Similarity=0.401 Sum_probs=180.0
Q ss_pred cCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC--CcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lv 374 (517)
+.|+..+.||+|+||.||+|+ ..+|+.||+|++...... +...-..+||.+|++++||||+++.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667889999999999999 568999999999866533 3344567999999999999999999988776 689999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+|||+. +|.-++.. .-.+++.+++.+++|++.||+|+|.+ +|+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999988 77777765 45799999999999999999999999 99999999999999999999999999999988766
Q ss_pred CceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCccccc
Q 010149 454 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~ 508 (517)
....+..+-|..|.|||++.+ ..|+.++|+||.|||+.||++|+..|+..++.++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ 328 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence 665666668999999999876 5799999999999999999999988887665433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=329.37 Aligned_cols=201 Identities=27% Similarity=0.428 Sum_probs=182.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.... ...+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999965 6889999998654433 234568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+.+ +|..++...+.++++.+..++.|++.||.|||++ +|.|||+||.|||++..+.+|++|||+|+.+.. ....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence 9987 9999999999999999999999999999999999 999999999999999999999999999998865 3455
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+.+.|||.|||||...+..|+..+|+||+|||+|||++|+.||....
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 667889999999999999999999999999999999999999997643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.40 Aligned_cols=219 Identities=22% Similarity=0.325 Sum_probs=191.8
Q ss_pred HHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 295 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 295 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
....++|+..++||+|+||.||.|+-+ +|..+|+|++++... .++.+....|-.+|...++|.||+++..|.+.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999954 799999999986543 23345688999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||||||++||++..+|...+.|++..++.++.+++-|+.-+|+. |++||||||+|+|||..|++||+|||++.-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999853211
Q ss_pred ----------------------CCCc------------------------eeeeccccccccCccccccCCCCcccceeh
Q 010149 452 ----------------------CDSH------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485 (517)
Q Consensus 452 ----------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 485 (517)
.+.. ......|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 001245999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCcCcCccccccCcccccC
Q 010149 486 FGILLLELISGLRALEFGKTANQKGAMLDWV 516 (517)
Q Consensus 486 ~Gvil~elltG~~P~~~~~~~~~~~~~~~w~ 516 (517)
+|||+|||+.|.+||..+++.+....++.|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999999999999999888777777663
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.71 Aligned_cols=206 Identities=25% Similarity=0.373 Sum_probs=182.0
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcc--hHHHHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
...+|..++.||+|+|++|++|+. ..++.+|||++.+...... .+-...|-++|.++ .||.|++|+-.|.++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999994 4789999999865433222 22356788888888 8999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+|+||+++|+|.+++++.+.+++...+.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|+.+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCc----------e--eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 453 DSH----------V--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 453 ~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
... . ...++||..|.+||++.....+..+|+|+||||+|+|+.|+.||....+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 211 1 1447899999999999999999999999999999999999999987654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.23 Aligned_cols=196 Identities=35% Similarity=0.531 Sum_probs=166.2
Q ss_pred CCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhc--cCCCcccceeeeEecCC----cceEE
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTTT----ERLLV 374 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~----~~~lv 374 (517)
....+++|+|+||.||||.++ ++.||||++... ..+.|++|-++++. ++|+||++++++-.... +++||
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 345678999999999999987 599999999643 35679999998875 48999999999987665 88999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~------~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
+||.+.|+|.++|+.+ .++|....+++..+++||+|||+. .+|+|+|||||++|||+.+|+++.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999999999876 689999999999999999999974 578999999999999999999999999999988
Q ss_pred cCCCCCc-eeeeccccccccCccccccCC------CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 449 LDHCDSH-VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 449 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
+...... .....+||.+|||||++.+.- .-.+.||||+|.|+|||++.-.-++.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 7654322 223366999999999996542 12468999999999999997665543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=305.65 Aligned_cols=202 Identities=23% Similarity=0.313 Sum_probs=176.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcc-hHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+.|+....+|+|+||.|||++.+ +|+.||||++........ .+-..+|++++++++|||+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677888999999999999976 699999999976544332 3346799999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|++..-|.+.-+....++.....+++.|+++|+.|+|++ +++||||||+|||++.++.+|+||||+|+.+.. ....
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 999865555544455689999999999999999999999 999999999999999999999999999998875 3455
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+....|..|.|||.+.+ .+|...+||||+||++.||++|..-|....
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 667779999999999987 789999999999999999999998776543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.47 Aligned_cols=203 Identities=30% Similarity=0.470 Sum_probs=177.9
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
..+....+.||+|+||+||+|... +...||||.+++.+..+...+|++|+++++.++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344556788999999999999843 35689999999887766788999999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC
Q 010149 372 LLVYPYMSNGSVASRLKA--------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
++|+|||..|+|.++|.. .++++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999961 12388999999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceee-eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 438 AVVGDFGLAKLLDHCDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 438 ~ki~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+||+|||+++.+-..+.+... ...-..+|||||.+..+++|++||||||||+|||++| |+.|+..-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence 999999999876554444322 2224579999999999999999999999999999999 99998653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=323.70 Aligned_cols=205 Identities=25% Similarity=0.374 Sum_probs=181.1
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC----cchHHHHHHHHHHhccC-CCcccceeeeEecCCc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 370 (517)
....|...+.||+|+||+|+.|.. .++..||+|++...... .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 446788999999999999999985 47899999977653111 22445678999999999 9999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CCeEEccccccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLL 449 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DFGla~~~ 449 (517)
.++||||+.+|+|.+++...+.+.+..++.++.|++.|++|+|++ +|+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999888999999999999999999999999 99999999999999999 99999999999877
Q ss_pred CCCCCceeeeccccccccCccccccCC-CC-cccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQ-SS-EKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~ 228 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV 228 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH
Confidence 4 2334556678999999999998866 75 789999999999999999999987553
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=289.97 Aligned_cols=198 Identities=28% Similarity=0.406 Sum_probs=173.6
Q ss_pred cCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcc-hHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.+|...+.+|+|.||.||+|+ .++|+.||||+++..+..++ .....+|++.++.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778899999999999999 45899999999987655544 3467899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+. +|...++. ...++..+.+.++.++++|++|+|.+ .|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 89998874 45789999999999999999999999 8999999999999999999999999999988765443
Q ss_pred eeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
.+.. +-|..|.|||.+.+. .|+...||||.|||+.||+-|..-|.
T Consensus 158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp 203 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP 203 (318)
T ss_pred cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence 3333 578999999998775 58999999999999999999864443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=311.01 Aligned_cols=200 Identities=30% Similarity=0.492 Sum_probs=172.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC--cceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lv~ 375 (517)
.++...+.||+|+||.||++... +|...|||.+....... ...+.+|+.++++++|||||+++|.....+ .+.+.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45667899999999999999965 48999999986653222 456889999999999999999999865555 588999
Q ss_pred ecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccccccccCC--
Q 010149 376 PYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDH-- 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~~~~~-- 451 (517)
||+++|+|.+++...+ .+++..++.+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999765 799999999999999999999999 9999999999999999 79999999999987663
Q ss_pred CCCceeeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
..........||+.|||||++..+. ...++||||+||++.||+||+.||..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 2223344567999999999998643 34599999999999999999999974
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=319.45 Aligned_cols=186 Identities=30% Similarity=0.490 Sum_probs=170.9
Q ss_pred CCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 303 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
..+-||+|+.|.||.|+++ ++.||||+++.-+ ..+|+.+++++||||+.+.|+|....-++||||||..|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3578999999999999997 7889999885422 367899999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccc
Q 010149 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462 (517)
Q Consensus 383 L~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~g 462 (517)
|++.|+....+.......|..+||.||.|||.+ .|||||||+-||||..+..+||+|||.++..... .....++|
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 999999999999999999999999999999999 9999999999999999999999999999876543 34456789
Q ss_pred cccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 463 t~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
|..|||||++.+.+.++|+||||||||||||+||..||..
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 9999999999999999999999999999999999999954
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=329.25 Aligned_cols=198 Identities=29% Similarity=0.499 Sum_probs=178.5
Q ss_pred CCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
...+.++||.|.||.||+|+++ ....||||.++....+.+..+|+.|..+|.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999976 246799999999888888889999999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||++|+|+.+|+. .+.+++.++..++++||.||.||-+. ++|||||.++|||++.+..+|++|||+++.+++...
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999984 56799999999999999999999999 999999999999999999999999999998866543
Q ss_pred ceeeecccc--ccccCccccccCCCCcccceehhhHHHHHHHh-CCCCc
Q 010149 455 HVTTAVRGT--VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRAL 500 (517)
Q Consensus 455 ~~~~~~~gt--~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~ 500 (517)
...+...|. .+|.|||.+..+++|.++|||||||++||.++ |.+|+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 333333333 69999999999999999999999999999887 99996
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.16 Aligned_cols=204 Identities=22% Similarity=0.324 Sum_probs=177.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||+||++... +++.||+|+++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 689999999964321 122346788999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~- 454 (517)
||+++|+|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999998888899999999999999999999999 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 455 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 455 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999998899999999999999999999999997
Q ss_pred cCcc
Q 010149 502 FGKT 505 (517)
Q Consensus 502 ~~~~ 505 (517)
....
T Consensus 238 ~~~~ 241 (363)
T cd05628 238 SETP 241 (363)
T ss_pred CCCH
Confidence 6543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=318.26 Aligned_cols=204 Identities=30% Similarity=0.496 Sum_probs=174.4
Q ss_pred HHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 292 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
+++....+.+.+.+.||+|+||+||+|++.. .||||+++.....+ ..+.|++|+..+++-||.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4455555667788999999999999999863 59999998665433 34579999999999999999999999999877
Q ss_pred ceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 371 RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
.+|..++++-+|+.+++. ...++..+.+.|+.||++||.|||.+ +|||||||+.||++++++.|||+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999984 45789999999999999999999999 9999999999999999999999999999643
Q ss_pred CCC-CCceeeeccccccccCcccccc---CCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 450 DHC-DSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 450 ~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
... .........|...|||||++.. .+|++.+||||||+|+|||+||..||.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 221 1111223348889999999864 468999999999999999999999997
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=301.62 Aligned_cols=204 Identities=28% Similarity=0.371 Sum_probs=179.3
Q ss_pred hcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.+.|+..++||.|..++||+|+ ...+..||||++.-++.......+.+|+..|+.++||||++++..|..+.+.|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578889999999999999999 457899999999877666556789999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||.+|++.++++. ...+++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999984 34589999999999999999999999 999999999999999999999999998765544332
Q ss_pred c---eeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 H---VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......||+.|||||++.. ..|+.|+||||||++.+||.+|..||...-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 1 1145679999999999543 468999999999999999999999997544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=313.23 Aligned_cols=201 Identities=24% Similarity=0.381 Sum_probs=179.1
Q ss_pred cCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
..|...+.||+|+.|.||.|+ ..+++.||||++.... ....+-+.+|+.+|+..+|+|||++++.|...++.|.||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 456677889999999999998 5578999999996543 23344578999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
|++|+|.+.+... .+++.++..|..++++||+|||.+ +|+|||||..|||++.+|.+||+|||++..+..... ..
T Consensus 352 m~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred cCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 9999999988755 489999999999999999999999 999999999999999999999999999988765443 44
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.+..||+.|||||+.....|++|.||||||++++||+-|..||-.+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 566799999999999999999999999999999999999999976543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.55 Aligned_cols=203 Identities=21% Similarity=0.282 Sum_probs=175.4
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.|+..+.||+|+||+||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999854 688999999965332 2234568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC--
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-- 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-- 454 (517)
|+++|+|.+++...+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999998888899999999999999999999998 999999999999999999999999999754311000
Q ss_pred --------------------------------------------ceeeeccccccccCccccccCCCCcccceehhhHHH
Q 010149 455 --------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 490 (517)
Q Consensus 455 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil 490 (517)
.......||+.|+|||.+.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234699999999999888899999999999999
Q ss_pred HHHHhCCCCcCcCcc
Q 010149 491 LELISGLRALEFGKT 505 (517)
Q Consensus 491 ~elltG~~P~~~~~~ 505 (517)
|||+||+.||.....
T Consensus 239 ~elltG~~Pf~~~~~ 253 (381)
T cd05626 239 FEMLVGQPPFLAPTP 253 (381)
T ss_pred HHHHhCCCCCcCCCH
Confidence 999999999976554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.31 Aligned_cols=201 Identities=22% Similarity=0.411 Sum_probs=182.6
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcc--hHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|++.+.||+|.||.|-+|+. ..|+.||||.+++....+. ...+.+|+++|+.++||||+.++.+|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577788999999999999994 6899999999987654432 335889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||..+|.|++|+...+.+++.+++.++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.. ..
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KK 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--cc
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999987753 34
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..++++|++.|.+||+..+.+| .+.+|-||+||+||-|+.|..||+.-+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 5567899999999999999887 578999999999999999999998654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=316.51 Aligned_cols=199 Identities=25% Similarity=0.358 Sum_probs=179.0
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
-|..++.||+|+.|.|..|++ .+|+.+|||++.+... ......+.+|+-+|+.+.|||++++++++++..+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366789999999999999995 5899999999976532 2234468899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++|.|++++-..+++.+.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|..-.+ ...
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gkl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Ccc
Confidence 999999999999999999999999999999999999998 999999999999999999999999999986443 344
Q ss_pred eeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
-.+.+|++.|.|||++.+.+| ..++||||.|||||.|+||+.||+.+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 456789999999999999887 57899999999999999999999844
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=319.71 Aligned_cols=213 Identities=26% Similarity=0.382 Sum_probs=185.6
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhcc-CCCcccceeeeEecCCcc
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 371 (517)
...++|...++||+|.||+|+.+..+ +++.+|||++++..... ..+..+.|.+++... +||.+++++..|...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34567888999999999999999976 68899999998775432 344677888888776 599999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
+.||||..||++..+ ...+.+++..++-++..|+.||.|||++ +||+||||-+|||+|.+|++||+|||+++..-.
T Consensus 445 ~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999994433 3456799999999999999999999999 999999999999999999999999999985332
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCccccccCccc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 513 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~~~~~~ 513 (517)
....+.+++|||.|||||++.+..|+..+|.|||||+||||+.|..||..+++++-++.++
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 2346778999999999999999999999999999999999999999999887766665554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=293.99 Aligned_cols=202 Identities=26% Similarity=0.349 Sum_probs=174.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcc-hHHHHHHHHHHhccCCCcccceeeeEecC--CcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 373 (517)
.++|+..+.|++|+||.||+|+.+ +++.||+|+++......+ .....+||.++.+.+|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356778899999999999999964 789999999986553333 23567999999999999999999988654 57899
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||++. +|...+.. ..++...+++.++.|+++|++|||.+ .|+|||||++|+|+++.|.+||+|||+|+.+..+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999987 88888874 45899999999999999999999999 8999999999999999999999999999988764
Q ss_pred CCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ...+...-|..|.|||.+.+. .|++..||||+|||+.||++++.-|....
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 3 334556679999999998765 58999999999999999999987776543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=311.94 Aligned_cols=202 Identities=24% Similarity=0.308 Sum_probs=174.9
Q ss_pred hcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCC-cceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT-ERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~-~~~lv 374 (517)
.++|...+.||.|+||.||+|+ ..+|..||||+++..-..-.+.--.+|+..++++. |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4578888999999999999999 45789999999976443222223468999999998 999999999999888 88999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+. +|++.++. +..+++..++.|+.||++||+|+|.+ |++|||+||+|||+.....+||+|||+|+.+...
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC-
Confidence 999976 99999984 56799999999999999999999999 9999999999999999999999999999987643
Q ss_pred CceeeeccccccccCccccc-cCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 454 SHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
...+..+.|..|+|||++. .+.|+.+.||||+|||++|+.+-+.-|....+
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 3456677999999999874 57789999999999999999998877765443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=319.29 Aligned_cols=204 Identities=22% Similarity=0.341 Sum_probs=176.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999965 689999999964321 122345788999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999998754321100
Q ss_pred -------------------------------------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCC
Q 010149 456 -------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498 (517)
Q Consensus 456 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~ 498 (517)
......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112359999999999988899999999999999999999999
Q ss_pred CcCcCcc
Q 010149 499 ALEFGKT 505 (517)
Q Consensus 499 P~~~~~~ 505 (517)
||.....
T Consensus 238 Pf~~~~~ 244 (364)
T cd05599 238 PFCSDNP 244 (364)
T ss_pred CCCCCCH
Confidence 9976543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=320.17 Aligned_cols=204 Identities=20% Similarity=0.290 Sum_probs=175.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||++... +++.||+|++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999854 789999999864321 223356888999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999998633210000
Q ss_pred ----------------------------------------------eeeeccccccccCccccccCCCCcccceehhhHH
Q 010149 456 ----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 489 (517)
Q Consensus 456 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvi 489 (517)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012459999999999988899999999999999
Q ss_pred HHHHHhCCCCcCcCcc
Q 010149 490 LLELISGLRALEFGKT 505 (517)
Q Consensus 490 l~elltG~~P~~~~~~ 505 (517)
+|||+||+.||.....
T Consensus 238 l~elltG~~Pf~~~~~ 253 (377)
T cd05629 238 MFECLIGWPPFCSENS 253 (377)
T ss_pred hhhhhcCCCCCCCCCH
Confidence 9999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.85 Aligned_cols=203 Identities=22% Similarity=0.279 Sum_probs=174.7
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.|+..+.||+|+||.||+|+.. +++.+|+|++..... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999964 688999999864321 2233468899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC---
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD--- 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~--- 453 (517)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998777899999999999999999999999 99999999999999999999999999975321100
Q ss_pred -------------------------------------------CceeeeccccccccCccccccCCCCcccceehhhHHH
Q 010149 454 -------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 490 (517)
Q Consensus 454 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil 490 (517)
........||+.|+|||++.+..++.++||||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234689999999999988999999999999999
Q ss_pred HHHHhCCCCcCcCcc
Q 010149 491 LELISGLRALEFGKT 505 (517)
Q Consensus 491 ~elltG~~P~~~~~~ 505 (517)
|||++|+.||...++
T Consensus 239 ~elltG~~Pf~~~~~ 253 (382)
T cd05625 239 YEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHhCCCCCCCCCH
Confidence 999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.19 Aligned_cols=199 Identities=24% Similarity=0.341 Sum_probs=177.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +++.||+|+++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999965 68899999986432 1223456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998664322
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....||+.|+|||.+....++.++|||||||++|||+||+.||....
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 23469999999999998889999999999999999999999996543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=281.50 Aligned_cols=201 Identities=29% Similarity=0.437 Sum_probs=180.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|++.+.||+|.||.||.|+.+ ++..||+|++.+.... .-..++.+|+++.+.++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367889999999999999999954 6789999999765422 2245789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 375 YPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 375 ~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||..+|+++..|. ....+++.....++.|+|.|+.|+|.. +|+||||||+|+|++..+..||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998 556799999999999999999999998 99999999999999999999999999886532
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|..||+...
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 344567889999999999999999999999999999999999999998644
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.65 Aligned_cols=203 Identities=21% Similarity=0.288 Sum_probs=175.2
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+|++.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999954 689999999864321 1223467899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC---
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD--- 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~--- 453 (517)
|+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998888899999999999999999999999 99999999999999999999999999975321000
Q ss_pred ---------------------------------------CceeeeccccccccCccccccCCCCcccceehhhHHHHHHH
Q 010149 454 ---------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 494 (517)
Q Consensus 454 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ell 494 (517)
........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00011346999999999999989999999999999999999
Q ss_pred hCCCCcCcCcc
Q 010149 495 SGLRALEFGKT 505 (517)
Q Consensus 495 tG~~P~~~~~~ 505 (517)
+|+.||.....
T Consensus 239 ~G~~Pf~~~~~ 249 (376)
T cd05598 239 VGQPPFLADTP 249 (376)
T ss_pred hCCCCCCCCCH
Confidence 99999976554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.69 Aligned_cols=199 Identities=25% Similarity=0.317 Sum_probs=176.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999965 689999999864321 123456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999865432
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 123458999999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.50 Aligned_cols=199 Identities=25% Similarity=0.350 Sum_probs=177.4
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+|++.+.||+|+||.||+|+.. +++.||+|+++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6788899999999999999975 589999999965321 2234568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999999999998888899999999999999999999999 999999999999999999999999999976543 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 2345699999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.17 Aligned_cols=196 Identities=24% Similarity=0.283 Sum_probs=171.7
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||+++.+ +|+.||+|+++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 789999999875321 222346788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecc
Q 010149 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461 (517)
Q Consensus 382 sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 461 (517)
+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 9999998888899999999999999999999999 99999999999999999999999999987532211 2223456
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||+.|+|||.+.+..++.++||||+||++|||+||+.||...+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 9999999999999899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.13 Aligned_cols=199 Identities=24% Similarity=0.305 Sum_probs=175.8
Q ss_pred cCCCCCCccccccccceEEEEeCC--CcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|+..+.||+|+||.||+|..+. +..||+|++.... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998543 3689999986432 122344688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 99999999999998888899999999999999999999999 9999999999999999999999999999876432
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 223569999999999988889999999999999999999999997644
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=313.81 Aligned_cols=206 Identities=22% Similarity=0.297 Sum_probs=176.9
Q ss_pred HHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 295 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 295 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
....++|+..+.||+|+||.||+++.. +++.+|+|++..... ......+.+|+.+++.++||||+++++++..+...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999965 588999999864221 12234578999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999999754 588999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeeeccccccccCccccccC----CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..........||+.|+|||.+... .++.++||||+||++|||++|+.||....
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 333233455699999999998653 37889999999999999999999997554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=295.15 Aligned_cols=195 Identities=27% Similarity=0.409 Sum_probs=165.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc-----ceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----RLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-----~~l 373 (517)
.|...+++|+|+||.||+|+.. +++.||||++..+.... .+|+++|++++|||||+++-+|....+ ..+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999965 57999999986554322 268999999999999999998865432 248
Q ss_pred EEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CCeEEcccccccc
Q 010149 374 VYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKL 448 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DFGla~~ 448 (517)
|||||+. +|.+.++. +..++.-.++-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 89888873 56788889999999999999999998 99999999999999965 8999999999998
Q ss_pred cCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+...... .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|...+.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~ 231 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS 231 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence 8765444 34457899999999876 5699999999999999999999988876554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=309.30 Aligned_cols=204 Identities=27% Similarity=0.427 Sum_probs=170.8
Q ss_pred HhcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 369 (517)
..++|.+.+.||+|+||.||+|.. .++..||+|+++..........+.+|++++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788899999999999999974 235689999997544434455789999999999 8999999999887654
Q ss_pred -cceEEEecCcCCChhhhhhcC----------------------------------------------------------
Q 010149 370 -ERLLVYPYMSNGSVASRLKAK---------------------------------------------------------- 390 (517)
Q Consensus 370 -~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------- 390 (517)
..++||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999988632
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc-eeeecccccc
Q 010149 391 ----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVG 465 (517)
Q Consensus 391 ----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~ 465 (517)
..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2477888999999999999999998 9999999999999999999999999999865332221 1223346688
Q ss_pred ccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 466 HIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 466 y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999988899999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=305.33 Aligned_cols=196 Identities=24% Similarity=0.294 Sum_probs=171.2
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||++... +|..||+|+++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999954 689999999965321 223346778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecc
Q 010149 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461 (517)
Q Consensus 382 sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 461 (517)
+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..... ........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccccc
Confidence 9999998877899999999999999999999999 9999999999999999999999999998753221 12223456
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.74 Aligned_cols=208 Identities=26% Similarity=0.348 Sum_probs=171.7
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-------------chHHHHHHHHHHhccCCCcccce
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------------GEIQFQTEVEMISLAVHRNLLRL 361 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~Ei~~l~~l~H~nIv~l 361 (517)
+..+.|++.+.||+|.||.|-+|+.. +++.||+|++.+..... ..+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999954 79999999996432111 12467899999999999999999
Q ss_pred eeeEecC--CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 362 IGFCMTT--TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 362 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
+.+..+. +..|||+|||..|.+...=.....+++.++++++.+++.||+|||.+ +|+||||||+|+|++++|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 9998765 56899999999998765444444499999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCC----CceeeeccccccccCccccccCC----CCcccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 440 VGDFGLAKLLDHCD----SHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 440 i~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
|+|||.+....... ........|||.|+|||....+. .+.+.||||+||+||.|+.|+.||.....-
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 99999987652211 11123356999999999987632 367899999999999999999999776543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=303.82 Aligned_cols=194 Identities=25% Similarity=0.328 Sum_probs=170.5
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|+||.||+|+.. +++.||+|+++... .......+..|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 58899999986432 122345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecccc
Q 010149 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463 (517)
Q Consensus 384 ~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt 463 (517)
.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 99998878899999999999999999999998 99999999999999999999999999997543222 223345699
Q ss_pred ccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 464 ~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 99999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.96 Aligned_cols=196 Identities=26% Similarity=0.300 Sum_probs=171.8
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||++... +|+.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999954 689999999975422 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecc
Q 010149 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461 (517)
Q Consensus 382 sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 461 (517)
+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..... ........
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccccc
Confidence 9999998878899999999999999999999999 9999999999999999999999999998754321 12223456
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 9999999999998899999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.59 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=172.9
Q ss_pred CCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|...+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999995 4789999999864322 22334678999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 999999888753 34689999999999999999999998 99999999999999999999999999998654321
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 2233468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=311.09 Aligned_cols=209 Identities=21% Similarity=0.287 Sum_probs=178.4
Q ss_pred HHHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecC
Q 010149 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 292 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
.++....++|+..+.||+|+||.||+++.. +++.+|+|++..... ......+.+|+.+++.++||||+++++.+...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455688999999999999999999965 688999999864221 12234578899999999999999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 9999999999999999998754 588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeccccccccCccccccC----CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.............||+.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 654333333455699999999998653 37889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.96 Aligned_cols=204 Identities=21% Similarity=0.336 Sum_probs=176.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||++... +++.||+|+++... .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999965 68999999986432 1223446788999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~- 454 (517)
||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 455 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 455 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred cCcc
Q 010149 502 FGKT 505 (517)
Q Consensus 502 ~~~~ 505 (517)
...+
T Consensus 238 ~~~~ 241 (360)
T cd05627 238 SETP 241 (360)
T ss_pred CCCH
Confidence 6554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=311.93 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=179.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +++.||+|+++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999965 689999999965321 123456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC--
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-- 453 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~-- 453 (517)
||+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998654332
Q ss_pred --------------------------CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 454 --------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 454 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122344599999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.39 Aligned_cols=203 Identities=20% Similarity=0.285 Sum_probs=175.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+++.. +++.||+|++.... .......+.+|+.++...+|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 67899999986422 1122345788999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999986 46789999999999999999999998 999999999999999999999999999987654333
Q ss_pred ceeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++.. +.++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 23334569999999999865 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=302.43 Aligned_cols=196 Identities=28% Similarity=0.375 Sum_probs=170.7
Q ss_pred CccccccccceEEEEe----CCCcEEEEEEecCCCC---CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 305 NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.||+|+||.||+++. .+++.||+|+++.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 3578999999864321 12234578899999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++|+|.+++...+.+.+..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 99999999998888889999999999999999999999 99999999999999999999999999987543222 222
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 34569999999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.54 Aligned_cols=200 Identities=26% Similarity=0.346 Sum_probs=173.0
Q ss_pred CCCCCCccccccccceEEEEe----CCCcEEEEEEecCCCC---CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 371 (517)
+|++.+.||+|+||.||+++. .+++.||+|++..... ......+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 3578999999864321 12234578899999999 599999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999998878899999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
..........||+.|+|||.+.+. .++.++|||||||++|||+||+.||..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 333333455699999999998764 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.94 Aligned_cols=203 Identities=31% Similarity=0.405 Sum_probs=185.8
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
..|...+.||+|+||.||+|.. ..++.||+|++......+...+.++|+.++...+++||.+++|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566779999999999999995 478999999998887777778899999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+.+|++.+.++....+++....-++.+++.|+.|||.+ +.+|||||+.|||+.++|.+|++|||.+..+.......
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999999999888889999999999999999999999 99999999999999999999999999998776543333
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.++.||+.|||||++....|+.|+||||||++.+||.+|..|+-...+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 677899999999999988999999999999999999999999876554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=303.20 Aligned_cols=203 Identities=22% Similarity=0.300 Sum_probs=174.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||.||+++.. +++.||+|++.... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 68999999986422 1122345888999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999975 45789999999999999999999999 999999999999999999999999999876544333
Q ss_pred ceeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 22233459999999999863 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=296.95 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=175.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|++.+.||+|+||.||+|+.+ +++.+|+|+++..... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 6889999998754322 234567899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|++++.+..+......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999987776665556789999999999999999999998 99999999999999999999999999998764433223
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 33456899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.16 Aligned_cols=192 Identities=31% Similarity=0.454 Sum_probs=161.8
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhc--cCCCcccceeeeEecCC----cc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTTT----ER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~----~~ 371 (517)
.......+.||+|.||+||+|.++ |+.||||++.... +..+.+|.++++. +||+||+.+++.-..++ +.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345667899999999999999998 8999999996433 5577788888764 59999999999876553 56
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-----QCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~-----~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
+||.+|.+.|||+++|.. ..++.....+++..+|.||+|||. +.+|.|.|||||+.|||+.+++.+.|+|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 899999999999999987 579999999999999999999995 46899999999999999999999999999999
Q ss_pred cccCCCCCc---eeeeccccccccCccccccCC------CCcccceehhhHHHHHHHh
Q 010149 447 KLLDHCDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELIS 495 (517)
Q Consensus 447 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~S~Gvil~ellt 495 (517)
......... .....+||.+|||||++...- ....+||||||.|+||+.-
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 766543222 223456999999999986432 2357999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=309.90 Aligned_cols=205 Identities=33% Similarity=0.448 Sum_probs=174.2
Q ss_pred HHhcCCCCCCccccccccceEEEEeCC--C--cE-EEEEEecCC--CCCcchHHHHHHHHHHhccCCCcccceeeeEecC
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQD--G--TV-VAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g--~~-vavK~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
...++....+.||+|+||.||+|+++. + .. ||||..+.. .......+|.+|.++|+.++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 344555566999999999999999653 2 23 899998752 3344566899999999999999999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
...++|||+|+||+|.++|+..+ .++..++..++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||+++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999766 599999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.-....... ....-..+|+|||.+..+.|+.++|||||||++||+++ |..||..-.
T Consensus 311 ~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 311 AGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred CCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 543111111 01124679999999999999999999999999999999 888987544
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.62 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=170.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCc-ccceeeeEecCC------c
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTT------E 370 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~------~ 370 (517)
.|+..+.||+|+||+||+|+.+ +|+.||+|+++..... +......+|+.+++.++|+| ||++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4555677999999999999954 7899999999866542 33345679999999999999 999999998877 6
Q ss_pred ceEEEecCcCCChhhhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAKP----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.++||||++. +|..++.... .++...++.++.||++||+|||++ +|+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 7899999976 8999887533 577788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+...-+. ...+...+|..|+|||++.+. .|+...||||+|||+.||++++.-|..+.+
T Consensus 168 ra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 168 RAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 9665322 234455689999999999876 689999999999999999998877765543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=306.16 Aligned_cols=203 Identities=25% Similarity=0.330 Sum_probs=176.8
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||+++.. +|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999964 689999999975432 223456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999865 6799999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeeeccccccccCccccc------cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 3334456999999999986 4567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.56 Aligned_cols=204 Identities=22% Similarity=0.280 Sum_probs=174.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
..++|+..+.||+|+||.||+++.. +++.+|+|++.... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467888999999999999999965 68899999986422 11223457889999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999988754 578899999999999999999998 99999999999999999999999999998764432
Q ss_pred CceeeeccccccccCccccccC----CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
........||+.|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 2233345699999999998643 47889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.03 Aligned_cols=201 Identities=26% Similarity=0.334 Sum_probs=172.7
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+|...+.||+|+||.||+|+.. +++.||+|+++.... ......+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999965 578999999875432 12233466777777766 5899999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 9999999999998877899999999999999999999998 99999999999999999999999999997543211 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++....++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 2334569999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.49 Aligned_cols=203 Identities=22% Similarity=0.288 Sum_probs=173.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||+++.+ +++.+|+|++.... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999965 57889999985422 1122335788999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999976 46789999999999999999999998 999999999999999999999999999976543333
Q ss_pred ceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 3333456999999999985 3467889999999999999999999997644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.13 Aligned_cols=203 Identities=33% Similarity=0.502 Sum_probs=176.8
Q ss_pred cCCCCCCccccccccceEEEEeC--CC----cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--DG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--~g----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
...+..+.||+|.||.||.|... +| ..||+|.++...+++...+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34456788999999999999954 23 3599999988877777889999999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccc
Q 010149 373 LVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 445 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGl 445 (517)
+++|||++|+|..+|++. ..++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999843 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeec-cccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 446 AKLLDHCDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 446 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+.+-..+....... .-..+|||||.+..+.++.|+|||||||++||++| |..||..-+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 995543333322222 23479999999999999999999999999999999 888986543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.71 Aligned_cols=202 Identities=25% Similarity=0.335 Sum_probs=178.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|+..+.||+|+||.||+++.. ++..+|+|.+..........++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999965 6889999998754333334578999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++|+|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+||++++++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence 9999999999988778999999999999999999999852 6999999999999999999999999999765332 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....|++.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233458999999999998899999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=296.55 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=172.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|+.+ ++..||+|+++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68899999997554444445678999999999999999999999998899999999
Q ss_pred CcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 985 898888643 4578999999999999999999998 999999999999999999999999999976543221 2
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 233458999999998865 568899999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=299.23 Aligned_cols=196 Identities=28% Similarity=0.380 Sum_probs=167.4
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhc-cCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.||+|+++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 578999999975321 1223345566666654 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|..++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 99999998877899999999999999999999998 99999999999999999999999999997643322 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 69999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=302.44 Aligned_cols=196 Identities=24% Similarity=0.287 Sum_probs=170.4
Q ss_pred CccccccccceEEEEe-CCCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||+++. .+|..||+|+++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999985 4789999999965321 222346778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 382 sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
+|..++.....+++..+..++.||+.||.|||+ . +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cccccc
Confidence 999999887789999999999999999999997 6 99999999999999999999999999987533211 222345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 69999999999998899999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=300.70 Aligned_cols=201 Identities=25% Similarity=0.335 Sum_probs=172.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCC-cccceeeeEecCCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lv~ 375 (517)
+|+..+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999965 57899999986532 122345677899999888765 5888999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 9999999999998877899999999999999999999998 99999999999999999999999999987532211 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2334569999999999999899999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=297.23 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=171.5
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++..........+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999965 6899999999755443444567889999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|++ ++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 577777654 45689999999999999999999999 99999999999999999999999999987543222 2
Q ss_pred eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2233458999999998865 4578899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.98 Aligned_cols=194 Identities=25% Similarity=0.331 Sum_probs=169.5
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.||+|+++.... ......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999965 688999999975322 22234578899998888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++..... .......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence 99999998778899999999999999999999999 9999999999999999999999999998743221 1223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 699999999999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.92 Aligned_cols=194 Identities=25% Similarity=0.337 Sum_probs=168.5
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.+|+|+++.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 678999999975422 22234577888888766 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|..++.....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 99999988778899999999999999999999999 99999999999999999999999999987532221 222345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 699999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=300.29 Aligned_cols=196 Identities=29% Similarity=0.370 Sum_probs=169.8
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.||+|+++.... ......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 578999999865321 22334577888888765 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|...+.....+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++....... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 99999998878899999999999999999999999 99999999999999999999999999987543222 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 69999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.82 Aligned_cols=202 Identities=27% Similarity=0.409 Sum_probs=179.7
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+...+.+.||+|.||.|..+....+..||||.++.........+|.+|+++|.+++|||||+++|+|..++..++++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 34556789999999999999998889999999998877777789999999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc-
Q 010149 379 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH- 455 (517)
Q Consensus 379 ~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~- 455 (517)
++|+|.+++... +........+|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||+++.+-..+.+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999865 4456677788999999999999998 9999999999999999999999999999966544443
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh--CCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt--G~~P~~~~ 503 (517)
......-..+|||||.+..++++.++|||+||+++||+++ ...||...
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 3344556789999999999999999999999999999876 77888653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=298.84 Aligned_cols=196 Identities=30% Similarity=0.394 Sum_probs=169.6
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.+ +++.||+|+++... .......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999965 68899999986432 122344567788888766 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 99999998878899999999999999999999998 99999999999999999999999999987543221 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 69999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=289.76 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=172.7
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.+|++.+.||+|+||.||+|.+. .+..||+|.++..........|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999853 36789999997654444456789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999875 35789999999999999999999998 99999999999999999999999999876543221
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
........++..|+|||.+....++.++|||||||++||+++ |+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 111122235678999999999999999999999999999775 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.63 Aligned_cols=202 Identities=24% Similarity=0.342 Sum_probs=178.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|++.+.||+|+||.||++... ++..+|+|.+..........++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467899999999999999999966 6889999988755433344578999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++|+|.+++...+.+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence 9999999999988778999999999999999999999742 7999999999999999999999999999765322 1
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 223458999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=297.90 Aligned_cols=196 Identities=30% Similarity=0.364 Sum_probs=167.4
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHH-HHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||+||+|+.. +|+.||+|++..... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 689999999864321 112234455554 56788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence 99999998888899999999999999999999999 9999999999999999999999999998753221 1223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 69999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=297.77 Aligned_cols=196 Identities=28% Similarity=0.353 Sum_probs=167.2
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHH-HHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 688999999864321 112334555554 57889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|...+.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999987532222 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 68999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.35 Aligned_cols=196 Identities=28% Similarity=0.358 Sum_probs=168.4
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhc-cCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.+ +|..||+|+++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 688999999975321 1223456667777765 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++.....+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 99999998877899999999999999999999999 99999999999999999999999999987432211 223445
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 69999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=297.71 Aligned_cols=201 Identities=24% Similarity=0.324 Sum_probs=172.2
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+|+..+.||+|+||.||+|... +|+.||+|+++.... ......+..|..++.... |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999964 689999999864321 223345778888888775 577888999999989999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GV 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC-Cc
Confidence 9999999999998878899999999999999999999998 9999999999999999999999999998754322 12
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2334569999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.40 Aligned_cols=210 Identities=18% Similarity=0.291 Sum_probs=174.6
Q ss_pred cCCCcccChHHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcc--hHHHHHHHHHHhccCCCcccc
Q 010149 283 LGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHRNLLR 360 (517)
Q Consensus 283 ~~~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~Ei~~l~~l~H~nIv~ 360 (517)
..+++.+...++ +......||+|++|.||+|.. +|+.||||+++....... .+.|.+|+.++.+++||||++
T Consensus 9 ~~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 9 INDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred cCcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 334455555554 222346799999999999998 588999999975432221 356889999999999999999
Q ss_pred eeeeEec----CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 010149 361 LIGFCMT----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436 (517)
Q Consensus 361 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 436 (517)
++|++.+ ....++||||+++|+|.+++.....+++.....++.|++.||.|||+.. +++||||||+||++++++
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENY 160 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCC
Confidence 9999876 3467899999999999999998888999999999999999999999732 788999999999999999
Q ss_pred CeEEcccccccccCCCCCceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 437 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 437 ~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||+...
T Consensus 161 ~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 161 KLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred cEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 99999999998654321 12348899999999976 688999999999999999999999998654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.84 Aligned_cols=196 Identities=29% Similarity=0.370 Sum_probs=168.2
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhc-cCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|... +++.||+|+++.... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999965 578999999865321 2223456667777765 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence 99999998777899999999999999999999998 99999999999999999999999999987532222 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 69999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=304.54 Aligned_cols=193 Identities=25% Similarity=0.323 Sum_probs=170.7
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|++.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 5799999999999999999995 468899999653 23467899999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+. ++|.+++.....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+..........
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 95 68998888777899999999999999999999998 999999999999999999999999999976433332333
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 445699999999999988999999999999999999999988743
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=298.69 Aligned_cols=196 Identities=26% Similarity=0.373 Sum_probs=171.5
Q ss_pred CccccccccceEEEEe----CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 305 NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
+.||+|+||.||+++. .+|+.+|+|+++.... ......+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3588999999965332 1223457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++...... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998877899999999999999999999998 99999999999999999999999999997654322 22334
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..|++.|+|||.+....++.++|||||||++|||+||+.||...+
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 569999999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.79 Aligned_cols=196 Identities=29% Similarity=0.356 Sum_probs=167.8
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHH-HHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||+||+|+.. +|+.+|+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999954 689999999864321 122334555554 46778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... .......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccc
Confidence 99999998888899999999999999999999998 9999999999999999999999999998753221 1222345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 69999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.34 Aligned_cols=196 Identities=28% Similarity=0.342 Sum_probs=166.4
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHH-HHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.+|+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 678899999864321 112234444443 56788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++.....+.+.....++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 99999998877889999999999999999999999 99999999999999999999999999997543221 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 69999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=295.47 Aligned_cols=194 Identities=26% Similarity=0.341 Sum_probs=169.2
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.+|+|+++..... .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 6789999999754321 2234577899988887 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|..++.....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 99999998777899999999999999999999999 99999999999999999999999999987532211 223345
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.37 Aligned_cols=199 Identities=27% Similarity=0.386 Sum_probs=168.7
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHH---hccCCCcccceeeeEecCCcceEE
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMI---SLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l---~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
|.+.+.||+|+||.||+|... +++.||+|+++.... ......+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999865 689999999964321 12234566666554 567899999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++|+|...+.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999988865 4689999999999999999999998 99999999999999999999999999987533221
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 22234569999999999998899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=292.99 Aligned_cols=201 Identities=26% Similarity=0.429 Sum_probs=169.5
Q ss_pred cCCCCCCccccccccceEEEEeCC-----------------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 361 (517)
.+|.+.+.||+|+||.||++.+++ +..||+|.++.........+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997532 346999998765444445679999999999999999999
Q ss_pred eeeEecCCcceEEEecCcCCChhhhhhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 010149 362 IGFCMTTTERLLVYPYMSNGSVASRLKAK-------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422 (517)
Q Consensus 362 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH 422 (517)
++++...+..++||||+++|+|.+++... ..+++.....++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999988532 2467888999999999999999998 9999
Q ss_pred cCCCCCceEEcCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh--CCCC
Q 010149 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRA 499 (517)
Q Consensus 423 ~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt--G~~P 499 (517)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 1223345789999999988889999999999999999997 5566
Q ss_pred cCc
Q 010149 500 LEF 502 (517)
Q Consensus 500 ~~~ 502 (517)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.66 Aligned_cols=203 Identities=25% Similarity=0.358 Sum_probs=181.6
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccC-CCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~l 373 (517)
...|+..+.||+|.||.||+++.+ +|+.+|+|.+.+..... ....+.+|+.+|+++. |||||.+.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456788899999999999999976 49999999997655433 2357899999999998 9999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC----CCeEEccccccccc
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKLL 449 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~DFGla~~~ 449 (517)
|||++.+|.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998866 499999999999999999999998 99999999999999633 47999999999987
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|..||......
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 75 44566778999999999999999999999999999999999999999876643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.37 Aligned_cols=204 Identities=29% Similarity=0.397 Sum_probs=172.0
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
.++|+..+.||+|+||.||+|+.. ++..||+|+++..........+.+|+++++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999998742 34579999997654444455688999999999 89999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC------------------------------------------------------------
Q 010149 371 RLLVYPYMSNGSVASRLKAK------------------------------------------------------------ 390 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 390 (517)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999987531
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc-eeee
Q 010149 391 ----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTA 459 (517)
Q Consensus 391 ----------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~-~~~~ 459 (517)
..+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2478888999999999999999998 9999999999999999999999999999765432221 1122
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..++..|+|||++....++.++|||||||++|||++ |+.||....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 335678999999988899999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=302.75 Aligned_cols=200 Identities=29% Similarity=0.397 Sum_probs=174.7
Q ss_pred CCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC------cceE
Q 010149 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ERLL 373 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------~~~l 373 (517)
+...+.||+|+||.||+|+. ..|+.||||.++........+...+|++++++++|||||++.+.-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44568899999999999995 4799999999987666666677899999999999999999999876543 5789
Q ss_pred EEecCcCCChhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCC--CeEEcccccc
Q 010149 374 VYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYY--EAVVGDFGLA 446 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~--~~ki~DFGla 446 (517)
|||||.+|+|...+.+ ...+++.+.+.+..++..||.|||++ +|+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999984 34699999999999999999999999 999999999999994 334 3599999999
Q ss_pred cccCCCCCceeeeccccccccCccccc-cCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+.+++. .....+.||..|++||.+. .+.|+.-+|.|||||++||.+||..||..-..
T Consensus 172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 987643 3667788999999999998 48899999999999999999999999976443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=300.55 Aligned_cols=203 Identities=29% Similarity=0.407 Sum_probs=171.6
Q ss_pred hcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
.++|...+.||+|+||.||+|+. .++..||||+++..........+.+|++++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688899999999999999963 245689999997554444456788999999999 89999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC------------------------------------------------------------
Q 010149 371 RLLVYPYMSNGSVASRLKAK------------------------------------------------------------ 390 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 390 (517)
.++||||+++|+|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999888532
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 391 ---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 391 ---------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1478889999999999999999998 9999999999999999999999999999865432221
Q ss_pred -eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 456 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 456 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1122335678999999999999999999999999999998 88898643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=282.70 Aligned_cols=208 Identities=24% Similarity=0.365 Sum_probs=174.7
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCC-CCCcchHHHHHHHHHHhccCCCcccceeeeEec-----CC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-----TT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-----~~ 369 (517)
....|...+.||+|+||.|.+++.. +|+.||+|++... ......++-.+|+++++.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666789999999999999954 7899999998632 222234567799999999999999999998865 35
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..|+|+|+|+ .+|...++.+..++.....-++.|+++||.|+|+. +|+||||||+|++++.+...||+|||+|+..
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 6799999995 59999999888899999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCC-CceeeeccccccccCccccc-cCCCCcccceehhhHHHHHHHhCCCCcCcCccccc
Q 010149 450 DHCD-SHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508 (517)
Q Consensus 450 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~ 508 (517)
.... ....+....|..|.|||.+. ..+|+...||||.|||+.||++|+.-|...+..++
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q 236 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ 236 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH
Confidence 5421 12224556899999999875 46799999999999999999999988877665433
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.07 Aligned_cols=200 Identities=22% Similarity=0.364 Sum_probs=169.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC-----cce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 372 (517)
+|++.+.||+|+||.||+|+.. ++..||+|+++.... .....++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999954 689999999864322 223446889999999999999999999886432 368
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||||+. ++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999998777899999999999999999999999 9999999999999999999999999999754322
Q ss_pred CC--ceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 453 DS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 453 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 11 12234568999999999865 67899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=293.04 Aligned_cols=196 Identities=30% Similarity=0.378 Sum_probs=169.5
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. +++.||+|+++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999997532 122334567888888777 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 99999998877899999999999999999999998 99999999999999999999999999987532211 222344
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 68999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=287.73 Aligned_cols=193 Identities=28% Similarity=0.381 Sum_probs=167.3
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|+||+||++... +++.+|+|.+...... .....+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 6889999998643221 1234577899999999999999999999999999999999999999
Q ss_pred hhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 384 ASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 384 ~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 88774 345689999999999999999999998 999999999999999999999999999976544322 2234
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 56899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.20 Aligned_cols=195 Identities=24% Similarity=0.389 Sum_probs=165.3
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999965 689999999965544334567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++|+|... ...++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.+.... ....
T Consensus 155 ~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 226 (353)
T PLN00034 155 DGGSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCN 226 (353)
T ss_pred CCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccc
Confidence 99998653 2356778889999999999999998 99999999999999999999999999998664321 1223
Q ss_pred eccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 459 AVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
...||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 4469999999998743 2345689999999999999999999974
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.65 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=180.8
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCc-ceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-RLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-~~lv~ 375 (517)
++|...+.+|+|+||.++..+.+ ++..+++|.+....... .....+.|+.++++++|||||.+.+.+++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888999999999999998865 67899999987554332 23367899999999999999999999999888 89999
Q ss_pred ecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 376 PYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 376 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+|++||++.+.+... ..+++.....++.|++.|+.|||++ +|+|||||+.||+++.++.+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999743 5789999999999999999999998 99999999999999999999999999999987654
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
. ......||+.||.||.+.+.+|..|+||||+||++|||.+-+++|...+.
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 2 34556799999999999999999999999999999999999999987664
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.23 Aligned_cols=201 Identities=24% Similarity=0.332 Sum_probs=171.8
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecCC-----cce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 372 (517)
+|+..+.||+|+||.||++.. .+|+.||+|++.... ......++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 478999999986432 1223456889999999999999999999998766 679
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+|+||+. ++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 58888887777899999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.........+++.|+|||.+.+. .++.++||||+||++|||++|+.||+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 33233334578999999998764 47899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=280.07 Aligned_cols=201 Identities=26% Similarity=0.416 Sum_probs=173.9
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|+..+.||+|+||.||++.++++..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 3577788999999999999998888899999886432 23467889999999999999999999999999999999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||.++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999874 34689999999999999999999998 999999999999999999999999999986543222222
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
....++..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 22335678999999988889999999999999999999 899997544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=285.61 Aligned_cols=200 Identities=29% Similarity=0.420 Sum_probs=172.7
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+|+..+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999964 689999999864322 1223457789999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999988764 34689999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||.+....++.++||||+|+++|||++|+.||....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1223458999999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=289.48 Aligned_cols=201 Identities=25% Similarity=0.459 Sum_probs=170.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.+|+..+.||+|+||.||+|++. ++. .||+|.++.........++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999854 333 48999987544444456788999999999999999999998764 5679
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++||+++|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999999976 34688999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcee-eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 453 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 453 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
..... ....++..|+|||++....++.++||||||+++|||++ |+.||+..
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22211 12234678999999999999999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=284.68 Aligned_cols=199 Identities=26% Similarity=0.406 Sum_probs=165.8
Q ss_pred CCCCCCccccccccceEEEEeC--CCcEEEEEEecCCCCCc-chHHHHHHHHHHhcc---CCCcccceeeeEec-----C
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMT-----T 368 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~-----~ 368 (517)
+|.+.+.||+|+||.||+|+.. ++..||+|+++...... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999853 46889999986543322 234566777776655 69999999998852 3
Q ss_pred CcceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
...++||||++ ++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 45789999997 589888864 34589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..... .......|++.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 865432 22334558999999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=272.78 Aligned_cols=203 Identities=24% Similarity=0.343 Sum_probs=178.3
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++.|++.++||+|.|+.||+... .+|+.+|+|++..... ..+.+++.+|+++.+.++|||||++...+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788889999999999999875 4789999998864432 22456788999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccccccccCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFGla~~~~~ 451 (517)
+|+|.|++|..-+-.+..+++..+..++.||+++|.|+|.+ +|||||+||+|+++.. .--+|++|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999988777667889999999999999999999999 9999999999999943 3358999999999876
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+........|||+|||||++...+|+..+|||+.|||||-|+.|..||-..+
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 4455566779999999999999999999999999999999999999997643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=267.79 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=175.3
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc---c----hHHHHHHHHHHhcc-CCCcccceeeeEec
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG---G----EIQFQTEVEMISLA-VHRNLLRLIGFCMT 367 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~----~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 367 (517)
.-..|...+++|.|..+.|.+...+ +|+..|+|++....... . .+.-..|+.+++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 4456788899999999999998855 68899999986432211 1 12356789999988 69999999999999
Q ss_pred CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
+...++|+|.|+.|.|++++...-.+++...++|+.|+.+|+.|||.+ .||||||||+|||+|++.++||+|||+|.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence 999999999999999999999988999999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCceeeeccccccccCccccc------cCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.+.+. ......+|||+|+|||.+. ...|+...|+|+.|||+|-++.|-.||-.
T Consensus 172 ~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 172 QLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred ccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 87643 4456788999999999884 24578899999999999999999999853
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=279.22 Aligned_cols=201 Identities=29% Similarity=0.468 Sum_probs=174.7
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 35688889999999999999998888899999886432 2346789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999864 35688999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
......++..|+|||++....++.++||||||+++|||+| |+.||...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 2223345678999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.64 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=171.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|+.+ +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999965 67889999997554444445678899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 985 78877764 34589999999999999999999998 999999999999999999999999999976433222 2
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223457899999998864 568899999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=282.47 Aligned_cols=202 Identities=31% Similarity=0.500 Sum_probs=172.5
Q ss_pred cCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|+..+.||+|+||.||+|.... ...||+|.++.........+|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778999999999999998542 25799999875544444567899999999999999999999999988999
Q ss_pred EEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 010149 373 LVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 436 (517)
++|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998643 4578899999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 437 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 437 ~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999976533221 12223346789999999988899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=277.62 Aligned_cols=202 Identities=30% Similarity=0.426 Sum_probs=174.5
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|...+.||+|++|.||+|...+++.||+|.++... ....++.+|++++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45688889999999999999998778899999986543 2356788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997543 689999999999999999999998 9999999999999999999999999999876532221
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.......+..|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1111223458999999988899999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=283.65 Aligned_cols=197 Identities=32% Similarity=0.541 Sum_probs=167.5
Q ss_pred CCccccccccceEEEEeC-----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.+.||.|.||.||+|.+. .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 357899999976544444678999999999999999999999999888899999999
Q ss_pred cCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc-
Q 010149 379 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH- 455 (517)
Q Consensus 379 ~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~- 455 (517)
++|+|.+++... ..+++..+..++.||++||.|||++ +++|+||+++||++++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999875 7899999999999999999999998 9999999999999999999999999999876332222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
......+...|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2223347789999999999889999999999999999999 78898654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=292.77 Aligned_cols=194 Identities=26% Similarity=0.315 Sum_probs=163.4
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhcc---CCCcccceeeeEecCCcceEEEecCcC
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA---VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
||+|+||+||+|+.. +++.||+|++...... .....+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 6899999998643211 1123345566666554 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+|.+++...+.+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 99999998888899999999999999999999999 99999999999999999999999999987543222 223345
Q ss_pred cccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.||+.|+|||.+.+. .++.++|||||||++|||+||+.||...+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 699999999998654 47899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.75 Aligned_cols=203 Identities=26% Similarity=0.458 Sum_probs=173.8
Q ss_pred cCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
.+|.+.+.||+|+||.||+|...+ +..||+|.++..........+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 47899999976554434568999999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCe
Q 010149 373 LVYPYMSNGSVASRLKAK--------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 438 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 438 (517)
+||||+++++|.+++... ..+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999998643 3478899999999999999999998 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 439 VVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 439 ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+|||+++........ ......+++.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999765332211 1123335788999999999999999999999999999999 999986433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=277.39 Aligned_cols=202 Identities=29% Similarity=0.415 Sum_probs=175.9
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC----cchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|...+.||+|++|.||+|.. .+++.+|+|.+...... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 46899999998643221 123468889999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|+||+++++|.+.+.....+++.....++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998877899999999999999999999998 99999999999999999999999999997654322
Q ss_pred Ccee--eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 2111 2345788999999999888999999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.61 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=172.3
Q ss_pred HhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~ 369 (517)
..++|.+.+.||+|+||.||+|+.. .+..||+|+++..........+.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888999999999999999852 234799999976544444567899999999996 999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcC-----------------------------------------------------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 390 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------- 390 (517)
..++||||+++|+|.+++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999887531
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 391 -------------------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 391 -------------------------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
..+++..+..++.|+++||.|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 2377888899999999999999998 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 434 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 434 ~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999865432221 1223346788999999988889999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=279.58 Aligned_cols=191 Identities=28% Similarity=0.376 Sum_probs=165.4
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|+||.||++..+ +|+.+|+|.+..... ......+..|++++++++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 689999999864321 12233456799999999999999999999999999999999999999
Q ss_pred hhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecc
Q 010149 384 ASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461 (517)
Q Consensus 384 ~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 461 (517)
.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 988753 33589999999999999999999998 9999999999999999999999999999866432 2223345
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 89999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.41 Aligned_cols=203 Identities=25% Similarity=0.388 Sum_probs=172.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|++.+.||+|+||.||+|+.. +|+.||+|+++..... ....+|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999965 6899999999754322 22456899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 376 PYMSNGSVASRLKA-----------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 376 e~~~~gsL~~~l~~-----------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
||+++|+|.+++.. ....++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998863 12356778889999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 445 LAKLLDHCDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 445 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9986521110 01122459999999999999999999999999999999999999997533
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.67 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=172.4
Q ss_pred CCCCCCccccccccceEEEEeC-C-CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-D-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.|...+.||+|+||.||+|... + +..||+|.+.... ......+.+|+.+++.++|||||++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3778899999999999999854 3 6778888764332 23334678899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 378 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 378 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999987753 45689999999999999999999998 99999999999999999999999999998764322
Q ss_pred C-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 2234456999999999999889999999999999999999999999754
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=284.53 Aligned_cols=201 Identities=25% Similarity=0.337 Sum_probs=175.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|++.+.||+|+||.||++... ++..+|+|.++.........++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999965 68889999986543333345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.++++....+++..+..++.|+++||.|||+.+ +++||||||+||++++++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence 999999999988788999999999999999999999732 8999999999999999999999999998755322 12
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 33458899999999988889999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=276.65 Aligned_cols=201 Identities=30% Similarity=0.481 Sum_probs=173.9
Q ss_pred cCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|+..+.||+|+||.||+|++.. ...||+|.++.........+|.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998642 4589999987655444456789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++++|.+++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999875 34789999999999999999999998 99999999999999999999999999998765222
Q ss_pred Cc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 454 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 454 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
.. ......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 21 2222335678999999988899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=276.97 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=173.1
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|...+.||+|+||.||+|..+++..+|+|.++... ....+|.+|+.++.+++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3567788999999999999998777789999986432 23457899999999999999999999999888899999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++|+|.+++.. ...+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++..........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999999875 34689999999999999999999998 999999999999999999999999999886543322222
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 22335678999999988889999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=276.13 Aligned_cols=199 Identities=29% Similarity=0.414 Sum_probs=171.3
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
+|+..+.||+|+||.||+|..+++..+|+|.+..... ...++.+|+++++.++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4677899999999999999988778899999864322 34568899999999999999999999999999999999999
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 380 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 380 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
+++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999999875 44689999999999999999999998 9999999999999999999999999999765432222222
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||+..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 2224568999999998899999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=281.18 Aligned_cols=205 Identities=25% Similarity=0.416 Sum_probs=172.0
Q ss_pred HhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
..++|+..+.||+|+||.||+|... .+..||+|+++.........++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567889999999999999998753 3567999998654433344578899999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEE
Q 010149 371 RLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 440 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 440 (517)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998642 2357888999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 441 GDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 441 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+|||+++......... .....+++.|+|||++....++.++|||||||++|||++ |..||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999987654322211 112235778999999988889999999999999999999 788886543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=276.87 Aligned_cols=204 Identities=25% Similarity=0.302 Sum_probs=174.1
Q ss_pred CCCCCCccccccccceEEEEeCC-CcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.|...+.||+|.-|+||.+.+++ +..+|+|++.+..... ...+.+.|-++|+.++||.++.|++.++.++..+++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45557889999999999999774 5899999997554332 23467789999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC---
Q 010149 377 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH--- 451 (517)
Q Consensus 377 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~--- 451 (517)
||+||+|...++++ +.+++..++-++..++-||+|||.. |||.|||||+||||.++|++.++||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999998854 4699999999999999999999999 999999999999999999999999998742210
Q ss_pred ------------------------------C-C---------------------CceeeeccccccccCccccccCCCCc
Q 010149 452 ------------------------------C-D---------------------SHVTTAVRGTVGHIAPEYLSTGQSSE 479 (517)
Q Consensus 452 ------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 479 (517)
. . ...+...+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 01123356999999999999999999
Q ss_pred ccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 480 KTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 480 ~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
++|.|+|||++|||+.|+.||....-.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 999999999999999999999765543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.48 Aligned_cols=206 Identities=24% Similarity=0.300 Sum_probs=174.3
Q ss_pred HHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC----
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT---- 369 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 369 (517)
....+|.+.+.||+|+||+||+|+. .+|+.||+|++..... ......+.+|+..+..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 4789999999865432 223456889999999999999999988775432
Q ss_pred ----cceEEEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEc
Q 010149 370 ----ERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 441 (517)
Q Consensus 370 ----~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 441 (517)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 25799999999999998863 34689999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCC-CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 442 DFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999998654322 122334569999999999999999999999999999999999999997543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.76 Aligned_cols=199 Identities=29% Similarity=0.479 Sum_probs=173.9
Q ss_pred CCCCccccccccceEEEEe-CCC----cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 302 SSKNLVGKGGFGNVYKGYL-QDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~-~~g----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
...++||+|+||+||+|.+ ..| .+||+|++..........++.+|+-.|..++|||+++++|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999985 333 4789999987777777789999999999999999999999998876 789999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+.|+|.++++. +..+-....+.|..|||+||.|||++ ++|||||.++|||+.+-..+||.|||+|+.+......
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999984 56788899999999999999999999 9999999999999999999999999999987654433
Q ss_pred eeeec-cccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..... .-.+.|||=|.+....|+.++|||||||++||++| |..|++...
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 33222 23468999999999999999999999999999999 999987543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=272.48 Aligned_cols=196 Identities=34% Similarity=0.489 Sum_probs=169.2
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChh
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 384 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 384 (517)
++||+|+||.||+|...++..+|+|.++..........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999875543333456889999999999999999999999999999999999999999
Q ss_pred hhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecccc
Q 010149 385 SRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463 (517)
Q Consensus 385 ~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt 463 (517)
+++.. ...+++..+..++.|++.||.|+|+. +++||||||+||++++++.+|++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 98874 34689999999999999999999998 999999999999999999999999999875443222222222346
Q ss_pred ccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 464 ~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
..|+|||++....++.++||||||+++||+++ |..||...
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 78999999988889999999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.20 Aligned_cols=202 Identities=29% Similarity=0.434 Sum_probs=169.4
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC-C
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-T 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-~ 369 (517)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++..........+..|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888999999999999999732 34789999987544333445678899999999 899999999988654 4
Q ss_pred cceEEEecCcCCChhhhhhcC-----------------------------------------------------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 390 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------- 390 (517)
..+++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 577999999999999888531
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce-eeecccccccc
Q 010149 391 --PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHI 467 (517)
Q Consensus 391 --~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~ 467 (517)
..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2578999999999999999999998 99999999999999999999999999998764332221 22334667899
Q ss_pred CccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 468 APEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 468 aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.52 Aligned_cols=218 Identities=23% Similarity=0.309 Sum_probs=192.0
Q ss_pred HHHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecC
Q 010149 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 292 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
.+++...++|.+.++||+|+||.|..++++ +++.+|+|++++... ......|.+|-++|..-+.+-||+++-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455666788999999999999999999975 688999999975322 23345799999999999999999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...|+|||||+||+|-..+.....+++..++-++..|+-||.-+|+. |+|||||||.|||+|..|++|++|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence 99999999999999999999888899999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCceeeeccccccccCccccc----c-CCCCcccceehhhHHHHHHHhCCCCcCcCccccccCcc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLS----T-GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 512 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~~~~~ 512 (517)
++....-.+...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..+...++-+.+
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI 293 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI 293 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence 8765555566677999999999984 2 67999999999999999999999999887655444433
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=278.30 Aligned_cols=193 Identities=26% Similarity=0.396 Sum_probs=169.8
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|+..+.||+|+||.||+|+. .+++.+|+|.+..........++.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999985 4789999999865443344557889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 82 DGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred CCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 999987542 468889999999999999999998 9999999999999999999999999999765432 222
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
...|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 34689999999999988899999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=279.54 Aligned_cols=201 Identities=29% Similarity=0.463 Sum_probs=171.0
Q ss_pred cCCCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|+..+.||+|+||.||+|.. .++..+|+|.++.........++.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567789999999999999984 24678999999754443344678899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 010149 374 VYPYMSNGSVASRLKAK-----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 436 (517)
||||+++++|.+++... ..+++.....++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999988522 2478899999999999999999998 999999999999999999
Q ss_pred CeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 437 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 437 ~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999986543221 12223335678999999988889999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.75 Aligned_cols=195 Identities=28% Similarity=0.391 Sum_probs=167.1
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-C-----CcccceeeeEecCCcce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-H-----RNLLRLIGFCMTTTERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~~~~~~~~~~~ 372 (517)
+|++.++||+|+||.|-+|.. ++++.||||+++.... -..+-..|+.++..++ | -|+|+++++|...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 788999999999999999994 5799999999976543 2345668999998886 3 36999999999999999
Q ss_pred EEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC--CCeEEcccccccc
Q 010149 373 LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--YEAVVGDFGLAKL 448 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DFGla~~ 448 (517)
||+|.+.. +|+++++.+ ..++...++.++.||+.||.+||+. +|||+||||+|||+.+- ..+||+|||.|.+
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999965 999999854 4688999999999999999999998 99999999999999643 3799999999987
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... ... ....+..|+|||++.+.+|+.+.||||||||+.||++|..-|..+.
T Consensus 341 ~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 543 222 4557889999999999999999999999999999999955454443
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=281.81 Aligned_cols=202 Identities=29% Similarity=0.392 Sum_probs=176.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCC--CCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG--NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.+.|..-++||+|+||.||.+..+ +|+.+|.|.+.+. +...++.-..+|-.++.++..+.||.+-..|+..+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356777899999999999998855 6899999887432 1223344567899999999999999999999999999999
Q ss_pred EecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 375 YPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+..|.||+|.-++.+ .+.+++..++-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|+|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999988875 34899999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... ...+||.+|||||++.+..|+...|.||+||++|||+.|+.||....
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 433 23369999999999999999999999999999999999999997543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=293.75 Aligned_cols=195 Identities=27% Similarity=0.435 Sum_probs=168.3
Q ss_pred ccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChh
Q 010149 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 384 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 384 (517)
+||+|.||+||.|+.. +...+|||-+....+. ...-+.+|+.+.++++|.|||+++|.+.+.+..-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999955 5667999998654432 2335789999999999999999999999999999999999999999
Q ss_pred hhhhc-CCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccccCCCCCceeeec
Q 010149 385 SRLKA-KPSL--DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 385 ~~l~~-~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
+.+.. -+++ ++.++--+.+||++||.|||++ .|||||||-.|||++ -.|.+||+|||.++.+..- ...+.++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 99984 4666 7888889999999999999999 999999999999995 6789999999999877543 2344556
Q ss_pred cccccccCccccccC--CCCcccceehhhHHHHHHHhCCCCcC-cCcc
Q 010149 461 RGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALE-FGKT 505 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvil~elltG~~P~~-~~~~ 505 (517)
-||..|||||++..+ .|..++|||||||++.||.||+.||- .+.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp 784 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP 784 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence 699999999999765 48899999999999999999999994 4443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=276.67 Aligned_cols=202 Identities=26% Similarity=0.425 Sum_probs=168.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.+|...+.||+|+||.||+|++. ++. .+++|.+..........++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35777899999999999999964 444 4777877543322233567788888999999999999998754 45778
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999975 45789999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... ......++..|+|||.+....++.++||||||+++|||+| |+.||...+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 221 2233457789999999988899999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=271.68 Aligned_cols=206 Identities=25% Similarity=0.313 Sum_probs=183.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcch--HHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
-++|+..++||+|.||+|..++-+ .++.+|+|++++....... ..-..|-+++...+||.+..+...|...+..+.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999854 7899999999876544322 3456788999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||..||.|+-++.....++++..+-+...|+.||.|||++ +||.||||.+|.|+|++|++||+|||+++.-- ...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 99999999999999888999999999999999999999999 99999999999999999999999999997421 233
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcccc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 507 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~ 507 (517)
..+.+++|||.|+|||++....|..++|.|.+||++|||+.|+.||...+-+.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 45677899999999999999999999999999999999999999998765443
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=278.54 Aligned_cols=198 Identities=27% Similarity=0.377 Sum_probs=171.0
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|+..+.||+|+||.||++... +++.+|+|.+....... ....+..|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999965 68899999986433222 234577899999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999988632 3589999999999999999999998 99999999999999999999999999987654322
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 112345899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=274.70 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=173.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|++.+.||+|+||.||+|+. .+++.+|+|++..... .....+.+|+.++.+++||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4688899999999999999996 4688999999864432 2344678899999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........ ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 99999999998777899999999999999999999998 999999999999999999999999999986543211 12
Q ss_pred eeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....|+..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 2345889999999874 3457889999999999999999999986443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=278.24 Aligned_cols=198 Identities=28% Similarity=0.403 Sum_probs=171.1
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|...+.||+|+||+||+|... +++.+|+|.+...... .....+.+|+++++.++|+||+++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556788999999999999864 6889999998643221 2234577899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999988864 34689999999999999999999998 99999999999999999999999999997654321
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 123345899999999998889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=274.58 Aligned_cols=201 Identities=27% Similarity=0.447 Sum_probs=172.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|...+.||+|+||.||+|..+ .++.||+|.+.... ....++.+|+++++.++||||+++++++......+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 34677889999999999999965 58899999986432 2345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|+++||+|||++ +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999864 34689999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2222234668999999988899999999999999999998 999986533
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.65 Aligned_cols=199 Identities=31% Similarity=0.446 Sum_probs=170.8
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.+|.+.+.||+|+||.||+|...++..||+|+++.... ...++.+|+++++.++||||+++++++. ....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46888899999999999999987777899999875332 3457899999999999999999999874 45678999999
Q ss_pred cCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999975 24579999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.....++..|+|||+..+..++.++||||||+++|||+| |+.||+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 223346778999999988899999999999999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=273.36 Aligned_cols=198 Identities=26% Similarity=0.400 Sum_probs=177.3
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
|.+.+.||+|+||.||+|.++ .|+.+|+|.+.... ...++..|+.+|.+.+.|++|+++|.|......++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 556788999999999999965 69999999997654 35678899999999999999999999999999999999999
Q ss_pred CCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 380 NGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 380 ~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
.|+..+.+. +++++++.++..++...++||+|||.. .-+|||||+.|||++.+|.+|++|||.|..+.+.. ....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN 187 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN 187 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence 999999987 567899999999999999999999998 78999999999999999999999999997654321 2334
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
++.||+-|||||++..-.|+.++||||+|++..||..|+.|+..-.+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 56799999999999999999999999999999999999999865443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.08 Aligned_cols=197 Identities=31% Similarity=0.457 Sum_probs=167.5
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
+.||+|+||.||+|... +++.+|+|.+...........+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999964 78999999886544444456789999999999999999999999999999999999999999
Q ss_pred hhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee-eecc
Q 010149 384 ASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVR 461 (517)
Q Consensus 384 ~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~-~~~~ 461 (517)
.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999875 34689999999999999999999998 999999999999999999999999999875442211111 1112
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.+..|+|||.+..+.++.++||||||+++|||++ |..||+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3467999999988889999999999999999998 888886433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=291.86 Aligned_cols=195 Identities=29% Similarity=0.481 Sum_probs=169.0
Q ss_pred CCCccccccccceEEEEeC-CCcEEEEEEe---cCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc--ceEEEe
Q 010149 303 SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRL---KDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE--RLLVYP 376 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~---~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--~~lv~e 376 (517)
..++||+|+|-+||+|... +|..||--.+ ..........+|..|+++++.++||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999965 5777774333 233344445689999999999999999999999987665 668999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~~~~~~ 455 (517)
.|..|+|..|+++.+..+....+.|+.||++||.|||++ +|+|+|||||-.||+|+ ..|.+||+|+|+|..+... +
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--H 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--c
Confidence 999999999999999999999999999999999999997 89999999999999997 4589999999999987643 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.. .+.|||.|||||++. ..|++.+||||||+-++||+|+..||.-
T Consensus 201 ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 201 AK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 22 367999999999996 7899999999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=276.79 Aligned_cols=204 Identities=30% Similarity=0.423 Sum_probs=171.6
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
+++|.+.+.||+|++|.||+|... .+..||+|.+...........|..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 466888999999999999999965 35789999886544444455789999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEc
Q 010149 372 LLVYPYMSNGSVASRLKAKP-------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVG 441 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~ 441 (517)
++||||+++++|.+++.... .+++..+..++.||+.|++|||++ +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 99999999999999987432 589999999999999999999998 999999999999998654 58999
Q ss_pred ccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 442 DFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999998663322111 112223568999999988899999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=278.14 Aligned_cols=199 Identities=26% Similarity=0.350 Sum_probs=176.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||++... +++.+|+|.++.... ......+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999965 689999999864322 223456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999999876433
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+++.|+|||.+.....+.++||||||+++|||++|+.||...+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233458899999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=272.00 Aligned_cols=200 Identities=31% Similarity=0.455 Sum_probs=171.4
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|++.+.||+|+||.||+|...++..+|+|.++.... ...++.+|+.++++++|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 346788899999999999999988888999999865432 3457899999999999999999999875 4568899999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999875 34589999999999999999999998 9999999999999999999999999999876443222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
......++..|+|||++...+++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 2222335678999999988889999999999999999999 88898653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.78 Aligned_cols=201 Identities=28% Similarity=0.433 Sum_probs=168.2
Q ss_pred cCCCCCCccccccccceEEEEeCC-C--cEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-g--~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|++.+.||+|+||.||+|+.++ + ..+++|.++..........+.+|++++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998653 3 347888886443333445788999999988 799999999999999999999
Q ss_pred EecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCe
Q 010149 375 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 438 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 438 (517)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999998643 2478899999999999999999998 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 439 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 439 ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+|||++...... ........+..|+|||++....++.++|||||||++|||+| |..||....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999998643211 11111123567999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=280.39 Aligned_cols=201 Identities=30% Similarity=0.457 Sum_probs=168.4
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCc--EEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 373 (517)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.++.........++.+|++++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356788899999999999999964 444 46888776544334456788999999999 89999999999999999999
Q ss_pred EEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC
Q 010149 374 VYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
||||+++++|.+++... ..+++..+..++.|++.|++|||++ +++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 99999999999998643 2578999999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 438 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 438 ~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+||+|||++....... ......++..|+|||++....++.++||||||+++|||+| |..||...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 9999999986422111 1111224668999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=271.41 Aligned_cols=195 Identities=29% Similarity=0.420 Sum_probs=164.1
Q ss_pred ccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 306 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
.||+|+||.||+|.+. .+..||+|++...........+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999754 356799999876544334457899999999999999999999875 457789999999999
Q ss_pred hhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee--e
Q 010149 383 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--A 459 (517)
Q Consensus 383 L~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~--~ 459 (517)
|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++............ .
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999874 45789999999999999999999998 9999999999999999999999999999865433222111 1
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..++..|+|||.+....++.++||||||+++||+++ |+.||....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 123578999999988889999999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=259.24 Aligned_cols=206 Identities=28% Similarity=0.344 Sum_probs=173.3
Q ss_pred HhcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC-----c
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----E 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~ 370 (517)
..++|.+.+.+|+|||+.||.+. ..++..+|+|++.-.. .++.+..++|++..++++|||+++++++...+. +
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45678899999999999999998 6688999999997554 445667889999999999999999999886543 4
Q ss_pred ceEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 371 RLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.|++++|+..|+|.+.+. ++..+++.+.+.|+.++++||.+||+. .+++.||||||.|||+.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999886 344799999999999999999999997 456999999999999999999999999998
Q ss_pred cccCCCCC--------ceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDS--------HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....-.-. ........|..|.|||.+. +...++++|||||||++|+|+.|..||+...
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 75421100 1112334789999999985 4557899999999999999999999998643
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=271.14 Aligned_cols=201 Identities=28% Similarity=0.424 Sum_probs=175.3
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|++|.||+|..+ +++.|++|.+.... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999965 68999999986432 223345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998753 5789999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||+..+..++.++||||||++++||++|+.||....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 2233458899999999998889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=290.96 Aligned_cols=197 Identities=27% Similarity=0.336 Sum_probs=171.4
Q ss_pred hcCCCCCCccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 356889999999999999999753 3578999987543 2346899999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||++. ++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.++|+|||++........
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99996 68888887777899999999999999999999998 999999999999999999999999999976544322
Q ss_pred c-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 H-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2234569999999999998899999999999999999999999996543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=287.67 Aligned_cols=193 Identities=33% Similarity=0.437 Sum_probs=168.9
Q ss_pred CCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|+..+.||+|+||.||-|+. .+.+.||||++.-.... ....++..|+..+.+++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44567899999999999994 57899999998643322 2235789999999999999999999999999999999999
Q ss_pred CcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|- |+-.+++. ..+++.+-++..|..+.++||+|||+. +.||||||+.|||+++.|.+|++|||.|..+.+.
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 95 58888776 456799999999999999999999999 9999999999999999999999999999877643
Q ss_pred eeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 457 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
..+.|||.|||||++. .+.|+-|+||||+|++-.||...++|+..
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 3467999999999874 57899999999999999999999999754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.38 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=168.4
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC-----
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----- 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 369 (517)
..++|...+.||+|+||.||+++.. +|..||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999864 689999999865432 223456789999999999999999999886543
Q ss_pred -cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 370 -ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 370 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..++||||+++ ++.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 46899999976 56665543 478899999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+
T Consensus 173 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 173 ACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 22233458999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=274.31 Aligned_cols=201 Identities=26% Similarity=0.454 Sum_probs=170.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|+..+.||+|+||+||+|.+. ++. .||+|+++.........++.+|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56778899999999999999853 444 4899998765544445678899999999999999999999875 45779
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++||+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 9999999999999975 45689999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 453 DSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 453 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.... .....+++.|+|||...+..++.++||||||+++|||++ |..||+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 2211 112235678999999988899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.11 Aligned_cols=202 Identities=25% Similarity=0.430 Sum_probs=175.1
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-----cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
+|...+.||+|+||.||+|...+++.+|+|.++..... .....+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778999999999999999888999999988643221 1224588999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC-
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD- 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~- 453 (517)
+||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998777889999999999999999999998 99999999999999999999999999987643211
Q ss_pred ----CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 ----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
........|+..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 111223458899999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=269.77 Aligned_cols=194 Identities=29% Similarity=0.409 Sum_probs=165.5
Q ss_pred ccccccccceEEEEe---CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 306 LVGKGGFGNVYKGYL---QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
.||+|+||.||+|.+ .++..+|+|+++..... ....++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 35788999998644322 23457889999999999999999999875 45678999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee--ee
Q 010149 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA 459 (517)
Q Consensus 382 sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~--~~ 459 (517)
+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.+........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777899999999999999999999998 999999999999999999999999999987654332211 12
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
..++..|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 224578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.24 Aligned_cols=201 Identities=20% Similarity=0.343 Sum_probs=173.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||.||+|+.. +++.||+|.++.... .....++.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999954 789999998764322 223456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++|+|.+++. ....+++..+..++.|+++||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875 234588999999999999999999998 999999999999999999999999999887643
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 221 122345888999999998888899999999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=271.18 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=163.1
Q ss_pred CccccccccceEEEEeCC---CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998876544344457889999999999999999999999999999999999999
Q ss_pred ChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 382 SVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 382 sL~~~l~~~-----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+|.+++... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999998642 2456778889999999999999998 99999999999999999999999999997543322111
Q ss_pred -eeeccccccccCccccccC-------CCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 457 -TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 457 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.....++..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1233477889999988532 35789999999999999996 999996543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=274.05 Aligned_cols=200 Identities=32% Similarity=0.406 Sum_probs=176.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|+..+.||.|++|.||+|+.. +++.+|+|.+...........+.+|+++++.++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777899999999999999965 688999999875544444567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++.+..... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999999865 789999999999999999999998 999999999999999999999999999987654322 222
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...++..|+|||++.+..++.++||||||+++|||+||+.||+..+
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 3458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=271.88 Aligned_cols=203 Identities=28% Similarity=0.438 Sum_probs=172.5
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.+|.+.+.||+|+||.||+|+.. .+..+|+|.++..........+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 23479999987544333455789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++++|.+++... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999754 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred Cceeee--ccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
...... ..++..|+|||.+....++.++||||||+++||+++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 222211 123568999999988889999999999999999887 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=294.69 Aligned_cols=196 Identities=23% Similarity=0.322 Sum_probs=161.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-------- 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------- 368 (517)
..+|...+.||+|+||.||+|+.. +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457889999999999999999964 68899999885422 2345799999999999999999887432
Q ss_pred CcceEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEccc
Q 010149 369 TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDF 443 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DF 443 (517)
...++||||+++ ++.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 6766654 356789999999999999999999999 999999999999998665 7999999
Q ss_pred ccccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 444 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 444 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|+|+.+..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99986643222 223458999999998865 468999999999999999999999997543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=270.64 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=172.9
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+.|.+.+.||+|+||.||+|..++++.+|+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 456888899999999999999988899999999865432 3457899999999999999999999864 4678999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999998864 34689999999999999999999998 9999999999999999999999999999766532222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 2223346678999999988889999999999999999999 999996443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.35 Aligned_cols=205 Identities=27% Similarity=0.407 Sum_probs=174.8
Q ss_pred HhcCCCCCCccccccccceEEEEeCC-----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec-CCc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTE 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~ 370 (517)
..++|...+.||+|+||.||+|...+ +..|++|++...........+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678889999999999999999765 688999998755444445678899999999999999999998776 467
Q ss_pred ceEEEecCcCCChhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcc
Q 010149 371 RLLVYPYMSNGSVASRLKAK--------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998642 4589999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 443 FGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+++.+...+... .....++..|+|||++....++.++||||||+++||+++ |+.||....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 99998664333221 122346778999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.83 Aligned_cols=201 Identities=25% Similarity=0.377 Sum_probs=171.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|+.+ +++.||+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999865 68899999987554444455678899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 97 588888764 45689999999999999999999998 999999999999999999999999999976433221 1
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223347899999998765 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=271.68 Aligned_cols=202 Identities=26% Similarity=0.389 Sum_probs=171.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC----cchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
.+|.+.+.||+|+||.||+|+.. ++..||+|.+...... .....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 5899999988532211 1234678899999999999999999988764 356
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
+++|||+++++|.+++.....+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 79999999999999998777789999999999999999999998 999999999999999999999999999876532
Q ss_pred CCC--ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 111 1122345889999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=275.40 Aligned_cols=202 Identities=27% Similarity=0.463 Sum_probs=170.9
Q ss_pred cCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
.+|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46778899999999999999842 34568999886433 233457899999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 373 LVYPYMSNGSVASRLKAKP-------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 489999999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+|||+++........ ......++..|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999765432211 1122335778999999988889999999999999999999 899986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=277.24 Aligned_cols=205 Identities=31% Similarity=0.456 Sum_probs=173.1
Q ss_pred HHhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
...++|+..+.||+|+||.||++... ....+|+|.+..........++.+|++++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34456888899999999999999864 23679999987554433445688999999999 799999999999999
Q ss_pred CcceEEEecCcCCChhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
...+++|||+++|+|.++++. ...+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 999999999999999999853 24689999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999876543221 1122235678999999988889999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=278.90 Aligned_cols=194 Identities=24% Similarity=0.351 Sum_probs=159.4
Q ss_pred CCccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec--CCcceEEEecC
Q 010149 304 KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVYPYM 378 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~ 378 (517)
.+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 467999999999999854 46789999986432 23457789999999999999999998864 34568999998
Q ss_pred cCCChhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCCeEEccccc
Q 010149 379 SNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGL 445 (517)
Q Consensus 379 ~~gsL~~~l~~---------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DFGl 445 (517)
.+ +|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 78777642 12588999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCC--ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 446 AKLLDHCDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 446 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 987643221 12234568999999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=270.87 Aligned_cols=202 Identities=31% Similarity=0.468 Sum_probs=175.3
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|.+.+.||+|+||.||+|..++++.+|+|.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 46788899999999999999998888899999987533 2356789999999999999999999999988899999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++... ..+++..+..++.|++.|+.|||++ +++|+||||+||++++++.+|++|||.+.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999754 3689999999999999999999999 9999999999999999999999999999866432222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......++..|+|||.+.+..++.++||||+|++++||+| |+.||....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2222235678999999998889999999999999999999 999986533
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=277.05 Aligned_cols=200 Identities=22% Similarity=0.372 Sum_probs=174.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|+..+.||+|+||.||+|+. .+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4688889999999999999995 4688999999865432 3345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... .
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (296)
T cd06654 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (296)
T ss_pred cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence 9999999998754 589999999999999999999999 9999999999999999999999999998765432211 2
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....|++.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 23458899999999988888999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=276.87 Aligned_cols=204 Identities=26% Similarity=0.429 Sum_probs=170.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
..++|++.+.||+|+||.||+|..+ .+..||+|.++..........+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567889999999999999999753 2458999988654433344568899999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEE
Q 010149 371 RLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 440 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 440 (517)
.++||||+++|+|.+++... ...++..+..++.|++.||.|||++ +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999632 2346778899999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 441 GDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 441 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998654322111 112235678999999988889999999999999999999 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=274.26 Aligned_cols=199 Identities=30% Similarity=0.423 Sum_probs=168.0
Q ss_pred CCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--CcceE
Q 010149 301 FSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 373 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 373 (517)
|...+.||+|+||+||.+.. .++..||+|.++..........+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988652 357889999987654333456788999999999999999999988654 34789
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+|||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999998764 589999999999999999999999 99999999999999999999999999998664322
Q ss_pred Cc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. ......++..|+|||.+....++.++||||||+++|||+||+.|+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 11 112223567799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=270.41 Aligned_cols=201 Identities=23% Similarity=0.363 Sum_probs=175.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|... +|+.+|+|.++.... ......+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 789999998864322 223457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++++|.+++.. ...+++..+..++.++++||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 34589999999999999999999998 999999999999999999999999999886543
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 3222 22345889999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=277.43 Aligned_cols=203 Identities=28% Similarity=0.378 Sum_probs=172.7
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
.++|...+.||+|+||.||+|... .+..+|+|.++..........+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888999999999999999741 35579999987554333445789999999999 79999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.+++|||+++|+|.++++... .+++.++..++.|++.||.|||++ +|+|+||||+||++++++.++++|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997532 389999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 449 LDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 449 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
....... ......++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 5432211 1222346778999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=275.26 Aligned_cols=200 Identities=25% Similarity=0.394 Sum_probs=171.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|+||.||++... ++..+|+|.++.........++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999975 78999999986543333345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999988753 37899999999999999999999632 8999999999999999999999999998765322
Q ss_pred ceeeeccccccccCccccccC------CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 22233578899999998544 3478999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=298.21 Aligned_cols=202 Identities=25% Similarity=0.318 Sum_probs=168.5
Q ss_pred CCCCCCccccccccceEEEEeCCC-cEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceee-eEec------CCc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIG-FCMT------TTE 370 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~-~~~~------~~~ 370 (517)
++.+.+.|.+|||+.||.|....+ ..+|+|++... .+......++||++|+++. |+|||.+++ .... .-+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 455678999999999999997655 99999999765 4556677899999999997 999999999 3322 135
Q ss_pred ceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 371 RLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.+|.||||++|.|-+++.. ...|++.++++|+.|+++|+++||.. +|+|||||||.+||||+.+++.||||||.|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 6899999999999999983 34599999999999999999999985 88999999999999999999999999999864
Q ss_pred cCCCC-Cce-------eeeccccccccCcccc---ccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 449 LDHCD-SHV-------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 449 ~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.-... ... .....-|+.|+|||++ .+...++|+|||++||+||-|+....||+.+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 32211 110 0112368999999987 4567899999999999999999999999865
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=273.64 Aligned_cols=200 Identities=24% Similarity=0.347 Sum_probs=172.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|+.. +++.+|+|.++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 45677788999999999999854 688999999865432 2234578899999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++...+.+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 99999999998888899999999999999999999999 99999999999999999999999999987654321 122
Q ss_pred eeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 458 TAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....|+..|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 3345899999999874 456788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=274.33 Aligned_cols=202 Identities=25% Similarity=0.326 Sum_probs=174.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ......+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999976 689999999864432 2233567899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++++|..+......+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 999999988887767799999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 223447889999999865 557889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=274.79 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=172.8
Q ss_pred cCCCCCCccccccccceEEEEeCC-----------------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-----------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 361 (517)
.+|.+.+.||+|+||.||+|...+ +..||+|.+..........++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 568889999999999999988542 246899998765544455678999999999999999999
Q ss_pred eeeEecCCcceEEEecCcCCChhhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 010149 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKP-----------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 430 (517)
Q Consensus 362 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NI 430 (517)
++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999987554 689999999999999999999998 999999999999
Q ss_pred EEcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh--CCCCcCc
Q 010149 431 LLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEF 502 (517)
Q Consensus 431 Ll~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt--G~~P~~~ 502 (517)
++++++.++|+|||+++....... .......++..|+|||++....++.++||||||+++|||++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999999999976543222 12233446788999999988889999999999999999998 6777754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=270.40 Aligned_cols=201 Identities=21% Similarity=0.317 Sum_probs=175.2
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|++.+.||+|+||.||++... +++.+|+|.++........+.+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999965 688999999865444444567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++++|.+++.. ...+++.....++.|++.||.|||++ +|+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999998864 34578999999999999999999998 999999999999999999999999999976643222 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....|++.|+|||.+....++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 233458899999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=272.34 Aligned_cols=202 Identities=32% Similarity=0.470 Sum_probs=175.6
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
..+|+..+.||+|+||.||+|...++..+|+|.+..... ....++..|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 456788899999999999999988899999999865432 2345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|++.|+.|||++ +++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999974 34689999999999999999999998 999999999999999999999999999976643221
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......++..|+|||.+....++.++||||||+++|+|++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 1223346778999999988889999999999999999998 899996543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=274.30 Aligned_cols=204 Identities=26% Similarity=0.427 Sum_probs=173.2
Q ss_pred hcCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|.+.+.||+|+||.||+|.... +..||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567888999999999999998642 3689999986554434455788999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEc
Q 010149 372 LLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 441 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 441 (517)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998632 2468889999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 442 DFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|||+++.+..... .......++..|+|||.+....++.++||||||+++|||+| |+.||...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999976543221 11223346789999999988889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=274.68 Aligned_cols=198 Identities=27% Similarity=0.381 Sum_probs=164.5
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhcc---CCCcccceeeeEecC-----C
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMTT-----T 369 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~-----~ 369 (517)
+|++.+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999965 68999999987543222 233566777776655 799999999988642 3
Q ss_pred cceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
..+++|||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 46899999985 888888643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...... ......|+..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 664322 223345899999999998889999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=275.73 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=176.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|+||+||++... +|+.+|+|++..........++.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999954 68899999887554444456789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++...+.+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++...... ..
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~ 159 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA 159 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---cc
Confidence 999999999987778999999999999999999999732 8999999999999999999999999998654321 12
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....|+..|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 23458999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=271.35 Aligned_cols=202 Identities=29% Similarity=0.499 Sum_probs=172.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CC---cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|+..+.||+|+||.||+|+.+ ++ ..+|+|.++.........++..|++++++++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999965 33 379999986554334456789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999875 45789999999999999999999998 99999999999999999999999999997664332
Q ss_pred Cceee--eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 454 SHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 454 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
..... ....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 22111 1123467999999988889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=264.29 Aligned_cols=203 Identities=25% Similarity=0.391 Sum_probs=171.4
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecC
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT 368 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~ 368 (517)
+.++-+.| .+.||+|+|+.|-.++ +.+|..+|||++.+.. -....+..+|++++.+.+ |+||++++++|+++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 44444444 3679999999999988 7789999999996542 234556789999998884 99999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC---eEEccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGL 445 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DFGl 445 (517)
...|||||-|.||+|..+++++..+++.++.++.++|+.||.|||.+ ||.|||+||+|||..+... +||+||.+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999999999999999999999999999999999 9999999999999976554 79999998
Q ss_pred ccccCCC------CCceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 446 AKLLDHC------DSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 446 a~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
+.-+... ......+.+|+..|||||+.. ...|+.+.|.||+|||+|-|++|..||..
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 8643211 111223456999999999763 35689999999999999999999999964
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.50 Aligned_cols=200 Identities=22% Similarity=0.277 Sum_probs=168.7
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC------
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 368 (517)
..++|...+.||+|+||.||+++.. .++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3467899999999999999999954 688999999865332 22345678899999999999999999987543
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 346899999975 67776653 478899999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 176 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 176 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 5432 12233468999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=268.64 Aligned_cols=196 Identities=31% Similarity=0.474 Sum_probs=167.1
Q ss_pred CccccccccceEEEEeC--C--CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ--D--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.. + +..+|+|.+..........++.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 26899999876554444567899999999999999999999876 4567999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee--
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT-- 458 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~-- 458 (517)
|+|.+++...+.+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999998 9999999999999999999999999999866443322111
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
...++..|+|||.+....++.++||||||+++|||++ |+.||+..+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 1123568999999988899999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=274.90 Aligned_cols=202 Identities=27% Similarity=0.471 Sum_probs=170.6
Q ss_pred cCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
.+|...+.||+|+||.||+|+.. ++..+++|.++... ......+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 35677889999999999999742 35678999885432 223457889999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 010149 373 LVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 436 (517)
+||||+++++|.+++... ..+++..+..++.||+.|++|||++ +|+||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 999999999999998643 2478999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 437 EAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 437 ~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.++|+|||++........ .......++..|+|||++....++.++||||||+++|||+| |+.||....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999976543221 11223346788999999988889999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=275.43 Aligned_cols=203 Identities=25% Similarity=0.364 Sum_probs=170.6
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++++|...+.||+|+||.||+|... +|..+|+|++...........+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3467888999999999999999854 688999999976544444456788999999999999999999999999999999
Q ss_pred ecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||++ +++.+.+. ....+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 57766654 345678889999999999999999998 999999999999999999999999999875432221
Q ss_pred ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||+...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1223347899999999865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.84 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=169.1
Q ss_pred CCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
+|...+.||+|+||.||+|... ++..||+|+++..........+.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556788999999999999853 2578999999754433334568899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC
Q 010149 374 VYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999998852 23478889999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 438 AVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 438 ~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999886543221 12223346789999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=274.42 Aligned_cols=199 Identities=30% Similarity=0.461 Sum_probs=173.3
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchH-HHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~-~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
|+..+.||+|+||+||+++.. +++.+|+|++.......... ....|+.+++.++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 445788999999999999966 56789999997654332222 2356999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++++|.+++.....+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+..... ......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999998777899999999999999999999999 999999999999999999999999999976422 223344
Q ss_pred eccccccccCccccc-cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 459 AVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...++..|+|||.+. ...++.++||||+|+++++|++|+.||...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 556899999999998 788999999999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.86 Aligned_cols=202 Identities=19% Similarity=0.273 Sum_probs=164.7
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCC------CcccceeeeEe
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH------RNLLRLIGFCM 366 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~~~~~ 366 (517)
+...+.+|.+.+.||+|+||+||+|+.. .++.||||+++.... ...++..|+.++++++| .+++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445678999999999999999999964 678999999864321 22345566666666544 45888888887
Q ss_pred cC-CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---------
Q 010149 367 TT-TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY--------- 436 (517)
Q Consensus 367 ~~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--------- 436 (517)
.. ...++|||++ +++|.+++.....+++..+..++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 64 4678899987 6789998887778999999999999999999999732 899999999999998765
Q ss_pred -------CeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 437 -------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 437 -------~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999876432 22234569999999999999999999999999999999999999997543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.67 Aligned_cols=203 Identities=25% Similarity=0.378 Sum_probs=171.0
Q ss_pred HhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~ 369 (517)
..++|.+.+.||+|+||.||+|++. .+..||+|+++..........+.+|++++.++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999853 346899999976544433457889999999997 999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcC-----------------------------------------------------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 390 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------- 390 (517)
..++||||+++|+|.++++..
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 999999999999999988632
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 010149 391 ---------------------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 431 (517)
Q Consensus 391 ---------------------------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NIL 431 (517)
..+++..+..++.|++.||.|||+. +++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 2367778899999999999999998 9999999999999
Q ss_pred EcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 432 LDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 432 l~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
+++++.+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999986532221 11222346789999999988889999999999999999998 8899864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=269.25 Aligned_cols=201 Identities=27% Similarity=0.472 Sum_probs=173.5
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcc--------hHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG--------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~--------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
+|...+.||+|++|.||+|... +++.+|+|.+........ .+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 688999998865432211 2457889999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.+++|||+++++|.+++...+.+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||.++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999998878899999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCc-----eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..... ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 21111 112235889999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=276.90 Aligned_cols=203 Identities=30% Similarity=0.455 Sum_probs=171.3
Q ss_pred hcCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
.++|.+.+.||+|+||.||+|+.. ++..||+|.++.........++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999999731 24579999986543334456788999999999 899999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
...+++|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999999999998642 2478889999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999998764332221 222335678999999988889999999999999999998 78888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=284.84 Aligned_cols=200 Identities=22% Similarity=0.268 Sum_probs=168.6
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC------
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 368 (517)
..++|...+.||+|+||.||+++.. .++.||+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999854 6889999998654322 2335677899999999999999999988643
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...++||||+++ ++.+.+.. .+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 246899999975 66666653 478999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 22234468999999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=271.58 Aligned_cols=197 Identities=25% Similarity=0.380 Sum_probs=160.6
Q ss_pred CccccccccceEEEEeCC---CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||+|...+ ...+|+|.+...........+.+|++.++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 35688888765443334457889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc-
Q 010149 382 SVASRLKAKP-----SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH- 455 (517)
Q Consensus 382 sL~~~l~~~~-----~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~- 455 (517)
+|.+++.... ..++.....++.||+.|++|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999987432 346788899999999999999998 9999999999999999999999999998754322211
Q ss_pred eeeeccccccccCcccccc-------CCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......++..|+|||++.. ..++.++|||||||++|||++ |..||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1122335678999998743 356789999999999999999 778886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=268.50 Aligned_cols=199 Identities=29% Similarity=0.423 Sum_probs=176.3
Q ss_pred cCCCCCCccccccccceEEEEeCC-CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|+||.||+|+..+ +..+++|.+..... ..++.+|++++++++||||+++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578889999999999999999764 78999999864432 56899999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999999874 45789999999999999999999998 999999999999999999999999999987654321 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 223447899999999988899999999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=281.46 Aligned_cols=199 Identities=26% Similarity=0.346 Sum_probs=167.8
Q ss_pred HHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC-----
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT----- 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----- 368 (517)
...++|...+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 46889999998653221 2234577899999999999999999987543
Q ss_pred -CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 369 -TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 369 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 3468999988 6789887764 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 65432 223458999999999876 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=272.77 Aligned_cols=202 Identities=30% Similarity=0.433 Sum_probs=170.3
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC-----
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT----- 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~----- 368 (517)
.++..|+..+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35567888899999999999999965 68899999986432 2345788999999988 799999999998753
Q ss_pred -CcceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccc
Q 010149 369 -TERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 445 (517)
Q Consensus 369 -~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGl 445 (517)
...+++|||+++++|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998753 4689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 446 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||+..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 986543221 223455899999999985 345788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=278.08 Aligned_cols=204 Identities=31% Similarity=0.440 Sum_probs=170.8
Q ss_pred hcCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
.++|.+.+.||+|+||.||++... +...+|+|.++.........++..|++++..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888999999999999999742 23579999997544333445688899999999 799999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
...++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 9999999999999999999743 2488999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
++++.+||+|||.++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999987654321111 111224568999999988889999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=268.71 Aligned_cols=202 Identities=27% Similarity=0.405 Sum_probs=171.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC----cchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
.+|...+.||+|+||.||+|... ++..+|+|++...... .....+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 6889999988643211 1234588899999999999999999988753 456
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++++||+++++|.+++.....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 79999999999999998777799999999999999999999998 999999999999999999999999999976543
Q ss_pred CCC--ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 211 1112345889999999998888999999999999999999999999644
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=273.99 Aligned_cols=202 Identities=30% Similarity=0.404 Sum_probs=169.7
Q ss_pred CCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
+|.+.+.||+|+||.||+|+.. ....+++|.+..........++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667889999999999999853 2357899988654433334578899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 010149 374 VYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 429 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~N 429 (517)
++||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999987531 2478899999999999999999998 99999999999
Q ss_pred eEEcCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 430 ILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 430 ILl~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999765332221 1122335678999999988889999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=277.92 Aligned_cols=203 Identities=30% Similarity=0.447 Sum_probs=170.5
Q ss_pred hcCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
.++|.+.+.||+|+||.||+|... ....+|+|.++.........++..|++++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788999999999999999742 24579999987554434455788999999998 699999999999998
Q ss_pred CcceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
...+++|||+++|+|.+++... ..+++.++..++.|++.||.|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 8899999999999999998642 3488999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
++++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999998654322111 112224567999999988889999999999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=270.49 Aligned_cols=202 Identities=28% Similarity=0.465 Sum_probs=170.6
Q ss_pred CCCCCCccccccccceEEEEeC-CC---cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+|...+.||+|+||.||+|... ++ ..||+|.++.........+|..|+.+++.++||||+++.+++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667899999999999999965 23 3699999875543334567999999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++++|.+++.. .+.+++.++..++.|++.|+.|||++ +++||||||+||+++.++.+|++|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999876543222
Q ss_pred cee--eecc--ccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... .... .+..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 111 1111 2457999999998899999999999999999886 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=275.14 Aligned_cols=201 Identities=26% Similarity=0.432 Sum_probs=168.7
Q ss_pred cCCCCCCccccccccceEEEEeCC---------------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceee
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD---------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~ 363 (517)
++|.+.+.||+|+||.||+++... ...||+|.++..........|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 23589999875543344557899999999999999999999
Q ss_pred eEecCCcceEEEecCcCCChhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 010149 364 FCMTTTERLLVYPYMSNGSVASRLKAK------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 431 (517)
Q Consensus 364 ~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NIL 431 (517)
++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999988642 2468899999999999999999998 9999999999999
Q ss_pred EcCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh--CCCCcCc
Q 010149 432 LDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEF 502 (517)
Q Consensus 432 l~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt--G~~P~~~ 502 (517)
+++++.+||+|||++......... ......++..|+|||.+..+.++.++||||||++++||++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999765332211 1122335678999999988889999999999999999998 5567754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=268.68 Aligned_cols=199 Identities=30% Similarity=0.431 Sum_probs=169.7
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|...+.||+|++|.||+|..+.+..+|+|.+.... .....+.+|+++++.++|||++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4577788999999999999998877789999886433 23457889999999999999999998875 45678999999
Q ss_pred cCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999753 3579999999999999999999998 99999999999999999999999999998764332222
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.....++..|+|||...+..++.++||||||+++|||+| |+.||...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 222346778999999988889999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.12 Aligned_cols=200 Identities=29% Similarity=0.431 Sum_probs=166.8
Q ss_pred CCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCc-----
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE----- 370 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~----- 370 (517)
|.+.+.||+|+||.||+|.... +..||+|+++..... ....++.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999998754322 234578999999999999999999998876554
Q ss_pred -ceEEEecCcCCChhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 371 -RLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 371 -~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
.++++||+++|+|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999988842 23689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 444 GLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 444 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
|+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9998664332221 112235678999999988889999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=267.34 Aligned_cols=197 Identities=32% Similarity=0.511 Sum_probs=172.8
Q ss_pred CccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|.... +..+++|.++.........++.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 7899999997655443456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 381 GSVASRLKAK---------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 381 gsL~~~l~~~---------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++|.+++... ..+++..+..++.|+++||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999864 7899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 452 CDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 452 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 321 12233457889999999988889999999999999999999 699997653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=267.23 Aligned_cols=202 Identities=23% Similarity=0.353 Sum_probs=175.7
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999884 468899999886433 233455788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++... ..+++..+..++.|+++|+.|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999754 4689999999999999999999998 999999999999999999999999999987644332
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 22334589999999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=271.72 Aligned_cols=198 Identities=26% Similarity=0.420 Sum_probs=169.1
Q ss_pred CCCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 372 (517)
.|.+.+.||+|+||.||.+.. .++..||+|.++..........+.+|+++++.++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467789999999999999974 357889999987554444456789999999999999999999998775 5678
Q ss_pred EEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 373 LVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999998654 4689999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCc
Q 010149 452 CDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 452 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
.... ......++..|+|||.+.+..++.++||||||+++|||+|++.|.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 3221 122344677899999998888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=269.25 Aligned_cols=194 Identities=30% Similarity=0.465 Sum_probs=162.5
Q ss_pred CccccccccceEEEEeCC-Cc--EEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|+.++ +. .+++|.++..........+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 47888887544334455788999999999 799999999999999999999999999
Q ss_pred CChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 381 GSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 381 gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 478999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 986322111 1111224567999999988889999999999999999997 99999643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=267.69 Aligned_cols=201 Identities=27% Similarity=0.357 Sum_probs=175.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|+||.||+|... +++.+++|.+...... ....+.+|++++++++||||+++++++......+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 56888899999999999999964 5788999998754332 456788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999999998765 6899999999999999999999998 99999999999999999999999999987654321 12
Q ss_pred eeeccccccccCccccccC---CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.+... .++.++||||||+++|||+||+.||....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2334588899999998776 78899999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=274.22 Aligned_cols=200 Identities=22% Similarity=0.369 Sum_probs=175.1
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|...+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 5788899999999999999995 4789999999865432 3345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......... .
T Consensus 98 ~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~ 172 (297)
T cd06656 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (297)
T ss_pred cCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence 9999999998653 579999999999999999999998 9999999999999999999999999998765433221 2
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23458899999999988889999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=269.57 Aligned_cols=202 Identities=25% Similarity=0.405 Sum_probs=170.2
Q ss_pred cCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|...+.||+|+||.||+|...+ ...||+|...........+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778999999999999998643 346899988655433345578999999999999999999998875 567899
Q ss_pred EecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999753 4589999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
........++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 222222335578999999988889999999999999999996 999996544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=273.78 Aligned_cols=198 Identities=31% Similarity=0.417 Sum_probs=172.3
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
|+..+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455678999999999999864 5789999998755444445578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+++|.+++.. ..+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++..+..... ....
T Consensus 86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06642 86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhc
Confidence 9999998865 4689999999999999999999998 999999999999999999999999999976543221 1223
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..|+..|+|||++.+..++.++||||||+++|||+||+.|+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 45788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=269.64 Aligned_cols=201 Identities=21% Similarity=0.355 Sum_probs=173.7
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|.. .++..+|+|.+..... .....++.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999995 4789999998864322 223357889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++++|.+++.. ...+++..+..++.|+++||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998862 45689999999999999999999998 999999999999999999999999999876643
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... ......|+..|+|||.+....++.++||||||+++|||++|..||...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 222 222345889999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.80 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=176.3
Q ss_pred CCCCCCccccccccceEEEEeCC---C--cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQD---G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~---g--~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.....+.||+|-||.||+|+..+ | -.||||.-+.....+..+.|..|..+|+.++|||||+++|+|.+ ...++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34456789999999999998532 3 35889998877666677789999999999999999999999986 467899
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||.++.|.|.++++. ...++......++.||..||+|||+. ++|||||..+|||+....-+|++|||+++.+++..
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999999985 45789999999999999999999999 99999999999999999999999999999998766
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
........-...|||||.+.-.+++.++|||.|||.+||++. |.+||..-
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 555554455679999999999999999999999999999887 99999753
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.97 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=174.4
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC----CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
+|...+.||+|++|.||+|... ++..|++|.+..... ......+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 789999998864332 12345688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
+||+++++|.+++.....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999998777799999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 223445889999999987766 8899999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=282.10 Aligned_cols=202 Identities=24% Similarity=0.375 Sum_probs=181.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcc-hHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
...|.+.+.||+|.|+.|..|+.. ++..||+|.+.+..-... ...+.+|+++|..++|||||+++.+.+.....|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456888999999999999999954 689999999976543322 234789999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+.+|.+++++...+...+..+..++.|+.+|++|+|++ .|||||||++|||++.+.++||+|||++.++.. ..
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~ 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GL 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--cc
Confidence 9999999999999888888899999999999999999999 999999999999999999999999999998873 34
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+...
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 5567889999999999988665 689999999999999999999998654
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=270.31 Aligned_cols=202 Identities=26% Similarity=0.467 Sum_probs=171.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.+|...+.||+|+||.||+|..+ +|. .+|+|............++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45777899999999999999864 333 5899988655443345678899999999999999999999987 78899
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++|+|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999875 34689999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCcee-eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..... ....++..|+|||.+....++.++|+||||+++||+++ |+.||+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 22211 11223568999999988889999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=267.93 Aligned_cols=203 Identities=29% Similarity=0.409 Sum_probs=176.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||.|+||+||+|... ++..+|+|++...........+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 68899999987554444556789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999753 4689999999999999999999998 999999999999999999999999999876654322
Q ss_pred c---eeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 H---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......|+..|+|||++... .++.++||||||++++||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 2 22334588999999998776 78999999999999999999999997543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=267.45 Aligned_cols=195 Identities=32% Similarity=0.443 Sum_probs=167.7
Q ss_pred CccccccccceEEEEeCC--C--cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQD--G--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|++|.||+|.+.+ + ..||+|.+..........++.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 36899999765543445679999999999999999999999988 888999999999
Q ss_pred CChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc--e
Q 010149 381 GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--V 456 (517)
Q Consensus 381 gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~--~ 456 (517)
++|.+++... ..+++.....++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999764 3689999999999999999999999 9999999999999999999999999999876442221 1
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.....++..|+|||++....++.++||||||+++|||+| |+.||...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112347789999999988899999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.99 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=173.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|+..+.||+|+||.||+|..+ +++.+|+|++...... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 5899999998654322 234568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|++++++.++......+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 999999988877666799999999999999999999998 99999999999999999999999999998654432 22
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 233457899999998865 457789999999999999999999986433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=273.81 Aligned_cols=201 Identities=21% Similarity=0.368 Sum_probs=175.5
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|+..+.||.|++|.||+|+. .+++.|++|.+.... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4578889999999999999985 478999999986433 33356788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999999988754 589999999999999999999999 999999999999999999999999999876543222 12
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
....++..|+|||.+....++.++|||||||++|||++|+.||...+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 234588999999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=266.98 Aligned_cols=200 Identities=26% Similarity=0.432 Sum_probs=171.9
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|...+.||+|+||.||+|...++..+|+|.++... .....+.+|++++++++|+||+++.+++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45788899999999999999998778889999886432 234578899999999999999999999887 778999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999875 34578899999999999999999998 9999999999999999999999999999765432222
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
......++..|+|||++....++.++||||||+++||++| |+.||...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 2222335678999999988889999999999999999999 89998754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=266.74 Aligned_cols=201 Identities=28% Similarity=0.458 Sum_probs=175.7
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|...+.||+|+||.||+|... +++.+++|.++..... .....+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999854 6899999998754432 2456789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999998877789999999999999999999998 999999999999999999999999999987654332211
Q ss_pred ---eeccccccccCccccccCC---CCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 458 ---TAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 458 ---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....++..|+|||++.... .+.++||||||++++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 1345789999999997766 889999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=279.49 Aligned_cols=203 Identities=27% Similarity=0.402 Sum_probs=168.1
Q ss_pred hcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC-C
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT-T 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-~ 369 (517)
.++|...+.||+|+||.||+|.. .+++.||||+++..........+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999973 357889999997554333445688999999999 689999999988654 4
Q ss_pred cceEEEecCcCCChhhhhhcC-----------------------------------------------------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAK----------------------------------------------------------- 390 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------- 390 (517)
..+++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 568999999999999988632
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-ceeeecc
Q 010149 391 --------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVR 461 (517)
Q Consensus 391 --------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~~ 461 (517)
..+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2367888899999999999999998 999999999999999999999999999976532211 1112233
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+++.|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5678999999988889999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.27 Aligned_cols=199 Identities=30% Similarity=0.436 Sum_probs=163.6
Q ss_pred CCCCccccccccceEEEEeCC-Cc--EEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC------Ccc
Q 010149 302 SSKNLVGKGGFGNVYKGYLQD-GT--VVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TER 371 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~~~ 371 (517)
.+.+.||+|+||.||+|...+ +. .+|+|.++..... .....+..|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 457889999999999999654 33 6899988654322 2345688999999999999999999987532 246
Q ss_pred eEEEecCcCCChhhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccc
Q 010149 372 LLVYPYMSNGSVASRLK------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 445 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGl 445 (517)
+++|||+++|+|.+++. ....+++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998873 223588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 446 AKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 446 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
++.+....... .....+++.|+|||......++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 98764322211 122235678999999998899999999999999999999 88898643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=272.31 Aligned_cols=201 Identities=23% Similarity=0.386 Sum_probs=170.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|++|.||+|+.+ +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999965 68999999987544333344577899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ +|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 985 89988864 34689999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 122346889999998865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=288.88 Aligned_cols=193 Identities=24% Similarity=0.287 Sum_probs=167.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
..+|.+.+.||+|+||.||+|+.. .++.||+|... ...+.+|++++++++|+|||++++++......++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 446888999999999999999965 57889999642 1245689999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
++. ++|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 995 688888764 34699999999999999999999999 9999999999999999999999999999865432221
Q ss_pred -eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 456 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 456 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2234569999999999999899999999999999999999887653
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=267.49 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=172.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC----CCcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
.+|...+.||+|+||.||+|... ++..+|+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 68999999875321 122334688999999999999999999998764 346
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++++||+++++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 79999999999999998777789999999999999999999998 999999999999999999999999999986532
Q ss_pred CC--CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. ........++..|+|||.+.+...+.++||||||++++||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 11 11122345889999999998888899999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=274.33 Aligned_cols=205 Identities=21% Similarity=0.308 Sum_probs=177.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.-|...+.||+|-|+.|-.|++ -+|..||||++.+.+... ....+.+|++.|+.++|||||+++.+.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577788999999999999984 479999999996654332 34467899999999999999999999999999999999
Q ss_pred cCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~~~~~ 454 (517)
.-++|+|++|+- ....+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- +-|-+|++|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 999999999986 456799999999999999999999998 999999999999885 5678999999999876643
Q ss_pred ceeeeccccccccCccccccCCCC-cccceehhhHHHHHHHhCCCCcCcCccccc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGKTANQ 508 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvil~elltG~~P~~~~~~~~~ 508 (517)
....+.+|+..|-|||++.+..|+ +++||||+|||||.|+.|+.||+...+.+.
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 334557899999999999988875 678999999999999999999986654443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=270.66 Aligned_cols=201 Identities=26% Similarity=0.465 Sum_probs=169.8
Q ss_pred cCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
.+|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 45677899999999999999632 35689999886432 333557999999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC
Q 010149 373 LVYPYMSNGSVASRLKAK---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998743 2478999999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 438 AVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 438 ~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 999999999755332211 1122235678999999988899999999999999999998 89998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=274.31 Aligned_cols=202 Identities=24% Similarity=0.326 Sum_probs=173.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||++... .++.|++|.+..... ......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999965 578999999865432 122346789999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC--
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-- 453 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~-- 453 (517)
||+++++|.+++...+.+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999986421100
Q ss_pred ------------CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 ------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
........++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00111234788999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=270.06 Aligned_cols=201 Identities=25% Similarity=0.399 Sum_probs=171.7
Q ss_pred cCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|+..+.||+|+||.||+|+.+ +.+.+++|.+...........+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999854 346799998865433223457899999999999999999999999989999
Q ss_pred EEEecCcCCChhhhhhcCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 373 LVYPYMSNGSVASRLKAKP---------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997544 689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 444 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 444 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
|++...............++..|+|||.+.....+.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987543322222233346778999999988888999999999999999999 7888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=270.42 Aligned_cols=200 Identities=30% Similarity=0.408 Sum_probs=174.9
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999965 588999999875544444567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++++|.+++... .+++.....++.|++.|++|||+. +++|+||+|+||++++++.++++|||++........ ...
T Consensus 85 ~~~~L~~~i~~~-~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06640 85 GGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence 999999998754 689999999999999999999998 999999999999999999999999999976643322 223
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...++..|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 3457889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=265.89 Aligned_cols=195 Identities=34% Similarity=0.510 Sum_probs=172.4
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|+..+.||+|+||.||+|... |+.||+|.++.... ...++.+|+.+++.++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46788899999999999999875 78999999975543 4567899999999999999999999999989999999999
Q ss_pred cCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997654 689999999999999999999999 999999999999999999999999999986532211
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 2235678999999988889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=268.32 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=176.9
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+|+..+.||.|+||.||+|... +++.+|+|.+...... .....+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777899999999999999975 6899999999654321 235678999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++++|.+++.....+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 999999999998777899999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....|+..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 233458899999999988889999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.12 Aligned_cols=202 Identities=24% Similarity=0.401 Sum_probs=169.4
Q ss_pred cCCCCCCccccccccceEEEEeC-----------------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-----------------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 361 (517)
++|++.+.||+|+||.||++... ++..+|+|+++.........+|.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 2446899998755444445679999999999999999999
Q ss_pred eeeEecCCcceEEEecCcCCChhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 010149 362 IGFCMTTTERLLVYPYMSNGSVASRLKAK-----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 430 (517)
Q Consensus 362 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NI 430 (517)
++++...+..+++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998643 2367889999999999999999998 999999999999
Q ss_pred EEcCCCCeEEcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh--CCCCcCcC
Q 010149 431 LLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS--GLRALEFG 503 (517)
Q Consensus 431 Ll~~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt--G~~P~~~~ 503 (517)
++++++.++|+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999997654322111 122234678999999888889999999999999999998 67787543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.55 Aligned_cols=200 Identities=30% Similarity=0.502 Sum_probs=172.2
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.+|+..+.||+|+||.||+|...++..+|+|.++... ....+|.+|++++++++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 3567788999999999999998778899999886432 23457899999999999999999999999999999999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++++|.+++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999875 34689999999999999999999998 999999999999999999999999999876543222112
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 22235678999999988889999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=279.58 Aligned_cols=192 Identities=25% Similarity=0.362 Sum_probs=165.3
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
....+|.+.+.||+|+||.||+|+.. ++..||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34567999999999999999999965 5778999975332 234689999999999999999999999999999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+||+. ++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 99995 588887764 56789999999999999999999998 9999999999999999999999999999754321
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456999999999999989999999999999999999976665
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.76 Aligned_cols=207 Identities=22% Similarity=0.345 Sum_probs=170.1
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
...++|.+.+.||+|+||+||+|... .+..+|+|.+..... ......|..|+.++..++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44568999999999999999999965 577899999864432 22345688999999999999999999988643 457
Q ss_pred eEEEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCceEEcC---------
Q 010149 372 LLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCD----PKIIHRDVKAANILLDE--------- 434 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~----~~ivH~Dlk~~NILl~~--------- 434 (517)
++||||+++|+|.+++.. ...+++..++.|+.||+.||.|||+... .+|+||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 899999999999998864 3579999999999999999999998521 25999999999999964
Q ss_pred --------CCCeEEcccccccccCCCCCceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 435 --------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 435 --------~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...+||+|||++..+... .......||+.|+|||++.. ..++.++||||||||+|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 234899999999865432 12234469999999999854 458899999999999999999999997543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=267.69 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=171.3
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc---------chHHHHHHHHHHhccCCCcccceeeeEecCC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG---------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 369 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 369 (517)
+|...+.||+|+||.||+|... +|+.+|+|.++...... ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999854 68999999885322111 1235788999999999999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++ +++||||+|+||++++++.++++|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999998877899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCc-eeeeccccccccCccccccCC--CCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 450 DHCDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 450 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...... ......|+..|+|||.+.... ++.++||||||+++||+++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 432111 123345889999999987654 788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=270.12 Aligned_cols=200 Identities=24% Similarity=0.328 Sum_probs=170.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.|++.+.||+|+||.||+|... ++..+++|.+.... .....++.+|+.+++.++||||+++++.+..+...++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56888899999999999999965 58899999986432 23345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++++|..++.+ ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999999887753 45689999999999999999999998 99999999999999999999999999987543221 11
Q ss_pred eeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 22345889999999884 345688999999999999999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=265.89 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=179.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|++|.||+|... +++.+++|++...........+.+|++.+.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 58999999987654334456799999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++++|.+++.....+++..+..++.|+++|+.|||+ . +++||||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999999877889999999999999999999999 8 9999999999999999999999999999876543322
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.+....++.++||||||+++|||+||+.||....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 223458899999999988889999999999999999999999996553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=268.06 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=170.8
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.+++++.....||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 44566666788999999999999954 67889999886543 22345788999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcC-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccccccccC
Q 010149 375 YPYMSNGSVASRLKAK-PSL--DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLD 450 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~~~~ 450 (517)
+||+++++|.+++... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999998753 445 8888999999999999999998 9999999999999976 6799999999987654
Q ss_pred CCCCceeeeccccccccCccccccCC--CCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... ......|++.|+|||++.... ++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 3222 222345889999999986543 788999999999999999999998643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=270.15 Aligned_cols=199 Identities=24% Similarity=0.375 Sum_probs=168.6
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|++|.||+|+.+ ++..||+|+++..... .....+.+|+.++.+++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999965 6899999998654322 2235688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
++ ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 588888753 25689999999999999999999998 99999999999999999999999999997654321
Q ss_pred ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 12223347889999998865 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.78 Aligned_cols=194 Identities=24% Similarity=0.351 Sum_probs=158.7
Q ss_pred CCccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec--CCcceEEEecC
Q 010149 304 KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVYPYM 378 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~ 378 (517)
...||+|+||.||+|+.. ++..+|+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 357999999999999965 35789999886432 23467889999999999999999998854 45678999998
Q ss_pred cCCChhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCCeEEccccc
Q 010149 379 SNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGL 445 (517)
Q Consensus 379 ~~gsL~~~l~~---------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DFGl 445 (517)
++ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 77776641 22578999999999999999999998 99999999999999 5667899999999
Q ss_pred ccccCCCCCc--eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 446 AKLLDHCDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 446 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9876443221 1233458999999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=270.53 Aligned_cols=202 Identities=24% Similarity=0.325 Sum_probs=173.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......|..|++++++++||||+++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356888899999999999999964 68899999986432 2334578899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999999875 45789999999999999999999999 999999999999999999999999999875533221
Q ss_pred eeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 223345899999999874 3456789999999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.53 Aligned_cols=202 Identities=27% Similarity=0.411 Sum_probs=174.2
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc-----chHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
+|+..+.||+|++|.||+|.. .+++.+|+|.++...... ...++..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 578999999986433211 23568899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~ 452 (517)
||||+++++|.+++.....+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .+||+|||.+..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999998877899999999999999999999999 999999999999998776 5999999998766432
Q ss_pred CC---ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......++..|+|||.+.+..++.++||||+|++++||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11 11223458899999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=268.29 Aligned_cols=201 Identities=28% Similarity=0.426 Sum_probs=174.0
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC---CCcccceeeeEecCCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.|+..+.||+|+||.||+|.. .+++.+|+|.++.........++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466788999999999999996 4789999999875544444567889999998886 999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999999998754 789999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......|+..|+|||.+..+ .++.++||||||+++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 22334588999999988654 468899999999999999999999975543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.69 Aligned_cols=206 Identities=29% Similarity=0.405 Sum_probs=177.6
Q ss_pred HHhcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
..+-++.....||.|.||.||.|. ..+|...|+|-++..... .......+|+.++..++|||+|+++|+-..++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345567778899999999999999 567999999988654332 234568899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
.||||++|+|.+.+......++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999999999888888999999999999999999999 99999999999999999999999999998876542
Q ss_pred Cc---eeeeccccccccCccccccCC---CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SH---VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .-....||+-|||||.+.+.. ...++||||+|||+.||+||++||..-+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 11 123456999999999996543 4568999999999999999999996433
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=265.17 Aligned_cols=189 Identities=27% Similarity=0.427 Sum_probs=161.3
Q ss_pred CccccccccceEEEEeCCCc-----------EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 305 NLVGKGGFGNVYKGYLQDGT-----------VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976432 5778877544322 5678899999999999999999999988 77899
Q ss_pred EEecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-------CeEEccccc
Q 010149 374 VYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-------EAVVGDFGL 445 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~ki~DFGl 445 (517)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998655 789999999999999999999998 999999999999999888 799999999
Q ss_pred ccccCCCCCceeeeccccccccCccccccC--CCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 446 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+..... .....++..|+|||++... .++.++||||||+++|||++ |..||...+
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 986543 1223467789999998776 78999999999999999999 577776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=263.72 Aligned_cols=200 Identities=32% Similarity=0.501 Sum_probs=172.6
Q ss_pred CCCCCccccccccceEEEEeCC-----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+++.+.||+|+||.||+++..+ +..||+|.++..........+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3457889999999999999653 38899999976544335668999999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 376 PYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||+++++|.+++..... +++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999975443 89999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
........+++.|+|||.+....++.++||||+|++++||++ |+.||+..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222212337789999999988889999999999999999999 78888643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=269.85 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=171.6
Q ss_pred CCCCCCccccccccceEEEEe----CCCcEEEEEEecCCCC---CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 371 (517)
+|++.+.||+|+||.||.++. .+|..||+|+++.... ......+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 3689999999865322 12235678899999999 599999999999988889
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++++|.+++.....+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999998777899999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeeeccccccccCccccccC--CCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
..........|+..|+|||.+... .++.++||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 332223345588999999998653 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=277.28 Aligned_cols=203 Identities=32% Similarity=0.445 Sum_probs=170.3
Q ss_pred cCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 369 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 369 (517)
.+|.+.+.||+|+||.||+|... .+..||+|.++.........++.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999742 12368999887544444456789999999999 7999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 370 ERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
..++++||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 999999999999999998642 2478899999999999999999998 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 434 EYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 434 ~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999998654322111 112234568999999988899999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.68 Aligned_cols=197 Identities=20% Similarity=0.257 Sum_probs=164.3
Q ss_pred CCCccccc--cccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 303 SKNLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 303 ~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
..++||+| +|++||++..+ +|+.||+|++....... ....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78899999864 78999999997543322 2345778999999999999999999999999999999999
Q ss_pred cCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc-
Q 010149 379 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH- 455 (517)
Q Consensus 379 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~- 455 (517)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999864 34589999999999999999999998 9999999999999999999999999865433211110
Q ss_pred -----eeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 456 -----VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 456 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0112246778999999875 4588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=274.09 Aligned_cols=202 Identities=30% Similarity=0.355 Sum_probs=173.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+|...+.||+|++|.||+|... +++.+|+|.+....... ....+.+|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6778899999999999999965 58999999997543322 34568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+.+++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998753 5689999999999999999999998 999999999999999999999999999875432111
Q ss_pred c----------------------------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 H----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0 1112357889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=268.95 Aligned_cols=198 Identities=24% Similarity=0.348 Sum_probs=168.9
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 556788999999999999965 57788999885432 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 380 NGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 380 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
+++|..++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999988764 45789999999999999999999998 99999999999999999999999999987543221 1223
Q ss_pred eccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 459 AVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...+++.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 345899999999974 345778999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=268.23 Aligned_cols=192 Identities=27% Similarity=0.353 Sum_probs=160.9
Q ss_pred ccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHh---ccCCCcccceeeeEecCCcceEEEecCc
Q 010149 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMIS---LAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~---~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
.||+|+||.||++... +++.+|+|.+...... .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6899999988654322 12233445544433 3479999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+||++++++.++++|||++....... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 999999998777899999999999999999999998 99999999999999999999999999987554322 123
Q ss_pred ccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 460 VRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..|+..|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 458999999998864 56789999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=269.06 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=175.5
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|+..+.||+|++|.||++..+ +++.+|+|++..........++.+|+++++.++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677889999999999999976 689999999876544445567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++++|.+++... ..+++.....++.|++.|+.|||+ . +++||||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999999865 788999999999999999999999 7 9999999999999999999999999998765322111
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 155889999999998889999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=270.56 Aligned_cols=202 Identities=27% Similarity=0.468 Sum_probs=171.0
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|+..+.||+|+||.||+|... ++..+|+|++..........++.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999853 46789999987554433456789999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 010149 372 LLVYPYMSNGSVASRLKAK----------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 429 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~N 429 (517)
+++|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 9999999999999998632 2468888999999999999999998 99999999999
Q ss_pred eEEcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 430 ILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 430 ILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
|++++++.++|+|||++........ ........+..|+|||.+....++.++|||||||++|||++ |..||..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999875432221 11122234678999999988899999999999999999998 8888854
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=264.84 Aligned_cols=196 Identities=23% Similarity=0.371 Sum_probs=158.5
Q ss_pred CccccccccceEEEEeCCC---cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.||+|+||.||+|...++ ..+++|.++..........|.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3589999999999975433 3466777655443344567999999999999999999999999999999999999999
Q ss_pred ChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC-Cce
Q 010149 382 SVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHV 456 (517)
Q Consensus 382 sL~~~l~~~----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~-~~~ 456 (517)
+|.++++.. ...++.....++.||++||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999998743 3456777889999999999999998 99999999999999999999999999986432111 111
Q ss_pred eeeccccccccCcccccc-------CCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 223457889999998743 245789999999999999997 56687543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=270.42 Aligned_cols=201 Identities=24% Similarity=0.324 Sum_probs=175.3
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|+||.||+|+.+ +++.||+|+++.... ......+.+|+++++.++|+||+++++++...+..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999965 588999999865432 22345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++++.+..+......+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99887777776666799999999999999999999999 999999999999999999999999999987655433233
Q ss_pred eeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 458 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 445688999999999887 7899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=268.09 Aligned_cols=199 Identities=23% Similarity=0.347 Sum_probs=165.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHH-HhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|++.+.||+|+||.||+|+.. +|+.||+|+++.........++..|+.. ++..+||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999965 6899999998765433334556666665 566789999999999999999999999
Q ss_pred cCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 377 YMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 377 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
|++ |+|.+++.. ...+++..+..++.|++.||+|||+++ +++||||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 578777652 346899999999999999999999853 8999999999999999999999999999865422
Q ss_pred CCceeeeccccccccCcccccc----CCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1222458889999998854 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=263.68 Aligned_cols=201 Identities=25% Similarity=0.346 Sum_probs=171.6
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC-CcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e 376 (517)
+|+..+.||+|++|.||++..+ +++.+|+|.+..... ......+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999965 578999999865332 22345688999999999999999999987644 45689999
Q ss_pred cCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++++|.+++.. ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 9999999999875 34689999999999999999999999 99999999999999999999999999998764322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......+++.|+|||.+.+..++.++||||||++++||++|+.||+..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22233458899999999998899999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=271.89 Aligned_cols=200 Identities=26% Similarity=0.497 Sum_probs=167.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|...+.||+|+||.||+|... +|. .+|+|.+..........++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777899999999999999853 444 57889886544333345788999999999999999999998754 4679
Q ss_pred EEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999998754 3689999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 1122335678999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.20 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=175.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+..+...||-|.||.||.|+|+ -.-.||||.++.+..+ ..+|..|..+|+.++|||+|+++|+|..+...|||.||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 45566789999999999999987 4678999999765532 56899999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|.+|+|.+||.. +..++.-..+.++-||+.||+||..+ ++|||||.++|+|+.++..+||+|||+++++......
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999999984 34567777889999999999999998 9999999999999999999999999999998764433
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......-...|.|||.+....++.|+|||+|||+|||+.| |..||..-+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 3332234578999999999999999999999999999999 889986543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=263.81 Aligned_cols=195 Identities=32% Similarity=0.482 Sum_probs=159.9
Q ss_pred CccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec-CCcceEEEecCc
Q 010149 305 NLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLVYPYMS 379 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~~ 379 (517)
+.||+|+||.||+|... ++..+|+|.+...........+.+|+.+++.++||||+++++++.. +...+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999988543333334578899999999999999999998764 556789999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc---
Q 010149 380 NGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--- 455 (517)
Q Consensus 380 ~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~--- 455 (517)
+|+|.+++... ...++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998753 4567888899999999999999998 9999999999999999999999999999765432111
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC-CCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEF 502 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~-~P~~~ 502 (517)
......++..|+|||.+....++.++||||||+++|||++|. .||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 111234577899999998888999999999999999999964 55543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=270.75 Aligned_cols=199 Identities=24% Similarity=0.363 Sum_probs=167.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|+||.||+|+.. +|+.+|+|+++..... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999965 6899999998653322 2234677899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ +|.+++.. ...+++..+..++.||++||.|||+. +++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 974 78777753 56789999999999999999999998 999999999999999999999999999986543221 1
Q ss_pred eeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....+++.|+|||.+.+. .++.++|||||||++|||+||+.|+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 2234578899999988664 4688999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=262.71 Aligned_cols=194 Identities=31% Similarity=0.461 Sum_probs=166.8
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEe-cCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-TTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~ 377 (517)
.+|...+.||+|+||.||++... |..+|+|.++... ....+.+|+.++++++|+|++++++++. ..+..+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46778899999999999999875 7889999886432 3457889999999999999999999765 44568899999
Q ss_pred CcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999987533 488999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
....++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 22335678999999988889999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=267.15 Aligned_cols=199 Identities=29% Similarity=0.450 Sum_probs=166.9
Q ss_pred cCCCCCCccccccccceEEEEeC-----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
.+|.+.+.||+|+||.||++..+ ++..||+|.++... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46778899999999999999742 57899999986443 23345788999999999999999999987543 457
Q ss_pred eEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 899999999999999875 34689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCcee--eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 451 HCDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 451 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
....... ....++..|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 3322111 11223456999999988889999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=261.49 Aligned_cols=196 Identities=32% Similarity=0.464 Sum_probs=168.1
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChh
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 384 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 384 (517)
+.||+|+||.||++...+++.||+|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999875443334567899999999999999999999999999999999999999999
Q ss_pred hhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee-eeccc
Q 010149 385 SRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-TAVRG 462 (517)
Q Consensus 385 ~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~-~~~~g 462 (517)
+++.. ...+++..+..++.+++.|+.|||++ +++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99864 44689999999999999999999999 999999999999999999999999999976542211111 11224
Q ss_pred cccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 463 t~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
+..|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 567999999988889999999999999999999 88888644
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=269.96 Aligned_cols=209 Identities=26% Similarity=0.386 Sum_probs=176.4
Q ss_pred HHhcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCc------chHHHHHHHHHHhccCCCcccceeeeEe-c
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG------GEIQFQTEVEMISLAVHRNLLRLIGFCM-T 367 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~-~ 367 (517)
...++|-...+||+|+|+.||+|. +...+.||||+-...+... ..+...+|.++.+.++||.||++++|+. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 344567778899999999999999 4567899999876443322 2234678999999999999999999985 5
Q ss_pred CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCCeEEcccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFG 444 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DFG 444 (517)
.+..+-|.||++|.+|.-+|+....+++.+++.|+.||+.||.||.+. +++|+|.||||.|||+- ..|.+||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 567889999999999999999999999999999999999999999986 88999999999999994 46789999999
Q ss_pred cccccCCCCC------ceeeeccccccccCcccccc----CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 445 LAKLLDHCDS------HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 445 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+++.++.... ..+....||..|++||.+.- .+.+.|+||||+|||+|..+.|++||.....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 9998865432 23455679999999998753 3578899999999999999999999976543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=263.66 Aligned_cols=193 Identities=26% Similarity=0.345 Sum_probs=170.9
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|++|.||+++.. +++.+|+|++...... .....+.+|+.+++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 5899999998654322 3345789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecccc
Q 010149 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463 (517)
Q Consensus 384 ~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt 463 (517)
.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 99998877899999999999999999999998 99999999999999999999999999998765432 22234588
Q ss_pred ccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 464 ~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..|+|||.+....++.++|+||+|+++|||++|+.||....
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.25 Aligned_cols=198 Identities=24% Similarity=0.343 Sum_probs=170.2
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
|.....||+|+||.||++... ++..||+|.+.... ......+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 333567999999999999864 68899999985432 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+++|.+++... .+++..+..++.||+.||.|||++ +|+||||||+||++++++.++|+|||++........ ....
T Consensus 103 ~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 103 GGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred CCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 99999988643 589999999999999999999998 999999999999999999999999999876543222 2223
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..|+..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 458899999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=263.77 Aligned_cols=190 Identities=23% Similarity=0.327 Sum_probs=159.0
Q ss_pred CccccccccceEEEEeCC-------------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 305 NLVGKGGFGNVYKGYLQD-------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
+.||+|+||.||+|+..+ ...|++|.+.... ......|.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2358888875432 23345688899999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC-------eEEccc
Q 010149 372 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-------AVVGDF 443 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~ki~DF 443 (517)
++||||+++|+|..++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998874 45689999999999999999999998 9999999999999987664 899999
Q ss_pred ccccccCCCCCceeeeccccccccCccccc-cCCCCcccceehhhHHHHHHH-hCCCCcCcC
Q 010149 444 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-SGLRALEFG 503 (517)
Q Consensus 444 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvil~ell-tG~~P~~~~ 503 (517)
|++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|+.|+...
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 998754321 1234788999999886 466889999999999999998 588887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=269.63 Aligned_cols=208 Identities=27% Similarity=0.357 Sum_probs=173.0
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEe--
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCM-- 366 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~-- 366 (517)
++.+..+.++|++.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++..+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455567789999999999999999999864 67899999875432 2245678899999998 6999999999874
Q ss_pred ---cCCcceEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 367 ---TTTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 367 ---~~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
..+..++||||+++++|.+++. ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 3345799999999999998775 235688999999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|+|||++..+..... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999986543222 2233458999999998753 447889999999999999999999987554
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=269.34 Aligned_cols=199 Identities=27% Similarity=0.369 Sum_probs=170.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC----cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
+|+..+.||+|+||.||+|... +++.||+|.++..... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999965 6899999999754322 1234567899999999999999999999998899999
Q ss_pred EecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+ +|+|.+++.... .+++..+..++.||++||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999998765 799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 157 RK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred cc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 22 222346788999998854 46789999999999999999997777643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=266.87 Aligned_cols=200 Identities=25% Similarity=0.344 Sum_probs=172.0
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999964 689999999875443 22345789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+ +++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999998864 45689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....|+..|+|||.+.+. .++.++||||+|++++||+||+.||...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 3344589999999988654 4688999999999999999998777543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=260.03 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=168.1
Q ss_pred cCCCCCCccccccccceEEEEeCC-----CcEEEEEEecCCCCCcc-hHHHHHHHHHHhccCCCcccceeeeEec-CCcc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMT-TTER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~ 371 (517)
..|+....||+|.||.||+|+-.+ .+.+|+|.++..+...+ .....+|+.+++.++|||++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888999999999999997332 23689999976644333 3457899999999999999999999887 7778
Q ss_pred eEEEecCcCCChhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC----CCeEEcc
Q 010149 372 LLVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY----YEAVVGD 442 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~D 442 (517)
++++||.+. +|.+.++ ....++...++.|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 8888886 234688999999999999999999999 69999999999999877 8999999
Q ss_pred cccccccCCCCCc--eeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 443 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 443 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
||+++.+...-.. ....++-|..|.|||.+.+. .||.+.|||+.|||+.||+|-+.-|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999987654322 23456679999999998775 589999999999999999998766654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=263.48 Aligned_cols=201 Identities=22% Similarity=0.345 Sum_probs=173.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|+||.||++... +|+.+|+|.+..... .....++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999854 689999999864322 22345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++++|.+++... ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988753 3578999999999999999999998 999999999999999999999999999986543221
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||++.+...+.++||||||++++||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 1223348889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.66 Aligned_cols=208 Identities=25% Similarity=0.349 Sum_probs=180.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcch--HHHHHHHHHHhcc-CCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 373 (517)
..+|....+||+|+||.|-.|..+ +.+.+|||++++....+.. +.-+.|-++++.. +-|.+++++.++..-+..|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 356788899999999999999865 4678999999876543322 2345677777766 57889999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+.+|+|-.++++-+.+.++.+.-+|..||-||-|||++ +|+.||||..||++|.+|++||+|||+++.-- .+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FD 503 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-cC
Confidence 999999999999999989999999999999999999999999 99999999999999999999999999997421 23
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcccccc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 509 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~~ 509 (517)
...+.+.+|||.|+|||++...+|...+|.|||||+||||+.|+.||+..++++.+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 45667889999999999999999999999999999999999999999987765433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=244.28 Aligned_cols=207 Identities=24% Similarity=0.321 Sum_probs=172.2
Q ss_pred HHHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHh-ccCCCcccceeeeEecCCcc
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~ 371 (517)
+....+.......||+|++|.|-+-++ ++|+..|+|+++..-.....++...|+++.. ....|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344445555678899999999988884 5899999999987766656677888888754 45799999999999999999
Q ss_pred eEEEecCcCCChhhhh----hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 372 LLVYPYMSNGSVASRL----KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
++.||.|+- ||..+- +.++.+++...-+|+..+.+||.|||++. .++|||+||+|||++.+|.+||+|||.+-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999965 776543 46778999999999999999999999985 89999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccCcccccc----CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.+.++ -..+.-.|...|||||.+.. ..|+.|+||||+|+++.||.+++.|++....
T Consensus 198 ~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 76542 12222348889999999853 4689999999999999999999999976443
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=270.69 Aligned_cols=195 Identities=22% Similarity=0.322 Sum_probs=169.4
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
...||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++++||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 457999999999999864 68999999986433 2334568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccc
Q 010149 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462 (517)
Q Consensus 383 L~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~g 462 (517)
|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++....... .......|
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 179 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG 179 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence 9987765 4689999999999999999999998 99999999999999999999999999987554322 12233458
Q ss_pred cccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 463 t~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999988889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=268.94 Aligned_cols=208 Identities=30% Similarity=0.395 Sum_probs=173.1
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
..++..++++|...+.||+|+||.||++.. .+++.+|+|++.... ....++.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 345555678899999999999999999996 468899999986432 2245677899999888 799999999998754
Q ss_pred -----CcceEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 369 -----TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 369 -----~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
...++||||+++++|.++++ ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 35789999999999999875 345789999999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeeccccccccCccccccC-----CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 999999886543221 12234588999999987543 36889999999999999999999986543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=273.82 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=171.4
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
.++||+|.||+||-|+.+ +|+.||||++.+... ..++.++.+|+.++..++||.||.+.-.|+..+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 588999999999999954 799999999965443 334567999999999999999999999999999999999999664
Q ss_pred Chhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CCeEEcccccccccCCCCCcee
Q 010149 382 SVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 382 sL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DFGla~~~~~~~~~~~ 457 (517)
=|.-++. +.+.+++..-+-+..||+.||.|||.+ +|+|.||||+|||+.+. ..+||+|||+|+.+.+. ...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--hhh
Confidence 4544554 456789988889999999999999999 99999999999999643 47999999999998753 344
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
..+.||+.|+|||++....|...-||||.|||+|--++|.-||+.+++
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 567899999999999999999999999999999999999999986554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=265.77 Aligned_cols=193 Identities=28% Similarity=0.362 Sum_probs=166.7
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|+||+||++... +|+.+|+|.+..... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 689999999864321 22244567899999999999999999999999999999999999999
Q ss_pred hhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecc
Q 010149 384 ASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461 (517)
Q Consensus 384 ~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 461 (517)
.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99987544 789999999999999999999998 999999999999999999999999999876543 11222345
Q ss_pred ccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 462 gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 7889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=264.26 Aligned_cols=192 Identities=28% Similarity=0.366 Sum_probs=161.1
Q ss_pred ccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHH---HHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 306 LVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVE---MISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~---~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
+||+|+||.||+|... +++.||+|.+...... .....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 6889999998653221 11223444443 3444579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+|+|.+++...+.+++..+..++.|+++|+.|||+. +|+||||||+||++++++.+||+|||++....... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 999999998777899999999999999999999998 99999999999999999999999999987553322 123
Q ss_pred ccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 460 VRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..|+..|+|||.+..+ .++.++||||+|+++|||++|+.||...
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 4589999999998754 6889999999999999999999999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=265.90 Aligned_cols=202 Identities=26% Similarity=0.394 Sum_probs=177.5
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.++.|+..+.||+|++|.||+|..+ ++..+++|++..... ....+.+|+++++.++|+|++++++++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566888899999999999999976 688999999965433 4567889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999998765 899999999999999999999998 999999999999999999999999998875543221
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 2223347889999999988889999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=265.18 Aligned_cols=199 Identities=31% Similarity=0.418 Sum_probs=173.4
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
-|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|+..+++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667788999999999999854 688999999865443344567889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..+..... ...
T Consensus 85 ~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 85 GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 999999988754 689999999999999999999998 999999999999999999999999999876543221 222
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...++..|+|||.+.....+.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 345888999999998888899999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=265.62 Aligned_cols=196 Identities=32% Similarity=0.528 Sum_probs=165.7
Q ss_pred CccccccccceEEEEeCC-------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 305 NLVGKGGFGNVYKGYLQD-------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.||+|+||.||+|+..+ +..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886544334456789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-----CeEEccccc
Q 010149 378 MSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-----EAVVGDFGL 445 (517)
Q Consensus 378 ~~~gsL~~~l~~-------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~ki~DFGl 445 (517)
+++++|.+++.. ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999863 23478899999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 446 AKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 446 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
++........ ......++..|+|||++.++.++.++||||||+++|||+| |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 9765332211 1122335688999999999999999999999999999998 99998654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=266.81 Aligned_cols=200 Identities=23% Similarity=0.370 Sum_probs=174.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|...+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888899999999999999854 68899999985432 23345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++... .+++..+..++.|++.|+.|||++ +++||||||+||++++++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 9999999998754 578999999999999999999999 999999999999999999999999998876543322 22
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....+++.|+|||.+....++.++||||||+++||+++|+.||...+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 23458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=252.32 Aligned_cols=198 Identities=26% Similarity=0.412 Sum_probs=167.4
Q ss_pred CCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEecCc
Q 010149 302 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
+....||+|+.|.|++++.+ .|..+|||.+.........+++...++++.+.. .|.||+.+|||..+...++-||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34577999999999999965 689999999987766666677777888776664 8999999999999999999999985
Q ss_pred CCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 380 NGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 380 ~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
. .+..+++ ..+++++..+-++...++.||.||.++. +|+|||+||+|||+|+.|++|++|||++-.+.+.. ..+
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 4 4555554 3567888888899999999999999875 99999999999999999999999999998776443 334
Q ss_pred eccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...|-+.|||||.+. ...|+.++||||||+.++||.||+.||..-+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 456999999999985 4578999999999999999999999997643
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=264.85 Aligned_cols=189 Identities=25% Similarity=0.340 Sum_probs=157.1
Q ss_pred ccccccccceEEEEeCC-------------------------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccc
Q 010149 306 LVGKGGFGNVYKGYLQD-------------------------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~ 360 (517)
.||+|+||.||+|++.. ...|++|++.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999997421 1358889885432 222346888999999999999999
Q ss_pred eeeeEecCCcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---
Q 010149 361 LIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY--- 436 (517)
Q Consensus 361 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--- 436 (517)
+++++......++||||+++|+|..++.. .+.+++..+..++.|+++||+|||++ +|+||||||+||++++++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999864 56789999999999999999999998 999999999999997654
Q ss_pred ----CeEEcccccccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHH-hCCCCcCcC
Q 010149 437 ----EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELI-SGLRALEFG 503 (517)
Q Consensus 437 ----~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~ell-tG~~P~~~~ 503 (517)
.+|++|||.+...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3799999988643221 12247788999998865 56899999999999999984 799998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=265.76 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=170.8
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|+..+.||+|++|.||+|+.. +|..||+|.++..........+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 688999999976554444556788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 379 SNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 379 ~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
++ +|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888877642 4689999999999999999999998 999999999999999999999999999976543211
Q ss_pred eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......++..|++||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223347889999998865 456889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=266.30 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=169.2
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|++|.||+|+.. +|+.||+|+++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999865 6899999998654322 2235688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 588888764 35689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 122334788999999886644 5889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=260.10 Aligned_cols=200 Identities=28% Similarity=0.415 Sum_probs=172.2
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|+++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 68899999986543 223345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~~ 454 (517)
+++++|.+++... ..+++..+..++.|+++|+.|||++ +++||||+|+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999753 4589999999999999999999998 999999999999998554 67999999998664322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......++..|+|||.+....++.++||||||+++|+|++|+.||+..+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 2223458899999999988888999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=264.61 Aligned_cols=201 Identities=27% Similarity=0.401 Sum_probs=171.1
Q ss_pred CCCCCCccccccccceEEEEeC-----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec--CCcce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~ 372 (517)
.|...+.||+|+||.||+|.+. ++..+|+|+++.........+|.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999854 3688999999755433245679999999999999999999999877 55789
Q ss_pred EEEecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 373 LVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997543 689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..... .....++..|+|||.+....++.++||||||++++||+||+.|+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 22211 11233566799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=265.58 Aligned_cols=209 Identities=29% Similarity=0.430 Sum_probs=172.8
Q ss_pred ChHHHHHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEec
Q 010149 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT 367 (517)
Q Consensus 290 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 367 (517)
++.++..+...|+..+.||+|+||.||+|+. .+++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4445555677899999999999999999996 468899999885432 2345678899988888 69999999999853
Q ss_pred ------CCcceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 368 ------TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 368 ------~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
....+++|||+++|+|.+++.. ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 3467899999999999998864 34578888999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999999876542221 122345889999999875 3467889999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=260.18 Aligned_cols=195 Identities=24% Similarity=0.304 Sum_probs=164.0
Q ss_pred HHHhcCCCCCCcc--ccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 295 QSATSNFSSKNLV--GKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 295 ~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
....++|++.+.+ |+|+||.||+++.+ ++..+|+|.+....... .|+.....+ +||||+++++.+...+.
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3344566666666 99999999999954 68889999986432111 122222222 69999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEccccccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLL 449 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~ 449 (517)
.++||||+++++|.+++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999998777899999999999999999999998 999999999999999988 9999999998765
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 4321 235889999999999888999999999999999999999999743
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=263.46 Aligned_cols=198 Identities=22% Similarity=0.326 Sum_probs=171.5
Q ss_pred CCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
|...+.||+|++|.||++.. .+++.+++|++.... ......+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 44467899999999999995 468899999885432 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||.+....... .....
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 9999999887 5689999999999999999999998 99999999999999999999999999887543321 12233
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 458999999999988889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=262.64 Aligned_cols=201 Identities=30% Similarity=0.422 Sum_probs=170.9
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCC-----
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT----- 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~----- 369 (517)
.+++|+..+.||+|++|.||+|... +++.+++|++..... ...++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 5678999999999999999999975 678999999865432 345789999999998 6999999999997654
Q ss_pred -cceEEEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 370 -ERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 370 -~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 37899999999999998863 35789999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++........ ......|+..|+|||++.. ..++.++||||||++++||++|+.||...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9876543222 2223458899999998753 34678999999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=259.98 Aligned_cols=204 Identities=28% Similarity=0.412 Sum_probs=171.5
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEec--CCcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lv~ 375 (517)
+|+..+.||+|+||.||++.. .++..+|+|.++.... .....++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 467789999999999999985 4688999999865432 2234568899999999999999999998764 34568999
Q ss_pred ecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 376 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 376 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||..+ +.+++||||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999864 457899999999999999999999221 229999999999999999999999999999876
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... .....+++.|+|||.+....++.++||||||+++++|++|+.||...+
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 543321 233458999999999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=264.45 Aligned_cols=199 Identities=26% Similarity=0.335 Sum_probs=171.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--CcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 375 (517)
++|+..+.||.|++|.||++... +++.+|+|.+..........++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999974 68899999987554444456789999999999999999999988654 3578999
Q ss_pred ecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++++|.+++. ....+++.....++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988765 234688999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. .....++..|+|||.+.+..++.++||||+|+++|||++|+.||+..
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 12345788999999998889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=260.94 Aligned_cols=195 Identities=29% Similarity=0.384 Sum_probs=169.6
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|+||.||+++.. +|+.+++|.+...... .....+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 4899999998654321 2345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-------ce
Q 010149 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-------HV 456 (517)
Q Consensus 384 ~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-------~~ 456 (517)
.+++.....+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99998777899999999999999999999998 999999999999999999999999999875433211 12
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.......+.++||||||++++||++|+.||....
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 233457889999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=271.09 Aligned_cols=201 Identities=22% Similarity=0.347 Sum_probs=167.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC-----cc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~ 371 (517)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+...........+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467899999999999999999854 689999999864433334456888999999999999999999876543 46
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++++||+++ ++.+.+.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999975 88877754 4689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCc--eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2211 1123458899999998654 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=260.54 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=169.6
Q ss_pred CCCCCCccccccccceEEEEeCC--CcEEEEEEecCCCC---------CcchHHHHHHHHHHhc-cCCCcccceeeeEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLKDGNA---------IGGEIQFQTEVEMISL-AVHRNLLRLIGFCMT 367 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~---------~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~ 367 (517)
+|+..+.||+|+||.||+|.... ++.+|+|.+..... .....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999764 68899998853221 1123456778887764 799999999999999
Q ss_pred CCcceEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcc
Q 010149 368 TTERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
.+..+++|||+++++|.+++. ....+++..+..++.|++.||.|||+ . +++||||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998874 34568999999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||.+....... ......|+..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99998655432 2334558899999999998889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=264.96 Aligned_cols=196 Identities=32% Similarity=0.415 Sum_probs=167.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..|...+.||+|+||.||+|+.. +++.||+|.+...... ....++.+|+++++.++||||+++.+++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999965 6899999998643322 22346889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||++ |++.+.+. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 57766665 345789999999999999999999998 9999999999999999999999999998765432
Q ss_pred ceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....+++.|+|||.+. ...++.++||||||+++|||+||+.||...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2235788999999874 456888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=263.69 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=170.3
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecC--CcceEEEe
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVYP 376 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 376 (517)
|++.+.||+|++|.||+|+.. +++.+|+|++.... .......+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999965 58899999997653 222345688999999999999999999999887 78999999
Q ss_pred cCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+++ +|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888888654 5799999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||+...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2333457889999997754 457899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=265.52 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=170.1
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC----
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT---- 369 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 369 (517)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578889999999999999999975 588999999965432 223356788999999999999999999987654
Q ss_pred ------cceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcc
Q 010149 370 ------ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 370 ------~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
..++|+||+++ ++...+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 67899999986 66666654 34689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 443 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998765433222223346788999998764 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=276.52 Aligned_cols=197 Identities=28% Similarity=0.404 Sum_probs=171.4
Q ss_pred CCCccccccccceEEEEeC--CC--cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 303 SKNLVGKGGFGNVYKGYLQ--DG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
..++||+|.||.|++|.|. +| ..||||.++.........+|.+|+.+|.+++|||+++++|+..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4578999999999999976 34 46899999876655556789999999999999999999999988 6778999999
Q ss_pred cCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+.|+|.+.|+. ...+-......++.|||.||.||..+ ++|||||..+|+|+-....+||+|||+.+.+...+...
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999985 45688888999999999999999999 99999999999999999999999999999887655443
Q ss_pred eee--ccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 457 TTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 457 ~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
... ..-.+.|+|||.+....++.++|||+|||++|||+| |..||-.-
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 221 123468999999999999999999999999999999 77888543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.61 Aligned_cols=200 Identities=24% Similarity=0.315 Sum_probs=169.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecC--CcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lv 374 (517)
++|+..+.||+|+||.||+|... +++.+|+|.++...... ....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999975 68899999997543222 233577899999999999999999998877 789999
Q ss_pred EecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++ +|.+.+... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 898888653 4589999999999999999999998 99999999999999999999999999998665432
Q ss_pred CceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
. ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||...
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22234478899999988654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=258.50 Aligned_cols=192 Identities=25% Similarity=0.344 Sum_probs=163.3
Q ss_pred CccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHH-HhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|... +|+.||+|.++..... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999864 6899999998643221 112234445444 4455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 99999998877899999999999999999999998 999999999999999999999999999875432 1234
Q ss_pred cccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.++..|+|||.+.+..++.++||||||+++|||+||..||...+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 58899999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=255.02 Aligned_cols=198 Identities=31% Similarity=0.455 Sum_probs=176.0
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++.+++++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3677889999999999999975 688999999965443 34567899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999998765 6789999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....++..|+|||.+....++.++||||||+++++|++|+.||...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3445889999999998888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=257.61 Aligned_cols=194 Identities=31% Similarity=0.479 Sum_probs=166.0
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|.+.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 3577889999999999999975 57889999986432 245788999999999999999999998654 578999999
Q ss_pred cCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999998753 3579999999999999999999998 9999999999999999999999999998754321
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......+..|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 112234578999999988899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=262.25 Aligned_cols=198 Identities=24% Similarity=0.381 Sum_probs=168.4
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
|+..+.||+|++|.||+|+.. +|..||+|++...... .....+.+|+++++.++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999964 7999999998654322 22356889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+ ++|.+++.... .+++..+..++.|+++||.|||++ +++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999887654 789999999999999999999998 9999999999999999999999999999765432211
Q ss_pred eeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1222468899999987654 5688999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=278.66 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=168.4
Q ss_pred CCCCCCccccccccceEEEEeCCCc-EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.|.+...||-|+||.||+|+.++.. ..|.|++. ........+|.-||++++..+||+||++++.|+..+..++..|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 3456778999999999999977544 45567663 334445668999999999999999999999999999999999999
Q ss_pred cCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
.||.+..++- -...+.+.++.-+++|++.||.|||++ +|+|||||+.|||++-+|.++++|||.+..... .....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 9999988765 356799999999999999999999999 999999999999999999999999998754322 22334
Q ss_pred eeccccccccCcccc-----ccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 458 TAVRGTVGHIAPEYL-----STGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
..+.|||.|||||+. ...+|+.++||||||++|.||..+..|-..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 566799999999976 456899999999999999999999999653
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=258.81 Aligned_cols=201 Identities=29% Similarity=0.424 Sum_probs=164.5
Q ss_pred CCCCCccccccccceEEEEeC----CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
|.+.+.||+|+||.||+|.+. +++.+|+|+++.... .....++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 368899999865432 223456889999999999999999999886542
Q ss_pred cceEEEecCcCCChhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
..++++||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 236889999999998876421 2578899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 444 GLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 444 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|.++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 999865432211 1122335678999999988889999999999999999999 889886543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=234.83 Aligned_cols=200 Identities=24% Similarity=0.373 Sum_probs=170.5
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcc-hHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|...+.||+|.||+||+|+.. +++.||+|+++-....++ .....+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555688999999999999954 688999999975544333 34678999999999999999999999999999999999
Q ss_pred CcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+.. +|..+.. -++.++...++.++.|+++||.|+|++ ++.|||+||.|.|++.+|+.|++|||+++.+.- ....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi-pvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRC 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC-ceEe
Confidence 976 6777665 367899999999999999999999999 999999999999999999999999999997754 2334
Q ss_pred eeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....-|..|.+|+++.+.+ |+...|+||-|||+.|+....+|.-.+.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 44556799999999987754 7889999999999999999777765543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-34 Score=256.58 Aligned_cols=194 Identities=28% Similarity=0.384 Sum_probs=163.1
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHh-ccCCCcccceeeeEecCCcceEEEecCcCC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
...||.|+||+|+|-.++ .|+.+|||+++........+++..|.+... .-+.||||+++|.+..++..|+-||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 567999999999998865 799999999987776666778888888654 44799999999999999999999999964
Q ss_pred Chhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 382 SVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 382 sL~~~l~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+..+-+ ++..+++.-.-+|..-.++||.||-+.. .|+|||+||+|||++..|.+|++|||.+-.+.. +..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 6654432 4556888888899999999999998765 899999999999999999999999999875542 222
Q ss_pred eeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.+.-.|-..|||||.+.. ..|+.++||||+|++|+|+.||+.|++.
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 333458899999999954 3489999999999999999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=270.08 Aligned_cols=200 Identities=24% Similarity=0.314 Sum_probs=169.3
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecC------
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 368 (517)
...+|+..+.||+|+||.||+|+.. +++.||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4567999999999999999999954 78999999986432 222334677899999999999999999988643
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...++||||+.+ +|.+.+... +++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 346899999964 888877644 88999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 168 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 54321 1223457899999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=260.27 Aligned_cols=197 Identities=25% Similarity=0.304 Sum_probs=163.8
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecC--CcceEEEe
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERLLVYP 376 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e 376 (517)
|...+.||+|+||.||+|... +++.+|+|+++............+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999954 689999999875433333334557888888885 99999999999887 88899999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|++ +++.+.+.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 478777764 45789999999999999999999998 9999999999999999 9999999999986643222
Q ss_pred eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 122447889999997644 557889999999999999999999997543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=284.97 Aligned_cols=199 Identities=22% Similarity=0.315 Sum_probs=158.8
Q ss_pred HhcCCCCCCccccccccceEEEEeCC--CcEEEEEEec--------------C--CCCCcchHHHHHHHHHHhccCCCcc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQD--GTVVAVKRLK--------------D--GNAIGGEIQFQTEVEMISLAVHRNL 358 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~--------------~--~~~~~~~~~~~~Ei~~l~~l~H~nI 358 (517)
..++|.+.+.||+|+||+||++..+. +...+.|.+. + .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45689999999999999999987542 2222222110 0 0111123458899999999999999
Q ss_pred cceeeeEecCCcceEEEecCcCCChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 359 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
+++++++...+..++|+|++. ++|.+++... ..........++.|++.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 4677766422 2234566778999999999999998 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCC
Q 010149 434 EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499 (517)
Q Consensus 434 ~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P 499 (517)
.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999987654333333445699999999999999999999999999999999998854
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=268.59 Aligned_cols=203 Identities=22% Similarity=0.332 Sum_probs=170.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEec----CCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 371 (517)
.++|+..+.||+|+||.||+|... +|..||+|++..... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999954 689999999875432 2234567789999999999999999998763 3457
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+. ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 89999996 68999998777899999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCc---eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 2211 1123468899999998765 568899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=259.83 Aligned_cols=190 Identities=24% Similarity=0.354 Sum_probs=158.1
Q ss_pred CccccccccceEEEEeCC--------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 305 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
+.||+|+||.||+|.... ...+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998542 2347888775332 2234568889999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC--------eEEccccccc
Q 010149 377 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVGDFGLAK 447 (517)
Q Consensus 377 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~ki~DFGla~ 447 (517)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. ++++|||.+.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999754 4689999999999999999999998 9999999999999987765 5999999886
Q ss_pred ccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCC-CCcCcC
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGL-RALEFG 503 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~-~P~~~~ 503 (517)
..... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+...
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 54321 22457889999999976 45789999999999999999995 555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=264.32 Aligned_cols=202 Identities=29% Similarity=0.375 Sum_probs=168.5
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecC--CcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 373 (517)
.++|++.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999965 68999999986443222 233567899999999999999999998765 45789
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++ +|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 78877764 46789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 222335788999998865 457899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=261.86 Aligned_cols=200 Identities=23% Similarity=0.356 Sum_probs=166.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|+..+.||+|++|.||+|+.+ +|+.||+|.+...... .....+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999965 6889999998654322 233568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~~~~~~~ 453 (517)
|++ +++.+++.... .+++..+..++.||+.||+|||++ +++||||+|+||++++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 47877775433 357888889999999999999998 9999999999999985 5579999999997654321
Q ss_pred CceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223347889999998865 45788999999999999999999999654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=262.68 Aligned_cols=200 Identities=26% Similarity=0.359 Sum_probs=170.8
Q ss_pred CCCCCCccccccccceEEEEe----CCCcEEEEEEecCCCC---CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 371 (517)
+|+..+.||+|++|.||+++. .++..+|+|.++.... ......+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366788999999999999884 3578899999864321 12234688999999999 599999999999988899
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++|+|.+++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999998777899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeeeccccccccCccccccCC--CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
..........|+..|+|||...+.. .+.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 3332233345889999999987654 68899999999999999999999953
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=262.58 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=164.9
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999964 689999999875443444567889999999986 99999999999998899999999
Q ss_pred CcCCChhhhh---h--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 378 MSNGSVASRL---K--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 378 ~~~gsL~~~l---~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+.. ++.++. . ....+++..+..++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554432 2 3457899999999999999999999742 8999999999999999999999999999765432
Q ss_pred CCceeeeccccccccCccccccC---CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
. ......|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 2 11223588999999998766 6889999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=262.54 Aligned_cols=202 Identities=20% Similarity=0.188 Sum_probs=154.4
Q ss_pred hcCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcc-h---------HHHHHHHHHHhccCCCcccceee
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGG-E---------IQFQTEVEMISLAVHRNLLRLIG 363 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~-~---------~~~~~Ei~~l~~l~H~nIv~l~~ 363 (517)
..+|.+.+.||+|+||.||+|...+ +..+|+|+......... + .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578899999999999999999654 34566665432221110 0 01122334456678999999999
Q ss_pred eEecCC----cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 364 FCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 364 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
++.... ..++++|++.. ++.+.+......++..+..++.|++.||+|||+. +|+||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 766543 23577777643 6666666555568888999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 440 VGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 440 i~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
|+|||+|+.+...... ......||+.|+|||...+..++.++|||||||+++||++|+.||...
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999865322211 112345999999999999999999999999999999999999999754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=253.42 Aligned_cols=200 Identities=30% Similarity=0.451 Sum_probs=176.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|++|.||+++.. +++.+++|.+...... .....+.+|++++++++|||++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 6789999999755322 2345789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++++|.+++.....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 99999999998778899999999999999999999998 9999999999999999999999999999876543322 2
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....++..|+|||.......+.++||||+|+++++|++|+.||...
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 3345889999999998877899999999999999999999998643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=260.54 Aligned_cols=203 Identities=25% Similarity=0.376 Sum_probs=176.8
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv 374 (517)
++|...+.||+|+||.||+|... +++.+|+|++..... ......+.+|.+++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999965 789999999865322 223456888999999998 99999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998887899999999999999999999998 999999999999999999999999999986543221
Q ss_pred -------------------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 -------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......++..|+|||.......+.++||||||++++++++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 12223457899999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=256.55 Aligned_cols=201 Identities=23% Similarity=0.375 Sum_probs=172.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|+..+.||+|+||.||+|... +|..+|+|.+..... ......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999965 588999999865322 12345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~~ 454 (517)
+++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987533 579999999999999999999998 999999999999999886 469999999986653222
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||.+....++.++||||||++++||++|+.||....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 2223458899999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=266.59 Aligned_cols=202 Identities=22% Similarity=0.267 Sum_probs=168.7
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv 374 (517)
....|++.+.||+||.+.||++...+.+.+|+|++..... ......|.+|+++|.+++ |.+||++++|...++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456888999999999999999988888888887754333 233456999999999994 99999999999999999999
Q ss_pred EecCcCCChhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||-+ .+|..+|+++.. ...-.++.+..|++.++.++|+. ||||.||||.|+|+-+ |.+||+|||+|..+....
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 99865 489999986543 22237889999999999999999 9999999999999976 789999999999887654
Q ss_pred Cce-eeeccccccccCccccccC-----------CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHV-TTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... ....+||+.||+||.+... +.++++||||+|||||+|+.|+.||..-
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 433 3456799999999988532 2467999999999999999999999643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=261.03 Aligned_cols=200 Identities=21% Similarity=0.294 Sum_probs=165.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccC-CCcccceeeeEecCCc-----
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE----- 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~----- 370 (517)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999965 6899999988654322 22356788999999995 6999999999887665
Q ss_pred ceEEEecCcCCChhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccc
Q 010149 371 RLLVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFG 444 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFG 444 (517)
.++||||+++ +|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78887753 23579999999999999999999998 9999999999999998 8899999999
Q ss_pred cccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+++.+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9976543211 1122346889999998865 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=253.81 Aligned_cols=202 Identities=29% Similarity=0.420 Sum_probs=177.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC--CcceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 375 (517)
+|...+.||+|++|.||+|... ++..+++|++..... ......+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667889999999999999976 789999999865432 23355788999999999999999999999988 7889999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++++|.+++.....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998777899999999999999999999998 9999999999999999999999999999876543321
Q ss_pred -eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......++..|+|||.+.....+.++||||||+++++|++|+.||...+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233458899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=267.63 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=168.9
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhcc-CCCcccceeeeEecC--Ccc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~--~~~ 371 (517)
..++|+..+.||+|+||.||+|... ++..+|+|++.... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999965 68899999885432 122334577899999999 999999999988654 357
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 89999997 5999888765 789999999999999999999998 999999999999999999999999999986543
Q ss_pred CCC----ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .......|+..|+|||.+.. ..++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 12233458899999998754 567889999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=253.36 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=176.3
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|...+.||+|+||.||++... ++..+++|++...... .....+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999965 6889999998654322 3445788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 378 MSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 378 ~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998753 6799999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......|++.|+|||......++.++||||+|+++++|++|+.||+...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 22333458899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=261.48 Aligned_cols=199 Identities=25% Similarity=0.414 Sum_probs=165.8
Q ss_pred cCCCCCCccccccccceEEEEeCC-CcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|+..+.||+|+||.||+|..++ ++.||||.++.........++..|+.++.+. .||||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999764 8999999997554444445667777766666 49999999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+++ ++.+.+.. ...+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++..+.....
T Consensus 95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 9854 67666653 457899999999999999999999732 899999999999999999999999999976543221
Q ss_pred eeeeccccccccCccccccCC----CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.....++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 12234788999999987553 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=269.64 Aligned_cols=215 Identities=22% Similarity=0.347 Sum_probs=184.0
Q ss_pred hcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
..-|...+.||-|+||+|.+++ .++...+|+|.+++.... ......+.|.++|+..+.+-||+|+-.|.+.+..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778899999999999998 455678999988654322 2234578899999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc-----
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL----- 449 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~----- 449 (517)
|+|++||++-.+|-+-+.+.+..++-++..+..|+++.|.. |+|||||||.|||||.+|++||+|||++.-+
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999998888899999999999999999999999 9999999999999999999999999998522
Q ss_pred ----CCCCCc--------------------------------eeeeccccccccCccccccCCCCcccceehhhHHHHHH
Q 010149 450 ----DHCDSH--------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 493 (517)
Q Consensus 450 ----~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~el 493 (517)
...+.+ ......||+.|+|||++....|+..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 111000 00124599999999999999999999999999999999
Q ss_pred HhCCCCcCcCccccccCccccc
Q 010149 494 ISGLRALEFGKTANQKGAMLDW 515 (517)
Q Consensus 494 ltG~~P~~~~~~~~~~~~~~~w 515 (517)
+.|+.||-...+.+..-.++.|
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeeh
Confidence 9999999988887777777777
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=261.41 Aligned_cols=194 Identities=31% Similarity=0.418 Sum_probs=165.5
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|+..+.||+|+||.||+|+.. ++..+|+|.+...... ....++.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999954 6889999998643222 2234688999999999999999999999999999999999
Q ss_pred CcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ ++.+.+. ....+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 7777665 355689999999999999999999998 9999999999999999999999999998754321
Q ss_pred eeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....|++.|+|||++. .+.++.++||||||+++|||++|+.||...
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2235888999999873 456889999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=259.86 Aligned_cols=194 Identities=22% Similarity=0.337 Sum_probs=168.5
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
...||+|+||.||++..+ ++..||+|.+.... ......+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 357999999999999864 78999999885432 2345568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccc
Q 010149 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462 (517)
Q Consensus 383 L~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~g 462 (517)
|.+++... .+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++....... .......|
T Consensus 104 L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 104 LTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 99987643 589999999999999999999998 99999999999999999999999999987654322 12233458
Q ss_pred cccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 463 t~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++.|+|||.+....++.++|+||+|+++|||++|+.||...
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 89999999998888899999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=261.02 Aligned_cols=202 Identities=28% Similarity=0.414 Sum_probs=166.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCc------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------ 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------ 370 (517)
++|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999965 6899999988643322 223456789999999999999999999876543
Q ss_pred --ceEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 371 --RLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 371 --~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
.++||||+.+ +|.+.+... ..+++.++..++.|++.||.|||++ +++|+||||+||++++++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4899999975 787777643 3689999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCc---eeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
........ ......++..|+|||.+.+. .++.++||||||+++|||+||+.||...+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 65432211 11223478899999987654 46889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=265.47 Aligned_cols=201 Identities=21% Similarity=0.327 Sum_probs=169.6
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecC-----Cc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 370 (517)
.++|.+.+.||+|+||+||+|+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999954 68999999986432 222344677899999999999999999988654 24
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++|+||+. ++|.+++...+.+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 789999996 68999988778899999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 322 12223457889999998764 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=254.99 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=173.6
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+|++.+.||+|+||.||++... +++.+|+|.+..... ......+.+|+++++.++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677899999999999999854 688999999865432 22344678899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 378 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 378 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998865 45689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......+++.|+|||.+.+..++.++|+||+|++++||++|+.||...+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2223448899999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=262.13 Aligned_cols=202 Identities=24% Similarity=0.372 Sum_probs=166.7
Q ss_pred CCCCCCccccccccceEEEEeC---CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 372 (517)
+|...+.||+|+||.||+|+.. ++..||+|.+..... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999965 478999999976331 22234678899999999999999999999887 7789
Q ss_pred EEEecCcCCChhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC----CCCeEEccc
Q 010149 373 LVYPYMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGDF 443 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~ki~DF 443 (517)
+||||+++ ++.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66665541 23688999999999999999999998 9999999999999999 999999999
Q ss_pred ccccccCCCCC--ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 444 GLAKLLDHCDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 444 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
|++........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99986643222 11223457889999998765 4578999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=257.66 Aligned_cols=198 Identities=25% Similarity=0.344 Sum_probs=168.1
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEecC
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
|.+.+.||+|++|.||+|+.. +++.|++|++.............+|+..+.+++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556788999999999999975 578999999865433223334567899999998 999999999999999999999999
Q ss_pred cCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+|+|.+++.... .+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 789999887654 789999999999999999999998 999999999999999999999999999986643222
Q ss_pred eeeccccccccCccccc-cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 22345788999999874 4557899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=264.89 Aligned_cols=201 Identities=23% Similarity=0.350 Sum_probs=173.0
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC-----cce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-----ERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 372 (517)
+|.+.+.||+|++|.||+|+.. +++.+|+|++..... ....+.+.+|+++++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 589999999865432 233457889999999999999999999988765 779
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++|||+++ +|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999984 8999988777899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC--ceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 21 112234578899999999877 78999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=265.19 Aligned_cols=205 Identities=25% Similarity=0.363 Sum_probs=170.7
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
..++...+++|...+.||+|+||.||+|.. .+++.||+|++..... ......+.+|++++++++||||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667789999999999999999999985 4789999999865321 22245678899999999999999999988643
Q ss_pred ------CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcc
Q 010149 369 ------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 369 ------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3357788876 77998877654 589999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 164 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 164 FGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred ccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999875432 1223457889999998865 567889999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=263.31 Aligned_cols=197 Identities=25% Similarity=0.357 Sum_probs=164.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
.++|...+.||+|+||.||+|+.. +|+.||+|+++.... ......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468888999999999999999954 689999999865322 222346789999999999999999999987543
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++|+||+.. ++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 35899999964 6766553 3589999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 123347889999999866 468899999999999999999999997644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=261.04 Aligned_cols=202 Identities=29% Similarity=0.405 Sum_probs=165.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
.++|.+.+.||+|+||.||+|... +++.+|+|++....... ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999965 68899999986543222 2345778999999999999999999876543
Q ss_pred --cceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 370 --ERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 370 --~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
..++|+||+.+ ++...+.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 35899999975 66666653 45799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc----------eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 447 KLLDHCDSH----------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 447 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 765432211 1123346888999998765 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=268.14 Aligned_cols=209 Identities=23% Similarity=0.288 Sum_probs=184.0
Q ss_pred cCCCCCCccccccccceEEEEeCCCc-EEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGT-VVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+++....||-|+||.|=.+...... .+|+|++++....+ +......|-.+|...+.|.||+++..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555678999999999999866433 48999887654333 3445778999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|-|-||.++..+..++.++....+-++.-+++|++|||.+ +||.|||||+|.+++.+|-+||.|||+|+.+... .
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--R 574 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--C
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999988753 3
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCccccccCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAM 512 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~~~~~ 512 (517)
.+-+++||+.|.|||++.+...+..+|.||+|+++|||+||..||...++...-..+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I 631 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI 631 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 455688999999999999999999999999999999999999999988876554433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=281.39 Aligned_cols=205 Identities=29% Similarity=0.416 Sum_probs=175.5
Q ss_pred HHHhcCCCCCCccccccccceEEEEeC----C----CcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeE
Q 010149 295 QSATSNFSSKNLVGKGGFGNVYKGYLQ----D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFC 365 (517)
Q Consensus 295 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 365 (517)
+...++..+.+.+|+|.||.|++|... . ...||||.++..........+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334455566679999999999999843 1 4579999998777666677899999999988 699999999999
Q ss_pred ecCCcceEEEecCcCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 010149 366 MTTTERLLVYPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAAN 429 (517)
Q Consensus 366 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~N 429 (517)
......++|+||++.|+|.+++.... .++..+...++.|||.||+||++. ++|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999998544 488999999999999999999999 99999999999
Q ss_pred eEEcCCCCeEEcccccccccCCCCCceeeeccc--cccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCc
Q 010149 430 ILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEF 502 (517)
Q Consensus 430 ILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~ 502 (517)
||+.++..+||+|||+|+.....+......-.| ...|||||.+....|+.|+|||||||++|||+| |..|+..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999665544443222222 456999999999999999999999999999999 7888864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=246.86 Aligned_cols=196 Identities=24% Similarity=0.319 Sum_probs=164.1
Q ss_pred HhcCCCC-CCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC----C
Q 010149 297 ATSNFSS-KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT----T 369 (517)
Q Consensus 297 ~~~~~~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~----~ 369 (517)
.+++|.+ .++||-|-.|.|-.++.+ +|+.+|+|++.+.. ...+|+++.-.. .|||||.++++|... .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3455544 368999999999999865 78999999997543 235788765443 699999999998653 4
Q ss_pred cceEEEecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFG 444 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFG 444 (517)
..++|||+|+||.|++.++.++ .+++.++..|+.||..|+.|||+. +|.||||||+|+|... |-.+|++|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 5679999999999999998655 499999999999999999999999 9999999999999964 4468999999
Q ss_pred cccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+|+.-.. .....+.+-|+.|.|||++...+|+...|+||+||++|-|+.|..||...
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 9986442 23344567899999999999999999999999999999999999999753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=285.75 Aligned_cols=197 Identities=29% Similarity=0.411 Sum_probs=160.1
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC------
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 368 (517)
+-..+|+..++||+||||.||+++.+ ||+.+|||++...........+.+|+.++++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888999999999999999976 89999999997665333445688999999999999999887542110
Q ss_pred --------------------------------------------------------------------------------
Q 010149 369 -------------------------------------------------------------------------------- 368 (517)
Q Consensus 369 -------------------------------------------------------------------------------- 368 (517)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEecCcCCChhhhhhcCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 010149 369 ---------------------------------TERLLVYPYMSNGSVASRLKAKPSL-DWATRKRIALGAARGLLYLHE 414 (517)
Q Consensus 369 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~~i~~~L~yLH~ 414 (517)
...||-||||+..++.+++..+... .....++++.+|++||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0125778999988888888765443 577889999999999999999
Q ss_pred cCCCCeEecCCCCCceEEcCCCCeEEcccccccccC----C-------------CCCceeeeccccccccCccccccC--
Q 010149 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD----H-------------CDSHVTTAVRGTVGHIAPEYLSTG-- 475 (517)
Q Consensus 415 ~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~-- 475 (517)
+ +||||||||.||++|++..+||+|||+|.... . ......+...||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998621 0 011122445699999999999764
Q ss_pred -CCCcccceehhhHHHHHHHh
Q 010149 476 -QSSEKTDVFGFGILLLELIS 495 (517)
Q Consensus 476 -~~~~~~Dv~S~Gvil~ellt 495 (517)
.|+.|+||||+|||++||+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=261.34 Aligned_cols=202 Identities=24% Similarity=0.302 Sum_probs=168.1
Q ss_pred cCCC-CCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-------------chHHHHHHHHHHhccCCCcccceee
Q 010149 299 SNFS-SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------------GEIQFQTEVEMISLAVHRNLLRLIG 363 (517)
Q Consensus 299 ~~~~-~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~Ei~~l~~l~H~nIv~l~~ 363 (517)
++|. ..+.||+|+||+||+|... +++.||+|.++...... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999965 68999999986433221 0124778999999999999999999
Q ss_pred eEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 364 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
++...+..++||||++ |+|.+++.....+++.....++.|++.||+|||+. +++||||+|+||+++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 68999998777899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCC-------------CceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 444 GLAKLLDHCD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 444 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|++....... ........++..|+|||.+.+. .++.++||||||+++|||+||+.||...+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9997654111 1111223467889999998654 46889999999999999999999996543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=249.17 Aligned_cols=194 Identities=30% Similarity=0.354 Sum_probs=170.7
Q ss_pred cccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
||+|+||.||++... +++.+|+|.+...... .....+..|+++++.++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998754332 2345788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeecccc
Q 010149 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463 (517)
Q Consensus 384 ~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt 463 (517)
.+++.....+++.....++.|+++|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 99998877899999999999999999999998 99999999999999999999999999998654322 122344588
Q ss_pred ccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 464 ~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..|+|||...+...+.++|+||||+++|||++|+.||...+
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999988888999999999999999999999996544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=254.10 Aligned_cols=197 Identities=26% Similarity=0.389 Sum_probs=164.9
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhcc---CCCcccceeeeEecCCc-----
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLA---VHRNLLRLIGFCMTTTE----- 370 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~----- 370 (517)
|++.+.||+|+||.||+|+.+ +++.+|+|+++...... ....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999976 48999999997543322 233466787776655 69999999999988776
Q ss_pred ceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.+++|||+++ +|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 888888653 3589999999999999999999998 999999999999999999999999999977
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
+..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 643221 12234788999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=259.18 Aligned_cols=196 Identities=23% Similarity=0.237 Sum_probs=161.0
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCC-CCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
.+.+|.|+++.||++.. +++.||+|+++.. ........+.+|+++++.++||||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555554 6899999998754 223344678999999999999999999999999999999999999999
Q ss_pred hhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC------
Q 010149 383 VASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS------ 454 (517)
Q Consensus 383 L~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~------ 454 (517)
|.+++.. ...+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999874 34688999999999999999999999 999999999999999999999999998865432111
Q ss_pred ceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11123347788999999865 35788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=253.68 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=170.4
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
|+..+.||+|++|.||+|+.. +++.+|+|.+..... ......+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 589999999976532 223456788999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+ ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||+|+||++++++.+||+|||.++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 8 5899999865 5799999999999999999999999 999999999999999999999999999986644322 12
Q ss_pred eeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....++..|+|||.+... .++.++||||||++++||++|+.||....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 223467889999998766 78999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=259.99 Aligned_cols=202 Identities=24% Similarity=0.340 Sum_probs=169.7
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEec-CCc
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTE 370 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~ 370 (517)
+...+++|+..+.||+|+||.||+|+.. ++..||+|++..... ......+..|++++.+++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999854 789999998854322 2234567889999999999999999998876 456
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++++||+ +++|.++++.. .+++.....++.|++.||.|||+. +|+||||+|+||++++++.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 78999998 56898887643 578888999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 122347889999998765 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=261.41 Aligned_cols=200 Identities=24% Similarity=0.346 Sum_probs=168.3
Q ss_pred HHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC----
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT---- 369 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 369 (517)
...++|+..+.||+|+||.||+|.. .++..||+|++..... ......+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999985 4789999999864322 222346789999999999999999999887543
Q ss_pred --cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 370 --ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 370 --~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|++|||++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999998 6789888764 4689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 167 QTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 123357889999998865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=259.41 Aligned_cols=197 Identities=25% Similarity=0.315 Sum_probs=161.5
Q ss_pred Cccccc--cccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
..||+| +||+||++... +|+.||+|++...... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999964 7999999998754322 2235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce--
Q 010149 381 GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-- 456 (517)
Q Consensus 381 gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~-- 456 (517)
+++.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988753 3589999999999999999999998 99999999999999999999999998654322111100
Q ss_pred ----eeeccccccccCccccccC--CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 ----TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0112256679999998763 47899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=255.36 Aligned_cols=194 Identities=32% Similarity=0.424 Sum_probs=164.4
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|...+.||+|+||.||+|+.. ++..+++|++...... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 6889999998643322 2234688899999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+. |++.+.+.. ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 577776653 45789999999999999999999998 999999999999999999999999999864322
Q ss_pred eeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345889999999974 456888999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=257.09 Aligned_cols=195 Identities=33% Similarity=0.433 Sum_probs=165.2
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3556788999999999999964 67899999886432 22233467889999999999999999999999999999999
Q ss_pred cCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+. |++.+.+. ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 997 57777664 345689999999999999999999998 9999999999999999999999999998765432
Q ss_pred eeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2234788999999874 356788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=259.78 Aligned_cols=201 Identities=21% Similarity=0.282 Sum_probs=165.3
Q ss_pred CCCCCCccccccccceEEEEeC-C--CcEEEEEEecCCCCC-cchHHHHHHHHHHhcc-CCCcccceeeeEecC----Cc
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-D--GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT----TE 370 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~----~~ 370 (517)
+|...+.||+|+||.||+++.. . +..+|+|++...... .....+.+|++++.++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4667889999999999999965 3 778999998643222 2245678899999988 599999999875432 34
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++++||+. ++|.+.+.....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678889886 68999998778899999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCc---eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 32211 1123458999999998765 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=252.96 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=170.4
Q ss_pred CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
|+..+.||+|++|.||+|+.. +++.+++|.++..... .....+..|++++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999965 6889999998654332 23456888999999999999999999999999999999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++ ++.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 88887765 45789999999999999999999998 99999999999999999999999999998765433 122
Q ss_pred eeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....++..|+|||.+.+. ..+.++||||+|+++|+|+||+.||....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 234478899999998766 78999999999999999999999996544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=248.11 Aligned_cols=199 Identities=24% Similarity=0.357 Sum_probs=165.3
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC----CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
+|.+.+.||+|+||.||+++.. .+..+++|.++... ......++..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777899999999999999864 34456666654321 122234577889999999999999999999999999999
Q ss_pred EecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 375 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 375 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
|||+++++|.+.+. ....+++..+..++.|++.|+.|||+. +++|+||+|+||++++ +.+||+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998875 345789999999999999999999998 9999999999999975 569999999987654
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... .......|++.|+|||.+....++.++|+||||+++|+|++|..||+..
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 322 2223445889999999998888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=259.26 Aligned_cols=200 Identities=24% Similarity=0.342 Sum_probs=164.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC---------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--------- 368 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--------- 368 (517)
.+|...+.||+|+||.||+|+.. +|+.||+|.+..... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888999999999999999964 689999999865433 3455688999999999999999999876543
Q ss_pred -----CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcc
Q 010149 369 -----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD 442 (517)
Q Consensus 369 -----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~D 442 (517)
...++||||++ ++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+||+++ +++.+|++|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 24689999997 5888887643 689999999999999999999998 999999999999997 456789999
Q ss_pred cccccccCCCCCc--eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 443 FGLAKLLDHCDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||.++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999765432111 1122347889999997654 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=243.65 Aligned_cols=180 Identities=21% Similarity=0.226 Sum_probs=155.0
Q ss_pred ccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChhhhhh
Q 010149 310 GGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK 388 (517)
Q Consensus 310 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 388 (517)
|.+|.||+++.. +++.+|+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999964 78999999986542 22344444555679999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccC
Q 010149 389 AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468 (517)
Q Consensus 389 ~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~a 468 (517)
....+++..+..++.|+++||.|||+. +|+||||||+||++++++.++++|||.+...... .....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 777899999999999999999999998 9999999999999999999999999988655432 122346778999
Q ss_pred ccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 469 PEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 469 PE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
||......++.++||||+|+++|||++|+.|++.
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999888889999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=242.11 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=176.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-c-hHHHHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-G-EIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~-~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
..++|....+||+|+|++|-.++++ +.+.+|+|+++++-..+ . ..=.+.|-.++.+. +||.+|.+..+|..+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467888999999999999999965 67899999997643221 1 12245676676655 7999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+|.||+++|+|--+++++..++++.++-+...|.-||.|||++ ||+.||||..|||+|..|++|++|+|+++.-- .
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 9999999999999999888999999999999999999999999 99999999999999999999999999997532 2
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
+...+.+++|||.|+|||.+.+..|....|.|++||+++||+.|+.||+.
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 34566778999999999999999999999999999999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=276.61 Aligned_cols=146 Identities=29% Similarity=0.398 Sum_probs=132.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +++.||+|+++..... .....+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999965 6899999999754322 12356889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
||+++++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=257.33 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=167.9
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCc----
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE---- 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~---- 370 (517)
..++|+..+.||+|++|.||+|+.. ++..||+|++..... ......+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567889999999999999999975 678999999864321 2223457789999999999999999998866554
Q ss_pred --ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 371 --RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 371 --~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 78999998 5699988875 4689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 223357889999998865 467889999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=241.52 Aligned_cols=200 Identities=25% Similarity=0.343 Sum_probs=168.7
Q ss_pred CCCCccccccccceEEEEeC-CCcEEEEEEecCC-CCCcchHHHHHHHHHHhccCCCcccceeeeEecC-----CcceEE
Q 010149 302 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TERLLV 374 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~~lv 374 (517)
+..+.||-|+||.||.+... +|+.||.|++..- ..-.+.+.+.+|++++..++|.|++..++...-. ++.|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34678999999999999854 8999999988532 2223356788999999999999999998876543 356788
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
.|.|.. +|..++-....++.+.++-+..||++||.|||+. +|.||||||.|.|++.+...||+|||+|+..+..+.
T Consensus 136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 899865 8888888888899999999999999999999998 999999999999999999999999999998765444
Q ss_pred ceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
...+...-|..|.|||.+.+. .|+.+.||||.|||+.|++..+.-|+...+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 444444578999999999874 589999999999999999999988876554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=261.38 Aligned_cols=202 Identities=22% Similarity=0.265 Sum_probs=152.1
Q ss_pred HhcCCCCCCccccccccceEEEEe-----------------CCCcEEEEEEecCCCCCc-------------chHHHHHH
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-----------------QDGTVVAVKRLKDGNAIG-------------GEIQFQTE 346 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~-------------~~~~~~~E 346 (517)
..++|++.+.||+|+||.||+|.. ..++.||||+++...... ....+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986432110 11123346
Q ss_pred HHHHhccCCCcc-----cceeeeEec--------CCcceEEEecCcCCChhhhhhcC-----------------------
Q 010149 347 VEMISLAVHRNL-----LRLIGFCMT--------TTERLLVYPYMSNGSVASRLKAK----------------------- 390 (517)
Q Consensus 347 i~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~----------------------- 390 (517)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 678887753 35679999999999999988631
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCc
Q 010149 391 -PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469 (517)
Q Consensus 391 -~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aP 469 (517)
..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1246778889999999999999998 999999999999999999999999999976543222111122357899999
Q ss_pred cccccCCC----------------------CcccceehhhHHHHHHHhCCC-CcC
Q 010149 470 EYLSTGQS----------------------SEKTDVFGFGILLLELISGLR-ALE 501 (517)
Q Consensus 470 E~~~~~~~----------------------~~~~Dv~S~Gvil~elltG~~-P~~ 501 (517)
|.+..... ..+.||||+||+++||++|.. |+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 98754321 134799999999999999985 664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=258.84 Aligned_cols=194 Identities=25% Similarity=0.355 Sum_probs=166.3
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++.|.....+|.|+|+.|-.+... +++..++|++.+... +-.+|+.++.+. .||||+++.+.+.+..+.++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 3567788888999999999998854 688899999976522 223567665554 699999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-cCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~ki~DFGla~~~~~~~ 453 (517)
||.+.++-+.+.+...+... ..+..|+.+|+.|+.|||++ |||||||||+|||+ ++.++++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999888887665555 78888999999999999999 99999999999999 58899999999999876543
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....+-|..|.|||++....|++++|+||||++||+|++|+.||...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 23335688999999999999999999999999999999999999754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=253.34 Aligned_cols=197 Identities=23% Similarity=0.333 Sum_probs=170.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-----cc--hHHHHHHHHHHhccC---CCcccceeeeEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GG--EIQFQTEVEMISLAV---HRNLLRLIGFCMT 367 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~--~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~ 367 (517)
.+|...+.+|+|+||.|+.+.++ +...|++|.+.++..- +. .-..-.|+.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999976 4567888988654211 00 112456999999887 9999999999999
Q ss_pred CCcceEEEecC-cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 368 TTERLLVYPYM-SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 368 ~~~~~lv~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
++.+||+||-. ++.+|++++...+.+++.+++.|++|++.|+++||++ +|||||||-+||.++.+|-+||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence 99999999986 4678999999999999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcC
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
...... ....++||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus 718 a~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876543 3445679999999999988777 566899999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=232.58 Aligned_cols=199 Identities=29% Similarity=0.425 Sum_probs=172.8
Q ss_pred CCCCCccccccccceEEEEeCC-CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
|...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 889999999754432245678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 380 NGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 380 ~gsL~~~l~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
+++|.+++..... +++.....++.++++++.|||+. +++|+|++|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999987655 89999999999999999999998 9999999999999999999999999999876543211223
Q ss_pred eccccccccCcccc-ccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 459 AVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 459 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34578899999998 667778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=257.13 Aligned_cols=210 Identities=28% Similarity=0.412 Sum_probs=176.3
Q ss_pred ChHHHHHHhcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEec
Q 010149 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT 367 (517)
Q Consensus 290 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 367 (517)
.++.+...++-|++.++||+|.+|.||+++ .++++.+|+|+...... .+++.+.|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344455567788999999999999999999 45789999998865433 345666778887766 79999999999864
Q ss_pred -----CCcceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEE
Q 010149 368 -----TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 440 (517)
Q Consensus 368 -----~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 440 (517)
+++.|||||||.+||.-++++. ...+.|..+.-|+..++.|+.|||.+ .++|||+|-.|||+++++.+|+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 5788999999999999999874 45789999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCceeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 441 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 441 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.|||.+..++. ......+..||+.|||||++.. ..|+.++|+||+|++..||--|..|+-...+
T Consensus 165 vDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 165 VDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred eeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 99999876654 2233445669999999999853 3467899999999999999999999865544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-30 Score=231.76 Aligned_cols=201 Identities=27% Similarity=0.435 Sum_probs=163.7
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecC--------C
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--------T 369 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--------~ 369 (517)
.|+....||+|.||.||+|+.+ .|+.||+|++.-++ ..+-...-.+|++++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999955 57888988764332 233334567899999999999999999988542 2
Q ss_pred cceEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..++||++++. +|.-.+... ..++..++.++++++..||.|+|.. .|+|||+||.|+|++.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 36899999987 788888754 5789999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC---ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+...+. ...+...-|..|.+||.+.+ ..|+++.|||.-|||+.||.||.+-++...
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 643322 12233346899999998866 568999999999999999999987765433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=228.99 Aligned_cols=187 Identities=32% Similarity=0.438 Sum_probs=166.2
Q ss_pred cccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChhhhhhc
Q 010149 311 GFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA 389 (517)
Q Consensus 311 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 389 (517)
+||.||+|+.. +|+.+++|++...........+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997654433256899999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCc
Q 010149 390 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469 (517)
Q Consensus 390 ~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aP 469 (517)
...+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..|++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 66689999999999999999999998 99999999999999999999999999998765432 22344588899999
Q ss_pred cccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 470 EYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 470 E~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
|......++.++||||||+++++|++|..||+.
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=258.76 Aligned_cols=197 Identities=21% Similarity=0.229 Sum_probs=142.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC-C----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeee------E
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-D----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF------C 365 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~------~ 365 (517)
..++|+..+.||+|+||.||+|++. + +..||+|++..... ...+..| .+....+.+++.+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4578999999999999999999965 4 68999998754221 1111111 1112222233322221 2
Q ss_pred ecCCcceEEEecCcCCChhhhhhcCCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 010149 366 MTTTERLLVYPYMSNGSVASRLKAKPS--------------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425 (517)
Q Consensus 366 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl 425 (517)
....+.++||||+++++|.+++..... .....+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 345678999999999999998864321 12234567999999999999998 9999999
Q ss_pred CCCceEEcC-CCCeEEcccccccccCCCCCceeeeccccccccCccccccC----------------------CCCcccc
Q 010149 426 KAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTD 482 (517)
Q Consensus 426 k~~NILl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 482 (517)
||+|||+++ ++.+||+|||+|+.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57999999999986654333344456789999999965322 2345679
Q ss_pred eehhhHHHHHHHhCCCCcC
Q 010149 483 VFGFGILLLELISGLRALE 501 (517)
Q Consensus 483 v~S~Gvil~elltG~~P~~ 501 (517)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999876654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=229.85 Aligned_cols=212 Identities=25% Similarity=0.338 Sum_probs=179.7
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeee
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 364 (517)
.+++.....++....++-+|.||.||.|.+. +.+.|-+|.++...++-+...+..|.-++.-+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3456666677888889999999999999654 3456778888777665555678888888888899999999998
Q ss_pred Eec-CCcceEEEecCcCCChhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 010149 365 CMT-TTERLLVYPYMSNGSVASRLKA--------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 435 (517)
Q Consensus 365 ~~~-~~~~~lv~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 435 (517)
+.+ ...++..|.++.-|+|..++.. ...++..+...++.|++.||+|||+. +|||.||.++|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 865 4567889999999999999971 23577888999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccCCCCCceee-eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCcc
Q 010149 436 YEAVVGDFGLAKLLDHCDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKT 505 (517)
Q Consensus 436 ~~~ki~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~~ 505 (517)
..+||+|=.+++.+.+.+.+... .......||+||.+....|+.++|||||||++|||+| |+.|+-.-++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 99999999999988777766443 3346789999999999999999999999999999999 9999865554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=216.70 Aligned_cols=197 Identities=20% Similarity=0.342 Sum_probs=165.1
Q ss_pred hcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCC--cceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT--ERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~--~~~l 373 (517)
.++|++.+.+|+|.+++||.|. ..+.+.++||+++.-. .+.+.+|+.++..++ ||||+++++...++. .+.|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678889999999999999998 5578899999997432 457889999999997 999999999987754 4679
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~~~~~~ 452 (517)
|+||+.+.+....- +.++..+++.++.+++.||.|+|+. ||+|||+||.|+++|. ....+++|+|+|.++.+.
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999987665433 4678888999999999999999999 9999999999999985 457999999999988654
Q ss_pred CCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
... .-...+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||-.+...
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 332 22235677889999865 45788899999999999999999999877653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=233.25 Aligned_cols=198 Identities=22% Similarity=0.282 Sum_probs=166.0
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-C-Cc----ccceeeeEecCC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-H-RN----LLRLIGFCMTTT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H-~n----Iv~l~~~~~~~~ 369 (517)
.+.+|.+...+|+|.||.|-.+... .+..||+|+++.-.. ..+.-.-|++++.++. + |+ +|.+.+++...+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3678999999999999999999854 478999999964332 2334567888988883 2 33 788889999999
Q ss_pred cceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE------------- 434 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~------------- 434 (517)
+.++|+|.+ |-|+++++..+ .+++...++.++.|++++++|||+. +++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999998 55999999854 4689999999999999999999999 9999999999999932
Q ss_pred -------CCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 435 -------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 435 -------~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..+|++|||.|.+-.... ..+..|..|.|||++.+-.++.++||||+||||.|+.||..-|+.-+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 2358899999998754322 45668999999999999999999999999999999999999887543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=253.24 Aligned_cols=194 Identities=28% Similarity=0.391 Sum_probs=160.0
Q ss_pred CCCCCccccccccc-eEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecC
Q 010149 301 FSSKNLVGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 301 ~~~~~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
|...+++|.|+.|+ ||+|... |+.||||++-.+. ..-..+|+..+..- +|||||++++...++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44557899999876 7999986 8899999985322 23456899998877 5999999999999999999999999
Q ss_pred cCCChhhhhhcC-CC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---C--CCeEEccccccccc
Q 010149 379 SNGSVASRLKAK-PS---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---Y--YEAVVGDFGLAKLL 449 (517)
Q Consensus 379 ~~gsL~~~l~~~-~~---l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~--~~~ki~DFGla~~~ 449 (517)
.. +|.+++... .. ......+.+..|++.||+|||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 999999863 11 11144578899999999999997 9999999999999975 3 46899999999988
Q ss_pred CCCCCcee--eeccccccccCccccccCCCCcccceehhhHHHHHHHhC-CCCcCcC
Q 010149 450 DHCDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG-LRALEFG 503 (517)
Q Consensus 450 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG-~~P~~~~ 503 (517)
........ ....||-+|+|||++.....+.++||||+|||+|+.++| ++||...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 76544322 345699999999999998888899999999999999996 8999754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=214.71 Aligned_cols=196 Identities=26% Similarity=0.308 Sum_probs=162.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCC-CCCcchHHHHHHHHHHhccCCCcccceeeeEecC------Cc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~~ 370 (517)
.+|.....+|.|.- .|-.+... .++.||+|+.... ......++..+|..++..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45667788888888 66666543 5889999987533 1122334567899999999999999999998643 45
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.|+|||+|.. +|...+. -.++-.+...+..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+.-.
T Consensus 96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence 6899999965 8888777 3478889999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
. ....+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|...
T Consensus 170 ~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 170 T--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred c--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 3 23456677899999999998888999999999999999999999988743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=204.36 Aligned_cols=183 Identities=37% Similarity=0.538 Sum_probs=159.6
Q ss_pred cccccccceEEEEeCC-CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChhh
Q 010149 307 VGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 385 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 385 (517)
||+|.+|.||++...+ ++.+++|++...........+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999765432234678999999999999999999999999999999999999999999
Q ss_pred hhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccccccccCCCCCceeeecccc
Q 010149 386 RLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463 (517)
Q Consensus 386 ~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~gt 463 (517)
++... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 99865 5789999999999999999999999 9999999999999999 89999999999986654321 12334478
Q ss_pred ccccCccccccC-CCCcccceehhhHHHHHH
Q 010149 464 VGHIAPEYLSTG-QSSEKTDVFGFGILLLEL 493 (517)
Q Consensus 464 ~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~el 493 (517)
..|++||..... ..+.++|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 899999999777 788999999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=211.14 Aligned_cols=197 Identities=21% Similarity=0.368 Sum_probs=157.4
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHH-hccCCCcccceee-eEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIG-FCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~~-~~~~~~~~~lv 374 (517)
.+.|.+.+.+|+|.||.+-.+.++ ..+.+++|.+.... ...++|.+|...- ..-.|.||+.-++ .|...+.++.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 356888999999999999999976 56789999886543 2356888888653 3346999998776 45566777899
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCCeEEcccccccccCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DFGla~~~~~~ 452 (517)
+||++.|+|.+-+... .+.+...++++.|++.|+.|||++ ++||||||.+|||+- +...+|++|||.++..+.
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 9999999999888754 478888999999999999999999 999999999999993 345899999999875432
Q ss_pred CCceeeeccccccccCccccccC-----CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.-....-+..|.+||..... ...+.+|||.||++++.++||+.||+...
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 11222356789999976432 34678999999999999999999998543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=216.37 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=166.4
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
+....+.|...+.||+|.|+.||++.+. ....||+|.+.....+ ....+|++++..+ -+.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3344567888999999999999999854 3678999999765543 4578999999888 499999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAK 447 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~ 447 (517)
+...+|+||++.....++.. .++..++..++..+..||.|+|.+ |||||||||+|+|.+ ..+.-.|.|||+|.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 99999999999988888776 467899999999999999999999 999999999999997 55678999999996
Q ss_pred ccCCC---------------------------------C----------CceeeeccccccccCcccccc-CCCCcccce
Q 010149 448 LLDHC---------------------------------D----------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDV 483 (517)
Q Consensus 448 ~~~~~---------------------------------~----------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv 483 (517)
..+.. . ........||++|.|||++.. ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21100 0 001112359999999999865 457899999
Q ss_pred ehhhHHHHHHHhCCCCcCcC
Q 010149 484 FGFGILLLELISGLRALEFG 503 (517)
Q Consensus 484 ~S~Gvil~elltG~~P~~~~ 503 (517)
||.|||++.+++++.||-..
T Consensus 262 ws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeccceeehhhccccccccC
Confidence 99999999999999998644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-26 Score=231.10 Aligned_cols=198 Identities=27% Similarity=0.374 Sum_probs=172.0
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|+....+|.|++|.|||++. ..++..|+|+++-.... ...-.++|+-+++..+|||||.++|.+...+..++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 35788889999999999999995 47899999999765432 23456789999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+.+|+|.+.-+..+++++.+...+.+..++|++|||++ +=+|||||-.|||+++.|.+|+.|||.+-.+.. ....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hhhh
Confidence 999999999999889999999999999999999999999 889999999999999999999999998865532 2223
Q ss_pred eeeccccccccCcccc---ccCCCCcccceehhhHHHHHHHhCCCCc
Q 010149 457 TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
...+.||+.|||||+. ..+.|..++|||+.|+...|+-.-+.|.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 4456799999999986 4567899999999999999987766664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=218.58 Aligned_cols=169 Identities=21% Similarity=0.208 Sum_probs=130.7
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeC--CCcEEEEEEecCCC----CCcchHHHHHHHHHHhccCCCcccceeeeEec
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 367 (517)
......+|...+.||+|+||+||+|+.+ +++.+|||++.... .......|.+|++++++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999864 57788999875331 11224468999999999999999853322
Q ss_pred CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEEcCCCCeEEcccccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~ki~DFGla 446 (517)
....++||||+++++|... ... . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+|
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 2467999999999999732 211 1 146789999999999998 9999999 999999999999999999999
Q ss_pred cccCCCCCce-------eeeccccccccCccccccC
Q 010149 447 KLLDHCDSHV-------TTAVRGTVGHIAPEYLSTG 475 (517)
Q Consensus 447 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 475 (517)
+.+....... -....+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 8765432111 1345688899999998654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=212.02 Aligned_cols=130 Identities=23% Similarity=0.368 Sum_probs=109.2
Q ss_pred cCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-----CC---cccceeeeEec--
Q 010149 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HR---NLLRLIGFCMT-- 367 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~---nIv~l~~~~~~-- 367 (517)
.+|.+.+.||-|-|++||.+. .++.+.||+|+.+.... ..+.-..||+++++++ |+ .||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 678889999999999999999 45788999999975432 2334678999998773 33 49999999964
Q ss_pred --CCcceEEEecCcCCChhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 368 --TTERLLVYPYMSNGSVASRLK--AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 368 --~~~~~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
+.+.++|+|++ |.+|..++. ....++...+++|++||+.||.|||.+| +|+|-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999999 558888876 3457899999999999999999999999 999999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=218.06 Aligned_cols=201 Identities=23% Similarity=0.229 Sum_probs=167.4
Q ss_pred HHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC------CCcccceeeeEec
Q 010149 295 QSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV------HRNLLRLIGFCMT 367 (517)
Q Consensus 295 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~l~~~~~~ 367 (517)
+....+|.+....|+|-|++|-+|..+ -|+.||||++...... .+.=+.|+++|+++. .-++++++..|..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 345678988999999999999999965 5889999999754322 233457899999884 3468999999999
Q ss_pred CCcceEEEecCcCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDF 443 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DF 443 (517)
.++.+||||-+. -+|.+.|+.. -.|....+..++.|+.-||..|-.. +|+|.||||.|||+++.. .+|||||
T Consensus 506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 999999999874 4899999854 3588899999999999999999987 999999999999998765 5799999
Q ss_pred ccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 444 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 444 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|.|........ ++..-+..|.|||++.+-+|+...|+||+||.||||.||+.-|....
T Consensus 582 GSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 582 GSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99987654332 22334567999999999999999999999999999999999886543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=238.44 Aligned_cols=187 Identities=35% Similarity=0.569 Sum_probs=134.9
Q ss_pred hhHHHHHHHHHHHHHhhhccCCCCCchHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCceeeeEEeCC-CCEEEEecCCCC
Q 010149 4 EEAVFCFVALFGLWTCACGLLSPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSD-GLVTGLGAPSQN 82 (517)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~~~c~w~gv~C~~-~~v~~l~l~~~~ 82 (517)
+.|.||+++++.+..+.|- + .+.|+.||++||+++.+|...+.+|+.. .+||.|.||+|++ ++|+.|+|++|+
T Consensus 7 ~~~~~~~~~~~~~~~~~~~--~---~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~ 80 (968)
T PLN00113 7 QHCPYLIFMLFFLFLNFSM--L---HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKN 80 (968)
T ss_pred CCCChHHHHHHHHHHHccC--C---CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCC
Confidence 3455555555544444431 1 3479999999999999898889999764 5899999999984 689999999999
Q ss_pred CcccccccccCCCCCcEEecccCccCCCCCCccc-ccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCC
Q 010149 83 LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 161 (517)
Q Consensus 83 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 161 (517)
++|.+|+.+..+++|+.|+|++|+++|.+|..+. ++++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|.
T Consensus 81 i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~ 158 (968)
T PLN00113 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPN 158 (968)
T ss_pred ccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCCh
Confidence 9999999999999999999999999988887765 778888888887777766554 2355555555555555555555
Q ss_pred CcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcc
Q 010149 162 SLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSL 198 (517)
Q Consensus 162 ~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~ 198 (517)
.++++++|++|+|++|.+++.+|..+. +.+++++|.+
T Consensus 159 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 200 (968)
T PLN00113 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200 (968)
T ss_pred HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCC
Confidence 555555555555555555555554332 3445555544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=220.34 Aligned_cols=160 Identities=38% Similarity=0.652 Sum_probs=123.6
Q ss_pred CCCCchHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCc-----eeeeEEeCC------CCEEEEecCCCCCcccccccccC
Q 010149 25 SPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPC-----SWALVTCSD------GLVTGLGAPSQNLSGTLSSSIGN 93 (517)
Q Consensus 25 ~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~~~c-----~w~gv~C~~------~~v~~l~l~~~~l~~~~~~~~~~ 93 (517)
...+.+.|+.||+++|+++.+|.. .+|.+ +|| .|.||.|+. ..|+.|+|++|++.|.+|+.+++
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence 345667899999999999987643 48964 455 699999952 14888888888888888888888
Q ss_pred CCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccC-CCcceE
Q 010149 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM-SQLAFL 172 (517)
Q Consensus 94 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~l 172 (517)
+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+++|.+|..+..+ .++.
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~-- 518 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA-- 518 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCc--
Confidence 8888888888888888888888888888888888888888888888888888888888888888888776543 1222
Q ss_pred eccCCCCCCCCCCCCcCcccccCCccccCCCCCCCC
Q 010149 173 DLSYNNLSGPVPSFHAKTFNITGNSLICATGAEEDC 208 (517)
Q Consensus 173 ~l~~N~l~~~~p~~~~~~~~l~~N~~~c~~~~~~~~ 208 (517)
.+++.+|+.+|+.+....|
T Consensus 519 -----------------~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 519 -----------------SFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred -----------------eEEecCCccccCCCCCCCC
Confidence 3466777777875543444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=231.37 Aligned_cols=146 Identities=16% Similarity=0.134 Sum_probs=114.5
Q ss_pred cCC-CcccceeeeE-------ecCCcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 010149 353 AVH-RNLLRLIGFC-------MTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423 (517)
Q Consensus 353 l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~ 423 (517)
.+| +||+++++++ ...+..+.++||+ +++|.+++.. ...+++.+++.++.||++||.|||++ +|+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 445 5888888877 2234567788887 5599999974 45699999999999999999999998 99999
Q ss_pred CCCCCceEEcC-------------------CCCeEEcccccccccCCCCC---------------ceeeeccccccccCc
Q 010149 424 DVKAANILLDE-------------------YYEAVVGDFGLAKLLDHCDS---------------HVTTAVRGTVGHIAP 469 (517)
Q Consensus 424 Dlk~~NILl~~-------------------~~~~ki~DFGla~~~~~~~~---------------~~~~~~~gt~~y~aP 469 (517)
||||+|||++. ++.+|++|||+++....... .......||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 45567777777754221000 001123478899999
Q ss_pred cccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 470 EYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 470 E~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
|++.+..++.++|||||||++|||++|..|+..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999988753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=182.95 Aligned_cols=141 Identities=16% Similarity=0.194 Sum_probs=110.8
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCc-c-------hHH-----------------HHHHHHHHhccCCCcc
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-G-------EIQ-----------------FQTEVEMISLAVHRNL 358 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~-------~~~-----------------~~~Ei~~l~~l~H~nI 358 (517)
.+.||+|+||.||+|...+|+.||+|+++...... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999997542111 0 112 2348899999988877
Q ss_pred cceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceEEcCCCC
Q 010149 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 359 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
.....+.. ...++||||++++++.........++......++.|++.+|.|+ |+. +|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence 54433322 33489999999987765544456789999999999999999999 677 999999999999998 478
Q ss_pred eEEcccccccccC
Q 010149 438 AVVGDFGLAKLLD 450 (517)
Q Consensus 438 ~ki~DFGla~~~~ 450 (517)
++|+|||+|...+
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=194.68 Aligned_cols=199 Identities=34% Similarity=0.464 Sum_probs=171.4
Q ss_pred CCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcc--hHHHHHHHHHHhccCCC-cccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG--EIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~ 377 (517)
|...+.||.|+||.||++... ..+++|.+........ ...+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999976 7899999976655443 66799999999999988 799999999777778999999
Q ss_pred CcCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCCC
Q 010149 378 MSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 378 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~ 453 (517)
+.++++.+++.... .+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777654 789999999999999999999999 999999999999999988 79999999998655433
Q ss_pred Cc-----eeeeccccccccCcccccc---CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ......|+..|+|||.+.. ..+....|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2355679999999999987 578889999999999999999999976544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-22 Score=196.78 Aligned_cols=200 Identities=22% Similarity=0.256 Sum_probs=162.7
Q ss_pred CCCCCCccccccccceEEEEeCCC--cEEEEEEecCCCCCcchHHHHHHHHHHhccCC----CcccceeeeE-ecCCcce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDG--TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH----RNLLRLIGFC-MTTTERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~~~~-~~~~~~~ 372 (517)
+|.+.+.||+|+||.||.+..... ..+|+|........... .+..|+.++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999996543 47888887654333322 67778888887763 5788888888 4677889
Q ss_pred EEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-----CCeEEccccc
Q 010149 373 LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-----YEAVVGDFGL 445 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~ki~DFGl 445 (517)
+||+.+ +.+|.++.... +.++..+...++.|++.+|++||+. |++||||||.|+.+... ..+.+.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999987 67999987533 5799999999999999999999999 99999999999999754 4689999999
Q ss_pred ccccC--CCCC----c--e-eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 446 AKLLD--HCDS----H--V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 446 a~~~~--~~~~----~--~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++... .... . . .....||.+|+++....+.+.+++.|+||++.++.|+..|..||....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 98322 1111 0 1 123559999999999999999999999999999999999999996544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=176.10 Aligned_cols=142 Identities=18% Similarity=0.159 Sum_probs=113.0
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcc-------------------------hHHHHHHHHHHhccCCCcc
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------------------------EIQFQTEVEMISLAVHRNL 358 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------~~~~~~Ei~~l~~l~H~nI 358 (517)
...||+|++|.||+|+..+|+.||||+++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999987899999999875421100 1123578889999999988
Q ss_pred cceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCC
Q 010149 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 359 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
.....+... ..++||||++++++.........++......++.|++.++.++|+ . +|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence 655544433 358999999988654432234567888999999999999999999 8 999999999999999 789
Q ss_pred eEEcccccccccCC
Q 010149 438 AVVGDFGLAKLLDH 451 (517)
Q Consensus 438 ~ki~DFGla~~~~~ 451 (517)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=176.12 Aligned_cols=202 Identities=20% Similarity=0.263 Sum_probs=167.2
Q ss_pred hcCCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCC-CcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lv~ 375 (517)
...|...+.||+|+||.+|.|. ..+|..||+|+-..... ..++..|..+...+++ ..|..+..|..+...-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3568889999999999999998 67899999998654432 3467789999998875 56777777888888889999
Q ss_pred ecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DFGla~~~~~ 451 (517)
+.. +.+|.+... -...++..+++-.+.|++.-++|+|.+ +++||||||+|.|.. ....+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 988 668988876 345689999999999999999999999 999999999999995 345688999999987654
Q ss_pred CCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 452 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 452 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
.... ......||.+|.+-....+.+.+.+.|+=|+|.++.+.--|..||+.-..+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3221 223456999999988887888899999999999999999999999876543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=179.59 Aligned_cols=172 Identities=10% Similarity=0.056 Sum_probs=132.5
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcch--HH------HHHHHHHHhccCCCcccceeeeEecC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGE--IQ------FQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~--~~------~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
...+|...+++|.|+||.||.... ++..+|+|.++........ .. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999765 5778999999754432211 11 67899999999999999998886543
Q ss_pred --------CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEE
Q 010149 369 --------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV 440 (517)
Q Consensus 369 --------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki 440 (517)
...+++|||++|.+|.+... ++. ....+++.++..+|+. +++|||+||+||++++++ +++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999987632 232 3456899999999999 999999999999999988 999
Q ss_pred cccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHH
Q 010149 441 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 494 (517)
Q Consensus 441 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ell 494 (517)
+|||..+........ ..+.....+..++|+||||+++....
T Consensus 176 iDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999988654221110 01333445667999999999887544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=176.81 Aligned_cols=198 Identities=20% Similarity=0.265 Sum_probs=166.6
Q ss_pred CCCCCCccccccccceEEEE-eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.|.+.+.||+|+||..+.|+ +-+++.||||.-..... ..++..|-+.++.+. .+.|...+-|-.+..+-.||+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 67889999999999999999 55799999997643322 346778888888774 68888888777788888899998
Q ss_pred CcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-----CCCeEEcccccccccCC
Q 010149 378 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 378 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DFGla~~~~~ 451 (517)
+ |-+|.++.. -...++..++..+|.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 668888776 355799999999999999999999999 9999999999999953 34589999999998765
Q ss_pred CCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ......||.+||+-....+.+.+.+.|+=|+|-++.+.+-|..||+.-.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 4432 2244569999999999999999999999999999999999999998644
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-21 Score=173.31 Aligned_cols=106 Identities=25% Similarity=0.205 Sum_probs=94.6
Q ss_pred CChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 381 GSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 381 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
|+|.+++.. ...+++.++..++.|+++||.|||++ + ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999986 45699999999999999999999998 5 999999999999999 99998754322
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25899999999999999999999999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-20 Score=166.86 Aligned_cols=184 Identities=17% Similarity=0.062 Sum_probs=137.4
Q ss_pred CCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcc---hHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEec
Q 010149 302 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG---EIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~---~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.....|++|+||+||.+.. .+..++.+.+........ ...+.+|+++++++. |+++.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997665 577888777754332111 124789999999995 5889999886 456899999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEEcCCCCeEEcccccccccCCCCCc-
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV-KAANILLDEYYEAVVGDFGLAKLLDHCDSH- 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~ki~DFGla~~~~~~~~~- 455 (517)
+++.+|...... ....++.|+++++.++|++ ||+|||| ||+|||+++++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999988754321 1245788999999999999 9999999 799999999999999999999854432210
Q ss_pred ---e--------eeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCc
Q 010149 456 ---V--------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 456 ---~--------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
. ......++.|++|+.... ...-...+.++-|.-+|.++|+..|.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 011225777888875422 22235678999999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-21 Score=201.69 Aligned_cols=201 Identities=21% Similarity=0.269 Sum_probs=160.4
Q ss_pred CCCCccccccccceEEEEeC-CCcEEEEEEecC----CCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 302 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKD----GNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~----~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
...+++|.|++|.|+..... .....+.|.+.. ... ......+..|..+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999987777633 334444443321 111 111112556676777889999998888877777766669
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~- 454 (517)
||+++ +|+..+.....+...++..+++|++.|+.|+|+. ||.|||+|++|++++.++.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 9999999877899999999999999999999999 999999999999999999999999999986654332
Q ss_pred --ceeeeccccccccCccccccCCCCc-ccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 455 --HVTTAVRGTVGHIAPEYLSTGQSSE-KTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 455 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
.......|+-.|+|||.+...+|++ ..||||.|+++..|++|+.||......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 4556678999999999999988875 579999999999999999999765543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-21 Score=193.61 Aligned_cols=187 Identities=25% Similarity=0.282 Sum_probs=160.8
Q ss_pred ccccccccceEEEE----eCCCcEEEEEEecCCCCCcch-HHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEecCc
Q 010149 306 LVGKGGFGNVYKGY----LQDGTVVAVKRLKDGNAIGGE-IQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~~~-~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 379 (517)
++|+|.||.|+.+. .+.|..+|+|+.++.....+. .....|..++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 335788899988754432221 24556788888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
+|.+...+.....+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999999888899999999999999999999999 9999999999999999999999999999865432221
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999997 566789999999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=171.74 Aligned_cols=193 Identities=22% Similarity=0.332 Sum_probs=152.8
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
...|.+...|+.|+|+++ |..+++|+++..... .-..+|.+|.-.++.+.||||+.++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345788899999999998 556667877654332 234579999999999999999999999999999999999999999
Q ss_pred hhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec
Q 010149 383 VASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460 (517)
Q Consensus 383 L~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~ 460 (517)
|+..++.+. ..+..++.+++.++++|++|||+. +|-|.---|.+..|++|++.+++|+- +-+++... ....
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq-----e~gr 346 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ-----EVGR 346 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee-----cccc
Confidence 999999654 357788999999999999999995 44455557899999999999988742 22222110 0111
Q ss_pred cccccccCccccccCCC---CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 461 RGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 461 ~gt~~y~aPE~~~~~~~---~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.-.+.||+||.++..+. -.++|+|||++++||+.|...||..-.
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 24688999999987654 357899999999999999999996443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.1e-19 Score=164.31 Aligned_cols=139 Identities=17% Similarity=0.211 Sum_probs=107.4
Q ss_pred CCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-----CCCcccceeeeEecCC---c-c
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-----VHRNLLRLIGFCMTTT---E-R 371 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~~~~~~~~---~-~ 371 (517)
++..+.||+|+||.||. .-.++.. +||++.... .....++.+|+.+++.+ .||||++++|++.++. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34568899999999996 3234444 689886543 22456789999999999 5799999999998864 3 2
Q ss_pred eEEEec--CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceEEcC----CCCeEEcc-c
Q 010149 372 LLVYPY--MSNGSVASRLKAKPSLDWATRKRIALGAARGL-LYLHEQCDPKIIHRDVKAANILLDE----YYEAVVGD-F 443 (517)
Q Consensus 372 ~lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~ki~D-F 443 (517)
.+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+| |
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 378999 5679999999764 45555 35678888887 999999 9999999999999974 34799999 5
Q ss_pred ccccc
Q 010149 444 GLAKL 448 (517)
Q Consensus 444 Gla~~ 448 (517)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 55443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=198.37 Aligned_cols=199 Identities=23% Similarity=0.297 Sum_probs=158.6
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHH---HHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ---TEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++...+.+|++.|=+|.+|+.++|. |+||++-+....-....|. +|++ ....+|||.+++..+.......|+|.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999998887 8889886544333333444 4444 556689999999988888888899999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc--cCCCCC
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL--LDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~--~~~~~~ 454 (517)
|+.+ +|++.+..++.+...+.+-|+.|++.|+..+|.. +|+|||||.+|||++..+.+.|+||-.-+. +.+.+.
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9976 9999999999999999999999999999999999 999999999999999999999999986542 221111
Q ss_pred c----eeeeccccccccCccccccC-----------CCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 H----VTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
. ...+...-..|+|||.+... ..+++.||||+||++.||++ |+.||+.++
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ 243 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ 243 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence 1 11222344679999987431 14678999999999999998 688887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=164.95 Aligned_cols=145 Identities=17% Similarity=0.157 Sum_probs=113.5
Q ss_pred cCCCCCCccccccccceEEEE--eCCCcEEEEEEecCCCCCc-----------------------chHHHHHHHHHHhcc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIG-----------------------GEIQFQTEVEMISLA 353 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l 353 (517)
..|.+.+.||+|+||.||+|+ ..+|+.||+|+++...... ....+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 346788999999999999998 5689999999987542110 012356899999988
Q ss_pred CCCc--ccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCce
Q 010149 354 VHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK-IIHRDVKAANI 430 (517)
Q Consensus 354 ~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-ivH~Dlk~~NI 430 (517)
.+.. +.+++++ ...++||||++++++.................++.|++.++.|||+. + ++||||||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 7533 2333332 34589999999988877654445566777789999999999999999 8 99999999999
Q ss_pred EEcCCCCeEEcccccccccCC
Q 010149 431 LLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 431 Ll~~~~~~ki~DFGla~~~~~ 451 (517)
+++ ++.++|+|||.+.....
T Consensus 181 li~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEE-CCCEEEEEChhhhccCC
Confidence 999 88999999999986543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.3e-19 Score=189.44 Aligned_cols=200 Identities=21% Similarity=0.236 Sum_probs=162.0
Q ss_pred HHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC---CCcccceeeeEecCC
Q 010149 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTT 369 (517)
Q Consensus 293 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~ 369 (517)
+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+....-+ |---.+++.+++ -+-|..+...+...+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 3445566788889999999999999998889999999876544321 111122333333 344566666667778
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-------CCCCeEEcc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-------EYYEAVVGD 442 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~~ki~D 442 (517)
.-++|+||.+.|+|.+++...+..+|.-...++.|+++.+++||.. +||||||||.|.||. +..-++|+|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 8899999999999999999888999999999999999999999999 999999999999994 234589999
Q ss_pred cccccccCCC-CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCC
Q 010149 443 FGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499 (517)
Q Consensus 443 FGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P 499 (517)
||.+.-+.-. +.......++|-.+--+|+..++.++..+|-|.++-+++-|+.|+.-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998755322 23455667789999999999999999999999999999999999743
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-18 Score=158.16 Aligned_cols=136 Identities=18% Similarity=0.240 Sum_probs=114.9
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCc-------chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.||+|++|.||+|.. .|..+++|+........ ....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 57789999865332111 123577899999999999998888888788889999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
+++++|.+.+..... .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999998875432 7889999999999999999 999999999999999 789999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=156.05 Aligned_cols=145 Identities=20% Similarity=0.181 Sum_probs=111.6
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC---------------------cchHHHHHHHHHHhc
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---------------------GGEIQFQTEVEMISL 352 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~Ei~~l~~ 352 (517)
+......|...+.||+|+||.||++..++|+.||||+++..... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333347778999999999999999888999999987543210 011235678888888
Q ss_pred cCCCc--ccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 010149 353 AVHRN--LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 430 (517)
Q Consensus 353 l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NI 430 (517)
+.|++ +.+.++ ....++||||+++++|...... .....++.+++.++.++|+. +++||||||+||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni 156 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI 156 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence 87774 334433 3456899999999998765431 34567889999999999998 999999999999
Q ss_pred EEcCCCCeEEcccccccccCC
Q 010149 431 LLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 431 Ll~~~~~~ki~DFGla~~~~~ 451 (517)
++++++.++|+|||++.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=154.74 Aligned_cols=132 Identities=19% Similarity=0.259 Sum_probs=108.9
Q ss_pred ccccccccceEEEEeCCCcEEEEEEecCCCCCc-------chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 306 LVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.||+|+||.||+|.+ +|..+++|+........ ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 47889999865432111 1245778999999999988776666667777789999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
++++|.+.+..... .++.+++.+|.+||+. +++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988764321 7899999999999999 999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=177.89 Aligned_cols=141 Identities=20% Similarity=0.278 Sum_probs=113.4
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC------cchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI------GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
...|...+.||+|+||.||+|.+.+...++.++....... .....+.+|++++..++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445668899999999999998764433332222221111 1124588999999999999999888888887888
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999998875 4578899999999999998 99999999999999 67899999999998654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.6e-17 Score=156.42 Aligned_cols=196 Identities=23% Similarity=0.292 Sum_probs=128.3
Q ss_pred CCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCC----------CcccceeeeEe---
Q 010149 303 SKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVH----------RNLLRLIGFCM--- 366 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H----------~nIv~l~~~~~--- 366 (517)
..+.||.|+++.||.++.. +|+.+|+|++..... ....+++++|.-....+.+ -.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4678999999999999976 589999999865442 2234567777655544322 12222222221
Q ss_pred ------cCC--------cceEEEecCcCCChhhhhh---c-CC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 010149 367 ------TTT--------ERLLVYPYMSNGSVASRLK---A-KP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425 (517)
Q Consensus 367 ------~~~--------~~~lv~e~~~~gsL~~~l~---~-~~---~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl 425 (517)
... ..+++|+-+. ++|.+.+. . .. .+....+..+..|+++.+++||+. |+||+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 111 2256777774 58877754 1 11 233445566778999999999999 9999999
Q ss_pred CCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCcccccc--------CCCCcccceehhhHHHHHHHhCC
Q 010149 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELISGL 497 (517)
Q Consensus 426 k~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvil~elltG~ 497 (517)
+|+|++++++|.++++||+.....+. .......+..|.+||.... ..++.+.|.|++|+++|.|.+|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999997765432 1111335678999997643 24788999999999999999999
Q ss_pred CCcCcCccc
Q 010149 498 RALEFGKTA 506 (517)
Q Consensus 498 ~P~~~~~~~ 506 (517)
.||+...++
T Consensus 248 lPf~~~~~~ 256 (288)
T PF14531_consen 248 LPFGLSSPE 256 (288)
T ss_dssp -STCCCGGG
T ss_pred CCCCCCCcc
Confidence 999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-17 Score=156.31 Aligned_cols=145 Identities=24% Similarity=0.313 Sum_probs=110.4
Q ss_pred cCCCcccceeeeEecC---------------------------CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHH
Q 010149 353 AVHRNLLRLIGFCMTT---------------------------TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 405 (517)
Q Consensus 353 l~H~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i 405 (517)
-+|||||++.++|.+. ...|+||.-.+. +|.+++-.+. .+.....-++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence 3699999999987642 234788887765 8888887653 5667777889999
Q ss_pred HHHHHHHHhcCCCCeEecCCCCCceEEc--CCC--CeEEcccccccccCCCCC-----ceeeeccccccccCccccccCC
Q 010149 406 ARGLLYLHEQCDPKIIHRDVKAANILLD--EYY--EAVVGDFGLAKLLDHCDS-----HVTTAVRGTVGHIAPEYLSTGQ 476 (517)
Q Consensus 406 ~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~--~~ki~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~ 476 (517)
++|+.|||.+ +|.|||+|+.|||+. +|+ ...|+|||++-.-+...- ...-...|...-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 999999999999993 444 468999998743221100 0112234778899999985432
Q ss_pred ------CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 477 ------SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 477 ------~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
...|+|.|+.|-+.||+++...||..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 24689999999999999999999975
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=138.34 Aligned_cols=135 Identities=19% Similarity=0.136 Sum_probs=114.6
Q ss_pred CCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCC--CcccceeeeEecCCcceEEEecCcC
Q 010149 303 SKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.+.||+|.++.||++...+ ..+++|....... ..++..|+..+..++| ..+.+++++....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35779999999999999864 7899999865432 4578899999999976 5888998888888889999999998
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 5677788899999999999986445799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-17 Score=163.81 Aligned_cols=152 Identities=27% Similarity=0.473 Sum_probs=128.3
Q ss_pred HhccCCCcccceeeeEecCCcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCCC
Q 010149 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKI-IHRDVKA 427 (517)
Q Consensus 350 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i-vH~Dlk~ 427 (517)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ...+++.....+.++|+.||.|+|+. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 3567899999999999999999999999999999999986 56789999999999999999999987 45 8999999
Q ss_pred CceEEcCCCCeEEcccccccccCCC-CCceeeeccccccccCccccccCC-------CCcccceehhhHHHHHHHhCCCC
Q 010149 428 ANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQ-------SSEKTDVFGFGILLLELISGLRA 499 (517)
Q Consensus 428 ~NILl~~~~~~ki~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~S~Gvil~elltG~~P 499 (517)
+|.++|....+|++|||+....... .........-...|.|||.+.... .+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876421 111112222456899999986531 46789999999999999999999
Q ss_pred cCcCc
Q 010149 500 LEFGK 504 (517)
Q Consensus 500 ~~~~~ 504 (517)
|+...
T Consensus 158 ~~~~~ 162 (484)
T KOG1023|consen 158 FDLRN 162 (484)
T ss_pred ccccc
Confidence 98644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=145.08 Aligned_cols=137 Identities=20% Similarity=0.246 Sum_probs=97.2
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCc-chHHH----------------------HHHHHHHhccCCCc--c
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQF----------------------QTEVEMISLAVHRN--L 358 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~----------------------~~Ei~~l~~l~H~n--I 358 (517)
.+.||+|+||+||+|...+|+.||||+++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986532211 11111 24444555544332 3
Q ss_pred cceeeeEecCCcceEEEecCcCCChhhh-hhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCC
Q 010149 359 LRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYY 436 (517)
Q Consensus 359 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~ 436 (517)
.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. . +|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence 333332 346899999999554321 1111 111 6678899999999999999 7 999999999999999 89
Q ss_pred CeEEcccccccccC
Q 010149 437 EAVVGDFGLAKLLD 450 (517)
Q Consensus 437 ~~ki~DFGla~~~~ 450 (517)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-17 Score=173.79 Aligned_cols=175 Identities=26% Similarity=0.353 Sum_probs=130.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|+..+.|..|++|.||.++++ ..+.+|+|+ ++.+.. .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh------hhc--cccccCCccee-----------------
Confidence 467888999999999999999876 456788843 322211 000 22222333332
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC---
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD--- 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~--- 453 (517)
|+-...++.-+.++... +.+++|+|+. +|+|||+||.|.+|+.-|++|++|||+.+..-...
T Consensus 136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 45555566545554433 7789999998 99999999999999999999999999987532110
Q ss_pred -----------CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCccccccCccc
Q 010149 454 -----------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAML 513 (517)
Q Consensus 454 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~~~~~~~~ 513 (517)
......++||+.|+|||++....|...+|.|++|+|+||.+-|+.||..+.+++.++..+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 012244679999999999999999999999999999999999999999987776666544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.4e-15 Score=139.99 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=107.0
Q ss_pred CCccc-cccccceEEEEeCCCcEEEEEEecCCCC------------CcchHHHHHHHHHHhccCCCcc--cceeeeEecC
Q 010149 304 KNLVG-KGGFGNVYKGYLQDGTVVAVKRLKDGNA------------IGGEIQFQTEVEMISLAVHRNL--LRLIGFCMTT 368 (517)
Q Consensus 304 ~~~lG-~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~~ 368 (517)
...|| .|+.|+||.+... +..+++|++..... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46688 8999999999875 77889998853210 0123457889999999998885 6677765433
Q ss_pred Cc----ceEEEecCcC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 369 TE----RLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 369 ~~----~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
.. .++||||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||+|||++.++.++|+||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 22 2599999997 6898887653 45543 357899999999999 9999999999999999899999999
Q ss_pred ccccccC
Q 010149 444 GLAKLLD 450 (517)
Q Consensus 444 Gla~~~~ 450 (517)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5e-16 Score=165.10 Aligned_cols=205 Identities=25% Similarity=0.339 Sum_probs=165.8
Q ss_pred cCCCCCCccccccccceEEEEeC--CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv 374 (517)
..|...+.||+|+|+.|-..... ....+|+|.+.... ......+...|..+-.... |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34666777999999999988753 34556777665432 2222334455777777776 99999999999999999999
Q ss_pred EecCcCCChhhhh-hcCC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccC
Q 010149 375 YPYMSNGSVASRL-KAKP-SLDWATRKRIALGAARGLLYLH-EQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLD 450 (517)
Q Consensus 375 ~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~ 450 (517)
.+|..++++.+.+ +... ..+......++.|+..++.|+| .. ++.|||+||+|.++++.+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999988 5443 6777888899999999999999 77 999999999999999999 99999999998776
Q ss_pred C--CCCceeeeccc-cccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCccc
Q 010149 451 H--CDSHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGKTA 506 (517)
Q Consensus 451 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~~~ 506 (517)
. .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 5 22233345568 9999999998774 5577899999999999999999999876543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.1e-16 Score=154.40 Aligned_cols=120 Identities=26% Similarity=0.391 Sum_probs=104.6
Q ss_pred cceEEEecCcCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
..++.|+++...+|.+++... ...++.....++.|++.|+.| + +.+|||+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999743 356788899999999999999 5 8999999999999999999999999998
Q ss_pred cccCCCC-----CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh
Q 010149 447 KLLDHCD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495 (517)
Q Consensus 447 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt 495 (517)
....... ....+...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7765443 112344569999999999999999999999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.4e-14 Score=144.56 Aligned_cols=142 Identities=23% Similarity=0.253 Sum_probs=100.8
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCc---------------------------------------chHHHH
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG---------------------------------------GEIQFQ 344 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---------------------------------------~~~~~~ 344 (517)
.+.||.|++|.||+|++++|+.||||+.+...... .+.+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999986432100 011244
Q ss_pred HHHHHHhcc----CCCcccceeeeE-ecCCcceEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 010149 345 TEVEMISLA----VHRNLLRLIGFC-MTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAAR-GLLYLHEQCD 417 (517)
Q Consensus 345 ~Ei~~l~~l----~H~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~-~L~yLH~~~~ 417 (517)
.|.+.+.++ +|.+-+.+-..+ ......++||||++|++|.+..... ... .+..++.++++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 455544444 232223333333 2345679999999999998876532 122 24556666666 46788887
Q ss_pred CCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 418 ~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
|++|+|+||.||++++++.++++|||++..+..
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-15 Score=130.27 Aligned_cols=125 Identities=27% Similarity=0.413 Sum_probs=100.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..+|.|-|++|.++ .+|+.+..|.+|+.|++++|++. .+|..++.+++|+.|+++-|++. .+|..|+.+|.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 47889999999998 77888999999999999999998 78889999999999999999998 88999999999999999
Q ss_pred cccccCC-CCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCcc
Q 010149 151 NNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198 (517)
Q Consensus 151 ~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~ 198 (517)
++|++.. .+|..|..|+.|+.|+|+.|.|.-.+|+.-. +.+.+.+|.+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCch
Confidence 9888863 4677777777777777777777754444322 3344455544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-13 Score=145.97 Aligned_cols=94 Identities=36% Similarity=0.597 Sum_probs=90.7
Q ss_pred CCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEecc
Q 010149 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 175 (517)
Q Consensus 96 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 175 (517)
.++.|+|++|.++|.+|..+++|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 58899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcC
Q 010149 176 YNNLSGPVPSFHAK 189 (517)
Q Consensus 176 ~N~l~~~~p~~~~~ 189 (517)
+|+|+|.+|..+..
T Consensus 499 ~N~l~g~iP~~l~~ 512 (623)
T PLN03150 499 GNSLSGRVPAALGG 512 (623)
T ss_pred CCcccccCChHHhh
Confidence 99999999987764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-14 Score=121.82 Aligned_cols=127 Identities=25% Similarity=0.447 Sum_probs=113.8
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCC-CCCccCCCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l 150 (517)
++..|++.+|.+. .+|.+++.++.|+.|+++-|++. .+|..|+.++.|+.|||++|+++. .+|..|..++.|+.|+|
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 5667889999887 89999999999999999999999 899999999999999999999984 48999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT 202 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~ 202 (517)
+.|.+. .+|..++++++|+.|.+..|.+-. .|.... +.+.+.||++.-.+
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqgnrl~vlp 189 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQGNRLTVLP 189 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhcccceeeecC
Confidence 999999 999999999999999999999984 555443 67889999985443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.2e-13 Score=140.10 Aligned_cols=146 Identities=20% Similarity=0.213 Sum_probs=93.9
Q ss_pred hcCCCCCCccccccccceEEEEeCC-CcEEEEEEecCCCCC---------------------------------cch---
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI---------------------------------GGE--- 340 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---------------------------------~~~--- 340 (517)
-..|+. +.||+|++|+||+|++++ |+.||||+.+..... +-.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999887 999999999743210 000
Q ss_pred ---HHHHHHHHHHhccC----CCcccceeeeEec-CCcceEEEecCcCCChhhh--hhcCCCCCHHHHHHHHHHHHHH-H
Q 010149 341 ---IQFQTEVEMISLAV----HRNLLRLIGFCMT-TTERLLVYPYMSNGSVASR--LKAKPSLDWATRKRIALGAARG-L 409 (517)
Q Consensus 341 ---~~~~~Ei~~l~~l~----H~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~l~~~~~~~i~~~i~~~-L 409 (517)
.+|.+|...+.+++ +.+.+.+-.++.+ ....++||||++|+.+.+. +...+ .+.. .++...++. +
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMK---LLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHH---HHHHHHHHHHH
Confidence 12344444333332 3333433333332 4567899999999999774 22222 2211 222222221 1
Q ss_pred HHHHhcCCCCeEecCCCCCceEEcCCC----CeEEcccccccccCC
Q 010149 410 LYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKLLDH 451 (517)
Q Consensus 410 ~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DFGla~~~~~ 451 (517)
..+... |++|+|+||.||+++.++ .+++.|||++..++.
T Consensus 274 ~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 223344 999999999999999888 999999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=116.75 Aligned_cols=131 Identities=19% Similarity=0.152 Sum_probs=97.1
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCccc-ceeeeEecCCcceEEEecCcCCC
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
.+.++.|.++.||++... +..+++|+...... ....+..|...+..+.+.+++ +++.+. ....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356899999999999875 77899998754432 123567888888888665554 444432 344689999999987
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 383 L~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
+.+. . .....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7643 0 112345778999999999872 12369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-11 Score=111.96 Aligned_cols=138 Identities=15% Similarity=0.151 Sum_probs=99.2
Q ss_pred CCccccccccceEEEEeCC-------CcEEEEEEecCCCC---------------------CcchHHH----HHHHHHHh
Q 010149 304 KNLVGKGGFGNVYKGYLQD-------GTVVAVKRLKDGNA---------------------IGGEIQF----QTEVEMIS 351 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~---------------------~~~~~~~----~~Ei~~l~ 351 (517)
...||.|.-+.||.|...+ +..+|||+++.... ......+ ++|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 47999999853210 0011122 37888888
Q ss_pred ccCC--CcccceeeeEecCCcceEEEecCcCCChhh-hhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCC
Q 010149 352 LAVH--RNLLRLIGFCMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKA 427 (517)
Q Consensus 352 ~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~Dlk~ 427 (517)
++.. -++.+++++ ...++||||+.++.+.. .++ ...++..+...+..+++.+|..| |+. ++|||||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 7753 345555544 56789999997654422 222 22455566778889999999998 777 999999999
Q ss_pred CceEEcCCCCeEEcccccccccC
Q 010149 428 ANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 428 ~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.||++++ +.+.|+|||.+...+
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 679999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-13 Score=137.05 Aligned_cols=116 Identities=26% Similarity=0.188 Sum_probs=90.4
Q ss_pred CCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 70 DGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 70 ~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
-..+..|+|+.|+++..-.+.+.+|+.|+.|+||+|.|...-++.+.-+++|++|+|++|+|+...+..|..|..|++|+
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 34678888899988888888888889999999999988888888888888899999999988866667777777777777
Q ss_pred hcccccCCCCCCCcccCCCcceEeccCCCCCCCCCC
Q 010149 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185 (517)
Q Consensus 150 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 185 (517)
|++|+++-.-...|..+++|+.|||++|.|++.+.+
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 777777744445666667777777777776655543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.5e-11 Score=113.22 Aligned_cols=144 Identities=19% Similarity=0.275 Sum_probs=112.3
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCC--cccceeeeEecCC---cceEEEecC
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR--NLLRLIGFCMTTT---ERLLVYPYM 378 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~---~~~lv~e~~ 378 (517)
.+.++.|.++.||++...+|..+++|............++..|.+++..+++. .+.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 35689999999999998777899999976543322345688999999988753 4566777766542 568999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ------------------------------------------- 415 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------------- 415 (517)
++.++.+.+.. ..++..+...++.+++++|.+||+.
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99888776542 4578888888999999999999852
Q ss_pred ----------CCCCeEecCCCCCceEEcC--CCCeEEcccccccc
Q 010149 416 ----------CDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKL 448 (517)
Q Consensus 416 ----------~~~~ivH~Dlk~~NILl~~--~~~~ki~DFGla~~ 448 (517)
....++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1246799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.6e-13 Score=134.74 Aligned_cols=125 Identities=31% Similarity=0.413 Sum_probs=77.5
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCC--------------------
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-------------------- 132 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-------------------- 132 (517)
...|+||+|+|..+..+-|-+|+.|-.||||+|++. .+|+.+..|..|++|+||+|.+.
T Consensus 128 ~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~ 206 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN 206 (1255)
T ss_pred cEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence 445666666666444455566666666666666666 55666666666666666666431
Q ss_pred -----CCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCC--C--CcCcccccCCccc
Q 010149 133 -----GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS--F--HAKTFNITGNSLI 199 (517)
Q Consensus 133 -----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~--~--~~~~~~l~~N~~~ 199 (517)
..+|.++..|.+|..+|||.|.+. .+|+.+-++++|+.|+||+|+|+..--. . ...++|++.|++.
T Consensus 207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc
Confidence 235556666666677777777776 6677777777777777777777632211 1 1166777777764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-13 Score=132.83 Aligned_cols=124 Identities=31% Similarity=0.439 Sum_probs=96.9
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCC-CCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-HLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l 150 (517)
++..||..+|-+ +++|+.++.+.+|..|+|..|++. .+| +|++++.|..|+++.|+|+ .+|.... ++++|..|||
T Consensus 184 ~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 455566555544 477888888888888888888887 677 7888888888888888888 6776655 7888888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc---CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~---~~~~l~~N~~~c 200 (517)
..|+++ .+|+.+.-+.+|.+||+|+|.|++.+++.-. +.+.+.|||+..
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlrT 311 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLRT 311 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchHH
Confidence 888888 8888888888899999999999877765432 677888888743
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-11 Score=124.61 Aligned_cols=166 Identities=19% Similarity=0.223 Sum_probs=125.8
Q ss_pred eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHH
Q 010149 320 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK 399 (517)
Q Consensus 320 ~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~ 399 (517)
..++.+|.|...+.... .......+-++.++.+|||||++++..++.....|+|+|-+. .|..++++.+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHH
Confidence 44788899988865543 223346677888999999999999999999999999999875 4666666433 55566
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCc
Q 010149 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479 (517)
Q Consensus 400 ~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 479 (517)
--+.||+.||.|||+.| +++|++|.-.-|++++.|+.||++|.++........ ......---.|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 67899999999999876 999999999999999999999999998864432221 011111223466676553333 2
Q ss_pred ccceehhhHHHHHHHhC
Q 010149 480 KTDVFGFGILLLELISG 496 (517)
Q Consensus 480 ~~Dv~S~Gvil~elltG 496 (517)
..|.|-||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 36999999999999999
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.8e-13 Score=133.72 Aligned_cols=126 Identities=35% Similarity=0.467 Sum_probs=109.7
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCC-cccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
..+|.||||+|.|. ..|..+..-+++-.|+||+|+|. .||. -|-+|+.|-+||||+|++. .+|+.+..|..|++|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 36899999999998 88999999999999999999999 6665 4678999999999999999 8899999999999999
Q ss_pred hcccccC-------------------------CCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 150 LNNNSLT-------------------------GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 150 l~~N~l~-------------------------~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
|++|.+. ..+|.++..|.+|..+|||.|+|. .+|+.+. +.+||++|.+.
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 9999654 247888999999999999999999 5665443 78999999985
Q ss_pred c
Q 010149 200 C 200 (517)
Q Consensus 200 c 200 (517)
-
T Consensus 259 e 259 (1255)
T KOG0444|consen 259 E 259 (1255)
T ss_pred e
Confidence 3
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.8e-11 Score=102.93 Aligned_cols=133 Identities=20% Similarity=0.270 Sum_probs=101.4
Q ss_pred CccccccccceEEEEeCCCcEEEEEE-ecCCCCCcc------hHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGG------EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~-~~~~~~~~~------~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
..+++|+-+.+|.+.+. |..+.+|. +++.-.... ..+-.+|..++.+.+--.|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999775 33445553 333222221 22467899999888766776666677888899999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
.++-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++.+-
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999888888754 245666677777889999 999999999999998765 999999999854
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-12 Score=126.42 Aligned_cols=139 Identities=25% Similarity=0.316 Sum_probs=121.5
Q ss_pred EEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec-CCCCC
Q 010149 66 VTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN-NFFTG 133 (517)
Q Consensus 66 v~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~ 133 (517)
|+|+. ...+.|+|..|+|+.+.|.+|+.+++|+.||||+|+|+-+-|++|.+|.+|..|-+.+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 88873 4688899999999988899999999999999999999988999999999988777666 99995
Q ss_pred CCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCCC
Q 010149 134 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATGA 204 (517)
Q Consensus 134 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~~ 204 (517)
.....|.+|.+|+.|.+.-|++.-...+.|..|++|..|.+..|.+....-..+. +.+.+.-|++.|.|..
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 5556899999999999999999988888999999999999999999843332333 7888999999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-11 Score=125.31 Aligned_cols=199 Identities=23% Similarity=0.189 Sum_probs=156.5
Q ss_pred CCCCCCcccc--ccccceEEEEe---CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 300 NFSSKNLVGK--GGFGNVYKGYL---QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 300 ~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
.|...+.+|+ |.+|.||.+.. .++..+|+|+-+..... .....=.+|....+++ .|+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999986 36788999875432211 1112234566666666 4999999888888888999
Q ss_pred EEEecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceEEcCC-CCeEEcccccc
Q 010149 373 LVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAAR----GLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLA 446 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~----~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DFGla 446 (517)
+-.|++. .++.++.+... .++......+..+..+ |+.++|.. .++|-|+||.||+..++ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence 9999885 68888887543 3777888888888888 99999999 99999999999999999 88999999999
Q ss_pred cccCCCCCc----eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 447 KLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 447 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..+....-. ......|...|++||.. ++-++..+|+|++|.++.+..+|.++.-.+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 877654421 22333588899999987 556788999999999999999998876554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.5e-12 Score=123.99 Aligned_cols=113 Identities=32% Similarity=0.490 Sum_probs=94.7
Q ss_pred cccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCc
Q 010149 84 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL 163 (517)
Q Consensus 84 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 163 (517)
.+.+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|..+-.+..|+.+-.++|++...-|..+
T Consensus 424 isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 424 ISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL 501 (565)
T ss_pred cccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence 3345667888999999999999998 89999999999999999999999 889888888888888888899985555569
Q ss_pred ccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 164 SNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 164 ~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
.+|.+|+.|||.+|.+...+| .+. +.+.+.||++.
T Consensus 502 ~nm~nL~tLDL~nNdlq~IPp-~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQQIPP-ILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhcceeccCCCchhhCCh-hhccccceeEEEecCCccC
Confidence 999999999999999995444 443 67888899883
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.8e-11 Score=113.32 Aligned_cols=148 Identities=24% Similarity=0.352 Sum_probs=114.7
Q ss_pred HhccCCCcccceeeeEecC-----CcceEEEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010149 350 ISLAVHRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKI 420 (517)
Q Consensus 350 l~~l~H~nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~i 420 (517)
+-++.|.|||+++.|+.+. .+..++.|||..|++..+|++ +..+....-.+|.-||+.||.|||+ |+|+|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence 3455699999999998654 346789999999999999973 4467778888999999999999998 69999
Q ss_pred EecCCCCCceEEcCCCCeEEccccccccc---CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC
Q 010149 421 IHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497 (517)
Q Consensus 421 vH~Dlk~~NILl~~~~~~ki~DFGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~ 497 (517)
+|+++.-+-|++..++-+||.----...- ............+-++|.|||+-.....+.++|||+||.-..||..|.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999999998432111100 000011112233678999999988888888999999999999998876
Q ss_pred C
Q 010149 498 R 498 (517)
Q Consensus 498 ~ 498 (517)
.
T Consensus 280 i 280 (458)
T KOG1266|consen 280 I 280 (458)
T ss_pred e
Confidence 4
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.6e-11 Score=119.78 Aligned_cols=122 Identities=29% Similarity=0.367 Sum_probs=94.6
Q ss_pred CCceeeeEEeCC----------------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCccc
Q 010149 59 DPCSWALVTCSD----------------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLL 122 (517)
Q Consensus 59 ~~c~w~gv~C~~----------------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 122 (517)
.+|.-.-..|++ ..+..||+++|.|+.+-+..|.++++|++++|.+|.++ .||.......+|+
T Consensus 50 c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~ 128 (873)
T KOG4194|consen 50 CPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLE 128 (873)
T ss_pred CCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccccccccee
Confidence 456666677763 24566999999999998999999999999999999999 8897666667799
Q ss_pred EEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCC
Q 010149 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 123 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 181 (517)
.|+|.+|.|+..-.+.+..++.|+.||||.|.|+..--+.|..-.++++|+|++|.|+.
T Consensus 129 ~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~ 187 (873)
T KOG4194|consen 129 KLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITT 187 (873)
T ss_pred EEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccc
Confidence 99999999986666778888888888888888884333455555566666666666654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-11 Score=121.72 Aligned_cols=196 Identities=22% Similarity=0.235 Sum_probs=146.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC--CCcEEEEEEecCCCCCcchHH-HHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~-~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
...+|..+..||.|.|+.|++...+ ++..+++|...........+. -..|+.+...+ .|.++++....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3456788899999999999998743 678899998765432211111 12344444333 5888888888777777788
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CCeEEcccccccccCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDH 451 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DFGla~~~~~ 451 (517)
+--||++++++.....-...+++..++.+..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.+..+.-
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence 9999999999887775555688889999999999999999998 99999999999999886 7889999999864221
Q ss_pred CCCceeeeccccccc-cCccccccCCCCcccceehhhHHHHHHHhCCC
Q 010149 452 CDSHVTTAVRGTVGH-IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~ 498 (517)
........+..| .+|+......+..+.|+||||.-+.|.++|..
T Consensus 420 ---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 420 ---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ---ecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 111111123334 35666667778889999999999999998864
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-11 Score=130.85 Aligned_cols=123 Identities=33% Similarity=0.513 Sum_probs=109.5
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCC-cccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+..|.|.+|.|+...=+.+.+.++|+.|+|++|+|. .+|. .+.+|..|+.|+||+|+++ .+|..+.+++.|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 5777899999999888888999999999999999999 5664 5789999999999999999 89999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCC-CCCCC----CcCcccccCCcc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSF----HAKTFNITGNSL 198 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~p~~----~~~~~~l~~N~~ 198 (517)
.+|+|. ..| .+.++++|+.+|+|.|+|+. .+|.. -.+.+||+||..
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 888 89999999999999999984 33332 338899999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-09 Score=96.02 Aligned_cols=142 Identities=18% Similarity=0.223 Sum_probs=105.9
Q ss_pred CCCccccccccceEEEEeCCCcEEEEEE-ecCCCCCc------chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 303 SKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIG------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~-~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
...++-+|+-+.|+++.++ |+...||. +.+..... ...+..+|++.+.+++--.|.-..-++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678899999999999987 66666653 33222221 1235778999999887666666666777778888999
Q ss_pred ecCcC-CChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEcccccccc
Q 010149 376 PYMSN-GSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKL 448 (517)
Q Consensus 376 e~~~~-gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DFGla~~ 448 (517)
||+++ .++.+++.. ...........++..|-+.+.-||.+ +|+||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 467777653 22233333478899999999999999 999999999999997655 357999999864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.3e-11 Score=106.75 Aligned_cols=104 Identities=31% Similarity=0.428 Sum_probs=33.3
Q ss_pred CEEEEecCCCCCccccccccc-CCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccC-CCCccchhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIG-NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLR 149 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~ 149 (517)
++++|+|.+|.|+.+ . .++ .+++|+.|+|++|.|+ .++ .+..|++|+.|+|++|+|+ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc-c-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 456677777777643 2 344 4677777777777777 343 4667777777777777777 444444 3567777777
Q ss_pred hcccccCCCC-CCCcccCCCcceEeccCCCCC
Q 010149 150 LNNNSLTGAI-PPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 150 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~ 180 (517)
|++|+|...- -..+..+++|+.|+|.+|+++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 7777776321 134556677777777777766
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.4e-11 Score=129.19 Aligned_cols=215 Identities=19% Similarity=0.215 Sum_probs=154.8
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
...+.+.+.+-+-+|.++.++.+.-. .|...+.|+........ .......+-.+.-..+||-++...--+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777778888999998877632 34344444433221111 1111222333333345566665544444556678
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
|+++|..+++|...++..+..+....+.....+.++++|||.. .+.|||++|.|.+...++..+++|||..+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 9999999999999999888788888888888899999999997 6899999999999999999999999844321100
Q ss_pred ------------------------CC------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 453 ------------------------DS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 453 ------------------------~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.. .......||+.|.+||...+......+|.|++|++++|.++|..||+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 012234589999999999999999999999999999999999999998
Q ss_pred CccccccCccc
Q 010149 503 GKTANQKGAML 513 (517)
Q Consensus 503 ~~~~~~~~~~~ 513 (517)
.+++..++.++
T Consensus 1038 ~tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 1038 ETPQQIFENIL 1048 (1205)
T ss_pred cchhhhhhccc
Confidence 88765554433
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-10 Score=77.39 Aligned_cols=40 Identities=53% Similarity=1.012 Sum_probs=31.4
Q ss_pred hHHHHHHHHHHHhCC-CCCCCCCCCCCCC-CCCceeeeEEeC
Q 010149 30 NYEVQALMGIKDSLH-DPHDVLNNWDENS-VDPCSWALVTCS 69 (517)
Q Consensus 30 ~~~~~al~~~k~~~~-~~~~~l~~W~~~~-~~~c~w~gv~C~ 69 (517)
++|++||++||+++. +|...+.+|+.++ .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 679999999999998 5778999999874 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.8e-09 Score=96.71 Aligned_cols=127 Identities=20% Similarity=0.272 Sum_probs=82.9
Q ss_pred ceEEEEeCCCcEEEEEEecCCCC------------C---------c----chHHHHHHHHHHhccCCCc--ccceeeeEe
Q 010149 314 NVYKGYLQDGTVVAVKRLKDGNA------------I---------G----GEIQFQTEVEMISLAVHRN--LLRLIGFCM 366 (517)
Q Consensus 314 ~Vy~~~~~~g~~vavK~~~~~~~------------~---------~----~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~ 366 (517)
.||.|...+|..+|+|+.+.... . . ......+|.+.|.++...+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999988899999999853210 0 0 0123678999999987664 4555544
Q ss_pred cCCcceEEEecCc--CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 367 TTTERLLVYPYMS--NGSVASRLKAKPSLDWATRKRIALGAARGLLYL-HEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 367 ~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
....+||||++ +..+....... ++......++.+++..+..+ |.. +|+||||.+.||+++++ .+.|+||
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred --eCCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 35689999998 54444333221 12345567788888866664 676 99999999999999987 9999999
Q ss_pred ccccccC
Q 010149 444 GLAKLLD 450 (517)
Q Consensus 444 Gla~~~~ 450 (517)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.9e-10 Score=102.68 Aligned_cols=103 Identities=34% Similarity=0.436 Sum_probs=37.1
Q ss_pred ccCCCCCcEEecccCccCCCCCCccc-ccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCc-ccCCC
Q 010149 91 IGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQ 168 (517)
Q Consensus 91 ~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~ 168 (517)
+.+...+++|+|++|.|+ .+. .++ .+.+|+.|+|++|+|+ .++ .+..++.|+.|++++|+|+ .+++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 456678999999999999 454 466 6899999999999999 454 6888999999999999999 565555 46899
Q ss_pred cceEeccCCCCCCCCCC-C---C--cCcccccCCcc
Q 010149 169 LAFLDLSYNNLSGPVPS-F---H--AKTFNITGNSL 198 (517)
Q Consensus 169 L~~l~l~~N~l~~~~p~-~---~--~~~~~l~~N~~ 198 (517)
|+.|+|++|+|...--- . + .+.+++.|||+
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 99999999999853211 1 1 15688999988
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.7e-09 Score=99.11 Aligned_cols=140 Identities=14% Similarity=0.051 Sum_probs=99.4
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCC----------cchHHHHHHHHHHhccCCCcc--cceeeeEec-----
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI----------GGEIQFQTEVEMISLAVHRNL--LRLIGFCMT----- 367 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~----- 367 (517)
+.+-.-....|++..+ +|+.+.||+....... .....+.+|...+.++...+| .+.+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667666 4788999977433211 011146788888877754443 344555543
Q ss_pred CCcceEEEecCcCC-Chhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-------CCC
Q 010149 368 TTERLLVYPYMSNG-SVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-------YYE 437 (517)
Q Consensus 368 ~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-------~~~ 437 (517)
....++|+|++++. +|.+++.. ....+......++.+++..+.-||.. ||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23467999999886 78888753 23456677889999999999999999 9999999999999975 467
Q ss_pred eEEcccccccc
Q 010149 438 AVVGDFGLAKL 448 (517)
Q Consensus 438 ~ki~DFGla~~ 448 (517)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.2e-10 Score=83.28 Aligned_cols=57 Identities=42% Similarity=0.564 Sum_probs=23.0
Q ss_pred CcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhccc
Q 010149 97 LQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153 (517)
Q Consensus 97 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 153 (517)
|++|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 444444444444322233444444444444444444333333333333333333333
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-10 Score=83.14 Aligned_cols=61 Identities=48% Similarity=0.637 Sum_probs=56.2
Q ss_pred CcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCC
Q 010149 119 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179 (517)
Q Consensus 119 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 179 (517)
++|++|+|++|+|+...+..|..+++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999966667899999999999999999977788999999999999999986
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-09 Score=117.90 Aligned_cols=104 Identities=24% Similarity=0.431 Sum_probs=50.7
Q ss_pred EeCCCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCC-------------
Q 010149 67 TCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG------------- 133 (517)
Q Consensus 67 ~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~------------- 133 (517)
.|...+.+.|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.
T Consensus 174 ~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~~~L~~L~ 247 (754)
T PRK15370 174 DCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLPDTIQEME 247 (754)
T ss_pred hhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhhccccEEE
Confidence 444445566666666655 3443331 34555555555555 3443332 244444444444441
Q ss_pred -------CCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCC
Q 010149 134 -------PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 134 -------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 181 (517)
.+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++
T Consensus 248 Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 248 LSINRITELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT 297 (754)
T ss_pred CcCCccCcCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc
Confidence 3443332 24555556666555 4454443 356666666666654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.3e-09 Score=115.57 Aligned_cols=78 Identities=28% Similarity=0.420 Sum_probs=55.4
Q ss_pred CCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEe
Q 010149 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 173 (517)
Q Consensus 94 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 173 (517)
..+.+.|+|+++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+
T Consensus 177 ~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 177 KNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred ccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 356789999999999 6887664 58999999999999 6777654 47777788877777 5555432 2344444
Q ss_pred ccCCCCC
Q 010149 174 LSYNNLS 180 (517)
Q Consensus 174 l~~N~l~ 180 (517)
|++|+++
T Consensus 248 Ls~N~L~ 254 (754)
T PRK15370 248 LSINRIT 254 (754)
T ss_pred CcCCccC
Confidence 4444444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.4e-09 Score=115.02 Aligned_cols=71 Identities=32% Similarity=0.374 Sum_probs=37.0
Q ss_pred cccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----Cccccc
Q 010149 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNIT 194 (517)
Q Consensus 120 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~ 194 (517)
+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|..+. +.++|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 4566666666666 344322 34555566666665 344322 34555666666665 3443222 445566
Q ss_pred CCccc
Q 010149 195 GNSLI 199 (517)
Q Consensus 195 ~N~~~ 199 (517)
+|++.
T Consensus 454 ~N~Ls 458 (788)
T PRK15387 454 GNPLS 458 (788)
T ss_pred CCCCC
Confidence 66653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-08 Score=93.42 Aligned_cols=138 Identities=21% Similarity=0.198 Sum_probs=99.1
Q ss_pred CCCCCccccccccceEEEEeCCCcEEEEEEecCCCC----------------C-----cchHHHHHHHHHHhccCCC--c
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA----------------I-----GGEIQFQTEVEMISLAVHR--N 357 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------~-----~~~~~~~~Ei~~l~~l~H~--n 357 (517)
..+.+.||.|.-+.||.|..+.|.++|||.-+.... . -+....++|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345789999999999999999999999997642210 0 0112356788888877544 4
Q ss_pred ccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC
Q 010149 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 358 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
+.+.+++ +...+||||+++-.|...- ++......++..|++-+.-+-.. ||||+|+++-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCC
Confidence 5555443 6778999999986665322 13344455666666666555555 9999999999999999999
Q ss_pred eEEcccccccccC
Q 010149 438 AVVGDFGLAKLLD 450 (517)
Q Consensus 438 ~ki~DFGla~~~~ 450 (517)
+.++||=-+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998776443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.8e-10 Score=106.13 Aligned_cols=103 Identities=24% Similarity=0.375 Sum_probs=72.5
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|||++|.++ .+..+..-++.++.|++|+|.|. .+- .+..|++|+.||||+|.++ .+..+-..|-+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4677888888776 66667777788888888888887 333 3777788888888888877 555555556666777777
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
.|.|. .+ ..+.++-+|..||+++|+|.
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchh
Confidence 77776 22 34666666777777777775
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.1e-10 Score=113.48 Aligned_cols=102 Identities=26% Similarity=0.455 Sum_probs=58.1
Q ss_pred EEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhccc
Q 010149 74 TGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153 (517)
Q Consensus 74 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 153 (517)
..|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.|.+|+.|.+..|++. .+|+.+..| .|..||+|.|
T Consensus 146 kvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScN 221 (722)
T KOG0532|consen 146 KVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCN 221 (722)
T ss_pred eeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccC
Confidence 33444444444 55555555555555555555555 45555555555555555555555 455555533 3556666666
Q ss_pred ccCCCCCCCcccCCCcceEeccCCCCC
Q 010149 154 SLTGAIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
+++ .||-.|.+|+.|++|-|.+|.|+
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCC
Confidence 666 66666666666666666666666
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.7e-10 Score=114.78 Aligned_cols=121 Identities=31% Similarity=0.488 Sum_probs=82.3
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.+|.|||+.|.++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+.|.+.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 4555666666666 5565565554 666666666666 66666776667777777777776 666677777777777777
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
.|++. .+|+.+.. -.|..||+|+|+++ .+|..|. +.+-|.+|++.
T Consensus 198 Rn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 198 RNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhh-hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 77777 66666664 35778888888888 5665554 55677888874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.2e-08 Score=98.58 Aligned_cols=165 Identities=19% Similarity=0.230 Sum_probs=124.8
Q ss_pred cccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec----CCcceEEEecCcC-CChh
Q 010149 311 GFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVYPYMSN-GSVA 384 (517)
Q Consensus 311 ~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 384 (517)
-..+.||+.. .||..+++|+++........ .-..-++.++++.|+|+|++..++.. +...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4467899984 48999999999543322111 12345788999999999999998863 4567899999985 5666
Q ss_pred hhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 385 SRLK---------------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 385 ~~l~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
++-- ++...++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 5432 223467889999999999999999999 9999999999999999999999999988766
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~ 497 (517)
...+. |-+ +.-.+-|.-.||.+++.|.||.
T Consensus 444 ~~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 444 QEDPT---------------EPL---ESQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred cCCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcc
Confidence 54320 111 1123567778999999999995
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-08 Score=109.87 Aligned_cols=95 Identities=27% Similarity=0.337 Sum_probs=63.9
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|++++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 57778888887774 453 2577888888888887 45643 356777777777777 455432 456667777
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 182 (517)
+|+|+ .+|.. +++|+.|+|++|+|++.
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L 317 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLASL 317 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCccccC
Confidence 77777 45542 35678888888887763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7e-08 Score=100.52 Aligned_cols=146 Identities=23% Similarity=0.297 Sum_probs=96.0
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC---------------------c------------------c
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---------------------G------------------G 339 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~------------------~ 339 (517)
..|+ .+.|+.++-|+||+|++++|+.||||+.+..-.. . .
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3443 4679999999999999999999999997432110 0 0
Q ss_pred hHHHHHHHHHHhcc-----CCCcccceeeeEecCCcceEEEecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHH-HHH
Q 010149 340 EIQFQTEVEMISLA-----VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGL-LYL 412 (517)
Q Consensus 340 ~~~~~~Ei~~l~~l-----~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L-~yL 412 (517)
+-+|..|..-+.++ ..+++.-..=|........|+|||++|-.+.+... ....++ +..++..++++. ..+
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQL 281 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 11244444444443 23333222223334577899999999988888743 123345 334444444432 222
Q ss_pred HhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 413 H~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
-.. |++|.|.+|.||+++.++.+-+.|||+...+++
T Consensus 282 ~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred Hhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 223 899999999999999999999999999876654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2e-07 Score=86.65 Aligned_cols=106 Identities=17% Similarity=0.183 Sum_probs=84.1
Q ss_pred HHHHHHHHHHhccCCCc--ccceeeeEecCC----cceEEEecCcCC-ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 010149 341 IQFQTEVEMISLAVHRN--LLRLIGFCMTTT----ERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLH 413 (517)
Q Consensus 341 ~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH 413 (517)
....+|...+..+.... ..+.+++..... ..++|+|++++. +|.+++......+......++.++++.++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35677887777664333 455666665532 347999999874 79998886545777888999999999999999
Q ss_pred hcCCCCeEecCCCCCceEEcCCC---CeEEccccccccc
Q 010149 414 EQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLL 449 (517)
Q Consensus 414 ~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DFGla~~~ 449 (517)
+. ||+|+|++++|||++.+. .+.++||+-++..
T Consensus 136 ~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 999999999999999877 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.9e-08 Score=112.54 Aligned_cols=124 Identities=21% Similarity=0.279 Sum_probs=74.4
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|+++.+. .++..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|..-..+|..+.++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 4556666666655 455556666677777776654444555 36666677777776665444666666677777777776
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCcc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSL 198 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~ 198 (517)
+|..-+.+|..+ ++++|+.|++++|...+.+|.... +.+++++|.+
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 654333566554 566666666666655444443322 4455555554
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-08 Score=99.02 Aligned_cols=89 Identities=25% Similarity=0.265 Sum_probs=52.8
Q ss_pred ccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcc
Q 010149 91 IGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170 (517)
Q Consensus 91 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 170 (517)
|..|++|+.|+|++|+|+++-+..|..+.+|+.|.|..|+|...--..|.++..|+.|+|.+|+|+..-|.+|..+..|.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 55566666666666666655555666666666666666666533334455566666666666666655555666666666
Q ss_pred eEeccCCCC
Q 010149 171 FLDLSYNNL 179 (517)
Q Consensus 171 ~l~l~~N~l 179 (517)
.|+|-.|.+
T Consensus 350 ~l~l~~Np~ 358 (498)
T KOG4237|consen 350 TLNLLSNPF 358 (498)
T ss_pred eeehccCcc
Confidence 666655554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.1e-09 Score=108.98 Aligned_cols=128 Identities=24% Similarity=0.295 Sum_probs=87.1
Q ss_pred CCEEEEecCCCCCcccccccccCCCC---CcEEecccCccCC----CCCCccccc-CcccEEEeecCCCCCC----CCcc
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTN---LQLVLLQNNNISG----HIPTEIGKL-SKLLTLDLSNNFFTGP----IPST 138 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~----~p~~ 138 (517)
.+++.|++++|.+.+..+..+..+.. |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 47888888888887666666655555 8888888888873 233345566 7888888888888843 3334
Q ss_pred CCCCccchhhhhcccccCCC----CCCCcccCCCcceEeccCCCCCCCCCCCC---------cCcccccCCcc
Q 010149 139 VSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVPSFH---------AKTFNITGNSL 198 (517)
Q Consensus 139 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---------~~~~~l~~N~~ 198 (517)
+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.....+ .+.+++++|++
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 56667788888888888742 33445556788888888888874322111 25667777654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.1e-09 Score=111.92 Aligned_cols=102 Identities=27% Similarity=0.423 Sum_probs=88.9
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
++..||+++|.++ ..|..+..+.+|+.|+++.|.+. ..|....++.+|++|.|.+|++. .+|.++..+.+|++|++|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3788999988876 88888999999999999999998 78888899999999999999999 899999999999999999
Q ss_pred ccccCCCCCCCcccCCCcceEeccCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYN 177 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N 177 (517)
.|++. .+|..+..++.+..+..++|
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcc
Confidence 99998 88887777776666666666
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.8e-07 Score=87.14 Aligned_cols=190 Identities=16% Similarity=0.198 Sum_probs=125.2
Q ss_pred CCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeE----e--cC-CcceE
Q 010149 302 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFC----M--TT-TERLL 373 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~----~--~~-~~~~l 373 (517)
.....||+|+.+.+|..--- +. .+.|++...... .. .+.++.|... .||-+-.=+.+- . +. ...-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa-~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA-AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCch-HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34678999999999964311 11 234666543221 11 1233344433 465433211111 1 11 12446
Q ss_pred EEecCcCCC-hhhhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 374 VYPYMSNGS-VASRL------KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 374 v~e~~~~gs-L~~~l------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.|+.+++.. ...+. +..+..+|...++.+..++.+.+-||+. |.+-+|+.++|+|+.+++.+.+.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 666665532 11111 2345689999999999999999999999 9999999999999999999999885533
Q ss_pred cccCCCCCceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhC-CCCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISG-LRALEF 502 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG-~~P~~~ 502 (517)
..-. .........|...|.+||... +..-+...|-|.+||++++++.| ++||..
T Consensus 165 qi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 165 QINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 2221 223344556899999999764 33456789999999999999997 999864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.2e-09 Score=112.79 Aligned_cols=124 Identities=31% Similarity=0.421 Sum_probs=96.0
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCc-cCCCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l 150 (517)
.+...+.+.|.|. .+..++.-+++|+.|||++|+++..- .+..|++|++|||++|++. .+|. ....+. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3455566667665 66677888999999999999999543 7889999999999999999 6664 333444 999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCC---CCCCc---CcccccCCccccCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV---PSFHA---KTFNITGNSLICAT 202 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~---p~~~~---~~~~l~~N~~~c~~ 202 (517)
++|.++. + ..+.+|.+|+.|||++|-|++-- |-+.. +.+.|.|||+-|..
T Consensus 240 rnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9999983 3 46889999999999999998632 22111 67899999998864
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-08 Score=95.62 Aligned_cols=115 Identities=26% Similarity=0.255 Sum_probs=94.1
Q ss_pred eeEEeCC------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCc
Q 010149 64 ALVTCSD------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 137 (517)
Q Consensus 64 ~gv~C~~------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 137 (517)
.-++|-+ ..|..|++++|++...-. +..|++|+.||||+|.++ .+-..-.+|-+.+.|.|+.|.|.. -+
T Consensus 294 N~I~~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LS 368 (490)
T KOG1259|consen 294 NLITQIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LS 368 (490)
T ss_pred cchhhhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hh
Confidence 4456643 478899999999984433 888999999999999999 555566788999999999999983 24
Q ss_pred cCCCCccchhhhhcccccCCCC-CCCcccCCCcceEeccCCCCCCCC
Q 010149 138 TVSHLETLQYLRLNNNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPV 183 (517)
Q Consensus 138 ~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~ 183 (517)
.+..|-+|..||+++|+|...- -..++++|.|+.+.|.+|.|.+.+
T Consensus 369 GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 369 GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 6788889999999999998321 257999999999999999999643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.9e-09 Score=103.86 Aligned_cols=128 Identities=24% Similarity=0.352 Sum_probs=89.6
Q ss_pred CEEEEecCCCCCcc----cccccccCC-CCCcEEecccCccCCC----CCCcccccCcccEEEeecCCCCCC----CCcc
Q 010149 72 LVTGLGAPSQNLSG----TLSSSIGNL-TNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPST 138 (517)
Q Consensus 72 ~v~~l~l~~~~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~ 138 (517)
+++.|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 48888998888873 344456666 8889999999988843 334456677888999999888842 3334
Q ss_pred CCCCccchhhhhcccccCCC----CCCCcccCCCcceEeccCCCCCCCC--------CC--CCcCcccccCCccc
Q 010149 139 VSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPV--------PS--FHAKTFNITGNSLI 199 (517)
Q Consensus 139 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~--------p~--~~~~~~~l~~N~~~ 199 (517)
+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. +. .-.+.+++++|.+.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 55567888889988888743 3345667788899999998887521 11 22367778887763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.5e-09 Score=86.79 Aligned_cols=105 Identities=23% Similarity=0.312 Sum_probs=80.3
Q ss_pred EEEEecCCCCCccccc---ccccCCCCCcEEecccCccCCCCCCcccc-cCcccEEEeecCCCCCCCCccCCCCccchhh
Q 010149 73 VTGLGAPSQNLSGTLS---SSIGNLTNLQLVLLQNNNISGHIPTEIGK-LSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 148 (517)
.-.++|+++.|- .++ ..+....+|+..+|++|.|. .+|+.|.. .+.++.|+|++|.|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 344677777664 333 34556667777888888888 56666654 458888899999988 788888888899999
Q ss_pred hhcccccCCCCCCCcccCCCcceEeccCCCCCC
Q 010149 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 149 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 181 (517)
+++.|.|. ..|..+..|.+|-.|+..+|.+.-
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~e 137 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAE 137 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCcccc
Confidence 99999888 777777788888888888888873
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.4e-07 Score=85.74 Aligned_cols=156 Identities=23% Similarity=0.269 Sum_probs=98.0
Q ss_pred ccChHHHHHHhcCCCCCCc---cccccccceEEEEeCCCcEEEEEEecCCCCCc--------chHH--------------
Q 010149 288 RFHFKELQSATSNFSSKNL---VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG--------GEIQ-------------- 342 (517)
Q Consensus 288 ~~~~~~l~~~~~~~~~~~~---lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------~~~~-------------- 342 (517)
..+...+....++..+.+. |+.|.-+.||+|...++..+|||+++...... +...
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3444555555555555444 55677788999998889999999996432211 0001
Q ss_pred -HHHHHHHHhccC--CCcccceeeeEecCCcceEEEecCcCC-ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 010149 343 -FQTEVEMISLAV--HRNLLRLIGFCMTTTERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418 (517)
Q Consensus 343 -~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~ 418 (517)
...|..-|.++. +-.+.+.+++ ..-.|||||+... .-.-.|+.- .+...+...+..++++.+.-|-..+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 122333333332 1222222222 2346999999653 112222221 2233367778888888888877633
Q ss_pred CeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 419 ~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 999999999999999 78999999999876654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.9e-08 Score=102.09 Aligned_cols=85 Identities=47% Similarity=0.625 Sum_probs=42.1
Q ss_pred CCCCCcEEecccCccCCCCCCcccccC-cccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcce
Q 010149 93 NLTNLQLVLLQNNNISGHIPTEIGKLS-KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAF 171 (517)
Q Consensus 93 ~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 171 (517)
.++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~ 190 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence 3344555555555555 4444444442 5555555555555 44444455555555555555555 44444434455555
Q ss_pred EeccCCCCC
Q 010149 172 LDLSYNNLS 180 (517)
Q Consensus 172 l~l~~N~l~ 180 (517)
|++++|+++
T Consensus 191 L~ls~N~i~ 199 (394)
T COG4886 191 LDLSGNKIS 199 (394)
T ss_pred eeccCCccc
Confidence 555555555
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.9e-07 Score=108.44 Aligned_cols=124 Identities=22% Similarity=0.232 Sum_probs=99.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|++.++.+. .+|..+ .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence 45777888777765 677776 5789999999999998 6888889999999999998765557774 888999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCcc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~ 198 (517)
++|.....+|..+.++++|+.|++++|..-+.+|.... +.++|++|..
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 99876668999999999999999999755456665432 6677887753
|
syringae 6; Provisional |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.2e-08 Score=84.72 Aligned_cols=111 Identities=21% Similarity=0.219 Sum_probs=88.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.++|++|.+....+.--...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+.
T Consensus 53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 47999999999998444444445679999999999999 89999999999999999999999 88999988999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
.+|.+. .+|..+---+++-..++.+|.+.+.-|
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 999998 777654332333444556666665444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.4e-08 Score=100.15 Aligned_cols=125 Identities=30% Similarity=0.467 Sum_probs=102.1
Q ss_pred CEEEEecCCCCCcccccccccCCC-CCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.++.|++.+|+++ .+|+....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.++.|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 5899999999998 7777777785 9999999999999 77778999999999999999999 78887778999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c 200 (517)
++|+++ .+|.....+..|++|.+++|++...+..... ..+.+.+|++.+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence 999999 8888777777799999999964423222111 344577777765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=90.14 Aligned_cols=143 Identities=21% Similarity=0.239 Sum_probs=91.4
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCC------------------------------------cchHHHHHHH
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI------------------------------------GGEIQFQTEV 347 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------------------------------~~~~~~~~Ei 347 (517)
.+.||.-+.|.||+|++++|+.||||+-+..-.. ..+-+|..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4679999999999999999999999986432110 1122355555
Q ss_pred HHHhcc----CCCcc---cceeeeE-ecCCcceEEEecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 010149 348 EMISLA----VHRNL---LRLIGFC-MTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDP 418 (517)
Q Consensus 348 ~~l~~l----~H~nI---v~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~ 418 (517)
+-..++ +|-+. |.+=.++ .-.....|+||||+|..+.+.-. ....++...+..- +.++ |++.-...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~---l~~~--~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNK---LVEA--YLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHH---HHHH--HHHHHHhc
Confidence 443332 34441 1122222 23456789999999988776543 1223454433333 3332 22322333
Q ss_pred CeEecCCCCCceEEcC----CCCeEEcccccccccCC
Q 010149 419 KIIHRDVKAANILLDE----YYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 419 ~ivH~Dlk~~NILl~~----~~~~ki~DFGla~~~~~ 451 (517)
|++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 66899999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.8e-06 Score=76.85 Aligned_cols=137 Identities=18% Similarity=0.117 Sum_probs=100.2
Q ss_pred cccccccceEEEEeCCCcEEEEEEecCCC--C---CcchHHHHHHHHHHhccCCCc--ccceeeeEe-cC----CcceEE
Q 010149 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGN--A---IGGEIQFQTEVEMISLAVHRN--LLRLIGFCM-TT----TERLLV 374 (517)
Q Consensus 307 lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~---~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~-~~----~~~~lv 374 (517)
-|+||-+-|++...+ |..+-+|+-...- . +-+...|.+|...+.++...+ +.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 366888889987765 4578888764111 1 335678999999988885333 33444 332 11 234699
Q ss_pred EecCcC-CChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC--eEEcccccccc
Q 010149 375 YPYMSN-GSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAKL 448 (517)
Q Consensus 375 ~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DFGla~~ 448 (517)
+|-+++ -+|.+++... .+.+...+..+..++++.++-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 5788887642 3457788889999999999999999 9999999999999986666 99999997753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.8e-06 Score=79.17 Aligned_cols=133 Identities=14% Similarity=0.106 Sum_probs=83.9
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc--ccceeeeEecCCcceEEEecCcCCC
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 24567788875432 2345678998888875433 3566777767777789999999863
Q ss_pred -hhhhhhcCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhc-CCCCeE
Q 010149 383 -VASRLKAKPSLDWATRKRIALGAARG---------------------------------------LLYLHEQ-CDPKII 421 (517)
Q Consensus 383 -L~~~l~~~~~l~~~~~~~i~~~i~~~---------------------------------------L~yLH~~-~~~~iv 421 (517)
+...+. .+......++.++++. ..+|... ..+.++
T Consensus 81 ~~~~~~~----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 81 SFSRIIS----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred chhhhhc----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 211110 0011111111111111 1222211 134678
Q ss_pred ecCCCCCceEEcCCCCeEEcccccccc
Q 010149 422 HRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 422 H~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.8e-08 Score=99.40 Aligned_cols=184 Identities=18% Similarity=0.133 Sum_probs=132.9
Q ss_pred CCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc-ccceeeeEecCCcceEEEecCc
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVYPYMS 379 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~~ 379 (517)
+..-+-.++|+++.+||.+-...+....+.+... ....-+++++.+++||| .+..++-+..+...+++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3334567899999999987443344446655332 33456789999999999 7777777777788889999998
Q ss_pred CC-Ch-hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 380 NG-SV-ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 380 ~g-sL-~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
.+ +. .........+...+...+...-+++++|+|+. .=+|+| ||+..+ +..|..||+....+.... ..
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 87 22 22111222333344445556667889999986 458998 777766 678999999987766433 33
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
....+++.++|||......+..+.|+|+.|+=..+|--|-.|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4556999999999999999999999999998777777777663
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-07 Score=98.94 Aligned_cols=95 Identities=21% Similarity=0.432 Sum_probs=75.6
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC--------ceeeeccccccccCcccccc
Q 010149 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS--------HVTTAVRGTVGHIAPEYLST 474 (517)
Q Consensus 403 ~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 474 (517)
.+++.|+.|+|... ++||++|.|++|.+++++..||+.|+.+........ ...........|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44559999999864 999999999999999999999999998865443111 11112235678999999998
Q ss_pred CCCCcccceehhhHHHHHHHhCCCC
Q 010149 475 GQSSEKTDVFGFGILLLELISGLRA 499 (517)
Q Consensus 475 ~~~~~~~Dv~S~Gvil~elltG~~P 499 (517)
...+.++|+||+|+++|.+..|..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999955544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.9e-06 Score=75.47 Aligned_cols=138 Identities=13% Similarity=0.095 Sum_probs=88.3
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHH---------HHHHHHHHhccCCCc---ccceeee
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ---------FQTEVEMISLAVHRN---LLRLIGF 364 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~~Ei~~l~~l~H~n---Iv~l~~~ 364 (517)
...+|...+++-......|.+-..+ |..+.+|..+..... .+.. ..+++....+++... ...++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456776777777666666665554 788999987654322 1211 223333333333222 2232222
Q ss_pred Eec-----CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 365 CMT-----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 365 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
... ....+++|||++|-.|.+... +++ .++..+.+++.-+|+. |++|+|..|+|+++++++ ++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EE
Confidence 222 234568999999987765432 222 3456677889999999 999999999999999655 99
Q ss_pred Ecccccccc
Q 010149 440 VGDFGLAKL 448 (517)
Q Consensus 440 i~DFGla~~ 448 (517)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999997653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.3e-07 Score=60.16 Aligned_cols=37 Identities=43% Similarity=0.619 Sum_probs=25.7
Q ss_pred CCCcEEecccCccCCCCCCcccccCcccEEEeecCCCC
Q 010149 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 132 (517)
Q Consensus 95 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 132 (517)
++|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46777777777777 56656777777777777777776
|
... |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.9e-06 Score=77.56 Aligned_cols=140 Identities=17% Similarity=0.166 Sum_probs=82.2
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc--ccceeeeEecC---CcceEEEecCc
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTT---TERLLVYPYMS 379 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~---~~~~lv~e~~~ 379 (517)
+.++.|..+.||+....+ ..+++|..... .....+..|..++..+.... +.+++.+.... ...+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999999876 68999987543 23456778888888775333 45666644332 23579999999
Q ss_pred CCChhh----------------hh---hcC----CCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 010149 380 NGSVAS----------------RL---KAK----PSLDWAT---------RKRI------------ALGAAR-GLLYLHE 414 (517)
Q Consensus 380 ~gsL~~----------------~l---~~~----~~l~~~~---------~~~i------------~~~i~~-~L~yLH~ 414 (517)
+..+.. .+ +.. ....... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 111 1111110 0000 111222 2333332
Q ss_pred ----cCCCCeEecCCCCCceEEc-CCCCeEEcccccccc
Q 010149 415 ----QCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKL 448 (517)
Q Consensus 415 ----~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~ 448 (517)
.....++|+|+.|+||+++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345799999999999999 666668999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.9e-05 Score=75.44 Aligned_cols=137 Identities=19% Similarity=0.153 Sum_probs=83.1
Q ss_pred cccccc-cceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEecCcCCChh
Q 010149 307 VGKGGF-GNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNGSVA 384 (517)
Q Consensus 307 lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 384 (517)
|-.|.+ ..||+.... +..+.+|+..... ..+...|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 344444 788998765 4678888875432 234567888877763 333556777776666789999999987776
Q ss_pred hhh-------------------hcCC----CCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 010149 385 SRL-------------------KAKP----SLDW--ATRKRIAL--------------------GAARGLLYLHE----Q 415 (517)
Q Consensus 385 ~~l-------------------~~~~----~l~~--~~~~~i~~--------------------~i~~~L~yLH~----~ 415 (517)
... +.-+ .+.. ........ .+......|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 1100 1110 00000000 01111122211 1
Q ss_pred CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 416 ~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 235689999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 517 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-102 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-100 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-37 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 455 bits (1173), Expect = e-159
Identities = 180/252 (71%), Positives = 210/252 (83%), Gaps = 5/252 (1%)
Query: 270 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVK 329
FFDV + EV LG LKRF +ELQ A+ NFS+KN++G+GGFG VYKG L DGT+VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 330 RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL-- 387
RLK+ GGE+QFQTEVEMIS+AVHRNLLRL GFCMT TERLLVYPYM+NGSVAS L
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 388 --KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 445
+++P LDW R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE +EAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505
AKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELI+G RA + +
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 506 ANQKGAML-DWV 516
AN ML DWV
Sbjct: 241 ANDDDVMLLDWV 252
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-121
Identities = 99/255 (38%), Positives = 148/255 (58%), Gaps = 21/255 (8%)
Query: 275 EQRREEVCLGNLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAV 328
E + EV F F EL++ T+NF + N +G+GGFG VYKGY+ + T VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 329 KRLKDGNAIG---GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVAS 385
K+L I + QF E+++++ H NL+ L+GF + LVY YM NGS+
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 386 RL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442
RL P L W R +IA GAA G+ +LHE IHRD+K+ANILLDE + A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 443 FGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501
FGLA+ + + +T+ + GT ++APE L G+ + K+D++ FG++LLE+I+GL A++
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 502 FGKTANQKGAMLDWV 516
+ + +LD
Sbjct: 236 EHR---EPQLLLDIK 247
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-110
Identities = 97/237 (40%), Positives = 140/237 (59%), Gaps = 10/237 (4%)
Query: 285 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ 344
R +L+ AT+NF K L+G G FG VYKG L+DG VA+KR ++ G E +F+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE-EFE 83
Query: 345 TEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL----KAKPSLDWATRKR 400
TE+E +S H +L+ LIGFC E +L+Y YM NG++ L S+ W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTA 459
I +GAARGL YLH + IIHRDVK+ NILLDE + + DFG++K D +H++T
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDWV 516
V+GT+G+I PEY G+ +EK+DV+ FG++L E++ A+ + +W
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWA 256
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-69
Identities = 65/224 (29%), Positives = 93/224 (41%), Gaps = 21/224 (9%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
L + + +G FG V+K L VAVK + Q + EV +
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPG 74
Query: 353 AVHRNLLRLIGFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 408
H N+L+ IG + L+ + GS++ LK + W IA ARG
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARG 133
Query: 409 LLYLHE-------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAV 460
L YLHE P I HRD+K+ N+LL A + DFGLA + S T
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 461 RGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELISGLRA 499
GT ++APE L + + D++ G++L EL S A
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 4e-59
Identities = 66/246 (26%), Positives = 99/246 (40%), Gaps = 33/246 (13%)
Query: 289 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE 348
E N L+G+G +G VYKG L D VAVK N F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKN 57
Query: 349 MISLAV--HRNLLRLIGFCMTT-----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 401
+ + + H N+ R I E LLV Y NGS+ L + DW + R+
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRL 116
Query: 402 ALGAARGLLYLHE------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--- 452
A RGL YLH P I HRD+ + N+L+ V+ DFGL+ L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 453 ----DSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELISGLRALE 501
+ + + GT+ ++APE L + ++ D++ G++ E+ L
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 502 FGKTAN 507
G++
Sbjct: 237 PGESVP 242
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 7e-57
Identities = 64/194 (32%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG V++ G+ VAVK L + + + F EV ++ H N++ +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 366 MTTTERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+V Y+S GS+ L A+ LD R +A A+G+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
R++K+ N+L+D+ Y V DFGL++L + + GT +APE L S+EK+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 483 VFGFGILLLELISG 496
V+ FG++L EL +
Sbjct: 222 VYSFGVILWELATL 235
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 304 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEI------QFQTEVEMISLAVHR 356
+ +GKGGFG V+KG ++D +VVA+K L G++ G +FQ EV ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQ 415
N+++L G +V ++ G + RL + W+ + R+ L A G+ Y+
Sbjct: 84 NIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 416 CDPKIIHRDVKAANILLDEYYEAV-----VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+P I+HRD+++ NI L E V DFGL++ H + + G +APE
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPE 196
Query: 471 YLSTGQS--SEKTDVFGFGILLLELISG 496
+ + +EK D + F ++L +++G
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTG 224
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
VG+G FG V K + VA+K+++ + F E+ +S H N+++L G C+
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIESESERK---AFIVELRQLSRVNHPNIVKLYGACL 71
Query: 367 TT----TERLLVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
E Y GS+ + L + P A L ++G+ YLH
Sbjct: 72 NPVCLVME------YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 420 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
+IHRD+K N+LL + + DFG A + T +G+ +APE S
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 479 EKTDVFGFGILLLELISG 496
EK DVF +GI+L E+I+
Sbjct: 182 EKCDVFSWGIILWEVITR 199
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-53
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEI---QFQTEVEMISLAVHRNLLRLIG 363
+G GGFG VY+ + G VAVK + + E ++ ++ H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
C+ LV + G + L K + A+ ARG+ YLH++ IIHR
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 424 DVKAANILLDEYYEAV--------VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
D+K++NIL+ + E + DFGLA+ + G +APE +
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRAS 189
Query: 476 QSSEKTDVFGFGILLLELISG 496
S+ +DV+ +G+LL EL++G
Sbjct: 190 MFSKGSDVWSYGVLLWELLTG 210
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-52
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 362
VGKG +G V++G Q G VAVK + E + E E+ + + H N+L I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFI 68
Query: 363 GFCMTT----TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 414
MT+ T+ L+ Y GS+ L+ +LD + RI L A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 415 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPE 470
Q P I HRD+K+ NIL+ + + + D GLA + + + GT ++APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 471 ------YLSTGQSSEKTDVFGFGILLLELISG 496
+ S ++ D++ FG++L E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-51
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 304 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
++GKG FG K + + G V+ +K L + + F EV+++ H N+L+ I
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 363 GFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G + Y+ G++ + W+ R A A G+ YLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT-------------TAVRGTVGHIA 468
HRD+ + N L+ E VV DFGLA+L+ + V G +A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISGLRA 499
PE ++ EK DVF FGI+L E+I + A
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 362
+GKG +G V+ G + G VAVK E + E E+ + H N+L I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97
Query: 363 GFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 414
+ + T+ L+ Y NGS+ LK +LD + ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 415 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPE 470
Q P I HRD+K+ NIL+ + + D GLA + V GT ++ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 471 ------YLSTGQSSEKTDVFGFGILLLELISG 496
+ QS D++ FG++L E+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+G G FG VYKG G V AVK L ++Q F+ EV ++ H N+L +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 366 MTTTERL-LVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
T +L +V + S+ L ++ + IA ARG+ YLH + IIHR
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHC-DSHVTTAVRGTVGHIAPEYLSTGQS---SE 479
D+K+ NI L E +GDFGLA SH + G++ +APE + S S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 480 KTDVFGFGILLLELISG 496
++DV+ FGI+L EL++G
Sbjct: 205 QSDVYAFGIVLYELMTG 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 44/198 (22%), Positives = 83/198 (41%), Gaps = 16/198 (8%)
Query: 307 VGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFC 365
+ + G ++KG Q G + VK LK + + + F E + + H N+L ++G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 366 MTTTERLL--VYPYMSNGSVASRL--KAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
+ + +M GS+ + L +D + + AL ARG+ +LH +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---S 478
+ + ++++DE A + + S + +APE L
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 479 EKTDVFGFGILLLELISG 496
D++ F +LL EL++
Sbjct: 190 RSADMWSFAVLLWELVTR 207
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-50
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--HRNLLRLI 362
+GKG FG V++G + G VAVK E + E E+ + H N+L I
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 363 GFCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE---- 414
T T+ LV Y +GS+ L + ++ ++AL A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 415 -QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT---TAVRGTVGHIAPE 470
Q P I HRD+K+ NIL+ + + D GLA D + GT ++APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 471 YL------STGQSSEKTDVFGFGILLLELISG 496
L +S ++ D++ G++ E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-49
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 304 KNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRL 361
L+GKG FG VY G + + VA++ + +++ F+ EV H N++
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
+G CM+ ++ ++ S + AK LD ++IA +G+ YLH + I
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD----SHVTTAVRGTVGHIAPEYLSTGQ 476
+H+D+K+ N+ D + V+ DFGL + G + H+APE +
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 477 S---------SEKTDVFGFGILLLELISG 496
S+ +DVF G + EL +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAR 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-49
Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 9/162 (5%)
Query: 32 EVQALMGIKDSLHDPHDVLNNWDENS-VDPCSWALVTCSD----GLVTGLGAPSQNLSGT 86
+ QAL+ IK L +P L++W + +W V C V L NL
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 87 --LSSSIGNLTNLQ-LVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 143
+ SS+ NL L L + NN+ G IP I KL++L L +++ +G IP +S ++
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 144 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
TL L + N+L+G +PPS+S++ L + N +SG +P
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 6/123 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L+G + + NL NL V L N + G G + L+ N + V
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGL 242
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNS 197
+ L L L NN + G +P L+ + L L++S+NNL G +P N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 198 LIC 200
+C
Sbjct: 303 CLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 2/105 (1%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
N+SG + + + L + N +SG +P I L L+ + N +G IP +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 142 LETL-QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L + ++ N LTG IPP+ +N++ LAF+DLS N L G
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 308 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G+G FG V+ G L+ VAVK ++ + +F E ++ H N++RLIG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 367 TTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+V + G + L+ L T ++ AA G+ YL + IHRD+
Sbjct: 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLSTGQSSEK 480
A N L+ E + DFG+++ D G + + APE L+ G+ S +
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEA--DGVYAA--SGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 481 TDVFGFGILLLELIS 495
+DV+ FGILL E S
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLRLIG 363
+G+G F VYKG + VA L+D E +F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 364 FCMTTTE---RLLVYP-YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+T + +++ M++G++ + LK + + +GL +LH P
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 420 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
IIHRD+K NI + +V +GD GLA L + AV GT +APE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEEK-YD 207
Query: 479 EKTDVFGFGILLLELISG 496
E DV+ FG+ +LE+ +
Sbjct: 208 ESVDVYAFGMCMLEMATS 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 304 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
++GKG FG VY G D A+K L + F E ++ H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 360 RLIGFCMTTTERLL-VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 417
LIG + + PYM +G + +++ + + L ARG+ YL EQ
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYL 472
K +HRD+ A N +LDE + V DFGLA+ + + + + + A E L
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTALESL 200
Query: 473 STGQSSEKTDVFGFGILLLELIS 495
T + + K+DV+ FG+LL EL++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 305 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L D AVK L IG QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 361 LIGFCMTTTE-RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 418
L+G C+ + L+V PYM +G + + ++ + L A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK--- 147
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLS 473
K +HRD+ A N +LDE + V DFGLA+ + + + + T + A E L
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALESLQ 205
Query: 474 TGQSSEKTDVFGFGILLLELIS 495
T + + K+DV+ FG+LL EL++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 308 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G G FG VYKG VA+K L++ + + E +++ + ++ RL+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G C T+ L+ M G + ++ K ++ + A+G+ YL ++ +++
Sbjct: 84 GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 476
HRD+ A N+L+ + DFGLAKLL + ++ A E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195
Query: 477 SSEKTDVFGFGILLLELIS 495
+ ++DV+ +G+ + EL++
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 305 NLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
++G+G FG VY G L D AVK L IG QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 361 LIGFCMTTTE-RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 418
L+G C+ + L+V PYM +G + + ++ + L A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK--- 211
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI-----APEYLS 473
K +HRD+ A N +LDE + V DFGLA+ + + T + A E L
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALESLQ 269
Query: 474 TGQSSEKTDVFGFGILLLELIS 495
T + + K+DV+ FG+LL EL++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT 291
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-36
Identities = 40/105 (38%), Positives = 61/105 (58%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+G + ++ N + L + L N +SG IP+ +G LSKL L L N G IP + +
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
++TL+ L L+ N LTG IP LSN + L ++ LS N L+G +P +
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 4/153 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L G + + + L+ ++L N+++G IP+ + + L + LSNN TG IP +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHAKTFNITGNSLIC 200
LE L L+L+NNS +G IP L + L +LDL+ N +G +P+ ++ I N +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI-- 570
Query: 201 ATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPK 233
G M + +
Sbjct: 571 -AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 44/104 (42%), Positives = 63/104 (60%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
LSGT+ SS+G+L+ L+ + L N + G IP E+ + L TL L N TG IPS +S+
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L ++ L+NN LTG IP + + LA L LS N+ SG +P+
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 4/123 (3%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
G S + N ++ + + N +SG+IP EIG + L L+L +N +G IP V
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-KTFNIT---GNS 197
L L L L++N L G IP ++S ++ L +DLS NNLSGP+P +TF N
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
Query: 198 LIC 200
+C
Sbjct: 739 GLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-34
Identities = 30/122 (24%), Positives = 53/122 (43%), Gaps = 5/122 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
G S + L+ + + GH ++ LD+S N +G IP +
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNITGN 196
+ L L L +N ++G+IP + ++ L LDLS N L G +P + +++ N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 197 SL 198
+L
Sbjct: 715 NL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 40/106 (37%), Positives = 60/106 (56%), Gaps = 2/106 (1%)
Query: 82 NLSGTLSSSIGN--LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N SG + ++ LQ + LQNN +G IP + S+L++L LS N+ +G IPS++
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L L+ L+L N L G IP L + L L L +N+L+G +PS
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 46/125 (36%), Positives = 63/125 (50%), Gaps = 8/125 (6%)
Query: 82 NLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGK--LSKLLTLDLSNNFFTGPIPST 138
SG L S+ NL+ +L + L +NN SG I + + + L L L NN FTG IP T
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNI 193
+S+ L L L+ N L+G IP SL ++S+L L L N L G +P T +
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 194 TGNSL 198
N L
Sbjct: 474 DFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 3/107 (2%)
Query: 82 NLSGTLSSSI-GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STV 139
+G + + G L + L N+ G +P G S L +L LS+N F+G +P T+
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMS-QLAFLDLSYNNLSGPVPS 185
+ L+ L L+ N +G +P SL+N+S L LDLS NN SGP+
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-31
Identities = 42/123 (34%), Positives = 62/123 (50%), Gaps = 9/123 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
N S + +G+ + LQ + + N +SG I ++L L++S+N F GPIP
Sbjct: 211 NFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LP 267
Query: 142 LETLQYLRLNNNSLTGAIPPSLS-NMSQLAFLDLSYNNLSGPVPSF-----HAKTFNITG 195
L++LQYL L N TG IP LS L LDLS N+ G VP F ++ ++
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 196 NSL 198
N+
Sbjct: 328 NNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 60/218 (27%)
Query: 25 SPKGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSD-----------GLV 73
+ + E+ L+ KD L D + +L +W N +PC++ VTC D L
Sbjct: 6 PSQSLYREIHQLISFKDVLPDKN-LLPDWSSNK-NPCTFDGVTCRDDKVTSIDLSSKPLN 63
Query: 74 TGLGAPSQ----------------NLSGTLSS-------------------------SIG 92
G A S +++G++S S+G
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 93 NLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTV---SHLETLQYL 148
+ + L+ + + +N + G KL+ L LDLS N +G L++L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
++ N ++G + +S L FLD+S NN S +P
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL 219
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 23/106 (21%), Positives = 48/106 (45%), Gaps = 2/106 (1%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNN--NISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
++G I N + N G ++ +LS ++++ + G T
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+ ++ +L ++ N L+G IP + +M L L+L +N++SG +P
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 6/107 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+ SG + + +G+ +L + L N +G IP + K S ++ NF G + +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKN 580
Query: 142 LETLQYLRL--NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
+ N G L+ +S +++ G
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 4/63 (6%)
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITG 195
+ ++ N A+ SL +++ L L LS ++++G V F + +++
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109
Query: 196 NSL 198
NSL
Sbjct: 110 NSL 112
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 308 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G+G FG V G VAVK LK + + E+E++ H N+++
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 363 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 419
G C L+ ++ +GS+ L K ++ + + A+ +G+ YL + +
Sbjct: 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---Q 146
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 476
+HRD+ A N+L++ ++ +GDFGL K + D T + APE L +
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 477 SSEKTDVFGFGILLLELIS 495
+DV+ FG+ L EL++
Sbjct: 206 FYIASDVWSFGVTLHELLT 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 304 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL 358
++G+G FG+V +G L+ VAVK +K N+ EI+ F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 359 LRLIGFC-----MTTTERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAAR 407
+RL+G C + +++ P+M G + + L + T + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRG 462
G+ YL + +HRD+ A N +L + V DFGL+K + D + V+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
A E L+ + K+DV+ FG+ + E+ +
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 308 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLI 362
GKG FG+V + L+ VAVK LK +I+ F E + H ++ +L+
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 363 GFC------MTTTERLLVYPYMSNGSVASRLKA------KPSLDWATRKRIALGAARGLL 410
G +++ P+M +G + + L A +L T R + A G+
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVG 465
YL + IHRD+ A N +L E V DFGL++ + D + V+
Sbjct: 152 YLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-- 206
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
A E L+ + +DV+ FG+ + E+++
Sbjct: 207 --ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 308 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G G FG VYKG VA+K L++ + + E +++ + ++ RL+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G C T+ L+ M G + ++ K ++ + A+G+ YL ++ +++
Sbjct: 84 GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 476
HRD+ A N+L+ + DFGLAKLL + ++ A E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRI 195
Query: 477 SSEKTDVFGFGILLLELIS 495
+ ++DV+ +G+ + EL++
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 308 GKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G+G FG V G +VAVK LK ++ E++++ H ++++
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 363 GFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
G C LV Y+ GS+ L + S+ A A G+ YLH Q
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ---HY 155
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLST 474
IHRD+ A N+LLD +GDFGLAK + + G APE L
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----APECLKE 211
Query: 475 GQSSEKTDVFGFGILLLELIS 495
+ +DV+ FG+ L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 304 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR 360
+G G FG+V +G + VA+K LK G + E +++ + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 419
LIG C +LV G + L + + + + + G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLS 473
+HRD+ A N+LL + A + DFGL+K L DS+ T G APE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECIN 186
Query: 474 TGQSSEKTDVFGFGILLLELIS 495
+ S ++DV+ +G+ + E +S
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS 208
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 308 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
GKG FG+V G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 363 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 419
G C + R L+ Y+ GS+ L+ K +D + +G+ YL + +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 134
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 476
IHRD+ NIL++ +GDFGL K+L D I APE L+ +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 477 SSEKTDVFGFGILLLELIS 495
S +DV+ FG++L EL +
Sbjct: 194 FSVASDVWSFGVVLYELFT 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 308 GKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G G FG V+KG V +K ++D + + I H +++RL+
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G C + LV Y+ GS+ ++ + +L + A+G+ YL E ++
Sbjct: 82 GLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMV 137
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 476
HR++ A N+LL + V DFG+A LL D + + ++ A E + G+
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALESIHFGK 193
Query: 477 SSEKTDVFGFGILLLELIS 495
+ ++DV+ +G+ + EL++
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+ + +G+G FG V+ G T VA+K LK G F E +++ H L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 241
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 416
++L + +V YMS GS+ LK + L +A A G+ Y+
Sbjct: 242 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
+HRD++AANIL+ E V DFGLA+L++ + + + APE G+
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 477 SSEKTDVFGFGILLLELIS 495
+ K+DV+ FGILL EL +
Sbjct: 358 FTIKSDVWSFGILLTELTT 376
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 21/199 (10%)
Query: 308 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
G+G FG VY+G + VAVK K + + +F +E ++ H ++++LIG
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
++ G + L+ K SL T +L + + YL +H
Sbjct: 81 II-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVH 136
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQ 476
RD+ NIL+ +GDFGL++ ++ D A +PE ++ +
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWM----SPESINFRR 190
Query: 477 SSEKTDVFGFGILLLELIS 495
+ +DV+ F + + E++S
Sbjct: 191 FTTASDVWMFAVCMWEILS 209
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 308 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
GKG FG+V G VVAVK+L+ F+ E+E++ H N+++
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYK 108
Query: 363 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 419
G C + R L+ Y+ GS+ L+ K +D + +G+ YL + +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 165
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQ 476
IHRD+ NIL++ +GDFGL K+L D I APE L+ +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 477 SSEKTDVFGFGILLLELIS 495
S +DV+ FG++L EL +
Sbjct: 225 FSVASDVWSFGVVLYELFT 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 9e-34
Identities = 61/190 (32%), Positives = 91/190 (47%), Gaps = 8/190 (4%)
Query: 308 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367
G+G FG V+ G T VA+K LK G F E +++ H L++L +
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 368 TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+V YMS GS+ LK + L +A A G+ Y+ +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485
+AANIL+ E V DFGLA+L++ + + + APE G+ + K+DV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 486 FGILLLELIS 495
FGILL EL +
Sbjct: 450 FGILLTELTT 459
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 18/198 (9%)
Query: 308 GKGGFGNVYKGYLQDG---TVVAVKRLKDG-NAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
G G FG V KGY Q VAVK LK+ N + + E ++ + ++R+IG
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
C +LV G + L+ + + + G+ YL E +HR
Sbjct: 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHR 141
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQS 477
D+ A N+LL + A + DFGL+K L +++ G APE ++ +
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYKF 197
Query: 478 SEKTDVFGFGILLLELIS 495
S K+DV+ FG+L+ E S
Sbjct: 198 SSKSDVWSFGVLMWEAFS 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 308 GKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
G G FG+V +G + VA+K LK G + E +++ + ++RLIG
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 365 CMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
C +LV G + L + + + + + G+ YL E+ +HR
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHR 460
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT--VGHIAPEYLSTGQSSEKT 481
++ A N+LL + A + DFGL+K L DS+ T G + APE ++ + S ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 482 DVFGFGILLLELIS 495
DV+ +G+ + E +S
Sbjct: 521 DVWSYGVTMWEALS 534
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 21/199 (10%)
Query: 308 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
G+G FG+V++G VA+K K+ + +F E + H ++++LIG
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
T ++ + G + S L+ K SLD A+ A + L YL + + +H
Sbjct: 84 VI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVH 139
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLSTGQ 476
RD+ A N+L+ +GDFGL++ ++ DS A +G APE ++ +
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APESINFRR 193
Query: 477 SSEKTDVFGFGILLLELIS 495
+ +DV+ FG+ + E++
Sbjct: 194 FTSASDVWMFGVCMWEILM 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 308 GKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
GKG FG+V G +VAVK+L+ + FQ E++++ +++
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 363 GFCMTTTER--LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK 419
G + LV Y+ +G + L+ + LD + + +G+ YL + +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---R 147
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYLS 473
+HRD+ A NIL++ + DFGLAKLL + G APE LS
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APESLS 203
Query: 474 TGQSSEKTDVFGFGILLLELIS 495
S ++DV+ FG++L EL +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
S + +G G FG V+ GY + VA+K +++G E F E E++ H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 65
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 417
++L G C+ LV +M +G ++ L+ + T + L G+ YL E
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 123
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLST 474
+IHRD+ A N L+ E V DFG+ + + T+ GT + +PE S
Sbjct: 124 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSF 179
Query: 475 GQSSEKTDVFGFGILLLELIS 495
+ S K+DV+ FG+L+ E+ S
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 66/203 (32%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 308 GKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQ--FQTEVE-MISLAVHRNLLR 360
G G FG V +G VAVK LK E F EV M SL HRNL+R
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIR 85
Query: 361 LIGFCMTTTERL-LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 418
L G T + +V GS+ RL+ + T R A+ A G+ YL +
Sbjct: 86 LYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG------TVGHIAPEYL 472
+ IHRD+ A N+LL +GDFGL + L D H APE L
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APESL 196
Query: 473 STGQSSEKTDVFGFGILLLELIS 495
T S +D + FG+ L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+ +G G FG V G + VAVK +K+G+ E +F E + + H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKL 65
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 417
++ G C +V Y+SNG + + L++ L+ + + G+ +L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-- 123
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYL 472
+ IHRD+ A N L+D V DFG+ + + D +V++ V+ + APE
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWS----APEVF 177
Query: 473 STGQSSEKTDVFGFGILLLELIS 495
+ S K+DV+ FGIL+ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 64/203 (31%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRN 357
+GKG FG+V G + G VAVK +K+ F E M L H N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLR-HSN 247
Query: 358 LLRLIGFCMTTTERLLVY---PYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYL 412
L++L+G E+ +Y YM+ GS+ R + + L + +L + YL
Sbjct: 248 LVQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 472
+HRD+ A N+L+ E A V DFGL K V+ T APE L
Sbjct: 306 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 358
Query: 473 STGQSSEKTDVFGFGILLLELIS 495
+ S K+DV+ FGILL E+ S
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+ + +G G FG V G + VA+K +K+G+ E +F E +++ H L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 81
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCD 417
++L G C ++ YM+NG + + L+ + + + YL +
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYL 472
+ +HRD+ A N L+++ V DFGL++ + D + ++ VR + PE L
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS----PPEVL 193
Query: 473 STGQSSEKTDVFGFGILLLELIS 495
+ S K+D++ FG+L+ E+ S
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 10/192 (5%)
Query: 308 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFC 365
G G +G VY+G + ++ VAVK LK+ +F E M + H NL++L+G C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLLGVC 285
Query: 366 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
++ +M+ G++ L+ + + +A + + YL ++ IHR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHR 342
Query: 424 DVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 483
++ A N L+ E + V DFGL++L+ + + APE L+ + S K+DV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 484 FGFGILLLELIS 495
+ FG+LL E+ +
Sbjct: 403 WAFGVLLWEIAT 414
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 21/199 (10%)
Query: 308 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
G+G FG+V++G VA+K K+ + +F E + H ++++LIG
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
T ++ + G + S L+ K SLD A+ A + L YL + + +H
Sbjct: 459 VI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVH 514
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPEYLSTGQ 476
RD+ A N+L+ +GDFGL++ ++ DS A ++ APE ++ +
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APESINFRR 568
Query: 477 SSEKTDVFGFGILLLELIS 495
+ +DV+ FG+ + E++
Sbjct: 569 FTSASDVWMFGVCMWEILM 587
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+G FG VY+G + T VA+K + + ++ I+F E ++ +++RL
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAK-------PSLDWATRKR---IALGAARGLLY 411
+G L++ M+ G + S L++ P L + + +A A G+ Y
Sbjct: 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---- 467
L+ K +HRD+ A N ++ E + +GDFG+ + + D +G G +
Sbjct: 154 LNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRW 206
Query: 468 -APEYLSTGQSSEKTDVFGFGILLLELIS 495
+PE L G + +DV+ FG++L E+ +
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 308 GKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
G G G V G L+ VA+K LK G F +E ++ H N++RL G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
++V YM NGS+ + L+ + G G+ YL + +H
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVH 174
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHIAPEYLSTGQ 476
RD+ A N+L+D V DFGL+++L D D+ TT +R T APE ++
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRT 230
Query: 477 SSEKTDVFGFGILLLELIS 495
S +DV+ FG+++ E+++
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 416
+RL T ++ YM NGS+ LK L +A A G+ ++ E+
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA------VRGTVGHIAPE 470
IHRD++AANIL+ + + DFGLA+L++ D+ T ++ T APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWT----APE 180
Query: 471 YLSTGQSSEKTDVFGFGILLLELIS 495
++ G + K+DV+ FGILL E+++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 308 GKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367
G G FG V+ T VAVK +K G+ F E ++ H L++L T
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 368 TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
++ +M+ GS+ LK+ + A G+ ++ ++ IHRD+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 310
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI---APEYLSTGQSSEKTD 482
+AANIL+ + DFGLA+++ + + TA G I APE ++ G + K+D
Sbjct: 311 RAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 483 VFGFGILLLELIS 495
V+ FGILL+E+++
Sbjct: 368 VWSFGILLMEIVT 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 308 GKGGFGNVYKGYLQDGTV-----VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
G G FG VYKG L+ + VA+K LK G + F E ++ H N++RL
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
G +++ YM NG++ L+ + G A G+ YL +
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYV 169
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHIAPEYLSTG 475
HRD+ A NIL++ V DFGL+++L D ++ TT+ +R T APE +S
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYR 225
Query: 476 QSSEKTDVFGFGILLLELIS 495
+ + +DV+ FGI++ E+++
Sbjct: 226 KFTSASDVWSFGIVMWEVMT 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 308 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 358
G+G FG V VAVK LKD +E+E M + H+N+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIA 402
+ L+G C ++ Y S G++ L+A+ + +
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 459
ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ +++ D + T
Sbjct: 164 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 460 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V+ APE L + ++DV+ FG+L+ E+ +
Sbjct: 221 LPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 62/209 (29%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHE 414
IG + + R ++ M+ G + S L+ SL +A A G YL E
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVV---GDFGLAKLLDHCDSHVTTAVRGTVGHI---- 467
IHRD+ A N LL V GDFG+A+ + +G +
Sbjct: 159 N---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPVKW 211
Query: 468 -APEYLSTGQSSEKTDVFGFGILLLELIS 495
PE G + KTD + FG+LL E+ S
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+GKG FG+V G + G VAVK +K+ F E +++ H NL
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 76
Query: 359 LRLIGFCMTTTERLLVY---PYMSNGSVAS--RLKAKPSLDWATRKRIALGAARGLLYLH 413
++L+G E+ +Y YM+ GS+ R + + L + +L + YL
Sbjct: 77 VQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIA 468
+HRD+ A N+L+ E A V DFGL K ++ T V+ T A
Sbjct: 135 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWT----A 182
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELIS 495
PE L + S K+DV+ FGILL E+ S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 308 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 358
G+G FG V VAVK LKD +E+E M + H+N+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK-----------RIA 402
+ L+G C ++ Y S G++ A R R
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 459
ARG+ YL Q K IHRD+ A N+L+ E + DFGLA+ +++ D + T
Sbjct: 210 YQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 460 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V+ APE L + ++DV+ FG+L+ E+ +
Sbjct: 267 LPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 15/211 (7%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 350
E + + + VG+G FG V++ Q G AVK+ + E+ E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVAC 104
Query: 351 SLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 410
+ ++ L G + + GS+ +K L A GL
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA----VRGTVG 465
YLH + +I+H DVKA N+LL + DFG A L + + GT
Sbjct: 165 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
H+APE + K D++ ++L +++G
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 304 KNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
++++G+G FG V K ++ A+KR+K+ + F E+E + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK----------------RIAL 403
L+G C L Y +G++ L+ L+ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
ARG+ YL ++ + IHRD+ A NIL+ E Y A + DFGL++ + V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 464 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELIS 495
+G + A E L+ + +DV+ +G+LL E++S
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
+N S +VG G FG V G L+ VA+K LK G F E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLH 413
H N++RL G + ++V YM NGS+ S L+ + G A G+ YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL-DHCDSHVTTA-----VRGTVGHI 467
+ +HRD+ A NIL++ V DFGL ++L D ++ TT +R T
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 468 APEYLSTGQSSEKTDVFGFGILLLELIS 495
+PE ++ + + +DV+ +GI+L E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 308 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNL 358
G+G FG V T VAVK LK +E+E M + H+N+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK-----------RIA 402
+ L+G C ++ Y S G++ A R + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 459
ARG+ YL + K IHRD+ A N+L+ E + DFGLA+ + H D + T
Sbjct: 198 YQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 460 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V+ APE L + ++DV+ FG+LL E+ +
Sbjct: 255 LPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 308 GKGGFGNVYKGYLQDGTV-VAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G G +G VY+G + ++ VAVK LK+ +F E ++ H NL++L+G C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 367 TTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRD 424
++ +M+ G++ L+ + + +A + + YL ++ IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 425 VKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VRGTVGHIAPEYLSTGQSSE 479
+ A N L+ E + V DFGL++L+ D++ A ++ T APE L+ + S
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT----APESLAYNKFSI 191
Query: 480 KTDVFGFGILLLELIS 495
K+DV+ FG+LL E+ +
Sbjct: 192 KSDVWAFGVLLWEIAT 207
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 36/217 (16%)
Query: 308 GKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 360
G+G FG V + VAVK LK+G +E++ +I + H N++
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 361 LIGFCMTTTE-RLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR-----------IAL 403
L+G C +++ + G++ + R + P +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA---- 459
A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 460 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
++ APE + + ++DV+ FG+LL E+ S
Sbjct: 213 PLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 27/206 (13%)
Query: 308 GKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
G+G F ++KG ++ T V +K L F M+S H++L+
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLV 75
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDP 418
G C+ E +LV ++ GS+ + LK K ++ + +A A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN--- 132
Query: 419 KIIHRDVKAANILLDEYYEAV--------VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+IH +V A NILL + + D G++ + + + PE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-KDILQERIPWV----PPE 187
Query: 471 YLSTGQS-SEKTDVFGFGILLLELIS 495
+ ++ + TD + FG L E+ S
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 62/209 (29%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G FG VY+G + VAVK L + + E+ F E +IS H+N++R
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKA-------KPSLDWATRKRIALGAARGLLYLHE 414
IG + + R ++ M+ G + S L+ SL +A A G YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVV---GDFGLAKLLDHCDSHVTTAVRGTVGHI---- 467
IHRD+ A N LL V GDFG+A+ + +G +
Sbjct: 200 N---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPVKW 252
Query: 468 -APEYLSTGQSSEKTDVFGFGILLLELIS 495
PE G + KTD + FG+LL E+ S
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 308 GKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 360
G G FG V + VAVK LK + +E++ M L H N++
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRK-------------RIALGAA 406
L+G C L++ Y G + + L+ K L+ + A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----VR 461
+G+ +L + IHRDV A N+LL + A +GDFGLA+ + + +++ V+
Sbjct: 175 QGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
APE + + ++DV+ +GILL E+ S
Sbjct: 232 WM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 37/218 (16%)
Query: 308 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 360
G G FG V + VAVK LK + +E++ + L H N++
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 361 LIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR-------------IA 402
L+G C L++ Y G + R S +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA--- 459
A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V
Sbjct: 152 YQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 460 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V+ APE + + ++DV+ +GI L EL S
Sbjct: 209 LPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
++GKG +G VY G L + +A+K +D E+ + H+N+++ +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLKHKNIVQYL 85
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA---RGLLYLHEQCDPK 419
G + + GS+++ L++K + I GL YLH+ +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 420 IIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS- 477
I+HRD+K N+L++ Y + + DFG +K L + T GT+ ++APE + G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 478 -SEKTDVFGFGILLLELISG 496
+ D++ G ++E+ +G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 34/215 (15%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+ FG VYKG+L VA+K LKD +F+ E + + H N++ L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGA 405
+G +++ Y S+G + L K +L+ +
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----V 460
A G+ YL ++H+D+ N+L+ + + D GL + + D + +
Sbjct: 138 AAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R APE + G+ S +D++ +G++L E+ S
Sbjct: 195 RWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 308 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+G FG V+ +D +VAVK LKD + FQ E E+++ H ++++
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKF 82
Query: 362 IGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSLDWATRKR-----------IALGA 405
G C ++V+ YM +G A A +D R+ IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----V 460
A G++YL Q +HRD+ N L+ +GDFG+++ + D + +
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R PE + + + ++DV+ FG++L E+ +
Sbjct: 200 RWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 53/206 (25%), Positives = 78/206 (37%), Gaps = 17/206 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--- 354
+F + +G G +G V+K +DG + AVKR + + E+ S
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQ 115
Query: 355 HRNLLRLIGFCMTTTERLLVYPYM--SNGSVASRLKAKP-SLDWATRKRIALGAARGLLY 411
H +RL +Y S+ +A SL A L +
Sbjct: 116 HPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
LH Q ++H DVK ANI L +GDFGL L + G ++APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPEL 227
Query: 472 LSTGQSSEKTDVFGFGILLLELISGL 497
L G DVF G+ +LE+ +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 15/198 (7%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+GKGGF ++ V A K L + + E+ + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVV 104
Query: 360 RLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
G + + +V S+ K + +L + G YLH
Sbjct: 105 GFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
++IHRD+K N+ L+E E +GDFGLA +++ GT +IAPE LS S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 219
Query: 479 EKTDVFGFGILLLELISG 496
+ DV+ G ++ L+ G
Sbjct: 220 FEVDVWSIGCIMYTLLVG 237
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 15/198 (7%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
+GKGGF ++ V A K L + + E+ + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVV 78
Query: 360 RLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
G + + +V S+ K + +L + G YLH
Sbjct: 79 GFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
++IHRD+K N+ L+E E +GDFGLA +++ GT +IAPE LS S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHS 193
Query: 479 EKTDVFGFGILLLELISG 496
+ DV+ G ++ L+ G
Sbjct: 194 FEVDVWSIGCIMYTLLVG 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 6/200 (3%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
F+ +GKG FG V+KG + VVA+K + A Q E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
+ + G + T+ ++ Y+ GS L+ P LD I +GL YLH +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE- 138
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
K IHRD+KAAN+LL E+ E + DFG+A L T V GT +APE +
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA 195
Query: 477 SSEKTDVFGFGILLLELISG 496
K D++ GI +EL G
Sbjct: 196 YDSKADIWSLGITAIELARG 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+G FG V+ + +VAVK LK+ + FQ E E++++ H++++R
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQHIVRF 108
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKA-KPSLDWATRKR--------------IALGAA 406
G C L+V+ YM +G + L++ P +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
G++YL +HRD+ N L+ + +GDFG+++ + D G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRTM 221
Query: 467 I-----APEYLSTGQSSEKTDVFGFGILLLELIS 495
+ PE + + + ++DV+ FG++L E+ +
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 42/223 (18%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 360
G G FG V VAVK LK+ +E++ M L H N++
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 361 LIGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRKR--------------- 400
L+G C + L++ Y G + + R K ++
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 401 ---IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457
A A+G+ +L + +HRD+ A N+L+ + DFGLA+ + ++V
Sbjct: 174 LLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 458 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
V+ APE L G + K+DV+ +GILL E+ S
Sbjct: 231 RGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 48/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++F +G+GGFG V++ D A+KR++ N + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 358 LLRLIGFCMTTTERLLVYP------------YMSNGSVASRLKAK---PSLDWATRKRIA 402
++R + + P ++ + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR- 461
L A + +LH + ++HRD+K +NI VGDFGL +D + T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 462 ----------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 494
GT +++PE + S K D+F G++L EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+G FG V K T VAVK LK+ + +E ++ H ++++L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 362 IGFCMTTTERLLVYPYMSNGSV-----ASRLKAKPSLDWATRK----------------- 399
G C LL+ Y GS+ SR L +
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 400 --RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457
A ++G+ YL E K++HRD+ A NIL+ E + + DFGL++ + DS+V
Sbjct: 152 LISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 458 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
+ V+ A E L + ++DV+ FG+LL E+++
Sbjct: 209 RSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 51/242 (21%), Positives = 97/242 (40%), Gaps = 28/242 (11%)
Query: 274 NEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKD 333
+ + +F+ + +S +G GG V++ + + A+K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 334 GNAIGGEIQ-FQTEVEMISLAVHRNL--LRLIGFCMTTTERLLVYPYM--SNGSVASRLK 388
A + ++ E+ ++ + +RL + +T +Y M N + S LK
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLK 119
Query: 389 AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLA 446
K S+D RK + +H+ I+H D+K AN L+ + ++ DFG+A
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV---DGMLKLIDFGIA 173
Query: 447 KLL-DHCDSHVTTAVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELI 494
+ S V + GTV ++ PE + S + S K+DV+ G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 495 SG 496
G
Sbjct: 234 YG 235
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
+F L+G GGFG V+K DG +KR+K N + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVN 65
Query: 358 LLRLIGFCMTTTERLLVYP----------------YMSNGSVASRLKAKPS--LDWATRK 399
++ G + G++ ++ + LD
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459
+ +G+ Y+H + K+I+RD+K +NI L + + +GDFGL L + D T +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRS 181
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498
GT+ +++PE +S+ ++ D++ G++L EL+
Sbjct: 182 K-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 24/225 (10%)
Query: 285 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF 343
+ +F+ ++ + +G+G FG +DG +K + E +
Sbjct: 14 GTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 344 -QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--------LD 394
+ EV +++ H N+++ +V Y G + R+ A+ LD
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 395 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454
W + I L L ++H++ KI+HRD+K+ NI L + +GDFG+A++L+
Sbjct: 130 WFVQ--ICLA----LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499
+ GT +++PE + K+D++ G +L EL + A
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVH 355
++ + ++G G V Y VA+KR L+ E+ E++ +S H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHH 72
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR-----IAL---GAAR 407
N++ + E LV +S GSV +K + IA
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT-VGH 466
GL YLH+ IHRDVKA NILL E + DFG++ L VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 467 ---IAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
+APE + + K D++ FGI +EL +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 308 GKGGFGNVYKGYLQDG------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+G FG V++ T+VAVK LK+ + + FQ E +++ + N+++L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 362 IGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSLDWATRK----------------- 399
+G C L++ YM+ G + SL +
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 400 --RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457
IA A G+ YL E+ K +HRD+ N L+ E + DFGL++ + D
Sbjct: 176 QLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---- 228
Query: 458 TAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIS 495
I PE + + + ++DV+ +G++L E+ S
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 60/201 (29%), Positives = 87/201 (43%), Gaps = 9/201 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVH 355
+F +GKG FGNVY Q ++A+K L G E Q + EVE+ S H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
N+LRL G+ T L+ Y G+V L+ D A L Y H +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
++IHRD+K N+LL E + DFG + GT+ ++ PE +
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLC--GTLDYLPPEMIEGR 182
Query: 476 QSSEKTDVFGFGILLLELISG 496
EK D++ G+L E + G
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG 203
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL--LRL 361
+G GG V++ + + A+K + A + ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 362 IGFCMTTTERLLVYPYM--SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+ +T +Y M N + S LK K S+D RK + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 420 IIHRDVKAANILLDEYYEAVV--GDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYL---- 472
I+H D+K AN L+ + ++ DFG+A + S V + GTV ++ PE +
Sbjct: 129 IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 473 -------STGQSSEKTDVFGFGILLLELISG 496
S + S K+DV+ G +L + G
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNL--LRL 361
+G GG V++ + + A+K + A + ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 362 IGFCMTTTERLLVYPYM--SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+ +T +Y M N + S LK K S+D RK + +H+
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 420 IIHRDVKAANILLDEYYEAVV--GDFGLAKLL-DHCDSHVTTAVRGTVGHIAPEYLS--- 473
I+H D+K AN L+ + ++ DFG+A + S V + G V ++ PE +
Sbjct: 176 IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 474 --------TGQSSEKTDVFGFGILLLELISG 496
+ S K+DV+ G +L + G
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 36/230 (15%)
Query: 298 TSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
S+F ++G+G FG V K D A+K+++ + +EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 357 NLLRLIGFCMTTTERLLVYP-------------YMSNGSVASRLKAKPS-LDWATRKRIA 402
++R + + Y NG++ + ++ R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC---------- 452
L Y+H Q IIHRD+K NI +DE +GDFGLAK +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 453 ----DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELISGL 497
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 43/214 (20%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVH 355
+NF + +G+G F VY+ L DG VA+K+++ + + + E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------LDWATRKRIALGA 405
N+++ + E +V G ++ +K + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ--LCSA- 148
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
L ++H + +++HRD+K AN+ + +GD GL + + + V GT
Sbjct: 149 ---LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499
+++PE + + K+D++ G LL E+ +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 30/204 (14%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
GKG F VY+ + G VA+K + + Q EV++ H ++L L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM---VQRVQNEVKIHCQLKHPSILEL 76
Query: 362 IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYL 412
+ + LV NG + LK + K + AR G+LYL
Sbjct: 77 YN-YFEDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYL 128
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 472
H I+HRD+ +N+LL + DFGLA L T GT +I+PE
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIA 184
Query: 473 STGQSSEKTDVFGFGILLLELISG 496
+ ++DV+ G + L+ G
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIG 208
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 48/234 (20%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 295 QSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 349
S ++++ +G G FG+V+K DG + A+KR K A + Q E+
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREV 61
Query: 350 ISLAV---HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKA----KPSLDWATRKRIA 402
+ AV H +++R L+ Y + GS+A + A K +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----------------YYEAVV--GDF 443
L RGL Y+H ++H D+K +NI + + + GD
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 444 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
G + G +A E L + K D+F + ++
Sbjct: 179 GHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 43/214 (20%), Positives = 73/214 (34%), Gaps = 19/214 (8%)
Query: 298 TSNFSSKNLVGKG--GFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLA 353
+ ++GKG V G V V+R+ + F Q E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIAL---GAARGLL 410
H N++ + E +V +M+ GS + D IA G + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALD 142
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI--- 467
Y+H +HR VKA++IL+ + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 468 ---APEYLSTGQS--SEKTDVFGFGILLLELISG 496
+PE L K+D++ GI EL +G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 24/225 (10%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 350
+ ++ +G+GGF V L DG A+KR+ E + Q E +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 351 SLAVHRNLLRLIGFCMTTTER----LLVYPYMSNGSVA----SRLKAKPSLDWATRKRIA 402
L H N+LRL+ +C+ L+ P+ G++ L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR- 461
LG RGL +H HRD+K NILL + + V+ D G A+
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 462 -------GTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISG 496
T+ + APE S E+TDV+ G +L ++ G
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 32/215 (14%)
Query: 308 GKGGFGNVYKGYLQDGTVVAVKRLK----------------DGNAIGGEIQFQTEVEMIS 351
+G F + +D A+K+ + + F+ E+++I+
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR---- 407
+ L G E ++Y YM N S+ + LD I + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 408 ----GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
Y+H + + I HRDVK +NIL+D+ + DFG ++ + D + + GT
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR-GT 213
Query: 464 VGHIAPEYLST--GQSSEKTDVFGFGILLLELISG 496
+ PE+ S + K D++ GI L +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLA 353
S ++ +G G +G K DG ++ K L G+ E Q +EV ++
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 354 VHRNLLRLIG-FCMTTTERL-LVYPYMSNGSVASRLKAKPS----------LDWATRKRI 401
H N++R T L +V Y G +AS + L T+ +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ--L 120
Query: 402 ALGAARGLLYLHEQCDP--KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459
L L H + D ++HRD+K AN+ LD +GDFGLA++L+H S T
Sbjct: 121 TLA----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF 176
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499
V GT +++PE ++ +EK+D++ G LL EL + +
Sbjct: 177 V-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 40/228 (17%), Positives = 77/228 (33%), Gaps = 27/228 (11%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQT 345
E Q + +L+G+G F VY+ ++ +K K N I Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDW-----ATRKR 400
+E + ++ ++ + +LV S G++ + + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG-----------DFGLAKLL 449
A+ + +H+ +IIH D+K N +L + D G + +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 450 DHC-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ TA T G E LS + + D FG + ++ G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 25/126 (19%), Positives = 49/126 (38%), Gaps = 7/126 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 140
+ + L++L+++ + N+ + +I +L L LDLS P+ +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNIT 194
L +LQ L +++N+ ++ L LD S N++ N+T
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 195 GNSLIC 200
N C
Sbjct: 552 QNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 6/123 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L S S + LQ++ L I LS L TL L+ N S
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF-----HAKTFNITG 195
L +LQ L +L + ++ L L++++N + S +P + + + +++
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 196 NSL 198
N +
Sbjct: 159 NKI 161
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 7/126 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 138
S N T+SS+ L L+ + Q++N+ + L L+ LD+S+
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 139 VSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVP-SFHA----KTFN 192
+ L +L+ L++ NS P + + L FLDLS L P +F++ + N
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 193 ITGNSL 198
++ N+
Sbjct: 501 MSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 25/109 (22%), Positives = 48/109 (44%), Gaps = 5/109 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVS 140
+ + L++LQ ++ N++ IG L L L++++N +P S
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLSGPVPS 185
+L L++L L++N + L + Q+ LDLS N ++ P
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-20
Identities = 20/101 (19%), Positives = 29/101 (28%), Gaps = 1/101 (0%)
Query: 87 LSSSIGNL-TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
NL + + + L N + +L LDLS L L
Sbjct: 19 FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
L L N + + S +S L L NL+
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
NL+ + IG+L L+ + + +N I S +P L+ L LDLS+N + +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 141 HLETLQY----LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L + L L+ N + P + + L L L N S V
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMK 218
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 21/121 (17%), Positives = 38/121 (31%), Gaps = 28/121 (23%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L ++ +L++LQ++ + +NN L+ L LD S N + H
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 142 LET-LQYLRLNNNSLTG--------------------------AIPPSLSNMSQLAFLDL 174
+ L +L L N A P M + L++
Sbjct: 541 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNI 599
Query: 175 S 175
+
Sbjct: 600 T 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 27/142 (19%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--------- 132
+ LTN+ L + I L+L N F
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 133 ----------GPIPSTVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLS 180
G + L +L++L L+ N L+ G S + L +LDLS+N +
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 181 GPVPSFHA----KTFNITGNSL 198
+F + + ++L
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 24/136 (17%), Positives = 46/136 (33%), Gaps = 20/136 (14%)
Query: 82 NLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 137
+ + + L + L+ L N ++ I K +L L L NNF + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 138 TVSH-LETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG----PVPSF 186
T L L+ RL N +L +L + L + L + F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 187 HA----KTFNITGNSL 198
+ +F++ ++
Sbjct: 279 NCLTNVSSFSLVSVTI 294
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 28/131 (21%), Positives = 41/131 (31%), Gaps = 24/131 (18%)
Query: 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQ---NNNISGHIPTEIGKLSKLLTLDLSN 128
LV G NL S++ L NL + + + I L+ + + L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 129 NFFTGPIPSTVSHLETLQYLRLNNNSLT-------------------GAIPPSLSNMSQL 169
S+ Q+L L N G S ++ L
Sbjct: 292 VTIERVKDF--SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
Query: 170 AFLDLSYNNLS 180
FLDLS N LS
Sbjct: 350 EFLDLSRNGLS 360
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 20/115 (17%), Positives = 33/115 (28%), Gaps = 10/115 (8%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPST 138
S N + L + L+NN S ++ I L+ L L F
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 139 V---SHLETLQYLRLNNNSLT------GAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
S LE L L + L I + ++ ++ L +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 16/127 (12%), Positives = 31/127 (24%), Gaps = 12/127 (9%)
Query: 82 NLSGTL-SSSIGNLTNLQLVLLQNNNISGHI---PTEIGKLSKLLTLDLSNN------FF 131
S + + I L L++ L + L L L + ++
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 132 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 191
I + L + L + ++ S L+L
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 192 NITGNSL 198
+T S
Sbjct: 329 RLTFTSN 335
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 13/130 (10%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--------G 133
T NL +L V + N +PT + L ++ ++++ N
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 134 PIPSTVSHLETLQYLRLNNNSL-TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---- 188
+ E +Q + + N+L T + SL M +L L+ YN L G +P+F +
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKL 355
Query: 189 KTFNITGNSL 198
+ N+ N +
Sbjct: 356 ASLNLAYNQI 365
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 26/131 (19%), Positives = 50/131 (38%), Gaps = 15/131 (11%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNI--------SGHIPTEIGKLSKLLTLDLS-NNFFT 132
L + + L +QL+ + N + K+ + + NN T
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
Query: 133 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKT-- 190
P+ +++ ++ L L N L G P+ + +LA L+L+YN ++ +F T
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 191 ---FNITGNSL 198
+ N L
Sbjct: 379 VENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 23/100 (23%), Positives = 45/100 (45%), Gaps = 4/100 (4%)
Query: 84 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 143
+ + +S+ + L ++ N + G +P G KL +L+L+ N T + E
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 144 TLQYLRLNNNSLTGAIPPSLS--NMSQLAFLDLSYNNLSG 181
++ L +N L IP ++S ++ +D SYN +
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 14/155 (9%)
Query: 76 LGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGP 134
+ + +Q++ + NN+ + + T + K+ KL L+ N G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 135 IPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHA----- 188
+P+ L L L N +T IP + Q+ L ++N L F A
Sbjct: 346 LPA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV 403
Query: 189 -KTFNITGNSLICATGAEEDCFGTAPMPLSFALNN 222
+ + N + + F P F N
Sbjct: 404 MSAIDFSYNEI---GSVDGKNFDPLD-PTPFKGIN 434
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 24/131 (18%), Positives = 47/131 (35%), Gaps = 12/131 (9%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPS 137
+N + + N L + L+ N ++ + + L L+ +DLS N F+ P+
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 138 TVSHLETLQYLRLNN------NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF--HAK 189
+ TL+ + N N P ++ L L + N++ +
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS 590
Query: 190 TFNITGNSLIC 200
+I N I
Sbjct: 591 VLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-22
Identities = 27/140 (19%), Positives = 48/140 (34%), Gaps = 11/140 (7%)
Query: 52 NWDENSVDPCSWAL---VTC-SDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNI 107
NW+ N + W V+ S+G VTGL SG + +IG LT L+++ L ++
Sbjct: 59 NWNFNK-ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 108 SG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET--LQYLRLNNNSLTGAIPP 161
P I + + L +N++ +I
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 162 SLSNMSQLAFLDLSYNNLSG 181
S + + NN++
Sbjct: 178 SSRITLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-22
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 10/115 (8%)
Query: 76 LGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-- 133
+G+ L + N+ + L NN IS S L +++L N T
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 134 -----PIPSTVSHLETLQYLRLNNNSLTGAIPPSL--SNMSQLAFLDLSYNNLSG 181
+ L + L N LT + + + L +DLSYN+ S
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 23/131 (17%), Positives = 42/131 (32%), Gaps = 20/131 (15%)
Query: 88 SSSIGNLTNLQLVLLQNNNISG-------HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
+++ + + N I + K + +++LSNN + S
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 141 HLETLQYLRLNNNSLTG-------AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----- 188
L + L N LT + N L +DL +N L+ F A
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514
Query: 189 -KTFNITGNSL 198
+++ NS
Sbjct: 515 LVGIDLSYNSF 525
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 19/109 (17%), Positives = 42/109 (38%), Gaps = 10/109 (9%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIP--TEIGKLSKLLTLDLSNNFFTG------ 133
++ ++ G ++ + +N + IP + +S + +D S N
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 134 -PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
P+ T + + L+NN ++ S S L+ ++L N L+
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 21/161 (13%), Positives = 44/161 (27%), Gaps = 7/161 (4%)
Query: 32 EVQALMGIKDSLHDPHDVLNN-WDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGTLSSS 90
V + + L WD + S G S
Sbjct: 17 IVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVS 76
Query: 91 IGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQ 146
+ + + + L+ SG +P IG+L++L L L ++ P +S + +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 147 YLRLNNNSLTGAIPPSLS--NMSQLAFLDLSYNNLSGPVPS 185
+ + S L ++ + +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 18/134 (13%), Positives = 39/134 (29%), Gaps = 28/134 (20%)
Query: 80 SQNLSGTLSSSIGNLTNLQ-------------------LVLLQNNNISGHIPTEIGKLSK 120
N +S ++ LT L+ + + L
Sbjct: 191 LSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD 250
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA--------IPPSLSNMSQLAFL 172
L +++ N +P+ + L +Q + + N ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 173 DLSYNNL-SGPVPS 185
+ YNNL + PV +
Sbjct: 311 YIGYNNLKTFPVET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 19/125 (15%), Positives = 39/125 (31%), Gaps = 11/125 (8%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S ++ S + +NNI+ + + +L+KL + N+ F
Sbjct: 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA 226
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK-----TFNIT 194
E +Y + N+ L +++ +P+F N+
Sbjct: 227 WENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 195 GNSLI 199
N I
Sbjct: 282 CNRGI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 19/105 (18%), Positives = 36/105 (34%), Gaps = 10/105 (9%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN------NFFTGPIPSTVSH 141
L L + L N+ S PT+ S L + N N P ++
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
+L L++ +N + + + ++ LD+ N S+
Sbjct: 565 CPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 14/109 (12%), Positives = 29/109 (26%), Gaps = 13/109 (11%)
Query: 82 NLSG----TLSSSIGNLTNLQ-LVLLQN-----NNISGHIPTEIGKLSKLLTLDLSNNFF 131
+LS + N + L+ + N P I L L + +N
Sbjct: 519 DLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 132 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + + L + +N + + L Y+
Sbjct: 579 RK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVE-MISLAVHRN 357
+F K+++G G G + + D VAVKR L + + EV+ + H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPN 79
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQC 416
++R + + + ++ ++ K + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 417 DPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLLDHCDS--HVTTAVRGTVGHIAP 469
I+HRD+K NIL+ A++ DFGL K L + V GT G IAP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 470 EYLSTGQS---SEKTDVFGFGILLLELISG 496
E LS + D+F G + +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 9/194 (4%)
Query: 306 LVGKGGFGNVYKG-YLQDGTVVAVKRL--KDGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+GKG FGNVY Q+ ++A+K L G E Q + E+E+ S H N+LR+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ L+ + G + L+ D A L Y HE+ K+IH
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIH 137
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+K N+L+ E + DFG + H S + GT+ ++ PE + EK D
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 483 VFGFGILLLELISG 496
++ G+L E + G
Sbjct: 195 LWCAGVLCYEFLVG 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVH 355
F +G+G +G+VYK + G +VA+K++ + ++Q E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDS 83
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHE 414
++++ G T+ +V Y GSV+ ++ + L I +GL YLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+ IHRD+KA NILL+ A + DFG+A L + T + GT +APE +
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 475 GQSSEKTDVFGFGILLLELISG---------LRAL 500
+ D++ GI +E+ G +RA+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 34/243 (13%)
Query: 284 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ 342
+L L+ F LVG G +G VYKG ++ G + A+K + + G E +
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEE 65
Query: 343 -FQTEVEMIS-LAVHRNLLRLIG-----FCMTTTERL-LVYPYMSNGSVASRLKAKPSLD 394
+ E+ M+ + HRN+ G ++L LV + GSV +K +
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-N 124
Query: 395 WATRKRIAL---GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451
+ IA RGL +LH+ K+IHRD+K N+LL E E + DFG++ LD
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELISG---------L 497
T + GT +APE ++ ++ + K+D++ GI +E+ G +
Sbjct: 182 TVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 498 RAL 500
RAL
Sbjct: 241 RAL 243
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
++ +G+G G VY + G VA++++ E+ E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
N++ + + E +V Y++ GS+ + +D + + L +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN- 135
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 477 SSEKTDVFGFGILLLELISG---------LRAL 500
K D++ GI+ +E+I G LRAL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 52/191 (27%), Positives = 92/191 (48%), Gaps = 6/191 (3%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC 365
+G G G V+K + G V+A K + Q E++++ ++ G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 366 MTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425
+ E + +M GS+ LK + ++++ +GL YL E+ KI+HRDV
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDV 158
Query: 426 KAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 485
K +NIL++ E + DFG++ L DS + V GT +++PE L S ++D++
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWS 215
Query: 486 FGILLLELISG 496
G+ L+E+ G
Sbjct: 216 MGLSLVEMAVG 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
S +G+G G V G VAVK + E+ EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHF 102
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
N++ + + E ++ ++ G++ + L+ + + L YLH Q
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
+IHRD+K+ +ILL + DFG + + V GT +APE +S
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217
Query: 477 SSEKTDVFGFGILLLELISG---------LRAL 500
+ + D++ GI+++E++ G ++A+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 301 FSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAVHRN 357
+ +G G FG VYK + G + A K K + + E+E+++ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPY 77
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQC 416
+++L+G + ++ + G+V + + L + + L +LH +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
+IIHRD+KA N+L+ + + DFG++ + + GT +APE +
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCET 193
Query: 477 SSE-----KTDVFGFGILLLELISG---------LRAL 500
+ K D++ GI L+E+ +R L
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 29/232 (12%), Positives = 63/232 (27%), Gaps = 44/232 (18%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK---------------------------RLKDGNAI 337
++G+ + + G V +K+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 338 GGEIQFQTEVEMISLAVHRNLLRLIGF--CMTTTERLLVYPYMSN------GSVASRLKA 389
++F +++ + ++R+ M R +YP M + + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 390 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449
SL R ++ L R L LH ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 450 DHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISG 496
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 29/238 (12%), Positives = 67/238 (28%), Gaps = 55/238 (23%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK---------------------------RLKDGNAI 337
++G+ + + G V +K+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 338 GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVYPYMSN------GSVASRLKA 389
++F +++ + ++R+ R +YP M + + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 390 KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449
SL R ++ L R L LH ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGILLLELISG 496
+ G PE + + + D + G+++ +
Sbjct: 257 GA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 23/220 (10%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
++ + +++G+G NV++G + G + A+K + + + E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 354 VHRNLLRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---ARG 408
H+N+++L TT R L+ + GS+ + L+ + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAVRGTV 464
+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTE 179
Query: 465 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELISG 496
++ P+ D++ G+ +G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 55/233 (23%), Positives = 86/233 (36%), Gaps = 39/233 (16%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLA 353
QS + S+ ++G G G V G VAVKR+ E++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESD 66
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR------ 407
H N++R T + N ++ +++K D + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 408 -GLLYLHEQCDPKIIHRDVKAANILLD-------------EYYEAVVGDFGLAKLLDHCD 453
G+ +LH KIIHRD+K NIL+ E ++ DFGL K LD
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 454 SHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELISG 496
S T + GT G APE L + + D+F G + ++S
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 24/241 (9%), Positives = 53/241 (21%), Gaps = 44/241 (18%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEM 349
L + G V+ ++ A+K + N+ +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 350 ISLAVHRNLLRLIGFC--------------------------MTTTERLLVYPYM--SNG 381
+ + + LL+ P
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 382 SVASRLKAKPS----LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437
+ S L + R L + ++H N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232
Query: 438 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELIS 495
++GD A V + E+L ST + + + G+ + +
Sbjct: 233 LMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 496 G 496
Sbjct: 289 L 289
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 43/201 (21%), Positives = 73/201 (36%), Gaps = 21/201 (10%)
Query: 306 LVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+ GG G +Y +G V +K L + E + ++ VH +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 364 FCMTTTERLLVYPYM-----SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
F T Y+ S+ K + A L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLHSI--- 201
Query: 419 KIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
+++ D+K NI+L E E + + D G ++ + GT G APE +
Sbjct: 202 GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVRTGP 253
Query: 478 SEKTDVFGFGILLLELISGLR 498
+ TD++ G L L L
Sbjct: 254 TVATDIYTVGRTLAALTLDLP 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 28/217 (12%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIG 363
++ +GGF VY+ + G A+KRL N EV M L+ H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 364 FCMTTTER-------LLVYPYMSNGSVAS---RLKAKPSLDWATRKRIALGAARGLLYLH 413
E L+ + G + +++++ L T +I R + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-----------VRG 462
Q P IIHRD+K N+LL + DFG A + H + +A
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 463 TVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISG 496
T + PE + + EK D++ G +L L
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 41/220 (18%), Positives = 87/220 (39%), Gaps = 23/220 (10%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
++ + +++G+G NV++G + G + A+K + + + E E++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 354 VHRNLLRLIGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRK---RIALGAARG 408
H+N+++L TT R L+ + GS+ + L+ + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAVRGTV 464
+ +L E I+HR++K NI+ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-GTE 179
Query: 465 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELISG 496
++ P+ D++ G+ +G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 27/122 (22%), Positives = 46/122 (37%), Gaps = 5/122 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L +++ + L + + N IS P KL L L+L +N + T +
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGN 196
L L L +NS+ L LDLS+N LS + + + ++ N
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 197 SL 198
+
Sbjct: 156 KI 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 27/133 (20%), Positives = 48/133 (36%), Gaps = 14/133 (10%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNIS--------GHIPTEIGKLSKLLTLDLSNNFFTG 133
N++ + L L+++ LQ+NN++ G + LS L L+L +N F
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 134 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----- 188
L L+ + L N+L +N L L+L N ++
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 189 -KTFNITGNSLIC 200
++ N C
Sbjct: 611 LTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 32/109 (29%), Positives = 44/109 (40%), Gaps = 5/109 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPSTV 139
LS T + L NLQ +LL NN I E+ S L L+LS+N P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLS---NMSQLAFLDLSYNNLSGPVPS 185
+ L L LNN L ++ L + + L LS + LS +
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-19
Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 18/135 (13%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF---------FT 132
NL+ + S L L+ L+ NNI + L + L+L +F
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 133 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---- 188
+ L+ L++L + +N + G + + L +L LS + S +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 189 -----KTFNITGNSL 198
N+T N +
Sbjct: 379 AHSPLHILNLTKNKI 393
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 20/92 (21%), Positives = 39/92 (42%)
Query: 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153
TN+ ++ L +N + + S+L +LD+ N + P L L+ L L +N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 154 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L+ + + + L L L N++ +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 27/110 (24%), Positives = 41/110 (37%), Gaps = 10/110 (9%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+S + +LQ ++L+ + P+ L L LDLSNN +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 140 SHLETLQYLRLNNNSLT--------GAIPPSLSNMSQLAFLDLSYNNLSG 181
LE L+ L L +N+L G L +S L L+L N
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 1/104 (0%)
Query: 79 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
G + L++L ++ L++N L +L +DL N S
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLS-NMSQLAFLDLSYNNLSG 181
++ +L+ L L N +T L LD+ +N
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 26/114 (22%), Positives = 40/114 (35%), Gaps = 4/114 (3%)
Query: 76 LGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF--FTG 133
+L S L L+ + +++N+I G L L L LSN+F
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 134 PIPSTVSHLET--LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
T L L L L N ++ + S + L LDL N + +
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG----KLSKLLTLDLSNNFFTGPIPS 137
++ G S+ L NL+ + L N+ S T S L L+L+ N +
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 138 TVSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG 181
S L L+ L L N + + + + + LSYN
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-18
Identities = 22/114 (19%), Positives = 36/114 (31%), Gaps = 8/114 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 151
+ L ++ L N IS L L LDL N + LE + + L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNITGNSL 198
N S + + L L L L S +++ N++
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 23/105 (21%), Positives = 43/105 (40%), Gaps = 5/105 (4%)
Query: 82 NLSGTLSSSIG---NLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIP 136
L +L+ + T+++ + L N+ +S T K + L LDLS N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 137 STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+ + L L+Y L N++ SL + + +L+L +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 22/99 (22%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-LSKLLTLDLSNNFFTGPIPSTVS 140
NL+ +S N +L+ + LQ N I+ G L LD+ N F S
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 141 HLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLS 175
+ + N L+ PP + D S
Sbjct: 631 FVNWINETHTNIPELSSHYLCNTPPHYHGFP-VRLFDTS 668
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 64/219 (29%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKR--LKDGNAIGGEIQFQTEVEMISLAV 354
FS +G G FG VY +++ VVA+K+ + EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 413
H N ++ G + LV Y GS + L+ L + GA +GL YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
+IHRDVKA NILL E +GDFG A ++ +S V GT +APE +
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223
Query: 474 TGQSSE---KTDVFGFGILLLELISG---------LRAL 500
+ K DV+ GI +EL + AL
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+ K +G GGFG V + G VA+K+ + + ++ E++++ H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 359 LRLI------GFCMTTTERLLVYPYMSNGSVASRLKAK---PSLDWATRKRIALGAARGL 409
+ LL Y G + L L + + + L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGH 466
YLHE +IIHRD+K NI+L + + + D G AK LD T V GT+ +
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTEFV-GTLQY 189
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+APE L + + D + FG L E I+G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 25/132 (18%), Positives = 44/132 (33%), Gaps = 17/132 (12%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP------- 134
S NL +L V L N +P + L +L +L+++ N
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 135 --IPSTVSHLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPSFHA-- 188
+ +Q + N+L P S L M +L LD +N + + +F
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNV 595
Query: 189 --KTFNITGNSL 198
+ N +
Sbjct: 596 KLTDLKLDYNQI 607
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 22/130 (16%), Positives = 38/130 (29%), Gaps = 28/130 (21%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG-------------------HIPTEIGKLSK 120
N +S +I LT LQ++ N+ + + L
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG---------AIPPSLSNMSQLAF 171
L ++L N +P + L LQ L + N + ++
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 172 LDLSYNNLSG 181
+ YNNL
Sbjct: 553 FYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 21/130 (16%), Positives = 43/130 (33%), Gaps = 12/130 (9%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPS 137
+N + N L + L+ N ++ + + L L +D+S N F+ P+
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
Query: 138 TVSHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-K 189
+ L+ + N + P ++ L L + N++
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLY 830
Query: 190 TFNITGNSLI 199
+I N I
Sbjct: 831 ILDIADNPNI 840
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-18
Identities = 22/113 (19%), Positives = 44/113 (38%), Gaps = 5/113 (4%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
S+S+ + L L+ +N + H+ G KL L L N + + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEG 623
Query: 148 LRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 198
L ++N L IP + ++ + +D SYN + + + G +
Sbjct: 624 LGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 4e-17
Identities = 25/129 (19%), Positives = 45/129 (34%), Gaps = 13/129 (10%)
Query: 79 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE--IGKLSKLLTLDLSNNFFTGPIP 136
+ L+ +Q+ + NN+ P + K+ KL LD +N
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HL 588
Query: 137 STVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHA------K 189
L L+L+ N + IP + Q+ L S+N L F+A
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG 647
Query: 190 TFNITGNSL 198
+ + + N +
Sbjct: 648 SVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 20/128 (15%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP------- 134
+ + N I+ I I +L+KL + +N+ FT
Sbjct: 412 PEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
Query: 135 ------------IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182
+ S+L+ L + L N +P L ++ +L L+++ N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 183 VPSFHAKT 190
T
Sbjct: 531 AQLKADWT 538
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-16
Identities = 12/103 (11%), Positives = 34/103 (33%), Gaps = 9/103 (8%)
Query: 86 TLSSSIG-NLTNLQLVLLQNNNISGHIP--TEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
+ ++ + +N + IP + + ++D S N + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 143 ET-----LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + L+ N + + S ++ + LS N ++
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 25/195 (12%), Positives = 54/195 (27%), Gaps = 36/195 (18%)
Query: 39 IKDSLHDPHDVLNNWDENSVDPCSWALVTC----SDGLVTGLGAPSQNLSGTLSSSIGNL 94
+ NW+ N + W ++G VTGL G + +IG L
Sbjct: 288 YYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 95 TNLQLVLLQNNNISGHIP-------------------------TEIGKLSKLLTLDLSNN 129
T L+++ ++ + + +L DL +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 130 FFT-----GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
PI + N +T I ++ +++L + + + +
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 185 SFHAKTFNITGNSLI 199
+ + N
Sbjct: 466 AVDWEDANSDYAKQY 480
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 8e-15
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 9/107 (8%)
Query: 80 SQNLSGTLSSSIGNLTNLQ-LVLLQN-----NNISGHIPTEIGKLSKLLTLDLSNNFFTG 133
S N + + N + L+ + N I PT I L+ L + +N
Sbjct: 761 SYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
Query: 134 PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + L L + +N S+ + L Y+
Sbjct: 821 -VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 11/111 (9%), Positives = 30/111 (27%), Gaps = 1/111 (0%)
Query: 75 GLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP 134
L + ++ + N + + ++ ++ L L+ G
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 135 IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+P + L L+ L +S T + + + +
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 6/194 (3%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRLI 362
+G GG VY VA+K + E F+ EV S H+N++ +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
LV Y+ +++ +++ L T G+ + H+ +I+H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVH 134
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+K NIL+D + DFG+AK L T V GTV + +PE + E TD
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 483 VFGFGILLLELISG 496
++ GI+L E++ G
Sbjct: 195 IYSIGIVLYEMLVG 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISLAVHRNLL 359
++G GG V+ L+D VAVK L+ D + +F+ E + + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL---RFRREAQNAAALNHPAIV 75
Query: 360 RL--IGFCMTTTERL--LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
+ G T L +V Y+ ++ + + + + A + L + H+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--AVRGTVGHIAPEYLS 473
IIHRDVK ANI++ V DFG+A+ + + VT AV GT +++PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
++DV+ G +L E+++G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTG 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 307 VGKGGFGNVYKGY-LQDGTVVAVK--RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G+G +G+V K G ++AVK R ++ +V M + +++ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-RSSDCPYIVQFYG 88
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRK-----RIALGAARGLLYLHEQCDP 418
+ + M + S K S+ +I L + L +L E
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS- 477
KIIHRD+K +NILLD + DFG++ L DS T G ++APE + S
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 478 ---SEKTDVFGFGILLLELISG 496
++DV+ GI L EL +G
Sbjct: 204 QGYDVRSDVWSLGITLYELATG 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 16/199 (8%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLRL- 361
LVG+GG G+VY+ +VA+K + + + + Q E +++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 362 -IGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
G +L + ++ +A+ L+ + L I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT--AVRGTVGHIAPEYLSTGQS 477
HRDVK NIL+ A + DFG+A D +T GT+ ++APE S +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 478 SEKTDVFGFGILLLELISG 496
+ + D++ +L E ++G
Sbjct: 213 TYRADIYALTCVLYECLTG 231
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 292 KELQSATSNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVK--RLKDGNAIGGEIQFQTEVE 348
+ Q+ ++ + +G G G V+K + + G V+AVK R I +V
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 408
+ S +++ G +T T+ + M + + + + + ++ + +
Sbjct: 78 LKSHD-CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
L YL E+ +IHRDVK +NILLDE + + DFG++ L D G ++A
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMA 192
Query: 469 PEYLSTGQSSE-----KTDVFGFGILLLELISG 496
PE + ++ + DV+ GI L+EL +G
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-21
Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 6/125 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 140
N LT+L + + N+ + + + + L LDLS
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITG 195
L LQ L +++N+L + + L+ LD S+N + FN+T
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 196 NSLIC 200
NS+ C
Sbjct: 555 NSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 7/126 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPST 138
S N + +S++ L LQ + Q++ + L KLL LD+S
Sbjct: 384 SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 139 VSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFN 192
L +L L++ NS + +N + L FLDLS L F + N
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 193 ITGNSL 198
++ N+L
Sbjct: 504 MSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 24/123 (19%), Positives = 45/123 (36%), Gaps = 6/123 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L S S N + LQ + L I L L L L+ N P + S
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSF-----HAKTFNITG 195
L +L+ L L + + L L++++N + +P++ + +++
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 196 NSL 198
N +
Sbjct: 163 NYI 165
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 23/100 (23%), Positives = 40/100 (40%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
TLS+ N TNL + L + L +L L++S+N S +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +L L + N + + LAF +L+ N+++
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 22/104 (21%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVS 140
+ S LT+L+ ++ ++ IG+L L L++++NF +P+ S
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLS 180
+L L ++ L+ N + L + + LD+S N +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 22/109 (20%), Positives = 34/109 (31%), Gaps = 5/109 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
++ + + L N + S+L LDLS L L L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 155 LTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 198
+ P S S ++ L L L+ K N+ N +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 7/104 (6%)
Query: 82 NLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
++ +L L+ + L N S I + L L LDLS N + +
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSY 370
Query: 140 SHLET--LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
S L T L++L L+ N + + + +L LD ++ L
Sbjct: 371 SDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 17/131 (12%), Positives = 38/131 (29%), Gaps = 12/131 (9%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLTLDLSNNFFTGPIPST 138
S N + L + L+ N S +I T + L+ L L F
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 139 VSHLETLQ--------YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-- 188
+ ++ RL + ++ ++ + L+ ++
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308
Query: 189 -KTFNITGNSL 198
++ +I L
Sbjct: 309 WQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 26/125 (20%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
N L N+ + L +I ++ ++ K K +L + P+
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLKQ-FPT--LD 326
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA------KTFNIT 194
L L+ L L N + I + L++LDLS N LS S+ + +++
Sbjct: 327 LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 195 GNSLI 199
N I
Sbjct: 385 FNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 24/135 (17%), Positives = 42/135 (31%), Gaps = 19/135 (14%)
Query: 82 NLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 137
+ + + L V + N I I + + KL L L NF + I
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 138 TV-SHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAF--LDLSYNNLSGPVPSF-- 186
T +L L RL + +L P + + + L+Y N
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282
Query: 187 ---HAKTFNITGNSL 198
+ ++ G S+
Sbjct: 283 CLANVSAMSLAGVSI 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-20
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTE---VEMISL 352
++FS ++G+GGFG VY D G + A+K L GE E + ++S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 353 AVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
++ + + T ++L + M+ G + L A + A GL +
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471
+H + +++RD+K ANILLDE+ + D GLA H +V GT G++APE
Sbjct: 308 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 472 LSTGQSSEKT-DVFGFGILLLELISGL 497
L G + + + D F G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 29/239 (12%)
Query: 281 VCLGNLKRFHFKELQSATSNFSSKNL---------VGKGGFGNVYKGY-LQDGTVVAVK- 329
+ L K F F +L + K L +G G G V + + VA++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 330 ------RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSV 383
+ + +TE+E++ H ++++ F + +V M G +
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL 226
Query: 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV---V 440
++ L AT K + YLHE IIHRD+K N+LL E +
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 441 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELISG 496
DFG +K+L ++ + + GT ++APE L + + + D + G++L +SG
Sbjct: 284 TDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 15/214 (7%)
Query: 294 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEV 347
+ S + S +G G +G V A+K ++ + EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 407
++ L H N+++L F LV G + + + + I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 408 GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 464
G+ YLH+ I+HRD+K N+LL ++ + DFGL+ + + + GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTA 202
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498
+IAPE L + EK DV+ G++L L++G
Sbjct: 203 YYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 43/200 (21%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGF 364
+G+G +G V K ++ G ++AVKR++ + + ++++ + G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATR----KRIALGAARGLLYLHEQCDPKI 420
+ + M + S+ K +IA+ + L +LH + +
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS--- 477
IHRDVK +N+L++ + + DFG++ L D G ++APE ++ +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 478 -SEKTDVFGFGILLLELISG 496
S K+D++ GI ++EL
Sbjct: 190 YSVKSDIWSLGITMIELAIL 209
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 24/122 (19%), Positives = 43/122 (35%), Gaps = 5/122 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L +++ L NL + L I +L TL L+ N + +S
Sbjct: 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG 103
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGN 196
+ L++L ++ L N L L L N++S +P K + N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 197 SL 198
++
Sbjct: 164 AI 165
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 27/126 (21%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
S++ + LQ + L ++S +P+ + LS L L LS N F + S+
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 142 LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNI 193
+L +L + N+ + L N+ L LDLS++++ ++ N+
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL 383
Query: 194 TGNSLI 199
+ N +
Sbjct: 384 SYNEPL 389
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 30/127 (23%), Positives = 56/127 (44%), Gaps = 9/127 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPIPST 138
L + L LQ + LQ N+ + L +L L LS +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHA----KTFNI 193
+ L+ + ++ L++N LT + +LS++ + +L+L+ N++S +PS +T N+
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554
Query: 194 TGNSLIC 200
N L C
Sbjct: 555 RQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 16/100 (16%), Positives = 33/100 (33%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+ + + L ++L N + T + L L + + +
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+TL+ L L +N ++ P +L LD N +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 3/106 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLL--QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+ + L + + + Q + S L LDL+ + +PS +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL 297
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L TL+ L L+ N S SN L L + N + +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 1/99 (1%)
Query: 84 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHL 142
S + + NL++LQ + L N + +L LDL+ S +L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
L+ L L+++ L + + L L+L N+
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 18/93 (19%), Positives = 26/93 (27%)
Query: 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153
+ + + N + T +L L LDL+ T L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 154 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF 186
L +LS L L +S
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 3/103 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFT--GPIPST 138
S N +L + ++ N + T + L L LDLS++
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+ +L LQ L L+ N + QL LDL++ L
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 25/101 (24%), Positives = 48/101 (47%), Gaps = 1/101 (0%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
+ ++S+ L L++++L ++S L + +DLS+N T +S
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
HL+ + YL L +N ++ +P L +SQ ++L N L
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 3/105 (2%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-T 138
+ L S + L+ L+ ++L N L L + N + +
Sbjct: 286 TATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 139 VSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSG 181
+ +LE L+ L L+++ + L N+S L L+LSYN
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 16/127 (12%), Positives = 34/127 (26%), Gaps = 8/127 (6%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSNNFFTGPIPS 137
+ N + + Q + I + + L + P+
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
Query: 138 TVSHLE--TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTF 191
L +++ + L + + S L LDL+ +LS K
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKL 306
Query: 192 NITGNSL 198
++ N
Sbjct: 307 VLSANKF 313
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 16/220 (7%)
Query: 288 RFHFKELQSAT-SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQF 343
++ + E Q F ++G+GGFG V+ ++ G + A K+L G
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWA-TRKRI 401
E ++++ R ++ L + T L LV M+ G + + + R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 402 ALGAAR---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458
A+ GL +LH++ II+RD+K N+LLD+ + D GLA L +
Sbjct: 292 IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 459 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
GT G +APE L G+ + + D F G+ L E+I+
Sbjct: 349 YA-GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 16/213 (7%)
Query: 294 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTE 346
+Q +T+ FS + ++GKG FG V G AVK + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA 406
V+++ H N+++L F LV + G + + ++ RI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
G+ Y+H+ KI+HRD+K N+LL + + DFGL+ + S GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGT 191
Query: 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+IAPE L G EK DV+ G++L L+SG
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 293 ELQSAT-SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI--GGEIQFQTEVE 348
E Q T + F ++GKGGFG V ++ G + A K+L+ GE E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 349 MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 407
++ R ++ L + T + L LV M+ G + + R AA
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAE 294
Query: 408 ---GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 464
GL LH + +I++RD+K NILLD++ + D GLA + + GTV
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRVGTV 349
Query: 465 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
G++APE + + + D + G LL E+I+G
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 25/222 (11%)
Query: 295 QSATSNFSSK----NLVGKGGFGNVYKG-YLQDGTVVAVK--------RLKDGNAIGGEI 341
+T F ++G+G V + + AVK
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 342 QFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKR 400
EV+ + ++ H N+++L T T LV+ M G + L K +L ++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
I + LH+ I+HRD+K NILLD+ + DFG + LD +
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC 184
Query: 461 RGTVGHIAPEYLSTGQSSEKT------DVFGFGILLLELISG 496
GT ++APE + + D++ G+++ L++G
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISL----AVH 355
L+GKGGFG V+ G+ L D VA+K R+ + + + EV ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
++RL+ + T +LV + + K L + + + H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 415 QCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
+ ++HRD+K NIL+D + DFG LL D T GT + PE++S
Sbjct: 158 R---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFD-GTRVYSPPEWIS 211
Query: 474 TGQ-SSEKTDVFGFGILLLELISG 496
Q + V+ GILL +++ G
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCG 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 26/223 (11%)
Query: 294 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLK------------DGNA 336
++ +G G +G V + A+K +K + N
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 337 IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWA 396
+ E+ ++ H N+++L LV + G + ++ + D
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 397 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 453
I G+ YLH+ I+HRD+K NILL + + DFGL+ D
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-D 202
Query: 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ + GT +IAPE L + +EK DV+ G+++ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 11/217 (5%)
Query: 285 NLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ- 342
+ R + + ++ ++GKG FG V K AVK + +A +
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 343 FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIA 402
EVE++ H N+++L ++ +V + G + + + RI
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTA 459
G+ Y+H+ I+HRD+K NILL ++ + + DFGL+ ++ +
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDR 183
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ GT +IAPE L G EK DV+ G++L L+SG
Sbjct: 184 I-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHR--N 357
L+G GGFG+VY G + D VA+K R+ D + + EV ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 358 LLRLIGFCMTTTERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
++RL+ + +L+ + + + +L + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 168
Query: 417 DPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
++HRD+K NIL+D + + DFG LL D+ T GT + PE++
Sbjct: 169 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD-GTRVYSPPEWIRYH 223
Query: 476 Q-SSEKTDVFGFGILLLELISG 496
+ V+ GILL +++ G
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCG 245
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 19/216 (8%)
Query: 291 FKELQSATSNFSS----KNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT 345
++L + F+ K +G G + + AVK + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----- 64
Query: 346 EVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG 404
E+E ++ H N++ L +V M G + ++ + +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLAKLLDHCDSHVTTAV 460
+ + YLH Q ++HRD+K +NIL + + DFG AK L + + T
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
T +APE L D++ G+LL +++G
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+++ +LT L+++ + +N IS + + LS+L +L L+NN + L L L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ N +T P L+++S++ D + +
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S + NL+ L + + N IS + L+KL L++ +N + S +++L L L
Sbjct: 237 SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL 292
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
LNNN L + ++ L L LS N+++
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ + N+T L + + NN I+ P + LS+L L++ N + + V L L+ L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+ +N ++ L+N+SQL L L+ N L
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 24/102 (23%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N + + S + N+T L + + + + T I L+ L +L L+ N P +
Sbjct: 140 GANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--L 195
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+ L +L Y N +T P ++NM++L L + N ++
Sbjct: 196 ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 19/93 (20%), Positives = 41/93 (44%), Gaps = 5/93 (5%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S + NLT + + L N+ + + ++ L L ++ + P +++L L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
LN N + P L++++ L + N ++
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 25/115 (21%), Positives = 50/115 (43%), Gaps = 11/115 (9%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L ++ +++ ++ I I L+ L L+L+ N T P +S+L L L
Sbjct: 38 VTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNL 93
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLI 199
+ N +T +L N++ L L L+ +N+S + + N+ N +
Sbjct: 94 YIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 20/96 (20%), Positives = 39/96 (40%), Gaps = 6/96 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+L +LQ +++ + +L + L ++ + +L L+YL
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYL 71
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
LN N +T P LSN+ +L L + N ++
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 9/91 (9%)
Query: 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153
L + N I L++ + L T + LE++ L +
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 154 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
+ + ++ L +L+L+ N ++ P
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 16/48 (33%), Positives = 23/48 (47%), Gaps = 2/48 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 129
L IG LTNL + L N+I+ P + LSK+ + D +N
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 56/247 (22%), Positives = 87/247 (35%), Gaps = 59/247 (23%)
Query: 304 KNLVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRN 357
K +G+G +G V Q + A+K +++ N E + +TEV ++ H N
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE-RIKTEVRLMKKLHHPN 89
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALG------------- 404
+ RL LV G + +L +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 405 --------------------AAR-------GLLYLHEQCDPKIIHRDVKAANILL--DEY 435
+ L YLH Q I HRD+K N L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKS 206
Query: 436 YEAVVGDFGLAKLLDHCDSH----VTTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGIL 489
+E + DFGL+K ++ +TT GT +APE L+T S K D + G+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 490 LLELISG 496
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 13/218 (5%)
Query: 284 GNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ 342
+ +F+ + ++ ++GKG FG V K AVK + +A +
Sbjct: 9 SGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 343 -FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 401
EVE++ H N+++L ++ +V + G + + + RI
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTT 458
G+ Y+H+ I+HRD+K NILL ++ + + DFGL+ ++ +
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD 182
Query: 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ GT +IAPE L G EK DV+ G++L L+SG
Sbjct: 183 RI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 14/103 (13%)
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR------ 461
+ +LH + ++HRD+K +NI VGDFGL +D + T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 462 -----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499
GT +++PE + S K D+F G++L EL+
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 17/71 (23%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
++F +G+GGFG V++ D A+KR++ N + EV+ ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 358 LLRLIGFCMTT 368
++R + T
Sbjct: 66 IVRYFNAWLET 76
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 24/221 (10%)
Query: 295 QSATSNFSSK----NLVGKGGFGNVYKG-YLQDGTVVAVK-------RLKDGNAIGGEIQ 342
+A F K +++G+G V + + G AVK RL
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 343 FQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRI 401
+ E + +A H +++ LI +++ LV+ M G + L K +L + I
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461
+ +LH I+HRD+K NILLD+ + + DFG + L+ +
Sbjct: 206 MRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC- 260
Query: 462 GTVGHIAPEYLSTGQS------SEKTDVFGFGILLLELISG 496
GT G++APE L ++ D++ G++L L++G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 18/92 (19%), Positives = 44/92 (47%), Gaps = 1/92 (1%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ I L+NL+ + + +++ + L+ L LD+S++ I + ++ L + +
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ N I P L + +L L++ ++ +
Sbjct: 142 DLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 19/91 (20%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ I N++ + + N + + I LS L L + T +S L +L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
+++++ +I ++ + ++ +DLSYN
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-15
Identities = 20/100 (20%), Positives = 43/100 (43%), Gaps = 3/100 (3%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+++ ++ LT+L L+ + ++ I T+I L K+ ++DLS N I +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
L L+ L + + + + + +L L + G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 24/115 (20%), Positives = 51/115 (44%), Gaps = 9/115 (7%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ + +L + L N N++ + T I + L ++N T + +S L L+ LR
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199
+ +T P+LS ++ L LD+S++ + + + +++ N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 7/93 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
LL ++ + +++ L + L+N T + + ++ L +NN
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
T P +S +S L L + +++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIP 106
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 39/251 (15%)
Query: 272 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 322
+ + RRE+ L L+ K+++ +F ++G+G FG V K
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---A 98
Query: 323 GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 379
V A+K L + E F+ E +++ + + L + L LV Y
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYV 157
Query: 380 NG---SVASRLKAKPSLDWATRKR-----IALGAARGLLYLHEQCDPKIIHRDVKAANIL 431
G ++ S+ + + + A R + + + +H+ +HRD+K NIL
Sbjct: 158 GGDLLTLLSKFEDRLPEEMA---RFYLAEMVIA----IDSVHQL---HYVHRDIKPDNIL 207
Query: 432 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGF 486
+D + DFG L + ++ GT +I+PE L + + D +
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 487 GILLLELISGL 497
G+ + E++ G
Sbjct: 268 GVCMYEMLYGE 278
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 6/115 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 138
S N T+SS+ L L+ + Q++N+ + L L+ LD+S+
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 139 VSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
+ L +L+ L++ NS P + + L FLDLS L FN
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----QLSPTAFN 491
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 21/105 (20%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-S 140
+ G S S T+L+ + L N + + + L +L LD ++ +V
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L L YL +++ A + +S L L ++ N+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 6/123 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L S S + LQ++ L I LS L TL L+ N S
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL-SGPVPSF-----HAKTFNITG 195
L +LQ L +L + ++ L L++++N + S +P + + + +++
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 196 NSL 198
N +
Sbjct: 159 NKI 161
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 20/100 (20%), Positives = 40/100 (40%), Gaps = 1/100 (1%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 140
+ + L++L+++ + N+ + +I +L L LDLS P+ +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +LQ L + +N L ++ L + L N
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 18/86 (20%), Positives = 27/86 (31%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
+ + + L N + +L LDLS L L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 155 LTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + S +S L L NL+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 24/104 (23%), Positives = 47/104 (45%), Gaps = 5/104 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-GPIPSTVS 140
+ + L++LQ ++ N++ IG L L L++++N +P S
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAF----LDLSYNNLS 180
+L L++L L++N + L + Q+ LDLS N ++
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRL 150
L +L+ + +N + +E+ L L LDLS N + G + +L+YL L
Sbjct: 323 KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ N + + + + QL LD ++NL
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 14/112 (12%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
+L+LV + KL L L ++N L +L++L L+
Sbjct: 305 GWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSR 356
Query: 153 NSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198
N L+ G S + L +LDLS+N + +F + + ++L
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 22/110 (20%), Positives = 37/110 (33%), Gaps = 12/110 (10%)
Query: 82 NLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 137
+ + + L + L+ L N ++ I K +L L L NNF + +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 138 TV-SHLETLQYLRL------NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
T L L+ RL N +L +L + L + L
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 25/129 (19%), Positives = 38/129 (29%), Gaps = 20/129 (15%)
Query: 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLL---QNNNISGHIPTEIGKLSKLLTLDLSN 128
LV G NL S++ L NL + + I L+ + + L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 129 NFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIPPSL----------------SNMSQLAF 171
S + L+ + SL ++ L F
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 172 LDLSYNNLS 180
LDLS N LS
Sbjct: 352 LDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 18/111 (16%), Positives = 32/111 (28%), Gaps = 10/111 (9%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLTLDL------SNNFFT 132
S N + L + L+NN S ++ T I L+ L L +
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 133 GPIPSTVSHLETLQYLRLNNNSLTG---AIPPSLSNMSQLAFLDLSYNNLS 180
S + L L L I + ++ ++ L +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 16/102 (15%), Positives = 37/102 (36%), Gaps = 2/102 (1%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPST 138
+ L +I +L L+ + L+ + P G + L L L + + +P
Sbjct: 214 RNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLD 272
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ L L+ L L +P ++ + + + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 3/101 (2%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
+L +SI NL NL+ + ++N+ +S + I L KL LDL P L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 146 QYLRL-NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+ L L + ++L +P + ++QL LDL +PS
Sbjct: 256 KRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 24/117 (20%), Positives = 52/117 (44%), Gaps = 15/117 (12%)
Query: 82 NLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK---------LSKLLTLDLSN 128
L+ L +SI +L L+ + ++ +P + L L +L L
Sbjct: 133 TLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+P+++++L+ L+ L++ N+ L+ A+ P++ ++ +L LDL P
Sbjct: 193 TGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 23/134 (17%), Positives = 48/134 (35%), Gaps = 19/134 (14%)
Query: 82 NLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 137
L L++LQ + + + +P + + + L TL L+ N +P+
Sbjct: 87 ELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPA 144
Query: 138 TVSHLETLQYLRLNNNSLTGAIPPSLSN---------MSQLAFLDLSYNNLSGPVPSFHA 188
+++ L L+ L + +P L++ + L L L + + S
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIAN 204
Query: 189 ----KTFNITGNSL 198
K+ I + L
Sbjct: 205 LQNLKSLKIRNSPL 218
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 10/117 (8%), Positives = 26/117 (22%), Gaps = 22/117 (18%)
Query: 85 GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS------- 137
G+ + + + + Q + + + + D + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 138 --------------TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ L L + L P +S L + + L
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 13/200 (6%)
Query: 302 SSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLL 359
+G+G F K + AVK + E Q E+ + H N++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIV 69
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
+L LV ++ G + R+K K I + ++H+
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---G 126
Query: 420 IIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
++HRD+K N+L ++ E + DFG A+L + + T T+ + APE L+
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 477 SSEKTDVFGFGILLLELISG 496
E D++ G++L ++SG
Sbjct: 186 YDESCDLWSLGVILYTMLSG 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
F ++G G F V+ G + A+K +K + + + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHE 66
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLH 413
N++ L +TT LV +S G + R+ + D + + L A + YLH
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA---VKYLH 123
Query: 414 EQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
E I+HRD+K N+L +E + ++ DFGL+K+ + ++TA GT G++APE
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTPGYVAPE 177
Query: 471 YLSTGQSSEKTDVFGFGILLLELISG 496
L+ S+ D + G++ L+ G
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 20/230 (8%)
Query: 279 EEVCLGNLKRFHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKD 333
+ K+++ + ++ + +G G FG V++ G A K +
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 334 GNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS- 392
+ E + E++ +S+ H L+ L E +++Y +MS G + ++ + +
Sbjct: 193 PHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 393 ---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 447
+ R GL ++HE +H D+K NI+ + DFGL
Sbjct: 252 MSEDEAVEYMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
LD V GT APE TD++ G+L L+SGL
Sbjct: 306 HLDP-KQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G F V K G A K + + + + EV ++ +H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 418
T+ +L+ +S G + L K SL + + + L G+ YLH +
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK--- 134
Query: 419 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
KI H D+K NI+L + DFGLA ++ GT +APE ++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVNY 192
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
+ D++ G++ L+SG
Sbjct: 193 EPLGLEADMWSIGVITYILLSGA 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 47/224 (20%), Positives = 89/224 (39%), Gaps = 26/224 (11%)
Query: 288 RFHFKELQSATSNFS-----SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 341
F+ + + SK ++G G G V + + + G A+K L D E+
Sbjct: 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV 72
Query: 342 QFQTEVEMISLAVHRNLLRLIGFCMTTTER----LLVYPYMSNGSVASRLKAKPSLDWAT 397
+ +++ ++ L++ M G + SR++ + +
Sbjct: 73 DH-----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 398 RK--RIALGAARGLLYLHEQCDPKIIHRDVKAANILL-DEYYEAVV--GDFGLAKLLDHC 452
R+ I + +LH I HRDVK N+L + +AV+ DFG AK
Sbjct: 128 REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-- 182
Query: 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ + T T ++APE L + + D++ G+++ L+ G
Sbjct: 183 QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 14/218 (6%)
Query: 287 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT 345
R + + F K +G G FG+V+ G +K + + Q +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 405
E+E++ H N++++ +V G + R+ + + A +
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 406 AR----GLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTT 458
+ L Y H Q ++H+D+K NIL + + DFGLA+L D H T
Sbjct: 130 MKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTN 185
Query: 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
A GT ++APE + K D++ G+++ L++G
Sbjct: 186 AA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 19/211 (9%)
Query: 298 TSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 351
+ F+ + +GKG F V + + G A + + Q + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARG 408
L H N++RL L++ ++ G + + A+ D + + L A
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA--- 122
Query: 409 LLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
+L+ H+ ++HR++K N+LL + + DFGLA ++ GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+++PE L + D++ G++L L+ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 28/113 (24%), Positives = 45/113 (39%), Gaps = 9/113 (7%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S + LT L + L N + + I L L L L N + P VS L LQ L
Sbjct: 281 SPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAK---TFNITGNSL 198
NN ++ SL+N++ + +L +N +S P + + +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L NL + NN ++ P + L+KL+ + ++NN P +++L L L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
L NN +T P L N++ L L+LS N +S
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S + LTNL+ ++ NN IS P +G L+ L L L+ N T++ L L L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
L NN ++ P LS +++L L L N +S
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 25/93 (26%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ NLTNL + L +N IS + + L+ L L N T P +++L TL+ L
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV-TDLKP--LANLTTLERL 182
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+++N ++ L+ ++ L L + N +S
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 6/99 (6%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
T + S +L + + I + L+ L ++ SNN T P + +L L
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKL 92
Query: 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
+ +NNN + P L+N++ L L L N ++ P
Sbjct: 93 VDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L +L N++ + L ++ TL V +L L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
+NN LT P L N+++L + ++ N ++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 20/94 (21%), Positives = 44/94 (46%), Gaps = 4/94 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
SS+ NLTN+ + +N IS P + L+++ L L++ +T + +++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182
+ +L P ++S+ D+++N S
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 12/86 (13%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 99 LVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGA 158
+ Q+ I+ L++ + L T + + L+ + L+ + +
Sbjct: 6 ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-- 59
Query: 159 IPPSLSNMSQLAFLDLSYNNLSGPVP 184
+ ++ L ++ S N L+ P
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVK---RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
L+G+G +G V + + AVK + K GE + E++++ H+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 362 --IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLY 411
+ + + +V Y G + LD KR + A GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGM--QEM-----LDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAP 469
LH Q I+H+D+K N+LL + G+A+ L D T+ +G+ P
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPP 180
Query: 470 EYLSTGQ--SSEKTDVFGFGILLLELISG 496
E + S K D++ G+ L + +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 20/203 (9%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-------RLKDGNAIGGEIQFQTEVEMISLAVHRNLL 359
G G G V + + VA+K + + +TE+E++ H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
++ F + +V M G + ++ L AT K + YLHE
Sbjct: 79 KIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---G 134
Query: 420 IIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
IIHRD+K N+LL E + DFG +K+L ++ + + GT ++APE L +
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVG 192
Query: 477 S---SEKTDVFGFGILLLELISG 496
+ + D + G++L +SG
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSG 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 52/228 (22%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-------------------------RLKDGNAIGGEI 341
GKG +G V Y D T A+K G
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 342 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRLKAKPSLDWATRK 399
Q E+ ++ H N+++L+ E L V+ ++ G V ++ T K
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------MEVPTLK 132
Query: 400 RIALGAAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451
++ AR G+ YLH Q KIIHRD+K +N+L+ E + DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 452 CDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISG 496
D+ ++ V GT +APE LS + S + DV+ G+ L + G
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 55/253 (21%), Positives = 93/253 (36%), Gaps = 41/253 (16%)
Query: 272 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 322
+E +++ L+ KE++ +F ++G+G F V K
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---T 85
Query: 323 GTVVAVKRLKDGNAIG-GEI-QFQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 379
G V A+K + + + GE+ F+ E +++ R + +L F L LV Y
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYV 144
Query: 380 NGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAANIL 431
G + + L +RI AR + +H +HRD+K NIL
Sbjct: 145 GGDLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNIL 194
Query: 432 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG------ 485
LD + DFG L + + GT +++PE L T +G
Sbjct: 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 486 -FGILLLELISGL 497
G+ E+ G
Sbjct: 255 ALGVFAYEMFYGQ 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 20/222 (9%)
Query: 287 KRFHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 341
K++ + ++ + +G G FG V++ G V K + +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY- 93
Query: 342 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL----DWAT 397
+ E+ +++ H L+ L E +L+ ++S G + R+ A+ +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 398 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSH 455
R A GL ++HE I+H D+K NI+ + + DFGLA L+ D
Sbjct: 154 YMRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEI 206
Query: 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
V T APE + TD++ G+L L+SGL
Sbjct: 207 VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 18/94 (19%), Positives = 40/94 (42%), Gaps = 2/94 (2%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ N ++ + ++++ + + + LDLS N + + ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L++N L L ++S L LDL+ N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 27/114 (23%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYL 148
S + + L NN I+ + G S++ LDL N + +TL++L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198
L N + + + ++L LDLS N L+ P F + ++ N L
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+L L+S + N++ + L N +S ++ +KL L+LS+N + +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L TL+ L LNNN + L + L + NN+S
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ +L+ L+ + L NN + E+ + TL +NN + + S + + +
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSC--SRGQGKKNI 125
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L NN +T S++ +LDL N +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 15/111 (13%), Positives = 33/111 (29%), Gaps = 4/111 (3%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L+ + L +N ++ + E + + + L NN I + + L++ L
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRG 246
Query: 153 NSLTGAIPPSL-SNMSQLAFLDLSYN-NLSGPVPSFHAKTFNITGNSLICA 201
N S ++ + L+G + C
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170
I ++ ++++ + S ++ L L+ N L+ L+ ++L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 171 FLDLSYNNLSGPVPSFHA----KTFNITGNSL 198
L+LS N L + +T ++ N +
Sbjct: 62 LLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 49/203 (24%), Positives = 82/203 (40%), Gaps = 21/203 (10%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G F V K G A K + + + + EV ++ +H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 418
T+ +L+ +S G + L K SL + + + L G+ YLH +
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYLHTK--- 134
Query: 419 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
KI H D+K NI+L + DFGLA ++ GT +APE ++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIF-GTPEFVAPEIVNY 192
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
+ D++ G++ L+SG
Sbjct: 193 EPLGLEADMWSIGVITYILLSGA 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 294 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEV 347
+ +A++ FS +GKG F V + G A K + + Q + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALG 404
+ H N++RL + LV+ ++ G + + A+ D + + L
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA---VVGDFGLAKLLDHCDSHVTTAVR 461
+ + Y H I+HR++K N+LL + + DFGLA ++ DS
Sbjct: 140 S---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFA 191
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT G+++PE L S+ D++ G++L L+ G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 25/214 (11%)
Query: 296 SATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQT 345
S + + N +G+G +G V A K ++D + +
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF------KQ 55
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA 405
E+E++ H N++RL T+ LV + G + R+ K + RI
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462
+ Y H+ + HRD+K N L + DFGLA + G
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVG 170
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
T +++P+ L G + D + G+++ L+ G
Sbjct: 171 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 14/208 (6%)
Query: 298 TSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMIS 351
++ FS +GKG F V + G A K + + Q + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
H N++RL + LV+ ++ G + + A+ A + Y
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAV---VGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
H I+HR++K N+LL + + DFGLA ++ DS GT G+++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLS 175
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISG 496
PE L S+ D++ G++L L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G +G V VAVK + A+ + E+ + + H N+++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQC 416
+ L Y S G + R++ + A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLMAGVVYLHGI- 124
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYLS- 473
I HRD+K N+LLDE + DFGLA + + + + GT+ ++APE L
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
+E DV+ GI+L +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 18/94 (19%), Positives = 40/94 (42%), Gaps = 2/94 (2%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ N ++ + ++++ + + + LDLS N + + ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L++N L L ++S L LDL+ N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 37/212 (17%), Positives = 69/212 (32%), Gaps = 10/212 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS 140
++ G + +Q + L+ N I + L L+L NF + V
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV 189
Query: 141 HLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGN 196
L+ L L++N L + P + + + ++ L N L + + F++ GN
Sbjct: 190 -FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN 247
Query: 197 SLICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFG 256
C T D F + A + L + C L
Sbjct: 248 GFHCGT--LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 257 FLLWWRQRHNQQIFFDVNEQRREEVCLGNLKR 288
L+ +++ + + +E R E N R
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 7/99 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+L L+S + N++ + L N +S ++ +KL L+LS+N + +
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LES 78
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L TL+ L LNNN + L + L + NN+S
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 23/102 (22%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 82 NLSG---TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
NLS + + +L+ L+ + L NN + E+ + TL +NN + +
Sbjct: 64 NLSSNVLYETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSC- 116
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
S + + + L NN +T S++ +LDL N +
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 15/92 (16%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170
I ++ ++++ + S ++ L L+ N L+ L+ ++L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 171 FLDLSYNNLSGPVPSFHA----KTFNITGNSL 198
L+LS N L + +T ++ N +
Sbjct: 62 LLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 9/97 (9%), Positives = 22/97 (22%), Gaps = 4/97 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L+ Q + + E ++ +D + I + L
Sbjct: 311 KRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 153 NSLTGAIPPSLSNMSQL---AFLDLSYNNLSGPVPSF 186
+L + ++L + L
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 18/169 (10%), Positives = 37/169 (21%), Gaps = 4/169 (2%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+ + L N + + I + +TL+ + +
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 140 SHLETLQYLRLNNNSLTG--AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNS 197
L S + L + Y + S
Sbjct: 381 RAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMY 440
Query: 198 LICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLG 246
T E+ L+ + + S + + + L S LG
Sbjct: 441 QHKETQLAEENA--RLKKLNGEADLALASANATLQELVVREQNLASQLG 487
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 18/202 (8%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
GKG F V + + G AVK + + E + E + + H +++ L
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLKHPHIVEL 91
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL----YLHEQCD 417
+ + +V+ +M + + + + + +A R +L Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 418 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
IIHRDVK +LL + +G FG+A L V GT +APE +
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207
Query: 475 GQSSEKTDVFGFGILLLELISG 496
+ DV+G G++L L+SG
Sbjct: 208 EPYGKPVDVWGCGVILFILLSG 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIG-GEIQF-QTEVEMISLAVH 355
+F +GKG FG V D + A+K + + E++ E++++ H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 356 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRK----RIALGAARGLL 410
L+ L + E + +V + G + L+ T K + + L
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA----LD 129
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
YL Q +IIHRD+K NILLDE+ + DF +A +L T + GT ++APE
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGTKPYMAPE 184
Query: 471 YLSTGQSSEKT---DVFGFGILLLELISGLR 498
S+ + + + D + G+ EL+ G R
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 8e-16
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 21/203 (10%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G F V K G A K RL + + EV ++ H N++ L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 418
T+ +L+ +S G + L K SL + + L G+ YLH +
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK--- 127
Query: 419 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+I H D+K NI+L + DFG+A ++ + GT +APE ++
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIF-GTPEFVAPEIVNY 185
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
+ D++ G++ L+SG
Sbjct: 186 EPLGLEADMWSIGVITYILLSGA 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 27/223 (12%)
Query: 296 SATSNFS-----SKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVE- 348
S + F ++++G+G V L AVK ++ + EVE
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEM 63
Query: 349 MISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 408
+ HRN+L LI F LV+ M GS+ S + + + + A
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 409 LLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHV-------TT 458
L +LH + I HRD+K NIL ++ + DF L + T
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 459 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELISG 496
G+ ++APE + D++ G++L L+SG
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 40/250 (16%)
Query: 272 DVNEQRREEVCLGNLKRF-----HFKELQSATSNFSSKNLVGKGGFGNVY----KGYLQD 322
D R+ + L R+ ++L+ ++ ++G+G FG V K
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---T 93
Query: 323 GTVVAVKRLKDGNAIG-GEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERL-LVYPYMS 379
V A+K L I + F E ++++ A +++L + L +V YM
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMP 152
Query: 380 NGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIHRDVKAANIL 431
G + + + + AR L +H IHRDVK N+L
Sbjct: 153 GGDLVNLMS---------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNML 200
Query: 432 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGFG 487
LD+ + DFG ++ GT +I+PE L + D + G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 488 ILLLELISGL 497
+ L E++ G
Sbjct: 261 VFLYEMLVGD 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 17/200 (8%)
Query: 308 GKGGFGNVYKG-YLQDGTVVAVK-----RLKDGNAIGGEI--QFQTEVEMISLAVHRNLL 359
G G FG V+ + V VK ++ + I + E+ ++S H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 360 RLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
+++ LV +G + + + P LD I + YL +
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK--- 149
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
IIHRD+K NI++ E + + DFG A L+ T GT+ + APE L G
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC-GTIEYCAPEVLM-GNPY 206
Query: 479 E--KTDVFGFGILLLELISG 496
+ +++ G+ L L+
Sbjct: 207 RGPELEMWSLGVTLYTLVFE 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
S ++G G FG V+K G +A K +K E + + E+ +++ H NL
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANL 148
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----LDWATRKRIALGAARGLLYLHE 414
++L + + +LV Y+ G + R+ + LD + G+ ++H+
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ 205
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 472
I+H D+K NIL + DFGLA+ + GT +APE +
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF-GTPEFLAPEVV 260
Query: 473 STGQSSEKTDVFGFGILLLELISGL 497
+ S TD++ G++ L+SGL
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAI-GGEIQF-QTEVEMISLAVH 355
+F ++G+G F V L A+K L+ + I ++ + E +++S H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 356 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR------- 407
++L F E+L Y NG + ++ R
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIV 140
Query: 408 -GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA-VRGTVG 465
L YLH + IIHRD+K NILL+E + DFG AK+L GT
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
+++PE L+ + + +D++ G ++ +L++GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 49/203 (24%), Positives = 78/203 (38%), Gaps = 21/203 (10%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G F V K G A K R K + EV ++ H N++ L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIALGAARGLLYLHEQCDP 418
T+ +L+ ++ G + L K SL + + L + YLH
Sbjct: 80 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYYLHSL--- 133
Query: 419 KIIHRDVKAANILL----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+I H D+K NI+L + DFGLA +D + GT +APE ++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIF-GTPEFVAPEIVNY 191
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
+ D++ G++ L+SG
Sbjct: 192 EPLGLEADMWSIGVITYILLSGA 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
GKG F V + G VA+K +L + + EV ++ + H N+++L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKL 79
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421
T L+ Y S G V L A + + + Y H++ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 479
HRD+KA N+LLD + DFG + + G + APE G+ +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQ-GKKYDGP 193
Query: 480 KTDVFGFGILLLELISG 496
+ DV+ G++L L+SG
Sbjct: 194 EVDVWSLGVILYTLVSG 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 25/175 (14%)
Query: 288 RFHFKELQSATS--NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----- 339
SATS + +G+G +G VYK VA+KR++ + G
Sbjct: 21 SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80
Query: 340 --EIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWAT 397
E+ E++ HRN++ L L++ Y N + + P +
Sbjct: 81 IREVSLLKELQ------HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRV 133
Query: 398 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG-----DFGLAK 447
K G+ + H + + +HRD+K N+LL + DFGLA+
Sbjct: 134 IKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 24/203 (11%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G +G V VAVK + A+ + E+ + + H N+++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQC 416
+ L Y S G + R+ + A+ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--------EPDIGMPEPDAQRFFHQLMAGVVYLHGI- 124
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC--DSHVTTAVRGTVGHIAPEYLS- 473
I HRD+K N+LLDE + DFGLA + + + + GT+ ++APE L
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 474 TGQSSEKTDVFGFGILLLELISG 496
+E DV+ GI+L +++G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISL- 352
ATS + +G G +G VYK G VA+K ++ N GG + V ++L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 353 -----AVHRNLLRLIGFCMTTTERL-----LVYPYMSN--GSVASRLKAKPSLDWATRKR 400
H N++RL+ C T+ LV+ ++ + + P L T K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-PPGLPAETIKD 124
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
+ RGL +LH I+HRD+K NIL+ + DFGLA+
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 20/199 (10%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G G G V + + + A+K L+D E++ + +++R++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVYE 125
Query: 367 TTTER----LLVYPYMSNGSVASRLKAKPSLDWATRK--RIALGAARGLLYLHEQCDPKI 420
L+V + G + SR++ + + R+ I + YLH I
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NI 182
Query: 421 IHRDVKAANILL-DEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
HRDVK N+L + A++ DFG AK +S +TT T ++APE L +
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKY 240
Query: 478 SEKTDVFGFGILLLELISG 496
+ D++ G+++ L+ G
Sbjct: 241 DKSCDMWSLGVIMYILLCG 259
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEV 347
Q + VG+G +G VYK G +VA+KR++ G EI E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAA 406
H N++ LI + LV+ +M + L + L + K
Sbjct: 77 H------HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
RG+ + H+ +I+HRD+K N+L++ + DFGLA+
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 23/203 (11%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVE-MISLAVHRNLLRLIGF 364
G+G F V + G A K LK E+ + ++ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR-------GLLYLHEQCD 417
T+E +L+ Y + G + S + + + R G+ YLH+
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-----VIRLIKQILEGVYYLHQN-- 150
Query: 418 PKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
I+H D+K NILL + + DFG+++ + H + + GT ++APE L+
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIM-GTPEYLAPEILNY 207
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
+ TD++ GI+ L++
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHT 230
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 294 LQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL---KDGNAIGGEIQFQT 345
S S + +G+G VY+ A+K L D + +T
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV------RT 97
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL---DWATRKRIA 402
E+ ++ H N+++L T TE LV ++ G + R+ K D A +
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTA 459
L A + YLHE I+HRD+K N+L + DFGL+K+++H + T
Sbjct: 158 LEA---VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTV 210
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
GT G+ APE L + D++ GI+ L+ G
Sbjct: 211 C-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 299 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
S F ++G+G FG V+ + A+K LK ++ + V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT-----LKVRDRVRTKM--- 75
Query: 355 HRNLLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR----- 400
R++L + + T +L L+ ++ G + +RL + +
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLAE 134
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
+AL L +LH II+RD+K NILLDE + DFGL+K +
Sbjct: 135 LALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSF 186
Query: 461 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
GTV ++APE + + ++ D + FG+L+ E+++G
Sbjct: 187 CGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 15/122 (12%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L NL+ + L NI +P + L L L++S N F P + L +L+ L + N
Sbjct: 194 GLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 153 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEE 206
+ ++ I + ++ L L+L++NNLS P F ++ N C
Sbjct: 252 SQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC------ 304
Query: 207 DC 208
DC
Sbjct: 305 DC 306
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
+L +L+++ L N+I I L+ L TL+L +N+ T +L L+ L L
Sbjct: 97 HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNN 178
NN + +IP + + + L LDL
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELK 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
+N + + L NNI L L L L N + L +L L L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 155 LTGAIPP-SLSNMSQLAFLDLSYNNLS 180
LT IP + +S+L L L N +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 6/97 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL- 150
L +L + L +N ++ IP+ LSKL L L NN + + +L L L
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179
Query: 151 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSF 186
L I + + L +L+L N+ +P+
Sbjct: 180 ELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MPNL 214
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
V+ +S +P I S L+L N T HL L+ L+L NS+
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 156 TGAIPP-SLSNMSQLAFLDLSYNNLS 180
I + + ++ L L+L N L+
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 16/69 (23%), Positives = 32/69 (46%), Gaps = 2/69 (2%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
S L++L+ + + N+ +S I L+ L+ L+L++N + + L L
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293
Query: 147 YLRLNNNSL 155
L L++N
Sbjct: 294 ELHLHHNPW 302
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 31/134 (23%), Positives = 56/134 (41%), Gaps = 15/134 (11%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVS 140
T++ + NL + + + N++ +P + L L L+LS N + S +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
Query: 141 HLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNIT 194
L LQ ++L L + P + ++ L L++S N L+ FH+ +T +
Sbjct: 270 ELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD 328
Query: 195 GNSLICATGAEEDC 208
N L C DC
Sbjct: 329 SNPLAC------DC 336
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
NL NL+ + L++N + IP + LS L LD+S N + L L+ L +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+N L I + S ++ L L L NL+
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 25/100 (25%), Positives = 53/100 (53%), Gaps = 2/100 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
NL+ + ++ +L L ++ L++ NI+ +L +L L++S+ + + +
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 142 LETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
L L + + +LT A+P ++ ++ L FL+LSYN +S
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 20/89 (22%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
L +L+ + L+ N++ IPTE L L+ L L + + L L+ L ++
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + P+ L L +++ NL+
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 18/100 (18%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L L+++ + + + L +L +++ T V HL L++L L+
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSY 257
Query: 153 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 191
N ++ I L + +L + L L+ F
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLA----VVEPYAF 292
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
L+NL + + N I + + L L +L++ +N S L +L+ L L
Sbjct: 102 GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE 160
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+LT +IP +LS++ L L L + N++
Sbjct: 161 KCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 4/108 (3%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
+L NL+ + + +N++ +I L+ L L L T IP+ SHL L LRL
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRL 183
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSL 198
+ ++ S + +L L++S+ + N+T S+
Sbjct: 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 2/87 (2%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
T +L+ L N I E L L+L+ N + P ++L L+ L L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 155 LTGAIPP-SLSNMSQLAFLDLSYNNLS 180
L IP + +S L LD+S N +
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIV 117
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 98 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 157
+ VL +P I ++ LDL N + L+ L LN N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 158 AIPP-SLSNMSQLAFLDLSYNNLS 180
A+ P + +N+ L L L N L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK 93
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 41/212 (19%), Positives = 82/212 (38%), Gaps = 25/212 (11%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVK----RLKDGNAIGGEIQFQTEVEMISL 352
+ +G+G FG V++ K + D + + E+ ++++
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV------KKEISILNI 57
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR----G 408
A HRN+L L + E ++++ ++S + R+ + +R +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEA 114
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGH 466
L +LH I H D++ NI+ + + +FG A+ L + +
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLF-TAPEY 169
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498
APE S TD++ G L+ L+SG+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 22/210 (10%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN 357
+ F L+GKG FG V + G A+K LK I + EV
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV-----IVAKDEVA--HTLTENR 200
Query: 358 LLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 408
+L+ + T +RL V Y + G + L + +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
L YLH + + +++RD+K N++LD+ + DFGL K D GT ++A
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLA 317
Query: 469 PEYLSTGQSSEKT-DVFGFGILLLELISGL 497
PE L + D +G G+++ E++ G
Sbjct: 318 PEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 34/126 (26%), Positives = 48/126 (38%), Gaps = 9/126 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 140
+ +SS L LQL+ L + I E L L LDL ++ P
Sbjct: 35 YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94
Query: 141 HLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFN 192
L L LRL L+ A+ N+ L LDLS N + PSF K+ +
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 193 ITGNSL 198
+ N +
Sbjct: 155 FSSNQI 160
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 9/120 (7%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-----SH 141
+ + +LQ+++L N S + + L L L N + +
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 198
L LQ L LN+N L P S+++ L L L+ N L+ + + +I+ N L
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 3/90 (3%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 151
L + +LL N I + L +L L+L + + I +L L+ L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 152 NNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 180
++ + + P + L L L + LS
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 23/126 (18%), Positives = 44/126 (34%), Gaps = 6/126 (4%)
Query: 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVL--LQNNNISGHIPTEIGKLSKLLTLDLSNNF 130
+ G G N+ ++ L + L + + L L L+L+ N
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301
Query: 131 FTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKT 190
L+ LQ L L+ N L + + ++A++DL N+++ +T
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA----IIQDQT 357
Query: 191 FNITGN 196
F
Sbjct: 358 FKFLEK 363
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 23/111 (20%), Positives = 38/111 (34%), Gaps = 18/111 (16%)
Query: 98 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 157
++ + N++ +P L+ L LS N+ S+ LE LQ L L +
Sbjct: 7 RIAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 158 AIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF---------NITGNSL 198
I + N+ L LDL + + H F + L
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIY----FLHPDAFQGLFHLFELRLYFCGL 109
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 32/133 (24%), Positives = 51/133 (38%), Gaps = 13/133 (9%)
Query: 79 PSQNLSGTLSSSIGNLT-NLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTG-PI 135
P LSG ++ + L+ L N + I + ++ L L L+ N F+
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 136 PSTVSHLETLQYLRLNNNSLTGAIPPSL-----SNMSQLAFLDLSYNNLSG-PVPSFHA- 188
T S +L+ L L N L A L +S L L L++N L+ P F
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 189 ---KTFNITGNSL 198
+ ++ N L
Sbjct: 504 TALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 9/116 (7%)
Query: 88 SSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--T 144
NL L + L N I ++ GKL+ L ++D S+N + L+ T
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 145 LQYLRLNNNSLTGAIPPSLSNMSQ------LAFLDLSYNNLSGPVPSFHAKTFNIT 194
L + L NSL + L LD+S N + + + + +
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 19/114 (16%), Positives = 45/114 (39%), Gaps = 7/114 (6%)
Query: 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLR 149
GN + + +N IS + ++ + P +T + L ++++L
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 198
L++ + + L L+L+YN ++ +F+ + N++ N L
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 30/213 (14%), Positives = 71/213 (33%), Gaps = 11/213 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+ L++LQ++ L +N ++ P L+ L L L++N T + +
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA 526
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICA 201
L+ L ++ N L P+ L+ LD+++N + N I
Sbjct: 527 N--LEILDISRNQLLA---PNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIA- 580
Query: 202 TGAEEDCFGTAPMPLS----FALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGF 257
G D + P S F+L+ + + + + + + L+ +
Sbjct: 581 -GPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVT 639
Query: 258 LLWWRQRHNQQIFFDVNEQRREEVCLGNLKRFH 290
+ + + + ++ ++
Sbjct: 640 KFRGFCFICYKTAQRLVFKDHPQGTEPDMYKYD 672
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 20/114 (17%), Positives = 34/114 (29%), Gaps = 20/114 (17%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS--KLLTLDLSNNFFTGPIPSTVSHLE- 143
L S G L +L+ + +N I E+ L L L+ N +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 144 -----TLQYLRLNNNSLTGAIP------------PSLSNMSQLAFLDLSYNNLS 180
L+ L ++ N T I SL + ++N+
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTA 459
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS 495
R + +APE + + ++DV+ FG+LL E+ S
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 32/156 (20%), Positives = 58/156 (37%), Gaps = 15/156 (9%)
Query: 308 GKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLR 360
G+G FG V + VAVK LK+G +E++ +I + H N++
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 361 LIGFCMTTTERLLV-YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
L+G C L+V + G++++ L++K R +G + +
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNEFVPYKTKGARFRQGKDYVG 143
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455
I D+K + + F K L +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 293 ELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----------EI 341
+++S + + +G+G F VYK +VA+K++K G+ EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 342 QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKR 400
+ E+ H N++ L+ + LV+ +M + +K L + K
Sbjct: 64 KLLQELS------HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
L +GL YLH+ I+HRD+K N+LLDE + DFGLAK
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 299 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
+F ++GKG FG V +K A+K LK + + T VE L++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 355 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 410
L + T E L V Y++ G + +++ D + A GL
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+LH + I++RD+K NILLD+ + DFG+ K + T GT +IAPE
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPE 188
Query: 471 YLSTGQSSEKT-DVFGFGILLLELISGL 497
L GQ + D + FG+LL E++ G
Sbjct: 189 IL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 299 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
++F+ ++GKG FG V KG + AVK LK I + +VE V
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDD-----DVE--CTMV 390
Query: 355 HRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALG 404
+ +L L G C T +RL V Y++ G + ++ A
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 450
Query: 405 AARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTV 464
A GL +L + II+RD+K N++LD + DFG+ K + D T GT
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTP 506
Query: 465 GHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
+IAPE + Q K+ D + FG+LL E+++G
Sbjct: 507 DYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKR-LKDGNAIGGEIQFQTEVEM 349
K + +++ ++G G FG V++ L + VA+K+ L+D E+Q V+
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK- 90
Query: 350 ISLAVHRNLLRLIGFCMTTTERL------LVYPYMS---NGSVASRLKAKPSLDWATRKR 400
H N++ L F + ++ LV Y+ + K K ++ K
Sbjct: 91 -----HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDHCDSHVTTA 459
R L Y+H I HRD+K N+LLD + + DFG AK+L + +V+
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 460 V----RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
R APE + + + D++ G ++ EL+ G
Sbjct: 203 CSRYYR------APELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 32/122 (26%), Positives = 53/122 (43%), Gaps = 15/122 (12%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L+NL+ + L N+ IP + L KL LDLS N + P + L LQ L +
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 153 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAEE 206
+ + I + N+ L ++L++NNL+ P F + ++ N C
Sbjct: 241 SQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC------ 293
Query: 207 DC 208
+C
Sbjct: 294 NC 295
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
+L +L+++ L N+I I L+ L TL+L +N T +L L+ L L
Sbjct: 86 HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 152 NNSLTGAIPPSL-SNMSQLAFLDLSYNN 178
NN + +IP + + L LDL
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 30/113 (26%), Positives = 49/113 (43%), Gaps = 10/113 (8%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL- 150
L NL + L +N ++ IP LSKL L L NN + + +L+ L L
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168
Query: 151 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198
L+ I + +S L +L+L+ NL +P+ +++GN L
Sbjct: 169 ELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 26/87 (29%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
TN +L+ L N I L L L LS N + L L L L +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 155 LTGAIPP-SLSNMSQLAFLDLSYNNLS 180
LT IP + +S+L L L N +
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE 149
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 5/86 (5%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
V+ N+ +P I + L+L N ++ HL L+ L+L+ N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 156 TGAIPP-SLSNMSQLAFLDLSYNNLS 180
I + + ++ L L+L N L+
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT 125
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 2/69 (2%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
S L +LQ + + + I I L L+ ++L++N T + L L+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282
Query: 147 YLRLNNNSL 155
+ L++N
Sbjct: 283 RIHLHHNPW 291
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHR 356
+ + LVG+G +G V K G +VA+K+ + + ++ E++++ H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRHE 84
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQ 415
NL+ L+ C LV+ ++ + ++ L+ P+ LD+ ++ G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446
IIHRD+K NIL+ + + DFG A
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISLAVH 355
+++ ++G G FG VY+ L D G +VA+K+ L+D E+Q +++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------H 106
Query: 356 RNLLRLIGFCMTTTERL------LVYPYMS---NGSVASRLKAKPSLDWATRKRIALGAA 406
N++RL F ++ E+ LV Y+ +AK +L K
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV-VGDFGLAKLLDH 451
R L Y+H I HRD+K N+LLD + + DFG AK L
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 43/224 (19%)
Query: 299 SNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRL-KDGNAIGGEIQFQTEVEMISLA 353
NF ++G G +G V+ K D G + A+K L K + T E
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----- 108
Query: 354 VHRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIAL 403
R +L I + T +L L+ Y++ G + + L R+R
Sbjct: 109 --RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--------QRERFTE 158
Query: 404 GAAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455
+ L +LH+ II+RD+K NILLD V+ DFGL+K ++
Sbjct: 159 HEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDV--FGFGILLLELISGL 497
GT+ ++AP+ + G S V + G+L+ EL++G
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 299 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
NF ++GKG FG V K G + AVK LK + + T E L++
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 355 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--- 407
RN L +L C T +RL V +++ G + ++ R AA
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF---DEARARFYAAEIIS 135
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
L++LH++ II+RD+K N+LLD + DFG+ K C+ T GT +I
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191
Query: 468 APEYLSTGQSSEKT-DVFGFGILLLELISGL 497
APE L D + G+LL E++ G
Sbjct: 192 APEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 351
+ +G+G +G V+K + +VA+KR++ + G EI E++
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLL 410
H+N++RL + + LV+ + + + LD K +GL
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL---DHCDSH--VTTAVRGTVG 465
+ H + ++HRD+K N+L++ E + +FGLA+ C S VT R
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR---- 168
Query: 466 HIAPEYL--STGQSSEKTDVFGFGILLLELISGLRAL 500
P+ L + S+ D++ G + EL + R L
Sbjct: 169 --PPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 25/116 (21%), Positives = 49/116 (42%), Gaps = 9/116 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
L++L+++ + N+ + +I +L L LDLS P+ + L +LQ L ++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 152 NNSLTGAIPPS-LSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNITGNSLIC 200
+N+ ++ ++ L LD S N++ N+T N C
Sbjct: 208 HNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 138
S N T+SS+ L L+ + Q++N+ + L L+ LD+S+ +
Sbjct: 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNG 144
Query: 139 V-SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+ + L +L+ L++ NS P + + L FLDLS L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 4/95 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLN 151
T+L+ + L N + + + L +L LD ++ S L L YL ++
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPS 185
+ + +S L L ++ N+
Sbjct: 135 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRLNN 152
++ + L++N + KL++L L LS+N + G + +L+YL L+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
N + + + + QL LD ++NL
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
+ + + ++ +PT I S L+L +N L L L L++N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 156 T--GAIPPSLSNMSQLAFLDLSYNNLS 180
+ G S + L +LDLS+N +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI 91
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKG--YLQDGTVVAVKRLKDGNAIGG-------EIQFQTE 346
A + +G+G +G V+K G VA+KR++ G E+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--- 64
Query: 347 VEMISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSN--GSVASRLKAKPSLDWATRK 399
+ + H N++RL C + LV+ ++ + ++ +P + T K
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIK 123
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
+ RGL +LH +++HRD+K NIL+ + + DFGLA+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 29/166 (17%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMI 350
S + +G+G FG V+K + G VA+K++ N G EI+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-- 74
Query: 351 SLAVHRNLLRLIGFCMTTTERL--------LVYPYMSN--GSVASRLKAKPSLDWATRKR 400
H N++ LI C T LV+ + + + S + K + KR
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 128
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446
+ GL Y+H KI+HRD+KAAN+L+ + DFGLA
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 31/204 (15%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G FG V G G VAVK +++ + +G + + E++ + L H ++++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHIIKL 76
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 413
T T+ +V Y+S G + + R+ AR + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
++HRD+K N+LLD + A + DFGL+ ++ + T+ G+ + APE +S
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVIS 183
Query: 474 -TGQSSEKTDVFGFGILLLELISG 496
+ + D++ G++L L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 30/123 (24%), Positives = 48/123 (39%), Gaps = 15/123 (12%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
L LQ + LQ+N + +P + L L L L N + L +L L L+
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICATGAE 205
N + + P + ++ +L L L NNLS P + + + N +C
Sbjct: 186 QNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC----- 239
Query: 206 EDC 208
DC
Sbjct: 240 -DC 241
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
L L+ + L +N + L +L TL L + + L LQYL L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYL 136
Query: 151 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+N+L A+P + ++ L L L N +S
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV- 139
+S ++S NL ++ L +N ++ I L+ L LDLS+N +
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101
Query: 140 SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
L L L L+ L + P ++ L +L L N L
Sbjct: 102 HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 1/87 (1%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
Q + L N IS L L L +N + + L L+ L L++N+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 155 LTGAIPPS-LSNMSQLAFLDLSYNNLS 180
++ P+ + +L L L L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 299 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
S+F ++GKG FG V K + AVK L+ + + + E L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 355 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR-----IALGA 405
+ L+ L F T ++L V Y++ G + L+ + R R IA
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYAAEIASA- 151
Query: 406 ARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
L YLH I++RD+K NILLD V+ DFGL K + + T+ GT
Sbjct: 152 ---LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 466 HIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
++APE L Q ++T D + G +L E++ GL
Sbjct: 205 YLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 299 SNFSSKNLVGKGGFGNVY---KGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
F ++GKGG+G V+ K + G + A+K LK + + +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTA--HTKA 70
Query: 355 HRNLLRLIG--------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR----- 400
RN+L + + T +L L+ Y+S G + +L+ +
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAE 129
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
I++ L +LH++ II+RD+K NI+L+ + DFGL K D VT
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTF 181
Query: 461 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
GT+ ++APE L + D + G L+ ++++G
Sbjct: 182 CGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 20/93 (21%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
+ L+ + + NN + + + L LDLS+N + + L+
Sbjct: 271 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLEN 328
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L++NS+ + S L L LS+N+
Sbjct: 329 LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 138
Q L N ++V +N+ + +P + ++ L+L++
Sbjct: 36 MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYA 94
Query: 139 VSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 180
++ T+Q L + N++ +PP N+ L L L N+LS
Sbjct: 95 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 8/106 (7%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
++ + + ++L+ L + I I T + L + N P ++ L
Sbjct: 68 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126
Query: 147 YLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSFHAKTF 191
L L N L+ ++P + N +L L +S NNL TF
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTF 167
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ + +Q + + N I ++P + + L L L N + + L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 147 YLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 180
L ++NN+L I + L L LS N L+
Sbjct: 151 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
N+S L S++ ++ + +N+I+ + + +L L L +N T + + +
Sbjct: 198 NVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLN 252
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L + L+ N L + M +L L +S N L
Sbjct: 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ + +L + N + + + + LD S+N + V L L+
Sbjct: 187 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILK 238
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +N+LT L N L +DLSYN L
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 13/103 (12%), Positives = 33/103 (32%), Gaps = 2/103 (1%)
Query: 79 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
P Q + S++ V + + E L+ + N+ +
Sbjct: 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 70
Query: 139 VSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+ ++ L LN+ + I + + + L + +N +
Sbjct: 71 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 20/99 (20%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N L+ + L+++ L +N++ H+ + +L L L +N +
Sbjct: 286 SNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-- 341
Query: 140 SHLETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYN 177
S TL+ L L++N ++ N+++ A D +
Sbjct: 342 STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 46/222 (20%)
Query: 299 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
+F ++G+G + V K + A+K +K E + E
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTE------ 59
Query: 355 HRNLLRLIG---------FCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALG 404
+++ C T RL V Y++ G + ++ ++++
Sbjct: 60 -KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--------RQRKLPEE 110
Query: 405 AAR--------GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456
AR L YLHE+ II+RD+K N+LLD + D+G+ K
Sbjct: 111 HARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT 166
Query: 457 TTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
T+ GT +IAPE L G+ + D + G+L+ E+++G
Sbjct: 167 TSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 39/156 (25%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMISL 352
+ +G+G +G VYK G A+K+++ G EI E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK---- 58
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLY 411
H N+++L T +LV+ ++ + L L+ T K L G+ Y
Sbjct: 59 --HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
H++ +++HRD+K N+L++ E + DFGLA+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 22/126 (17%), Positives = 43/126 (34%), Gaps = 20/126 (15%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS-------------KLLTLDLSNNFFT 132
+ N+ + + + P G+ + L+L+N +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 133 GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
+P HLE+ L + NSLT +P ++ L + + LS P +
Sbjct: 85 -SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL--EYLG 137
Query: 193 ITGNSL 198
++ N L
Sbjct: 138 VSNNQL 143
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 21/116 (18%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT---------------EIGKLSKLLTL 124
S N L +L +L + +S P E+ S L +
Sbjct: 99 SCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKII 158
Query: 125 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
D+ NN +P +L+++ NN L P L N+ L + N+L
Sbjct: 159 DVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 26/120 (21%), Positives = 40/120 (33%), Gaps = 12/120 (10%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N L +L + NN + +P E+ L L + NN +P
Sbjct: 161 DNNSLKKLPDLPPSLEFIAA---GNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPD-- 212
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNSL 198
+L+ + NN L P L N+ L + N L P + N+ N L
Sbjct: 213 -LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 13/101 (12%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+ +L +L +L N+++ +P L LL + + + P
Sbjct: 79 NNLGLSSLPELPPHLESLVA---SCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-- 132
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+YL ++NN L P L N S L +D+ N+L
Sbjct: 133 -----LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK 166
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 19/104 (18%), Positives = 35/104 (33%), Gaps = 18/104 (17%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL------- 142
+ T LQ L ++N++ +P E + + + + P
Sbjct: 6 RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 143 ------ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L LNN L+ ++P + L L S N+L+
Sbjct: 65 LRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT 104
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 24/114 (21%), Positives = 37/114 (32%), Gaps = 21/114 (18%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP------------TEI-GKLSKLLTLDL 126
N L +LT L + + +S P + L L++
Sbjct: 265 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 324
Query: 127 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
SNN +P+ L+ L + N L +P N L L + YN L
Sbjct: 325 SNNKLIE-LPAL---PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 15/101 (14%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
NL TL +L L + ++N ++ +P L+ LD+S N F+G +
Sbjct: 245 DNNLLKTLPDLPPSLEALNV---RDNYLT-DLPELPQSLTF---LDVSENIFSG-LS--- 293
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L YL ++N + ++ + L L++S N L
Sbjct: 294 ELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 17/116 (14%), Positives = 35/116 (30%), Gaps = 22/116 (18%)
Query: 80 SQNLSGTLSSSIGNLTNL---------------QLVLLQNNNISGHIPTEIGKLSKLLTL 124
S N + NL L + L+ N+ +P L +L
Sbjct: 345 SFNHLAEVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQL--- 401
Query: 125 DLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ N P E+++ LR+N+ + + +L +++
Sbjct: 402 HVETNPLRE-FPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 21/127 (16%), Positives = 36/127 (28%), Gaps = 28/127 (22%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N L + L L N+++ +P L +L + N P
Sbjct: 325 SNNKLIELPALPPRLERLIA---SFNHLA-EVPELPQNLKQL---HVEYNPLRE-FPDIP 376
Query: 140 SHLET----------------LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPV 183
+E L+ L + N L P + + L ++ + P
Sbjct: 377 ESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPY 432
Query: 184 PSFHAKT 190
H T
Sbjct: 433 EFAHETT 439
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 20/158 (12%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-------EIQFQTEVEMIS 351
NF +G+G +G VYK G VVA+K+++ G EI E+
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--- 60
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGL 409
H N+++L+ T + LV+ ++ + + A + K +GL
Sbjct: 61 ---HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
+ H +++HRD+K N+L++ + DFGLA+
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK----DG---NAIGGEIQFQTEV 347
S++S F +G G + VYKG G VA+K +K +G AI EI E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKEL 60
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN------GSVASRLKAKPSLDWATRKRI 401
+ H N++RL T + LV+ +M N S + L+ K
Sbjct: 61 K------HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELNLVKYF 113
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446
+GL + HE KI+HRD+K N+L+++ + +GDFGLA
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
+ L+ + + NN + + + L LDLS+N + + L+ L L+
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLD 326
Query: 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+NS+ + S L L LS+N+
Sbjct: 327 HNSIV-TLKL--STHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 138
Q L N ++V +N+ + +P + ++ L+L++
Sbjct: 30 MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYA 88
Query: 139 VSHLETLQYLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 180
++ T+Q L + N++ +PP N+ L L L N+LS
Sbjct: 89 FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ + +Q + + N I ++P + + L L L N + + L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 147 YLRLNNNSLTGAIPPS-LSNMSQLAFLDLSYNNLS 180
L ++NN+L I + L L LS N L+
Sbjct: 145 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 24/115 (20%), Positives = 45/115 (39%), Gaps = 9/115 (7%)
Query: 82 NLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+ S + + L ++ LQ+NN++ + L+ +DLS N +
Sbjct: 211 DASHNSINVVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNIT 194
++ L+ L ++NN L A+ + L LDLS+N+L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL----HVERNQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 5/99 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
N+S L S++ ++ + +N+I+ + + +L L L +N T + + +
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLN 246
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L + L+ N L + M +L L +S N L
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ + +L + N + + + + LD S+N + V L L+
Sbjct: 181 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILK 232
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +N+LT L N L +DLSYN L
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 13/103 (12%), Positives = 33/103 (32%), Gaps = 2/103 (1%)
Query: 79 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
P Q + S++ V + + E L+ + N+ +
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 64
Query: 139 VSHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+ ++ L LN+ + I + + + L + +N +
Sbjct: 65 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 9/144 (6%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQT--EVEMISLAVHRNLLRLIG 363
+G+G +G V+K G +VA+K+ + I+ E+ M+ H NL+ L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV-IKKIALREIRMLKQLKHPNLVNLLE 69
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIH 422
LV+ Y + +V L + K I + + + H+ IH
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIH 125
Query: 423 RDVKAANILLDEYYEAVVGDFGLA 446
RDVK NIL+ ++ + DFG A
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFA 149
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 55/201 (27%), Positives = 80/201 (39%), Gaps = 27/201 (13%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G G FG +VAVK ++ G AI +Q E+ H N++R +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVIL 86
Query: 367 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDP 418
T T ++ Y S G + R+ R + AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI--------CNAGRFSEDEARFFFQQLLSGVSYCHSM--- 135
Query: 419 KIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-TG 475
+I HRD+K N LLD + DFG +K S + V GT +IAPE L
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVLLRQE 193
Query: 476 QSSEKTDVFGFGILLLELISG 496
+ DV+ G+ L ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVG 214
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 46/256 (17%)
Query: 265 HNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVY----KGYL 320
N + EE N + +F ++G+G + V K
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-- 75
Query: 321 QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG---------FCMTTTER 371
+ A++ +K E + E +++ C T R
Sbjct: 76 -TDRIYAMRVVKKELVNDDEDIDWVQTE-------KHVFEQASNHPFLVGLHSCFQTESR 127
Query: 372 L-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLHEQCDPKIIH 422
L V Y++ G + ++ ++++ AR L YLHE+ II+
Sbjct: 128 LFFVIEYVNGGDLMFHMQ--------RQRKLPEEHARFYSAEISLALNYLHER---GIIY 176
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT- 481
RD+K N+LLD + D+G+ K T+ GT +IAPE L G+ +
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSV 234
Query: 482 DVFGFGILLLELISGL 497
D + G+L+ E+++G
Sbjct: 235 DWWALGVLMFEMMAGR 250
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 24/99 (24%), Positives = 39/99 (39%), Gaps = 7/99 (7%)
Query: 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS----HLETLQYLR 149
L+++ + + ++ L TLDLS+N G + TLQ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 150 LNNN---SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L N + +G + QL LDLS+N+L +
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 23/103 (22%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV 139
+ SG S+ LQ + L +N++ S+L +L+LS
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182
+ L L L+ N L PS + Q+ L L N
Sbjct: 274 AKLSV---LDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 28/110 (25%), Positives = 38/110 (34%), Gaps = 9/110 (8%)
Query: 80 SQNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEI----GKLSKLLTLDLSNNFFT-- 132
+Q S S + L + L +N G K L L L N
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 133 -GPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
G + + LQ L L++NSL A SQL L+LS+ L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 4/111 (3%)
Query: 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET---LQYL 148
G + L+ + T+I K L L + I + LQ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS-GPVPSFHAKTFNITGNSL 198
L N +TG PP L + L+ N+S ++ A+ L
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 295 QSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKR-LKDGNAIGGEIQFQTEVEMISL 352
+ F + + G+G FG V G + G VA+K+ ++D E+Q ++ +++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAV 75
Query: 353 AVHRNLLRLIGFCMTTTER-------LLVYPYMS---NGSVASRLKAKPSLDWATRKRIA 402
H N+++L + T ER +V Y+ + + + + + K
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTAV- 460
R + LH + HRD+K N+L++E + DFG AK L + +V
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 461 ---RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
R APE + Q + D++ G + E++ G
Sbjct: 195 RYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 300 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLK----DG---NAIGGEIQFQTEVEMIS 351
+ + +G+G + VYKG +VA+K ++ +G AI E+ +++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLK--- 58
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLL 410
H N++ L T LV+ Y+ + L + ++ K RGL
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447
Y H Q K++HRD+K N+L++E E + DFGLA+
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 27/127 (21%), Positives = 46/127 (36%), Gaps = 11/127 (8%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-LSKLLTLDLSNNFFT---GPIPS 137
L LS+ L ++ + ++N+ + +P + L L LDLS N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 138 TVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTF 191
+LQ L L+ N L L + L LD+S N S +
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFL 415
Query: 192 NITGNSL 198
N++ +
Sbjct: 416 NLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 28/126 (22%), Positives = 44/126 (34%), Gaps = 14/126 (11%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S+N + S ++ + L + I + T I L LD+SNN S
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD----SFS 447
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNIT 194
L LQ L ++ N L +P + S L + +S N L + +
Sbjct: 448 LFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 195 GNSLIC 200
N C
Sbjct: 506 TNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 25/106 (23%), Positives = 44/106 (41%), Gaps = 3/106 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS 140
++ + NLQ+++L+++ I+ I + L L LDLS+N + S
Sbjct: 37 KITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 141 HLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPS 185
L +L+YL L N SL N++ L L + +
Sbjct: 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 1/116 (0%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLET 144
++S NLTNLQ + + N I L+ L L++ ++ +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 145 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 200
+ +L L+ + + +S + +L+L NL+ S + +
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 18/89 (20%), Positives = 36/89 (40%)
Query: 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
G ++ + L N I+ ++ + L L L ++ L +L++L L+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+N L+ +S L +L+L N
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 6/93 (6%)
Query: 93 NLTNLQLVLLQNNNIS---GHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQY 147
+L +L+ + L N + G L TL LS N + L+ L
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L ++ N+ +P S ++ FL+LS +
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 16/112 (14%), Positives = 36/112 (32%)
Query: 69 SDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128
+D L + + + T L + + + L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + + S LE ++ + + N+ + ++ L FLDLS N +
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 12/93 (12%), Positives = 31/93 (33%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
LT+L + ++ ++ + + + + L L + + L +++Y
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L + +L L + + S
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAI-GGEIQ-FQTEVEMISLAVH 355
F +G G FG V ++ G A+K L + +I+ E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 356 RNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
L++L F L +V Y++ G + S L+ + A YLH
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+I+RD+K N+L+D+ V DFG AK + T + GT +APE + +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILS 212
Query: 475 GQSSEKTDVFGFGILLLELISGL 497
++ D + G+L+ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 299 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
++F+ ++GKG FG V KG + AVK LK I + T VE LA+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 355 HRN---LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL 410
L +L C T +RL V Y++ G + ++ A A GL
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 411 YLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPE 470
+L + II+RD+K N++LD + DFG+ K + D T GT +IAPE
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPE 191
Query: 471 YLSTGQSSEKT-DVFGFGILLLELISGL 497
+ Q K+ D + FG+LL E+++G
Sbjct: 192 II-AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 299 SNFSSKNLVGKGGFGNV----YKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
++F L+GKG FG V K G A+K L+ I + T E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 355 HRN--LLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKR-----IALGAA 406
R+ L L + T +RL V Y + G + L + R R I
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYGAEIVSA-- 117
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
L YLH + +++RD+K N++LD+ + DFGL K D GT +
Sbjct: 118 --LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEY 171
Query: 467 IAPEYLSTGQSSEKT-DVFGFGILLLELISGL 497
+APE L + D +G G+++ E++ G
Sbjct: 172 LAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 30/176 (17%)
Query: 307 VGKGGFGNVYKG---YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
VG+G +G+VYK +D A+K+++ G + E+ ++ H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQK 85
Query: 364 FCMTTTERL--LVYPYMS--------NGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 413
++ +R L++ Y + K L K + G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAV----VGDFGLA-------KLLDHCDSHVTT 458
++HRD+K ANIL+ + D G A K L D V T
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 25/101 (24%), Positives = 41/101 (40%), Gaps = 12/101 (11%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N +L + L L + N ++ +P +L +L +S N T +P
Sbjct: 209 YNNRLTSLPALPSGLKELIV---SGNRLT-SLPVLPSELKEL---MVSGNRLTS-LPML- 259
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L + N LT +P SL ++S ++L N LS
Sbjct: 260 --PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 15/101 (14%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N +L + L L+ + N ++ +P L +L
Sbjct: 69 PDNNLTSLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-- 122
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L + N LT ++P L L +S N L+
Sbjct: 123 -----LCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 14/87 (16%), Positives = 36/87 (41%), Gaps = 8/87 (9%)
Query: 94 LTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153
++ + + ++ +P + + TL + +N T +P+ L+ L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA---LPPELRTLEVSGN 91
Query: 154 SLTGAIPPSLSNMSQLAFLDLSYNNLS 180
LT ++P + +L+ +L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP 117
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 27/117 (23%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG----------------HIPTEIGKLSKLLT 123
S N +L L L + ++ +P L +
Sbjct: 89 SGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQE--- 145
Query: 124 LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +S+N +P+ S L L NN LT ++P S L L +S N L+
Sbjct: 146 LSVSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 11/100 (11%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N +L L L + N ++ +P L L + N T +P ++
Sbjct: 229 SGNRLTSLPVLPSELKELMV---SGNRLT-SLPMLPSGLLSL---SVYRNQLTR-LPESL 280
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
HL + + L N L+ +L + ++ +
Sbjct: 281 IHLSSETTVNLEGNPLS---ERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 15/101 (14%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N +L L L + +N ++ +P +L KL NN T +P
Sbjct: 129 FGNQLTSLPVLPPGLQELSV---SDNQLA-SLPALPSELCKL---WAYNNQLTS-LPML- 179
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
LQ L +++N L ++P S L L N L+
Sbjct: 180 --PSGLQELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT 214
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 12/91 (13%), Positives = 27/91 (29%), Gaps = 4/91 (4%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
+L L +L + N ++ +P + LS T++L N + + + +
Sbjct: 255 SLPMLPSGLLSLSV---YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 176
A + L +
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 33/205 (16%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G G FG V G G VAVK +++ + +G + + E++ + L H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHIIKL 81
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 413
T ++ +V Y+S G + + R+ +R G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
++HRD+K N+LLD + A + DFGL+ ++ + T+ G+ + APE +S
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVIS 188
Query: 474 TGQSSE--KTDVFGFGILLLELISG 496
G+ + D++ G++L L+ G
Sbjct: 189 -GRLYAGPEVDIWSSGVILYALLCG 212
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 5/89 (5%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
+ L + + + NI+ IP G L L L N T +++ L L L L+
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 153 NSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
NS++ A+ SL+N L L L+ N L
Sbjct: 226 NSIS-AVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 92 GNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150
G +L + L N I+ + L+ L L LS N + ++++ L+ L L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
NNN L +P L++ + + L NN+S
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L NL + L N+IS + L L L+NN +P ++ + +Q + L+N
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHN 272
Query: 153 NSLTG------AIPPSLSNMSQLAFLDLSYNNLS 180
N+++ P + + + + L N +
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L L+ + L N + +P ++ L L + N T S + L + + L
Sbjct: 98 PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154
Query: 153 NSLT-GAIPP-SLSNMSQLAFLDLSYNNLS 180
N L I + M +L+++ ++ N++
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 24/86 (27%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
+ L+ LQNN I+ + L L TL L NN + P + L L+ L L+ N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 155 LTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +P + L L + N ++
Sbjct: 112 LK-ELPEKMP--KTLQELRVHENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG------PIPSTVSHLETLQ 146
N +L+ + L NN + +P + + + L NN + P + +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 147 YLRLNNNSLT-GAIPPSL-SNMSQLAFLDLSYN 177
+ L +N + I PS + A + L
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
+L++V + + +P ++ LDL NN T +L+ L L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 156 TGAIPPSLSNMSQLAFLDLSYNNLS 180
+ P + + + +L L LS N L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK 113
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 6/121 (4%)
Query: 82 NLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPST 138
+S + I L + L +N I I E + SKL L L +N +
Sbjct: 178 RISEAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGS 236
Query: 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHAKTFNITGNS 197
+S L TL+ L L+NN L+ +P L ++ L + L NN++ V F F +
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295
Query: 198 L 198
Sbjct: 296 Y 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 7/95 (7%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
L +L ++L NN IS I + L KL L +S N IP + +L
Sbjct: 71 KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLV 126
Query: 147 YLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
LR+++N + +P S + + +++ N L
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 25/102 (24%), Positives = 40/102 (39%), Gaps = 10/102 (9%)
Query: 93 NLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
L N+ + + N + + KL L +S TG IP + ETL L L+
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLD 201
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
+N + AI L S+L L L +N + + +
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIR----MIENGSLS 238
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
+ L + L +N I I L L L L NN + +P+ + L+ LQ + L+
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLH 272
Query: 152 NNSLTGAIPPS-------LSNMSQLAFLDLSYNNLS 180
N++T + + + + L N +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 22/87 (25%), Positives = 32/87 (36%), Gaps = 7/87 (8%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNS 154
L + + ++ IP ++ L L L +N I L L L +N
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 155 LTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+ I SLS + L L L N LS
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 28/86 (32%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
+ L+ LQNN+IS + L L L L NN + S L LQ L ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 155 LTGAIPPSLSNMSQLAFLDLSYNNLS 180
L IPP+L S L L + N +
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIR 136
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 9/93 (9%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET------LQ 146
L L+ + L NN +S +P + L L + L N T + +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297
Query: 147 YLRLNNNSLT-GAIPPSL-SNMSQLAFLDLSYN 177
+ L NN + + P+ ++ +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/86 (26%), Positives = 38/86 (44%), Gaps = 5/86 (5%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
+L++V + + +P EI LDL NN + L+ L L L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 156 TGAIPP-SLSNMSQLAFLDLSYNNLS 180
+ I + S + +L L +S N+L
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV 115
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 14/85 (16%)
Query: 82 NLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEI-------GKLSKLLTLDLSNNF 130
+L + + + +L LQ+V L NNI+ + K + + L NN
Sbjct: 247 HLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 131 FTGPI--PSTVSHLETLQYLRLNNN 153
P+T + ++ N
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 23/196 (11%), Positives = 51/196 (26%), Gaps = 40/196 (20%)
Query: 306 LVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEIQ--FQTEVEMISLAVHRNLLR 360
G ++ D VA+ + + ++ + +S + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
++ T L+V ++ GS+ PS A R A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA---GV 150
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEK 480
+ + + + V+ + ++ +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD--ANPQ 182
Query: 481 TDVFGFGILLLELISG 496
D+ G G L L+
Sbjct: 183 DDIRGIGASLYALLVN 198
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 5e-12
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 4/93 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L + + L +N + +P + L L L S+N + V++L LQ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQEL 513
Query: 149 RLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLS 180
L NN L A L + +L L+L N+L
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 5e-07
Identities = 18/78 (23%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPST 138
S N L ++ L L+++ +N + ++ + L +L L L NN
Sbjct: 471 SHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP 528
Query: 139 VSHLETLQYLRLNNNSLT 156
+ L L L NSL
Sbjct: 529 LVSCPRLVLLNLQGNSLC 546
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ + NLT + + L N + + I L + TLDL++ T P ++ L LQ L
Sbjct: 79 APLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ N +T I P L+ ++ L +L + +S
Sbjct: 135 YLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 24/92 (26%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L NL + L++N I+ + + L+K+ L+LS N S ++ L++++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTL 112
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L + +T P L+ +S L L L N ++
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ +L + + ++ I + L+ L+ L+L +N T P + +L + L
Sbjct: 35 VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ N L + ++ + + LDL+ ++
Sbjct: 91 ELSGNPLKN-VSA-IAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L N + +N++ L + TL T I V +L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKD 72
Query: 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
N +T + P L N++++ L+LS N L
Sbjct: 73 NQITD-LAP-LKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 7/113 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ + NL+ L + +N IS I + L L+ + L NN + P +++ L +
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTF---NITGNSL 198
L N ++T +N+ + P T+ N+T N
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 4/94 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S + +L NL V L+NN IS P + S L + L+N T ++L +
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182
+ + + P ++S+ A +L++N S
Sbjct: 247 KGPSGAPI--APATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 14/80 (17%), Positives = 30/80 (37%), Gaps = 6/80 (7%)
Query: 101 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 160
+ Q I+ P L+ + + + T T + L+ + L +T I
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE 57
Query: 161 PSLSNMSQLAFLDLSYNNLS 180
+ ++ L L+L N ++
Sbjct: 58 G-VQYLNNLIGLELKDNQIT 76
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 30/91 (32%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
G L L + L +N + +P L L LD+S N T +P L LQ L L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
N L +PP L + +L L L+ NNL+
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLE 143
+L L L ++ + N ++ +P L +L L L N +P + +
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTP 148
Query: 144 TLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
L+ L L NN+LT +P L + + L L L N+L
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
+ ++ L N + + ++L L+L T + L L L L++N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQ 88
Query: 155 LTGAIPPSLSNMSQLAFLDLSYNNLS 180
L ++P + L LD+S+N L+
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 28/87 (32%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
L LQ + L+ N + +P + KL L L+NN T +P+ + + LE L L L
Sbjct: 122 GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLL 179
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYN 177
NSL IP L F L N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 16/121 (13%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
+ NL+ + L +N++ + + L L L L NN + + LQ L L
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYL 143
Query: 151 NNNSLTGAIPP----SLSNMSQLAFLDLSYNNLS-------GPVPSFHAKTFNITGNSLI 199
+ N ++ P + + +L LDLS N L +P++ + N L
Sbjct: 144 SQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
Query: 200 C 200
C
Sbjct: 203 C 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 31/124 (25%), Positives = 54/124 (43%), Gaps = 20/124 (16%)
Query: 61 CSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI--GKL 118
C+ +++CS L Q+L + L+ L +NN+S + E +L
Sbjct: 18 CASNILSCSK---QQLPNVPQSLP----------SYTALLDLSHNNLS-RLRAEWTPTRL 63
Query: 119 SKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSY 176
+ L +L LS+N I S + L+YL L++N L + S++ L L L
Sbjct: 64 TNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYN 121
Query: 177 NNLS 180
N++
Sbjct: 122 NHIV 125
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 21/98 (21%), Positives = 38/98 (38%), Gaps = 10/98 (10%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNS 154
++ + ++P + + LDLS+N + + L L L L++N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 155 LTGAIPP-SLSNMSQLAFLDLSYNNLSGPVPSFHAKTF 191
L I + + L +LDLS N+L + F
Sbjct: 76 LN-FISSEAFVPVPNLRYLDLSSNHLH----TLDEFLF 108
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 299 SNFSSKNLVGKGGFGNVY----KGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVE------ 348
+F +G G FG V+ + +G A+K LK + +VE
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKE-----IVVRLKQVEHTNDER 57
Query: 349 -MISLAVHRNLLRLIGFCMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRK----RIA 402
M+S+ H ++R+ +++ ++ Y+ G + S L+ K +
Sbjct: 58 LMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRG 462
L L YLH + II+RD+K NILLD+ + DFG AK + VT + G
Sbjct: 117 LA----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCG 165
Query: 463 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
T +IAPE +ST ++ D + FGIL+ E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 35/176 (19%), Positives = 58/176 (32%), Gaps = 15/176 (8%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETL 145
+S L +LQ + ++ I LS L+ L L N F + + + L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANL 105
Query: 146 QYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFNITGNS 197
+ L L +L GA+ ++ L L L NN+ P F ++T N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165
Query: 198 LICATGAEEDCFGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLIL 253
+ E+ L S + M + G+ S+ L
Sbjct: 166 VKS---ICEEDLLNFQGKHFTLLRLSSITLQD-MNEYWLGWEKCGNPFKNTSITTL 217
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 19/168 (11%)
Query: 50 LNNWDENSVDPCSWALVTCSDGLVTGLGAPSQ---NLSG----TLSSSI-GNLTNLQLVL 101
L+N + GL A +LS L S+ + T+L+ +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 102 LQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAI 159
L N I+ I L+ LL L+LS NF I S + +L+ L+ L L+ N + A+
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-AL 362
Query: 160 PP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSLICA 201
S + L L L N L S P F + + N C+
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 3/91 (3%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
++ V L N+I+ T +L L L + I + L +L L+L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 154 SLTGAIPPS-LSNMSQLAFLDLSYNNLSGPV 183
+ + ++ L L L+ NL G V
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 22/118 (18%), Positives = 44/118 (37%), Gaps = 17/118 (14%)
Query: 79 PSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKL---SKLLTLDLSNNF----- 130
L + T++ + L N + +K+ +L LSN++
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 131 -----FTGPIPSTVSHLET--LQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
F P T LE ++ L+ + + A+ S+ S+ + L L L+ N ++
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 80 SQN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG---KLSKLLTLDLSNNFFTGPI 135
S N L+ T+ + G+LT L+ ++LQ N + + ++ L LD+S N +
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 136 PSTV-SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
S ++L L +++N LT I L ++ LDL N +
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 21/107 (19%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTV 139
++ + NN ++ + G L++L TL L N I
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT 370
Query: 140 SHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPS 185
+ +++LQ L ++ NS++ S L L++S N L+ +
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
+ +LQ + + N++S LL+L++S+N T I ++ L L+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLH 429
Query: 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICA 201
+N + +IP + + L L+++ N L P F + + N C+
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+S +S I +L+ L+++++ +N I + +L LDLS+N I
Sbjct: 32 YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISC--HP 88
Query: 142 LETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLS 180
L++L L+ N+ A+P NMSQL FL LS +L
Sbjct: 89 TVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 36/221 (16%), Positives = 65/221 (29%), Gaps = 11/221 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
++ + N IS ++I LSKL L +S+N S + L+YL L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 155 LTGAIPPSLSNMSQLAFLDLSYNNLS--GPVPSFHA----KTFNITGNSLICATGAEEDC 208
L N L LDLS+N F K ++ L ++
Sbjct: 81 LVKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 209 FGTAPMPLSFALNNSPNSKPSGMPKGQKIALALGSSLGCISLLILGFGF--LLWWRQRHN 266
+ + L P G+ +L + IL + +
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 267 QQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLV 307
+ + D + L + + +
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 24/96 (25%), Positives = 36/96 (37%), Gaps = 4/96 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
+N+ + + K+S L LD SNN T + HL L+ L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 153 NSLTGAIPPS---LSNMSQLAFLDLSYNNLSGPVPS 185
N L + + M L LD+S N++S
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 22/162 (13%), Positives = 41/162 (25%), Gaps = 13/162 (8%)
Query: 50 LNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNL---TNLQLVLLQNNN 106
D S ++ ++ L + + I L T + + N
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
Query: 107 ISGHIPTEIG-----KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 161
+ G + L L + ++ F P + +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318
Query: 162 SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSL 198
S +S LD S N L + +T + N L
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 25/99 (25%), Positives = 47/99 (47%), Gaps = 8/99 (8%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+ T + S L L + N++I+ T I KL+ L L ++N T + +S
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQ 83
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L YL ++N LT + ++ +++L +L+ N L+
Sbjct: 84 NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 8/91 (8%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ + T L + N ++ ++L TLD S N T VS + L L
Sbjct: 143 DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ N++T L+ QL FLD S N L+
Sbjct: 198 CDTNNITK---LDLNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+ T L + N I+ + + + L L+ N T ++
Sbjct: 157 LNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQ 210
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +L ++N LT I ++ ++QL + D S N L+
Sbjct: 211 NIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 26/112 (23%), Positives = 44/112 (39%), Gaps = 12/112 (10%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ TNL + +N ++ ++ + L+KL L+ N T VS L YL
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLN 133
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 198
N+LT +S+ +QL LD N + T + + N +
Sbjct: 134 CARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
+ T I N QL+ Q ++ ++L LD T + +S
Sbjct: 260 HCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQ 316
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L YL LNN LT + +S+ ++L L ++
Sbjct: 317 NPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 7/105 (6%)
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
N + + +L+ L +LD N+ T + + L L L +N++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI 76
Query: 156 TGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-KTFNITGNSL 198
T + LS + L +L N L+ V N N L
Sbjct: 77 T-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 19/90 (21%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ L + +N ++ I + L++L D S N T + VS L L L
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLH 260
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
L I L++ +QL +
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRK 287
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 16/99 (16%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
+ + T L+ + N +I +GK+ L + T+++ +
Sbjct: 334 DVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVS 391
Query: 150 LNNNSLTG---AIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
+ G I P + A +++ NLS P+
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 14/83 (16%), Positives = 29/83 (34%), Gaps = 7/83 (8%)
Query: 98 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 157
L Q + + P + + + + L TL L +N+S+T
Sbjct: 2 TLKAGQTQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD 56
Query: 158 AIPPSLSNMSQLAFLDLSYNNLS 180
+ ++ L L + NN++
Sbjct: 57 M--TGIEKLTGLTKLICTSNNIT 77
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVK-----RLKDGNAIGGEIQFQTEVEMISLAVHRNLLRL 361
G+G FG V + VA+K LK + + + E+ + L H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM---RVEREISYLKLLRHPHIIKL 74
Query: 362 IGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR--------GLLYLH 413
T T+ ++V Y + G + + +KR+ R + Y H
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYI--------VEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
KI+HRD+K N+LLD+ + DFGL+ ++ + + T+ G+ + APE ++
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC-GSPNYAAPEVIN 180
Query: 474 TGQSSE--KTDVFGFGILLLELISG 496
G+ + DV+ GI+L ++ G
Sbjct: 181 -GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
SS+ +L L+ + L++N IS I + L +L +L L NN T + +S L L L
Sbjct: 103 SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTL 158
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +N ++ I P L+ +++L L LS N++S
Sbjct: 159 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 10/94 (10%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP--STVSHLETLQ 146
I L N+ + L N ++ I + L L L L N I S++ L+ L+
Sbjct: 59 QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLK 112
Query: 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L +N ++ I L ++ QL L L N ++
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ NL NL + L N I + + + L KL +L L +N + + + HL L+ L
Sbjct: 81 KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESL 136
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L NN +T LS +++L L L N +S
Sbjct: 137 YLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L ++ ++ N++I + I L + L L+ N T I +++L+ L +L
Sbjct: 37 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWL 92
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ N + + L ++ +L L L +N +S
Sbjct: 93 FLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ + LT L + L++N IS I + L+KL L LS N + ++ L+ L L
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVL 202
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
L + SN+ + + +L P +
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 10/90 (11%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPSTVSHLETLQYLRL 150
L+ +++ + +L+ + + +N+ I +L + L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGI----QYLPNVTKLFL 72
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
N N LT I P L+N+ L +L L N +
Sbjct: 73 NGNKLTD-IKP-LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 4/92 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ LT LQ + L N+IS + L L L+L + + S+L +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + SL P +S+ ++ ++
Sbjct: 227 KNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 11/105 (10%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLN 151
L++LQ ++ N++ IG L L L++++N +P S+L L++L L+
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 152 NNSLTGAIPP----SLSNMSQLAF-LDLSYNNLSGPVPSFHAKTF 191
+N + +I L M L LDLS N ++ F
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAF 197
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
+ LQ++ L I I LS L TL L+ N + S L +LQ L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVA 107
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
+L ++ ++ L L++++N +
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKL----LTLDLSNNFFTGPIPSTVSHLETLQY 147
NLTNL+ + L +N I I L ++ L+LDLS N I L+
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204
Query: 148 LRLNNNSLTGAIPP-SLSNMSQLAFLDLSYN 177
L L+ N L ++P ++ L + L N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 6/98 (6%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ IG+L L+ + + +N I E L+ L LDLS+N + + L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 147 Y----LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L+ N + I P +L L L N L
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 17/71 (23%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQL 169
IP + LDLS N + LQ L L+ + I ++S L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 170 AFLDLSYNNLS 180
+ L L+ N +
Sbjct: 79 STLILTGNPIQ 89
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 18/74 (24%), Positives = 28/74 (37%), Gaps = 2/74 (2%)
Query: 81 QNLSGTLSSSIGNLTNLQLVL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
Q++ T + + L L L L N ++ I K +L L L N
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIF 220
Query: 140 SHLETLQYLRLNNN 153
L +LQ + L+ N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 39/236 (16%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQT---------EV 347
S ++ + + G +G V G +G VA+KR+ + + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 348 EMISLAVHRNLLRLIG-FCMTTTERL----LVYPYMS---NGSVASRLKAKPSLDWATRK 399
+++ H N+L L F + LV M + + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQ 137
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459
GL LHE ++HRD+ NILL + + + DF LA+ D++ T
Sbjct: 138 YFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA-DANKTHY 193
Query: 460 V-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
V R APE + ++ D++ G ++ E+ + +AL G NQ
Sbjct: 194 VTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQ 242
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
SS+ +L L+ + L++N IS I + L +L +L L NN T + +S L L L
Sbjct: 106 SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTL 161
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +N ++ I P L+ +++L L LS N++S
Sbjct: 162 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 10/94 (10%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP--STVSHLETLQ 146
I L N+ + L N ++ I + L L L L N + S++ L+ L+
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDEN----KVKDLSSLKDLKKLK 115
Query: 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L +N ++ I L ++ QL L L N ++
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 21/92 (22%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ L ++ ++ N++I + I L + L L+ N T P +++L+ L +L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L+ N + + L ++ +L L L +N +S
Sbjct: 96 FLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 4/104 (3%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ + LT L + L++N IS I + L+KL L LS N + ++ L+ L L
Sbjct: 150 TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVL 205
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
L + SN+ + + +L P +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+ LT LQ + L N+IS + + L L L+L + + S+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + SL P +S+ ++ ++
Sbjct: 230 KNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S L+ +++ + +L+ + + +N+ + + +L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-V-QGIQYLPNVTKL 73
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
LN N LT I P L+N+ L +L L N +
Sbjct: 74 FLNGNKLT-DIKP-LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 11/80 (13%), Positives = 29/80 (36%), Gaps = 6/80 (7%)
Query: 101 LLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 160
+ I ++ + +L T T + L ++ + NN+ + ++
Sbjct: 8 ITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ 62
Query: 161 PSLSNMSQLAFLDLSYNNLS 180
+ + + L L+ N L+
Sbjct: 63 G-IQYLPNVTKLFLNGNKLT 81
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 24/153 (15%)
Query: 308 GKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM 366
G G G V + + + A+K L+D E++ + +++R++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDVYE 81
Query: 367 TTTER----LLVYPYMSNGSVASRLKAKPSLDWATRK-----RIALGAARGLLYLHEQCD 417
L+V + G + SR++ + + R+ + A + YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSI-- 136
Query: 418 PKIIHRDVKAANILL---DEYYEAVVGDFGLAK 447
I HRDVK N+L + DFG AK
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 38/243 (15%)
Query: 287 KRFHFKELQSAT----SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI 341
+F+ E+ +T + + +G G G V Y VA+K+L
Sbjct: 46 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------- 97
Query: 342 QFQT---------EVEMISLAVHRNLLRLI------GFCMTTTERLLVYPYMSNGSVASR 386
FQ E+ ++ H+N++ L+ + LV M + +
Sbjct: 98 PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQ 155
Query: 387 LKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446
+ LD + G+ +LH IIHRD+K +NI++ + DFGLA
Sbjct: 156 VIQME-LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-T 505
+ S + T T + APE + E D++ G ++ E++ + L G+
Sbjct: 212 RTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDY 268
Query: 506 ANQ 508
+Q
Sbjct: 269 IDQ 271
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 40/231 (17%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
+ + +G G G V Y VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 348 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKA--KPSLDWATR 398
++ H+N++ L+ T + L +V M + L + LD
Sbjct: 76 VLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHERM 129
Query: 399 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458
+ G+ +LH IIHRD+K +NI++ + DFGLA+ S + T
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 184
Query: 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
T + APE + E D++ G ++ E+I G L G +Q
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQ 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 4e-10
Identities = 33/210 (15%), Positives = 55/210 (26%), Gaps = 48/210 (22%)
Query: 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRL-------------KDGNAIGGEIQF 343
T +G+G FG V++ D T VA+K + K I EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 344 QTEVEMISLAV---HRNLLRLIGFCM-----------------------------TTTER 371
E+ ++S V + L ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 431
L + G + AT K I L + HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194
Query: 432 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461
L + + K + ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 27/101 (26%), Positives = 43/101 (42%), Gaps = 15/101 (14%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+QN +L +L L +N +S +P L LD+ NN T +P
Sbjct: 88 TQNALISLPELPASLEYLD---ACDNRLS-TLPELPASLKH---LDVDNNQLTM-LPELP 139
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ LE Y+ +NN LT +P ++ L L + N L+
Sbjct: 140 ALLE---YINADNNQLT-MLPELPTS---LEVLSVRNNQLT 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 15/101 (14%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N TL +L +L + NN ++ +P L + + NN T +P
Sbjct: 108 CDNRLSTLPELPASLKHLDV---DNNQLT-MLPELPALLEYI---NADNNQLTM-LPELP 159
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ LE L + NN LT +P + L LD+S N L
Sbjct: 160 TSLEVL---SVRNNQLT-FLPELPES---LEALDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 19/117 (16%), Positives = 36/117 (30%), Gaps = 7/117 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVL----LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI 135
S NL +L + + + + N I+ HIP I L T+ L +N + I
Sbjct: 188 STNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246
Query: 136 PSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
++S + + N D S ++ ++
Sbjct: 247 RESLSQQTAQPDYHGPRIYFS--MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 18/101 (17%), Positives = 43/101 (42%), Gaps = 14/101 (13%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
++ +L ++ + ++ + N + +P L L D +N + +P
Sbjct: 67 NRLNLSSLPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPEL- 118
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+L++L ++NN LT +P + L +++ N L+
Sbjct: 119 --PASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT 153
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
LT L+L+ L +N + +P I +L L TL +++N +P V L L LRL
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
+ N L ++PP + ++++L +L L YN L
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
+ + + LQ+N +S +L+KL L L++N +P+ + L+ L+ L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
L A+P + + LA L L N L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 6/91 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
L NL+ + + +N + +P + +L L L L N +P V L L YL L
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSL 140
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
N L ++P + ++ L L L N L
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 28/91 (30%), Positives = 40/91 (43%), Gaps = 6/91 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
L NL + L N + +P + L+KL L L N +P V L +L+ LRL
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRL 164
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
NN L +P +++L L L N L
Sbjct: 165 YNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
+LT L + L N + +P + KL+ L L L NN +P L L+ L+L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKL 188
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYN 177
+NN L + ++ +L L L N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 6e-10
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 13/104 (12%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQ 168
+ L L + N + + L L+ L + + L + P + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 169 LAFLDLSYNNLS----GPVPSFHAKTFNITGNSLICATGAEEDC 208
L+ L+LS+N L V + ++GN L C C
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC------SC 119
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 19/92 (20%), Positives = 32/92 (34%), Gaps = 2/92 (2%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTE-IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
+ NL + ++N H+ + L +L L + + P L
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
L L+ N+L ++ L L LS N L
Sbjct: 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 1e-05
Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 4/79 (5%)
Query: 80 SQNLSGTL-SSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPS 137
+Q L + L L+ + + + + + + +L L+LS N
Sbjct: 40 NQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWK 98
Query: 138 TVSHLETLQYLRLNNNSLT 156
TV L +LQ L L+ N L
Sbjct: 99 TVQGL-SLQELVLSGNPLH 116
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 22/106 (20%), Positives = 44/106 (41%), Gaps = 8/106 (7%)
Query: 80 SQN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT----GP 134
+QN + ++ L LQ ++LQ N + + + +L+ +
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 135 IPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
T + E++ L L++N LTG++ L ++ LDL N +
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 22/100 (22%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+N + N+++L+ + + N++ S +L L+LS+N TG + +
Sbjct: 390 KNFFKV-ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
++ L L+NN + +IP ++++ L L+++ N L
Sbjct: 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 84 SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLT-LDLSNNFFTGPIPSTVSHL 142
S + ++ ++ L +N ++G + L + LDL NN IP V+HL
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFR---CLPPKVKVLDLHNNRIMS-IPKDVTHL 472
Query: 143 ETLQYLRLNNNSLTGAIPP-SLSNMSQLAFLDLSYNN 178
+ LQ L + +N L ++P ++ L ++ L N
Sbjct: 473 QALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 17/114 (14%)
Query: 68 CSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLS 127
C+ L+ G P N ++ V N N++ H+P ++ + L LS
Sbjct: 16 CALALIVGSMTPFSNELESM------------VDYSNRNLT-HVPKDL--PPRTKALSLS 60
Query: 128 NNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
N + +S L L+ LRL++N + ++ + L +LD+S+N L
Sbjct: 61 QNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ 113
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 13/148 (8%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIG-----KLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
++ + + N I+ I E L L+ + N F + S +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSLICAT 202
L+ + + S FL+ + N + +T + N L
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL---K 390
Query: 203 GAEEDCFGTAPMPLSFALNNSPNSKPSG 230
+ T M L+ S NS S
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSH 418
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 49/235 (20%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
+ S VG G +G+V + G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 348 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 400
++ H N++ L+ T L LV P+M + + K S + +
Sbjct: 75 LLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEE--KIQY 130
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
+ +GL Y+H ++HRD+K N+ ++E E + DFGLA+ H D+ +T V
Sbjct: 131 LVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV 184
Query: 461 -----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
R APE LS ++ D++ G ++ E+++G + L GK +Q
Sbjct: 185 VTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 232
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 11/94 (11%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQ 146
+ + TNL+ + L +N IS + + + L+KL L ++ N + ++ + L
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRN----RL-KNLNGIPSACLS 109
Query: 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L+NN L SL ++ L L + N L
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 16/92 (17%), Positives = 39/92 (42%), Gaps = 6/92 (6%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
L N L +++ + + +LS + + N+ + + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L++N ++ + P L ++++L L ++ N L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 18/101 (17%), Positives = 39/101 (38%), Gaps = 8/101 (7%)
Query: 82 NLSGTLSSSIGNLTNLQLVLL--QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
+++ ++ + + L L NN + + L L L + NN +
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK--SIVML 146
Query: 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L L+ L L+ N +T L+ + ++ ++DL+
Sbjct: 147 GFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 7/90 (7%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
S+ +L NL+++ ++NN + I +G LSKL LDL N T ++ L+ + ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI 177
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNN 178
L + +L + +
Sbjct: 178 DLTGQKCV---NEPVKYQPELYITNTVKDP 204
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 14/92 (15%), Positives = 32/92 (34%), Gaps = 4/92 (4%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148
+G L+ L+++ L N I+ + + +L K+ +DL+ L +
Sbjct: 144 VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
Query: 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
+ + P +SN + +
Sbjct: 202 KDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 45/254 (17%), Positives = 87/254 (34%), Gaps = 68/254 (26%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT---EVEM 349
L++++ +S +G G FG V + + + G A+K++ + E+++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDI 53
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGA---- 405
+ + H N+++L+ + TT + P + K + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 406 -------------------------------------ARGLLYLHEQCDPKIIHRDVKAA 428
R + ++H I HRD+K
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 429 NILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTD 482
N+L++ + + DFG AK L + V R APE L + + D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSID 224
Query: 483 VFGFGILLLELISG 496
++ G + ELI G
Sbjct: 225 LWSIGCVFGELILG 238
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 21/122 (17%), Positives = 42/122 (34%), Gaps = 16/122 (13%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVS--------HLE 143
++ N+ ++L + S + L+L + S +S
Sbjct: 196 SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 144 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA----KTFNITGNSL 198
T + +++ + SL + L+ +S L L+ S N L P F + + N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
Query: 199 IC 200
C
Sbjct: 314 DC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
++ + L NN I+ +++ + L L L++N I S L +L++L L+ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
L+ + S +S L FL+L N
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 16/92 (17%), Positives = 38/92 (41%), Gaps = 3/92 (3%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151
+LT LQ++ + N + I + L+ L L++ + P ++ ++ + +L L+
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 152 NNSLTGAIPP-SLSNMSQLAFLDLSYNNLSGP 182
+ + S + L+L +L
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
NLQ ++L +N I+ I + L L LDLS N+ + + S+ L +L +L L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNL 131
Query: 151 NNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPS 185
N + + S++++L L + + +
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 13/103 (12%), Positives = 35/103 (33%), Gaps = 8/103 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
LT L+ + + +++ + P + + + L L + V +++ L L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 153 NSLTG----AIPP----SLSNMSQLAFLDLSYNNLSGPVPSFH 187
L + SL + ++ +L + +
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 27/71 (38%), Positives = 36/71 (50%), Gaps = 4/71 (5%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMSQL 169
IP+ + + +LDLSNN T S + LQ L L +N + I S S++ L
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 170 AFLDLSYNNLS 180
LDLSYN LS
Sbjct: 103 EHLDLSYNYLS 113
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
+ + VG G +G V + G VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 348 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 400
++ H N++ L+ T E L LV P+M + +K + L +
Sbjct: 76 RLLKHMRHENVIGLLD-VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQF 132
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
+ +GL Y+H IIHRD+K N+ ++E E + DFGLA+ DS +T V
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYV 186
Query: 461 -----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
R APE L+ + ++ D++ G ++ E+I+G + L G +Q
Sbjct: 187 VTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQ 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 18/103 (17%), Positives = 39/103 (37%), Gaps = 7/103 (6%)
Query: 88 SSSIGNLTNLQ-LVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLET 144
S + NL N+ + + + + + + LSK+ +++ N I L
Sbjct: 48 SHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPL 106
Query: 145 LQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPS 185
L++L + N L P + + L+++ N +P
Sbjct: 107 LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ + + ++ + +N IP G ++ LTL L NN FT + + L
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLD 182
Query: 147 YLRLNNNSLTGAIPP-SLSNM-SQLAFLDLSYNNLS 180
+ LN N I + + S + LD+S +++
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 19/91 (20%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 88 SSSIGNLTNLQLVL-LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLET- 144
++ L N L L L NN + + +KL + L+ N + I + +
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 145 LQYLRLNNNSLTGAIPP-SLSNMSQLAFLDL 174
L ++ S+T A+P L ++ +L +
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 26/117 (22%), Positives = 46/117 (39%), Gaps = 11/117 (9%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
L L+ + NN I+ I S + + L++N + + LE+L+ L L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLML 112
Query: 151 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSLICA 201
+N +T + S +S + L L N + + +F T N+ N C
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 13/84 (15%)
Query: 110 HIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNMS 167
HIP L L+NN FT L L+ + +NN +T I + S
Sbjct: 29 HIPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 168 QLAFLDLSYNNLSGPVPSFHAKTF 191
+ + L+ N L + K F
Sbjct: 82 GVNEILLTSNRLE----NVQHKMF 101
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 11/117 (9%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
L+ + L NN IS + + L L +L L N T +P ++ L +LQ L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLL 111
Query: 151 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNL-SGPVPSFHA----KTFNITGNSLICA 201
N N + + + ++ L L L N L + +F +T ++ N IC
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 4/88 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
+ + L+ N I P KL +DLSNN + + L +L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
+T +P SL + L L L+ N ++
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN 117
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 27/132 (20%), Positives = 47/132 (35%), Gaps = 15/132 (11%)
Query: 61 CSWALVTCSDGLVTGL--GAPSQ----NLSGTLSSSIG-----NLTNLQLVLLQNNNISG 109
CS + C + VT + P T I +L+ + + N++
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 110 HIPTEI-GKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP-SLSNM 166
I ++ L KL + + N P +L LQYL ++N + +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 167 SQLAFLDLSYNN 178
Q LD+ N
Sbjct: 128 LQKVLLDIQDNI 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 6/85 (7%)
Query: 94 LTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
+L L NNN+ +P ++ S + LD+S + +L+ L+ N
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235
Query: 153 NSLTGAIPPSLSNMSQLAFLDLSYN 177
P+L + L L+Y
Sbjct: 236 LKKL----PTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 25/108 (23%), Positives = 37/108 (34%), Gaps = 9/108 (8%)
Query: 93 NLTNLQ-LVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150
NL L + + + NN+ +I E L L L +SN H L +
Sbjct: 77 NLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 135
Query: 151 NNNSLTGAIPP-SLSNMS-QLAFLDLSYNNLSGPVPSFHAKTFNITGN 196
+N I S +S + L L+ N + H FN T
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ----EIHNSAFNGTQL 179
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI--GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150
+ L+ +Q+N I G + + L L+ N S + + +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 151 NNNSLTGAIPP-SLSNMSQLAFLDLSYNNLS 180
+NN+L +P S LD+S +
Sbjct: 186 DNNNLE-ELPNDVFHGASGPVILDISRTRIH 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 37/202 (18%), Positives = 76/202 (37%), Gaps = 35/202 (17%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---EVEMISLA 353
+ ++L+G G +G+V + Y + VVA+K++ I + E+ +++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRL 109
Query: 354 VHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAA-- 406
H ++++++ + +V S K R + L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKK------LFRTPVYLTELHI 158
Query: 407 --------RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458
G+ Y+H I+HRD+K AN L+++ V DFGLA+ +D+ ++ +
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 459 AVRGTVGHIAPEYLSTGQSSEK 480
+ K
Sbjct: 216 LPISPREDDMNLVTFPHTKNLK 237
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 9e-09
Identities = 45/273 (16%), Positives = 76/273 (27%), Gaps = 93/273 (34%)
Query: 262 RQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLV--GKGGFGNVYKGY 319
R ++ Q+F N R + L++ EL+ A KN++ G G G K
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYL--KLRQ-ALLELRPA------KNVLIDGVLGSG---K-- 163
Query: 320 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL-----LV 374
T VA+ + + ++ ++L C + L L+
Sbjct: 164 ----TWVALDVCLS---YKVQCKMDFKIFWLNL----------KNCNSPETVLEMLQKLL 206
Query: 375 YPYMSNGSVASRLKAKPSL---DWATRKRIALGA---ARGLLYLHEQCDPKIIHRDVKAA 428
Y N + S + L R L + LL L + K A
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW----NA- 261
Query: 429 NILLDEYYEAVVGDFGLAKLLDHC-------DSHVTTAVRG-TVGHIAPEYLSTGQSSEK 480
F L C VT + T HI+ ++ S + ++
Sbjct: 262 --------------FNL-----SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 481 TDVFGFGILLLELISGLRALEFGKTANQKGAML 513
L K + + L
Sbjct: 303 V---------KSL--------LLKYLDCRPQDL 318
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.1 bits (134), Expect = 9e-09
Identities = 20/117 (17%), Positives = 38/117 (32%), Gaps = 13/117 (11%)
Query: 77 GAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI------GKLSKLLTLDLSNNF 130
G P + L S + NL L L + + + L L + +
Sbjct: 204 GLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263
Query: 131 FTGPIPSTVSH---LETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLS 180
+ L L+ + ++ LT + + + L F+++ YN LS
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 3e-04
Identities = 15/99 (15%), Positives = 33/99 (33%), Gaps = 9/99 (9%)
Query: 75 GLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK---LSKLLTLDLSNNFF 131
G S NL+ + + + + + L +L T+D+S
Sbjct: 234 GFDGDMNVFRPLFSK--DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291
Query: 132 TG----PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNM 166
T + V ++ L+++ + N L+ + L
Sbjct: 292 TDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 26/244 (10%)
Query: 269 IFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVA 327
++ DVN R E + ++ +G+G + V++ + + V
Sbjct: 10 VYTDVNTHRPREYWDYESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 65
Query: 328 VKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSV 383
VK LK I EI+ + +L N++ L R LV+ +++N
Sbjct: 66 VKILKPVKKKKIKREIKI-----LENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--- 117
Query: 384 ASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVG 441
+ K +L + + L Y H I+HRDVK N+++D E+ + +
Sbjct: 118 -TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 442 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRAL 500
D+GLA+ + V + PE L Q D++ G +L +I
Sbjct: 174 DWGLAEFYHPGQEY-NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
Query: 501 EFGK 504
G
Sbjct: 232 FHGH 235
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
+ + + VG G +G+V + + G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 348 EMISLAVHRNLLRLIGFCMTTTERL-------LVYPYMSNGSVASRLKAKPSLDWATRKR 400
++ H N++ L+ T L LV M + + +K + L +
Sbjct: 80 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQF 136
Query: 401 IALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV 460
+ RGL Y+H IIHRD+K +N+ ++E E + DFGLA+ H +T V
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV 190
Query: 461 RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
T + APE L+ ++ D++ G ++ EL++G R L G +Q
Sbjct: 191 -ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQ 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 46/236 (19%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
+++ + +G+G +G V Y + VA+K++ F+ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREI 76
Query: 348 EMISLAVHRNLLRLIG-FCMTTTERL----LVYPYMSNGSVASRLKAKPSLDWATRKRIA 402
+++ H N++ + T E++ +V M + +L L
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFL 134
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH------- 455
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 456 -VTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
T R APE L++ ++ D++ G +L E++S R + GK +Q
Sbjct: 192 VATRWYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQ 240
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 27/102 (26%), Positives = 40/102 (39%), Gaps = 9/102 (8%)
Query: 82 NLSGTLSSSIGNL----TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS 137
+L G I NL + +N I + L +L TL ++NN
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEG 82
Query: 138 TVSHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYN 177
L L L L NNSL G + P L+++ L +L + N
Sbjct: 83 LDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 3/93 (3%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
++ N + + L+ I I L + +D S+N + L L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +NNN + + L L L+ N+L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 53/246 (21%), Positives = 94/246 (38%), Gaps = 57/246 (23%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
S + +G GG G V+ VA+K+ I E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK----------IVLTDPQSVKHALREI 59
Query: 348 EMISLAVHRNLLRLI----------GFCMTTTERL----LVYPYMSNGSVASRLKAKPSL 393
++I H N++++ + + L +V YM + + + + L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPL 117
Query: 394 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHC 452
+ RGL Y+H ++HRD+K AN+ ++ E +GDFGLA+++D
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 453 DSH--------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503
SH VT R +P LS ++ D++ G + E+++G + L G
Sbjct: 175 YSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAG 227
Query: 504 K-TANQ 508
Q
Sbjct: 228 AHELEQ 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 49/249 (19%), Positives = 87/249 (34%), Gaps = 69/249 (27%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQT---------EV 347
N+ K+L+G+G +G VY Y VA+K++ F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76
Query: 348 EMISLAVHRNLLRLIGFCMTTTERL-----LVYPYMSNGSVASRLKAKPSLDWATRKRIA 402
+++ ++RL + +V S LK + I
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK------LFKTPIF 125
Query: 403 LGAA----------RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452
L G ++HE IIHRD+K AN LL++ V DFGLA+ ++
Sbjct: 126 LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 453 DSHVTTAVRGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGILL 490
APE + ++ ++ D++ G +
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 491 LELISGLRA 499
EL++ L++
Sbjct: 243 AELLNMLQS 251
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 19/94 (20%), Positives = 42/94 (44%), Gaps = 5/94 (5%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ 146
+ +++ L + + L NNI I + + + L L L N I + + +TL+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLE 96
Query: 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L ++ N + ++ + + L L +S N ++
Sbjct: 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 19/94 (20%), Positives = 31/94 (32%), Gaps = 11/94 (11%)
Query: 90 SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149
++L I + + L L LS N +S L ++ LR
Sbjct: 21 VATEAEKVEL-HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLR 73
Query: 150 ---LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L N + I + L L +SYN ++
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 3/99 (3%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S++ G L L+ + N ++ I + KL+KL L+LS+N +G +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 140 SHLETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYN 177
L +L L+ N + + L + L LDL
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
++ L L ++N + + +L L N T I + + L L+ L L++
Sbjct: 18 DVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELSD 73
Query: 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
N ++G + L L+LS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-06
Identities = 23/81 (28%), Positives = 36/81 (44%), Gaps = 8/81 (9%)
Query: 82 NLSGTLSSSIGNL---TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
+ +SI NL L+ + L +N +SG + K L L+LS N ST
Sbjct: 48 STINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LST 105
Query: 139 VSHLETLQYLR---LNNNSLT 156
+ L+ L+ L+ L N +T
Sbjct: 106 IEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 8e-04
Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 117 KLSKLLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 175
S + L L N+ G + E L++L N LT +L +++L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 176 YNNLSGPVPSFHA-----KTFNITGNSL 198
N +SG + N++GN +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 31/158 (19%), Positives = 49/158 (31%), Gaps = 39/158 (24%)
Query: 94 LTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL------- 142
L Q+V L + ++ I + + L L+L +N V +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG---DVGVHCVLQGLQTP 83
Query: 143 -ETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLSGPV----------PSFH 187
+Q L L N LT G + +L + L L LS N L P
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 188 AKTFNITGNSLICATGAEEDCFGTAPMPLSFALNNSPN 225
+ + S + A E L+ L P+
Sbjct: 144 LEKLQLEYCS-LSAASCEP---------LASVLRAKPD 171
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 22/116 (18%), Positives = 41/116 (35%), Gaps = 22/116 (18%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIP 136
+ L + + L L QN ++ G + + + L L L LS+N
Sbjct: 74 HCVLQGLQTPSCKIQKLSL---QNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG---D 127
Query: 137 STVSHLE--------TLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 180
+ + L L+ L+L SL+ + L L +S N+++
Sbjct: 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 16/113 (14%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGP-- 134
+ L L S L L+L ++ ++ + + + L L L +N
Sbjct: 188 RVLCQGLKDSPCQLEALKL---ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 135 ---IPSTVSHLETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 180
P + L+ L + +T G + L L L L+ N L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 18/104 (17%), Positives = 37/104 (35%), Gaps = 19/104 (18%)
Query: 93 NLTNLQLVLLQNNNIS----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL------ 142
L+ + L+ ++S + + + L +SNN + V L
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN---EAGVRVLCQGLKD 196
Query: 143 --ETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 180
L+ L+L + +T + +++ + L L L N L
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 5/67 (7%)
Query: 119 SKLLTLDLSNNFFTGP-IPSTVSHLETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLD 173
+ +LD+ + + L+ Q +RL++ LT I +L LA L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 174 LSYNNLS 180
L N L
Sbjct: 63 LRSNELG 69
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 17/114 (14%)
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
R + LH +IHRD+K +N+L++ + V DFGLA+++D + + G
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE-SAADNSEPTGQQSG 178
Query: 467 I----------APEY-LSTGQSSEKTDVFGFGILLLELISGLRALEFGK-TANQ 508
+ APE L++ + S DV+ G +L EL R + G+ +Q
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 45/226 (19%), Positives = 85/226 (37%), Gaps = 55/226 (24%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-----------A 353
+G G F V+ + + T VA+K ++ + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 354 VHRNLLRLIGF-----------CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRI 401
++L+L+ M E L + ++ + + + L + K+I
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVF-EVL----GENLLALIKKYEHRGIPLIYV--KQI 136
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDE------YYEAVVGDFGLAKLLDHCDSH 455
+ GL Y+H +C IIH D+K N+L++ + + D G A D H
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---H 191
Query: 456 VTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
T ++ R +PE L D++ L+ ELI+G
Sbjct: 192 YTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-07
Identities = 22/83 (26%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 98 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG 157
+LVL + G I + L L L N S + L L+ L L+ N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFG 85
Query: 158 AIPPSLSNMSQLAFLDLSYNNLS 180
+ + L L+LS N L
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 5/100 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
++ G + NL+ + L N + + + KL KL L+LS N G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLA 91
Query: 140 SHLETLQYLRLNNNSLT--GAIPPSLSNMSQLAFLDLSYN 177
L L +L L+ N L + P L + L LDL
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-06
Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 8/81 (9%)
Query: 82 NLSGTLSSSIGNL---TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138
+L S+ NL L+ + L N I G + KL L L+LS N ST
Sbjct: 55 SLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--IST 112
Query: 139 VSHLETLQYLR---LNNNSLT 156
+ L+ L+ L+ L N +T
Sbjct: 113 LEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 21/87 (24%), Positives = 34/87 (39%), Gaps = 8/87 (9%)
Query: 118 LSKLLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 176
+ + L L N G I + L++L L N L +L + +L L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 177 NNLSGPVPSFHA-----KTFNITGNSL 198
N + G + N++GN L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
+ + + LQ+ ++ L+KL L+L N + + V L L L L NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNL 179
L ++P + +++QL L L N L
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
LT L + L N + + + L++L TL L+NN +P V HL L L L
Sbjct: 57 GLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYL 114
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNLS 180
N L ++P + +++L L L+ N L
Sbjct: 115 GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
+LT L + L N + +P+ + +L+KL L L+ N IP+ L LQ L L
Sbjct: 105 HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNN 178
+ N L + + +L + L + N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 39/167 (23%), Positives = 59/167 (35%), Gaps = 34/167 (20%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG----EIQFQTEV---EMISLAVHRN 357
+G GGFG +Y + A +K G E++F V + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 358 LLRLIGF-----CMTTTERLLVYPYMSNGSVASRLKAKPSLDW---ATRK-------RIA 402
L +G T + Y +M V RL L ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFM----VMERLG--IDLQKISGQNGTFKKSTVLQLG 157
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 447
+ L Y+HE +H D+KAAN+LL V D+GL+
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 43/243 (17%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKD--GNAIGG-----EIQFQTEVEM 349
+ +GKG +G V+K + G VVAVK++ D N+ EI +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI-----L 62
Query: 350 ISLAVHRNLLRLIGFCMTTTER--LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAAR 407
L+ H N++ L+ +R LV+ YM + + L+ ++ + +
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIK 120
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHI 467
+ YLH ++HRD+K +NILL+ V DFGL++ + +
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 468 --------------------APEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK-T 505
APE L ++ D++ G +L E++ G + + G T
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSST 236
Query: 506 ANQ 508
NQ
Sbjct: 237 MNQ 239
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/135 (20%), Positives = 52/135 (38%), Gaps = 22/135 (16%)
Query: 60 PCSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGN----------LTNLQLVLLQNNNISG 109
VT ++ S + + L N++ + L N +
Sbjct: 18 FAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL-- 75
Query: 110 HIPTEIG---KLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPPSLSN 165
+I +L+ L L L+ N +P+ V L L+ L L N L ++P + +
Sbjct: 76 ---HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 166 -MSQLAFLDLSYNNL 179
++ L +L+L++N L
Sbjct: 131 KLTNLTYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150
LTNL ++L N + +P + KL+ L L L N +P V L L YL L
Sbjct: 83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 151 NNNSLTGAIPPSL-SNMSQLAFLDLSYNNL 179
+N L ++P + ++ L LDLSYN L
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 94 LTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLN 151
LTNL+ ++L N + +P + KL+ L L+L++N +P V L L L L+
Sbjct: 108 LTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLS 165
Query: 152 NNSLTGAIPPSL-SNMSQLAFLDLSYNNL 179
N L ++P + ++QL L L N L
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
++ + L N + +P E+ L +DLSNN + + S++ L L L+ N
Sbjct: 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 155 LTGAIPPSL-SNMSQLAFLDLSYNNLS 180
L IPP + L L L N++S
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 9/71 (12%)
Query: 111 IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSL-SNMSQL 169
IP ++ +L L N FT +P +S+ + L + L+NN ++ + SNM+QL
Sbjct: 29 IPRDVTEL------YLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 170 AFLDLSYNNLS 180
L LSYN L
Sbjct: 81 LTLILSYNRLR 91
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 37/170 (21%)
Query: 306 LVGKGGFGNVYKGYLQDGT------VVAVKRLKDGNA-IGGEIQFQTEV---EMISLAVH 355
+G+GGFG +Y + VK N + E++F E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 356 RNLLRLIGFCM-----TTTERLLVYPYMSNGSVASRLKAKPSL----DWATRK------- 399
L+ +G + Y +M + R L + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFG--SDLQKIYEANAKRFSRKTVL 155
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 447
+++L L Y+HE +H D+KA+N+LL+ V D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 47/216 (21%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVH-----RNL 358
++GKG FG V K Y + VA+K +++ Q E+ ++ L N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 359 LRLIGF-------CMTTTERLL--VYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARG 408
+ ++ CMT E L +Y + K + SL RK A +
Sbjct: 162 IHMLENFTFRNHICMTF-ELLSMNLYELIKKN------KFQGFSLP-LVRK-FAHSILQC 212
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAV-----R 461
L LH+ +IIH D+K NILL + + V DFG + V T + R
Sbjct: 213 LDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYR 266
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
APE + + D++ G +L EL++G
Sbjct: 267 ------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 4/87 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
TN Q++ L +N I+ P L L L L +N +P V L L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTN 98
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNL 179
LT +P ++ + L L + N L
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKL 124
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 27/170 (15%), Positives = 51/170 (30%), Gaps = 39/170 (22%)
Query: 307 VGKGGFGNVYKGY---------LQDGTVVAVKRLKDGNAIGGEIQF-QTEVEMISLAVHR 356
+ G +Y+ ++K + E F Q + + + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGS-----VASRLKAKPSL----DWATRK-------- 399
L + T + + V L SL D + +
Sbjct: 110 KLYSTPLLAIPT-----CMGFGVHQDKYRFLVLPSLG--RSLQSALDVSPKHVLSERSVL 162
Query: 400 RIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVV--GDFGLAK 447
++A L +LHE +H +V A NI +D ++ V +G A
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 17/116 (14%), Positives = 33/116 (28%), Gaps = 22/116 (18%)
Query: 87 LSSSIGNLTNLQLVLLQNNNIS-------------GHIPTEIGKLSKLLTLDLSNNFFTG 133
L + T L+ + L NN + + + L ++ N
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173
Query: 134 P----IPSTVSHLETLQYLRLNNNSLT-----GAIPPSLSNMSQLAFLDLSYNNLS 180
T L +++ N + + L+ +L LDL N +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 18/112 (16%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNF---FTGPIPSTV 139
+ + + +++ ++L N I + I L + S+ F IP +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 140 SHL-------ETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLS 180
L L +RL++N+ + LS + L L L N L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
+ L+ N++ +L+ L L L N +P+ V + L +L YL L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNL 179
L ++P + ++QL L L+ N L
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 32/109 (29%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 74 TGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFT 132
T L + +L + LT+L + L N + +P + KL+ L L+LS N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 133 GPIPSTV-SHLETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNL 179
+P+ V L L+ L LN N L ++P + ++QL L L N L
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNN 153
++ + L++N + KL++L L LS N +P V L L L L+ N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHEN 86
Query: 154 SLTGAIPPSL-SNMSQLAFLDLSYNNL 179
L ++P + ++QL L L N L
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 20/116 (17%), Positives = 47/116 (40%), Gaps = 19/116 (16%)
Query: 81 QNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGP- 134
L+ L+S ++T+L L N + E+ + + +++L+L N GP
Sbjct: 185 AELAKFLASIPASVTSLDL---SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241
Query: 135 ---IPSTVSHLETLQYLRLNNNSLTG-------AIPPSLSNMSQLAFLDLSYNNLS 180
+ L+ LQ + L+ + + A+ + N+ ++ +D + +
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 13/100 (13%)
Query: 94 LTNLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGP----IPSTVSHLET 144
+ + LQ N++ ++ L ++ TL LSNN T + ++ +
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 145 LQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLS 180
+ +L L + L + L QL L+++YN
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 45/217 (20%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL------AVHRN 357
+L+GKG FG V K Y + VA+K +K+ A Q Q EV ++ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117
Query: 358 LLRLIGF-------CMTTTERLLV--YPYM-SNGSVASRLKAKPSLDWATRKRIALGAAR 407
++ L C+ E L Y + + L ++ A
Sbjct: 118 IVHLKRHFMFRNHLCLVF-EMLSYNLYDLLRNTNFRGVSLNLT--------RKFAQQMCT 168
Query: 408 GLLYLHEQCDPKIIHRDVKAANILLDEYYEAV--VGDFGLAKLLDHCDSHVTTAV----- 460
LL+L + IIH D+K NILL + + DFG + + +
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQSRFY 224
Query: 461 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL 497
R +PE L D++ G +L+E+ +G
Sbjct: 225 R------SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 35/157 (22%), Positives = 58/157 (36%), Gaps = 33/157 (21%)
Query: 307 VGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAVHRNLLRLIGF 364
+G G FG++Y G + G VA+K Q E ++ + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKPSL----DWATRK-------RIALGAARGLLYLH 413
++V + PSL ++ +RK +A + Y+H
Sbjct: 74 GAEGDYNVMVMELLG-----------PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 414 EQCDPKIIHRDVKAANILLDEYYEA---VVGDFGLAK 447
+ IHRDVK N L+ + + DFGLAK
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 20/85 (23%), Positives = 27/85 (31%), Gaps = 13/85 (15%)
Query: 110 HIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTGAIPPSL-SNMS 167
IP +L L++N + L L L L N LT I P+ S
Sbjct: 26 DIPLHTTEL------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 168 QLAFLDLSYNNLSGPVPSFHAKTFN 192
+ L L N + K F
Sbjct: 79 HIQELQLGENKIK----EISNKMFL 99
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.86 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.77 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.74 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.71 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.71 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.68 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.66 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.65 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.64 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.64 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.63 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.63 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.63 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.62 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.62 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.62 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.62 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.61 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.61 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.61 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.61 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.61 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.61 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.6 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.59 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.58 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.58 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.58 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.58 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.57 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.57 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.55 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.54 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.54 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.54 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.53 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.53 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.52 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.52 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.5 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.5 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.49 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.49 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.49 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.49 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.48 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.48 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.47 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.47 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.46 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.46 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.45 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.45 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.44 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.42 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.42 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.42 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.41 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.39 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.39 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.38 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.38 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.38 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.36 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.33 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.33 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.33 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.27 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.26 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.25 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.24 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.24 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.17 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.12 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.89 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.82 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.74 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.73 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.69 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.54 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.18 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.17 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.92 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.63 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.44 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.37 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.24 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.11 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.8 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.49 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.44 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.22 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.19 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.16 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.24 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.18 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.68 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.11 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.28 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.99 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.29 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 85.42 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=387.13 Aligned_cols=204 Identities=24% Similarity=0.364 Sum_probs=183.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... .......+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46888999999999999999964 79999999996432 2233567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC-C
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-S 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~-~ 454 (517)
||+++|+|.+++...+.+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.... .
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999999875433 2
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 334567899999999999999999999999999999999999999976543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=387.51 Aligned_cols=201 Identities=24% Similarity=0.383 Sum_probs=175.7
Q ss_pred CCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
+...+.||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999863 46789999998665555567899999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCe
Q 010149 375 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 438 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 438 (517)
||||++|+|.++|... ..++|.++..++.|||+||+|||++ +||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 9999999999999632 3589999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 439 VVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 439 ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+|||+|+.....+. .......||++|||||++.++.|+.++|||||||++|||+| |+.||....
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999987643322 22345579999999999999999999999999999999999 899997543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=386.41 Aligned_cols=202 Identities=27% Similarity=0.457 Sum_probs=175.5
Q ss_pred cCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|...+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45667889999999999999863 47889999997543 334567999999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 373 LVYPYMSNGSVASRLKAK-------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
+|||||++|+|.++++.. ..++|.++..++.||++||+|||++ +|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 999999999999999743 3699999999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+|||+|+.....+... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999998765433322 223458999999999999999999999999999999999 899997643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=381.49 Aligned_cols=201 Identities=31% Similarity=0.462 Sum_probs=168.8
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.+++...+.||+|+||+||+|++++ .||||+++.... ....++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567778899999999999999763 599999875432 2334579999999999999999999998865 56899999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC-C
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-S 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~-~ 454 (517)
|+++|+|.++++. ...+++.++..|+.||++||+|||++ +||||||||+|||+++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999974 45799999999999999999999998 99999999999999999999999999998765432 2
Q ss_pred ceeeeccccccccCcccccc---CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|||||++.. +.|+.++|||||||++|||+||+.||....
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 23445679999999999853 468999999999999999999999997543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=389.23 Aligned_cols=203 Identities=23% Similarity=0.348 Sum_probs=173.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999964 7999999999754432 234578999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999643 4579999999999999999999999 9999999999999999999999999999876431 1
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 223456799999999999999999999999999999999999999976543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=385.43 Aligned_cols=200 Identities=22% Similarity=0.334 Sum_probs=179.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.|+..+.||+|+||+||+|+.. +|+.||||++..... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45788899999999999999965 799999999965432 3345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.... ...
T Consensus 153 ~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 153 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 9999999999764 699999999999999999999999 99999999999999999999999999998775432 234
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||....
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 45679999999999999999999999999999999999999997644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=385.12 Aligned_cols=201 Identities=26% Similarity=0.472 Sum_probs=168.9
Q ss_pred CCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
+|...+.||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..++
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4556788999999999999864 47899999997543 3345679999999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCe
Q 010149 374 VYPYMSNGSVASRLKAK---------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 438 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 438 (517)
|||||++|+|.++++.. ..++|.++..|+.||++||+|||++ +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 99999999999998642 3589999999999999999999998 99999999999999999999
Q ss_pred EEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 439 VVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 439 ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+|||+|+.....+. .......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 9999999987654332 23345679999999999999999999999999999999999 999997543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=381.28 Aligned_cols=197 Identities=24% Similarity=0.268 Sum_probs=173.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.|...+.||+|+||+||+|+.+ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45677788999999999999965 689999999975432 24799999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCCCCc-
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCDSH- 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~~~- 455 (517)
+++|+|.++++..+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999888899999999999999999999999 999999999999999987 6999999999877543211
Q ss_pred ---eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 ---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 1234579999999999999999999999999999999999999997544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=381.96 Aligned_cols=203 Identities=26% Similarity=0.350 Sum_probs=173.3
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|++.+.||+|+||+||+|+.. .++.||+|+++.... .....++.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56889999999999999999852 478999999965432 2223468899999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+++|+|.+++...+.+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999999888899999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+.
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence 233456799999999999999999999999999999999999999976543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=372.31 Aligned_cols=197 Identities=29% Similarity=0.420 Sum_probs=169.9
Q ss_pred CCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEec----CCcceEEE
Q 010149 302 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVY 375 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lv~ 375 (517)
...+.||+|+||+||+|+.. ++..||+|++...... .....|.+|++++++++|||||++++++.. +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999965 6899999999654322 234569999999999999999999999865 34578999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++|+|.+++...+.+++..+..++.||+.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 9999999999999888899999999999999999999997 12399999999999998 479999999999986433
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......+||+.|||||++.+ +|+.++|||||||++|||+||+.||...
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 23445679999999998864 6999999999999999999999999643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=368.55 Aligned_cols=200 Identities=23% Similarity=0.389 Sum_probs=165.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||+||+|+.. +|+.||+|+++.... ......+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999954 799999999965432 223457899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+ +|+|.+++...+.+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 999 679999999888999999999999999999999999 9999999999999999999999999999876532 2
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||+...
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 3345679999999999988776 579999999999999999999997643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=386.51 Aligned_cols=200 Identities=22% Similarity=0.334 Sum_probs=180.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++|||||++++++.+.+..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56888999999999999999965 699999999975432 3345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
|++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.... ...
T Consensus 230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 9999999999754 599999999999999999999999 99999999999999999999999999998775432 234
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 45679999999999999999999999999999999999999997544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=378.21 Aligned_cols=211 Identities=26% Similarity=0.378 Sum_probs=181.7
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCC-Ccccceee
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIG 363 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~ 363 (517)
.++++...++|++.+.||+|+||+||+|++.. ++.||||+++.........+|.+|++++.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34455556789999999999999999998542 368999999876555556679999999999965 89999999
Q ss_pred eEecC-CcceEEEecCcCCChhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 010149 364 FCMTT-TERLLVYPYMSNGSVASRLKA----------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK 426 (517)
Q Consensus 364 ~~~~~-~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 426 (517)
+|.++ +..++|||||++|+|.++|+. ...+++.++..++.|||+||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99765 567999999999999999964 23489999999999999999999999 99999999
Q ss_pred CCceEEcCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 427 AANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 427 ~~NILl~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543332 3445679999999999999999999999999999999998 999997543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=368.23 Aligned_cols=199 Identities=27% Similarity=0.402 Sum_probs=163.5
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC----cceEEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERLLVY 375 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~lv~ 375 (517)
+|...+.||+|+||+||+|+++ |+.||||+++... .....++.|+..+.+++|||||+++|++.+++ ..+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4566789999999999999985 8999999996432 11223345666667889999999999998654 468999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
||+++|+|.++++.. .++|..+.+++.|+++||+|||++ .+++|+||||||+|||+++++++||+|||+|+...
T Consensus 81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 999999999999865 589999999999999999999976 25689999999999999999999999999998765
Q ss_pred CCCCce---eeeccccccccCccccccC------CCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 451 HCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 451 ~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
...... .....||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 443322 2345699999999998654 467899999999999999999887753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=364.76 Aligned_cols=198 Identities=24% Similarity=0.394 Sum_probs=161.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc-------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------- 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------- 370 (517)
++|++.+.||+|+||+||+|+.. +|+.||||+++........+.+.+|++++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999964 7899999999765544445678999999999999999999999876443
Q ss_pred -----ceEEEecCcCCChhhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcc
Q 010149 371 -----RLLVYPYMSNGSVASRLKAKPS---LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 371 -----~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
.++||||+++|+|.+++..... .++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999986543 45677889999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCc-----------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 443 FGLAKLLDHCDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 443 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999876543221 1234569999999999999999999999999999999997 7753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=361.81 Aligned_cols=202 Identities=21% Similarity=0.350 Sum_probs=174.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC------Cc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~~ 370 (517)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57888999999999999999964 7999999999754432 2345688999999999999999999987643 56
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||++ |+|.+++...+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 799999996 67999999888999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC---CceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 321 2233456799999999998764 56899999999999999999999997654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=354.51 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=171.3
Q ss_pred HhcCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 371 (517)
..+.|++.+.||+|+||+||+|+.+ .++.||+|++.... ...++.+|++++..+ +|||||++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4578999999999999999999853 46889999986543 345688999999988 699999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DFGla~~~~ 450 (517)
++||||+++|+|.++++ .+++.+++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999985 589999999999999999999999 99999999999999876 799999999998654
Q ss_pred CCCC---------------------------ceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 451 HCDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 451 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 3211 112345699999999998765 589999999999999999999999965
Q ss_pred Cc
Q 010149 503 GK 504 (517)
Q Consensus 503 ~~ 504 (517)
+.
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=374.02 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=174.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHH---HHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQT---EVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~---Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|++.++||+|+||+||+|+.. +|+.||+|++++... ......+.+ ++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57889999999999999999965 699999999964321 112223333 456677889999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++ +||||||||+|||++++|++||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999999888899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||....
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 345679999999999964 579999999999999999999999997543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=347.67 Aligned_cols=227 Identities=74% Similarity=1.198 Sum_probs=197.8
Q ss_pred hhhhhhhcCCCcccChHHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCC
Q 010149 276 QRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 355 (517)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H 355 (517)
+..+....+.+..+.+.++....++|...+.||+|+||.||+|+..+|+.||+|+++..........+.+|+++++.++|
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 86 (326)
T 3uim_A 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH 86 (326)
T ss_dssp --------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred ccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence 34444556778889999999999999999999999999999999888999999999766544445579999999999999
Q ss_pred CcccceeeeEecCCcceEEEecCcCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 010149 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 431 (517)
Q Consensus 356 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NIL 431 (517)
|||+++++++......++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++.++|+||||||+|||
T Consensus 87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 99999999999999999999999999999999753 34999999999999999999999987789999999999999
Q ss_pred EcCCCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 432 LDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 432 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
+++++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||+||+.||+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred ECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 99999999999999998765555555666799999999999888899999999999999999999999974
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=363.44 Aligned_cols=201 Identities=23% Similarity=0.344 Sum_probs=179.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|++.+.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|+++|+.++|||||++++++.+....++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57889999999999999999965 79999999996543 22345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC--CCeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--YEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DFGla~~~~~~~~ 454 (517)
+++|+|.+++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999999864 45799999999999999999999999 99999999999999854 89999999999987643
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 334456799999999999999999999999999999999999999976543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.86 Aligned_cols=212 Identities=21% Similarity=0.284 Sum_probs=184.8
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEec
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 367 (517)
+.++....++|+..+.||+|+||+||+|+.+ +++.||+|+++.... ......+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455566788999999999999999999976 578999999964221 1122348899999999999999999999999
Q ss_pred CCcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999986 56899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+..............||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 876654444445567999999999986 56789999999999999999999999976543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=326.70 Aligned_cols=202 Identities=24% Similarity=0.301 Sum_probs=179.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|+.. +|+.||+|+++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999965 68999999996432 1233456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence 9999999999998877899999999999999999999999 9999999999999999999999999999864322 22
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 3345679999999999999999999999999999999999999997544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.76 Aligned_cols=210 Identities=21% Similarity=0.285 Sum_probs=182.2
Q ss_pred HHHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecC
Q 010149 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 292 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
.++....++|...+.||+|+||+||+|+.. +++.||+|+++... .......+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344456678999999999999999999965 68999999986421 112234578999999999999999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999999764 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeccccccccCccccccCC----CCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.............||+.|+|||++.... ++.++|||||||++|||++|+.||.....
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 7654433445667999999999997654 78999999999999999999999976543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=340.21 Aligned_cols=212 Identities=22% Similarity=0.290 Sum_probs=183.7
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEec
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 367 (517)
+++.....++|+..+.||+|+||.||+|+.+ +|+.||+|+++.... ......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455556788999999999999999999975 799999999964221 1123358899999999999999999999999
Q ss_pred CCcceEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++++||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999863 4799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccCccccc-------cCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+..............||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 877654433344567999999999987 35689999999999999999999999976543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.88 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=175.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|.+.+.||+|+||.||+|+.. ++..||+|++....... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999954 68999999986543322 235789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++++|.+++...+.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999998878899999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||.+.+..++.++||||||+++|||+||+.||+...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34445669999999999999999999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=321.56 Aligned_cols=211 Identities=45% Similarity=0.773 Sum_probs=184.5
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
+.++...+++|...+.||+|+||.||+|+.++++.||+|++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 334455678999999999999999999998889999999986543 3345678999999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.++||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999743 2589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCC-CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 447 KLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 447 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+...... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||....+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 8654322 2223344589999999999888999999999999999999999999976543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.57 Aligned_cols=202 Identities=25% Similarity=0.367 Sum_probs=179.2
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..+|.+.+.||+|+||.||+|+. .+|+.||+|++...... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999996 57999999999654322 23456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999998765332
Q ss_pred eeeeccccccccCccccccCCCC-cccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..++ .++||||+||++|||++|+.||+...
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 23445699999999999887764 79999999999999999999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=329.93 Aligned_cols=205 Identities=29% Similarity=0.376 Sum_probs=175.4
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
..++|+..+.||+|+||.||+|+.+ +|+.||+|+++... .......+.+|.+++..+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467889999999999999999965 68999999996432 122345678899999887 6999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999998878899999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 2334456799999999999988899999999999999999999999976543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=324.26 Aligned_cols=202 Identities=24% Similarity=0.317 Sum_probs=180.3
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-----chHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.+.|.+.+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457888999999999999999965 68999999997544321 245789999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC----CeEEccccccc
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK 447 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DFGla~ 447 (517)
++||||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999888899999999999999999999999 999999999999998877 79999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... ......||+.|+|||.+....++.++||||+||++|||++|+.||....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 765422 2344569999999999998899999999999999999999999997543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=315.42 Aligned_cols=201 Identities=22% Similarity=0.367 Sum_probs=179.3
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
..+|...+.||+|+||+||+|.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45789999999999999999995 5789999999865432 335678899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 99999999999865 589999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 344569999999999999999999999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.35 Aligned_cols=201 Identities=24% Similarity=0.336 Sum_probs=177.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 373 (517)
.++|+..+.||+|+||.||+|+.+ +++.||+|+++..... .....+..|..++.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999965 6789999999754322 2234578899998876 89999999999999999999
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+++|+|..++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 999999999999998878899999999999999999999999 9999999999999999999999999999853322
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 2334456799999999999999999999999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.66 Aligned_cols=199 Identities=30% Similarity=0.420 Sum_probs=178.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|+.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999965 78999999996432 1223456789999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999888899999999999999999999999 999999999999999999999999999987543
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2234569999999999999999999999999999999999999997544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=323.79 Aligned_cols=205 Identities=27% Similarity=0.374 Sum_probs=179.3
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcc
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 371 (517)
...++|...+.||+|+||.||+|+.+ +|+.||+|+++.... ......+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578899999999999999999975 689999999965321 22345677899888876 899999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998777899999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 22 23445679999999999999899999999999999999999999997644
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=325.67 Aligned_cols=200 Identities=26% Similarity=0.332 Sum_probs=177.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999965 68899999986432 1223457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+... .
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 9999999999999888899999999999999999999999 9999999999999999999999999999876532 2
Q ss_pred eeeeccccccccCcccccc---CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 456 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 3345679999999999864 45889999999999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.21 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=176.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999965 7899999999655444444568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-c
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-H 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-~ 455 (517)
|+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999999888899999999999999999999998 999999999999999999999999999986543221 2
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 2234569999999999987765 789999999999999999999997544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.00 Aligned_cols=202 Identities=31% Similarity=0.473 Sum_probs=176.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||+||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46778899999999999999965 6899999998543 233456799999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999986 56799999999999999999999999 99999999999999999999999999998764332211
Q ss_pred -------------eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 -------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 114569999999999999999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=324.87 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=176.6
Q ss_pred cCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 369 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 369 (517)
++|.+.+.||+|+||.||+|+.. ++..||+|+++.........++.+|+++++++ +||||+++++++...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56788899999999999999852 35679999997654444456799999999999 8999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 370 ERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
..++||||+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 999999999999999999753 2479999999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 434 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 434 ~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999876543321 2233457889999999999999999999999999999999 999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=322.44 Aligned_cols=200 Identities=25% Similarity=0.341 Sum_probs=177.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|...+.||+|+||.||+|+.+ +++.||+|+++...... ....+.+|..++.++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46788899999999999999965 68899999997543222 234578899999887 899999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 99999999999998777899999999999999999999999 99999999999999999999999999998643222
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 233456799999999999998999999999999999999999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.97 Aligned_cols=211 Identities=21% Similarity=0.306 Sum_probs=182.9
Q ss_pred ccChHHHHHHhcC----------CCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCC
Q 010149 288 RFHFKELQSATSN----------FSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356 (517)
Q Consensus 288 ~~~~~~l~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~ 356 (517)
.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence 4556666666543 555678999999999999976 79999999996543 33456788999999999999
Q ss_pred cccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 010149 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY 436 (517)
Q Consensus 357 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~ 436 (517)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|+++||.|||+. +|+||||||+||+++.++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999999998754 689999999999999999999998 999999999999999999
Q ss_pred CeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 437 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 437 ~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 179 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999987654322 2344569999999999999999999999999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=324.20 Aligned_cols=201 Identities=17% Similarity=0.217 Sum_probs=174.7
Q ss_pred HhcCCCCCCccccccccceEEEE------eCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC---CCcccceeeeEec
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMT 367 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~ 367 (517)
..++|.+.+.||+|+||.||+|. ..+++.||+|+++.. ...++..|++++..++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45678888999999999999994 446889999999643 2456778888887776 9999999999999
Q ss_pred CCcceEEEecCcCCChhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC--------
Q 010149 368 TTERLLVYPYMSNGSVASRLK-----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-------- 434 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-------- 434 (517)
.+..++||||+++|+|.+++. ....+++..+..++.||++||+|||++ +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997 356799999999999999999999998 9999999999999998
Q ss_pred ---CCCeEEcccccccccCC-CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 435 ---YYEAVVGDFGLAKLLDH-CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 435 ---~~~~ki~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++.+||+|||+|+.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999976532 22334455679999999999999999999999999999999999999986543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=322.83 Aligned_cols=204 Identities=25% Similarity=0.317 Sum_probs=179.1
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
..++|...+.||+|+||.||+|+.+ +|+.||+|+++... .......+..|..++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467888999999999999999976 47899999996532 122345678899999887 8999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999998777899999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 175 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 223445679999999999999999999999999999999999999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=319.05 Aligned_cols=203 Identities=26% Similarity=0.347 Sum_probs=170.0
Q ss_pred hcCCCCCCccccccccceEEEEe----CCCcEEEEEEecCCCC---CcchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
.++|+..+.||+|+||.||+++. .+|+.||+|+++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688899999999999999986 4789999999975432 1223457889999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999998777899999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 173 HD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 22 222344569999999999998899999999999999999999999997644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=321.39 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=178.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||+|+.. +|+.||+|+++... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999965 68999999986432 1223457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999998877899999999999999999999999 9999999999999999999999999999876432
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 234569999999999999999999999999999999999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.58 Aligned_cols=203 Identities=31% Similarity=0.470 Sum_probs=169.5
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..++|.+.+.||+|+||.||+|+. +|+.||+|++...... ....++.+|++++++++||||+++++++......++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456788899999999999999987 4889999999755432 22356889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 376 PYMSNGSVASRLKAKPS---LDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
||+++|+|.+++..... +++..+..++.|+++||+|||++ + |+||||||+||++++++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999986543 89999999999999999999998 7 9999999999999999999999999998654
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ........||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 222334569999999999999999999999999999999999999997644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.07 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=178.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-----chHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
+.|...+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+|+++++.++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888899999999999999965 68999999997543221 3467899999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC----CeEEcccccccc
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL 448 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DFGla~~ 448 (517)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+++++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999998888899999999999999999999999 999999999999999887 799999999987
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 65322 2234569999999999998899999999999999999999999996543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.40 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=179.1
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
..++|...+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467889999999999999999965 6899999999754432 2335688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEcccccccccCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLLDH 451 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DFGla~~~~~ 451 (517)
|||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999999998888899999999999999999999999 999999999999998654 599999999987653
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 2334569999999999998899999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=313.79 Aligned_cols=200 Identities=21% Similarity=0.293 Sum_probs=177.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||.||+|+.. +++.+|+|.++... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467888999999999999999965 68899999986432 234568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC--CCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DFGla~~~~~~~ 453 (517)
|+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999999999764 4799999999999999999999999 9999999999999987 789999999999877543
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 23344569999999999988889999999999999999999999997644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=312.57 Aligned_cols=202 Identities=25% Similarity=0.331 Sum_probs=172.2
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||+||+|+..+|+.||+|+++...... ....+.+|++++++++||||+++++++......++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997543322 23568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+++ +|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 77777764 45699999999999999999999999 999999999999999999999999999987653322
Q ss_pred eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 2334468999999999876 568999999999999999999999997544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=312.73 Aligned_cols=202 Identities=27% Similarity=0.411 Sum_probs=162.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|+..+.||+|+||.||+|... +|+.||+|+++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999964 6899999999765544445678899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 377 YMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 377 ~~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
|++ |+|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999888632 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3222 2234468999999999876 468999999999999999999999997544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=316.00 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=175.0
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|.+.+.||+|+||.||+|... .+..||||+++..........|.+|+++++.++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999974 35569999997655444556799999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999743 5799999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.. ......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 22 2223346788999999988899999999999999999999 999996543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.02 Aligned_cols=202 Identities=28% Similarity=0.348 Sum_probs=170.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHH-HhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEM-ISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|+..+.||+|+||.||+|+.+ +++.||+|+++..... .....+..|..+ ++.++||||+++++++...+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46788999999999999999965 6889999999754322 223456667766 5778999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-N 193 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-C
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC-C
Confidence 99999999999998877899999999999999999999999 9999999999999999999999999999864322 2
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 23345679999999999999999999999999999999999999997654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.74 Aligned_cols=204 Identities=21% Similarity=0.296 Sum_probs=178.5
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
..++|...+.||+|+||.||+|... +|+.+|+|++...... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567889999999999999999854 7899999999754432 2345688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCCeEEcccccccccCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DFGla~~~~~ 451 (517)
|||+++|+|.+.+...+.+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999999888899999999999999999999999 999999999999998 567899999999987654
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 166 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 166 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp TC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 32 22344569999999999998899999999999999999999999996543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.49 Aligned_cols=202 Identities=30% Similarity=0.460 Sum_probs=165.5
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.+|.+.+.||+|+||.||+|+.. ++..||||+++.........+|.+|+.++++++||||+++++++......++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 57789999997654444456799999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999864 4699999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 454 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 454 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
... .....+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 122235778999999999999999999999999999998 99999654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=316.99 Aligned_cols=201 Identities=22% Similarity=0.377 Sum_probs=176.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|.+.+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+++++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688899999999999999996 578999999986432 1122357889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+ +|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 689999988777899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
......||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||+....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 2234569999999999987776 6899999999999999999999976543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=305.52 Aligned_cols=215 Identities=43% Similarity=0.742 Sum_probs=187.5
Q ss_pred CCcccChHHHHHHhcCCCCC------CccccccccceEEEEeCCCcEEEEEEecCCCC---CcchHHHHHHHHHHhccCC
Q 010149 285 NLKRFHFKELQSATSNFSSK------NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH 355 (517)
Q Consensus 285 ~~~~~~~~~l~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~H 355 (517)
....|.+.++..++++|... +.||+|+||.||+|+. +++.||+|++..... ......+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678899999999999877 8999999999999987 488999999865432 2234578999999999999
Q ss_pred CcccceeeeEecCCcceEEEecCcCCChhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK---AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 356 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
|||+++++++...+..++||||+++++|.+++. ....+++..+..++.|+++||.|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999986 345699999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||+...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999876543222 2334569999999998854 58899999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=314.50 Aligned_cols=200 Identities=21% Similarity=0.321 Sum_probs=174.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC--cceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999965 589999999976554445667889999999999999999999998765 668999
Q ss_pred ecCcCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCCeEEcccccccc
Q 010149 376 PYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLAKL 448 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DFGla~~ 448 (517)
||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997533 389999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCceeeeccccccccCccccc--------cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...... .....||+.|+|||.+. +..++.++|||||||++|||+||+.||...
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 23456999999999886 567899999999999999999999999743
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=308.00 Aligned_cols=200 Identities=22% Similarity=0.301 Sum_probs=172.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|+..+.||+|+||+||+|+.. +++.||+|+++...... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46788899999999999999965 68999999997554332 34578899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|++++.+..+....+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cc
Confidence 998744444444567899999999999999999999999 99999999999999999999999999998765322 22
Q ss_pred eeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 33456899999999987765 79999999999999999999999643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=305.24 Aligned_cols=202 Identities=27% Similarity=0.417 Sum_probs=179.4
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|...+.||+|+||.||+|..+++..||+|+++.... ...++.+|++++.+++||||+++++++......++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356788899999999999999998888999999975432 346789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999754 4599999999999999999999999 99999999999999999999999999998766544333
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.....+|+.|+|||.+....++.++||||||+++|||+| |+.||+...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 344457788999999988889999999999999999999 999997544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=307.16 Aligned_cols=201 Identities=30% Similarity=0.486 Sum_probs=178.2
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|...+.||+|+||.||+|+..+++.||+|++..... ...++.+|++++++++||||+++++++.+....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 56778899999999999999988899999999975432 3567999999999999999999999999999999999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999964 45689999999999999999999999 999999999999999999999999999987654322233
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
....+++.|+|||.+....++.++||||+|+++|||++ |+.||....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 34457788999999998999999999999999999999 999997544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.67 Aligned_cols=203 Identities=25% Similarity=0.292 Sum_probs=169.7
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999954 68999999996431 222334678899999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++.....+++..+..++.||++||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 9999999999999887889999999999999999999998 7 9999999999999999999999999999864332
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 223345679999999999999999999999999999999999999997554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.24 Aligned_cols=204 Identities=24% Similarity=0.344 Sum_probs=171.0
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcc---
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER--- 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~--- 371 (517)
.++|.+.+.||+|+||.||+|+. .+++.||+|+++...... ....+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999995 578999999997643322 234688999999999999999999998776554
Q ss_pred -eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 -LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 -~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++++|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 89999999999999998777899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43222 2234568999999999999999999999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=312.46 Aligned_cols=201 Identities=23% Similarity=0.384 Sum_probs=171.7
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------ 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------ 370 (517)
.++|+..+.||+|+||.||+|+.. +|+.||||+++..........+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999976 7999999999765555556789999999999999999999999865432
Q ss_pred ---------------------------------------------------ceEEEecCcCCChhhhhhcCC---CCCHH
Q 010149 371 ---------------------------------------------------RLLVYPYMSNGSVASRLKAKP---SLDWA 396 (517)
Q Consensus 371 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~---~l~~~ 396 (517)
.++||||+++|+|.+++.... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 689999999999999998643 35667
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-----------ceeeecccccc
Q 010149 397 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-----------HVTTAVRGTVG 465 (517)
Q Consensus 397 ~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-----------~~~~~~~gt~~ 465 (517)
.+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999999 999999999999999999999999999987654321 11233469999
Q ss_pred ccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 466 y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.47 Aligned_cols=212 Identities=26% Similarity=0.388 Sum_probs=180.7
Q ss_pred ChHHHHHHhcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCccccee
Q 010149 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLI 362 (517)
Q Consensus 290 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 362 (517)
...++....++|.+.+.||+|+||.||+|++ .+++.||||+++..........+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445555678899999999999999999973 246899999997655444456799999999999 799999999
Q ss_pred eeEecCCc-ceEEEecCcCCChhhhhhcCCC-------------------------------------------------
Q 010149 363 GFCMTTTE-RLLVYPYMSNGSVASRLKAKPS------------------------------------------------- 392 (517)
Q Consensus 363 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------- 392 (517)
+++...+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 8899999999999999975432
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-
Q 010149 393 -----------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 454 (517)
Q Consensus 393 -----------------l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~- 454 (517)
+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 89999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.......||+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 23344568999999999999999999999999999999998 999997543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=307.00 Aligned_cols=201 Identities=23% Similarity=0.359 Sum_probs=171.8
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|+..+|+.||+|+++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 467888999999999999999988999999999654322 2235788999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ +|.+++.. .+.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 89888875 46799999999999999999999999 999999999999999999999999999987643222 2
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+ ..++.++||||+|+++|||+||+.||....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 233458999999999865 458999999999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.71 Aligned_cols=202 Identities=23% Similarity=0.315 Sum_probs=175.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC----CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
.+.|++.+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 346888999999999999999964 68999999985321 1123567899999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC---eEEccccc
Q 010149 373 LVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGL 445 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DFGl 445 (517)
+||||+++|+|.+.+.. ...+++..+..++.||++||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999887753 34589999999999999999999999 9999999999999986654 99999999
Q ss_pred ccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 446 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 98765432 2233456999999999999889999999999999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.16 Aligned_cols=204 Identities=29% Similarity=0.432 Sum_probs=176.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|...+.||+|+||.||+|+.. +++.||||+++.........+|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 456778899999999999999976 7899999999755433334568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+++|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999753 4689999999999999999999999 9999999999999999999999999999865432111
Q ss_pred ee-eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.. ....+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11 11235778999999998899999999999999999999 999997543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.35 Aligned_cols=201 Identities=27% Similarity=0.414 Sum_probs=169.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-------------------------cchHHHHHHHHHHhc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-------------------------GGEIQFQTEVEMISL 352 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-------------------------~~~~~~~~Ei~~l~~ 352 (517)
++|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999964 6889999998654321 113468899999999
Q ss_pred cCCCcccceeeeEec--CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 010149 353 AVHRNLLRLIGFCMT--TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANI 430 (517)
Q Consensus 353 l~H~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NI 430 (517)
++||||+++++++.. ....++||||+++++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 999999999999986 4578999999999999887654 4799999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEcccccccccCCCCCceeeeccccccccCccccccCC---CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 431 LLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 431 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999987654322 234456999999999997655 4788999999999999999999997543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=315.86 Aligned_cols=199 Identities=26% Similarity=0.371 Sum_probs=162.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467888999999999999999976 57899999997543 23567899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFGla~~~~~~~ 453 (517)
|+++|+|.+++...+.+++..+..++.|+++||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999999999999888899999999999999999999999 9999999999999975 889999999999865432
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 22334569999999999999899999999999999999999999996544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=307.22 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=176.0
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|...+.||+|+||.||+|...++..||+|+++.... ...++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 456788899999999999999998888999999975432 356789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999975 56799999999999999999999999 99999999999999999999999999998765432222
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.....+|+.|+|||.+....++.++||||+|+++|||+| |+.||....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 333447788999999998899999999999999999998 999997544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=331.56 Aligned_cols=202 Identities=28% Similarity=0.372 Sum_probs=178.5
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+++++.++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999965 79999999986432 122345688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 375 YPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
|||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997543 499999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 2 2334579999999999998899999999999999999999999997643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=315.31 Aligned_cols=205 Identities=28% Similarity=0.460 Sum_probs=178.0
Q ss_pred HhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
..++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|++++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3567888999999999999999964 3488999999765544445679999999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 010149 371 RLLVYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK 426 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 426 (517)
.++||||+++|+|.+++... ..+++..+..++.||++||.|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999753 5689999999999999999999999 99999999
Q ss_pred CCceEEcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 427 AANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 427 ~~NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+||++++++.+||+|||+++....... .......+|+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543221 12234458899999999998899999999999999999999 999997543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.68 Aligned_cols=193 Identities=23% Similarity=0.346 Sum_probs=153.7
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEecCcCC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
.+.||+|+||.||+|+.. +++.||+|++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 6899999998542 3456789999999997 999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEcccccccccCCCCCceee
Q 010149 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 382 sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DFGla~~~~~~~~~~~~ 458 (517)
+|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...... ....
T Consensus 92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 9999999888899999999999999999999999 999999999999998765 79999999998665432 2234
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 4568999999999999999999999999999999999999997543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=305.62 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=164.0
Q ss_pred hcCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.++|.+.+.||+|+||.||+|+... +..||+|+++..........+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3567888999999999999998642 45799999876544444567899999999999999999999974 567889
Q ss_pred EEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999854 4699999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.........+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 3333334457889999999998899999999999999999997 999997544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.39 Aligned_cols=201 Identities=24% Similarity=0.335 Sum_probs=177.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 357889999999999999999965 68999999986543 2234578899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC--CCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DFGla~~~~~~~ 453 (517)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999999754 4799999999999999999999999 9999999999999974 5679999999998765432
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 2334469999999999999899999999999999999999999997544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.82 Aligned_cols=200 Identities=26% Similarity=0.310 Sum_probs=166.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|...+.||+|+||.||+++.. +++.||+|++..... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 357888999999999999999965 789999999975432 23568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC--eEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++...+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 999999999998777899999999999999999999999 9999999999999987765 999999999743321
Q ss_pred ceeeeccccccccCccccccCCCCcc-cceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||.+.+..++.+ +||||+||++|||++|+.||....
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 22234569999999999988777655 899999999999999999997643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.58 Aligned_cols=199 Identities=19% Similarity=0.212 Sum_probs=174.9
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.++|...+.||+|+||.||+|+. .+|+.||||++..... ..++.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 35788899999999999999995 5789999999865432 23578999999999 9999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC-----eEEccccccccc
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLL 449 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DFGla~~~ 449 (517)
||+ +++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 9999999985 46799999999999999999999999 9999999999999998887 999999999876
Q ss_pred CCCCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 450 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 450 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 443221 123556999999999999999999999999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.15 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=177.9
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||+|+.. +|+.||+|++..... ......+..|++++++++||||+++++++......++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999975 699999999964321 223457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999874 34699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 322 233457999999999999999999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=318.55 Aligned_cols=202 Identities=25% Similarity=0.346 Sum_probs=174.9
Q ss_pred cCCCCCCccccccccceEEEEe----CCCcEEEEEEecCCCC---CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
++|.+.+.||+|+||.||+|+. .+++.||||+++.... ......+.+|++++..+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999996 3689999999864321 12234567899999999 69999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||+++|+|.+++.....+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999999998777899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
...........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 433333445679999999999975 34788999999999999999999999754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.31 Aligned_cols=204 Identities=29% Similarity=0.402 Sum_probs=177.8
Q ss_pred hcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|.+.+.||+|+||.||+|+. .++..||+|+++.........++.+|+++++.++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999985 245889999997655444456789999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 010149 372 LLVYPYMSNGSVASRLKAKP------------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 427 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~ 427 (517)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999997543 389999999999999999999999 999999999
Q ss_pred CceEEcCCCCeEEcccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 428 ANILLDEYYEAVVGDFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 428 ~NILl~~~~~~ki~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+||++++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998765433222 223447889999999988889999999999999999999 999997544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=327.09 Aligned_cols=202 Identities=26% Similarity=0.431 Sum_probs=175.9
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
..++|...+.||+|+||.||+|.++++..||||+++... ....+|.+|++++++++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 345677889999999999999999888999999997543 24668999999999999999999999986 567899999
Q ss_pred cCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999743 3689999999999999999999999 999999999999999999999999999987653222
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.......+++.|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 22223346789999999998999999999999999999999 999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.91 Aligned_cols=201 Identities=25% Similarity=0.420 Sum_probs=178.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|.+.+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999965 799999999964321 123456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+...
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 2334569999999999987765 689999999999999999999997644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.93 Aligned_cols=204 Identities=31% Similarity=0.435 Sum_probs=177.6
Q ss_pred hcCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
.++|.+.+.||+|+||.||+|+.. .+..||+|+++.........++.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357788899999999999999852 24679999997665444456789999999999 999999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
+..++||||+++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999999999999754 3589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999987654322 22233457889999999999999999999999999999999 999997543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.08 Aligned_cols=202 Identities=23% Similarity=0.308 Sum_probs=177.7
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc-------chHHHHHHHHHHhccCCCcccceeeeEecC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTT 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 368 (517)
..++|...+.||+|+||.||+|+. .+++.||+|+++...... ....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346788999999999999999995 478999999997543211 223577899999999999999999999999
Q ss_pred CcceEEEecCcCC-ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 369 TERLLVYPYMSNG-SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 369 ~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
+..++||||+..| +|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999777 9999999888899999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcC
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 7654332 234569999999999987776 78999999999999999999999653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.25 Aligned_cols=203 Identities=33% Similarity=0.427 Sum_probs=171.4
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc----ceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE----RLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~----~~l 373 (517)
.++|++.+.||+|+||.||+|+.. ++.||||+++... .....+..|+.++++++||||+++++++..... .++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 356888999999999999999876 7999999996432 223456678889999999999999999987554 589
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-------DPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
||||+++|+|.++++.. .+++..+..++.|+++||+|||+.+ .++|+||||||+|||+++++.+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999999999865 4899999999999999999999752 348999999999999999999999999999
Q ss_pred cccCCCCCc-eeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSH-VTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 876543322 2233569999999999876 356678999999999999999999997543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=307.13 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=179.6
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-----chHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|.+.+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999965 68999999997543322 246789999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC----CeEEccccccc
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK 447 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DFGla~ 447 (517)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999888899999999999999999999999 999999999999999888 79999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 765432 2234569999999999998899999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.15 Aligned_cols=205 Identities=25% Similarity=0.316 Sum_probs=179.9
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 372 (517)
..++|+..+.||+|+||.||+|+.. +++.||||+++... .......+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567889999999999999999965 68899999996432 122345678899999887 7999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||||+++|+|.+++...+.+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999999999877899999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 496 -~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 496 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp -TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 2234456799999999999999999999999999999999999999976543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.00 Aligned_cols=203 Identities=32% Similarity=0.445 Sum_probs=174.7
Q ss_pred cCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|...+.||+|+||.||+|++. ++..||||+++.........++.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56778899999999999999843 467899999976555555567899999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEcc
Q 010149 373 LVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGD 442 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~D 442 (517)
+||||+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999742 3589999999999999999999999 999999999999999555 599999
Q ss_pred cccccccCCCC-CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 443 FGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99997542211 122234458899999999999999999999999999999998 999997544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=299.58 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=179.7
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456888999999999999999965 7899999999755444455678999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-c
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-H 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-~ 455 (517)
|+++++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||.+........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999998877899999999999999999999999 999999999999999999999999999976543221 1
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||.+....+ +.++||||||+++|||++|+.||+...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2234568999999999987665 789999999999999999999997644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=326.24 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=177.3
Q ss_pred hcCCCCCCccccccccceEEEEeCC-CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|...+.||+|+||.||+|++.. +..||||+++... ....+|.+|++++++++||||+++++++......++|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3457778999999999999999764 8899999997543 235679999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999974 34689999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.......+++.|+|||.+....++.++|||||||++|||+| |+.||...+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 22233446789999999998899999999999999999999 999997544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.07 Aligned_cols=204 Identities=21% Similarity=0.267 Sum_probs=168.6
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999965 68899999997543222 235688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999998877899999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 33345569999999999998899999999999999999999999997644
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.83 Aligned_cols=202 Identities=25% Similarity=0.454 Sum_probs=167.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|...+.||+|+||.||+|+.. +++ .||+|.++.........++.+|+.++++++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 46788899999999999999954 444 46888886555555567899999999999999999999999875 4789
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
|+||+++|+|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999975 56799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 322 2233447889999999999999999999999999999999 999997543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=304.98 Aligned_cols=202 Identities=24% Similarity=0.318 Sum_probs=172.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|...+.||+|+||.||+|+.. +|+.||+|++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999975 58999999986544322 24568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 999999999998888899999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+ ..++.++||||+|+++|||+||+.||....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999875 678999999999999999999999997654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.20 Aligned_cols=205 Identities=28% Similarity=0.424 Sum_probs=175.4
Q ss_pred HhcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTT 369 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 369 (517)
..++|...+.||+|+||.||+|.. .++..||+|+++..........+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456788899999999999999985 245689999997654444556799999999999 8999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 010149 370 ERLLVYPYMSNGSVASRLKAKP-----------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK 426 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 426 (517)
..++||||+++|+|.+++.... .+++..+..++.||++||.|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 9999999999999999997542 379999999999999999999999 99999999
Q ss_pred CCceEEcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 427 AANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 427 ~~NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986643322 22334457889999999988999999999999999999998 999997644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.26 Aligned_cols=204 Identities=20% Similarity=0.249 Sum_probs=176.0
Q ss_pred hcCCCCCCccccc--cccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKG--GFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
..+|++.+.||+| +||.||+|+.. +|+.||||+++...... ....+.+|+++++.++|||||++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568889999999 99999999975 79999999997543322 23568889999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 374 VYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999754 6799999999999999999999999 999999999999999999999999998865422
Q ss_pred CCC------ceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDS------HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 110 11122358999999999977 678999999999999999999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.18 Aligned_cols=204 Identities=25% Similarity=0.387 Sum_probs=163.5
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccC-CCcccceeeeEecCC--cc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTT--ER 371 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~--~~ 371 (517)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568999999999999999999954 789999999864422 223446788999999997 999999999997544 67
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||++ |+|.+++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999998 5899888764 689999999999999999999999 999999999999999999999999999986532
Q ss_pred CC--------------------CceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 452 CD--------------------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 452 ~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.. ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11 112234579999999999876 6789999999999999999999999976543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.60 Aligned_cols=203 Identities=24% Similarity=0.379 Sum_probs=166.5
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-------CcchHHHHHHHHHHhccCCCcccceeeeEec
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 367 (517)
...++|...+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34578999999999999999999965 689999999864321 1112358899999999999999999999754
Q ss_pred CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEcccc
Q 010149 368 TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVGDFG 444 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DFG 444 (517)
+..++||||+++|+|.+++.....+++..+..++.|+++||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 45789999999999999998888899999999999999999999999 999999999999997544 59999999
Q ss_pred cccccCCCCCceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+++..... .......||+.|+|||++. ...++.++|||||||++|||+||+.||....
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 99876532 2334566999999999985 3678899999999999999999999997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.73 Aligned_cols=195 Identities=25% Similarity=0.339 Sum_probs=167.0
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999964 689999999975432 345678999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE--cCCCCeEEcccccccccCCCCCceeee
Q 010149 383 VASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 383 L~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||+ ++++.+||+|||+++.+.... ....
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence 99988643 4689999999999999999999999 99999999999999 567899999999998765432 2233
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 459999999999998899999999999999999999999997654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=299.48 Aligned_cols=202 Identities=23% Similarity=0.344 Sum_probs=178.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|++++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999965 6899999999654322 23356889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC---eEEcccccccccCCC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHC 452 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DFGla~~~~~~ 452 (517)
||+++++|.+.+.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998778899999999999999999999999 9999999999999986655 999999999876543
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 2 2234569999999999999999999999999999999999999996543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=302.74 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=170.4
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC----CcchHHHHHHHHHHhccC---CCcccceeeeEecC
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA----IGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTT 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~ 368 (517)
..++|++.+.||+|+||+||+|+. .+++.||+|+++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 4789999999864321 112346677888777664 99999999999875
Q ss_pred C-----cceEEEecCcCCChhhhhhcCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEc
Q 010149 369 T-----ERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 441 (517)
Q Consensus 369 ~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 441 (517)
. ..++||||+. |+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 3689999997 599999986543 99999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 442 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999866432 22344569999999999999999999999999999999999999997544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=298.46 Aligned_cols=202 Identities=27% Similarity=0.432 Sum_probs=157.0
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+. .+|+.||+|++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4688889999999999999996 4789999999864321 122357889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999864 6799999999999999999999999 999999999999999999999999999987653222
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 2234568999999999988889999999999999999999999997654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.94 Aligned_cols=202 Identities=31% Similarity=0.493 Sum_probs=176.0
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
..++|...+.||+|+||.||+|+..++..||+|+++... .....+.+|+++++.++||||+++++++. .+..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 345788899999999999999998888899999997543 23567899999999999999999999986 456899999
Q ss_pred cCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++++|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997543 689999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 33333457789999999988889999999999999999999 999997543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.53 Aligned_cols=202 Identities=25% Similarity=0.438 Sum_probs=171.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|...+.||+|+||.||+|+.. +++ .||+|.+...........+.+|+.+++.++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999964 444 388888865544444456788999999999999999999886 466889
Q ss_pred EEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999764 5789999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... ......|++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 322 2344558889999999998999999999999999999999 999997543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.41 Aligned_cols=201 Identities=30% Similarity=0.472 Sum_probs=177.4
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|...+.||+|+||.||+|+..+++.||+|+++.... ...++.+|++++++++||||+++++++...+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 56778899999999999999988889999999975432 3467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++++|.+++... ..+++..+..++.|+++||.|||++ +++||||||+||++++++.+||+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999754 5689999999999999999999999 999999999999999999999999999987643222222
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
....+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 33457789999999988899999999999999999999 899997543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.62 Aligned_cols=201 Identities=31% Similarity=0.434 Sum_probs=170.1
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|...+.||+|+||.||+|.++++..||||+++... ....+|.+|++++++++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 35677788999999999999999888889999997543 235679999999999999999999999876 678999999
Q ss_pred CcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999999974 35689999999999999999999999 9999999999999999999999999999876543323
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
......+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 3334457889999999998999999999999999999999 999997543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=304.71 Aligned_cols=204 Identities=28% Similarity=0.412 Sum_probs=178.4
Q ss_pred hcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
.++|...+.||+|+||.||+|+. .+++.||+|+++..........+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788889999999999999984 356889999997655444456799999999999 99999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 371 RLLVYPYMSNGSVASRLKAKP------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
.++||||+++|+|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 999999999999999997543 489999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999876544332 2234457889999999998999999999999999999999 999997543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=307.37 Aligned_cols=204 Identities=30% Similarity=0.455 Sum_probs=176.7
Q ss_pred hcCCCCCCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
.++|...+.||+|+||.||+|+.. ++..||+|+++.........++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999853 46789999997655444456789999999999 899999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
+..++||||+++|+|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997543 389999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999876543322 1233447889999999988889999999999999999999 999997543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=302.73 Aligned_cols=196 Identities=31% Similarity=0.464 Sum_probs=165.4
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhc--cCCCcccceeeeEecC----Ccc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCMTT----TER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~----~~~ 371 (517)
.++|.+.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788899999999999999998 5899999998643 24456667776665 7999999999987553 447
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
++||||+++|+|.++++. ..+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 899999999999999965 46899999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCce---eeeccccccccCccccccC------CCCcccceehhhHHHHHHHhC----------CCCcCc
Q 010149 444 GLAKLLDHCDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISG----------LRALEF 502 (517)
Q Consensus 444 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvil~elltG----------~~P~~~ 502 (517)
|+++......... .....||+.|+|||.+... .++.++||||||+++|||+|| +.||..
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9998665433322 2234699999999999776 456799999999999999999 888754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=297.15 Aligned_cols=200 Identities=22% Similarity=0.316 Sum_probs=176.7
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||.||+|+.. ++..+|+|++..... .....+.+|++++++++||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 456888999999999999999965 577999999865432 335678999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~~~~ 453 (517)
|+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999999998877899999999999999999999999 99999999999999 788999999999998765432
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 164 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 2234569999999999865 48999999999999999999999997644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=299.98 Aligned_cols=200 Identities=23% Similarity=0.330 Sum_probs=171.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|... ++..+|+|++...........+.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999964 68999999997665555567899999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccC
Q 010149 378 MSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 378 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~ 450 (517)
+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998853 46799999999999999999999999 99999999999999 456789999999998654
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......||+.|+|||.+. ..++.++||||||+++|||++|+.||....
T Consensus 179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 32 2233456999999999885 568899999999999999999999997543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.26 Aligned_cols=209 Identities=21% Similarity=0.271 Sum_probs=180.9
Q ss_pred CcccChHHHHHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-----CCccc
Q 010149 286 LKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HRNLL 359 (517)
Q Consensus 286 ~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv 359 (517)
...+.+++.....++|.+.+.||+|+||.||+|+. .+++.||||+++... .....+..|+++++.++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 34555666666778999999999999999999996 478999999996422 23446778999998886 99999
Q ss_pred ceeeeEecCCcceEEEecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---
Q 010149 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--- 434 (517)
Q Consensus 360 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~--- 434 (517)
++++++...+..++||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 9999999999999999999 899999997543 589999999999999999999999 9999999999999975
Q ss_pred ----------------------CCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHH
Q 010149 435 ----------------------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 492 (517)
Q Consensus 435 ----------------------~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~e 492 (517)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999865432 234568999999999999999999999999999999
Q ss_pred HHhCCCCcCcCc
Q 010149 493 LISGLRALEFGK 504 (517)
Q Consensus 493 lltG~~P~~~~~ 504 (517)
|+||+.||....
T Consensus 252 ll~g~~pf~~~~ 263 (360)
T 3llt_A 252 LYTGSLLFRTHE 263 (360)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHHCCCCCCCCc
Confidence 999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.22 Aligned_cols=200 Identities=24% Similarity=0.309 Sum_probs=169.1
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCC--CcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lv 374 (517)
.++|.+.+.||+|+||.||++...+++.||+|++...... .....+.+|++++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568889999999999999999888999999999754332 223568999999999976 9999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|| +.+++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99 56789999999888899999999999999999999999 999999999999997 57899999999987654322
Q ss_pred c-eeeeccccccccCcccccc-----------CCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 455 H-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 455 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||+.
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 2 2334569999999999864 6788999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=300.55 Aligned_cols=201 Identities=30% Similarity=0.454 Sum_probs=174.4
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|.+.+.||+|+||.||+|... ++..||+|++..... ......+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356888999999999999999865 578999999854321 12245688999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 99999999999998777899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 2234569999999999999899999999999999999999999997544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=302.93 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=172.4
Q ss_pred cCCCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
..|+..+.||+|+||.||+|++ .+++.||+|+++..........+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477789999999999999983 368999999998665555567899999999999999999999999876 567
Q ss_pred eEEEecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 89999999999999995 456799999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 451 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 451 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
..... ......||..|+|||.+.+..++.++||||+|+++|||+||+.|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 54332 2234558889999999999899999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=318.53 Aligned_cols=196 Identities=31% Similarity=0.453 Sum_probs=171.2
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC-cceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT-ERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e 376 (517)
.++|...+.||+|+||.||+|... |+.||||+++... ....|.+|++++++++||||+++++++...+ ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 356778899999999999999986 7899999997543 3467999999999999999999999987765 6899999
Q ss_pred cCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++...+ .+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999998543 379999999999999999999999 9999999999999999999999999999854322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.....+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 122357889999999999999999999999999999999 999997543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=297.55 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=175.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-----cchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|...+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46788899999999999999976 6899999998754322 13567899999999999999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC----CeEEcccccccc
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAKL 448 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DFGla~~ 448 (517)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999998777899999999999999999999999 999999999999998877 899999999987
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 162 IEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 65322 2234459999999999998899999999999999999999999997543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.97 Aligned_cols=200 Identities=21% Similarity=0.314 Sum_probs=173.8
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC--cceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +|+.||+|+++..........+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999965 589999999976554445667889999999999999999999998765 668999
Q ss_pred ecCcCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCCeEEcccccccc
Q 010149 376 PYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVGDFGLAKL 448 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DFGla~~ 448 (517)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997533 399999999999999999999999 99999999999999 7778899999999987
Q ss_pred cCCCCCceeeeccccccccCcccccc--------CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.... .......||+.|+|||.+.. ..++.++|||||||++|||+||+.||...
T Consensus 166 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 166 LEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 6542 22234569999999999864 56788999999999999999999999743
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=311.25 Aligned_cols=209 Identities=25% Similarity=0.295 Sum_probs=172.9
Q ss_pred HHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC----CCcchHHHHHHHHHHhccCCCcccceeeeEec
Q 010149 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN----AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367 (517)
Q Consensus 293 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 367 (517)
++....++|...+.||+|+||.||+|+.. ++..||+|++.... .......+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556678999999999999999999964 68899999986432 22345678999999999999999999999999
Q ss_pred CCcceEEEecCcCCChhhhhhc----------------------------------------CCCCCHHHHHHHHHHHHH
Q 010149 368 TTERLLVYPYMSNGSVASRLKA----------------------------------------KPSLDWATRKRIALGAAR 407 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~~i~~ 407 (517)
.+..++||||+++|+|.+++.. ...+++..+..++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998852 112357778899999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCceEEcCCC--CeEEcccccccccCCCC---CceeeeccccccccCcccccc--CCCCcc
Q 010149 408 GLLYLHEQCDPKIIHRDVKAANILLDEYY--EAVVGDFGLAKLLDHCD---SHVTTAVRGTVGHIAPEYLST--GQSSEK 480 (517)
Q Consensus 408 ~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~ki~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 480 (517)
||+|||++ +|+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||.+.. ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 89999999998653322 112345569999999999865 678899
Q ss_pred cceehhhHHHHHHHhCCCCcCcCc
Q 010149 481 TDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 481 ~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+||||||+++|||++|+.||....
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.39 Aligned_cols=197 Identities=21% Similarity=0.324 Sum_probs=171.9
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
..++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3467888999999999999999965 688999999965432 234688888777 799999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-C---CeEEcccccccccC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-Y---EAVVGDFGLAKLLD 450 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~---~~ki~DFGla~~~~ 450 (517)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++ +|+||||||+|||+.++ + .+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999998888899999999999999999999999 99999999999998543 3 49999999998765
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 4322 23445689999999999888899999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.38 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=180.1
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..++|...+.||+|+||.||+|... ++..||+|+++... ....++.+|++++++++||||+++++++......++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 4567888899999999999999976 48899999996533 34567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 376 PYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 376 e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999975 34589999999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
........+++.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 444444557889999999998899999999999999999999 999997544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=309.73 Aligned_cols=207 Identities=28% Similarity=0.388 Sum_probs=178.0
Q ss_pred HHHhcCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEec
Q 010149 295 QSATSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT 367 (517)
Q Consensus 295 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 367 (517)
....++|...+.||+|+||.||+|.... ...||+|.++..........+.+|+++++.+ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445778889999999999999999642 2479999997655444556789999999999 89999999999999
Q ss_pred CCcceEEEecCcCCChhhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 368 TTERLLVYPYMSNGSVASRLKA--------------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 9999999999999999999863 34579999999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 434 EYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 434 ~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999865433222 2234457889999999988899999999999999999999 999997543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=299.32 Aligned_cols=202 Identities=25% Similarity=0.359 Sum_probs=178.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|...+.||+|+||.||+|... +++.+|+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56788899999999999999975 5889999998654322 23456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++....... .
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999998765322 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2334569999999999998889999999999999999999999997643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.39 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=166.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|...+.||+|+||.||+|+.. +++.||+|+++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46788899999999999999965 78999999997554333333456799999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 984 88888875 44689999999999999999999999 99999999999999999999999999998654322 22
Q ss_pred eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 234458999999999876 568999999999999999999999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.09 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=178.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|...+.||+|+||.||+|... ++..||+|+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356888999999999999999965 7899999999765444445678999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++++|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 186 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 9999999999988778999999999999999999999832 7999999999999999999999999999754321 2
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234469999999999999999999999999999999999999997644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=302.53 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=169.3
Q ss_pred cCCCCC-CccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSK-NLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+.|.+. +.||+|+||.||+|.. .+++.||||++.... ......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 457664 7899999999999995 478999999996543 33456788999999884 7999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC---eEEcccccccccCCC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHC 452 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DFGla~~~~~~ 452 (517)
||+++|+|.+++.....+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999998877899999999999999999999999 9999999999999998776 999999999765322
Q ss_pred CC------ceeeeccccccccCcccccc-----CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 11 11223459999999999865 567899999999999999999999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=303.13 Aligned_cols=200 Identities=28% Similarity=0.468 Sum_probs=168.6
Q ss_pred cCCCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--Ccc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 371 (517)
++|++.+.||+|+||.||+|++ .+++.||+|+++... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5678889999999999999984 368899999996432 23345789999999999999999999998653 558
Q ss_pred eEEEecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 89999999999999997643 599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 451 HCDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 451 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.... .......++..|+|||.+.+..++.++||||||+++|||+||..|+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 4322 122334477889999999999999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=299.34 Aligned_cols=203 Identities=24% Similarity=0.400 Sum_probs=171.7
Q ss_pred hcCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.++|...+.||+|+||.||+|+..+ +..||+|+++..........+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4578888999999999999998542 346999999765544456679999999999999999999999765 45789
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++++|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999999999975 45699999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.........+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 3333344557889999999988899999999999999999998 999996543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.32 Aligned_cols=201 Identities=18% Similarity=0.230 Sum_probs=166.7
Q ss_pred hcCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCc----------chHHHHHHHHHHhccCCCcccce
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIG----------GEIQFQTEVEMISLAVHRNLLRL 361 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~----------~~~~~~~Ei~~l~~l~H~nIv~l 361 (517)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++....... ....+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999998754 4789999986543110 01123445556777889999999
Q ss_pred eeeEecC----CcceEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--C
Q 010149 362 IGFCMTT----TERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--E 434 (517)
Q Consensus 362 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~ 434 (517)
++++... ...++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 9998765 3478999999 99999999864 6799999999999999999999999 999999999999999 8
Q ss_pred CCCeEEcccccccccCCCCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 435 YYEAVVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 435 ~~~~ki~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 899999999999876432211 11334599999999999998999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.90 Aligned_cols=195 Identities=23% Similarity=0.352 Sum_probs=155.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC-----Cc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 370 (517)
.++|.+.+.||+|+||.||+|+.. +++.||||++...... ....++.+|+++++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999865 7899999999654322 2345688999999999999999999998543 46
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||+. |+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999985 68999998888899999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--------------------------ceeeeccccccccCcccc-ccCCCCcccceehhhHHHHHHHhC
Q 010149 451 HCDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISG 496 (517)
Q Consensus 451 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvil~elltG 496 (517)
.... .......||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3211 122345689999999976 566799999999999999999994
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.46 Aligned_cols=199 Identities=22% Similarity=0.270 Sum_probs=165.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
.++|...+.||+|+||.||+|+.. +++.||||++..... .....++.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999854 689999999965422 223456889999999999999999999997653
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++||||++++ +.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 459999999874 6666643 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 22344569999999999999999999999999999999999999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.49 Aligned_cols=197 Identities=26% Similarity=0.270 Sum_probs=164.6
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||+||+|+.. +|+.||||++...... ....++..|+..+.+. +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 7999999998654322 2233455566555544 8999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+ +++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 999 6688888764 45699999999999999999999999 9999999999999999999999999999876432
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334559999999998865 789999999999999999999877654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=305.39 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=160.5
Q ss_pred HhcCCCCCCccccccccceEEEEeCC-C---cEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQD-G---TVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
..++|...+.||+|+||.||+|+... + ..||+|+++.... .....++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45678899999999999999999653 3 2799999975432 23356799999999999999999999999877665
Q ss_pred ------eEEEecCcCCChhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 372 ------LLVYPYMSNGSVASRLKAK------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 372 ------~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||++++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 8999999999999998632 2589999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999999876443221 2223447789999999999999999999999999999999 999997544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=312.44 Aligned_cols=195 Identities=23% Similarity=0.332 Sum_probs=161.7
Q ss_pred cCCCCC-CccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHH-hccCCCcccceeeeEec----CCcc
Q 010149 299 SNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGFCMT----TTER 371 (517)
Q Consensus 299 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~----~~~~ 371 (517)
++|... +.||+|+||+||+|+.. +|+.||||+++. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345554 68999999999999965 689999999853 23567888876 45589999999998865 5567
Q ss_pred eEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccccc
Q 010149 372 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 446 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFGla 446 (517)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 8999999999999999864 3599999999999999999999998 9999999999999997 789999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..... .......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 865432 22334568999999999999999999999999999999999999997544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=305.11 Aligned_cols=202 Identities=25% Similarity=0.359 Sum_probs=178.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|...+.||+|+||.||++... +++.+|+|++...... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46778899999999999999965 5789999998654322 23456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++...... .
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999998765322 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 2334569999999999998889999999999999999999999997643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.76 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=172.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|...+.||+|+||.||+|+.. +|+.||+|++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46778899999999999999965 58999999986544322 23457899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 999999999888777899999999999999999999999 99999999999999999999999999998664422 22
Q ss_pred eeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3345689999999998765 78999999999999999999999997654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=305.81 Aligned_cols=211 Identities=26% Similarity=0.390 Sum_probs=180.2
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceee
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIG 363 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 363 (517)
..+.....++|.+.+.||+|+||.||+|+. .+++.||+|+++..........+.+|++++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445567899999999999999999974 356899999997655444456789999999999 7999999999
Q ss_pred eEecCC-cceEEEecCcCCChhhhhhcCCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 010149 364 FCMTTT-ERLLVYPYMSNGSVASRLKAKPS----------------LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVK 426 (517)
Q Consensus 364 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk 426 (517)
++...+ ..++||||+++|+|.+++..... +++..+..++.|+++||.|||++ +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 987755 48999999999999999986543 89999999999999999999999 99999999
Q ss_pred CCceEEcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 427 AANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 427 ~~NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654332 22334457899999999999999999999999999999998 999997543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=306.28 Aligned_cols=203 Identities=22% Similarity=0.315 Sum_probs=167.5
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
..++|.+.+.||+|+||+||+|+.. +++.||+|+++...... ....+.+|++++++++||||+++++++......++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3467888999999999999999854 78999999997543322 234578999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-----CCCCeEEccccccccc
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-----EYYEAVVGDFGLAKLL 449 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-----~~~~~ki~DFGla~~~ 449 (517)
|||+++ +|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++ +++.+||+|||+++..
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999985 9999999888899999999999999999999999 999999999999994 5556999999999876
Q ss_pred CCCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 53322 22334589999999998764 48999999999999999999999997544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=312.67 Aligned_cols=200 Identities=23% Similarity=0.298 Sum_probs=170.0
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccC--CCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|.+.+.||+|+||.||+|...+++.||||++...... .....+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999999654332 23457899999999996 599999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
| +.+++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56789999999888899999999999999999999999 999999999999996 589999999999876543222
Q ss_pred -eeeeccccccccCcccccc-----------CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 456 -VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 456 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 2344569999999999864 46889999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.63 Aligned_cols=200 Identities=25% Similarity=0.332 Sum_probs=169.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC-----Cc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 370 (517)
.++|.+.+.||+|+||.||+|+.. +++.||||+++..... ....++.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467889999999999999999965 6889999999754322 2345788999999999999999999999766 56
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||++ |+|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999987 59999999888899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---------------------eeeeccccccccCcccc-ccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 451 HCDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 451 ~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
..... ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 33211 12456799999999986 56679999999999999999998766654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=298.03 Aligned_cols=202 Identities=30% Similarity=0.411 Sum_probs=179.6
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.+.|...+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999854 6899999999766555556789999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999999999875 4689999999999999999999999 99999999999999999999999999998765422 22
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 234568999999999999999999999999999999999999997543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.06 Aligned_cols=205 Identities=23% Similarity=0.362 Sum_probs=178.7
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-------chHHHHHHHHHHhcc-CCCcccceeee
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLA-VHRNLLRLIGF 364 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 364 (517)
.....++|.+.+.||+|+||.||+|+.. +|+.||||+++...... ....+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455677999999999999999999975 79999999986543211 123578899999998 79999999999
Q ss_pred EecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 365 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
+......++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999999998777899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccCcccccc------CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 998765432 2334569999999999853 35788999999999999999999999654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.85 Aligned_cols=200 Identities=19% Similarity=0.227 Sum_probs=174.8
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.++|.+.+.||+|+||.||+|+. .+++.||+|++..... ...+.+|++++..+ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45788899999999999999995 5789999999864432 34578899999998 7999999999999999999999
Q ss_pred ecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC-----eEEccccccccc
Q 010149 376 PYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-----AVVGDFGLAKLL 449 (517)
Q Consensus 376 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DFGla~~~ 449 (517)
||+ +++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 99999999854 4699999999999999999999998 9999999999999987776 999999999876
Q ss_pred CCCCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 543221 2344569999999999999899999999999999999999999997643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=306.23 Aligned_cols=211 Identities=25% Similarity=0.405 Sum_probs=180.1
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeee
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 364 (517)
.+++....++|...+.||+|+||.||+|+.. +++.||+|++..........++.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3444556678999999999999999999854 3678999999765544445578999999999999999999999
Q ss_pred EecCCcceEEEecCcCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 010149 365 CMTTTERLLVYPYMSNGSVASRLKAK----------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 434 (517)
Q Consensus 365 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 434 (517)
+...+..++||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||++++
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 99999999999999999999998631 4579999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 435 YYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 435 ~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 999999999999865432211 1122346889999999998899999999999999999999 899987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=297.65 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=177.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999965 67899999986432 1223457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 9999999999998777899999999999999999999998 9999999999999999999999999999765432
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||+...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 2234569999999999999899999999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.78 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=166.0
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
.++|...+.||+|+||.||+|+. .+|+.||+|++...... ....++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688889999999999999996 47999999999654322 22456889999999999999999999997653
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 459999999 7899999876 4689999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 234568999999999876 679999999999999999999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=293.18 Aligned_cols=198 Identities=32% Similarity=0.561 Sum_probs=169.2
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcch------HHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGE------IQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~------~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
.++|...+.||+|+||.||+|+. .+++.||+|++......... ..+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35788889999999999999996 47899999998654433221 57899999999999999999999986554
Q ss_pred ceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEcCCCC-----eEEcc
Q 010149 371 RLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYE-----AVVGD 442 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~-----~ki~D 442 (517)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888864 45799999999999999999999998 7 999999999999988776 99999
Q ss_pred cccccccCCCCCceeeeccccccccCcccc--ccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999975432 23445699999999998 34567899999999999999999999997543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.00 Aligned_cols=197 Identities=32% Similarity=0.439 Sum_probs=171.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+.|...+.||+|+||.||+|+. .+|+.||||++....... ...++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3477788999999999999995 578999999996543322 2346889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||++ |+|.+.+. ....+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 57877775 456799999999999999999999999 9999999999999999999999999999865432
Q ss_pred ceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....||+.|+|||.+. ...++.++|||||||++|||+||+.||....
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2346999999999984 5678999999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.39 Aligned_cols=199 Identities=14% Similarity=0.147 Sum_probs=162.5
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCC--CCcchHHHHHHH---HHHhccCCCccccee-------ee
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEV---EMISLAVHRNLLRLI-------GF 364 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------~~ 364 (517)
.++|...+.||+|+||.||+|+. .+|+.||||++.... .......+.+|+ +.++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46688889999999999999996 569999999997432 223346788999 455566899999998 55
Q ss_pred EecCC-----------------cceEEEecCcCCChhhhhhcCCCCC-------HHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010149 365 CMTTT-----------------ERLLVYPYMSNGSVASRLKAKPSLD-------WATRKRIALGAARGLLYLHEQCDPKI 420 (517)
Q Consensus 365 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~-------~~~~~~i~~~i~~~L~yLH~~~~~~i 420 (517)
+...+ ..++||||+ +|+|.+++...+.++ +..+..++.||++||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 679999998543343 488889999999999999999 99
Q ss_pred EecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCccccccC-----------CCCcccceehhhHH
Q 010149 421 IHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGIL 489 (517)
Q Consensus 421 vH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvi 489 (517)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986332 3345567 999999999877 89999999999999
Q ss_pred HHHHHhCCCCcCcCcc
Q 010149 490 LLELISGLRALEFGKT 505 (517)
Q Consensus 490 l~elltG~~P~~~~~~ 505 (517)
+|||+||+.||.....
T Consensus 303 l~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 303 IYWIWCADLPITKDAA 318 (377)
T ss_dssp HHHHHHSSCCC-----
T ss_pred HHHHHHCCCCCccccc
Confidence 9999999999975443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=294.45 Aligned_cols=201 Identities=28% Similarity=0.472 Sum_probs=163.2
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC---cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI---GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|+..+.||+|+||.||+|+.. +..||+|+++..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56788899999999999999975 889999998654322 22457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC--------CCCeEEccccccc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE--------YYEAVVGDFGLAK 447 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~ki~DFGla~ 447 (517)
||+++++|.+++.. ..+++..+..++.|+++||.|||++...+|+||||||+||++++ ++.+||+|||+++
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999864 47899999999999999999999982122999999999999986 6789999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654322 223469999999999998899999999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.82 Aligned_cols=196 Identities=22% Similarity=0.323 Sum_probs=170.2
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC--CcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 375 (517)
++|...+.||+|+||.||+|+.+ ++.||+|+++..... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56788899999999999999986 889999999765432 2345789999999999999999999999887 7789999
Q ss_pred ecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++|+|.+++.... .+++..+..++.|+++||.|||+. + |+||||||+||++++++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998654 589999999999999999999998 7 99999999999999999999999998764332
Q ss_pred CCCceeeeccccccccCccccccCCCCc---ccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ...||+.|+|||.+.+..++. ++||||||+++|||+||+.||....
T Consensus 166 ~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 166 P------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp T------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred c------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 1 235899999999997655444 7999999999999999999997543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.94 Aligned_cols=199 Identities=30% Similarity=0.418 Sum_probs=172.9
Q ss_pred CCCCCccccccccceEEEEeC-----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC--CcceE
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQ-----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT--TERLL 373 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 373 (517)
|...+.||+|+||.||++.++ +++.||+|+++..........+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377899999999999988642 68899999998665444456799999999999999999999999874 56789
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 99999999999999865 489999999999999999999999 99999999999999999999999999998776543
Q ss_pred Cc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. ......+|..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 22 223445888999999999889999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=300.93 Aligned_cols=205 Identities=29% Similarity=0.386 Sum_probs=158.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..++|.+.+.||+|+||.||+|+.. +++.||+|++..........++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4568899999999999999999954 689999999875544444567889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 376 PYMSNGSVASRLKA--------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 376 e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
||+++++|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999863 45689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 6643221 12234569999999999865 568999999999999999999999997643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.38 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=178.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++......++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999965 789999999865432 23456789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~~ 451 (517)
|||+.+|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999998888899999999999999999999999 99999999999999 5678999999999987654
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||....
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2234569999999999865 68999999999999999999999997644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.75 Aligned_cols=201 Identities=23% Similarity=0.351 Sum_probs=173.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC------------cchHHHHHHHHHHhccCCCcccceeee
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI------------GGEIQFQTEVEMISLAVHRNLLRLIGF 364 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 364 (517)
.++|.+.+.||+|+||+||+|+.. +++.||+|+++..... .....+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999965 6889999999654321 224578899999999999999999999
Q ss_pred EecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---CeEEc
Q 010149 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY---EAVVG 441 (517)
Q Consensus 365 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~ 441 (517)
+.+....++||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999998777899999999999999999999999 999999999999998776 69999
Q ss_pred ccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 442 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|||+++...... ......||+.|+|||.+. ..++.++||||+||++|+|++|+.||....
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998765432 233456999999999986 568999999999999999999999997644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.42 Aligned_cols=201 Identities=33% Similarity=0.495 Sum_probs=161.4
Q ss_pred CCCCCCccccccccceEEEEeC--C--CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec-CCcceEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ--D--GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lv 374 (517)
.|...+.||+|+||.||+|+.. + +..||+|.++.........+|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556788999999999999853 2 246899998765544556789999999999999999999998764 4578899
Q ss_pred EecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cc---eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 454 SH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 454 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.. ......+++.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 11 1233457889999999999999999999999999999999 66777543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.83 Aligned_cols=202 Identities=28% Similarity=0.413 Sum_probs=171.3
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC--------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-------- 368 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------- 368 (517)
++|.+.+.||+|+||.||+|+. .+|+.||+|++...... .....+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5688899999999999999997 47899999998654432 2345788999999999999999999999774
Q ss_pred CcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
+..++||||+++ +|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999986 66666653 46799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCD---SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+.... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765322 122234568999999998875 558999999999999999999999997644
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=302.66 Aligned_cols=202 Identities=30% Similarity=0.481 Sum_probs=168.4
Q ss_pred cCCCCCCccccccccceEEEEeCC-----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD-----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.+|...+.||+|+||.||+|.... +..||+|+++.........++.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667899999999999998642 246999999765544445678999999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999753 6799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 453 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 453 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 221 1222346789999999998899999999999999999999 99999644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.73 Aligned_cols=201 Identities=24% Similarity=0.383 Sum_probs=171.7
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+.|...+.||+|+||.||+|+.. ++..||+|+++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999965 688999999975432 233567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CCeEEcccccccccCCC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DFGla~~~~~~ 452 (517)
||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++.. +.+||+|||+++.....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999998777899999999999999999999999 99999999999999764 45999999999876542
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++. ..++.++||||+||++|||++|+.||....
T Consensus 193 --~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2233456999999999985 568999999999999999999999997544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.95 Aligned_cols=195 Identities=28% Similarity=0.432 Sum_probs=166.5
Q ss_pred ccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcCCC
Q 010149 306 LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 306 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
.||+|+||.||+|.+. ++..||||+++.........+|.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 4668999999876555556789999999999999999999999976 56899999999999
Q ss_pred hhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee--ee
Q 010149 383 VASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TA 459 (517)
Q Consensus 383 L~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~--~~ 459 (517)
|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.+........ ..
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 9999974 45699999999999999999999999 999999999999999999999999999987654322211 22
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..+++.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 235689999999998999999999999999999998 999997644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=295.27 Aligned_cols=199 Identities=31% Similarity=0.425 Sum_probs=169.8
Q ss_pred CCCCCCccccccccceEEEEeC-C---CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc-eEE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-D---GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER-LLV 374 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~-~lv 374 (517)
.|...+.||+|+||.||+|+.. + +..+|+|++...........+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455688999999999999853 2 2379999997655444556789999999999999999999999876665 899
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999986 46789999999999999999999999 99999999999999999999999999998654322
Q ss_pred ---CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 454 ---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 454 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
........+++.|+|||.+.+..++.++||||||+++|||+||..|+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 112234458899999999999999999999999999999999766654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=293.63 Aligned_cols=202 Identities=24% Similarity=0.405 Sum_probs=169.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999976 78999999986432 122345788999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 99999999999998777899999999999999999999999 99999999999999999999999999998765322
Q ss_pred ceeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||+...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 2234458999999999987665 689999999999999999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.28 Aligned_cols=208 Identities=22% Similarity=0.282 Sum_probs=170.4
Q ss_pred hHHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcc----------hHHHHHHHHHHhccCCCcccc
Q 010149 291 FKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG----------EIQFQTEVEMISLAVHRNLLR 360 (517)
Q Consensus 291 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------~~~~~~Ei~~l~~l~H~nIv~ 360 (517)
..++....++|...+.||+|+||.||+|...+|..||||++........ ...+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4677788899999999999999999999988899999999965332211 257899999999999999999
Q ss_pred eeeeEecC-----CcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 010149 361 LIGFCMTT-----TERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 434 (517)
Q Consensus 361 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 434 (517)
+++++... ...++||||++ |+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 99998543 34689999998 578777764 44799999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 435 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 435 ~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999754332 22334568999999999876 678999999999999999999999997644
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.22 Aligned_cols=202 Identities=25% Similarity=0.459 Sum_probs=168.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|...+.||+|+||.||+|+.. +++ .||+|.+...........+.+|+.+++.++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999954 444 468888876555556778999999999999999999999998754 789
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
|+||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999975 45799999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 221 2233447889999999999999999999999999999999 999997543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.25 Aligned_cols=201 Identities=27% Similarity=0.427 Sum_probs=172.8
Q ss_pred CCCCCC-ccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 300 NFSSKN-LVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 300 ~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
+|.+.+ .||+|+||.||+|+.. ++..||+|+++.........++.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444455 8999999999999853 57889999997655444556799999999999999999999999 456789999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 99999999999864 45699999999999999999999999 999999999999999999999999999987754332
Q ss_pred ce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.. .....+|+.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 22 123346889999999988889999999999999999999 999997543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.25 Aligned_cols=195 Identities=30% Similarity=0.455 Sum_probs=163.2
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|++.+.||+|+||.||+|+.. ++.||+|++... .....|.+|++++++++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 45777899999999999999986 788999998643 33567899999999999999999999887 4589999999
Q ss_pred cCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC-eEEcccccccccCCCCC
Q 010149 379 SNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE-AVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 379 ~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-~ki~DFGla~~~~~~~~ 454 (517)
++|+|.+++.... .+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999998654 4789999999999999999999932239999999999999998886 799999999765422
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 22345999999999999989999999999999999999999999743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.63 Aligned_cols=200 Identities=25% Similarity=0.409 Sum_probs=175.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|...+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 356888999999999999999965 789999999975432 234568899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~~~~ 453 (517)
|+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 999999999998777899999999999999999999999 99999999999999 78899999999999764332
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2233458999999999999899999999999999999999999996543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=324.82 Aligned_cols=201 Identities=31% Similarity=0.442 Sum_probs=175.4
Q ss_pred HhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
..++|.+.+.||+|+||.||+|.++++..||||+++.... ...+|.+|++++++++||||+++++++.+ +..++|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4456778899999999999999998888899999975442 35679999999999999999999999876 67899999
Q ss_pred cCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999974 35689999999999999999999999 999999999999999999999999999987643211
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
.......++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12223346789999999998999999999999999999999 99999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.35 Aligned_cols=201 Identities=26% Similarity=0.376 Sum_probs=174.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC-CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN-AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.++|.+.+.||+|+||+||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999965 78999999986432 1223567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCCeEEcccccccccCCC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DFGla~~~~~~ 452 (517)
||+++|+|.+.+.....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999998777899999999999999999999999 999999999999995 4567999999999876542
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++.+ .++.++||||+||++|+|++|+.||....
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22334569999999999865 58999999999999999999999996543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.10 Aligned_cols=210 Identities=23% Similarity=0.336 Sum_probs=176.9
Q ss_pred ChHHHHHHhcCCCCC-CccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhcc-CCCcccceeeeE
Q 010149 290 HFKELQSATSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA-VHRNLLRLIGFC 365 (517)
Q Consensus 290 ~~~~l~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 365 (517)
.++..+...+.|.+. +.||+|+||.||+|+.. +++.||+|+++..... .....+.+|+.++..+ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455566677776 88999999999999965 6899999999754322 2356788999999988 469999999999
Q ss_pred ecCCcceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEE
Q 010149 366 MTTTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVV 440 (517)
Q Consensus 366 ~~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki 440 (517)
......++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999999864 36799999999999999999999999 9999999999999987 789999
Q ss_pred cccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 441 GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 441 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+|||+++...... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998765322 2234569999999999999999999999999999999999999997544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.65 Aligned_cols=201 Identities=22% Similarity=0.344 Sum_probs=176.6
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcc----------------hHHHHHHHHHHhccCCCcccce
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGG----------------EIQFQTEVEMISLAVHRNLLRL 361 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------------~~~~~~Ei~~l~~l~H~nIv~l 361 (517)
.++|.+.+.||+|+||.||+|.. +|+.||+|++........ ...+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999999 899999999864321111 1679999999999999999999
Q ss_pred eeeEecCCcceEEEecCcCCChhhh------hhc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEE
Q 010149 362 IGFCMTTTERLLVYPYMSNGSVASR------LKA--KPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILL 432 (517)
Q Consensus 362 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl 432 (517)
++++...+..++||||+++|+|.++ +.. ...+++..+..++.|++.||.|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 665 5789999999999999999999998 8 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCceeeeccccccccCccccccC-CCCc-ccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999875432 33445699999999999877 5666 99999999999999999999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.02 Aligned_cols=202 Identities=28% Similarity=0.393 Sum_probs=171.3
Q ss_pred cCCCCCC-ccccccccceEEEEe---CCCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKN-LVGKGGFGNVYKGYL---QDGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~-~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.+|.+.+ .||+|+||.||+|.. .+++.||+|+++...... ...++.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 899999999999964 246889999997553322 245789999999999999999999999 5667899
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
||||+++++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 999999999999999888899999999999999999999999 99999999999999999999999999998765443
Q ss_pred Ccee--eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.... ....+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 3222 22346789999999988889999999999999999999 999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=300.09 Aligned_cols=201 Identities=25% Similarity=0.390 Sum_probs=170.3
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-------CcchHHHHHHHHHHhccCCCcccceeeeEecCC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 369 (517)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457888999999999999999965 688999999865321 112235889999999999999999999987654
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC---eEEcccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFGLA 446 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DFGla 446 (517)
.++||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 899999999999999998888899999999999999999999999 9999999999999987664 999999999
Q ss_pred cccCCCCCceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 876432 2223456999999999874 5678899999999999999999999997543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=307.01 Aligned_cols=200 Identities=19% Similarity=0.211 Sum_probs=165.4
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCc----------chHHHHHHHHHHhccCCCcccceeee
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIG----------GEIQFQTEVEMISLAVHRNLLRLIGF 364 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~----------~~~~~~~Ei~~l~~l~H~nIv~l~~~ 364 (517)
++|.+.+.||+|+||.||+|+.. ++..+|+|++....... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999975 57889999986543211 11236678888899999999999999
Q ss_pred Eec----CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC--Ce
Q 010149 365 CMT----TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY--EA 438 (517)
Q Consensus 365 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~ 438 (517)
+.. ....++||||+ +++|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 987 67789999999 999999998777899999999999999999999999 999999999999999887 99
Q ss_pred EEcccccccccCCCCC------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 439 VVGDFGLAKLLDHCDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 439 ki~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999987643211 111345699999999999998999999999999999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.23 Aligned_cols=201 Identities=30% Similarity=0.464 Sum_probs=170.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcE--EEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTV--VAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|...+.||+|+||.||+|+.. ++.. +|+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888899999999999999964 5654 4999987654444556799999999999 899999999999999999999
Q ss_pred EecCcCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCe
Q 010149 375 YPYMSNGSVASRLKAKP----------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 438 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 438 (517)
|||+++|+|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 439 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 439 ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
||+|||+++..... .......+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999743321 11223347889999999988889999999999999999998 999997544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.31 Aligned_cols=200 Identities=33% Similarity=0.494 Sum_probs=160.6
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||.||+|+.. ..+|+|+++..... .....|.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467888999999999999999865 35999999755432 2345689999999999999999999965 4567899999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC-C
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-S 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~-~ 454 (517)
|+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999999999963 45799999999999999999999999 99999999999999999999999999997654322 2
Q ss_pred ceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.......||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 2233456999999999986 567888999999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=292.74 Aligned_cols=197 Identities=28% Similarity=0.406 Sum_probs=170.1
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEec----CCcceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~l 373 (517)
.|...+.||+|+||.||+|... ++..||+|++...... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3566778999999999999964 6889999998754322 234568899999999999999999998865 345789
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEc-CCCCeEEcccccccccC
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLD-EYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~ 450 (517)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. + |+||||||+||+++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999998877899999999999999999999998 7 99999999999998 78999999999997654
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||...
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 32 233456999999999886 46899999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.53 Aligned_cols=194 Identities=25% Similarity=0.359 Sum_probs=168.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CC-------cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DG-------TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
++|...+.||+|+||.||+|+.. ++ ..||+|++.... ......+.+|++++++++||||+++++++...+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 56778899999999999999855 23 479999986433 3345679999999999999999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC--------eEEc
Q 010149 371 RLLVYPYMSNGSVASRLKAKPS-LDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--------AVVG 441 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~ki~ 441 (517)
.++||||+++|+|.+++..... +++..+..++.|+++||.|||++ +|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999986544 89999999999999999999999 9999999999999998887 9999
Q ss_pred ccccccccCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 442 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 442 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.
T Consensus 164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 9999875432 123458899999999987 678999999999999999999655543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=292.69 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=170.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
.++|...+.||+|+||.||+|+.. +++.||+|+++.... .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999975 799999999975432 23345788899999888 999999999999999999999
Q ss_pred EecCcCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---------------
Q 010149 375 YPYMSNGSVASRLKAK----PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--------------- 435 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--------------- 435 (517)
|||+++++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753 6789999999999999999999999 99999999999999844
Q ss_pred ----CCeEEcccccccccCCCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 436 ----YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 436 ----~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|+.|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999998765432 23489999999999765 5678999999999999999999876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=294.95 Aligned_cols=201 Identities=33% Similarity=0.496 Sum_probs=168.6
Q ss_pred cCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEe-cCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM-TTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~-~~~~~~l 373 (517)
.+|...+.||+|+||.||+|+..+ ...+|+|.++..........+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998542 23689999976554445567999999999999999999999865 4567889
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++|+|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999975 45689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CC---ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC-CCcCc
Q 010149 453 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEF 502 (517)
Q Consensus 453 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~-~P~~~ 502 (517)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++|. .||..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 21 1223345788999999999999999999999999999999954 55543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=302.96 Aligned_cols=202 Identities=22% Similarity=0.334 Sum_probs=173.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC-----Ccc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~ 371 (517)
..+|...+.||+|+||.||+|+.. +++.||+|++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999965 68899999997544444446789999999999999999999999755 357
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++ +|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 899999984 899988764 589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCce--eeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22211 234569999999998654 458999999999999999999999997654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.51 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=172.9
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+|+.++..++||||+++++++......++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567889999999999999999965 58999999996543 2457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 9999999999987 456799999999999999999999999 99999999999999999999999999998664322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 22234468999999999998899999999999999999999999997543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=301.56 Aligned_cols=203 Identities=27% Similarity=0.354 Sum_probs=168.5
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc----chHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
..++|...+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+|+++++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4567999999999999999999965 68999999997533221 124688999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++ +|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 888887753 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 432 223345689999999998654 58899999999999999999999987644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.25 Aligned_cols=203 Identities=26% Similarity=0.405 Sum_probs=172.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEec--CCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~l 373 (517)
.++|...+.||+|+||.||+|... +++.||+|++...... .....+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999965 7899999999754422 234568999999999999999999998754 567899
Q ss_pred EEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceEEcCCCCeEEcccc
Q 010149 374 VYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPK-----IIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~-----ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||++++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999874 34589999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+++...... .......|++.|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 998765322 22233468999999999998899999999999999999999999997644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=305.66 Aligned_cols=198 Identities=22% Similarity=0.326 Sum_probs=165.5
Q ss_pred HHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC------
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------ 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 368 (517)
...++|...+.||+|+||.||+|+. .+|+.||+|++...... ..+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4567899999999999999999985 57899999998654322 23799999999999999999998543
Q ss_pred --------------------------------CcceEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHH
Q 010149 369 --------------------------------TERLLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYL 412 (517)
Q Consensus 369 --------------------------------~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yL 412 (517)
...++||||+++ +|.+.+. ....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 236799999985 7766654 467899999999999999999999
Q ss_pred HhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccccCCCCCceeeeccccccccCccccccC-CCCcccceehhhHHH
Q 010149 413 HEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILL 490 (517)
Q Consensus 413 H~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil 490 (517)
|+. +|+||||||+|||++ +++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999998 68899999999998765432 22344689999999998764 589999999999999
Q ss_pred HHHHhCCCCcCcCc
Q 010149 491 LELISGLRALEFGK 504 (517)
Q Consensus 491 ~elltG~~P~~~~~ 504 (517)
|||++|+.||....
T Consensus 233 ~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 233 GELILGKPLFSGET 246 (383)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.97 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=154.5
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC------C
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------T 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 369 (517)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999985 4789999999965432 22345688999999999999999999998654 5
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 578999999 6799988875 4699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 421 234569999999999876 678999999999999999999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=298.98 Aligned_cols=204 Identities=31% Similarity=0.444 Sum_probs=171.6
Q ss_pred hcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|.+.+.||+|+||.||+|+. .++..||+|++..........++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45788899999999999999984 257789999997554444556789999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEc
Q 010149 372 LLVYPYMSNGSVASRLKAK-------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVG 441 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~ 441 (517)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999754 3489999999999999999999999 9999999999999984 4469999
Q ss_pred ccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 442 DFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|||+++....... .......|++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 9999975533221 22234457899999999988899999999999999999998 999997543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=295.42 Aligned_cols=206 Identities=27% Similarity=0.431 Sum_probs=164.1
Q ss_pred HHhcCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
...++|...+.||+|+||.||+|... .+..||+|+++..... .....+.+|+.++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999854 3458999999754332 234568999999999999999999999987653
Q ss_pred -----ceEEEecCcCCChhhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 371 -----RLLVYPYMSNGSVASRLK------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 371 -----~~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
.++||||+++|+|.+++. ....+++..+..++.|+++||.|||++ +|+||||||+||++++++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 489999999999999983 345799999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999866433221 2233457889999999999999999999999999999999 889987544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=295.00 Aligned_cols=201 Identities=21% Similarity=0.356 Sum_probs=163.9
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC--cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+|.+.+.||+|+||.||+|.. .+|+.||+|+++..... ....++.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688889999999999999996 47899999999753322 23456889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998863 56789999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. .......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 22 2223445899999999999889999999999999999999999999653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=303.25 Aligned_cols=199 Identities=22% Similarity=0.277 Sum_probs=163.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
.++|...+.||+|+||.||+|+.. +++.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999854 6899999999754322 23456889999999999999999999997654
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 57999999975 78887763 589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 22334569999999999999899999999999999999999999997654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=292.28 Aligned_cols=195 Identities=27% Similarity=0.454 Sum_probs=171.1
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec--------
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-------- 367 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-------- 367 (517)
...+|+..+.||+|+||.||+|+.. +++.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3456888999999999999999976 79999999996532 356789999999999999999998854
Q ss_pred --------CCcceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC
Q 010149 368 --------TTERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE 437 (517)
Q Consensus 368 --------~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 437 (517)
....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 3447899999999999999964 35799999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 438 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 438 ~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999998765432 2233459999999999998899999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.40 Aligned_cols=193 Identities=20% Similarity=0.287 Sum_probs=169.7
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEec--CCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT--TTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~--~~~~~lv 374 (517)
++|++.+.||+|+||.||+|+. .+++.||+|+++.. ....+.+|++++++++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5688899999999999999985 57899999998643 2467899999999997 9999999999987 5667899
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~ 453 (517)
|||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999886 488999999999999999999999 999999999999999776 89999999998765432
Q ss_pred CceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 454 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
. .....|+..|+|||.+.. ..++.++|||||||++|||++|+.||..+
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2 234468999999999876 67899999999999999999999999654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.23 Aligned_cols=201 Identities=21% Similarity=0.269 Sum_probs=169.0
Q ss_pred HhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeE-ecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC-MTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~-~~~~~~~lv 374 (517)
..++|...+.||+|+||.||+|+. .+++.||+|++..... ..++.+|+++++.++|++++..++++ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999995 5789999998754432 23578899999999998888777766 556677999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~ 450 (517)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999873 55799999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 43221 2234569999999999999999999999999999999999999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.51 Aligned_cols=196 Identities=30% Similarity=0.408 Sum_probs=167.0
Q ss_pred CccccccccceEEEEeC---CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||.||+|.+. .++.||||+++..... ....++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 4678999999754332 234679999999999999999999999864 567899999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc--eee
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH--VTT 458 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~--~~~ 458 (517)
|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999888899999999999999999999999 9999999999999999999999999999876543321 222
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
...+|+.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3346789999999999999999999999999999998 999997644
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=298.69 Aligned_cols=201 Identities=27% Similarity=0.394 Sum_probs=174.0
Q ss_pred cCCCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec--CCcc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~ 371 (517)
++|...+.||+|+||.||+|++ .+++.||+|++.... ......+.+|++++++++||||+++++++.. ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5678889999999999999983 368899999997543 2334568999999999999999999998874 4557
Q ss_pred eEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 899999999999999975 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 451 HCDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 451 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 43332 123345888899999999888999999999999999999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.24 Aligned_cols=200 Identities=22% Similarity=0.275 Sum_probs=172.0
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeE-ecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFC-MTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~-~~~~~~~lv~ 375 (517)
.++|...+.||+|+||.||+|+. .+|+.||+|++..... ..++.+|+++++.++|++++..++++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788899999999999999996 5789999999865432 34688999999999998877777666 5566778999
Q ss_pred ecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~~ 451 (517)
||+ +++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 899999997 456799999999999999999999999 99999999999999 4888999999999987654
Q ss_pred CCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 3321 1234569999999999999999999999999999999999999997643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.44 Aligned_cols=203 Identities=25% Similarity=0.333 Sum_probs=176.6
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--------cchHHHHHHHHHHhccC-CCcccceeeeEe
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--------GGEIQFQTEVEMISLAV-HRNLLRLIGFCM 366 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~ 366 (517)
..++|...+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467888999999999999999975 6899999999654311 11345789999999996 999999999999
Q ss_pred cCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccc
Q 010149 367 TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLA 446 (517)
Q Consensus 367 ~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla 446 (517)
.....++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999998877899999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeeccccccccCccccc------cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 8765432 223456899999999885 4567899999999999999999999996543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=299.28 Aligned_cols=209 Identities=30% Similarity=0.434 Sum_probs=170.7
Q ss_pred ChHHHHHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEec
Q 010149 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMT 367 (517)
Q Consensus 290 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 367 (517)
.+.++....++|.+.+.||+|+||.||+|+. .+|+.||+|++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3344445667899999999999999999996 478999999986443 2346788999999998 79999999999976
Q ss_pred ------CCcceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeE
Q 010149 368 ------TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439 (517)
Q Consensus 368 ------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 439 (517)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 45789999999999999999753 5789999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 440 VGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 440 i~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||+||+.||....
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998654322 1223446999999999986 5678899999999999999999999996543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.50 Aligned_cols=196 Identities=19% Similarity=0.258 Sum_probs=169.1
Q ss_pred cCCCCCCccccccccceEEEEeCC---------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccc---------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLR--------- 360 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~--------- 360 (517)
++|.+.+.||+|+||.||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578889999999999999999763 789999998643 35789999999999999988
Q ss_pred ------eeeeEec-CCcceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 010149 361 ------LIGFCMT-TTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANIL 431 (517)
Q Consensus 361 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NIL 431 (517)
+++++.. ....++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5667765 67789999999 99999999865 6899999999999999999999999 9999999999999
Q ss_pred EcCCC--CeEEcccccccccCCCCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 432 LDEYY--EAVVGDFGLAKLLDHCDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 432 l~~~~--~~ki~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999866432211 113346999999999999989999999999999999999999999764
Q ss_pred c
Q 010149 504 K 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 272 ~ 272 (352)
T 2jii_A 272 L 272 (352)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.08 Aligned_cols=202 Identities=23% Similarity=0.350 Sum_probs=171.4
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC-----Ccc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~~ 371 (517)
.++|...+.||+|+||.||+|+.. +|+.||||++..........++.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999965 68999999997544444455788999999999999999999988654 567
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||++ |+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999997 5899988764 689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc---------eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2211 1123468999999998754 678999999999999999999999997644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.42 Aligned_cols=199 Identities=29% Similarity=0.437 Sum_probs=163.7
Q ss_pred HHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc--CCCcccceeeeEecC-
Q 010149 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA--VHRNLLRLIGFCMTT- 368 (517)
Q Consensus 292 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~~~~~~~- 368 (517)
.......++|.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 333445578999999999999999999986 899999998533 234455566665554 899999999999877
Q ss_pred ---CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceEEcCCCCeEE
Q 010149 369 ---TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC-----DPKIIHRDVKAANILLDEYYEAVV 440 (517)
Q Consensus 369 ---~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~ki 440 (517)
...++||||+++|+|.++++.. .+++..+..++.|++.||.|||+++ .++|+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6789999999999999999765 6899999999999999999999752 448999999999999999999999
Q ss_pred cccccccccCCCCCce---eeeccccccccCccccccCCCCcc------cceehhhHHHHHHHhC
Q 010149 441 GDFGLAKLLDHCDSHV---TTAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELISG 496 (517)
Q Consensus 441 ~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~S~Gvil~elltG 496 (517)
+|||+++.+....... .....||+.|+|||.+.+...+.+ +|||||||++|||+||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 9999997664432221 124469999999999987766554 9999999999999999
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=288.97 Aligned_cols=198 Identities=23% Similarity=0.391 Sum_probs=168.4
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
+|.....||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345566899999999999995 468899999986543 233467899999999999999999999999999999999999
Q ss_pred cCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEcccccccccCCCCC
Q 010149 379 SNGSVASRLKAK---PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 379 ~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~~~~~~~~ 454 (517)
++++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999999753 3567899999999999999999999 9999999999999987 89999999999987654221
Q ss_pred ceeeeccccccccCccccccCC--CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
......|++.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 223456899999999987643 78999999999999999999999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.73 Aligned_cols=204 Identities=21% Similarity=0.281 Sum_probs=159.7
Q ss_pred HHHHHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc-
Q 010149 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE- 370 (517)
Q Consensus 293 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~- 370 (517)
+.....++|.+.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++.++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34556788999999999999999999975 689999999865332 23456778888888999999999999976443
Q ss_pred ------ceEEEecCcCCChhhh----hhcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCceEEcC-CCC
Q 010149 371 ------RLLVYPYMSNGSVASR----LKAKPSLDWATRKRIALGAARGLLYLH--EQCDPKIIHRDVKAANILLDE-YYE 437 (517)
Q Consensus 371 ------~~lv~e~~~~gsL~~~----l~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~~~ivH~Dlk~~NILl~~-~~~ 437 (517)
.++||||++++ |... ......+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 68999999874 4433 335667899999999999999999999 77 9999999999999996 899
Q ss_pred eEEcccccccccCCCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 438 AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 438 ~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|||+||+.||....
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 9999999998765432 22345689999999998654 48999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=293.64 Aligned_cols=203 Identities=22% Similarity=0.327 Sum_probs=170.7
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467888999999999999999976 58999999986543 334567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 99999999998874 56799999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred ceeeeccccccccCcccc-----ccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYL-----STGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||.+ ....++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 112234589999999998 35678899999999999999999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.98 Aligned_cols=200 Identities=21% Similarity=0.272 Sum_probs=157.7
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHH-HHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~-~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.++|+..+.||+|+||.||+|+. .+|+.||+|+++.........+ +.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45788899999999999999996 4789999999976543333333 445555688889999999999999999999999
Q ss_pred ecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
||+++ +|.+++. ....+++..+..++.|++.||.|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99985 8877665 4568999999999999999999999853 899999999999999999999999999987643
Q ss_pred CCCceeeeccccccccCcccc----ccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
.. ......||+.|+|||.+ ....++.++||||||+++|||+||+.||+.
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 22 22334599999999996 556789999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.24 Aligned_cols=195 Identities=28% Similarity=0.367 Sum_probs=162.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC------cc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------~~ 371 (517)
.+|...+.||+|+||.||+|+.. +|+.||||++..... .+.+|+++++.++|||||++++++.... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35777899999999999999975 689999999865332 2347999999999999999999885421 25
Q ss_pred eEEEecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CCeEEcccccc
Q 010149 372 LLVYPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLA 446 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DFGla 446 (517)
++||||+++ ++.+.+. ....+++..+..++.||++||.|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 5655543 356799999999999999999999998 99999999999999965 57899999999
Q ss_pred cccCCCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 87643322 2345689999999998664 78999999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=298.78 Aligned_cols=202 Identities=33% Similarity=0.515 Sum_probs=162.7
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHH--HhccCCCcccceeeeEec-----CCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEM--ISLAVHRNLLRLIGFCMT-----TTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~--l~~l~H~nIv~l~~~~~~-----~~~ 370 (517)
.++|.+.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35788899999999999999987 58999999986432 3344455554 445899999999986542 224
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC------DPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
.++||||+++|+|.+++.... .++..+..++.|+++||.|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 589999999999999997654 589999999999999999999863 3489999999999999999999999999
Q ss_pred cccccCCCC-------CceeeeccccccccCcccccc-------CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 445 LAKLLDHCD-------SHVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 445 la~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+++.+.... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 998764322 112234469999999999876 4567899999999999999999888765443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.12 Aligned_cols=196 Identities=24% Similarity=0.355 Sum_probs=163.9
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc------ce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------RL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------~~ 372 (517)
.+|...+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 467888999999999999999877777999988543322 2369999999999999999999965433 67
Q ss_pred EEEecCcCCChhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccc
Q 010149 373 LVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKL 448 (517)
Q Consensus 373 lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~ 448 (517)
+||||++++.+.... .....+++..+..++.||++||+|||++ +|+||||||+|||++ +++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875443332 2356799999999999999999999999 999999999999999 799999999999987
Q ss_pred cCCCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 643322 2345689999999998654 58999999999999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=290.28 Aligned_cols=196 Identities=31% Similarity=0.451 Sum_probs=164.7
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecC-CcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-TERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e 376 (517)
.++|...+.||+|+||.||+|..+ |+.||+|+++... ....+.+|++++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 356788899999999999999875 8899999986532 346789999999999999999999997654 47899999
Q ss_pred cCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++++|.+++.... .+++..+..++.|+++||.|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997543 388999999999999999999999 9999999999999999999999999999765432
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 122347889999999998899999999999999999998 999997543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.40 Aligned_cols=197 Identities=22% Similarity=0.277 Sum_probs=170.4
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc------CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA------VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~~~~~~~~~ 370 (517)
..+|++.+.||+|+||.||+|+.. +++.||||+++... ....++.+|+++++.+ .|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 356888999999999999999865 58999999996432 2234677888887766 57799999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC--eEEcccccc
Q 010149 371 RLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE--AVVGDFGLA 446 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DFGla 446 (517)
.++||||+. ++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 6899988754 3589999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 223568999999999999999999999999999999999999997654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.75 Aligned_cols=197 Identities=24% Similarity=0.355 Sum_probs=153.6
Q ss_pred CCC-CCccccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec--CCcceEE
Q 010149 301 FSS-KNLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLV 374 (517)
Q Consensus 301 ~~~-~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lv 374 (517)
|.+ .+.||+|+||.||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++.. ....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 444 568999999999999965 57899999996443 23468899999999999999999999954 5678999
Q ss_pred EecCcCCChhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCCeEEc
Q 010149 375 YPYMSNGSVASRLKA---------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL----DEYYEAVVG 441 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~---------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~ 441 (517)
|||+++ +|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||+ ++++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 78777752 12489999999999999999999999 99999999999999 778899999
Q ss_pred ccccccccCCCCC--ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 442 DFGLAKLLDHCDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987653221 22344569999999999877 458999999999999999999999997543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=295.22 Aligned_cols=201 Identities=28% Similarity=0.388 Sum_probs=168.3
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec----CCcce
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERL 372 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~ 372 (517)
.++|...+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++.. ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 35688899999999999999996 578999999986432 2345578899999999999999999999873 34678
Q ss_pred EEEecCcCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 373 LVYPYMSNGSVASRLKA----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
+||||+++|+|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999998874 56799999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCc--------eeeeccccccccCccccccCC---CCcccceehhhHHHHHHHhCCCCcCc
Q 010149 449 LDHCDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 449 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 4321100 012234799999999986543 68899999999999999999999964
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=303.15 Aligned_cols=198 Identities=11% Similarity=0.040 Sum_probs=152.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC--cchHHHHHHHHHHhcc--CCCccccee-------eeEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLA--VHRNLLRLI-------GFCM 366 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~Ei~~l~~l--~H~nIv~l~-------~~~~ 366 (517)
..|...+.||+|+||.||+|+.. +|+.||+|+++..... .....+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 44778899999999999999965 7899999999765432 2234577885544444 699988755 3443
Q ss_pred cC-----------------CcceEEEecCcCCChhhhhhc-CCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeEe
Q 010149 367 TT-----------------TERLLVYPYMSNGSVASRLKA-KPSLDWATR------KRIALGAARGLLYLHEQCDPKIIH 422 (517)
Q Consensus 367 ~~-----------------~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~------~~i~~~i~~~L~yLH~~~~~~ivH 422 (517)
.. ...++||||++ |+|.+++.. ...+.+..+ ..++.||++||+|||++ +|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 32 23689999999 899999975 233455555 67889999999999999 9999
Q ss_pred cCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCc
Q 010149 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 423 ~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
|||||+|||+++++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986542 2224457799999999987 67999999999999999999999999
Q ss_pred CcCc
Q 010149 501 EFGK 504 (517)
Q Consensus 501 ~~~~ 504 (517)
....
T Consensus 294 ~~~~ 297 (371)
T 3q60_A 294 GLVT 297 (371)
T ss_dssp TBCC
T ss_pred CCcC
Confidence 8663
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=287.93 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=170.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC---CcchHHHHHHHHHHhccCCCcccceeeeEe--cCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVHRNLLRLIGFCM--TTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~--~~~~~ 371 (517)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 688999999964321 234567899999999999999999999984 44578
Q ss_pred eEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 372 LLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
++||||++++ |.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999987 7666653 45789999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CceeeeccccccccCccccccCC--CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCD-SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 5322 22334556999999999987643 4779999999999999999999997643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.96 Aligned_cols=204 Identities=24% Similarity=0.380 Sum_probs=171.8
Q ss_pred HhcCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
..++|...+.||+|+||.||+|+.. .+..||+|+++..........|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3456778889999999999999864 256799999876544444567999999999999999999999985 45689
Q ss_pred EEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 373 LVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
+||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999999854 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..........+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 43333334457889999999988899999999999999999997 999997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=294.34 Aligned_cols=206 Identities=27% Similarity=0.380 Sum_probs=173.8
Q ss_pred cChHHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhc--cCCCcccceeeeEe
Q 010149 289 FHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL--AVHRNLLRLIGFCM 366 (517)
Q Consensus 289 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~ 366 (517)
..+.......++|...+.||+|+||.||+|+.. |+.||+|++... ....+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 333444556678999999999999999999985 899999998643 34567788888876 78999999999998
Q ss_pred cCC----cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceEEcC
Q 010149 367 TTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH--------EQCDPKIIHRDVKAANILLDE 434 (517)
Q Consensus 367 ~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~ 434 (517)
... ..++||||+++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||+||++++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 876 789999999999999999764 6899999999999999999999 66 9999999999999999
Q ss_pred CCCeEEcccccccccCCCCCc---eeeeccccccccCccccccC------CCCcccceehhhHHHHHHHhC---------
Q 010149 435 YYEAVVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISG--------- 496 (517)
Q Consensus 435 ~~~~ki~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvil~elltG--------- 496 (517)
++.+||+|||++......... ......||+.|+|||.+... .++.++||||||+++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876543322 12344699999999998765 334789999999999999999
Q ss_pred -CCCcCcC
Q 010149 497 -LRALEFG 503 (517)
Q Consensus 497 -~~P~~~~ 503 (517)
+.||...
T Consensus 263 ~~~p~~~~ 270 (342)
T 1b6c_B 263 YQLPYYDL 270 (342)
T ss_dssp CCCTTTTT
T ss_pred cccCcccc
Confidence 7787653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.34 Aligned_cols=197 Identities=23% Similarity=0.348 Sum_probs=167.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcc----
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER---- 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~---- 371 (517)
.++|...+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999965 6899999999754322 2245688999999999999999999999877654
Q ss_pred --eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 372 --LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 372 --~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 588887753 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 195 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 195 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43 2234568999999999877 678999999999999999999999997544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=294.40 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=172.2
Q ss_pred cCCCCCCccccccccceEEEEe-----CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC--cc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT--ER 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~ 371 (517)
.+|...+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4577889999999999999983 368899999997532 334567899999999999999999999987654 67
Q ss_pred eEEEecCcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 372 LLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 8999999999999999864 4699999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 451 HCDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 451 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
...... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 433221 1233477889999999888899999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=293.44 Aligned_cols=202 Identities=26% Similarity=0.415 Sum_probs=171.0
Q ss_pred HhcCCCCCCccccccccceEEEEe--CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhcc---CCCcccceeeeEe----
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYL--QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA---VHRNLLRLIGFCM---- 366 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~---- 366 (517)
..++|.+.+.||+|+||.||+|+. .+|+.||+|+++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456889999999999999999997 46889999998643322 2233566788777666 8999999999987
Q ss_pred -cCCcceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccc
Q 010149 367 -TTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDF 443 (517)
Q Consensus 367 -~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DF 443 (517)
.....++||||++ |+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 4566789999998 6999998753 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 444 GLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 444 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999865432 22234568999999999998899999999999999999999999997644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=294.88 Aligned_cols=202 Identities=26% Similarity=0.331 Sum_probs=154.5
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEec--------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMT-------- 367 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~-------- 367 (517)
..+|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++.++. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346788899999999999999964 78999999985432 233456889999999996 9999999999842
Q ss_pred CCcceEEEecCcCCChhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceEEcCCCCeEEcc
Q 010149 368 TTERLLVYPYMSNGSVASRLKA---KPSLDWATRKRIALGAARGLLYLHEQCDPK--IIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 368 ~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~--ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
....++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 334689999996 689888763 56799999999999999999999998 7 99999999999999999999999
Q ss_pred cccccccCCCCCce-----------eeeccccccccCcccc---ccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 443 FGLAKLLDHCDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 443 FGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
||+++......... .....||+.|+|||.+ ....++.++||||||+++|||+||+.||+...
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99998765432211 1134589999999998 56678999999999999999999999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=291.29 Aligned_cols=200 Identities=26% Similarity=0.346 Sum_probs=152.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHH-HHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|...+.||+|+||.||+|... +|+.||+|+++.........++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888999999999999999975 789999999976544333445666665 7788899999999999999999999999
Q ss_pred cCcCCChhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 377 YMSNGSVASRLKA-----KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 377 ~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
|+++ +|.+++.. ...+++..+..++.|+++||.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 78777652 567999999999999999999999853 899999999999999999999999999986643
Q ss_pred CCCceeeeccccccccCcccc----ccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 452 CDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.. ......||+.|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 22 22233599999999998 4567899999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=293.30 Aligned_cols=196 Identities=23% Similarity=0.352 Sum_probs=166.5
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-chHHHHHHHHHHhccCCCcccceeeeEecCCc------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE------ 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------ 370 (517)
++|...+.||+|+||.||+|+.. +|+.||||++....... ....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999964 68999999997543222 24568899999999999999999999987654
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 489999998 588887754 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 233468999999999876 678999999999999999999999997644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=285.73 Aligned_cols=202 Identities=26% Similarity=0.375 Sum_probs=175.4
Q ss_pred HhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
..++|.+.+.||+|+||.||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467889999999999999999975 789999999865432 23456789999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CCeEEcccccccccCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY---YEAVVGDFGLAKLLDH 451 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DFGla~~~~~ 451 (517)
|||+++++|.+.+.....+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999988777899999999999999999999999 99999999999999754 4699999999987653
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 177 ~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 32 2223458999999998865 48899999999999999999999997543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=288.11 Aligned_cols=202 Identities=32% Similarity=0.425 Sum_probs=163.3
Q ss_pred cCCCCCCccccccccceEEEEeC--CCc--EEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--DGT--VVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|...+.||+|+||.||+|++. ++. .||+|+++.... ......+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56788899999999999999853 333 689999865432 233457899999999999999999999998754 88
Q ss_pred EEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 373 LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
+||||+++++|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999999999875 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 452 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 452 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..... .....+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 33321 223457889999999988889999999999999999999 999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=289.14 Aligned_cols=201 Identities=23% Similarity=0.324 Sum_probs=163.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEe----------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCM---------- 366 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~---------- 366 (517)
.++|...+.||+|+||.||+|+.. +++.||+|++.... .....++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 357888999999999999999976 58999999986442 233467889999999999999999999874
Q ss_pred ----cCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEc
Q 010149 367 ----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVG 441 (517)
Q Consensus 367 ----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~ 441 (517)
+....++||||++ |+|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+||+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3356789999998 599999875 4689999999999999999999999 999999999999997 56799999
Q ss_pred ccccccccCCCCC--ceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 442 DFGLAKLLDHCDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 442 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
|||+++....... .......++..|+|||.+.. ..++.++||||||+++|||+||+.||....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999987643211 12233457899999998865 678999999999999999999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.51 Aligned_cols=200 Identities=21% Similarity=0.270 Sum_probs=171.0
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCC-cccceeeeEecCCcceEEE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR-NLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lv~ 375 (517)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ..++..|++++..++|+ ++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36788999999999999999995 5789999998865433 23578899999999874 5555666667778889999
Q ss_pred ecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---cCCCCeEEcccccccccCC
Q 010149 376 PYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 376 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DFGla~~~~~ 451 (517)
||+ +++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 8999999974 56799999999999999999999999 99999999999999 6889999999999987654
Q ss_pred CCCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 452 CDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 452 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3321 1225569999999999999999999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=291.25 Aligned_cols=197 Identities=21% Similarity=0.308 Sum_probs=171.1
Q ss_pred hcCCCCCCccccccccceEEEEe--CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc------ccceeeeEecCC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL--QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLIGFCMTTT 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~~~~~~ 369 (517)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 35788899999999999999986 368899999996432 23456888999988886654 999999999999
Q ss_pred cceEEEecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE------------- 434 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~------------- 434 (517)
..++||||+ +++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999997654 689999999999999999999999 9999999999999987
Q ss_pred ------CCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 435 ------YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 435 ------~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999865432 233468999999999999899999999999999999999999997654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.25 Aligned_cols=198 Identities=22% Similarity=0.265 Sum_probs=167.7
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC--------CCcccceeeeEe--
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV--------HRNLLRLIGFCM-- 366 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~~~~~-- 366 (517)
.++|.+.+.||+|+||+||+|+. .+++.||+|+++.. ......+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 46788999999999999999985 46889999999643 223456889999998885 788999999987
Q ss_pred --cCCcceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC------
Q 010149 367 --TTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY------ 436 (517)
Q Consensus 367 --~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~------ 436 (517)
.....++||||+ ++++.+.+... ..+++..+..++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 556789999999 55666655432 56999999999999999999999864 899999999999999775
Q ss_pred -------------------------------------------CeEEcccccccccCCCCCceeeeccccccccCccccc
Q 010149 437 -------------------------------------------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473 (517)
Q Consensus 437 -------------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 473 (517)
.+||+|||++...... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999876432 23346899999999999
Q ss_pred cCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 474 TGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 474 ~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..++.++|||||||++|||+||+.||....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999997544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.99 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=174.4
Q ss_pred HHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc-----chHHHHHHHHHHhccC--CCcccceeeeEec
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLIGFCMT 367 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~ 367 (517)
...++|.+.+.||+|+||.||+|+. .+++.||+|+++...... ....+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3456788999999999999999985 478999999996543221 2235678999999986 5999999999999
Q ss_pred CCcceEEEecCcC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEccccc
Q 010149 368 TTERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGL 445 (517)
Q Consensus 368 ~~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGl 445 (517)
.+..++|||++.+ ++|.+++.....+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999976 89999998878899999999999999999999999 999999999999999 789999999999
Q ss_pred ccccCCCCCceeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcC
Q 010149 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 446 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++..... ......||+.|+|||.+....+ +.++||||||+++|||+||+.||+..
T Consensus 197 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 197 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 9876532 2234569999999999877665 78899999999999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=292.03 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=166.3
Q ss_pred HHHhcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc-----chHHHHHHHHHHhcc----CCCcccceeee
Q 010149 295 QSATSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLA----VHRNLLRLIGF 364 (517)
Q Consensus 295 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l----~H~nIv~l~~~ 364 (517)
....++|.+.+.||+|+||.||+|+. .+++.||+|+++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34557899999999999999999985 478999999996543221 223456788888888 89999999999
Q ss_pred EecCCcceEEEec-CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcc
Q 010149 365 CMTTTERLLVYPY-MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGD 442 (517)
Q Consensus 365 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~D 442 (517)
+...+..++|||| +.+++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||+++ +++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 78999999998877899999999999999999999999 999999999999999 889999999
Q ss_pred cccccccCCCCCceeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcC
Q 010149 443 FGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 443 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
||+++...... .....|+..|+|||.+....+ +.++||||||+++|||++|+.||+..
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 99998765422 234559999999999877665 45899999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=289.38 Aligned_cols=203 Identities=23% Similarity=0.302 Sum_probs=169.5
Q ss_pred HHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccC--CCcccceeeeEecCCcce
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAV--HRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~ 372 (517)
...++|.+.+.||+|+||.||++...+++.||+|++...... .....+.+|++++.+++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345678889999999999999999888999999999654322 23457899999999997 599999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||| +.+++|.+++.....+++..+..++.|+++||.|||++ +|+||||||+||++++ +.+||+|||+++.....
T Consensus 105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9999 56789999999888899999999999999999999999 9999999999999965 89999999999876443
Q ss_pred CCc-eeeeccccccccCcccccc-----------CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... ......|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 221 2234468999999999865 46888999999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=291.23 Aligned_cols=203 Identities=25% Similarity=0.402 Sum_probs=168.2
Q ss_pred HHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
...++|...+.||+|+||.||+|.... .+|+|+++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345678899999999999999999764 499999875432 22334678899999999999999999999999999999
Q ss_pred EecCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++++|.+++...+ .+++..+..++.|+++||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999998644 789999999999999999999999 999999999999998 6799999999987543211
Q ss_pred ----CceeeeccccccccCcccccc---------CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 ----SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112233458999999999864 457889999999999999999999997544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=310.53 Aligned_cols=201 Identities=28% Similarity=0.399 Sum_probs=173.5
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec------CCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT------TTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~------~~~ 370 (517)
.++|.+.+.||+|+||.||+|... +|+.||+|+++..........+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999964 6899999998765444445678999999999999999999998765 667
Q ss_pred ceEEEecCcCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCC---eEEcccc
Q 010149 371 RLLVYPYMSNGSVASRLKAKP---SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYE---AVVGDFG 444 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DFG 444 (517)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 799999999999999998543 589999999999999999999998 9999999999999997765 8999999
Q ss_pred cccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 998765432 223456999999999999999999999999999999999999999653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=293.51 Aligned_cols=201 Identities=25% Similarity=0.310 Sum_probs=170.2
Q ss_pred HHhcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CC-----cccceeeeEecC
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HR-----NLLRLIGFCMTT 368 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~~~~~~~ 368 (517)
...++|.+.+.||+|+||+||+|+.. +++.||||+++... ....++..|+.+++.++ |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34578999999999999999999965 68899999996432 22446778888888774 55 499999999999
Q ss_pred CcceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCCeEEcccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFG 444 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DFG 444 (517)
+..++||||++ |+|.+++... ..+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999999996 5999998754 4689999999999999999999952 23899999999999994 57789999999
Q ss_pred cccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 233568999999999999999999999999999999999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=317.90 Aligned_cols=192 Identities=24% Similarity=0.353 Sum_probs=166.3
Q ss_pred cCCCCCCccccccccceEEEEeC--CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCc-----c
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE-----R 371 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-----~ 371 (517)
++|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67888999999999999999975 6899999998754443445578899999999999999999999987665 6
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
++||||+++++|.+++.. .+++..+..++.||++||.|||++ +|+||||||+|||++++ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999988765 689999999999999999999999 99999999999999985 899999999987654
Q ss_pred CCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 452 CDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 452 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
. ....||+.|+|||++.+.. +.++|||||||++|||++|..||..
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred C-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 2 3346999999999987654 8899999999999999999988864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.29 Aligned_cols=193 Identities=28% Similarity=0.431 Sum_probs=160.2
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec---------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT--------- 367 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--------- 367 (517)
.++|+..+.||+|+||.||+|+.. +++.||+|+++.. ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456888999999999999999964 7899999998542 2234578899999999999999999998865
Q ss_pred ----CCcceEEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcc
Q 010149 368 ----TTERLLVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGD 442 (517)
Q Consensus 368 ----~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 442 (517)
....++||||+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 3456899999999999999984 34678899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-------------CceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHh
Q 010149 443 FGLAKLLDHCD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELIS 495 (517)
Q Consensus 443 FGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~ellt 495 (517)
||++....... ........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99998654321 1122344589999999998754 68999999999999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.65 Aligned_cols=192 Identities=16% Similarity=0.157 Sum_probs=159.2
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCC-------CcchHHHHHHHHHHhccC---------CCccccee
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-------IGGEIQFQTEVEMISLAV---------HRNLLRLI 362 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~Ei~~l~~l~---------H~nIv~l~ 362 (517)
++|...+.||+|+||+||+|+. +|+.||||+++.... ......+.+|++++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577889999999999999998 689999999975432 222367889999988875 66666655
Q ss_pred ee-----------------Eec-------------CCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 010149 363 GF-----------------CMT-------------TTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 412 (517)
Q Consensus 363 ~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yL 412 (517)
+. +.. ....++||||+++|++.+.+.. ..+++..++.++.||+.||+||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 54 332 6788999999999987776654 5689999999999999999999
Q ss_pred H-hcCCCCeEecCCCCCceEEcCCC--------------------CeEEcccccccccCCCCCceeeeccccccccCccc
Q 010149 413 H-EQCDPKIIHRDVKAANILLDEYY--------------------EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEY 471 (517)
Q Consensus 413 H-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~ 471 (517)
| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||+
T Consensus 178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9 88 999999999999999887 8999999999876432 2369999999999
Q ss_pred cccCCCCcccceehhhHH-HHHHHhCCCCcCc
Q 010149 472 LSTGQSSEKTDVFGFGIL-LLELISGLRALEF 502 (517)
Q Consensus 472 ~~~~~~~~~~Dv~S~Gvi-l~elltG~~P~~~ 502 (517)
+.+.. +.++||||+|++ .+++++|..||..
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 97665 889999998777 7889999999853
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.30 Aligned_cols=196 Identities=21% Similarity=0.303 Sum_probs=145.5
Q ss_pred hcCCCCC-CccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec----CCcc
Q 010149 298 TSNFSSK-NLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTER 371 (517)
Q Consensus 298 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 371 (517)
.++|.+. ++||+|+||.||+|+.. +|+.||+|++... .....+....+...+||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4567774 46999999999999976 6899999998642 1122233334567799999999999876 3447
Q ss_pred eEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccccc
Q 010149 372 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 446 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFGla 446 (517)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 8999999999999999864 3699999999999999999999999 9999999999999976 455999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+..... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 865432 2234568999999999988889999999999999999999999996544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.96 Aligned_cols=196 Identities=26% Similarity=0.293 Sum_probs=156.1
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEecC
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.|...+.||+|+||+||.+...+|+.||||++... ....+.+|++++.++ +||||+++++++......++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34456889999999998766667999999998643 234678899999876 8999999999999999999999999
Q ss_pred cCCChhhhhhcCCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-------------CCe
Q 010149 379 SNGSVASRLKAKPSL-------DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY-------------YEA 438 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l-------~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ 438 (517)
+ |+|.+++...... ++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999854332 2334568999999999999999 99999999999999754 489
Q ss_pred EEcccccccccCCCCCc---eeeeccccccccCcccccc-------CCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 439 VVGDFGLAKLLDHCDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 439 ki~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999877543322 1234569999999999865 568999999999999999999 99999653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=287.83 Aligned_cols=197 Identities=19% Similarity=0.289 Sum_probs=168.6
Q ss_pred hcCCCCCCccccccccceEEEEeC-CC-cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc------ccceeeeEecCC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DG-TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN------LLRLIGFCMTTT 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~~~~~~ 369 (517)
.++|.+.+.||+|+||.||+|+.. ++ ..||+|+++... .....+.+|++++++++|++ ++.+.+++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 467888999999999999999964 34 689999996432 23456888999999887666 899999999999
Q ss_pred cceEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE---------------
Q 010149 370 ERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--------------- 432 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl--------------- 432 (517)
..++||||+ ++++.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 56777766543 4699999999999999999999998 99999999999999
Q ss_pred ----cCCCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 433 ----DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 433 ----~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999865432 233569999999999999999999999999999999999999997644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=282.97 Aligned_cols=198 Identities=24% Similarity=0.363 Sum_probs=151.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHH-HHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|+..+.||+|+||.||+|... +|+.||+|++..........+ +.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56778899999999999999975 789999999976543333333 4445556788899999999999999999999999
Q ss_pred cCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+ ++.+..+.. ....+++..+..++.|+++||.|||+ . +|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99 445555544 35679999999999999999999998 5 89999999999999999999999999997654322
Q ss_pred ceeeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 223446999999999984 45688999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.45 Aligned_cols=197 Identities=26% Similarity=0.349 Sum_probs=157.8
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+....++||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 45777899999999997655556799999999964332 2356899999988 799999999999999999999999
Q ss_pred CcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-----CCCeEEcccccccccCC
Q 010149 378 MSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 378 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DFGla~~~~~ 451 (517)
++ |+|.+++.... ...+..+..++.||++||.|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 97 59999987543 455566789999999999999999 9999999999999953 23578999999987653
Q ss_pred CCC--ceeeeccccccccCccccc---cCCCCcccceehhhHHHHHHHh-CCCCcCcC
Q 010149 452 CDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIS-GLRALEFG 503 (517)
Q Consensus 452 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~ 503 (517)
... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||...
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 321 2234456999999999997 4567889999999999999999 99999643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=290.44 Aligned_cols=197 Identities=22% Similarity=0.311 Sum_probs=165.9
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-----------CCcccceeeeEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLIGFCM 366 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~~~~ 366 (517)
.+|.+.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|++++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 5788899999999999999996 478999999996432 23456788999988876 899999999987
Q ss_pred cCC----cceEEEecCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc------C
Q 010149 367 TTT----ERLLVYPYMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD------E 434 (517)
Q Consensus 367 ~~~----~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~------~ 434 (517)
... ..++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+++ +|+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 654 678999999 8899999875 345999999999999999999999853 899999999999994 4
Q ss_pred CCCeEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 435 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 435 ~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.+.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 457999999999876432 223468999999999999899999999999999999999999997544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=269.87 Aligned_cols=174 Identities=11% Similarity=0.045 Sum_probs=152.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|.+.+.||+|+||.||+|+.. +++.||+|+++...... ....+.+|+..+.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999975 58999999997654322 2357899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++++|.+++... ....++..++.|++.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999654 35667889999999999999999 99999999999999999999998544
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
|++ .++.++||||||+++|||+||+.||.....
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 367899999999999999999999986544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=288.68 Aligned_cols=199 Identities=16% Similarity=0.132 Sum_probs=154.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCC-Ccccceee---------e-
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVH-RNLLRLIG---------F- 364 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H-~nIv~l~~---------~- 364 (517)
..|...+.||+|+||.||+|+. .+|+.||||+++...... ..+.+.+|+.+++.++| +|...... .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466678999999999999994 479999999997433322 24678999999999987 32211111 1
Q ss_pred -----------Eec-----CCcceEEEecCcCCChhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 010149 365 -----------CMT-----TTERLLVYPYMSNGSVASRLK-------AKPSLDWATRKRIALGAARGLLYLHEQCDPKII 421 (517)
Q Consensus 365 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iv 421 (517)
... ....+++|+++ +++|.+++. ....+++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12345667765 579998884 134578889999999999999999999 999
Q ss_pred ecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeeccccccccCcccc----------ccCCCCcccceehhhHHHH
Q 010149 422 HRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL 491 (517)
Q Consensus 422 H~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S~Gvil~ 491 (517)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999999986542 2344567 999999999 5556888999999999999
Q ss_pred HHHhCCCCcCcCccc
Q 010149 492 ELISGLRALEFGKTA 506 (517)
Q Consensus 492 elltG~~P~~~~~~~ 506 (517)
||+||+.||......
T Consensus 309 elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 309 WIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHSSCCCCTTGGG
T ss_pred HHHHCCCCCCCcchh
Confidence 999999999765543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=264.98 Aligned_cols=174 Identities=22% Similarity=0.354 Sum_probs=149.5
Q ss_pred cCCCCC-CccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHH-hccCCCcccceeeeEec----CCcc
Q 010149 299 SNFSSK-NLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI-SLAVHRNLLRLIGFCMT----TTER 371 (517)
Q Consensus 299 ~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~----~~~~ 371 (517)
++|... +.||+|+||.||+|.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 445555 7899999999999996 4789999999853 23567888887 66699999999999876 6678
Q ss_pred eEEEecCcCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccccc
Q 010149 372 LLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 446 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFGla 446 (517)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998643 699999999999999999999999 9999999999999998 789999999998
Q ss_pred cccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... +..++.++||||||+++|||+||+.||....
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 6543 2346789999999999999999999996543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.41 Aligned_cols=186 Identities=15% Similarity=0.057 Sum_probs=132.7
Q ss_pred cccccccceEEEE-eCCCcEEEEEEecCCCCC---------cchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEEE
Q 010149 307 VGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI---------GGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 307 lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~---------~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
.+.|+.|.+..++ .-.|+.+|+|++...... ...++|.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555544 234888999999654211 1234699999999999 7999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||++|++|.+++...+.++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+...... .
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999999999988888764 5889999999999999 99999999999999999999999999998765432 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRAL 500 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~ 500 (517)
......||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3345679999999999864 5677899999999988877665543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=239.28 Aligned_cols=171 Identities=32% Similarity=0.544 Sum_probs=158.6
Q ss_pred CCchHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCce--eeeEEeCC----CCEEEEecCCCCCcc--cccccccCCCCCc
Q 010149 27 KGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCS--WALVTCSD----GLVTGLGAPSQNLSG--TLSSSIGNLTNLQ 98 (517)
Q Consensus 27 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~~~c~--w~gv~C~~----~~v~~l~l~~~~l~~--~~~~~~~~l~~L~ 98 (517)
.|.++|++||++||+++.||. .+++|..+ .+||. |.||+|+. ++|+.|+|++|++.+ .+|+.++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 467899999999999999887 78999764 58998 99999985 789999999999999 9999999999999
Q ss_pred EEeccc-CccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCC
Q 010149 99 LVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177 (517)
Q Consensus 99 ~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 177 (517)
+|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCc------CcccccCCccc
Q 010149 178 NLSGPVPSFHA------KTFNITGNSLI 199 (517)
Q Consensus 178 ~l~~~~p~~~~------~~~~l~~N~~~ 199 (517)
+++|.+|..+. +.+++++|.+.
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeee
Confidence 99988887553 56789999874
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-28 Score=255.39 Aligned_cols=186 Identities=16% Similarity=0.190 Sum_probs=148.3
Q ss_pred CCCCccccccccceEEEEeCCCcEEEEEEecCCCCCc-------chHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 302 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIG-------GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
...+.||+|+||.||+|... +..+++|+........ ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34678999999999999554 7888998865432211 123489999999999999999877777788889999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999986 568999999999999999 9999999999999999 999999999998754322
Q ss_pred ce------eeeccccccccCcccccc--CCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 455 HV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 455 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
.. .....||+.|||||++.. ..|+...|+||..+-..+.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11 235679999999999976 567888999999999999988887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=211.47 Aligned_cols=164 Identities=13% Similarity=0.073 Sum_probs=128.2
Q ss_pred HHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-----------------cchHHHHHHHHHHhccCC
Q 010149 293 ELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-----------------GGEIQFQTEVEMISLAVH 355 (517)
Q Consensus 293 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~Ei~~l~~l~H 355 (517)
.+......|...+.||+|+||.||+|...+|+.||+|+++..... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 344445566777999999999999999977999999999643211 12346889999999998
Q ss_pred CcccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 010149 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY 435 (517)
Q Consensus 356 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~ 435 (517)
| +++.+++. .+..++||||+++|+|.+ +.. .....++.|+++||.|||+. +|+||||||+|||++ +
T Consensus 163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 5 67777554 366799999999999998 532 23457999999999999999 999999999999999 9
Q ss_pred CCeEEcccccccccCCCCCceeeeccccccccCcccccc----------CCCCcccceeh
Q 010149 436 YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST----------GQSSEKTDVFG 485 (517)
Q Consensus 436 ~~~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~S 485 (517)
+.+||+|||+|+. +..|+|||++.. .++...+|+|.
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999999999963 345788988743 34455566654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=240.69 Aligned_cols=152 Identities=30% Similarity=0.444 Sum_probs=109.9
Q ss_pred CCchHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCceeeeEEeCCCCEEEEecCCCCCccc---ccc--------------
Q 010149 27 KGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGT---LSS-------------- 89 (517)
Q Consensus 27 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~~~---~~~-------------- 89 (517)
.+.++|++||++||+++.||. .+++|.. +.|||.|.||+|+.++|+.|+|+++++.|. +|+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~ 85 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECT
T ss_pred cCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCc
Confidence 346789999999999999998 8999984 459999999999988999999999999987 554
Q ss_pred ---------cccCCCCCcEEecccCccCCCCCC--cccccCcccEEEeecCCCCCCCCccC-CCCccchhhhhcccccCC
Q 010149 90 ---------SIGNLTNLQLVLLQNNNISGHIPT--EIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRLNNNSLTG 157 (517)
Q Consensus 90 ---------~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~ 157 (517)
.++++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++
T Consensus 86 ~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 165 (768)
T 3rgz_A 86 NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165 (768)
T ss_dssp TSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEE
T ss_pred CCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCC
Confidence 566667777777777777776766 67777777777777777776666554 556666666666666655
Q ss_pred CCCCC---cccCCCcceEeccCCCCC
Q 010149 158 AIPPS---LSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 158 ~~p~~---~~~l~~L~~l~l~~N~l~ 180 (517)
..|.. +.++++|++|++++|.++
T Consensus 166 ~~~~~~~~~~~l~~L~~L~Ls~n~l~ 191 (768)
T 3rgz_A 166 ANVVGWVLSDGCGELKHLAISGNKIS 191 (768)
T ss_dssp ETHHHHHHTTCCTTCCEEECCSSEEE
T ss_pred cCChhhhhhccCCCCCEEECCCCccc
Confidence 44433 333333333333333333
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-24 Score=238.12 Aligned_cols=168 Identities=25% Similarity=0.342 Sum_probs=148.5
Q ss_pred CCchHHHHHHHHHHHhCCCCCCCCCCCCCCC----CCC--cee------------eeEEeC-CCCEEEEecCCCCCcccc
Q 010149 27 KGVNYEVQALMGIKDSLHDPHDVLNNWDENS----VDP--CSW------------ALVTCS-DGLVTGLGAPSQNLSGTL 87 (517)
Q Consensus 27 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~----~~~--c~w------------~gv~C~-~~~v~~l~l~~~~l~~~~ 87 (517)
.+..+|++||++||+++.+| +|+.++ .+| |.| .||+|+ .++|+.|+|+++++.|.+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 34567999999999999887 675543 456 999 999998 489999999999999999
Q ss_pred cccccCCCCCcEEec-ccCccCCC--------------------------------------------------------
Q 010149 88 SSSIGNLTNLQLVLL-QNNNISGH-------------------------------------------------------- 110 (517)
Q Consensus 88 ~~~~~~l~~L~~L~l-~~N~l~~~-------------------------------------------------------- 110 (517)
|++|++|++|+.|+| ++|.++|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 77766544
Q ss_pred --------------------CCCcccccCcccEEEeecCCCCC-----------------CCCccCC--CCccchhhhhc
Q 010149 111 --------------------IPTEIGKLSKLLTLDLSNNFFTG-----------------PIPSTVS--HLETLQYLRLN 151 (517)
Q Consensus 111 --------------------~p~~~~~l~~L~~L~l~~N~l~~-----------------~~p~~~~--~l~~L~~L~l~ 151 (517)
+|..|++|++|++|+|++|+|+| .+|+.++ ++++|++|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 88899999999999999999998 3999988 99999999999
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCC-CCC-CCCCC------------CcCcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNN-LSG-PVPSF------------HAKTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~-~~p~~------------~~~~~~l~~N~~~ 199 (517)
+|++.|.+|..+.++++|+.|+|++|+ |+| .+|.. ..+.+++++|.+.
T Consensus 500 ~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp SCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred CCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 999999999999999999999999998 998 66653 2367888999886
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.5e-24 Score=228.79 Aligned_cols=169 Identities=24% Similarity=0.335 Sum_probs=150.5
Q ss_pred chHHHHHHHHHHHhCCCCCCC--------CCCCCCCCCCCcee---eeEEeCC-CCEEEEecCCCCCcccccccccCCCC
Q 010149 29 VNYEVQALMGIKDSLHDPHDV--------LNNWDENSVDPCSW---ALVTCSD-GLVTGLGAPSQNLSGTLSSSIGNLTN 96 (517)
Q Consensus 29 ~~~~~~al~~~k~~~~~~~~~--------l~~W~~~~~~~c~w---~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~ 96 (517)
...|++||.+|++++.++.+. ..+|+.+ .+||.| .||+|+. ++|+.|+|+++++.|.+|+++++|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 346999999999999876543 3379874 699999 9999975 69999999999999999999999999
Q ss_pred CcEEecccCc----------------------------------------------------------------------
Q 010149 97 LQLVLLQNNN---------------------------------------------------------------------- 106 (517)
Q Consensus 97 L~~L~l~~N~---------------------------------------------------------------------- 106 (517)
|++|+|++|.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 9999999884
Q ss_pred --------cCCCCCCcccccCcccEEEeecCCCCCC-----------------CCccCC--CCccchhhhhcccccCCCC
Q 010149 107 --------ISGHIPTEIGKLSKLLTLDLSNNFFTGP-----------------IPSTVS--HLETLQYLRLNNNSLTGAI 159 (517)
Q Consensus 107 --------l~~~~p~~~~~l~~L~~L~l~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~ 159 (517)
++| +|..|+++++|++|+|++|+|+|. +|+.++ ++++|++|+|++|++.|.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 445 899999999999999999999986 999999 9999999999999999999
Q ss_pred CCCcccCCCcceEeccCCC-CCC-CCCCCC-----------cCcccccCCccc
Q 010149 160 PPSLSNMSQLAFLDLSYNN-LSG-PVPSFH-----------AKTFNITGNSLI 199 (517)
Q Consensus 160 p~~~~~l~~L~~l~l~~N~-l~~-~~p~~~-----------~~~~~l~~N~~~ 199 (517)
|..++++++|++|+|++|+ ++| .+|..+ .+.+++++|.+.
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 9999999999999999999 998 777532 377889999885
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-23 Score=205.35 Aligned_cols=170 Identities=18% Similarity=0.256 Sum_probs=150.8
Q ss_pred CCCchHHHHHHHHHHHhC-CCCCCCCCCCC---CCCCCCceeeeEEeC----------CCCEEEEecCCCCCcccccccc
Q 010149 26 PKGVNYEVQALMGIKDSL-HDPHDVLNNWD---ENSVDPCSWALVTCS----------DGLVTGLGAPSQNLSGTLSSSI 91 (517)
Q Consensus 26 ~~~~~~~~~al~~~k~~~-~~~~~~l~~W~---~~~~~~c~w~gv~C~----------~~~v~~l~l~~~~l~~~~~~~~ 91 (517)
..+..+|++||++||+++ .||.+.+.+|. ....++|.|.|+.|. ..+|+.|+|++|++. .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 345678999999999998 57878788995 445689999999995 268999999999998 889999
Q ss_pred cCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCccc------
Q 010149 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSN------ 165 (517)
Q Consensus 92 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------ 165 (517)
+++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 89999999999999999999999 88999999999999999999999999988765
Q ss_pred ---CCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 166 ---MSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 166 ---l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+++|+.|+|++|+|+ .+|..+. +.+++++|.+.
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 999999999999999 6666544 67889999875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=183.07 Aligned_cols=145 Identities=22% Similarity=0.255 Sum_probs=131.2
Q ss_pred CCCceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEe
Q 010149 58 VDPCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDL 126 (517)
Q Consensus 58 ~~~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 126 (517)
.+.|+|.+|.|+. ..++.|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 4789999999984 36889999999999999999999999999999999998666677899999999999
Q ss_pred ecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccC
Q 010149 127 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 127 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~ 201 (517)
++|+|++..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999777777899999999999999999 8899999999999999999999987776554 6789999999988
Q ss_pred CC
Q 010149 202 TG 203 (517)
Q Consensus 202 ~~ 203 (517)
+.
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 64
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.5e-21 Score=178.87 Aligned_cols=144 Identities=24% Similarity=0.304 Sum_probs=131.3
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
.|.|..|.|++ ..++.|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 37899999973 3689999999999988888999999999999999999988899999999999999999
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.++..+. +.+++++|++.|.|.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 999965556689999999999999999988899999999999999999999988876554 678999999999875
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=176.00 Aligned_cols=144 Identities=21% Similarity=0.255 Sum_probs=130.9
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCccccc-ccccCCCCCcEEecccCccCCCCCCcccccCcccEEEee
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLS 127 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 127 (517)
-|.|..+.|++ ..++.|+|++|++++..+ ..|..+++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus 10 ~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 10 RCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 37899999974 247789999999998865 458999999999999999998888899999999999999
Q ss_pred cCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCC
Q 010149 128 NNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT 202 (517)
Q Consensus 128 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~ 202 (517)
+|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+++++|++.|.+
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 9999988888899999999999999999988899999999999999999999998887765 67899999999987
Q ss_pred C
Q 010149 203 G 203 (517)
Q Consensus 203 ~ 203 (517)
.
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.4e-20 Score=169.97 Aligned_cols=145 Identities=23% Similarity=0.257 Sum_probs=128.3
Q ss_pred CCceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEee
Q 010149 59 DPCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLS 127 (517)
Q Consensus 59 ~~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 127 (517)
..|.|.+|.|+. .+++.|+|++|++++..+..+..+++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 5 C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 5 CSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence 348999999973 358999999999998877889999999999999999997666678999999999999
Q ss_pred cCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCC
Q 010149 128 NNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICAT 202 (517)
Q Consensus 128 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~ 202 (517)
+|++++..+..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|.+
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 9999976667789999999999999999977777789999999999999999987776544 67899999998876
Q ss_pred C
Q 010149 203 G 203 (517)
Q Consensus 203 ~ 203 (517)
+
T Consensus 165 ~ 165 (208)
T 2o6s_A 165 P 165 (208)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.4e-20 Score=177.88 Aligned_cols=138 Identities=17% Similarity=0.162 Sum_probs=107.0
Q ss_pred CCCCCccccccccceEEEEe-CCCcE--EEEEEecCCCCCc-----------------------chHHHHHHHHHHhccC
Q 010149 301 FSSKNLVGKGGFGNVYKGYL-QDGTV--VAVKRLKDGNAIG-----------------------GEIQFQTEVEMISLAV 354 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~ 354 (517)
|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ....+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 9999975432110 0125788999999998
Q ss_pred CCcc--cceeeeEecCCcceEEEecCcC-C----ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCC
Q 010149 355 HRNL--LRLIGFCMTTTERLLVYPYMSN-G----SVASRLKAKPSLDWATRKRIALGAARGLLYLH-EQCDPKIIHRDVK 426 (517)
Q Consensus 355 H~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ivH~Dlk 426 (517)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 8864 333332 467899999943 4 56655432 234567889999999999999 87 99999999
Q ss_pred CCceEEcCCCCeEEcccccccccC
Q 010149 427 AANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 427 ~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
|+|||+++ .++|+|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 99999999998654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=164.34 Aligned_cols=144 Identities=22% Similarity=0.292 Sum_probs=106.1
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCcccccc-cccCCCCCcEEecccCccCCCCCCcccccCcccEEEee
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSS-SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLS 127 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 127 (517)
.|.|..|.|+. ..++.|+|++|++++..+. .++.+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 37898888873 2577788888888766654 47788888888888888887777788888888888888
Q ss_pred cCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCC
Q 010149 128 NNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG 203 (517)
Q Consensus 128 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~ 203 (517)
+|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+.... +...+.++...|..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 8888877777788888888888888888877788888888888888888888876653211 222444555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.4e-19 Score=168.25 Aligned_cols=128 Identities=23% Similarity=0.248 Sum_probs=112.2
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|++|++.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 57889999999998888899999999999999999998888889999999999999999997777788999999999999
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+|+|++..+..+..+++|+.|+|++|+|++.++..+. +.+++++|.+.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 9999976666788899999999999999987775543 67888999874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.3e-19 Score=195.73 Aligned_cols=135 Identities=33% Similarity=0.516 Sum_probs=124.7
Q ss_pred EEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccc
Q 010149 75 GLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154 (517)
Q Consensus 75 ~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 154 (517)
.++++.+.+.|.+|..++++++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..++++++|+.|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 35677788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCCCCCCCCC
Q 010149 155 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGAEEDCFG 210 (517)
Q Consensus 155 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~~~~~~~~ 210 (517)
++|.+|..+.++++|++|+|++|+|+|.+|.... ....+.||+.+||.+.. .|..
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 9999999999999999999999999999997543 45678999999998765 6643
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-18 Score=162.84 Aligned_cols=131 Identities=24% Similarity=0.277 Sum_probs=120.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 57999999999999999999999999999999999999877788999999999999999999777777899999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~ 201 (517)
++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+++++|++.|.
T Consensus 139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999977777899999999999999999988876554 6889999999887
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.6e-18 Score=164.15 Aligned_cols=128 Identities=26% Similarity=0.329 Sum_probs=87.3
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 36667777777776666667777777777777777775444455677777777777777775555566777777777777
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+|++++..|..|..+++|++|+|++|+|++.++..+. +.+++++|.+.
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 170 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK 170 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc
Confidence 7777766666677777777777777777765554433 55666777653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.1e-20 Score=193.00 Aligned_cols=136 Identities=20% Similarity=0.252 Sum_probs=86.2
Q ss_pred eeeeEEeCC-CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCccc-ccCcccEEEeecCCCCCCCCccC
Q 010149 62 SWALVTCSD-GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTV 139 (517)
Q Consensus 62 ~w~gv~C~~-~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~ 139 (517)
.+.++.|.. ..++.|+|++|.+++..|..++++++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.|++. | .+
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~ 187 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQ 187 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CC
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-cc
Confidence 344444432 3566677777777766666677777777777777777766666664 567777777777777644 2 23
Q ss_pred CCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccC
Q 010149 140 SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 140 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~ 201 (517)
..+++|+.|+|++|+|++ +|+.+..+++|+.|+|++|+|++. |..+. +.+++++|++.|+
T Consensus 188 ~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~l-p~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEE-CTTCCCCTTCCEEECTTCCBCHH
T ss_pred ccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCccc-chhhccCCCCCEEEcCCCCCcCc
Confidence 346777777777777774 444466777777777777777753 33222 4566777776655
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=4.1e-18 Score=155.77 Aligned_cols=127 Identities=23% Similarity=0.349 Sum_probs=114.5
Q ss_pred EEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCC-cccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 74 TGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPT-EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 74 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
+.|+++++++. .+|..+.. +|++|+|++|+|++..|. .|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57899999995 67776644 999999999999976664 489999999999999999988899999999999999999
Q ss_pred cccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|+|++..|..|..+++|++|+|++|+|++.+|..+. +.+++++|++.|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999988888899999999999999999999887665 678999999998865
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-18 Score=152.03 Aligned_cols=125 Identities=24% Similarity=0.264 Sum_probs=83.6
Q ss_pred CceeeeEEeCCC-----------CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 60 PCSWALVTCSDG-----------LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 60 ~c~w~gv~C~~~-----------~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
.|.|.+|.|+.. .++.|++++|++++..+..+..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 478999999742 466667777776665555666677777777777777655555566677777777777
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
|+|++..+..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 77775555556666777777777777764444445666777777777777766555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=153.11 Aligned_cols=124 Identities=23% Similarity=0.346 Sum_probs=105.6
Q ss_pred EecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhccccc
Q 010149 76 LGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155 (517)
Q Consensus 76 l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 155 (517)
+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 444556665 5565543 68999999999998 7888999999999999999999987778899999999999999999
Q ss_pred CCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 156 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 156 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
++..|..|..+++|+.|+|++|+|++.++..+. +.+++++|++.|+|.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 988888899999999999999999977776554 678999999999875
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-17 Score=160.47 Aligned_cols=133 Identities=22% Similarity=0.215 Sum_probs=93.4
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..+..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 35777777777777666666777777777777777777666666677777777777777777655556677777777777
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
++|++++..|..+..+++|+.|++++|++++.+|..+. +.+++++|++.|.++
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 77777766666667777777777777777776665443 566777777766643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.4e-18 Score=169.95 Aligned_cols=149 Identities=13% Similarity=0.124 Sum_probs=103.4
Q ss_pred HHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCC-------------cchHHHHHHHHHHhccCCCcccc
Q 010149 294 LQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI-------------GGEIQFQTEVEMISLAVHRNLLR 360 (517)
Q Consensus 294 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~ 360 (517)
+.....-|.+.+.||+|+||.||+|...+|+.||||+++..... ........++++.+...|+|+++
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 33333448889999999999999999989999999998642110 01112223333333333444444
Q ss_pred eeeeEe------cCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 010149 361 LIGFCM------TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE 434 (517)
Q Consensus 361 l~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~ 434 (517)
++.... .....++||||+++++|...... .....++.|++.+|.|||+. +||||||||.|||+++
T Consensus 170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred HHhcCCCCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 332211 11345799999999888765432 23457889999999999998 9999999999999988
Q ss_pred CCC----------eEEcccccccccCC
Q 010149 435 YYE----------AVVGDFGLAKLLDH 451 (517)
Q Consensus 435 ~~~----------~ki~DFGla~~~~~ 451 (517)
++. +.|+||+-+.....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCcccccccccceEEEEeCCcccCCC
Confidence 773 89999998765443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=180.49 Aligned_cols=157 Identities=21% Similarity=0.217 Sum_probs=124.5
Q ss_pred CCCCCCCCCCCC---CCCCceee----eEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCc
Q 010149 45 DPHDVLNNWDEN---SVDPCSWA----LVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNN 106 (517)
Q Consensus 45 ~~~~~l~~W~~~---~~~~c~w~----gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~ 106 (517)
|+.+.+++|+.+ +.+||.+. .|.|+. ..++.|||++|+|++..+.+|.++++|++|+|++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 344445555432 22567653 478972 368999999999998888999999999999999999
Q ss_pred cCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCC-CCC
Q 010149 107 ISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPS 185 (517)
Q Consensus 107 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~p~ 185 (517)
|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++. +|.
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9987788899999999999999999966667899999999999999999977777899999999999999999864 455
Q ss_pred CCc-----CcccccCCccccC
Q 010149 186 FHA-----KTFNITGNSLICA 201 (517)
Q Consensus 186 ~~~-----~~~~l~~N~~~c~ 201 (517)
.+. +.+++++|++...
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEE
T ss_pred hhccchhhhhhcccCcccccc
Confidence 543 6789999988543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.8e-18 Score=169.63 Aligned_cols=139 Identities=27% Similarity=0.280 Sum_probs=114.3
Q ss_pred ceeeeEEeCC-----------CCEEEEecCCCCCccccccccc-CCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 61 CSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIG-NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 61 c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
|.+..|.|+. ..++.|+|++|++++..+..+. ++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6788899973 2477899999999988888887 899999999999999977777899999999999999
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC--------cCcccccCCccc
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--------AKTFNITGNSLI 199 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--------~~~~~l~~N~~~ 199 (517)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++..+ .+.++|++|++.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99997667778889999999999999987778888888999999999998887555443 145566666653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-18 Score=168.40 Aligned_cols=130 Identities=25% Similarity=0.396 Sum_probs=77.1
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
++.|+|++|.+++.+|..+..++ |++|+|++|++++.+|..|.++++|+.|+|++|++++.+|. +..+++|++|+|++
T Consensus 176 L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~ 253 (313)
T 1ogq_A 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRN 253 (313)
T ss_dssp CCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCS
T ss_pred CcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcC
Confidence 34444444444444444444443 44444444444444455555555566666666666544433 55666777777777
Q ss_pred cccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCCC
Q 010149 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 204 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~~ 204 (517)
|+|++.+|..+..+++|+.|+|++|+|+|.+|.... +.+++++|+..|+.+.
T Consensus 254 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp SCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred CcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence 777777777777777777777777777777776522 5667777777777543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.5e-17 Score=157.15 Aligned_cols=127 Identities=22% Similarity=0.242 Sum_probs=73.3
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
+++.|+|++|.++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 62 ~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 141 (270)
T 2o6q_A 62 KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG 141 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECC
Confidence 56666666666665444455666666666666666665444455666666666666666665555555666666666666
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSL 198 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~ 198 (517)
+|+|++..+..|..+++|+.|+|++|++++.++..+. +.+++++|++
T Consensus 142 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (270)
T 2o6q_A 142 YNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcC
Confidence 6666644444455566666666666666554443332 4455555554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.1e-17 Score=159.11 Aligned_cols=130 Identities=22% Similarity=0.227 Sum_probs=75.8
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|++|.++ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 156 (290)
T 1p9a_G 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (290)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence 4555555555555 455555666666666666666665545556666666666666666665444455666666666666
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICAT 202 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~ 202 (517)
+|+|++..+..+..+++|+.|+|++|+|+..++..+. +.+++++|++.|.|
T Consensus 157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 157 NNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 6666644344455566666666666666633332222 45566666666654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=159.91 Aligned_cols=128 Identities=20% Similarity=0.208 Sum_probs=79.6
Q ss_pred CCEEEEecCCCC-CcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQN-LSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
.+++.|+|++|. +....|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 356667777665 5555566666666777777777766665566666666666666666666654445566666666666
Q ss_pred hcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcc
Q 010149 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSL 198 (517)
Q Consensus 150 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~ 198 (517)
|++|++++..+..+..+++|+.|+|++|++++..|..+. +.+++++|.+
T Consensus 160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 213 (285)
T 1ozn_A 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcC
Confidence 666666644444566666666666666666655554433 4455555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=7.5e-17 Score=147.40 Aligned_cols=124 Identities=27% Similarity=0.353 Sum_probs=112.4
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
.|.|..|.|++ ..++.|+|++|+++ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 47788899973 36889999999998 7789999999999999999999988888899999999999999
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.....
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99998888899999999999999999996666679999999999999999986543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.2e-17 Score=169.31 Aligned_cols=133 Identities=22% Similarity=0.252 Sum_probs=124.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|++++|.+.+.+|..++.+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999888999999999999999999999888899999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
++|++++..|..+..+++|++|+|++|+|++.++..+. +.+++++|++.|.++
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999988899999999999999999999987776543 788999999999876
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.6e-17 Score=159.32 Aligned_cols=131 Identities=20% Similarity=0.277 Sum_probs=61.7
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCC-CCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
+++.|++++|.+.+..+..+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 34444444444444444444444444445554444443 34444444555555555555554444444444555555555
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc------CcccccCCccccCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICAT 202 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~------~~~~l~~N~~~c~~ 202 (517)
++|++++..+..+..+++|+.|+|++|++++.+|..+. +.+++++|++.|.+
T Consensus 207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 55555433333444445555555555555544443221 33445555554443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-16 Score=142.39 Aligned_cols=128 Identities=21% Similarity=0.247 Sum_probs=110.6
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
.+.+++++++++ .+|..+ .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 367899999988 455444 47999999999999977777789999999999999999976667789999999999999
Q ss_pred cccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|+|++..+..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999977777789999999999999999987776543 678999999988654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=152.25 Aligned_cols=128 Identities=20% Similarity=0.184 Sum_probs=111.8
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 58899999999998888899999999999999999997777789999999999999999997777889999999999999
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCC-CCCCCc-----CcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~~~-----~~~~l~~N~~~ 199 (517)
+|++++..+..+..+++|++|++++|++++. +|..+. +.+++++|.+.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence 9999977676899999999999999999873 466554 67788888763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-16 Score=148.64 Aligned_cols=115 Identities=17% Similarity=0.201 Sum_probs=108.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 57999999999999988889999999999999999999888888999999999999999999888999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 185 (517)
++|+|++..|..|..+++|+.|+|++|++++..+-
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 99999988899999999999999999999987663
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.9e-16 Score=169.05 Aligned_cols=143 Identities=20% Similarity=0.230 Sum_probs=124.6
Q ss_pred CCCceee----eEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCccc
Q 010149 58 VDPCSWA----LVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLL 122 (517)
Q Consensus 58 ~~~c~w~----gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 122 (517)
.+||.|. .|.|++ .+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 3667763 588863 4689999999999999888999999999999999999988888999999999
Q ss_pred EEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCC-CCCCCCc-----CcccccCC
Q 010149 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNITGN 196 (517)
Q Consensus 123 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~p~~~~-----~~~~l~~N 196 (517)
+|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++ .+|..+. +.+++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999998889999999999999999999997777889999999999999999986 5676554 67888898
Q ss_pred cccc
Q 010149 197 SLIC 200 (517)
Q Consensus 197 ~~~c 200 (517)
.+..
T Consensus 164 ~l~~ 167 (606)
T 3vq2_A 164 YIQT 167 (606)
T ss_dssp CCCE
T ss_pred ccee
Confidence 8753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=142.48 Aligned_cols=127 Identities=22% Similarity=0.218 Sum_probs=111.2
Q ss_pred CCEEEEecCCCCCc-ccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLS-GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
..++.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 47899999999998 88999999999999999999999965 7899999999999999999987888888899999999
Q ss_pred hcccccCCCC-CCCcccCCCcceEeccCCCCCCCCC---CCCc-----CcccccCCccc
Q 010149 150 LNNNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPVP---SFHA-----KTFNITGNSLI 199 (517)
Q Consensus 150 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~p---~~~~-----~~~~l~~N~~~ 199 (517)
|++|+|++.. +..+..+++|+.|++++|++++.++ ..+. +.+++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 9999999532 2789999999999999999997766 2222 67788888763
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.8e-16 Score=150.46 Aligned_cols=129 Identities=22% Similarity=0.237 Sum_probs=116.4
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCC-CCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-FTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~ 149 (517)
..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 368999999999998888889999999999999999998889999999999999999997 8866688999999999999
Q ss_pred hcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 150 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
|++|++++..|..+.++++|++|++++|++++.++..+. +.+++++|.+.
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence 999999988888999999999999999999987776553 77889999774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-16 Score=165.19 Aligned_cols=142 Identities=22% Similarity=0.283 Sum_probs=124.3
Q ss_pred CCceeee--EEeCC----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCC-CCcccccCcccEEE
Q 010149 59 DPCSWAL--VTCSD----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHI-PTEIGKLSKLLTLD 125 (517)
Q Consensus 59 ~~c~w~g--v~C~~----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ 125 (517)
+.|.|.+ |.|+. .+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4566666 89974 35899999999999999999999999999999999998666 56799999999999
Q ss_pred eecCCCCCCCCccCCCCccchhhhhcccccCCCCCCC--cccCCCcceEeccCCCCCCCCCCC-Cc-----CcccccCCc
Q 010149 126 LSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPSF-HA-----KTFNITGNS 197 (517)
Q Consensus 126 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~~~~p~~-~~-----~~~~l~~N~ 197 (517)
|++|++++..|..+.++++|++|+|++|++++.+|.. +..+++|++|+|++|++++..|.. +. +.+++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999865554 999999999999999999987865 32 778999998
Q ss_pred ccc
Q 010149 198 LIC 200 (517)
Q Consensus 198 ~~c 200 (517)
+..
T Consensus 166 l~~ 168 (455)
T 3v47_A 166 VKS 168 (455)
T ss_dssp BSC
T ss_pred ccc
Confidence 743
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-16 Score=170.43 Aligned_cols=134 Identities=19% Similarity=0.268 Sum_probs=122.7
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCcc-CCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNI-SGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l-~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
..++.++++.|.+.+..+..+..+++|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 4678889999999999999999999999999999975 456788999999999999999999988999999999999999
Q ss_pred hcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc------CcccccCCccccCCCC
Q 010149 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLICATGA 204 (517)
Q Consensus 150 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~------~~~~l~~N~~~c~~~~ 204 (517)
|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+++++|++.|+|..
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 999999988888999999999999999999999887654 5689999999999863
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-16 Score=169.93 Aligned_cols=139 Identities=22% Similarity=0.277 Sum_probs=121.8
Q ss_pred CceeeeEEeCC-------------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEe
Q 010149 60 PCSWALVTCSD-------------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDL 126 (517)
Q Consensus 60 ~c~w~gv~C~~-------------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 126 (517)
.|.|.|+ |+. .+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899998 862 37999999999999999999999999999999999999888899999999999999
Q ss_pred ecCCCCCCCCccCCCCccchhhhhcccccCC-CCCCCcccCCCcceEeccCCCCCCCCC-CCCc-----CcccccCCccc
Q 010149 127 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVP-SFHA-----KTFNITGNSLI 199 (517)
Q Consensus 127 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~p-~~~~-----~~~~l~~N~~~ 199 (517)
++|++++..|..++++++|++|+|++|++++ .+|..+.++++|++|++++|++.+.+| ..+. +.+++++|.+.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999997777779999999999999999996 467889999999999999999655555 3443 67788888774
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=159.33 Aligned_cols=139 Identities=22% Similarity=0.303 Sum_probs=119.5
Q ss_pred CCceeeeEEeC--C-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEE
Q 010149 59 DPCSWALVTCS--D-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLD 125 (517)
Q Consensus 59 ~~c~w~gv~C~--~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 125 (517)
.+|.|.|+ |+ . .+++.|+|++|++++..+..+.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 28 ~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 28 LSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp CEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 67889887 64 1 3799999999999987777999999999999999999988888999999999999
Q ss_pred eecCCCCCCCCccCCCCccchhhhhcccccCCCCCC--CcccCCCcceEeccCCC-CCCCCCCCCc-----CcccccCCc
Q 010149 126 LSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNN-LSGPVPSFHA-----KTFNITGNS 197 (517)
Q Consensus 126 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~-l~~~~p~~~~-----~~~~l~~N~ 197 (517)
|++|++++..+..+.++++|++|+|++|+++ .+|. .+..+++|++|++++|+ +++.+|..+. +.+++++|.
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 9999999544455899999999999999999 5555 79999999999999994 7766666554 678888987
Q ss_pred cc
Q 010149 198 LI 199 (517)
Q Consensus 198 ~~ 199 (517)
+.
T Consensus 186 l~ 187 (353)
T 2z80_A 186 LQ 187 (353)
T ss_dssp CC
T ss_pred cC
Confidence 74
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=147.48 Aligned_cols=127 Identities=27% Similarity=0.321 Sum_probs=113.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+.+. +.+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 63 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 4799999999999873 47899999999999999999877777899999999999999999777778899999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
++|++++..|..+..+++|+.|++++|++++.+|..+. +.+++++|.+.
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 99999977777789999999999999999988776543 77899999875
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-16 Score=174.11 Aligned_cols=167 Identities=24% Similarity=0.251 Sum_probs=78.9
Q ss_pred chHHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCceeeeEEeCCCCEEEEecCCCCCc------------------c----
Q 010149 29 VNYEVQALMGIKDSLHDP-HDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLS------------------G---- 85 (517)
Q Consensus 29 ~~~~~~al~~~k~~~~~~-~~~l~~W~~~~~~~c~w~gv~C~~~~v~~l~l~~~~l~------------------~---- 85 (517)
...++++|+++..+...+ ...-..|...+...+.|.+++++..+++.|+|.+|++. +
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~ 209 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDI 209 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcccc
Confidence 355778899998887422 22234565555556678877776555555544333221 1
Q ss_pred -----cccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCC
Q 010149 86 -----TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP 160 (517)
Q Consensus 86 -----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 160 (517)
..+..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|
T Consensus 210 ~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp 286 (727)
T 4b8c_D 210 ENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP 286 (727)
T ss_dssp ------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCC
T ss_pred ccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccC
Confidence 12444566666666666666666 56666666666666666666666 66666666666666666666666 566
Q ss_pred CCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 161 PSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 161 ~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
..|++|++|++|+|++|.|+ .+|..+. +.++|++|++.
T Consensus 287 ~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 287 AELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp SSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred hhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 66666666666666666665 3444333 45666666653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-16 Score=148.24 Aligned_cols=127 Identities=18% Similarity=0.233 Sum_probs=112.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCc-cCCCCCCcccccCcccEEEeec-CCCCCCCCccCCCCccchhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNN-ISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYL 148 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L 148 (517)
..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 579999999999998888899999999999999997 8866667899999999999999 99997667789999999999
Q ss_pred hhcccccCCCCCCCcccCCCcc---eEeccCC-CCCCCCCCCCc-----C-cccccCCccc
Q 010149 149 RLNNNSLTGAIPPSLSNMSQLA---FLDLSYN-NLSGPVPSFHA-----K-TFNITGNSLI 199 (517)
Q Consensus 149 ~l~~N~l~~~~p~~~~~l~~L~---~l~l~~N-~l~~~~p~~~~-----~-~~~l~~N~~~ 199 (517)
+|++|++++ +|. +..+++|+ .|++++| ++++.++..+. + .+++++|.+.
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 999999995 776 88888888 9999999 99977776554 5 7888898874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-16 Score=175.14 Aligned_cols=131 Identities=27% Similarity=0.338 Sum_probs=98.2
Q ss_pred CEEEEecCCCCCcccccc-cccCCCCCcEEecccCccC-----CCCCCcccccCcccEEEeecCCCCCCCCccCCCCccc
Q 010149 72 LVTGLGAPSQNLSGTLSS-SIGNLTNLQLVLLQNNNIS-----GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 145 (517)
+++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..+..+++|
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 506 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence 566666666666654432 3455677777777777776 3444567788888888888888887777778888888
Q ss_pred hhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCccccCCCC
Q 010149 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLICATGA 204 (517)
Q Consensus 146 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~c~~~~ 204 (517)
+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+. +.+++++|++.|.|..
T Consensus 507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 8888888888866555554 7888888888888888887765 6789999999998864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=154.74 Aligned_cols=126 Identities=21% Similarity=0.334 Sum_probs=111.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccc---------cCcccEEEeecCCCCCCCCccCCC
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK---------LSKLLTLDLSNNFFTGPIPSTVSH 141 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~p~~~~~ 141 (517)
.+++.|+|++|.++ .+|..++++++|++|+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..+..
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp TTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred CCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence 47899999999998 78989999999999999999888899987765 999999999999999 88999999
Q ss_pred CccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 142 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+++|++|+|++|+++ .+|..+..+++|+.|+|++|++.+.+|..+. +.+++++|.+.
T Consensus 205 l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 266 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266 (328)
T ss_dssp CTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTC
T ss_pred CCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCch
Confidence 999999999999999 5777899999999999999999998887665 67888888764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=7.3e-16 Score=161.08 Aligned_cols=138 Identities=17% Similarity=0.152 Sum_probs=123.2
Q ss_pred eeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCC
Q 010149 62 SWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF 130 (517)
Q Consensus 62 ~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 130 (517)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 367899973 368899999999999999999999999999999999998889999999999999999999
Q ss_pred CCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 131 FTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 131 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+. +.+++++|.+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 9966666789999999999999999988899999999999999999999987776654 67888888774
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-15 Score=142.85 Aligned_cols=114 Identities=18% Similarity=0.173 Sum_probs=105.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 47999999999999999999999999999999999999666666899999999999999999888999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
++|+|++..+..|..+++|+.|+|++|+++....
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9999998777889999999999999999986443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=136.18 Aligned_cols=108 Identities=25% Similarity=0.327 Sum_probs=94.6
Q ss_pred EEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccc
Q 010149 75 GLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154 (517)
Q Consensus 75 ~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 154 (517)
.|++++|+++ .+|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 4556677776 466655 3899999999999998889999999999999999999997777778999999999999999
Q ss_pred cCCCCCCCcccCCCcceEeccCCCCCCCCCC
Q 010149 155 LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185 (517)
Q Consensus 155 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 185 (517)
|++..+..|..+++|+.|+|++|++++..+.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9977777899999999999999999987663
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=6.8e-16 Score=149.26 Aligned_cols=116 Identities=22% Similarity=0.237 Sum_probs=87.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..+..+.++++|++|+|++|++++..|..|.++++|++|++++|++++..+..+..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 46777888888887777777778888888888888887766677777888888888888877665556777778888888
Q ss_pred cccccCCC-CCCCcccCCCcceEeccCCCCCCCCCCC
Q 010149 151 NNNSLTGA-IPPSLSNMSQLAFLDLSYNNLSGPVPSF 186 (517)
Q Consensus 151 ~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 186 (517)
++|++++. +|..+..+++|+.|+|++|++++.++..
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 88887753 5777777777888887777777655443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4e-16 Score=167.97 Aligned_cols=133 Identities=21% Similarity=0.227 Sum_probs=100.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCC-CCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG-HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
..++.|++++|.+.+..|..+.++++|++|+|++|++++ .+|..|..+++|+.|+|++|++++..|..+..+++|++|+
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 357777777777777777777778888888888888776 3677778888888888888888877777788888888888
Q ss_pred hcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC------cCcccccCCccccCCCC
Q 010149 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH------AKTFNITGNSLICATGA 204 (517)
Q Consensus 150 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~------~~~~~l~~N~~~c~~~~ 204 (517)
|++|++++.+|..+..+++|+.|+|++|+|+. +|..+ .+.+++++|++.|+++.
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 88888887777788888888888888888874 33322 25667888888887763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=146.78 Aligned_cols=125 Identities=25% Similarity=0.243 Sum_probs=86.0
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|++|.+++..+..|..+++|++|+|++|.|++. |.. ..+++|++|+|++|+|+ .+|..+..+++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 577788888888777777777777777777777777743 322 56677777777777776 566666677777777777
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+|+|++..|..|..+++|+.|+|++|+|++.++..+. +.+++++|.+.
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 7777755556677777777777777777765554433 55666666664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=157.87 Aligned_cols=131 Identities=23% Similarity=0.283 Sum_probs=101.2
Q ss_pred CEEEEecCCCCCcccccc-------------------------cccCCCCCcEEecccCccCCCCCCcccccCcccEEEe
Q 010149 72 LVTGLGAPSQNLSGTLSS-------------------------SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDL 126 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~-------------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 126 (517)
+++.|+|++|.+....+. .|.++++|++|+|++|+++ .+| .+..+++|+.|+|
T Consensus 137 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~L 214 (440)
T 3zyj_A 137 KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDL 214 (440)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEEC
T ss_pred cCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEEC
Confidence 566777777766654443 3556666666777777776 455 4677778888888
Q ss_pred ecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccC
Q 010149 127 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 127 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~ 201 (517)
++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|+
T Consensus 215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 88888877788888888889999999988887788888999999999999999987776554 6788999999998
Q ss_pred CCC
Q 010149 202 TGA 204 (517)
Q Consensus 202 ~~~ 204 (517)
|..
T Consensus 295 C~l 297 (440)
T 3zyj_A 295 CDI 297 (440)
T ss_dssp STT
T ss_pred CCc
Confidence 753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-16 Score=138.13 Aligned_cols=112 Identities=21% Similarity=0.258 Sum_probs=102.6
Q ss_pred CCEEEEecCCCCCc-ccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLS-GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..+.++++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 47899999999998 89999999999999999999999965 6899999999999999999987888888899999999
Q ss_pred hcccccCCC-CCCCcccCCCcceEeccCCCCCCCCC
Q 010149 150 LNNNSLTGA-IPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 150 l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
|++|++++. .|..+..+++|+.|++++|++++.++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999953 34889999999999999999997765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=9e-16 Score=165.00 Aligned_cols=152 Identities=14% Similarity=0.107 Sum_probs=105.0
Q ss_pred CCCCCCCCCCCCCCce----eeeEEeCC------------------CCEEEEecCCCCCcccccccccCCCCCcEEeccc
Q 010149 47 HDVLNNWDENSVDPCS----WALVTCSD------------------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQN 104 (517)
Q Consensus 47 ~~~l~~W~~~~~~~c~----w~gv~C~~------------------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~ 104 (517)
...+++|.+. .+||. |.++.|+. ..++.++++++.+....+..+.++++|++|+|++
T Consensus 6 ~~~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~ 84 (597)
T 3oja_B 6 RYNVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84 (597)
T ss_dssp -----CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTT
T ss_pred cccccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCC
Confidence 3456788764 35553 66665541 2356677777777665555677788888888888
Q ss_pred CccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 105 NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 105 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
|.+++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|.|++.+|
T Consensus 85 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 164 (597)
T 3oja_B 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164 (597)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred CCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh
Confidence 88887777778888888888888888887777777788888888888888875444556778888888888888887777
Q ss_pred CCCc-----CcccccCCccc
Q 010149 185 SFHA-----KTFNITGNSLI 199 (517)
Q Consensus 185 ~~~~-----~~~~l~~N~~~ 199 (517)
..+. +.+++++|.+.
T Consensus 165 ~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 165 DTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp TTTTTCTTCCEEECTTSCCS
T ss_pred hhhhcCCcCcEEECcCCCCC
Confidence 6544 56677777664
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.1e-15 Score=138.22 Aligned_cols=127 Identities=20% Similarity=0.202 Sum_probs=111.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 47999999999999877778899999999999999999777777899999999999999999777777899999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCcCcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~l~~N~~~ 199 (517)
++|++++..+..+..+++|+.|++++|.+.+..|. .+.+++.+|.+.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~--l~~L~~~~n~~~ 178 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG--IRYLSEWINKHS 178 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT--THHHHHHHHHCT
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCCC--HHHHHHHHHhCC
Confidence 99999977777799999999999999999988773 245566666653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-15 Score=134.65 Aligned_cols=108 Identities=24% Similarity=0.268 Sum_probs=96.0
Q ss_pred EEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhccc
Q 010149 74 TGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNN 153 (517)
Q Consensus 74 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 153 (517)
+.+++++|++. .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56888899885 6777664 89999999999999888999999999999999999999765666799999999999999
Q ss_pred ccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 154 SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 154 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
+|++..+..|..+++|+.|+|++|+++...+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9996666669999999999999999997665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=163.15 Aligned_cols=137 Identities=19% Similarity=0.145 Sum_probs=122.5
Q ss_pred eeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCC
Q 010149 63 WALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFF 131 (517)
Q Consensus 63 w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 131 (517)
+..|.|.+ ..++.|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 34588862 4689999999999999999999999999999999999998899999999999999999999
Q ss_pred CCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCC-CCCCCc----CcccccCCccc
Q 010149 132 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA----KTFNITGNSLI 199 (517)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~~~----~~~~l~~N~~~ 199 (517)
++..|..++++++|++|+|++|++++..|..+.++++|++|++++|++++. +|.... +.+++++|.+.
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 166 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence 988899999999999999999999976688899999999999999999984 354432 77888998875
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.8e-15 Score=163.62 Aligned_cols=139 Identities=23% Similarity=0.225 Sum_probs=118.7
Q ss_pred ceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecC
Q 010149 61 CSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 129 (517)
Q Consensus 61 c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 129 (517)
|.+..|.|+. .+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4455577752 47899999999999888888999999999999999999888989999999999999999
Q ss_pred CCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 130 FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 130 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.+|..+. +.+++++|.+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence 99955555799999999999999999977778899999999999999999988877654 67788888764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=156.44 Aligned_cols=132 Identities=22% Similarity=0.278 Sum_probs=104.5
Q ss_pred CCEEEEecCCCCCccccccc-------------------------ccCCCCCcEEecccCccCCCCCCcccccCcccEEE
Q 010149 71 GLVTGLGAPSQNLSGTLSSS-------------------------IGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLD 125 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~-------------------------~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 125 (517)
.+++.|+|++|.+....+.. |.++++|++|+|++|++++ +| .+..+++|+.|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~ 224 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELE 224 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEE
Confidence 36777888877776544433 5566667777777777773 44 477788888888
Q ss_pred eecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcccc
Q 010149 126 LSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 200 (517)
Q Consensus 126 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c 200 (517)
|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.++..+. +.++|++|++.|
T Consensus 225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 888888877788889999999999999999988888899999999999999999987776654 678999999999
Q ss_pred CCCC
Q 010149 201 ATGA 204 (517)
Q Consensus 201 ~~~~ 204 (517)
+|..
T Consensus 305 dC~~ 308 (452)
T 3zyi_A 305 DCDI 308 (452)
T ss_dssp STTT
T ss_pred CCCc
Confidence 9863
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.3e-15 Score=140.31 Aligned_cols=113 Identities=21% Similarity=0.185 Sum_probs=104.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|++.+..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 47999999999998777778899999999999999999777777899999999999999999 88999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
++|+|++..+..+..+++|+.|+|++|.+++..+
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999997767789999999999999999998776
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=6e-16 Score=151.94 Aligned_cols=139 Identities=23% Similarity=0.267 Sum_probs=118.2
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCC--CCCCcccccCcccEEEe
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDL 126 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l 126 (517)
.|.|.+|.|+. ..++.|+|++|+++...+..|.++++|++|+|++|+++. ..|..+..+++|++|+|
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 48999999974 368999999999996555668999999999999999983 33667778999999999
Q ss_pred ecCCCCCCCCccCCCCccchhhhhcccccCCCCC-CCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 127 SNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 127 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|..+. +.+++++|.+.
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 999998 678889999999999999999996554 5788999999999999999988777654 67888888874
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.9e-15 Score=155.43 Aligned_cols=137 Identities=20% Similarity=0.217 Sum_probs=117.6
Q ss_pred eeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCC
Q 010149 63 WALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFF 131 (517)
Q Consensus 63 w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 131 (517)
|..|.|.+ ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 56788863 3689999999999999999999999999999999999988889999999999999999999
Q ss_pred CCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCC-CCc-----CcccccCCccc
Q 010149 132 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHA-----KTFNITGNSLI 199 (517)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~-----~~~~l~~N~~~ 199 (517)
++..+..+..+++|++|+|++|+|++..+..|.++++|+.|++++|+..+.+|. .+. +.+++++|.+.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 977777799999999999999999966667889999999999998544444443 332 67888888774
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-15 Score=163.86 Aligned_cols=131 Identities=24% Similarity=0.299 Sum_probs=84.5
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCC---CCCcccccCcccEEEeecCCCCCCCCccCCCCccchhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH---IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 148 (517)
+++.|++++|.+.+..|..++.+++|++|+|++|++++. .+..+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 505 (606)
T 3t6q_A 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505 (606)
T ss_dssp TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence 455566666666655566666666666666666666541 22446666666666666666666666666666777777
Q ss_pred hhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 149 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
+|++|++++..|..+.++++| .|++++|++++.+|..+. +.+++++|++.|.|+
T Consensus 506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 506 DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 777777766666666667777 777777777766665433 567777777777654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.5e-15 Score=152.85 Aligned_cols=129 Identities=16% Similarity=0.142 Sum_probs=107.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|+++++.+....+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..+.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 35777888888887655556788999999999999999777778999999999999999999877888999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
++|+++...+..+.++++|++|++++|++++.+|..+. +.+++++|.+.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 99999944444468899999999999999987776554 67888888874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.1e-15 Score=146.56 Aligned_cols=137 Identities=24% Similarity=0.338 Sum_probs=119.7
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
.|.|+.+.|+. ..++.|+|++|++.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 37899999973 3689999999999988888999999999999999999988899999999999999999
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCC--CCCCCCc----CcccccCCccc
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG--PVPSFHA----KTFNITGNSLI 199 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~p~~~~----~~~~l~~N~~~ 199 (517)
|+++ .+|..+. ++|++|++++|++++..+..+..+++|+.|++++|.++. ..|..+. +.+++++|.+.
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 9999 7777766 899999999999996666679999999999999999963 5555543 67888888774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=161.43 Aligned_cols=131 Identities=21% Similarity=0.284 Sum_probs=74.8
Q ss_pred EEEEecCCCCCccccc-ccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCC-CCCCccCCCCccchhhhh
Q 010149 73 VTGLGAPSQNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-GPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l 150 (517)
++.|++++|.+.+..| ..+.++++|++|+|++|.+.+..|..+.++++|+.|+|++|+++ +.+|..+..+++|++|+|
T Consensus 398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l 477 (570)
T 2z63_A 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477 (570)
T ss_dssp CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence 3444444444444333 34555555555555555555555555556666666666666655 345566666666666666
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
++|++++..|..+..+++|+.|++++|++++.+|..+. +.+++++|++.|.++
T Consensus 478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 66666655566666666666666666666665554432 455666666665543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=7.1e-15 Score=131.34 Aligned_cols=104 Identities=25% Similarity=0.254 Sum_probs=93.5
Q ss_pred CcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccC
Q 010149 97 LQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 176 (517)
Q Consensus 97 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 176 (517)
.+.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887764 8999999999999988899999999999999999999977777789999999999999
Q ss_pred CCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 177 NNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 177 N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|+|++.++..+. +.++|++|++.|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999988876554 688999999998864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=3e-15 Score=167.32 Aligned_cols=139 Identities=24% Similarity=0.213 Sum_probs=107.2
Q ss_pred ceeeeEEeCCCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCC-CCcccccCcccEEEeecCCCCCCCCccC
Q 010149 61 CSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTGPIPSTV 139 (517)
Q Consensus 61 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 139 (517)
|.|..|.+-..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.+|++|++|+|++|++++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 456666664567888999999988888888888888888888888666555 6778888888888888888887778888
Q ss_pred CCCccchhhhhcccccCCCCCCC--cccCCCcceEeccCCCCCCCCCC-CCc-----CcccccCCccc
Q 010149 140 SHLETLQYLRLNNNSLTGAIPPS--LSNMSQLAFLDLSYNNLSGPVPS-FHA-----KTFNITGNSLI 199 (517)
Q Consensus 140 ~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~~~~p~-~~~-----~~~~l~~N~~~ 199 (517)
.++++|++|+|++|++++.+|.. +.++++|++|+|++|.+++..|. .+. +.+++++|.+.
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 88888888888888888766654 78888888888888888776542 232 56677777663
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-15 Score=166.71 Aligned_cols=125 Identities=26% Similarity=0.376 Sum_probs=115.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 57899999999998 78888889999999999999999 89999999999999999999999 88999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc------CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~------~~~~l~~N~~~ 199 (517)
++|.|+ .+|..|++|++|+.|+|++|+|++.+|..+. ..++|.+|.+.
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~ 354 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPE 354 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence 999998 8899999999999999999999999988764 23678888774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=7.7e-15 Score=145.65 Aligned_cols=137 Identities=26% Similarity=0.373 Sum_probs=117.6
Q ss_pred CceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 60 PCSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 60 ~c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
.|.|+.+.|++ ..++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 47899999973 3688899999999988888999999999999999999988899999999999999999
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCC--CCCCCCc-----CcccccCCccc
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG--PVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~p~~~~-----~~~~l~~N~~~ 199 (517)
|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.++. ..+..+. +.+++++|.+.
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 9999 6777665 789999999999997777778999999999999999964 4554443 66788888763
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=156.33 Aligned_cols=129 Identities=19% Similarity=0.121 Sum_probs=114.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 47999999999999998999999999999999999999888888999999999999999999655556799999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~ 199 (517)
++|.|++..|..|..+++|+.|+|++|.|++..+..+. +.+++++|.+.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccc
Confidence 99999988888999999999999999999986544443 55667777653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=9.5e-15 Score=151.03 Aligned_cols=137 Identities=20% Similarity=0.193 Sum_probs=116.3
Q ss_pred eeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCC
Q 010149 63 WALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFF 131 (517)
Q Consensus 63 w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 131 (517)
|..|.|.+ ..++.|+|++|++.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 66889973 3578899999999999999999999999999999999988888999999999999999999
Q ss_pred CCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCC-CCc-----CcccccCCccc
Q 010149 132 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHA-----KTFNITGNSLI 199 (517)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~-----~~~~l~~N~~~ 199 (517)
++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.+|. .+. +.+++++|.+.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 966667899999999999999999976677888999999999998554444443 332 67788888775
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-15 Score=165.10 Aligned_cols=127 Identities=22% Similarity=0.343 Sum_probs=118.3
Q ss_pred CCEEEEecCCCCCccc-----------------cccccc--CCCCCcEEecccCccCCCCCCcccccCcccEEEeecCC-
Q 010149 71 GLVTGLGAPSQNLSGT-----------------LSSSIG--NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF- 130 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~-----------------~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~- 130 (517)
.+++.|+|++|.++|. +|+.++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5799999999999996 999999 99999999999999999999999999999999999998
Q ss_pred CCC-CCCccCCCC------ccchhhhhcccccCCCCCC--CcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCC
Q 010149 131 FTG-PIPSTVSHL------ETLQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGN 196 (517)
Q Consensus 131 l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N 196 (517)
++| .+|..++.+ ++|++|+|++|+++ .+|. .++++++|+.|++++|+++|.+| .+. +.+++++|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 998 899988887 99999999999999 8998 99999999999999999999998 444 77889999
Q ss_pred ccc
Q 010149 197 SLI 199 (517)
Q Consensus 197 ~~~ 199 (517)
.+.
T Consensus 364 ~l~ 366 (636)
T 4eco_A 364 QIT 366 (636)
T ss_dssp EEE
T ss_pred ccc
Confidence 876
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.54 E-value=9e-16 Score=162.61 Aligned_cols=133 Identities=22% Similarity=0.410 Sum_probs=95.6
Q ss_pred CCCCCCCCCCCc-----eeeeE-EeCCCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccE
Q 010149 50 LNNWDENSVDPC-----SWALV-TCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLT 123 (517)
Q Consensus 50 l~~W~~~~~~~c-----~w~gv-~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 123 (517)
+.+|.. +.++| .|.|+ .|..++++.|+|++|++++ +|..+ +++|++|+|++|+|+ .+| ..+++|++
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 445644 34778 79999 7987889999999999987 77766 378888888888888 677 45678888
Q ss_pred EEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCccc
Q 010149 124 LDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI 199 (517)
Q Consensus 124 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~ 199 (517)
|+|++|+|++ +|. +.. +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+. +.+++++|.+.
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLT 173 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCC
Confidence 8888888885 666 554 77777777777775 555 46667777777777765 333222 55666666653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=154.66 Aligned_cols=130 Identities=20% Similarity=0.177 Sum_probs=109.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 36888999999999888888999999999999999999777788899999999999999998777788899999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCC-CCCCCCc-----CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG-PVPSFHA-----KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~p~~~~-----~~~~l~~N~~~c 200 (517)
++|++++..+..++++++|++|++++|.+++ .+|..+. +.+++++|.+..
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~ 163 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce
Confidence 9999986555578889999999999999887 4566544 677888887643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=4.5e-15 Score=148.44 Aligned_cols=131 Identities=18% Similarity=0.178 Sum_probs=105.3
Q ss_pred ceeeeEEeCCCCEEEEecCCC-CCcccccccccCCCCCcEEeccc-CccCCCCCCcccccCcccEEEeecCCCCCCCCcc
Q 010149 61 CSWALVTCSDGLVTGLGAPSQ-NLSGTLSSSIGNLTNLQLVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138 (517)
Q Consensus 61 c~w~gv~C~~~~v~~l~l~~~-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 138 (517)
|.|..|.|+ ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..
T Consensus 8 C~~~~v~~~----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp SSSSCEECC----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred ccCCEEEcC----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 888877775 34 565 4777 99999999999996 9999887789999999999999999999988899
Q ss_pred CCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCC-Cc-----CcccccCCccccCCCC
Q 010149 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF-HA-----KTFNITGNSLICATGA 204 (517)
Q Consensus 139 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~-----~~~~l~~N~~~c~~~~ 204 (517)
|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|.....-. +. ....+..+.+.|..+.
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 99999999999999999966555666665 999999999998654421 11 2233455667776543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.6e-14 Score=129.46 Aligned_cols=104 Identities=29% Similarity=0.314 Sum_probs=92.2
Q ss_pred CcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccC
Q 010149 97 LQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 176 (517)
Q Consensus 97 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 176 (517)
-+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999997 7888775 8999999999999988899999999999999999999976666689999999999999
Q ss_pred CCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 177 NNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 177 N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|+|++.++..+. +.++|++|++.|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999987776444 678999999988764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.53 E-value=8.7e-15 Score=156.17 Aligned_cols=132 Identities=20% Similarity=0.273 Sum_probs=83.0
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCC--CCCcccccCcccEEEeecCCCCCCCCcc-CCCC-----
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--IPTEIGKLSKLLTLDLSNNFFTGPIPST-VSHL----- 142 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l----- 142 (517)
..++.|+|++|.+++.+|..++++++|++|+|++|++++. +|..+.++++|++|+|++|++++.+|.. +..+
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 4677777777777777777777777777777777777642 2345666777777777777776544432 4444
Q ss_pred -----------------ccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcccc
Q 010149 143 -----------------ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 200 (517)
Q Consensus 143 -----------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c 200 (517)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence 45556666666665 5566566667777777777777743333222 456677777766
Q ss_pred CCC
Q 010149 201 ATG 203 (517)
Q Consensus 201 ~~~ 203 (517)
.|+
T Consensus 512 ~c~ 514 (562)
T 3a79_B 512 TCP 514 (562)
T ss_dssp CHH
T ss_pred Ccc
Confidence 653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=8.2e-15 Score=159.98 Aligned_cols=133 Identities=22% Similarity=0.245 Sum_probs=100.9
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCC----C----CcccccCcccEEEeecCCCCCCCCccCCCCc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHI----P----TEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE 143 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~----p----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 143 (517)
+++.|+|++|++++..+..+..+++|++|+|++|++++.. | ..|.++++|+.|+|++|+++...+..|.+++
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 560 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence 5777778888877776777777888888888888777431 1 2367788888888888888843334678888
Q ss_pred cchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC------cCcccccCCccccCCCC
Q 010149 144 TLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH------AKTFNITGNSLICATGA 204 (517)
Q Consensus 144 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~------~~~~~l~~N~~~c~~~~ 204 (517)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.+|..+ .+.+++++|++.|+|..
T Consensus 561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 88888888888886666667888888888888888888776533 26788999999998763
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=6.4e-15 Score=156.65 Aligned_cols=109 Identities=26% Similarity=0.283 Sum_probs=100.7
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999997 566 999999999999999999 889999999999999999999995 77 89999999999999
Q ss_pred ccccCCCC-CCCcccCCCcceEeccCCCCCCCCCC
Q 010149 152 NNSLTGAI-PPSLSNMSQLAFLDLSYNNLSGPVPS 185 (517)
Q Consensus 152 ~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~p~ 185 (517)
+|+|++.. |..+..+++|+.|+|++|+|++.+|.
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 99999776 99999999999999999999987764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.9e-15 Score=154.75 Aligned_cols=131 Identities=21% Similarity=0.179 Sum_probs=98.8
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
++.|++++|+..+.+|+.+....+|+.|+|++|++++..+..|.++++|+.|+|++|.+++..+..+..+++|+.|+|++
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence 44444444444444444444444566666666777743335678888999999999999877777888999999999999
Q ss_pred cccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|++++..|..|..+++|+.|+|++|+|++.++..+. +.+++++|++.|.|.
T Consensus 282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 999988888999999999999999999987766544 678899999998875
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.3e-15 Score=135.54 Aligned_cols=122 Identities=20% Similarity=0.306 Sum_probs=69.1
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
+++.|++++|++. .+| .+..+++|++|++++|.++ .+ ..+..+++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4556666666665 334 4556666666666666554 22 255566666666666666665555566666666666666
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCC-CCCCCCCCC----cCcccccCCcc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNN-LSGPVPSFH----AKTFNITGNSL 198 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~p~~~----~~~~~l~~N~~ 198 (517)
+|++++..|..+..+++|+.|++++|+ ++ .+|... .+.+++++|.+
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCC
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCC
Confidence 666665555556666666666666665 33 233211 14555555554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-14 Score=145.50 Aligned_cols=129 Identities=19% Similarity=0.121 Sum_probs=113.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+.+..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++...+..+.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 47999999999999888889999999999999999999888888999999999999999999444444699999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~~~ 199 (517)
++|++++..|..+..+++|+.|++++|++++.....+. +.+++++|.+.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccc
Confidence 99999988888899999999999999999976444443 66778887663
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.2e-15 Score=155.21 Aligned_cols=132 Identities=23% Similarity=0.298 Sum_probs=81.9
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCC--CCCCcccccCcccEEEeecCCCCCCCCcc-CCCCccchh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPST-VSHLETLQY 147 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~ 147 (517)
..++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+++|++
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 467778888888877777777777778888887777775 44556777777777777777777645543 555555555
Q ss_pred hhhcccccCC---------------------CCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccC
Q 010149 148 LRLNNNSLTG---------------------AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 148 L~l~~N~l~~---------------------~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~ 201 (517)
|+|++|++++ .+|..+..+++|+.|+|++|+|++.++..+. +.+++++|++.|.
T Consensus 404 L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp EECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred EECcCCCCCcchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence 5555555444 4454445555555555555555533322121 4455555555555
Q ss_pred C
Q 010149 202 T 202 (517)
Q Consensus 202 ~ 202 (517)
|
T Consensus 484 c 484 (520)
T 2z7x_B 484 C 484 (520)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.50 E-value=8.6e-15 Score=134.08 Aligned_cols=124 Identities=15% Similarity=0.248 Sum_probs=106.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|++++|.++ .++.+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|++|+|
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 47999999999665 3457999999999999999999888889999999999999999999888899999999999999
Q ss_pred cccc-cCCCCCCCcccCCCcceEeccCCCCCCCCCCC-C--cCcccccCCcc
Q 010149 151 NNNS-LTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF-H--AKTFNITGNSL 198 (517)
Q Consensus 151 ~~N~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~--~~~~~l~~N~~ 198 (517)
++|+ ++ .+| .+..+++|+.|++++|++++..+-. + .+.+++++|++
T Consensus 144 ~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 144 SYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC--
T ss_pred cCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCccc
Confidence 9999 55 676 7999999999999999999744211 1 17788999986
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-14 Score=145.03 Aligned_cols=132 Identities=22% Similarity=0.220 Sum_probs=116.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 47999999999999988899999999999999999999877778999999999999999999888999999999999999
Q ss_pred cccccCCCCCCC-c---ccCCCcceEeccCCCCCCCCCCCCc-------CcccccCCccccCCC
Q 010149 151 NNNSLTGAIPPS-L---SNMSQLAFLDLSYNNLSGPVPSFHA-------KTFNITGNSLICATG 203 (517)
Q Consensus 151 ~~N~l~~~~p~~-~---~~l~~L~~l~l~~N~l~~~~p~~~~-------~~~~l~~N~~~c~~~ 203 (517)
++|+|++ +|.. + ..+++|+.|+|++|+|++.++..+. +.++|.+|++.|+|.
T Consensus 144 ~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 144 SQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999995 5544 4 6799999999999999976544332 568999999999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.4e-15 Score=147.14 Aligned_cols=127 Identities=20% Similarity=0.242 Sum_probs=81.3
Q ss_pred CEEEEecCCCCCcccccccc--cCCCCCcEEecccCccCCCCCCccccc-----CcccEEEeecCCCCCCCCccCCCCcc
Q 010149 72 LVTGLGAPSQNLSGTLSSSI--GNLTNLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGPIPSTVSHLET 144 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~ 144 (517)
+++.|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..++.+++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 56677777777777666665 6677777777777777755 6666666 67777777777777666667777777
Q ss_pred chhhhhcccccCCC--CCCCc--ccCCCcceEeccCCCCCCC--CCCC------CcCcccccCCccc
Q 010149 145 LQYLRLNNNSLTGA--IPPSL--SNMSQLAFLDLSYNNLSGP--VPSF------HAKTFNITGNSLI 199 (517)
Q Consensus 145 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~l~l~~N~l~~~--~p~~------~~~~~~l~~N~~~ 199 (517)
|++|+|++|++.|. +|..+ ..+++|++|+|++|+|++. ++.. ..+.+++++|.+.
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 241 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 77777777776544 22233 6666777777777777631 1111 2256666666653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.5e-14 Score=140.09 Aligned_cols=125 Identities=24% Similarity=0.302 Sum_probs=80.9
Q ss_pred CCEEEEecCCCCCc--ccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhh
Q 010149 71 GLVTGLGAPSQNLS--GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYL 148 (517)
Q Consensus 71 ~~v~~l~l~~~~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 148 (517)
..++.|++++|.+. +..+..+.++++|++|++++|+++ .+|..+. ++|+.|+|++|++++..|..+..+++|+.|
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 46777888888775 366677777777777777777776 4554443 566666666666665556666666666666
Q ss_pred hhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 149 RLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 149 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
+|++|++++..+..+..+++|+.|+|++|+++ .+|..+. +.+++++|++.
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 66666666555556666666666666666666 3443322 45666666653
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-14 Score=143.68 Aligned_cols=125 Identities=19% Similarity=0.272 Sum_probs=59.7
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCccc-ccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
++.|+|++|.+++..+..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|++++. |. ...+++|++|+|+
T Consensus 122 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls 199 (317)
T 3o53_A 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLS 199 (317)
T ss_dssp CEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECC
T ss_pred CCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECC
Confidence 44444444444444444455555555555555555544444332 445555555555555522 21 2234555555555
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~ 201 (517)
+|+|+ .+|..+..+++|+.|+|++|+|++ +|..+. +.+++++|++.|+
T Consensus 200 ~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp SSCCC-EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CCcCC-cchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 55555 233345555555555555555553 222221 4455555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.5e-14 Score=145.08 Aligned_cols=127 Identities=21% Similarity=0.214 Sum_probs=110.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCc--cCCCCccchhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS--TVSHLETLQYL 148 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L 148 (517)
.+++.|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|. .+..+++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 57999999999999988899999999999999999999654445899999999999999999 4554 78999999999
Q ss_pred hhccc-ccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcc
Q 010149 149 RLNNN-SLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSL 198 (517)
Q Consensus 149 ~l~~N-~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~ 198 (517)
++++| .+++..|..+..+++|+.|++++|++++.+|..+. +.+++++|.+
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 99999 47766678899999999999999999988887665 5677888765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.7e-14 Score=134.93 Aligned_cols=127 Identities=17% Similarity=0.176 Sum_probs=109.6
Q ss_pred CCEEEEecCCCC-CcccccccccCCCCCcEEeccc-CccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccch--
Q 010149 71 GLVTGLGAPSQN-LSGTLSSSIGNLTNLQLVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQ-- 146 (517)
Q Consensus 71 ~~v~~l~l~~~~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-- 146 (517)
.+++.|++++|. +++..+..|.++++|++|+|++ |++++..|..|.++++|++|+|++|++++ +|. +..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 479999999997 8877777899999999999998 99997777889999999999999999995 776 88888888
Q ss_pred -hhhhccc-ccCCCCCCCcccCCCcc-eEeccCCCCCCCCCCCCc----CcccccCCc-cc
Q 010149 147 -YLRLNNN-SLTGAIPPSLSNMSQLA-FLDLSYNNLSGPVPSFHA----KTFNITGNS-LI 199 (517)
Q Consensus 147 -~L~l~~N-~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~p~~~~----~~~~l~~N~-~~ 199 (517)
+|++++| ++++..+..|..+++|+ .|++++|+++..++..+. +.+++++|+ +.
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~ 193 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLT 193 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCC
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcc
Confidence 9999999 99966667799999999 999999999954444333 678899995 64
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.48 E-value=8.2e-15 Score=162.41 Aligned_cols=136 Identities=18% Similarity=0.220 Sum_probs=117.1
Q ss_pred ceeeeEEeC---CCCEEEEecCCCCCcc-----------------ccccccc--CCCCCcEEecccCccCCCCCCccccc
Q 010149 61 CSWALVTCS---DGLVTGLGAPSQNLSG-----------------TLSSSIG--NLTNLQLVLLQNNNISGHIPTEIGKL 118 (517)
Q Consensus 61 c~w~gv~C~---~~~v~~l~l~~~~l~~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l 118 (517)
+...|+.-. -.+++.|+|++|.++| .+|+.++ ++++|++|+|++|++.+.+|..|++|
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 445554321 2579999999999999 4999988 99999999999999999999999999
Q ss_pred CcccEEEeecCC-CCC-CCCccCCCCc-------cchhhhhcccccCCCCCC--CcccCCCcceEeccCCCCCCCCCCCC
Q 010149 119 SKLLTLDLSNNF-FTG-PIPSTVSHLE-------TLQYLRLNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSFH 187 (517)
Q Consensus 119 ~~L~~L~l~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~p~~~ 187 (517)
++|+.|+|++|+ ++| .+|..++.++ +|+.|+|++|+|+ .+|. .+.++++|+.|+|++|+|+ .+| .+
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~ 591 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AF 591 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CC
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hh
Confidence 999999999998 998 7888777665 9999999999999 8898 8999999999999999999 777 33
Q ss_pred c-----CcccccCCccc
Q 010149 188 A-----KTFNITGNSLI 199 (517)
Q Consensus 188 ~-----~~~~l~~N~~~ 199 (517)
. +.+++++|.+.
T Consensus 592 ~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 592 GTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp CTTSEESEEECCSSCCS
T ss_pred cCCCcceEEECcCCccc
Confidence 3 67888898875
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.4e-14 Score=142.43 Aligned_cols=125 Identities=21% Similarity=0.226 Sum_probs=63.6
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCC--C--CCcccccCcccEEEeecCCCCCCCCc----cCCCCc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--I--PTEIGKLSKLLTLDLSNNFFTGPIPS----TVSHLE 143 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~ 143 (517)
+++.|+|++|.+.+..+..++.+++|++|+|++|++.+. + +..+.++++|++|+|++|+++ .+|. .+..++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGV 224 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC
Confidence 455555555555555555555555555555555554431 1 112244555555555555554 2222 134455
Q ss_pred cchhhhhcccccCCCCCCCcccC---CCcceEeccCCCCCCCCCCCCc---CcccccCCcc
Q 010149 144 TLQYLRLNNNSLTGAIPPSLSNM---SQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSL 198 (517)
Q Consensus 144 ~L~~L~l~~N~l~~~~p~~~~~l---~~L~~l~l~~N~l~~~~p~~~~---~~~~l~~N~~ 198 (517)
+|++|+|++|+|++..|..+..+ ++|++|+|++|+|+ .+|..+. +.+++++|++
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRL 284 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCC
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcC
Confidence 56666666666665555555554 45666666666665 3333222 4555666655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-14 Score=130.83 Aligned_cols=122 Identities=19% Similarity=0.205 Sum_probs=100.5
Q ss_pred CCEEEEecCCCCCcccccccccCCC-CCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLT-NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 149 (517)
..++.|+|++|+++. +|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..|..+..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 478999999999995 454 55555 999999999999965 5799999999999999999954444458999999999
Q ss_pred hcccccCCCCCC--CcccCCCcceEeccCCCCCCCCCCC----Cc-----CcccccCCcc
Q 010149 150 LNNNSLTGAIPP--SLSNMSQLAFLDLSYNNLSGPVPSF----HA-----KTFNITGNSL 198 (517)
Q Consensus 150 l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~p~~----~~-----~~~~l~~N~~ 198 (517)
|++|+|+ .+|. .+..+++|+.|++++|+++.. |.. +. +.+++++|+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCH
Confidence 9999997 6776 899999999999999999854 442 22 6677777765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.5e-15 Score=143.89 Aligned_cols=128 Identities=22% Similarity=0.207 Sum_probs=91.8
Q ss_pred CCEEEEecCCCCCcccccccccCC-----CCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCC--CCccC--CC
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNL-----TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP--IPSTV--SH 141 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~--~~ 141 (517)
.+++.|+|++|.+++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4688888888888877 7777776 8888888888888877778888888888888888887754 33344 67
Q ss_pred CccchhhhhcccccCC--CCC-CCcccCCCcceEeccCCCCCCCCCC-CC-----cCcccccCCccc
Q 010149 142 LETLQYLRLNNNSLTG--AIP-PSLSNMSQLAFLDLSYNNLSGPVPS-FH-----AKTFNITGNSLI 199 (517)
Q Consensus 142 l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~l~l~~N~l~~~~p~-~~-----~~~~~l~~N~~~ 199 (517)
+++|++|+|++|+|++ .++ ..+..+++|+.|+|++|+|++.+|. .+ .+.+++++|.+.
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 7788888888888772 112 2334667788888888888776642 11 166777777764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.2e-14 Score=127.71 Aligned_cols=111 Identities=24% Similarity=0.203 Sum_probs=98.7
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCC-CccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPI-PSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ 149 (517)
.+++.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++.. +..+..+++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 4799999999999977 88999999999999999999878888888999999999999999532 27899999999999
Q ss_pred hcccccCCCCC---CCcccCCCcceEeccCCCCCCCC
Q 010149 150 LNNNSLTGAIP---PSLSNMSQLAFLDLSYNNLSGPV 183 (517)
Q Consensus 150 l~~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~~~~ 183 (517)
|++|++++..+ ..+..+++|+.|++++|.++..+
T Consensus 127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred eeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 99999995544 38999999999999999998543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.2e-14 Score=150.85 Aligned_cols=125 Identities=21% Similarity=0.161 Sum_probs=109.1
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57899999999999888899999999999999999999888999999999999999999999 67776 8999999999
Q ss_pred cccccCC-CCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCcc
Q 010149 151 NNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198 (517)
Q Consensus 151 ~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~ 198 (517)
++|++++ .+|..|.++++|++|++++|++++.....+. +.+++++|.+
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence 9999996 4568999999999999999999863322211 6678888876
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.4e-14 Score=139.75 Aligned_cols=125 Identities=22% Similarity=0.291 Sum_probs=104.5
Q ss_pred CCEEEEecCCCCCccc--cc--ccccCCCCCcEEecccCccCCCCCC----cccccCcccEEEeecCCCCCCCCccCCCC
Q 010149 71 GLVTGLGAPSQNLSGT--LS--SSIGNLTNLQLVLLQNNNISGHIPT----EIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~--~~--~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 142 (517)
.+++.|+|++|.+.+. ++ ..++.+++|++|+|++|+++ .+|. .+.++++|++|+|++|+|++..|..+..+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 4799999999998764 32 33478999999999999998 4444 25788999999999999998889888877
Q ss_pred ---ccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCC-CCCCCc--CcccccCCccc
Q 010149 143 ---ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP-VPSFHA--KTFNITGNSLI 199 (517)
Q Consensus 143 ---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~~~--~~~~l~~N~~~ 199 (517)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. .+..+. +.+++++|++.
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTTS
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccEEECcCCCCC
Confidence 69999999999999 7888875 8999999999999984 333333 78899999884
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-14 Score=150.71 Aligned_cols=128 Identities=20% Similarity=0.187 Sum_probs=111.1
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCC-CCCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ 149 (517)
.+++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..+.++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 579999999999999999999999999999999999998777779999999999999999996 4678899999999999
Q ss_pred hcccccCCCCC-CCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcc
Q 010149 150 LNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSL 198 (517)
Q Consensus 150 l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~ 198 (517)
|++|++.+.+| ..+.++++|++|++++|++++.+|..+. +.+++++|.+
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 99999655665 6899999999999999999998887654 3455555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.3e-14 Score=149.94 Aligned_cols=32 Identities=22% Similarity=0.094 Sum_probs=26.6
Q ss_pred chHHHHHHHHHHhccCCCcccceeeeEecCCc
Q 010149 339 GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 339 ~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 370 (517)
+..+|..|++++.+++|+|+|+++|||.....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~~ 353 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVID 353 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChHH
Confidence 45689999999999999999999999987543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.2e-13 Score=135.24 Aligned_cols=123 Identities=23% Similarity=0.283 Sum_probs=56.4
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccC--CCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNIS--GHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
++.|++++|.+.+..+..+.++++|+.|+|++|.++ +..|..+..+ +|++|++++|+++ .+|..+. ++|++|+|
T Consensus 125 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l 200 (332)
T 2ft3_A 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHL 200 (332)
T ss_dssp CCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBC
T ss_pred CCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEEC
Confidence 334444444444333334455555555555555553 2333333333 2222222222222 1222211 35555555
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
++|++++..|..+..+++|+.|+|++|++++.+|..+. +.+++++|.+.
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 55555555555555666666666666666555443332 44555555553
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.2e-14 Score=151.54 Aligned_cols=125 Identities=25% Similarity=0.206 Sum_probs=108.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57899999999999888889999999999999999999888889999999999999999999 67766 8999999999
Q ss_pred cccccCC-CCCCCcccCCCcceEeccCCCCCCCCCCCC--c--CcccccCCcc
Q 010149 151 NNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSGPVPSFH--A--KTFNITGNSL 198 (517)
Q Consensus 151 ~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~--~~~~l~~N~~ 198 (517)
++|++++ .+|..++++++|++|++++|++++.....+ . +.+++++|.+
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccc
Confidence 9999997 578899999999999999999986322211 1 6678888876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.44 E-value=7.4e-14 Score=139.53 Aligned_cols=104 Identities=17% Similarity=0.227 Sum_probs=94.4
Q ss_pred cEEecccC-ccCCCCCCcccccCcccEEEeec-CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEecc
Q 010149 98 QLVLLQNN-NISGHIPTEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 175 (517)
Q Consensus 98 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 175 (517)
..++++++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 899 6888 99999999999996 99997777899999999999999999999889999999999999999
Q ss_pred CCCCCCCCCCCCc----CcccccCCccccCCC
Q 010149 176 YNNLSGPVPSFHA----KTFNITGNSLICATG 203 (517)
Q Consensus 176 ~N~l~~~~p~~~~----~~~~l~~N~~~c~~~ 203 (517)
+|+|++.+|..+. +.++|.+|++.|.|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999988776654 678999999999876
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.42 E-value=2e-13 Score=132.94 Aligned_cols=121 Identities=29% Similarity=0.390 Sum_probs=89.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..+ +.++++|++|+|++|++++ +| .+..+++|++|+|++|++++ + +.+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 467888888888876554 7888888888888888874 44 47888888888888888874 3 46777888888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC---cCcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~ 199 (517)
++|++++. ..+..+++|+.|++++|++++.+|-.. .+.+++++|.+.
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCC
Confidence 88888754 567788888888888888887655111 156777777764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-13 Score=130.40 Aligned_cols=121 Identities=24% Similarity=0.328 Sum_probs=76.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++..+ +.++++|++|+|++|++++ +|. +.. ++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 356677777777765444 6677777777777777764 443 222 677777777777764 33 4667777777777
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICA 201 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~ 201 (517)
++|+|++ +| .+..+++|+.|+|++|++++. +.... +.+++++|++.+.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 7777774 33 566777777777777777765 21111 4566777766443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.42 E-value=7.2e-16 Score=141.45 Aligned_cols=127 Identities=20% Similarity=0.288 Sum_probs=103.9
Q ss_pred CCEEEEecCCCCCcccccc------cccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCcc
Q 010149 71 GLVTGLGAPSQNLSGTLSS------SIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLET 144 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 144 (517)
.+++.++++.+.+.|.+|. .+..+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3566677777778777776 88999999999999999995 77 8899999999999999999 78888888899
Q ss_pred chhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCC-CCC-----cCcccccCCccccCC
Q 010149 145 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLICAT 202 (517)
Q Consensus 145 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p-~~~-----~~~~~l~~N~~~c~~ 202 (517)
|+.|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+ .+.+++++|++.+.+
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 156 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence 9999999999985 55 68889999999999999986432 111 277889999886553
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.41 E-value=3.1e-14 Score=124.08 Aligned_cols=104 Identities=24% Similarity=0.255 Sum_probs=93.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCC-CCccCCCCccchhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP-IPSTVSHLETLQYLR 149 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~ 149 (517)
.+++.|++++|.+++. +.++.+++|++|+|++|++++.+|..+.++++|++|+|++|++++. .|..+..+++|++|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 5799999999999977 7899999999999999999987898888899999999999999963 348899999999999
Q ss_pred hcccccCCCCC---CCcccCCCcceEeccC
Q 010149 150 LNNNSLTGAIP---PSLSNMSQLAFLDLSY 176 (517)
Q Consensus 150 l~~N~l~~~~p---~~~~~l~~L~~l~l~~ 176 (517)
+++|++++..+ ..+..+++|+.|++++
T Consensus 120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 120 LFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999996554 4799999999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=2.7e-13 Score=133.25 Aligned_cols=123 Identities=25% Similarity=0.355 Sum_probs=93.9
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++. +.+..+++|++|+|++|++++ +| .+..+++|++|+|++|++++. +. +..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEc
Confidence 4788899999988864 368888899999999998885 44 388888888888888888854 33 778888888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC---cCcccccCCccccC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLICA 201 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~c~ 201 (517)
++|++++ ++. +..+++|+.|++++|++++..+-.. .+.+++++|++...
T Consensus 159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBC
T ss_pred cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcc
Confidence 8888884 444 7888888888888888886554111 16678888877543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.6e-13 Score=134.78 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=97.0
Q ss_pred ceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCC-CcccccCcccE-EEee
Q 010149 61 CSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLT-LDLS 127 (517)
Q Consensus 61 c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~l~ 127 (517)
|.|..|.|++ ..++.|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|+. ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 7899999973 246778888888876555677888888888888888766555 35677777654 5666
Q ss_pred cCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccC-CCCCCCCCCCCc------CcccccCCccc
Q 010149 128 NNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY-NNLSGPVPSFHA------KTFNITGNSLI 199 (517)
Q Consensus 128 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~p~~~~------~~~~l~~N~~~ 199 (517)
+|+++...|..|..+++|++|++++|+|++..+..+....++..|++.+ |+++...+..+. +.+++++|.+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 7888866677778888888888888888765555666666777777754 456544443332 34567777663
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-13 Score=124.40 Aligned_cols=106 Identities=21% Similarity=0.244 Sum_probs=95.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCc--cCCCCccchhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS--TVSHLETLQYL 148 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L 148 (517)
.+++.|+|++|.+++. +.+..+++|++|+|++|+|++..|..+..+++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 3799999999999976 78999999999999999999654455599999999999999997 6776 88999999999
Q ss_pred hhcccccCCCCCCC----cccCCCcceEeccCCCCC
Q 010149 149 RLNNNSLTGAIPPS----LSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 149 ~l~~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~ 180 (517)
+|++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999 67775 899999999999999875
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.38 E-value=5.6e-13 Score=130.91 Aligned_cols=121 Identities=24% Similarity=0.393 Sum_probs=82.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+.+..+ +..+++|++|+|++|++++ +| .+..+++|++|+|++|++++ +|. +..+++|++|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 467777777777775444 7777777777777777774 33 57777777777777777774 333 777777777777
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCC---CcCcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~ 199 (517)
++|++++. +. +..+++|+.|+|++|++++..+-. -.+.+++++|.+.
T Consensus 137 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 137 DLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred CCCccCcC-cc-ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccC
Confidence 77777743 32 777777777777777777644411 0156677777663
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-13 Score=130.22 Aligned_cols=121 Identities=26% Similarity=0.340 Sum_probs=104.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+++. | .+..+++|++|+|++|++++ + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|
T Consensus 90 ~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCCC-h-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 5799999999999863 3 49999999999999999996 4 4799999999999999999964 68899999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c 200 (517)
++|++++..| +..+++|+.|+|++|+|++. |.... +.+++++|++.+
T Consensus 164 ~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 164 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred cCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 9999996544 99999999999999999974 33211 678999998854
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.3e-13 Score=127.44 Aligned_cols=121 Identities=26% Similarity=0.363 Sum_probs=101.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|++++|+++. ++ .+..+++|++|+|++|++++. |. +.++++|++|+|++|++++ +|.... ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 478999999999984 55 789999999999999999964 44 9999999999999999995 554333 99999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC----cCcccccCCccccC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLICA 201 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~c~ 201 (517)
++|+|++ +| .+..+++|+.|+|++|+|++.. ... .+.+++++|++...
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcch
Confidence 9999995 44 6999999999999999999753 221 17889999988544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.36 E-value=7.9e-13 Score=141.43 Aligned_cols=121 Identities=30% Similarity=0.389 Sum_probs=78.9
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+.+..| +..+++|+.|+|++|.|++ +| .+..|++|+.|+|++|+|++ + +.+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 467777777777776544 6777777777777777763 33 56777777777777777774 2 34666777777777
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC---cCcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~ 199 (517)
++|+|++. ..+..+++|+.|+|++|+|++.+|-.. .+.++|++|.+.
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCC
Confidence 77777643 456667777777777777766555111 145666666653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.34 E-value=6e-13 Score=132.76 Aligned_cols=122 Identities=24% Similarity=0.317 Sum_probs=75.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|++++|.+.+..+ +..+++|+.|+|++|++++. |. +..+++|++|+|++|.+++ + +.+..+++|++|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 356666677766665444 66666777777777766643 32 6666677777777776663 2 34666666667777
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c 200 (517)
++|++++. +.+..+++|+.|++++|++++..|..+. +.+++++|++..
T Consensus 273 ~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 273 GSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 77666642 3466666666667766666655554322 556666666543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.33 E-value=4.6e-13 Score=132.11 Aligned_cols=123 Identities=25% Similarity=0.229 Sum_probs=86.9
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccC-CCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV-SHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l 150 (517)
.++.|++++|.+++..+.. +++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+ ..+++|++|+|
T Consensus 100 ~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 4555566666665554433 5678888888888887667778888888888888888886666665 36788888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~ 199 (517)
++|+|++. |. ...+++|+.|+|++|+|++.++.... +.+++++|.+.
T Consensus 177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 88888744 33 33578888888888888865554221 67788888775
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=138.17 Aligned_cols=101 Identities=24% Similarity=0.370 Sum_probs=91.3
Q ss_pred CCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEecc
Q 010149 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLS 175 (517)
Q Consensus 96 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 175 (517)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47789999999995 786 999999999999999999 899999999999999999999996 77 89999999999999
Q ss_pred CCCCCCCC-CCCCc-----CcccccCCccccC
Q 010149 176 YNNLSGPV-PSFHA-----KTFNITGNSLICA 201 (517)
Q Consensus 176 ~N~l~~~~-p~~~~-----~~~~l~~N~~~c~ 201 (517)
+|+|++.+ |..+. +.++|++|++...
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 99999986 76654 7789999998433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-12 Score=138.73 Aligned_cols=121 Identities=26% Similarity=0.334 Sum_probs=104.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|.+.+. +.+..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++. ..+..+++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 5799999999999863 379999999999999999995 44 699999999999999999964 68899999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC----cCcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~c 200 (517)
++|+|++..| +..+++|+.|+|++|+|++. |... .+.++|++|++..
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 9999997665 99999999999999999975 3321 1778899998854
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.31 E-value=5.2e-13 Score=143.10 Aligned_cols=134 Identities=23% Similarity=0.326 Sum_probs=87.4
Q ss_pred CCCCCCCCCCCCCceeeeEE--------eCCCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccC
Q 010149 48 DVLNNWDENSVDPCSWALVT--------CSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS 119 (517)
Q Consensus 48 ~~l~~W~~~~~~~c~w~gv~--------C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 119 (517)
..+++|... .+||.|.|.. |....++.|++++|+++ .+|..+. ++|+.|+|++|+|+ .+|. .++
T Consensus 10 ~~w~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 10 AVWSAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp CHHHHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 345567543 4778886642 33446888888888887 6676665 78888888888888 5665 567
Q ss_pred cccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCc
Q 010149 120 KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNS 197 (517)
Q Consensus 120 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~ 197 (517)
+|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++. |..+. +.+++++|.
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~l-p~~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSL-PVLPPGLQELSVSDNQ 152 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCC-CCCCTTCCEEECCSSC
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcC-CCCCCCCCEEECcCCc
Confidence 8888888888887 4665 56777777777777773 444 345566666666666542 22222 455555555
Q ss_pred c
Q 010149 198 L 198 (517)
Q Consensus 198 ~ 198 (517)
+
T Consensus 153 l 153 (622)
T 3g06_A 153 L 153 (622)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=135.88 Aligned_cols=112 Identities=28% Similarity=0.342 Sum_probs=81.1
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|++++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 167 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSV 167 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence 467888888888887 666 655 88888888888885 665 57788888888888884 665 4677888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----------CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----------KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----------~~~~l~~N~~~c 200 (517)
++|+|++ +|. +. ++|+.|+|++|+|+ .+|. +. +.++|++|.+..
T Consensus 168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~~ 221 (571)
T 3cvr_A 168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRENRITH 221 (571)
T ss_dssp CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCSSCCCC
T ss_pred CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCCCccee
Confidence 8888875 666 55 77788888888777 3443 22 445677776653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=8.8e-12 Score=119.23 Aligned_cols=146 Identities=12% Similarity=0.054 Sum_probs=112.5
Q ss_pred HHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEE
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv 374 (517)
.....|.....++.|+.+.||++... +..+++|+...... .....+.+|.++++.+. +..+.++++++...+..++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456777778888888999998755 68899999864321 12335788999998884 66788899999888889999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ--------------------------------------- 415 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------------------------------------- 415 (517)
|||++|.+|.+.... ......++.+++++|..||+.
T Consensus 89 ~e~i~G~~l~~~~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCCT-----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccCC-----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999998876321 122457888999999999981
Q ss_pred -----------------CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 416 -----------------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 416 -----------------~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013589999999999998766667999998754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.28 E-value=3.1e-12 Score=133.13 Aligned_cols=104 Identities=29% Similarity=0.403 Sum_probs=60.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|++++|.+.+..+ +..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 356666666666665544 5666666666666666664322 5566666666666666664322 555566666666
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGP 182 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 182 (517)
++|++++..| +..+++|+.|++++|++++.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 6666664433 45555555555555555543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.27 E-value=9.7e-12 Score=128.89 Aligned_cols=116 Identities=24% Similarity=0.335 Sum_probs=79.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|++++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|+|++. | ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 3677777777777764 4 57777777777777777775 34 77777777777777777753 3 777777777777
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc--CcccccCCc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA--KTFNITGNS 197 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~l~~N~ 197 (517)
++|++++ +| ++.+++|++|++++|+|++....... +.+++++|.
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNK 159 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTCS
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCCC
Confidence 7777775 44 67777777777777777764211111 455666664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.26 E-value=7.3e-13 Score=137.25 Aligned_cols=124 Identities=24% Similarity=0.288 Sum_probs=58.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccC-------------------------------
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS------------------------------- 119 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~------------------------------- 119 (517)
.+++.|++++|++ |.+|++++++++|++|++++|+++|.+|..+++++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 3566677777777 67777777777777777777777766776666544
Q ss_pred --cccEEEeecCCCCCCCCccCCC----------------C-ccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCC
Q 010149 120 --KLLTLDLSNNFFTGPIPSTVSH----------------L-ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 120 --~L~~L~l~~N~l~~~~p~~~~~----------------l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
+|++|+|++|++++ +|..+.+ + ++|++|+|++|++++ +| .++++++|++|++++|+++
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~ 166 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc
Confidence 35555555555553 4432211 1 355666666666663 55 4666666777777777666
Q ss_pred CCCCCCCc--CcccccCCccc
Q 010149 181 GPVPSFHA--KTFNITGNSLI 199 (517)
Q Consensus 181 ~~~p~~~~--~~~~l~~N~~~ 199 (517)
+ +|.... +.+++++|.+.
T Consensus 167 ~-lp~~~~~L~~L~L~~n~l~ 186 (454)
T 1jl5_A 167 K-LPDLPPSLEFIAAGNNQLE 186 (454)
T ss_dssp C-CCCCCTTCCEEECCSSCCS
T ss_pred c-cCCCcccccEEECcCCcCC
Confidence 5 333322 55666666553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=126.82 Aligned_cols=115 Identities=24% Similarity=0.331 Sum_probs=61.6
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
+++.|++++|.+++ +| +++++++|++|++++|++++ +|..+ ++|++|+|++|++++ +| .++.+++|+.|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 45556666666654 44 36666666666666666663 44332 355666666666653 44 45566666666666
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~ 199 (517)
+|++++ +|... ++|+.|++++|+++ .+|.... +.+++++|.+.
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCC
Confidence 666553 33321 34555555555555 3333111 45666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.24 E-value=5.2e-12 Score=125.91 Aligned_cols=120 Identities=19% Similarity=0.367 Sum_probs=88.7
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++ +|. +..+++|++|++
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEEC
Confidence 467788888888775444 7788888888888888885433 7788888888888888884 333 778888888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC----cCcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~ 199 (517)
++|++++ + +.+..+++|+.|++++|++++. |... .+.+++++|++.
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCC
Confidence 8888874 3 4577888888888888888764 3211 167778888764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.24 E-value=7.9e-12 Score=130.05 Aligned_cols=123 Identities=30% Similarity=0.412 Sum_probs=100.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|++++|.+.+. +.+..+++|+.|++++|.+++..| +..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 4788999999998864 468889999999999999986554 8889999999999999995443 888999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc---CcccccCCccccC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTFNITGNSLICA 201 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~---~~~~l~~N~~~c~ 201 (517)
++|++++..| +..+++|+.|+|++|++++.+|.... +.+++++|++...
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 9999996543 88899999999999999987762211 6788888887543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.24 E-value=3.7e-14 Score=129.93 Aligned_cols=110 Identities=24% Similarity=0.247 Sum_probs=98.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|+|++|++++ +| .+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|++|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 579999999999987 66 8999999999999999999 789888889999999999999995 55 6889999999999
Q ss_pred cccccCCCCC-CCcccCCCcceEeccCCCCCCCCCC
Q 010149 151 NNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPS 185 (517)
Q Consensus 151 ~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~ 185 (517)
++|++++..+ ..+..+++|++|++++|++++.+|.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999994322 4788999999999999999987765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=125.79 Aligned_cols=118 Identities=27% Similarity=0.278 Sum_probs=88.8
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|++++|++++. .++++++|++|++++|+..+.+ .+..+++|+.|+|++|++++ +| +..+++|+.|++
T Consensus 127 ~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l 198 (457)
T 3bz5_A 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNC 198 (457)
T ss_dssp TTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred CcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence 4688899999998874 3778888888888888666566 37788888888888888885 55 777888888888
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCC-CCc--CcccccCCcccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS-FHA--KTFNITGNSLIC 200 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~--~~~~l~~N~~~c 200 (517)
++|++++. .+..+++|+.|++++|+|++ +|- .+. +.+++++|++..
T Consensus 199 ~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 199 DTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCSC
T ss_pred cCCcCCee---ccccCCCCCEEECcCCcccc-cCccccCCCCEEEeeCCcCCC
Confidence 88888854 37778888888888888887 341 111 667788887743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=115.68 Aligned_cols=137 Identities=15% Similarity=0.076 Sum_probs=100.4
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc--ccceeeeEecCCcceEEEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~ 377 (517)
.+....+.+.|..+.||++...+|..+++|+.... ....+..|+++++.+.+.+ +.+++++....+..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 33333333456669999998777888999997543 1235778999988886545 45688888877788999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC----------------------------------------- 416 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------------- 416 (517)
+++.++. .. ..+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 97 VPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp CSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9998884 22 112 2367788888888888641
Q ss_pred --------------CCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 417 --------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 417 --------------~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2.4e-13 Score=134.99 Aligned_cols=136 Identities=19% Similarity=0.204 Sum_probs=102.9
Q ss_pred CCceeeeEEeCCCCEEEEecCCCCCcccccccccCC--CCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCC-C
Q 010149 59 DPCSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNL--TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP-I 135 (517)
Q Consensus 59 ~~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~ 135 (517)
-|.+|.++.|+...++.|+++++++. +..+..+ ++++.|++++|.+.+..|. +.++++|++|+|++|.+++. +
T Consensus 35 vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 45579988887667888888888776 4556666 7888888888888876654 56788888888888888755 7
Q ss_pred CccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCC-CCCCC-CCCCC-----cCcccccCC-cc
Q 010149 136 PSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN-NLSGP-VPSFH-----AKTFNITGN-SL 198 (517)
Q Consensus 136 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N-~l~~~-~p~~~-----~~~~~l~~N-~~ 198 (517)
|..+..+++|++|+|++|++++..|..+..+++|++|+|++| .+++. +|..+ .+.+++++| .+
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l 181 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 181 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCc
Confidence 777888888888888888888777778888888888888888 67652 33322 266777777 44
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.2e-12 Score=129.64 Aligned_cols=128 Identities=21% Similarity=0.279 Sum_probs=84.2
Q ss_pred CCEEEEecCCCCCccccc----ccccCCC-CCcEEecccCccCCCCCCccccc-----CcccEEEeecCCCCCCCCccCC
Q 010149 71 GLVTGLGAPSQNLSGTLS----SSIGNLT-NLQLVLLQNNNISGHIPTEIGKL-----SKLLTLDLSNNFFTGPIPSTVS 140 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~ 140 (517)
..++.|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 347777777777776655 5666777 77777777777776666666664 7777777777777765555433
Q ss_pred C----C-ccchhhhhcccccCCCCCCCcc----c-CCCcceEeccCCCCCCCCCCC----------CcCcccccCCcc
Q 010149 141 H----L-ETLQYLRLNNNSLTGAIPPSLS----N-MSQLAFLDLSYNNLSGPVPSF----------HAKTFNITGNSL 198 (517)
Q Consensus 141 ~----l-~~L~~L~l~~N~l~~~~p~~~~----~-l~~L~~l~l~~N~l~~~~p~~----------~~~~~~l~~N~~ 198 (517)
. + ++|++|+|++|+|++..+..+. . .++|++|+|++|+|++..+.. -.+.+++++|.+
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 3 3 6777777777777755443332 2 257777777777777433221 235667777766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.7e-10 Score=115.68 Aligned_cols=142 Identities=13% Similarity=0.179 Sum_probs=105.8
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEec--CCCCCcchHHHHHHHHHHhccC--CCcccceeeeEecC---CcceEEEe
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLK--DGNAIGGEIQFQTEVEMISLAV--HRNLLRLIGFCMTT---TERLLVYP 376 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~---~~~~lv~e 376 (517)
.+.++.|.++.||+....+ ..+++|+.. ..........+.+|.++++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999988764 678888775 3322223346788999998886 44578888888766 34789999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---------------------------------------- 416 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------------------------------------- 416 (517)
|+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 122 FVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred ecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 99998775422 234678889999999999999999720
Q ss_pred ---------------CCCeEecCCCCCceEEcCCCC--eEEcccccccc
Q 010149 417 ---------------DPKIIHRDVKAANILLDEYYE--AVVGDFGLAKL 448 (517)
Q Consensus 417 ---------------~~~ivH~Dlk~~NILl~~~~~--~ki~DFGla~~ 448 (517)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.14 E-value=6.7e-13 Score=134.64 Aligned_cols=129 Identities=19% Similarity=0.233 Sum_probs=81.5
Q ss_pred CCEEEEecCCCCCcc----cccccccCC---------CCCcEEecccCccC-CCCC---CcccccCcccEEEeecCCCC-
Q 010149 71 GLVTGLGAPSQNLSG----TLSSSIGNL---------TNLQLVLLQNNNIS-GHIP---TEIGKLSKLLTLDLSNNFFT- 132 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~----~~~~~~~~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~- 132 (517)
.+++.|+|++|.+.+ .++..+..+ ++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 467777777777752 344555555 67777777777776 3344 34556677777777777776
Q ss_pred -C---CCCccCCCCccchhhhhcccccC----CCCCCCcccCCCcceEeccCCCCCCC----CCCC-------CcCcccc
Q 010149 133 -G---PIPSTVSHLETLQYLRLNNNSLT----GAIPPSLSNMSQLAFLDLSYNNLSGP----VPSF-------HAKTFNI 193 (517)
Q Consensus 133 -~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~l~l~~N~l~~~----~p~~-------~~~~~~l 193 (517)
| ..|..+..+++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|.|++. +|.. -.+.++|
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L 281 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEEC
Confidence 2 23336666777777777777774 45666667777777777777777654 2221 1256667
Q ss_pred cCCccc
Q 010149 194 TGNSLI 199 (517)
Q Consensus 194 ~~N~~~ 199 (517)
++|.+.
T Consensus 282 ~~n~i~ 287 (386)
T 2ca6_A 282 QYNEIE 287 (386)
T ss_dssp CSSCCB
T ss_pred cCCcCC
Confidence 777663
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.14 E-value=8.4e-11 Score=125.96 Aligned_cols=34 Identities=35% Similarity=0.347 Sum_probs=15.3
Q ss_pred ccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCC
Q 010149 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 143 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~ 254 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT 254 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC
Confidence 344455555555542 33 22344444444444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.13 E-value=4.6e-11 Score=119.39 Aligned_cols=116 Identities=16% Similarity=0.159 Sum_probs=95.9
Q ss_pred EeCCCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCc-cCCCCccc
Q 010149 67 TCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETL 145 (517)
Q Consensus 67 ~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L 145 (517)
+|+.. .++.++++++ .+|..+ .++|++|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.++++|
T Consensus 8 ~C~~~---~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l 81 (350)
T 4ay9_X 8 HCSNR---VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81 (350)
T ss_dssp EEETT---EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTC
T ss_pred EeeCC---EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhh
Confidence 46542 4677889988 677766 47899999999999955556799999999999999999876664 67889887
Q ss_pred hh-hhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc
Q 010149 146 QY-LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 188 (517)
Q Consensus 146 ~~-L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 188 (517)
.+ +.+++|+|++..|..|..+++|++|++++|+|++.++..+.
T Consensus 82 ~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~ 125 (350)
T 4ay9_X 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125 (350)
T ss_dssp CEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTC
T ss_pred hhhhcccCCcccccCchhhhhccccccccccccccccCCchhhc
Confidence 65 67778999977788999999999999999999987765544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.9e-12 Score=130.19 Aligned_cols=113 Identities=24% Similarity=0.225 Sum_probs=62.6
Q ss_pred CEEEEecCCCCCcccccccccCC-----CCCcEEecccCccCCCCCCcccc----c-CcccEEEeecCCCCCCCCccCC-
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNL-----TNLQLVLLQNNNISGHIPTEIGK----L-SKLLTLDLSNNFFTGPIPSTVS- 140 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~~p~~~~- 140 (517)
+++.|+|++|.+.+..+..+..+ ++|++|+|++|++++..+..+.. + ++|++|+|++|+|++..+..+.
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 56666666666665555555543 66666666666666554443333 2 5666666666666644443322
Q ss_pred ---C-CccchhhhhcccccCCCCC----CCcccCC-CcceEeccCCCCCCCCC
Q 010149 141 ---H-LETLQYLRLNNNSLTGAIP----PSLSNMS-QLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 141 ---~-l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~l~l~~N~l~~~~p 184 (517)
. .++|++|+|++|+|++..+ ..+..++ +|++|+|++|+|++..+
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~ 184 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence 2 2466666666666663222 2223333 66666666666665443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-12 Score=130.38 Aligned_cols=128 Identities=20% Similarity=0.240 Sum_probs=98.4
Q ss_pred CCEEEEecCCCCCccc-ccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecC-CCCCC-CCccCCCCccchh
Q 010149 71 GLVTGLGAPSQNLSGT-LSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN-FFTGP-IPSTVSHLETLQY 147 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~ 147 (517)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.+++..|..++++++|++|+|++| .+++. +|..+..+++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4788889998888766 7888888889999999988888777878888888899999888 67753 6666778888888
Q ss_pred hhhccc-ccCCC-CCCCcccCC-CcceEeccCC--CCC-CCCCCCC-----cCcccccCCcc
Q 010149 148 LRLNNN-SLTGA-IPPSLSNMS-QLAFLDLSYN--NLS-GPVPSFH-----AKTFNITGNSL 198 (517)
Q Consensus 148 L~l~~N-~l~~~-~p~~~~~l~-~L~~l~l~~N--~l~-~~~p~~~-----~~~~~l~~N~~ 198 (517)
|+|++| ++++. ++..+..++ +|++|++++| .++ +.+|..+ .+.+++++|..
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 888888 88753 566677888 8888888888 454 3333322 26777888773
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.10 E-value=9e-13 Score=133.66 Aligned_cols=110 Identities=19% Similarity=0.280 Sum_probs=58.4
Q ss_pred CCEEEEecCCCCCcc----cccccccCCCCCcEEecccCccCCCCCCcc----ccc---------CcccEEEeecCCCC-
Q 010149 71 GLVTGLGAPSQNLSG----TLSSSIGNLTNLQLVLLQNNNISGHIPTEI----GKL---------SKLLTLDLSNNFFT- 132 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~l---------~~L~~L~l~~N~l~- 132 (517)
.+++.|+|++|.+.+ .+|..+..+++|++|+|++|.+++..+..+ ..+ ++|++|+|++|+++
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 355556666665555 355555555666666666665543222222 222 56666666666655
Q ss_pred CCCC---ccCCCCccchhhhhcccccC--C---CCCCCcccCCCcceEeccCCCCC
Q 010149 133 GPIP---STVSHLETLQYLRLNNNSLT--G---AIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 133 ~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
+.+| ..+..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.|+
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence 2233 24445556666666666655 2 23335556666666666666664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-10 Score=113.14 Aligned_cols=187 Identities=19% Similarity=0.185 Sum_probs=122.0
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCc--ccceeeeEecCC---cceEEEec
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRN--LLRLIGFCMTTT---ERLLVYPY 377 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lv~e~ 377 (517)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+.+....... ..++|||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4668999999999863 45888876432 23456889999998773 333 334444433322 34789999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ------------------------------------------ 415 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------------ 415 (517)
++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988765332 2467788888899999999988861
Q ss_pred -------------CCCCeEecCCCCCceEEcC--CCCeEEcccccccccCCCCCceee-------------ecccccccc
Q 010149 416 -------------CDPKIIHRDVKAANILLDE--YYEAVVGDFGLAKLLDHCDSHVTT-------------AVRGTVGHI 467 (517)
Q Consensus 416 -------------~~~~ivH~Dlk~~NILl~~--~~~~ki~DFGla~~~~~~~~~~~~-------------~~~gt~~y~ 467 (517)
..+.++|+|++|.||++++ ...+.|+||+.+..-+....-... ......++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1245899999999999998 456789999998754321000000 000001111
Q ss_pred C-ccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 468 A-PEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 468 a-PE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
. |+.... .....+.|+++.++|.+.+|..||.
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 222111 1223689999999999999998873
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.89 E-value=8e-12 Score=129.54 Aligned_cols=129 Identities=16% Similarity=0.108 Sum_probs=85.6
Q ss_pred CCEEEEecCCCCCcccc-----cccccCCCCCcEEecccCccCCC----CCCcccccCcccEEEeecCCCCCCCCccCCC
Q 010149 71 GLVTGLGAPSQNLSGTL-----SSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 141 (517)
.+++.|+|++|.+...- +..+..+++|++|+|++|++++. +|..+.++++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 56788888888776542 22333578888888888888743 5666777888888888888876443333322
Q ss_pred -----CccchhhhhcccccCCC----CCCCcccCCCcceEeccCCCCCCCCCC----------CCcCcccccCCccc
Q 010149 142 -----LETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVPS----------FHAKTFNITGNSLI 199 (517)
Q Consensus 142 -----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~p~----------~~~~~~~l~~N~~~ 199 (517)
.++|++|+|++|.+++. +|..+..+++|+.|+|++|++++..+. .-.+.+++++|.+.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 25778888888877754 455566677788888888877653221 12356777777663
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.82 E-value=4e-11 Score=113.98 Aligned_cols=124 Identities=20% Similarity=0.190 Sum_probs=83.1
Q ss_pred CceeeeEEeCCC--CEEEEecCC---CCCcccccc------------------------cccCCCCCcE--EecccCccC
Q 010149 60 PCSWALVTCSDG--LVTGLGAPS---QNLSGTLSS------------------------SIGNLTNLQL--VLLQNNNIS 108 (517)
Q Consensus 60 ~c~w~gv~C~~~--~v~~l~l~~---~~l~~~~~~------------------------~~~~l~~L~~--L~l~~N~l~ 108 (517)
.|.|.|+.|+.+ +|+.+...+ ..+.+.+++ .+...+.|+. ++++.|+..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 578999999853 665554433 122222221 1333334444 566667443
Q ss_pred ---CCCCCcccccCcccEEEeecCCCCC--CCCccCCCCccchhhhhcccccCCCCCCCcccCC--CcceEeccCCCCCC
Q 010149 109 ---GHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS--QLAFLDLSYNNLSG 181 (517)
Q Consensus 109 ---~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~l~l~~N~l~~ 181 (517)
+.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+++
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 2122222468899999999999997 4567777899999999999999954 4455555 89999999999998
Q ss_pred CCCC
Q 010149 182 PVPS 185 (517)
Q Consensus 182 ~~p~ 185 (517)
.+|.
T Consensus 235 ~~~~ 238 (267)
T 3rw6_A 235 TFRD 238 (267)
T ss_dssp GCSS
T ss_pred ccCc
Confidence 7763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.74 E-value=7e-11 Score=118.90 Aligned_cols=128 Identities=18% Similarity=0.174 Sum_probs=87.7
Q ss_pred CCEEEEecCCCCCcccccccc-cCCCCCcEEecccCccCCCCCCcc-----cccCcccEEEeecCCCCC----CCCccCC
Q 010149 71 GLVTGLGAPSQNLSGTLSSSI-GNLTNLQLVLLQNNNISGHIPTEI-----GKLSKLLTLDLSNNFFTG----PIPSTVS 140 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~ 140 (517)
..++.|+|++|.++..-...+ ..+++|+.|+|++|.|+..-...+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 478888888888865433333 346678888888888874332333 245778888888888863 2344456
Q ss_pred CCccchhhhhcccccCCC----CCCCcccCCCcceEeccCCCCCCCCC----C-----CCcCcccccCCcc
Q 010149 141 HLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPVP----S-----FHAKTFNITGNSL 198 (517)
Q Consensus 141 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~p----~-----~~~~~~~l~~N~~ 198 (517)
.+++|++|+|++|+|+.. ++..+...++|+.|+|++|.|+.... . .-.+.++|++|++
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 778888899999888742 34556677888999999998874321 1 1136788888876
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-10 Score=120.46 Aligned_cols=129 Identities=19% Similarity=0.155 Sum_probs=102.5
Q ss_pred CCEEEEecCCCCCccc----ccccccCCCCCcEEecccCccCCCCCCcccc-----cCcccEEEeecCCCCCC----CCc
Q 010149 71 GLVTGLGAPSQNLSGT----LSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-----LSKLLTLDLSNNFFTGP----IPS 137 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~p~ 137 (517)
.+++.|+|++|+++.. ++..+.++++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5799999999999875 6778888999999999999997544444443 36999999999999865 566
Q ss_pred cCCCCccchhhhhcccccCCCCCCCccc-----CCCcceEeccCCCCCC----CCCCCC-----cCcccccCCccc
Q 010149 138 TVSHLETLQYLRLNNNSLTGAIPPSLSN-----MSQLAFLDLSYNNLSG----PVPSFH-----AKTFNITGNSLI 199 (517)
Q Consensus 138 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~----~~p~~~-----~~~~~l~~N~~~ 199 (517)
.+..+++|++|+|++|++++..+..+.. .++|+.|+|++|++++ .+|..+ .+.+++++|++.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 6778899999999999998654444443 6799999999999985 555432 277899999874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.69 E-value=1.4e-09 Score=103.45 Aligned_cols=81 Identities=25% Similarity=0.311 Sum_probs=67.5
Q ss_pred ccCCCCCcEEecccCccCC--CCCCcccccCcccEEEeecCCCCCCCCccCCCCc--cchhhhhcccccCCCCCC-----
Q 010149 91 IGNLTNLQLVLLQNNNISG--HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLE--TLQYLRLNNNSLTGAIPP----- 161 (517)
Q Consensus 91 ~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~----- 161 (517)
..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 166 ~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~ 243 (267)
T 3rw6_A 166 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI 243 (267)
T ss_dssp HHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred HhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence 3578999999999999997 5567788999999999999999964 3455555 899999999999987773
Q ss_pred --CcccCCCcceEe
Q 010149 162 --SLSNMSQLAFLD 173 (517)
Q Consensus 162 --~~~~l~~L~~l~ 173 (517)
.+..+++|+.||
T Consensus 244 ~~il~~~P~L~~LD 257 (267)
T 3rw6_A 244 SAIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHHCTTCCEES
T ss_pred HHHHHHCcccCeEC
Confidence 367889998886
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.64 E-value=7.7e-10 Score=111.27 Aligned_cols=112 Identities=16% Similarity=0.213 Sum_probs=89.3
Q ss_pred CEEEEecCCCCCcccccccc-----cCCCCCcEEecccCccCC----CCCCcccccCcccEEEeecCCCCCC----CCcc
Q 010149 72 LVTGLGAPSQNLSGTLSSSI-----GNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPST 138 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~ 138 (517)
+++.|+|++|+++..-...+ ...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|++. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 68999999999986544444 356889999999999974 2445567889999999999999842 3556
Q ss_pred CCCCccchhhhhcccccCCC----CCCCcccCCCcceEeccCCCCCCCC
Q 010149 139 VSHLETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSGPV 183 (517)
Q Consensus 139 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~ 183 (517)
+..+++|+.|+|++|.|+.. ++..+...++|++|+|++|.|+...
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g 255 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEG 255 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHH
Confidence 77788999999999999842 3445566799999999999998543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.54 E-value=6.9e-08 Score=95.30 Aligned_cols=100 Identities=14% Similarity=0.090 Sum_probs=60.7
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCccc-EEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLL-TLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
+++.|+|++|+++.+.+..|.++++|+.|+|.+| ++..-+..|.+|++|+ .|+|++ +++..-+..|.+|++|+.|+|
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l 304 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA 304 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence 5666666666666555556666666666666665 5544445566666666 666666 555344456666666666666
Q ss_pred cccccCCCCCCCcccCCCcceEe
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLD 173 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~ 173 (517)
++|+++..-+..|.++++|+.|+
T Consensus 305 ~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 305 TGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCccCccchhhhcCCcchhhhc
Confidence 66666644445666666666655
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.51 E-value=9.2e-08 Score=94.38 Aligned_cols=125 Identities=17% Similarity=0.211 Sum_probs=78.1
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccc---------------------------------
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGK--------------------------------- 117 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--------------------------------- 117 (517)
..++.|+|++ +++.+-+..|.++++|+.|+|++|.+....+..|.+
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 3788899988 888777788999999999999999865333333332
Q ss_pred ---------------------------------------------cCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 118 ---------------------------------------------LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 118 ---------------------------------------------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
+++|+.|+|++|+++...+..|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 45666666666666633344566666666666666
Q ss_pred cccCCCCCCCcccCCCcc-eEeccCCCCCCCCCCCCc-----CcccccCCcc
Q 010149 153 NSLTGAIPPSLSNMSQLA-FLDLSYNNLSGPVPSFHA-----KTFNITGNSL 198 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~ 198 (517)
| ++..-+.+|.++++|+ .+++.+ .++...+..|. +.+++.+|.+
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i 309 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI 309 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence 6 5534445566666666 666666 55543344443 3444555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=5e-09 Score=94.48 Aligned_cols=111 Identities=14% Similarity=0.203 Sum_probs=81.3
Q ss_pred CCCEEEEecCCC-CCccc----ccccccCCCCCcEEecccCccCCC----CCCcccccCcccEEEeecCCCCCC----CC
Q 010149 70 DGLVTGLGAPSQ-NLSGT----LSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IP 136 (517)
Q Consensus 70 ~~~v~~l~l~~~-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p 136 (517)
...++.|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|... +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 357888999988 77642 455667778899999999988732 334455667899999999988743 34
Q ss_pred ccCCCCccchhhhh--cccccCCC----CCCCcccCCCcceEeccCCCCC
Q 010149 137 STVSHLETLQYLRL--NNNSLTGA----IPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 137 ~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
..+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56677788889999 77888742 3344556678888888888875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2e-06 Score=81.97 Aligned_cols=135 Identities=19% Similarity=0.141 Sum_probs=96.3
Q ss_pred cccccccc-ceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCcceEEEecCcCCC
Q 010149 306 LVGKGGFG-NVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTERLLVYPYMSNGS 382 (517)
Q Consensus 306 ~lG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~gs 382 (517)
.+..|..| .||+.... ++..+.+|+-... ....+..|...++.+. +--+.++++++.+.+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34556666 58987754 4667889986432 2446788998888774 2235678888888888999999999988
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 010149 383 VASRLKAKPSLDWATRKRIALGAARGLLYLHEQ----------------------------------------------- 415 (517)
Q Consensus 383 L~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------------------------------------------- 415 (517)
+.+..... ......+..++++.|.-||..
T Consensus 107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77655422 123345666677777777742
Q ss_pred --------CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 416 --------CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 416 --------~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999877778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3e-06 Score=82.56 Aligned_cols=137 Identities=18% Similarity=0.167 Sum_probs=94.4
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCC---cccceeeeEe-cCCcceEEEecCc
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCM-TTTERLLVYPYMS 379 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~-~~~~~~lv~e~~~ 379 (517)
.+.++.|....||+. |..+++|+... ......+..|.+++..+.+. .+.+.+.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356788888899987 56678887532 12345688999999988653 2456666664 3455789999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 010149 380 NGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-------------------------------------------- 415 (517)
Q Consensus 380 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~-------------------------------------------- 415 (517)
|.++.+..- ..++..+...++.++++.|..||+.
T Consensus 97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 988765321 1234555556666666666666542
Q ss_pred -------------CCCCeEecCCCCCceEEcC---CCC-eEEccccccccc
Q 010149 416 -------------CDPKIIHRDVKAANILLDE---YYE-AVVGDFGLAKLL 449 (517)
Q Consensus 416 -------------~~~~ivH~Dlk~~NILl~~---~~~-~ki~DFGla~~~ 449 (517)
..+.++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 489999988754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.3e-06 Score=87.04 Aligned_cols=81 Identities=10% Similarity=0.005 Sum_probs=54.2
Q ss_pred Ccc-ccccccceEEEEeC-------CCcEEEEEEecCCCC--CcchHHHHHHHHHHhccC-C--CcccceeeeEecC---
Q 010149 305 NLV-GKGGFGNVYKGYLQ-------DGTVVAVKRLKDGNA--IGGEIQFQTEVEMISLAV-H--RNLLRLIGFCMTT--- 368 (517)
Q Consensus 305 ~~l-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~~--- 368 (517)
+.| +.|....+|+.... ++..+++|+...... ......+..|..+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 556 88889999988754 266788887654320 111235678888887774 2 2466777777654
Q ss_pred CcceEEEecCcCCChhh
Q 010149 369 TERLLVYPYMSNGSVAS 385 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~ 385 (517)
...++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.18 E-value=1.5e-07 Score=100.51 Aligned_cols=104 Identities=10% Similarity=0.080 Sum_probs=65.0
Q ss_pred CEEEEecCCCCC-c-ccccccccCCCCCcEEecccCccCCC----CCCcccccCcccEEEeecCCCCC----CCCccCCC
Q 010149 72 LVTGLGAPSQNL-S-GTLSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTG----PIPSTVSH 141 (517)
Q Consensus 72 ~v~~l~l~~~~l-~-~~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~ 141 (517)
+++.|+|+++.- + ..++....++++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 377777777651 1 11223334677778888887777654 33344567777777777777763 23334456
Q ss_pred CccchhhhhcccccCCCCCCCcccCCCcceEeccC
Q 010149 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 176 (517)
Q Consensus 142 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 176 (517)
+++|+.|+|++|.+.+ +|..+..+++|+.|+++.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 6777777777777763 556666666666666664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.17 E-value=1.4e-08 Score=91.61 Aligned_cols=115 Identities=18% Similarity=0.169 Sum_probs=85.5
Q ss_pred cccccccccCCCCCcEEecccC-ccCCC----CCCcccccCcccEEEeecCCCCCC----CCccCCCCccchhhhhcccc
Q 010149 84 SGTLSSSIGNLTNLQLVLLQNN-NISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNS 154 (517)
Q Consensus 84 ~~~~~~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~ 154 (517)
...+...+...++|++|+|++| .+... +...+...++|++|+|++|+|... +...+...++|++|+|++|+
T Consensus 25 ~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~ 104 (185)
T 1io0_A 25 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 104 (185)
T ss_dssp HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence 3445666788999999999999 88732 344566778999999999999742 33445556889999999999
Q ss_pred cCCC----CCCCcccCCCcceEec--cCCCCCCCCCCC---------CcCcccccCCcc
Q 010149 155 LTGA----IPPSLSNMSQLAFLDL--SYNNLSGPVPSF---------HAKTFNITGNSL 198 (517)
Q Consensus 155 l~~~----~p~~~~~l~~L~~l~l--~~N~l~~~~p~~---------~~~~~~l~~N~~ 198 (517)
|+.. +...+...++|++|+| ++|.|+..-... -.+.++|++|.+
T Consensus 105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 9843 4567788889999999 889998532211 125677777765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.09 E-value=7.9e-07 Score=94.83 Aligned_cols=125 Identities=12% Similarity=0.074 Sum_probs=83.9
Q ss_pred CCEEEEecCCCCCccc----ccccccCCCCCcEEecccCccCC----CCCCcccccCcccEEEeecCCCCCCCCccCCCC
Q 010149 71 GLVTGLGAPSQNLSGT----LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 142 (517)
.+++.|+|++|.+++. ++..+..+++|+.|+|++|.+++ .++..+.++++|+.|+|++|.+.+ +|..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 4788888888887655 44556678888888888888873 334445678888888888888874 66777777
Q ss_pred ccchhhhhcccccC---CCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCc
Q 010149 143 ETLQYLRLNNNSLT---GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNS 197 (517)
Q Consensus 143 ~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~ 197 (517)
++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+. +.+++++|.
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 88888887753322 233455666677777777665332 3343332 556666665
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-05 Score=80.73 Aligned_cols=76 Identities=16% Similarity=0.079 Sum_probs=49.1
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCC------CcchHHHHHHHHHHhccCC--Cccc-ceeeeEecCCcceE
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA------IGGEIQFQTEVEMISLAVH--RNLL-RLIGFCMTTTERLL 373 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~Ei~~l~~l~H--~nIv-~l~~~~~~~~~~~l 373 (517)
.+.+|.|.++.||++... +++.+++|....... .....++..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899998653221 1123456778888877632 3333 45443 4456789
Q ss_pred EEecCcCC
Q 010149 374 VYPYMSNG 381 (517)
Q Consensus 374 v~e~~~~g 381 (517)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.02 E-value=7.1e-08 Score=103.00 Aligned_cols=86 Identities=17% Similarity=0.252 Sum_probs=39.1
Q ss_pred CCCCcEEecccCccCCCCCCccc-ccCcccEEEee--c----CCCCCCCC-----ccCCCCccchhhhhcccccCCCCCC
Q 010149 94 LTNLQLVLLQNNNISGHIPTEIG-KLSKLLTLDLS--N----NFFTGPIP-----STVSHLETLQYLRLNNNSLTGAIPP 161 (517)
Q Consensus 94 l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~~~~p-----~~~~~l~~L~~L~l~~N~l~~~~p~ 161 (517)
+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++... ..+..+++|+.|+|++ .+++..+.
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 55566665555555543333333 35566666665 2 34431110 1133445555555544 33332222
Q ss_pred Cccc-CCCcceEeccCCCCC
Q 010149 162 SLSN-MSQLAFLDLSYNNLS 180 (517)
Q Consensus 162 ~~~~-l~~L~~l~l~~N~l~ 180 (517)
.+.. +++|+.|+|++|.++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~ 469 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDS 469 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSS
T ss_pred HHHHhchhccEeeccCCCCc
Confidence 3332 445555555555554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=4.5e-05 Score=75.05 Aligned_cols=138 Identities=17% Similarity=0.228 Sum_probs=78.4
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-----CCccccee-e--eEecCCcceEEEe
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----HRNLLRLI-G--FCMTTTERLLVYP 376 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~-~--~~~~~~~~~lv~e 376 (517)
+.++.|..+.||+....+| .+++|+.... ..++..|.+++..+. .|.++.-. | +....+..+++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999887655 5889988642 223334555544432 34433311 1 1223556789999
Q ss_pred cCcCCChh--------------hhhh---c-C--C--------CCCHHHH------------------------------
Q 010149 377 YMSNGSVA--------------SRLK---A-K--P--------SLDWATR------------------------------ 398 (517)
Q Consensus 377 ~~~~gsL~--------------~~l~---~-~--~--------~l~~~~~------------------------------ 398 (517)
|++|..+. ..++ . . + .-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 0111 1 0 0 0122211
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 399 -KRIALGAARGLLYLHE----------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 399 -~~i~~~i~~~L~yLH~----------~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..+...+.+++.+|++ ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666653 1245899999999999998888999999998854
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=4.8e-07 Score=90.20 Aligned_cols=125 Identities=18% Similarity=0.193 Sum_probs=77.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCccc--ccCcccEEEeec--CCCCCC-----CCccC--
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIG--KLSKLLTLDLSN--NFFTGP-----IPSTV-- 139 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~-----~p~~~-- 139 (517)
.+++.|+|+++.-. .+++ + .+++|+.|+|..+.++...-..+. .+++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 57888998776211 2333 4 378899999988877633222333 688899988863 222111 11122
Q ss_pred CCCccchhhhhcccccCCCCCCCcc---cCCCcceEeccCCCCCCC----CCCC-----CcCcccccCCcc
Q 010149 140 SHLETLQYLRLNNNSLTGAIPPSLS---NMSQLAFLDLSYNNLSGP----VPSF-----HAKTFNITGNSL 198 (517)
Q Consensus 140 ~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~l~l~~N~l~~~----~p~~-----~~~~~~l~~N~~ 198 (517)
..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|++. ++.. ..+.+++++|.+
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 2478889999988888743322222 478899999999888753 2222 126677777765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.92 E-value=1.8e-07 Score=99.80 Aligned_cols=126 Identities=12% Similarity=0.093 Sum_probs=88.8
Q ss_pred CCEEEEecCCCCCccccccccc-CCCCCcEEecc--c----CccCCCCCC------cccccCcccEEEeecCCCCCCCCc
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIG-NLTNLQLVLLQ--N----NNISGHIPT------EIGKLSKLLTLDLSNNFFTGPIPS 137 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~ 137 (517)
.+++.|.+..+++++.....+. .+++|+.|+|+ + |.+++ .|. .+..+++|+.|+|++ .+++..+.
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 4678888888888877666665 58899999998 4 56652 221 256788999999977 66655445
Q ss_pred cCCC-CccchhhhhcccccCCCCCCCc-ccCCCcceEeccCCCCCCCCCCC------CcCcccccCCcc
Q 010149 138 TVSH-LETLQYLRLNNNSLTGAIPPSL-SNMSQLAFLDLSYNNLSGPVPSF------HAKTFNITGNSL 198 (517)
Q Consensus 138 ~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~~~~p~~------~~~~~~l~~N~~ 198 (517)
.+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+.. ..+.+++++|++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 5554 7889999999998875444444 56888999999999986433321 126677888765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.81 E-value=1.9e-05 Score=79.85 Aligned_cols=122 Identities=14% Similarity=0.117 Sum_probs=89.7
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCC-----CCCCccCCCCccch
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT-----GPIPSTVSHLETLQ 146 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~ 146 (517)
.++.|++++ +++.+-...|.+ .+|+.+.| .|.++..-+..|.+|++|+.+++.+|.+. ...+..|.+|++|+
T Consensus 227 ~L~~l~l~~-~l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~ 303 (401)
T 4fdw_A 227 QLKTIEIPE-NVSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA 303 (401)
T ss_dssp TCCCEECCT-TCCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred CCCEEecCC-CccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence 677788876 466555667777 78999999 45566555778999999999999998875 24456788999999
Q ss_pred hhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCcc
Q 010149 147 YLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198 (517)
Q Consensus 147 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~ 198 (517)
.++|. |.++..-...|.++++|+.++|.+| ++...+..|. +.+.+.+|.+
T Consensus 304 ~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 304 RFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp EECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred eEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence 99998 4577455678888999999999665 6543344443 5566666644
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00012 Score=71.20 Aligned_cols=135 Identities=16% Similarity=0.146 Sum_probs=90.0
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC---CCcccceeeeEecCCcceEEEecCcC
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV---HRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
.+.|+.|....+|+.... +..+++|+.... ....+..|.+.++.+. ...+.+++++....+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456899999999998864 678888987532 2456888988888773 35577888888777889999999998
Q ss_pred CChhh-----------hhhcC---C-------------------CCCHHHHH---HHH----------------HHHHHH
Q 010149 381 GSVAS-----------RLKAK---P-------------------SLDWATRK---RIA----------------LGAARG 408 (517)
Q Consensus 381 gsL~~-----------~l~~~---~-------------------~l~~~~~~---~i~----------------~~i~~~ 408 (517)
..+.. .++.. + .-+|.... ++. ..+.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76421 11211 1 01454321 111 111111
Q ss_pred H-HHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 409 L-LYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 409 L-~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 23321 2356899999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00015 Score=73.80 Aligned_cols=78 Identities=12% Similarity=0.037 Sum_probs=45.5
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeeec-cccccccCccccccC---CCCcccceehhhHHHHH
Q 010149 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAV-RGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLE 492 (517)
Q Consensus 417 ~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~Dv~S~Gvil~e 492 (517)
.+.++|||++|.||++++++ ++++||+.+..-... ....... .-...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 44899999999999998876 999999988753211 0000000 011345666544311 11123444566666676
Q ss_pred HHhC
Q 010149 493 LISG 496 (517)
Q Consensus 493 lltG 496 (517)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.70 E-value=4.7e-05 Score=77.00 Aligned_cols=121 Identities=15% Similarity=0.119 Sum_probs=91.7
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.+.|+ +++..+-...|.++++|+.|+|.+| ++..-...|.+ .+|+.+.|. |.++..-+..|.+|++|+.+++
T Consensus 203 ~~L~~l~lp-~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLP-VTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECC-TTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeC-CchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEe
Confidence 367788887 4477777788999999999999986 55455567777 899999994 5566455778999999999999
Q ss_pred cccccC-----CCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCC
Q 010149 151 NNNSLT-----GAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGN 196 (517)
Q Consensus 151 ~~N~l~-----~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N 196 (517)
.+|.+. ..-+..|..+++|+.++|. |.++......|. +.+.|..|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 998875 2445789999999999999 457644444444 44555444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00025 Score=68.12 Aligned_cols=78 Identities=19% Similarity=0.223 Sum_probs=54.7
Q ss_pred CCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCC---cccceeeeEecCCcceEEEec
Q 010149 301 FSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR---NLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 301 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~~~~~lv~e~ 377 (517)
....+.+|.|..+.||+..+.+|+.+.+|+..... ......|..|.+.|+.+.-. -+.+.+++ +..++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 33456789999999999999999999999875432 22234578899888877422 23344443 245789999
Q ss_pred CcCCCh
Q 010149 378 MSNGSV 383 (517)
Q Consensus 378 ~~~gsL 383 (517)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=2.7e-06 Score=84.75 Aligned_cols=126 Identities=16% Similarity=0.176 Sum_probs=78.7
Q ss_pred CCEEEEecCCCCC---------cccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCC-
Q 010149 71 GLVTGLGAPSQNL---------SGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS- 140 (517)
Q Consensus 71 ~~v~~l~l~~~~l---------~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~- 140 (517)
.+++.|.+.++.. .+.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..+.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 4677777765432 1234455677889999999887312 2443 4 378999999998887643223333
Q ss_pred -CCccchhhhhcc--cccCCC-----CCCCc--ccCCCcceEeccCCCCCCCCCCC--------CcCcccccCCccc
Q 010149 141 -HLETLQYLRLNN--NSLTGA-----IPPSL--SNMSQLAFLDLSYNNLSGPVPSF--------HAKTFNITGNSLI 199 (517)
Q Consensus 141 -~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~l~l~~N~l~~~~p~~--------~~~~~~l~~N~~~ 199 (517)
.+|+|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+++..+.. ..+.++|+.|.+.
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~ 292 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence 678899988863 332222 11122 24789999999999887432111 1277888888763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.44 E-value=9.7e-06 Score=71.44 Aligned_cols=83 Identities=14% Similarity=0.098 Sum_probs=41.3
Q ss_pred CCcEEecccCccCCCCCCcccccCcccEEEeecCC-CCCCCCccCCCC----ccchhhhhcccc-cCCCCCCCcccCCCc
Q 010149 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNF-FTGPIPSTVSHL----ETLQYLRLNNNS-LTGAIPPSLSNMSQL 169 (517)
Q Consensus 96 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 169 (517)
.|+.|||+++.++..--..+.++++|+.|+|+++. ++..--..++.+ ++|++|+|+++. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45556665555542222234555666666666653 442211223332 346666666653 442211235566777
Q ss_pred ceEeccCCC
Q 010149 170 AFLDLSYNN 178 (517)
Q Consensus 170 ~~l~l~~N~ 178 (517)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777777654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0006 Score=65.84 Aligned_cols=136 Identities=13% Similarity=0.076 Sum_probs=74.0
Q ss_pred CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcc-cceeeeEecCCcceEEEecC-cCC
Q 010149 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVYPYM-SNG 381 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~-~~g 381 (517)
.+.|+.|....+|+. ..+++|+....... ......|..+++.+....+ .+++++ ..+..++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 577889999999998 45788887543211 1123467777766643333 344443 344567899999 554
Q ss_pred Chhh--------h----------hhcCC-CC----C-HHHHHHHHHH--------------HHHHHH----HHHh-cCCC
Q 010149 382 SVAS--------R----------LKAKP-SL----D-WATRKRIALG--------------AARGLL----YLHE-QCDP 418 (517)
Q Consensus 382 sL~~--------~----------l~~~~-~l----~-~~~~~~i~~~--------------i~~~L~----yLH~-~~~~ 418 (517)
++.. . ++..+ .+ + +.....+... +.+.+. .+.. ...+
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4321 0 01110 00 1 1111111110 111111 1111 1233
Q ss_pred CeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 419 ~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
.++|+|+.+.||+ .+++.+.++||..+..-
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 5899999999999 56677899999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00064 Score=66.64 Aligned_cols=139 Identities=15% Similarity=0.054 Sum_probs=70.9
Q ss_pred Cccccccccc-eEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCC--CcccceeeeEecCCcceEEEecCcCC
Q 010149 305 NLVGKGGFGN-VYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH--RNLLRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 305 ~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~g 381 (517)
+.++.|.... +|+....+|..+++|....... .++..|+.++..+.. -.+.+++.+.. +..+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCc
Confidence 4566665554 6777654467777776543221 223456666555532 22445665533 2337899999776
Q ss_pred Chhhhhhc--------------------------CCCCCHHHHH-------H-H------------HHHHHHHHHHHHh-
Q 010149 382 SVASRLKA--------------------------KPSLDWATRK-------R-I------------ALGAARGLLYLHE- 414 (517)
Q Consensus 382 sL~~~l~~--------------------------~~~l~~~~~~-------~-i------------~~~i~~~L~yLH~- 414 (517)
.+.+.+.. .+.++..... . + ...+.+.+..+.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 55433211 0112221110 0 0 0011112222211
Q ss_pred --cCCCCeEecCCCCCceEEcCC----CCeEEccccccccc
Q 010149 415 --QCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKLL 449 (517)
Q Consensus 415 --~~~~~ivH~Dlk~~NILl~~~----~~~ki~DFGla~~~ 449 (517)
...+.++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999875 67899999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0016 Score=63.42 Aligned_cols=154 Identities=9% Similarity=0.039 Sum_probs=83.4
Q ss_pred hHHHHHHhcCCCC-----CCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc--ccceee
Q 010149 291 FKELQSATSNFSS-----KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIG 363 (517)
Q Consensus 291 ~~~l~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~ 363 (517)
.+++......|.. .+.|+.|....+|+....+| .+++|+..... ...++..|.+++..+.... +.+++.
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 3444444444543 23466788889999887655 57789886421 1234556777766553212 223332
Q ss_pred e------EecCCcceEEEecCcCCChhh--------------hhhc---C-C-C----C---CHHHHHH-----------
Q 010149 364 F------CMTTTERLLVYPYMSNGSVAS--------------RLKA---K-P-S----L---DWATRKR----------- 400 (517)
Q Consensus 364 ~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~---~-~-~----l---~~~~~~~----------- 400 (517)
. ....+..+++++|++|..+.. .++. . . . . .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 122345689999998865321 0111 0 0 0 1 1222110
Q ss_pred -HHHHHHHHHHHHHhc----CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 401 -IALGAARGLLYLHEQ----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 401 -i~~~i~~~L~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
+...+.+.++++++. ..+.++|+|+++.||+++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234799999999999999876668999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0027 Score=61.86 Aligned_cols=139 Identities=14% Similarity=0.130 Sum_probs=79.9
Q ss_pred CccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc--ccceeee-----EecCCcceEEEec
Q 010149 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN--LLRLIGF-----CMTTTERLLVYPY 377 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~-----~~~~~~~~lv~e~ 377 (517)
..++ |....||+....+|+.+++|+...... ....+..|..++..+.... +.+++.. ....+..+++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 888899998877777899999863321 2345667777776663222 3444433 1123455789999
Q ss_pred CcCCChhh-----h---------hh----c-----CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 010149 378 MSNGSVAS-----R---------LK----A-----KPSLDWATR----KRI---------------ALGAARGLLYLHEQ 415 (517)
Q Consensus 378 ~~~gsL~~-----~---------l~----~-----~~~l~~~~~----~~i---------------~~~i~~~L~yLH~~ 415 (517)
+++..+.. . ++ . ....++... ..+ ...+.+.++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754320 0 11 0 011222211 011 11111223333221
Q ss_pred ----CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 416 ----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 416 ----~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.18 E-value=3.5e-05 Score=67.83 Aligned_cols=86 Identities=14% Similarity=0.178 Sum_probs=65.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCc-cCCCCCCccccc----CcccEEEeecCC-CCCCCCccCCCCcc
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNN-ISGHIPTEIGKL----SKLLTLDLSNNF-FTGPIPSTVSHLET 144 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~ 144 (517)
-++++|||+++.++..--..+..+++|+.|+|+++. ++..--..+..+ ++|++|+|+++. ++..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999876555667899999999999985 663211234443 479999999974 77543345778999
Q ss_pred chhhhhcccc-cC
Q 010149 145 LQYLRLNNNS-LT 156 (517)
Q Consensus 145 L~~L~l~~N~-l~ 156 (517)
|+.|+|++.. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999875 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00034 Score=58.52 Aligned_cols=35 Identities=29% Similarity=0.256 Sum_probs=15.0
Q ss_pred chhhhhcccccCCCCCCCcccCCCcceEeccCCCC
Q 010149 145 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179 (517)
Q Consensus 145 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l 179 (517)
|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 34444444444422233344455555544444433
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0018 Score=64.62 Aligned_cols=139 Identities=16% Similarity=0.145 Sum_probs=82.5
Q ss_pred CCccccccccceEEEEeC--------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc-ccceeeeEecCCcceEE
Q 010149 304 KNLVGKGGFGNVYKGYLQ--------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLV 374 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~~lv 374 (517)
.+.+..|-...+|+.... ++..+.+|+.... ......+.+|.++++.+.-.. ..++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 355777888999998864 2478899986321 223445678988887774222 3566666543 299
Q ss_pred EecCcCCChhhh-----------------hhc-----CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 010149 375 YPYMSNGSVASR-----------------LKA-----KPSL--DWATRKRIALGAAR-------------------GLLY 411 (517)
Q Consensus 375 ~e~~~~gsL~~~-----------------l~~-----~~~l--~~~~~~~i~~~i~~-------------------~L~y 411 (517)
|||+++.++... ++. .... -+.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998554311 111 1111 24555555544322 2333
Q ss_pred HHh-----cCCCCeEecCCCCCceEEcCC----CCeEEcccccccc
Q 010149 412 LHE-----QCDPKIIHRDVKAANILLDEY----YEAVVGDFGLAKL 448 (517)
Q Consensus 412 LH~-----~~~~~ivH~Dlk~~NILl~~~----~~~ki~DFGla~~ 448 (517)
|.+ .....++|+|+.+.||+++++ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 123468899999999999876 7899999998863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00079 Score=68.58 Aligned_cols=73 Identities=15% Similarity=0.166 Sum_probs=48.7
Q ss_pred CCccccccccceEEEEeCC--------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcc-cceeeeEecCCcceEE
Q 010149 304 KNLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLV 374 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lv 374 (517)
.+.|+.|-...||+....+ +..+.+|+.... .....+..|..+++.+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 3557888889999998653 478999988431 112456678888887743334 566665532 389
Q ss_pred EecCcCCCh
Q 010149 375 YPYMSNGSV 383 (517)
Q Consensus 375 ~e~~~~gsL 383 (517)
+||+++.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.11 E-value=2.2e-05 Score=70.47 Aligned_cols=84 Identities=18% Similarity=0.217 Sum_probs=46.5
Q ss_pred CCCEEEEecCCC-CCcc----cccccccCCCCCcEEecccCccCC----CCCCcccccCcccEEEeecCCCCCC----CC
Q 010149 70 DGLVTGLGAPSQ-NLSG----TLSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IP 136 (517)
Q Consensus 70 ~~~v~~l~l~~~-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p 136 (517)
+..++.|+|+++ ++.. .+...+..-+.|+.|+|++|+|.. .+.+.+..-+.|+.|+|++|+|... +-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 346777777764 5432 234455556677777777777762 2223344456677777777776632 11
Q ss_pred ccCCCCccchhhhhccc
Q 010149 137 STVSHLETLQYLRLNNN 153 (517)
Q Consensus 137 ~~~~~l~~L~~L~l~~N 153 (517)
+.+..-+.|++|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 22333345666666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0011 Score=55.48 Aligned_cols=56 Identities=20% Similarity=0.278 Sum_probs=42.2
Q ss_pred EEecCCCCCc-ccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCC
Q 010149 75 GLGAPSQNLS-GTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 132 (517)
Q Consensus 75 ~l~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 132 (517)
.++.++++|+ ..+|..+ -++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566677775 3556443 346899999999999666667888999999999999775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0019 Score=64.25 Aligned_cols=73 Identities=10% Similarity=0.055 Sum_probs=42.8
Q ss_pred CccccccccceEEEEeCC---------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcc-cceeeeEecCCcceEE
Q 010149 305 NLVGKGGFGNVYKGYLQD---------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLV 374 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lv 374 (517)
+.++.|....+|+....+ +..+.+|+...... ...+...|.++++.+...++ .++++.. ..++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 457788889999988654 26788888754321 11123567777776643333 3566543 24789
Q ss_pred EecCcCCCh
Q 010149 375 YPYMSNGSV 383 (517)
Q Consensus 375 ~e~~~~gsL 383 (517)
|||+++.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0046 Score=63.31 Aligned_cols=74 Identities=9% Similarity=0.063 Sum_probs=46.7
Q ss_pred CCccccccccceEEEEeCC-CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcc-cceeeeEecCCcceEEEecCcCC
Q 010149 304 KNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLVYPYMSNG 381 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g 381 (517)
.+.|+.|-...+|+....+ +..+.+|+...... ...+...|..++..+...++ .++++.+. + .+||||+++.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 3567888889999998764 47788888743221 11122578888887765454 46666652 2 3599999874
Q ss_pred Ch
Q 010149 382 SV 383 (517)
Q Consensus 382 sL 383 (517)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.015 Score=56.99 Aligned_cols=33 Identities=21% Similarity=0.274 Sum_probs=28.5
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 417 ~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
...++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 347999999999999998888999999887643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0026 Score=63.41 Aligned_cols=102 Identities=12% Similarity=0.109 Sum_probs=59.1
Q ss_pred EEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 73 VTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 73 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
++.+.+..+ +...-...+.+...|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|+.+.+.+
T Consensus 219 l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~ 295 (379)
T 4h09_A 219 LKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDN 295 (379)
T ss_dssp CSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECC
T ss_pred cceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccc
Confidence 444444332 34344455666777777777655 44333455666677777776543 3323334566667777777766
Q ss_pred cccCCCCCCCcccCCCcceEeccCC
Q 010149 153 NSLTGAIPPSLSNMSQLAFLDLSYN 177 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~l~l~~N 177 (517)
|.++..-+..|.++.+|+.+.|..+
T Consensus 296 ~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 296 SAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccceehhhhhcCCCCCCEEEcCcc
Confidence 6666333456666777777776543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0038 Score=62.67 Aligned_cols=87 Identities=13% Similarity=0.139 Sum_probs=47.8
Q ss_pred cccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCC
Q 010149 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS 167 (517)
Q Consensus 88 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 167 (517)
...|.+++.|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++..-..+|.+++
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 345666666666666554433 334456666666666664 3344233345566666666666543 4322334566666
Q ss_pred CcceEeccCC
Q 010149 168 QLAFLDLSYN 177 (517)
Q Consensus 168 ~L~~l~l~~N 177 (517)
+|+.+.+..+
T Consensus 335 ~L~~i~ip~s 344 (394)
T 4gt6_A 335 QLERIAIPSS 344 (394)
T ss_dssp TCCEEEECTT
T ss_pred CCCEEEECcc
Confidence 6666666543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0025 Score=63.97 Aligned_cols=87 Identities=11% Similarity=0.064 Sum_probs=69.6
Q ss_pred cccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCC
Q 010149 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMS 167 (517)
Q Consensus 88 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 167 (517)
...+..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-...|.+|++|+.++|..| ++..-..+|.+++
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 356788999999999765 66455677999999999999755 66445678899999999999877 6644467899999
Q ss_pred CcceEeccCC
Q 010149 168 QLAFLDLSYN 177 (517)
Q Consensus 168 ~L~~l~l~~N 177 (517)
+|+.+++..|
T Consensus 367 ~L~~i~lp~~ 376 (394)
T 4fs7_A 367 NLKKVELPKR 376 (394)
T ss_dssp TCCEEEEEGG
T ss_pred CCCEEEECCC
Confidence 9999999765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0031 Score=63.35 Aligned_cols=105 Identities=14% Similarity=0.166 Sum_probs=79.8
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.+.+.++- ...-...|.++++|+.+.+. +.++..-...|.++++|+.++|.+| ++..-...|.+|++|+.+.|.
T Consensus 266 ~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 46666666543 33556778899999999996 4566455578999999999999865 553455689999999999996
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
.+ ++..-..+|.++++|+.+++.+|...
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 55 66344568999999999999987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.00029 Score=63.17 Aligned_cols=92 Identities=14% Similarity=0.142 Sum_probs=65.8
Q ss_pred ccccccCCCCCcEEecccC-ccCC----CCCCcccccCcccEEEeecCCCCCC----CCccCCCCccchhhhhcccccCC
Q 010149 87 LSSSIGNLTNLQLVLLQNN-NISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTG 157 (517)
Q Consensus 87 ~~~~~~~l~~L~~L~l~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 157 (517)
+...+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|+|... +.+.+..-+.|+.|+|++|+|+.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 4445566789999999986 7762 1334566678999999999999832 22334455789999999999984
Q ss_pred C----CCCCcccCCCcceEeccCCC
Q 010149 158 A----IPPSLSNMSQLAFLDLSYNN 178 (517)
Q Consensus 158 ~----~p~~~~~l~~L~~l~l~~N~ 178 (517)
. +-..+..-+.|+.|+|++|.
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHHHHHhhCCceeEEECCCCc
Confidence 2 22345556779999998763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.006 Score=61.17 Aligned_cols=110 Identities=11% Similarity=0.010 Sum_probs=80.4
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.+.+..+ +.......|.....|+.+.+..+.+. ...|..+++|+.+.+.++ ++..-...|.++++|+.++|.
T Consensus 254 ~l~~~~~~~~-~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 254 DLESISIQNN-KLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp SCCEEEECCT-TCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeEEcCCC-cceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 3455555544 33355677888999999998877654 346889999999999876 663455678999999999997
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 188 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 188 (517)
++ ++..-..+|.++++|+.+++..| ++......|.
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 55 66344678999999999999877 6644344444
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.24 E-value=0.014 Score=37.89 Aligned_cols=31 Identities=29% Similarity=0.428 Sum_probs=20.6
Q ss_pred eeeehhhhhHHHHHHHHHHHHHhhhhhcccc
Q 010149 237 IALALGSSLGCISLLILGFGFLLWWRQRHNQ 267 (517)
Q Consensus 237 ~~~~~~~~~~~~~l~~~~~~~~~~~r~~~~~ 267 (517)
..++.+++.+++.++++++.+++++|+|+.+
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 4566677777777766666666777666544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.18 E-value=0.034 Score=55.19 Aligned_cols=90 Identities=11% Similarity=0.051 Sum_probs=47.1
Q ss_pred ccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCC
Q 010149 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 168 (517)
Q Consensus 89 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 168 (517)
..+....+|+.+.+..+ +...-...|.+++.|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++..-...|..+++
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 34455556666666444 22233445556666666666554 33233345555666666665433 33222345566666
Q ss_pred cceEeccCCCCCC
Q 010149 169 LAFLDLSYNNLSG 181 (517)
Q Consensus 169 L~~l~l~~N~l~~ 181 (517)
|+.+.+.+|.++.
T Consensus 288 L~~i~l~~~~i~~ 300 (379)
T 4h09_A 288 LTKVVMDNSAIET 300 (379)
T ss_dssp CCEEEECCTTCCE
T ss_pred cccccccccccce
Confidence 6666666665553
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.016 Score=37.48 Aligned_cols=32 Identities=25% Similarity=0.428 Sum_probs=20.4
Q ss_pred eeeehhhhhHHHHHHHHHHHHHhhhhhccccc
Q 010149 237 IALALGSSLGCISLLILGFGFLLWWRQRHNQQ 268 (517)
Q Consensus 237 ~~~~~~~~~~~~~l~~~~~~~~~~~r~~~~~~ 268 (517)
..++.+++.+++.++++++.+++++|+|+.++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34666666667776666666666776665543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.68 E-value=0.084 Score=53.27 Aligned_cols=137 Identities=9% Similarity=0.073 Sum_probs=81.5
Q ss_pred CccccccccceEEEEeCC--------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCc-ccceeeeEecCCcceEEE
Q 010149 305 NLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRN-LLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~ 375 (517)
+.+..|-...+|+....+ +..+.+|+...... ...+..+|..+++.+...+ ..++++.+ ..++||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 456678889999988753 57888888644321 1123356777777664223 34555433 237899
Q ss_pred ecCcCCChhh-------h-------h---h---c---------C-CCCCHHHHHHHHHHH-------------------H
Q 010149 376 PYMSNGSVAS-------R-------L---K---A---------K-PSLDWATRKRIALGA-------------------A 406 (517)
Q Consensus 376 e~~~~gsL~~-------~-------l---~---~---------~-~~l~~~~~~~i~~~i-------------------~ 406 (517)
||+++.+|.. . + + . . .+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 0 1 0 0 111244444443322 2
Q ss_pred HHHHHHHh---------------------cCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 407 RGLLYLHE---------------------QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 407 ~~L~yLH~---------------------~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
..+.+|.+ .....++|+|+.+.||+ ++++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11236889999999999 8888999999998863
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.56 E-value=0.053 Score=34.98 Aligned_cols=28 Identities=18% Similarity=0.475 Sum_probs=16.0
Q ss_pred ehhhhhHHHHHHHHHHHHHhhhhhcccc
Q 010149 240 ALGSSLGCISLLILGFGFLLWWRQRHNQ 267 (517)
Q Consensus 240 ~~~~~~~~~~l~~~~~~~~~~~r~~~~~ 267 (517)
+++.++|+++++++++++++|+|+|+.+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 4444455556666666666666666544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.11 E-value=0.21 Score=45.03 Aligned_cols=102 Identities=15% Similarity=0.077 Sum_probs=66.0
Q ss_pred CChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceeee
Q 010149 381 GSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTA 459 (517)
Q Consensus 381 gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 459 (517)
-+|.++|. .+.++++.+++.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 47888887 456899999999999999998765221111 1233456899999999988764 2110
Q ss_pred ccccccccCccccccCCCCcccceehhhHHHHHHHhCCCC
Q 010149 460 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRA 499 (517)
Q Consensus 460 ~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P 499 (517)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223456888763 4556788999999999987764433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.86 E-value=0.32 Score=43.75 Aligned_cols=86 Identities=9% Similarity=0.016 Sum_probs=61.7
Q ss_pred CCCcccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 010149 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD 433 (517)
Q Consensus 354 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~ 433 (517)
.||+++.. .+-...+...+.|+.-+.+.=+..++ .++...+++++.+|+....+++.. +|--++|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEc
Confidence 58888866 45555565555555443222222233 468899999999999888776654 7888999999999
Q ss_pred CCCCeEEcccccccc
Q 010149 434 EYYEAVVGDFGLAKL 448 (517)
Q Consensus 434 ~~~~~ki~DFGla~~ 448 (517)
.++.+++.-.|+-..
T Consensus 114 ~~~~p~i~~RGik~~ 128 (215)
T 4ann_A 114 RDGLPIAKTRGLQNV 128 (215)
T ss_dssp TTSCEEESCCEETTT
T ss_pred CCCCEEEEEccCccC
Confidence 999999998887543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.28 E-value=0.093 Score=52.58 Aligned_cols=29 Identities=31% Similarity=0.461 Sum_probs=24.8
Q ss_pred eEecCCCCCceEE------cCCCCeEEcccccccc
Q 010149 420 IIHRDVKAANILL------DEYYEAVVGDFGLAKL 448 (517)
Q Consensus 420 ivH~Dlk~~NILl------~~~~~~ki~DFGla~~ 448 (517)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.99 E-value=1.8 Score=38.95 Aligned_cols=85 Identities=13% Similarity=0.073 Sum_probs=60.9
Q ss_pred CCCcccceeeeEecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCceEE
Q 010149 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLL-YLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 354 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~~~ivH~Dlk~~NILl 432 (517)
.||.+ -...-.+++...+.++--+++.=+..++ .++...+++++.+|+.... +++.. +|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEE
Confidence 57777 3344456666666666554443333443 4688999999999888777 66544 788899999999
Q ss_pred cCCCCeEEcccccccc
Q 010149 433 DEYYEAVVGDFGLAKL 448 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~ 448 (517)
|.++.++|.-.|+-..
T Consensus 118 ~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 118 NRALEPFFLHVGVKES 133 (219)
T ss_dssp CTTCCEEESCCEETTT
T ss_pred eCCCcEEEEEcCCccc
Confidence 9999999988886543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.29 E-value=0.14 Score=52.44 Aligned_cols=62 Identities=6% Similarity=-0.016 Sum_probs=18.4
Q ss_pred CCCccccccccceEEEEeCC-CcEEEE------EEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEec
Q 010149 303 SKNLVGKGGFGNVYKGYLQD-GTVVAV------KRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT 367 (517)
Q Consensus 303 ~~~~lG~G~fg~Vy~~~~~~-g~~vav------K~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 367 (517)
..+.+| ||.||+|.+.. ..+||| |..+..... .....|.+|..++...+|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999764 367888 766543222 223467888888888999999999987753
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.42 E-value=0.28 Score=31.29 Aligned_cols=28 Identities=29% Similarity=0.383 Sum_probs=13.1
Q ss_pred eeeehhhhhHHHHHHHHHHHHHhhhhhc
Q 010149 237 IALALGSSLGCISLLILGFGFLLWWRQR 264 (517)
Q Consensus 237 ~~~~~~~~~~~~~l~~~~~~~~~~~r~~ 264 (517)
..++.+++.+++.++++.+.+++++|||
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 3445555555555442444444555543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 517 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-58
Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 6/204 (2%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
++ +F + +G G G V+K G V+A K + Q E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 412
++ G + E + +M GS+ LK + ++++ +GL YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYL 472
E+ KI+HRDVK +NIL++ E + DFG++ L + + GT +++PE L
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL 175
Query: 473 STGQSSEKTDVFGFGILLLELISG 496
S ++D++ G+ L+E+ G
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVG 199
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-56
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 8/212 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+G G FG V+ GY T VAVK LK G+ F E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS--LDWATRKRIALGAARGLLYLHEQC 416
+RL T ++ YM NGS+ LK L +A A G+ ++ E+
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
IHRD++AANIL+ + + DFGLA+L++ + + + APE ++ G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 477 SSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+ K+DV+ FGILL E+++ R G T +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-55
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRN 357
+ +G G FG VYKG VAVK L ++Q F+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQC 416
+L +G+ T + +V + S+ L + + IA A+G+ YLH +
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTG 475
IIHRD+K+ NI L E +GDFGLA + SH + G++ +APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 476 QS---SEKTDVFGFGILLLELISG 496
S ++DV+ FGI+L EL++G
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTG 205
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-53
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 6/211 (2%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
S + +G G FG V+ GY + VA+K +++G E F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSL-DWATRKRIALGAARGLLYLHEQCD 417
++L G C+ LV+ +M +G ++ L+ + L T + L G+ YL E C
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
+IHRD+ A N L+ E V DFG+ + + +T + V +PE S +
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 478 SEKTDVFGFGILLLELISGLRALEFGKTANQ 508
S K+DV+ FG+L+ E+ S + ++ ++
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (450), Expect = 2e-52
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 289 FHFKELQSATSNFSSK---------NLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGN 335
F F++ A F+ + ++G G FG V G+L + VA+K LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 336 AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLD 394
F +E ++ H N++ L G +T +++ +M NGS+ S L+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 395 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454
+ G A G+ YL + +HRD+ A NIL++ V DFGL++ L+ S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 455 HVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
T + + APE + + + +DV+ +GI++ E++S + T
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-52
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 11/211 (5%)
Query: 296 SATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLA 353
S ++ +G G +G K DG ++ K L G+ E Q +EV ++
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 354 VHRNLLRLIGFCMTTTERLL--VYPYMSNGSVASRL----KAKPSLDWATRKRIALGAAR 407
H N++R + T L V Y G +AS + K + LD R+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 408 GLLYLHEQ--CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVG 465
L H + ++HRD+K AN+ LD +GDFGLA++L+H D+ A GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPY 179
Query: 466 HIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+++PE ++ +EK+D++ G LL EL +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-52
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 11/224 (4%)
Query: 292 KELQSATSNFSSKNLV-GKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEV 347
K+L N ++ G G FG+V +G + VA+K LK G + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 348 EMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK-PSLDWATRKRIALGAA 406
+++ + ++RLIG C +LV G + L K + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 407 RGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--TAVRGTV 464
G+ YL E+ +HRD+ A N+LL + A + DFGL+K L DS+ T +A + +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 465 GHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
APE ++ + S ++DV+ +G+ + E +S + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-51
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 6/200 (3%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
++ +G+G +G V VAVK + A+ + E+ + + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
++ G + L Y S G + R++ + +R G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQ- 476
I HRD+K N+LLDE + DFGLA + + + + + GT+ ++APE L +
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 477 SSEKTDVFGFGILLLELISG 496
+E DV+ GI+L +++G
Sbjct: 183 HAEPVDVWSCGIVLTAMLAG 202
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-51
Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 6/198 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+ + +G G FG V G + VA+K +K+G+ E +F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCD 417
++L G C ++ YM+NG + + L+ + + + YL +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS 477
+HRD+ A N L+++ V DFGL++ + + + + V PE L +
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 478 SEKTDVFGFGILLLELIS 495
S K+D++ FG+L+ E+ S
Sbjct: 179 SSKSDIWAFGVLMWEIYS 196
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-51
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 8/212 (3%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+ + +G+G FG V+ G T VA+K LK G F E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQC 416
++L + +V YMS GS+ LK + L +A A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
+HRD++AANIL+ E V DFGLA+L++ + + + APE G+
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 477 SSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+ K+DV+ FGILL EL + R G +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-51
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 307 VGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQ-FQTEVEMISLAVHRNLLRLIGF 364
+G+G F VYKG + VA L+D E Q F+ E EM+ H N++R
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 365 CMTTTER----LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
+T + +LV M++G++ + LK + + +GL +LH + P I
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 135
Query: 421 IHRDVKAANILL-DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSE 479
IHRD+K NI + +GD GLA L + AV GT +APE + E
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKYDE 191
Query: 480 KTDVFGFGILLLELISG 496
DV+ FG+ +LE+ +
Sbjct: 192 SVDVYAFGMCMLEMATS 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 6e-51
Identities = 57/250 (22%), Positives = 105/250 (42%), Gaps = 34/250 (13%)
Query: 290 HFKELQSATSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQF 343
L+ +N +G+G FG V++ + T+VAVK LK+ + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 344 QTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK--------------- 388
Q E +++ + N+++L+G C L++ YM+ G + L+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 389 ---------AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAV 439
P L A + IA A G+ YL E+ K +HRD+ N L+ E
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 440 VGDFGLAKLLDHCD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR 498
+ DFGL++ + D + + PE + + + ++DV+ +G++L E+ S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 499 ALEFGKTANQ 508
+G +
Sbjct: 241 QPYYGMAHEE 250
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-50
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVH 355
+F +GKG FGNVY Q ++A+K L G E Q + EVE+ S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
N+LRL G+ T L+ Y G+V L+ D A L Y H +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
++IHRD+K N+LL E + DFG + H S T + GT+ ++ PE +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 476 QSSEKTDVFGFGILLLELISG 496
EK D++ G+L E + G
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVG 200
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-50
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 14/218 (6%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH 355
+F ++G+G FG VY G L D AVK L IG QF TE ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 356 RNLLRLIGFCMTT-TERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLH 413
N+L L+G C+ + L+V PYM +G + + + L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD---SHVTTAVRGTVGHIAPE 470
K +HRD+ A N +LDE + V DFGLA+ + + H T + V +A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 471 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
L T + + K+DV+ FG+LL EL++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-50
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGT-----VVAVKRLKDGNAIGGEIQFQTEVEMISLA 353
S + + ++G G FG VYKG L+ + VA+K LK G + F E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLDWATRKRIALGAARGLLYL 412
H N++RL G +++ YM NG++ + + G A G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 470
+HRD+ A NIL++ V DFGL+++L D ++ T+ + + APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 471 YLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+S + + +DV+ FGI++ E+++ + + ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-49
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 10/210 (4%)
Query: 305 NLVGKGGFGNVYKGYLQD---GTVVAVKRLKDGNAIGGEI-QFQTEVEMISLAVHRNLLR 360
+G G FG V KGY Q VAVK LK+ + E ++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 361 LIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKI 420
+IG C + +LV G + L+ + + + G+ YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 421 IHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
+HRD+ A N+LL + A + DFGL+K L D T + V APE ++ + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 479 EKTDVFGFGILLLELISGLRALEFGKTANQ 508
K+DV+ FG+L+ E S + G ++
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-49
Identities = 63/205 (30%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAV 354
FS +G G FG VY +++ VVA+K++ E EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE 414
H N ++ G + LV Y + K L + GA +GL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 415 QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLST 474
+IHRDVKA NILL E +GDFG A ++ +S V GT +APE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185
Query: 475 ---GQSSEKTDVFGFGILLLELISG 496
GQ K DV+ GI +EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAER 210
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-49
Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+GKG FG+V G G VAVK +K+ F E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62
Query: 359 LRLIGFCMTTTERL-LVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQ 415
++L+G + L +V YM+ GS+ L+++ L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
+HRD+ A N+L+ E A V DFGL K S + V APE L
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175
Query: 476 QSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+ S K+DV+ FGILL E+ S R
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-49
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 34/241 (14%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 351
N ++G G FG V VAVK LK+ +E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK--------------------- 390
L H N++ L+G C + L++ Y G + + L++K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 391 --PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448
L + A A+G+ +L + +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 449 LDHCDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTAN 507
+ ++V R V +APE L G + K+DV+ +GILL E+ S G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 508 Q 508
Sbjct: 274 A 274
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 4e-49
Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 8/231 (3%)
Query: 287 KRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGNAIGGEIQFQT 345
++ + + ++ + K+ +G G +G VY+G + VAVK LK+ E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 346 EVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRL--KAKPSLDWATRKRIAL 403
E ++ H NL++L+G C ++ +M+ G++ L + + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 404 GAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGT 463
+ + YL + IHRD+ A N L+ E + V DFGL++L+ +
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 464 VGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 514
+ APE L+ + S K+DV+ FG+LL E+ + + G +Q +L+
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-48
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 25/230 (10%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYLQDG---TVVAVKRLKDGNAIGGEIQFQTEVEMIS-LAV 354
++ ++++G+G FG V K ++ A+KR+K+ + F E+E++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----------------AKPSLDWATR 398
H N++ L+G C L Y +G++ L+ +L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 399 KRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458
A ARG+ YL + + IHRD+ A NIL+ E Y A + DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
R V +A E L+ + +DV+ +G+LL E++S G T +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-48
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 22/211 (10%)
Query: 304 KNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+ +GKG FG V++G G VAVK + E+ + H N+L I
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64
Query: 364 FCM----TTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC--- 416
T T+ LV Y +GS+ L + ++AL A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 417 --DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV---TTAVRGTVGHIAPEY 471
P I HRD+K+ NIL+ + + D GLA D + GT ++APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 472 LST------GQSSEKTDVFGFGILLLELISG 496
L +S ++ D++ G++ E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARR 214
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 7e-48
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 29/237 (12%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMIS- 351
+ S +G G FG V + VAVK LK + +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 352 LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAK------------------PSL 393
L H N++ L+G C L++ Y G + + L+ K +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 394 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453
D + A+G+ +L + IHRD+ A NILL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 454 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQK 509
++ V R V +APE + + ++DV+ +GI L EL S + G + K
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-47
Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIG 363
+G G FG VYK + + A K + + E + E+++++ H N+++L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLD 76
Query: 364 FCMTTTERLLVYPYMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
++ + + G+V + + + + L + + + L YLH+ KIIH
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS----- 477
RD+KA NIL + + DFG++ + + GT +APE + S
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 478 SEKTDVFGFGILLLELISG 496
K DV+ GI L+E+
Sbjct: 193 DYKADVWSLGITLIEMAEI 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-46
Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 7/200 (3%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
++ +G+G G VY + G VA++++ E E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
N++ + + E +V Y++ GS+ + D + + L +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN- 135
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
++IHRD+K+ NILL + DFG + S +T V GT +APE ++
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 477 SSEKTDVFGFGILLLELISG 496
K D++ GI+ +E+I G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 8e-46
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 9/215 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV 354
+G+G FG+V++G VA+K K+ + +F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 355 HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLH 413
H ++++LIG T ++ + G + S L+ + SLD A+ A + L YL
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
+ + +HRD+ A N+L+ +GDFGL++ ++ + + + + +APE ++
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 474 TGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+ + +DV+ FG+ + E++ G N
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-45
Identities = 51/222 (22%), Positives = 109/222 (49%), Gaps = 9/222 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKG-YLQDGTV----VAVKRLKDGNAIGGEIQFQTEVEMISLA 353
+ F ++G G FG VYKG ++ +G VA+K L++ + + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 354 VHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 413
+ ++ RL+G C+T+T +L+ + + K ++ + A+G+ YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYL 472
++ +++HRD+ A N+L+ + DFGLAKLL + + + + +A E +
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 473 STGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 514
+ ++DV+ +G+ + EL++ G A++ ++L+
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 7/201 (3%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--GGEIQFQTEVEMISLAVHR 356
+F ++G+G F V L A+K L+ + I E +++S H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
++L + Y NG + ++ S D + L YLH +
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTG 475
IIHRD+K NILL+E + DFG AK+L + GT +++PE L+
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 476 QSSEKTDVFGFGILLLELISG 496
+ + +D++ G ++ +L++G
Sbjct: 186 SACKSSDLWALGCIIYQLVAG 206
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (399), Expect = 2e-44
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 31/240 (12%)
Query: 261 WRQRHNQQIFFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY- 319
W+Q + Q + E + + V L + E +G G FG V++
Sbjct: 9 WKQYYPQPV-----EIKHDHV----LDHYDIHEE------------LGTGAFGVVHRVTE 47
Query: 320 LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMS 379
G A K + + E + E++ +S+ H L+ L E +++Y +MS
Sbjct: 48 RATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106
Query: 380 NGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL--DEYY 436
G + ++ + +GL ++HE +H D+K NI+
Sbjct: 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSN 163
Query: 437 EAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
E + DFGL LD S T GT APE TD++ G+L L+SG
Sbjct: 164 ELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-44
Identities = 69/236 (29%), Positives = 94/236 (39%), Gaps = 25/236 (10%)
Query: 282 CLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTVVAVKRLKDGNAI 337
CL K E +G G FG V +G VAVK LK
Sbjct: 3 CLIGEKDLRLLEK------------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 50
Query: 338 GGEI--QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASR-LKAKPSLD 394
E F EV + HRNL+RL G +T + +V GS+ R K +
Sbjct: 51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL 109
Query: 395 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454
T R A+ A G+ YL + IHRD+ A N+LL +GDFGL + L D
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
Query: 455 H--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
H + + APE L T S +D + FG+ L E+ + + G +Q
Sbjct: 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (392), Expect = 3e-43
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAV-- 354
+FS ++G+GGFG VY G + A+K L GE E M+SL
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 355 -HRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLH 413
++ + T + + M+ G + L A + A GL ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 414 EQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLS 473
+ +++RD+K ANILLDE+ + D GLA H + GT G++APE L
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQ 178
Query: 474 TGQS-SEKTDVFGFGILLLELISG 496
G + D F G +L +L+ G
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRG 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-43
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 291 FKELQSATSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEM 349
+K+ + + ++++G G F V + +VA+K + G E + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 409
+ H N++ L + L+ +S G + R+ K R+ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 410 LYLHEQCDPKIIHRDVKAANILL---DEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGH 466
YLH+ I+HRD+K N+L DE + ++ DFGL+K+ D V + GT G+
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGY 175
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+APE L+ S+ D + G++ L+ G
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 153 bits (388), Expect = 8e-43
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 10/195 (5%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G G FG V++ G V K + + + E+ +++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDA 94
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
E +L+ ++S G + R+ A+ + A A GL ++HE I+H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 151
Query: 424 DVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
D+K NI+ + + V DFGLA L+ + T APE + T
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 482 DVFGFGILLLELISG 496
D++ G+L L+SG
Sbjct: 210 DMWAIGVLGYVLLSG 224
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (380), Expect = 2e-42
Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 21/213 (9%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI--------GGEIQFQTEVE-M 349
N+ K ++G+G V + AVK + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 350 ISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGL 409
++ H N+++L T T LV+ M G + L K +L ++I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 410 LYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAP 469
LH+ I+HRD+K NILLD+ + DFG + LD V GT ++AP
Sbjct: 124 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAP 178
Query: 470 EYLSTGQS------SEKTDVFGFGILLLELISG 496
E + + ++ D++ G+++ L++G
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-42
Identities = 52/227 (22%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
+ +G+G FG VY+G + T VA+K + + ++ I+F E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 353 AVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLK----------AKPSLDWATRKRIA 402
+++RL+G L++ M+ G + S L+ + ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 403 LGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVR 461
A G+ YL+ K +HRD+ A N ++ E + +GDFG+ + + D
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
V ++PE L G + +DV+ FG++L E+ + G + Q
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-41
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 8/201 (3%)
Query: 300 NFSSKNLVGKGGFGNVYKG-YLQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAV-H 355
+F ++GKG FG V+ + + A+K LK + + E ++SLA H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
L + T V Y++ G + +++ D + A GL +LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
I++RD+K NILLD+ + DFG+ K D+ T GT +IAPE L
Sbjct: 123 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 476 QSSEKTDVFGFGILLLELISG 496
+ + D + FG+LL E++ G
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIG 199
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 29/236 (12%)
Query: 299 SNFSSKNLVGKGGFGNVYKGYL--------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMI 350
+G+G FG V T VAVK LK +E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 351 S-LAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPS----------------L 393
+ H+N++ L+G C ++ Y S G++ L+A+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 394 DWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453
A ARG+ YL K IHRD+ A N+L+ E + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 454 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+ T R V +APE L + ++DV+ FG+LL E+ + + G +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-40
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 28/235 (11%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY------LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL 352
+G+G FG V + VAVK LK+G +E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 353 AVHR-NLLRLIGFCMTTTERL-LVYPYMSNGSVASRLK----------------AKPSLD 394
H N++ L+G C L ++ + G++++ L+ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 395 WATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 455 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQ 508
+V R + +APE + + ++DV+ FG+LL E+ S + G ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (363), Expect = 4e-40
Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLI 362
++G GG V+ L+ VAVK L+ A +F+ E + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 363 GFCMTTTERL----LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
T +V Y+ ++ + + + + A + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--- 130
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV--TTAVRGTVGHIAPEYLSTGQ 476
IIHRDVK ANI++ V DFG+A+ + + V T AV GT +++PE
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 477 SSEKTDVFGFGILLLELISG 496
++DV+ G +L E+++G
Sbjct: 191 VDARSDVYSLGCVLYEVLTG 210
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-40
Identities = 42/195 (21%), Positives = 80/195 (41%), Gaps = 11/195 (5%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G+G FG V++ K +K ++ + E+ ++++A HRN+L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHES 69
Query: 365 CMTTTERLLVYPYMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
+ E ++++ ++S + R+ L+ L +LH I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 424 DVKAANILLDEYYEAVV--GDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 481
D++ NI+ + + +FG A+ L D+ + APE S T
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTAT 184
Query: 482 DVFGFGILLLELISG 496
D++ G L+ L+SG
Sbjct: 185 DMWSLGTLVYVLLSG 199
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 2e-39
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI--QFQTEVEMISLAVH 355
+F +G G FG V+ +G A+K LK + + E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 356 RNLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ 415
++R+ G + ++ Y+ G + S L+ K A L YLH +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 416 CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
II+RD+K NILLD+ + DFG AK + VT + GT +IAPE +ST
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTK 176
Query: 476 QSSEKTDVFGFGILLLELISG 496
++ D + FGIL+ E+++G
Sbjct: 177 PYNKSIDWWSFGILIYEMLAG 197
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (354), Expect = 9e-39
Identities = 42/198 (21%), Positives = 85/198 (42%), Gaps = 4/198 (2%)
Query: 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNL 358
+ +G+G +G VYK G A+K+++ + G E+ ++ H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 359 LRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDP 418
++L T +LV+ ++ + L+ T K L G+ Y H++
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 419 KIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSS 478
+++HRD+K N+L++ E + DFGLA+ T + + + + S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 479 EKTDVFGFGILLLELISG 496
D++ G + E+++G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 45/207 (21%), Positives = 90/207 (43%), Gaps = 12/207 (5%)
Query: 298 TSNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR 356
+++ + +G+G +G V Y + VA+K++ + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 357 NLLRLIGFCMTTTERLLVYPYM----SNGSVASRLKAKPSLDWATRKRIALGAARGLLYL 412
N++ + T + Y+ + LK + L RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 413 HEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL--DHCDSHVTTAVRGTVGHIAPE 470
H ++HRD+K +N+LL+ + + DFGLA++ DH + T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 471 YLSTGQ-SSEKTDVFGFGILLLELISG 496
+ + ++ D++ G +L E++S
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSN 209
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 17/233 (7%)
Query: 294 LQSATSNFSSKNLVGKGGFGNVYKGY--LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMI 350
L A + +G+G +G V+K G VA+KR++ G + EV ++
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 351 SLAV---HRNLLRLIGFCMTTTERLLVYPYMSNGSVAS------RLKAKPSLDWATRKRI 401
H N++RL C + + V +P + T K +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 402 ALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVR 461
RGL +LH +++HRD+K NIL+ + + DFGLA++ + + V
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VV 176
Query: 462 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLD 514
T+ + APE L + D++ G + E+ +Q G +LD
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 10/198 (5%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAI----GGEIQFQTEVEMISLAVHRNLL 359
+ +G+G F VYK +VA+K++K G+ G E++++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
L+ + LV+ +M L + K L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120
Query: 420 IIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-S 478
I+HRD+K N+LLDE + DFGLAK + T V T + APE L +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYG 179
Query: 479 EKTDVFGFGILLLELISG 496
D++ G +L EL+
Sbjct: 180 VGVDMWAVGCILAELLLR 197
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-37
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 6/200 (3%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRN 357
NF +G+G +G VYK G VVA+K+++ D G E+ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGSVAS-RLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
+++L+ T + LV+ ++ A + K +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
++HRD+K N+L++ + DFGLA+ T V L
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 477 SSEKTDVFGFGILLLELISG 496
S D++ G + E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVTR 199
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 20/201 (9%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
++G G G V + + + A+K L+D E++ + +++R++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL-----HWRASQCPHIVRIVDV 73
Query: 365 CMTTTER----LLVYPYMSNGSVASRLKAKP--SLDWATRKRIALGAARGLLYLHEQCDP 418
L+V + G + SR++ + + I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 419 KIIHRDVKAANILLDEYYE---AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
I HRDVK N+L + DFG AK +S T T ++APE L
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 476 QSSEKTDVFGFGILLLELISG 496
+ + D++ G+++ L+ G
Sbjct: 189 KYDKSCDMWSLGVIMYILLCG 209
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-36
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL 358
+++ ++G G FG VY+ L G +VA+K++ + E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 359 LRLIGFCMTTTER------LLVYPYMSNG---SVASRLKAKPSLDWATRKRIALGAARGL 409
+RL F ++ E+ LV Y+ +AK +L K R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 410 LYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIA 468
Y+H I HRD+K N+LLD + + DFG AK L + +V+ +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 469 PEYLSTGQSSEKTDVFGFGILLLELISG 496
+ DV+ G +L EL+ G
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG 219
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 1e-35
Identities = 43/221 (19%), Positives = 74/221 (33%), Gaps = 17/221 (7%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G G FG++Y G + G VA+K Q E ++ + + I +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 365 CMTTTERL-LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
C + +V + T +A + Y+H + IHR
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHR 127
Query: 424 DVKAANIL---LDEYYEAVVGDFGLAKLLDHCDSHV------TTAVRGTVGHIAPEYLST 474
DVK N L + + DFGLAK +H + GT + +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 475 GQSSEKTDVFGFGILLLELISGLRALEFGKTANQKGAMLDW 515
+ S + D+ G +L+ G + K A ++
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLK-----DGNAIGGEIQFQTEVEMISL--AVHRN 357
L+G GGFG+VY G + D VA+K ++ D + + EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 358 LLRLIGFCMTTTERLLVYPYMSNGS-VASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
++RL+ + +L+ + + + +L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 417 DPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
++HRD+K NIL+D E + DFG LL V T GT + PE++
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYH 184
Query: 476 Q-SSEKTDVFGFGILLLELISG 496
+ V+ GILL +++ G
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCG 206
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (329), Expect = 5e-35
Identities = 35/204 (17%), Positives = 67/204 (32%), Gaps = 19/204 (9%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLL-RLIG 363
+G+G FG +++G L + VA+K + Q + E L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 364 FCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHR 423
F +LV + T A + +HE+ +++R
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 424 DVKAANILLDEYYEAVVG-----DFGLAKLLD------HCDSHVTTAVRGTVGHIAPEYL 472
D+K N L+ DFG+ K H + GT +++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 473 STGQSSEKTDVFGFGILLLELISG 496
+ S + D+ G + + + G
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRG 209
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-35
Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 7/200 (3%)
Query: 300 NFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGE--IQFQTEVEMISLAVHR 356
+F L+GKG FG V G A+K L+ I + TE ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 357 NLLRLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC 416
L L T V Y + G + L + + A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYLH 122
Query: 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQ 476
+++RD+K N++LD+ + DFGL K D GT ++APE L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 477 SSEKTDVFGFGILLLELISG 496
D +G G+++ E++ G
Sbjct: 182 YGRAVDWWGLGVVMYEMMCG 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 20/220 (9%)
Query: 289 FHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ 342
F+ +E+ + VG G +G V + G VA+K+L + + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 343 FQTEVEMISLAVHRNLLRLIGFCMT------TTERLLVYPYMSNGSVASRLKAKPSLDWA 396
E+ ++ H N++ L+ T+ LV P+M G+ +L L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGED 121
Query: 397 TRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456
+ + +GL Y+H IIHRD+K N+ ++E E + DFGLA+ DS +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 175
Query: 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
T V L+ + ++ D++ G ++ E+I+G
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 9e-34
Identities = 48/201 (23%), Positives = 78/201 (38%), Gaps = 15/201 (7%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI-----QFQTEVEMISLAVHRNLL 359
+G G F V K G A K +K + EV ++ H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 360 RLIGFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPK 419
L T+ +L+ ++ G + L K SL G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 133
Query: 420 IIHRDVKAANILLDEY----YEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTG 475
I H D+K NI+L + + DFGLA +D + + GT +APE ++
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIVNYE 191
Query: 476 QSSEKTDVFGFGILLLELISG 496
+ D++ G++ L+SG
Sbjct: 192 PLGLEADMWSIGVITYILLSG 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 9e-34
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 17/212 (8%)
Query: 299 SNFSSKNLVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGG-EIQFQTEVEMISLAVHR 356
S + +G+G FG V+K + G VA+K++ N G I E++++ L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 357 NLLRLIGFCMTTTER--------LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARG 408
N++ LI C T LV+ + + + KR+ G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS---HVTTAVRGTVG 465
L + KI+HRD+KAAN+L+ + DFGLA+ + + T T+
Sbjct: 130 L---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 466 HIAPEYLSTGQS-SEKTDVFGFGILLLELISG 496
+ PE L + D++G G ++ E+ +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 43/206 (20%), Positives = 79/206 (38%), Gaps = 5/206 (2%)
Query: 305 NLVGKGGFGNVYKGY-LQDGTVVAVKRLK-DGNAIGGEIQFQTEVEMISLAVHRNLLRLI 362
+G+G +G V+K + +VA+KR++ D + G E+ ++ H+N++RL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 363 GFCMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIH 422
+ + LV+ + LD K + L L ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSRNVLH 124
Query: 423 RDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 482
RD+K N+L++ E + +FGLA+ + V S D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 483 VFGFGILLLELISGLRALEFGKTANQ 508
++ G + EL + R L G +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 3e-33
Identities = 51/232 (21%), Positives = 92/232 (39%), Gaps = 16/232 (6%)
Query: 274 NEQRREEVCLGNLKRFHFKELQSATSNFSSKN------LVGKGGFGNVYKGY-LQDGTVV 326
+EQ + L K K+ ++ + N + + +G G FG V + G
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 327 AVKRLKDGNAIGGEI--QFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSNGSVA 384
A+K L + + E ++ L++L + +V Y++ G +
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 385 SRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 444
S L+ + A YLH +I+RD+K N+L+D+ V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
AK T + GT +APE + + ++ D + G+L+ E+ +G
Sbjct: 187 FAK---RVKGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (299), Expect = 1e-30
Identities = 50/252 (19%), Positives = 93/252 (36%), Gaps = 38/252 (15%)
Query: 268 QIFFDVNEQRREE--------VCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGY 319
+++ DVN R E V GN + +G+G + V++
Sbjct: 8 RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRK------------LGRGKYSEVFEAI 55
Query: 320 -LQDGTVVAVKRLKDGNAIGGEIQFQTEVE-MISLAVHRNLLRLIGFCMTTTERL--LVY 375
+ + V VK LK + + + E++ + +L N++ L R LV+
Sbjct: 56 NITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111
Query: 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-E 434
+++N + +L + + L Y H I+HRDVK N+++D E
Sbjct: 112 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHE 165
Query: 435 YYEAVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLEL 493
+ + + D+GLA+ + + PE L Q D++ G +L +
Sbjct: 166 HRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 494 ISGLRALEFGKT 505
I G
Sbjct: 224 IFRKEPFFHGHD 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 20/237 (8%)
Query: 270 FFDVNEQRREEVCLGNLKRFHFKELQSATSNFSSKNLVGKGGFGNVYKGYL----QDGTV 325
V + R G+ ++ + NF ++G G +G V+ G +
Sbjct: 2 LLTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLVRKISGHDTGKL 54
Query: 326 VAVKRLKDGNAIGGEI---QFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLVYPYMSNG 381
A+K LK + +TE +++ + L+ L T T+ L+ Y++ G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 382 SVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 441
+ + L + + + +L L II+RD+K NILLD V+
Sbjct: 115 ELFTHLSQRERFTE---HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171
Query: 442 DFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELISG 496
DFGL+K ++ GT+ ++AP+ + G S + D + G+L+ EL++G
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 6e-28
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 289 FHFKELQSATSNFSSK----NLVGKGGFGNVYKGY-LQDGTVVAVKRL-KDGNAIGGEIQ 342
F+ +EL + + VG G +G+V + + G VAVK+L + +I +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 343 FQTEVEMISLAVHRNLLRLIGFCMTTT-----ERLLVYPYMSNGSVASRLKAKPSLDWAT 397
E+ ++ H N++ L+ + + ++ + + +K + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122
Query: 398 RKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457
+ + RGL Y+H IIHRD+K +N+ ++E E + DFGLA H D +T
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMT 176
Query: 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
V L+ ++ D++ G ++ EL++G
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-27
Identities = 45/221 (20%), Positives = 78/221 (35%), Gaps = 22/221 (9%)
Query: 290 HFKELQSATSNFSSKN------LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEI- 341
F ++ S F+ +G G G V Y VA+K+L
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 342 QFQTEVEMISLAVHRNLLRLIGFCMTT------TERLLVYPYMSNGSVASRLKAKPSLDW 395
+ E+ ++ H+N++ L+ + LV M
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---H 118
Query: 396 ATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455
+ G+ +LH IIHRD+K +NI++ + DFGLA+ S
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSF 173
Query: 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+ T T + APE + E D++ G ++ E++
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 6e-24
Identities = 39/210 (18%), Positives = 74/210 (35%), Gaps = 23/210 (10%)
Query: 306 LVGKGGFGNVYKGY-LQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGF 364
+G G F V+ + + T VA+K ++ + E++++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 365 CMTTTERLLVY----------------PYMSNGSVASRLKAKPSLDWATRKRIALGAARG 408
+LL + N + + K+I+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 409 LLYLHEQCDPKIIHRDVKAANILLDEY-YEAVVGDFGLAKLLDHCDSHVTTA-VRGTVGH 466
L Y+H +C IIH D+K N+L++ + +A L + C T +
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 467 IAPEYLSTGQSSEKTDVFGFGILLLELISG 496
+PE L D++ L+ ELI+G
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITG 225
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.7 bits (232), Expect = 9e-23
Identities = 23/160 (14%), Positives = 48/160 (30%), Gaps = 24/160 (15%)
Query: 305 NLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA---------IGGEIQFQTEVEMISLAVH 355
L+G+G V+ Y + VK K G+ G++ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 356 RNLLRLIGFCMTTT----ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLY 411
R L +L G + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAK 118
Query: 412 LHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451
+ + I+H D+ N+L+ E + DF + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGE 154
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 32 EVQALMGIKDSLHDPHDVLNNWDENSVDPC--SWALVTCSD----GLVTGLGAPSQNLSG 85
+ QAL+ IK L +P L++W + D C +W V C V L NL
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 86 --TLSSSIGNLTNLQLVLLQNN-NISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
+ SS+ NL L + + N+ G IP I KL++L L +++ +G IP +S +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 143 ETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFN 192
+TL L + N+L+G +PPS+S++ L + N +SG +P +
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.9 bits (164), Expect = 5e-13
Identities = 22/71 (30%), Positives = 35/71 (49%), Gaps = 2/71 (2%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL-NNN 153
NL + L+NN I G +P + +L L +L++S N G IP +L+ NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
Query: 154 SLTGAIPPSLS 164
L G+ P+ +
Sbjct: 303 CLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 2e-10
Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 150 LNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLIC 200
L NN + G +P L+ + L L++S+NNL G +P N +C
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 3/58 (5%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT--GPIPS 137
+ GTL + L L + + NN+ G IP + G L + +NN P+P+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 3e-14
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
NL NL + L NNIS P + L+KL L +NN + S++++L + +L +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360
Query: 153 NSLTGAIPPSLSNMSQLAFLDLSYN 177
N ++ P L+N++++ L L+
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.2 bits (160), Expect = 3e-12
Identities = 30/116 (25%), Positives = 44/116 (37%), Gaps = 24/116 (20%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIP--------------------TEIGKLSKLLTLDLSN 128
+ + LT L + L N IS P + I L L L L
Sbjct: 257 APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184
N + P VS L LQ L NN ++ SL+N++ + +L +N +S P
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 1e-10
Identities = 33/134 (24%), Positives = 55/134 (41%), Gaps = 29/134 (21%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP------------ 136
++ +LTNL + L NN IS P + L+KL L L N + P
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 137 --------STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA 188
S +S+L+ L YL L N+++ P +S++++L L + N +S S
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLAN 349
Query: 189 ----KTFNITGNSL 198
+ N +
Sbjct: 350 LTNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 30/127 (23%), Positives = 47/127 (37%), Gaps = 27/127 (21%)
Query: 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154
TNL + L N + + L+ L LDL+NN + P +S L L L+L N
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 155 LTGAIP--------------------PSLSNMSQLAFLDLSYNNLSGPVPSFHA---KTF 191
++ P +SN+ L +L L +NN+S P +
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 192 NITGNSL 198
N +
Sbjct: 335 FFANNKV 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 10/67 (14%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 118 LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177
L++ + L T + + + L+ + L+ + + + ++ L ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 178 NLSGPVP 184
L+ P
Sbjct: 77 QLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 8/74 (10%)
Query: 81 QNLSGTLS-SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
N++ T+S + + +T LQ L +I G + L+ L ++ SNN T P +
Sbjct: 32 TNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--L 84
Query: 140 SHLETLQYLRLNNN 153
+L L + +NNN
Sbjct: 85 KNLTKLVDILMNNN 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 5e-11
Identities = 41/211 (19%), Positives = 72/211 (34%), Gaps = 16/211 (7%)
Query: 61 CSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSK 120
C +V CSD GL ++L + L+ LQNN I+ + L
Sbjct: 10 CHLRVVQCSD---LGLEKVPKDLP----------PDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 121 LLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L TL L NN + P + L L+ L L+ N L + +L + +
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116
Query: 181 GPVPSFHAKTFNIT-GNSLICATGAEEDCFGTAPMPLSFAL-NNSPNSKPSGMPKG-QKI 237
V + + + G + + ++G E F + + + + P G+P ++
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL 176
Query: 238 ALALGSSLGCISLLILGFGFLLWWRQRHNQQ 268
L + + G L N
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 5e-09
Identities = 32/167 (19%), Positives = 58/167 (34%), Gaps = 7/167 (4%)
Query: 36 LMGIKDSLHDPHDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLT 95
L + + + L + + +V LG SG + + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 96 NLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
L + + + NI+ IP + L L L N T +++ L L L L+ NS+
Sbjct: 151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 156 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSL 198
+ SL+N L L L+ N L + + N++
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 2e-08
Identities = 24/97 (24%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETL 145
T+ + L + + L +N + P + L L L S+N L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLP--RL 67
Query: 146 QYLRLNNNSLTG-AIPPSLSNMSQLAFLDLSYNNLSG 181
Q L L NN L A L + +L L+L N+L
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 2e-04
Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 2/84 (2%)
Query: 146 QYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLICATGAE 205
+ L L + LT + L + + LDLS+N L P+ A + A
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 206 EDCFGTAPMPLSFALNNSPNSKPS 229
+ + NN +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAA 82
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNN---L 179
L L++ T + + L + +L L++N L +PP+L+ + L L S N +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 180 SGPVPSFHAKTFNITGNSL 198
G + + N L
Sbjct: 59 DGVANLPRLQELLLCNNRL 77
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 3e-08
Identities = 22/130 (16%), Positives = 41/130 (31%), Gaps = 28/130 (21%)
Query: 76 LGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLS---------------- 119
L +S + L +L +LL N ++ P L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 120 --------KLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAF 171
L L L++N + + LQ R +++ + ++P L+
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD---L 273
Query: 172 LDLSYNNLSG 181
L+ N+L G
Sbjct: 274 KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 27/125 (21%), Positives = 43/125 (34%), Gaps = 4/125 (3%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSH 141
L + +L NL + L N IS L L L L N P
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 142 LETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNS 197
L L L L N+L+ +L+ + L +L L+ N + + F + +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSE 259
Query: 198 LICAT 202
+ C+
Sbjct: 260 VPCSL 264
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 27/144 (18%), Positives = 44/144 (30%), Gaps = 25/144 (17%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHI-------------------------PTEIG 116
+S ++S NL ++ L +N ++ P
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 117 KLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSY 176
L +L TL L P L LQYL L +N+L + ++ L L L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 177 NNLSGPVPSFHAKTFNITGNSLIC 200
N +S ++ L
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQ 186
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 4e-08
Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 5/83 (6%)
Query: 121 LLTLDLSNNFFT-GPIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLS 175
+ +LD+ + + L+ Q +RL++ LT I +L LA L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 176 YNNLSGPVPSFHAKTFNITGNSL 198
N L + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 96 NLQLVLLQNNNISGHIPTEI-GKLSKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRL 150
++Q + +Q +S E+ L + + L + T I S + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
+N L + Q + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 9/77 (11%)
Query: 119 SKLLTLDLSNNFFTG----PIPSTVSHLETLQYLRLNNNSLTGAIPPSLS-----NMSQL 169
S L L L++ + + +T+ +L+ L L+NN L A L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 170 AFLDLSYNNLSGPVPSF 186
L L S +
Sbjct: 429 EQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 4e-06
Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 9/85 (10%)
Query: 93 NLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVS-----HLE 143
+ L+++ L + ++S + + L LDLSNN +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 144 TLQYLRLNNNSLTGAIPPSLSNMSQ 168
L+ L L + + + L + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 7e-05
Identities = 13/75 (17%), Positives = 31/75 (41%), Gaps = 11/75 (14%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISGHIPTEIGK-----LSKLLTLDLSNNFFTGPIPSTVSH 141
L++++ +L+ + L NN + ++ + L L L + +++ +
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME----- 443
Query: 142 LETLQYLRLNNNSLT 156
+ LQ L + SL
Sbjct: 444 -DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 9/76 (11%)
Query: 87 LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHL 142
+ + L Q+V L + ++ I + + L L+L +N V
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78
Query: 143 -----ETLQYLRLNNN 153
+Q L L N
Sbjct: 79 LQTPSCKIQKLSLQNC 94
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 9e-08
Identities = 21/80 (26%), Positives = 29/80 (36%), Gaps = 8/80 (10%)
Query: 102 LQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 161
N S I + L L++SNN +P+ LE L + N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPE 321
Query: 162 SLSNMSQLAFLDLSYNNLSG 181
N L L + YN L
Sbjct: 322 LPQN---LKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 2e-07
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
+L+ + + NN + +P +L + L S N +P + L+ L +
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VP---ELPQNLKQLHVEY 333
Query: 153 NSLTGAIPPSLSNMSQL 169
N L P ++ L
Sbjct: 334 NPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 15/73 (20%), Positives = 26/73 (35%), Gaps = 11/73 (15%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTV 139
S N L + L L N+++ +P L L + N P
Sbjct: 292 SNNKLIELPALPPRLERLI---ASFNHLA-EVPELPQNLK---QLHVEYNPLRE-FP--- 340
Query: 140 SHLETLQYLRLNN 152
E+++ LR+N+
Sbjct: 341 DIPESVEDLRMNS 353
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 3e-07
Identities = 17/105 (16%), Positives = 38/105 (36%), Gaps = 12/105 (11%)
Query: 102 LQNNNISGHIPTEIGK------LSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
L + I+ +PT I + ++ + +L T + T + L ++ + NN+ +
Sbjct: 3 LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI 58
Query: 156 TGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHAKTFNITGNSLIC 200
+ + + L L+ N L+ P + K
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENK 101
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 13/85 (15%), Positives = 31/85 (36%), Gaps = 10/85 (11%)
Query: 79 PSQNLSGTLSSSIG------NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFT 132
P + + T+ + I L+ +++ + +L+ + + +N+
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 133 GPIPSTVSHLETLQYLRLNNNSLTG 157
+ +L + L LN N LT
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 4e-07
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 82 NLSGT--LSSSIGNLTNLQLVLLQ-NNNISGHIPTEIGKLSKLLTLDLSNNFFTG-PIPS 137
+L+G G L + ++ + + E ++ +DLSN+ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG 65
Query: 138 TVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 173
+S LQ L L L+ I +L+ S L L+
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 6e-05
Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 4/123 (3%)
Query: 44 HDPHDVLNNWDENSVDPCSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQ-LVLL 102
L+ + +N LV LV + S L L LQ L L
Sbjct: 149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 208
Query: 103 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 162
+ +I E+G++ L TL + G + E L +L++N + T P+
Sbjct: 209 RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPT 265
Query: 163 LSN 165
+ N
Sbjct: 266 IGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 9e-04
Identities = 9/59 (15%), Positives = 21/59 (35%), Gaps = 2/59 (3%)
Query: 123 TLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181
TLDL+ + + + R + + + S ++ +DLS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 9e-07
Identities = 16/62 (25%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 91 IGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150
+ NL+ L + +N IS P + L L+ + L NN + P +++ L + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 151 NN 152
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 6e-06
Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 115 IGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDL 174
+ LSKL TL +N + P ++ L L + L NN ++ P L+N S L + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 175 S 175
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 5e-05
Identities = 15/40 (37%), Positives = 21/40 (52%), Gaps = 2/40 (5%)
Query: 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128
S + +L NL V L+NN IS P + S L + L+N
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 9e-05
Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 6/77 (7%)
Query: 103 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 162
Q I+ P L+ + + + T + T + L+ + L +T
Sbjct: 5 QPTAINVIFPDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EG 58
Query: 163 LSNMSQLAFLDLSYNNL 179
+ ++ L L+L N +
Sbjct: 59 VQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 13/63 (20%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 93 NLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152
L N + +N++ + L + TL T V +L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 153 NSL 155
N +
Sbjct: 73 NQI 75
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 114 EIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLD 173
E+ K++ L ++ T +P + + L L+ N L +L ++L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 174 LSYNN 178
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 9e-05
Identities = 14/53 (26%), Positives = 19/53 (35%), Gaps = 1/53 (1%)
Query: 103 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSL 155
NNN++ + L L TL L N IP L + L+ N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 1/50 (2%)
Query: 82 NLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFF 131
NL+ + + L NL +LLQ N++ IP L L N +
Sbjct: 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 3e-06
Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 9/103 (8%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--IPTEIGKLSKLLTLDLSNNFFTGPIPS 137
+++ TL N+ L + L NN + + + + K L L+LS N
Sbjct: 50 RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL 109
Query: 138 TVSHLETLQYLRLNNNSLTGAIPPS-------LSNMSQLAFLD 173
L+ L L+ NSL+ +L LD
Sbjct: 110 DKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 6e-05
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 4/101 (3%)
Query: 89 SSIGNLTNLQL--VLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTG--PIPSTVSHLET 144
S +L + VL + ++++ + + +LL+L+LSNN + S V
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 145 LQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPS 185
L+ L L+ N L +L L L N+LS
Sbjct: 93 LKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 9e-06
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 3/93 (3%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
++ N + + L+ I I L + +D S+N L L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180
L +NNN + + L L L+ N+L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.003
Identities = 10/58 (17%), Positives = 20/58 (34%), Gaps = 7/58 (12%)
Query: 122 LTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
LT +L + ++ + L L + I + + Q +D S N +
Sbjct: 3 LTAELIEQ------AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 2e-05
Identities = 20/92 (21%), Positives = 37/92 (40%), Gaps = 4/92 (4%)
Query: 88 SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQY 147
+ L L+ + L +N IS +P L+ L +L+L++N F E L+
Sbjct: 95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAWFAEWLRK 153
Query: 148 LRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNL 179
LN + P + ++ DL ++
Sbjct: 154 KSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 7e-05
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 4/60 (6%)
Query: 103 QNNNISGHIPTEI-GKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPP 161
+NN +P ++ S + LD+S + +L+ L+ N +P
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 11/79 (13%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 103 QNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPS 162
Q+ I+ L++ + L T + + + L+ + L+ + +
Sbjct: 4 QDTPINQIFTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DG 57
Query: 163 LSNMSQLAFLDLSYNNLSG 181
+ ++ L ++ S N L+
Sbjct: 58 VEYLNNLTQINFSNNQLTD 76
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 8/65 (12%), Positives = 25/65 (38%), Gaps = 4/65 (6%)
Query: 119 SKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDL 174
K L LD + + + ++++ + L+ N++ + ++++ L +
Sbjct: 7 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 175 SYNNL 179
S
Sbjct: 67 SDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.002
Identities = 11/80 (13%), Positives = 24/80 (30%), Gaps = 4/80 (5%)
Query: 80 SQNLSGTLSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGPI 135
+ ++ + + +++ ++L N I + I L + S+ F
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 136 PSTVSHLETLQYLRLNNNSL 155
L L L L
Sbjct: 76 DEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.003
Identities = 14/45 (31%), Positives = 18/45 (40%), Gaps = 5/45 (11%)
Query: 141 HLETLQYLRLNNNSLTGAIPPSL-----SNMSQLAFLDLSYNNLS 180
LQ LRL N + +L M L FL+L+ N S
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.64 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.41 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.39 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.37 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.23 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.16 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.12 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.11 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.1 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.02 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.97 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.34 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.27 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.99 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.86 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.68 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.62 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.1 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.35 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.29 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=373.42 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=178.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++........+++.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357888999999999999999964 7899999999765444445578999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-c
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS-H 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~-~ 455 (517)
|+++|+|.+++.....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999999888899999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred eeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|||||++.+..+ +.++||||+||++|||+||+.||+...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 2345679999999999987775 678999999999999999999997544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=379.24 Aligned_cols=201 Identities=25% Similarity=0.347 Sum_probs=180.9
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++.........++.+|+.++++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 567899999999999999999964 7899999999765555556679999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+.... .
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 158 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---H
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC---C
Confidence 99999999999887889999999999999999999996 5 899999999999999999999999999986542 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++.+..|+.++||||+||++|||+||+.||...+
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234579999999999999999999999999999999999999997654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=364.71 Aligned_cols=200 Identities=31% Similarity=0.461 Sum_probs=180.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... .......+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 68999999986432 1233567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++...+.+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 9999999999999878899999999999999999999999 9999999999999999999999999999866432
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 2345679999999999999999999999999999999999999997654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=361.97 Aligned_cols=198 Identities=29% Similarity=0.471 Sum_probs=165.8
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4677889999999999999999888999999997543 34568999999999999999999999999999999999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 99999998864 45689999999999999999999999 999999999999999999999999999987765444444
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
....||+.|+|||++.+..++.++|||||||++|||+|+..|+.
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 45669999999999999999999999999999999999655543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=362.55 Aligned_cols=200 Identities=22% Similarity=0.365 Sum_probs=179.3
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4699999999999999999995 4799999999875432 3356789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+++|+|.+++... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+.... ...
T Consensus 99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 9999999988754 699999999999999999999999 99999999999999999999999999998775433 233
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
....||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 45569999999999999999999999999999999999999997544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=366.25 Aligned_cols=204 Identities=24% Similarity=0.364 Sum_probs=179.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .......+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56888999999999999999964 78999999986432 1233457899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~- 454 (517)
||+++|+|.+++...+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999888899999999999999999999999 999999999999999999999999999987754322
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||...+.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 233456799999999999999999999999999999999999999986543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=359.42 Aligned_cols=201 Identities=30% Similarity=0.479 Sum_probs=169.2
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|...+.||+|+||+||+|+++. .||||+++.... ....++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678889999999999999998753 599999975432 3345679999999999999999999998754 56899999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC-
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS- 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~- 454 (517)
|+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999974 45699999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeccccccccCcccccc---CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|||||++.. ..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 23345679999999999864 358899999999999999999999997543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=361.95 Aligned_cols=205 Identities=26% Similarity=0.403 Sum_probs=165.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEec--CCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT--TTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lv 374 (517)
++|++.+.||+|+||+||+|+.+ +|+.||+|+++..... .....+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999964 7899999999765432 234568899999999999999999999865 3457899
Q ss_pred EecCcCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 375 YPYMSNGSVASRLK----AKPSLDWATRKRIALGAARGLLYLHEQC--DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 375 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
|||+++|+|.+++. ....+++..++.++.||+.||.|||++. ..+|+||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999886 3567999999999999999999999861 12499999999999999999999999999988
Q ss_pred cCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 75432 23345679999999999999999999999999999999999999997644
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-46 Score=365.58 Aligned_cols=202 Identities=27% Similarity=0.420 Sum_probs=179.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|+..+.||+|+||+||+|+++ +|+.||||+++... ...++|.+|++++++++|||||+++|++.+.+..++|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 456788899999999999999975 58899999987543 235679999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 377 YMSNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 377 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|+++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999999864 45789999999999999999999999 999999999999999999999999999998765544
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......|++.|+|||++.+..++.++|||||||++|||++|+.|+..+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 44455568999999999999999999999999999999999887765443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-46 Score=365.89 Aligned_cols=202 Identities=24% Similarity=0.379 Sum_probs=164.3
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.+.|+..+.||+|+||+||+|+.. +|+.||||++...........+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999965 6899999999765544445678899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DFGla~~~~~~~ 453 (517)
|+++|+|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999999999888999999999999999999999999 999999999999994 5789999999999876532
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 22344569999999999999999999999999999999999999997544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=360.14 Aligned_cols=199 Identities=31% Similarity=0.488 Sum_probs=174.8
Q ss_pred hcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
.++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 35677889999999999999999888999999997543 235679999999999999999999998754 567999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++|+|.+++... ..+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999987643 3589999999999999999999998 9999999999999999999999999999987654444
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
......||+.|+|||.+....++.++|||||||++|||+||..|+..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 44455689999999999989999999999999999999997766543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-46 Score=364.38 Aligned_cols=203 Identities=29% Similarity=0.451 Sum_probs=166.0
Q ss_pred cCCCCCCccccccccceEEEEeC-CC---cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DG---TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|+..+.||+|+||+||+|+++ ++ ..||||.+.........++|.+|++++++++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34666789999999999999965 23 368999987655555556799999999999999999999999999999999
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++.. .+.+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999998875 45799999999999999999999998 99999999999999999999999999998765432
Q ss_pred Cce----eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 221 122357899999999999999999999999999999998 899997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=351.79 Aligned_cols=201 Identities=25% Similarity=0.412 Sum_probs=181.5
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|+..+.||+|+||+||+|++++++.||||+++.... ...+|.+|++++++++|||||+++|++.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57889999999999999999998888999999975433 3568999999999999999999999999999999999999
Q ss_pred cCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 379 SNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 379 ~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
++|+|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.+........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999999865 456789999999999999999999998 999999999999999999999999999987765444444
Q ss_pred eeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 458 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 45669999999999999999999999999999999998 899997644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=360.89 Aligned_cols=202 Identities=23% Similarity=0.328 Sum_probs=176.1
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
+.|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46788899999999999999964 68999999996543 33456789999999999999999999999999999999999
Q ss_pred CcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 378 MSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 378 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
+++|+|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 999999998764 56799999999999999999999999 9999999999999999999999999999764321 112
Q ss_pred eeeccccccccCccccc-----cCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 457 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.....||+.|+|||++. ...|+.++|||||||++|||+||+.||.....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 23456999999999983 45688999999999999999999999976543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=364.48 Aligned_cols=203 Identities=24% Similarity=0.296 Sum_probs=182.2
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||.||+|+. .+|+.||+|+++... .......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999996 479999999996432 2233567889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999998764322 2
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 33456799999999999999999999999999999999999999976543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=353.25 Aligned_cols=197 Identities=29% Similarity=0.420 Sum_probs=169.0
Q ss_pred CCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEec----CCcceEEE
Q 010149 302 SSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMT----TTERLLVY 375 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lv~ 375 (517)
...+.||+|+||+||+|+.. +++.||+|++...... .....|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999965 6889999998754322 234568999999999999999999999865 34468999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCCeEEcccccccccCCCCC
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD-EYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DFGla~~~~~~~~ 454 (517)
||+++|+|.+++.....+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 9999999999999888899999999999999999999998 12399999999999996 578999999999986543
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.......||+.|||||++.+ +++.++|||||||++|||+||+.||...
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 23345679999999999865 6999999999999999999999999654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-45 Score=360.96 Aligned_cols=200 Identities=30% Similarity=0.416 Sum_probs=180.4
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999964 69999999996432 2233567899999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 9999999999999888999999999999999999999999 9999999999999999999999999999876532
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.....
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 2346799999999999999999999999999999999999999976543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-45 Score=359.39 Aligned_cols=197 Identities=31% Similarity=0.403 Sum_probs=174.9
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.|+..+.||+|+||+||+|+. .+|+.||||+++...... ....+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478889999999999999995 478999999997554332 23468899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
|+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988887778899999999999999999999999 999999999999999999999999999986543
Q ss_pred eeeccccccccCcccccc---CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 233569999999999853 468999999999999999999999996543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=355.61 Aligned_cols=202 Identities=27% Similarity=0.433 Sum_probs=174.2
Q ss_pred cCCCCCCc-cccccccceEEEEeC---CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNL-VGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~-lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|...+. ||+|+||+||+|.++ ++..||||+++........++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999854 3567999999766555556689999999999999999999999865 567899
Q ss_pred EecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~ 453 (517)
|||+++|+|.+++.. +..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999998764 46799999999999999999999999 99999999999999999999999999999876543
Q ss_pred Cce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 454 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 454 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... .....||+.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 322 233458999999999999999999999999999999998 999997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=354.17 Aligned_cols=202 Identities=24% Similarity=0.324 Sum_probs=180.0
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-----cchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-----GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++..... ...+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357889999999999999999964 7899999998643321 2346799999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC----CeEEccccccc
Q 010149 372 LLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY----EAVVGDFGLAK 447 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DFGla~ 447 (517)
++||||+++|+|.+++...+.+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+|++|||+|+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999998878899999999999999999999999 999999999999998776 49999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 166 ~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 166 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp ECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 765432 2344569999999999999999999999999999999999999997644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=353.54 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=168.8
Q ss_pred cCCCCCCccccccccceEEEEeCCC-----cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDG-----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
+.|+..++||+|+||.||+|+++.. ..||||+++.........+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999996532 47999999765555555679999999999999999999999999999999
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+.+|++.+.+.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999988764 46799999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc--eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 453 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 453 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
... ......||+.|+|||++.+..++.++|||||||++|||+||..|+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 222 223445899999999999999999999999999999999977776543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=350.69 Aligned_cols=196 Identities=30% Similarity=0.406 Sum_probs=168.3
Q ss_pred CccccccccceEEEEeC---CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecCcC
Q 010149 305 NLVGKGGFGNVYKGYLQ---DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYMSN 380 (517)
Q Consensus 305 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 380 (517)
+.||+|+||+||+|.++ .++.||||+++..... ...++|.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 3468999999754332 234579999999999999999999999865 467899999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee--e
Q 010149 381 GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT--T 458 (517)
Q Consensus 381 gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~--~ 458 (517)
|+|.+++.....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+........ .
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999888899999999999999999999998 999999999999999999999999999987755433322 3
Q ss_pred eccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
...||+.|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 4468999999999999999999999999999999998 899997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=358.87 Aligned_cols=204 Identities=28% Similarity=0.429 Sum_probs=173.8
Q ss_pred hcCCCCCCccccccccceEEEEeCC------CcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
.++|+..+.||+|+||+||+|+... ...||+|++...........+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998642 2369999997655555566799999999988 89999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 010149 371 RLLVYPYMSNGSVASRLKAK-----------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKA 427 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~ 427 (517)
.++||||+++|+|.++++.. ..+++..++.++.||++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 99999999999999999743 2489999999999999999999999 999999999
Q ss_pred CceEEcCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 428 ANILLDEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 428 ~NILl~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+|||++.++.+||+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876543332 2334568999999999999999999999999999999998 899997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-44 Score=360.28 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=178.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57889999999999999999964 78999999996543 23345788999999999999999999999999999999999
Q ss_pred CcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCCeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DFGla~~~~~~~~ 454 (517)
+++|+|.+++. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 99999999985 455799999999999999999999999 999999999999996 4678999999999877643
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|||||++.+..++.++||||+||++|||+||+.||....
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 23345679999999999999999999999999999999999999997554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-45 Score=351.22 Aligned_cols=200 Identities=32% Similarity=0.443 Sum_probs=169.5
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 5688899999999999999999888899999997543 235679999999999999999999999854 5689999999
Q ss_pred cCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 379 SNGSVASRLKA--KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 379 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++|+|.+++.. .+.++|.++..++.||++||+|||++ +|+||||||+|||+++++++||+|||+|+.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999988863 35699999999999999999999999 99999999999999999999999999998765444444
Q ss_pred eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 457 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|+|||++..+.++.++|||||||++|||+||+.|+....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 445669999999999999999999999999999999999877765543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-44 Score=359.20 Aligned_cols=199 Identities=23% Similarity=0.308 Sum_probs=179.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVY 375 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 375 (517)
++|++.+.||+|+||.||+|+.+ +|+.||||+++... .......+.+|+++++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47888999999999999999964 79999999986432 1233457889999999999999999999999999999999
Q ss_pred ecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 376 PYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 376 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
||+.+|+|.+++...+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999876532
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.....||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 234569999999999999999999999999999999999999997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-44 Score=357.30 Aligned_cols=200 Identities=24% Similarity=0.340 Sum_probs=178.4
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++|||||++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5788999999999999999996 4799999999865432 2345688999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCCeEEcccccccccCCCCC
Q 010149 378 MSNGSVASRLKAK-PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD--EYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 378 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DFGla~~~~~~~~ 454 (517)
+++|+|.+++... ..+++.+++.++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999999887654 4699999999999999999999999 999999999999998 6789999999999987643
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 23445569999999999999999999999999999999999999997644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=352.01 Aligned_cols=203 Identities=27% Similarity=0.363 Sum_probs=177.8
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCC--CCcchHHHHHHHHHHh-ccCCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGN--AIGGEIQFQTEVEMIS-LAVHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999965 78999999996432 1223345666776654 68999999999999999999999
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDS 454 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~ 454 (517)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999999999999888899999999999999999999999 99999999999999999999999999998665432
Q ss_pred ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 455 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 455 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 233445799999999999999999999999999999999999999976543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=344.68 Aligned_cols=204 Identities=24% Similarity=0.384 Sum_probs=165.4
Q ss_pred hcCCCCCCccccccccceEEEEeCC----CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD----GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
.++|++.+.||+|+||.||+|++.. +..||||.++..........|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3568888999999999999998642 45789999876555445567999999999999999999999986 467899
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
||||+++|+|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+||++++++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999998764 55799999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCcc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGKT 505 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~~ 505 (517)
.........||+.|+|||.+....++.++|||||||++|||+| |+.||.....
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 4444555668999999999999999999999999999999998 8899976543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=355.80 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=173.3
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCC--CcchHHHHH---HHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNA--IGGEIQFQT---EVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~---Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ......+.+ |+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999965 699999999853221 112223444 466777888999999999999999999
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
+||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999999888899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 2 234569999999999865 568999999999999999999999997644
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-43 Score=343.01 Aligned_cols=204 Identities=23% Similarity=0.329 Sum_probs=171.8
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc--chHHHHHHHHHHhccCCCcccceeeeEecCCc----
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTE---- 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~---- 370 (517)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.....+ ....|.+|+++++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35788999999999999999995 479999999997654332 23468999999999999999999999876543
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||+++|+|.+++...+.+++.++..++.||++||+|||++ +|+||||||+|||++.++..+++|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 689999999999999998888899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCC--ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 3222 23345579999999999999999999999999999999999999997654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-43 Score=340.61 Aligned_cols=202 Identities=25% Similarity=0.341 Sum_probs=178.1
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCc--------chHHHHHHHHHHhccC-CCcccceeeeEecC
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIG--------GEIQFQTEVEMISLAV-HRNLLRLIGFCMTT 368 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--------~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~ 368 (517)
++|+..+.||+|+||+||+|+. .+|+.||||+++...... ....+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6788899999999999999996 478999999996543221 1235889999999997 99999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
+..++||||+++|+|.++++..+.+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999888999999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeeccccccccCcccccc------CCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
+.... ......||+.|+|||.+.. ..++.++||||+||++|||+||+.||.....
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 75432 2344569999999998853 3468899999999999999999999986653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-44 Score=347.94 Aligned_cols=206 Identities=27% Similarity=0.424 Sum_probs=177.7
Q ss_pred HHhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC
Q 010149 296 SATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT 369 (517)
Q Consensus 296 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 369 (517)
...++|+..+.||+|+||+||+|+.+ +++.||||+++.........+|.+|++++++++||||+++++++....
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34567999999999999999999864 357899999976655545667999999999999999999999999999
Q ss_pred cceEEEecCcCCChhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 010149 370 ERLLVYPYMSNGSVASRLKAK------------------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDV 425 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dl 425 (517)
..+++|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEE
Confidence 999999999999999998632 2489999999999999999999999 9999999
Q ss_pred CCCceEEcCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC-CCcCcC
Q 010149 426 KAANILLDEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEFG 503 (517)
Q Consensus 426 k~~NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~-~P~~~~ 503 (517)
||+|||++.++++||+|||+|+.+..... .......|++.|+|||.+....++.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999986644322 2334556899999999999999999999999999999999996 566554
Q ss_pred c
Q 010149 504 K 504 (517)
Q Consensus 504 ~ 504 (517)
.
T Consensus 247 ~ 247 (301)
T d1lufa_ 247 A 247 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=345.83 Aligned_cols=201 Identities=20% Similarity=0.299 Sum_probs=178.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++... .....+.+|+++++.++|||||++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357888999999999999999965 68899999997543 224468899999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC--CCeEEcccccccccCCCC
Q 010149 377 YMSNGSVASRLKAKP-SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEY--YEAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DFGla~~~~~~~ 453 (517)
|+++|+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999998654 799999999999999999999999 99999999999999854 48999999999876543
Q ss_pred CceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.......||+.|+|||...+..++.++||||+||++|||++|+.||.....
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 233445699999999999999999999999999999999999999976543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=345.69 Aligned_cols=202 Identities=25% Similarity=0.454 Sum_probs=169.2
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc----EEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcceE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT----VVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 373 (517)
++|+..+.||+|+||+||+|++. +|+ .||+|+++........++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999864 443 68999987665555677899999999999999999999999864 5678
Q ss_pred EEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 374 VYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++||+.+|+|.+.+.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 8999999999988764 56799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 453 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 453 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 332 2334468999999999999999999999999999999999 788887543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=342.45 Aligned_cols=197 Identities=27% Similarity=0.326 Sum_probs=169.1
Q ss_pred CCccccccccceEEEEeC-CCcEEEEEEecCCCCCc----chHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEecC
Q 010149 304 KNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG----GEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPYM 378 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 378 (517)
.++||+|+||+||+|+.. +|+.||||+++...... ....+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 68999999996543221 1346889999999999999999999999999999999999
Q ss_pred cCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCceee
Q 010149 379 SNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVTT 458 (517)
Q Consensus 379 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~ 458 (517)
+++++.........+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9998888877778899999999999999999999999 999999999999999999999999999987654322 233
Q ss_pred eccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 459 AVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 459 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...||+.|+|||.+.. ..++.++||||+||++|||+||+.||....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 4569999999998865 457999999999999999999999997543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=333.49 Aligned_cols=195 Identities=31% Similarity=0.458 Sum_probs=163.1
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec-CCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~ 377 (517)
++|+..+.||+|+||.||+|.++ |..||||+++... ..++|.+|++++++++|||||+++|++.+ .+..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 45667889999999999999986 7899999996533 34679999999999999999999999865 4567999999
Q ss_pred CcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 378 MSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 378 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999743 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred eeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 223458899999999999999999999999999999998 677776543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=343.25 Aligned_cols=195 Identities=23% Similarity=0.327 Sum_probs=168.4
Q ss_pred cCCCCC-CccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhc-cCCCcccceeeeEec----CCcc
Q 010149 299 SNFSSK-NLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISL-AVHRNLLRLIGFCMT----TTER 371 (517)
Q Consensus 299 ~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~----~~~~ 371 (517)
++|.+. ++||+|+||+||+|+. .+++.||||+++. ...+.+|++++.+ .+|||||++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 567765 4699999999999996 5789999999853 2457789988655 489999999999865 3567
Q ss_pred eEEEecCcCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCCeEEcccccc
Q 010149 372 LLVYPYMSNGSVASRLKAK--PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE---YYEAVVGDFGLA 446 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DFGla 446 (517)
++||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999753 4699999999999999999999999 9999999999999985 557999999999
Q ss_pred cccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 447 KLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 447 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
+...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||....
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 8765432 2344569999999999999999999999999999999999999997544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=334.30 Aligned_cols=202 Identities=32% Similarity=0.424 Sum_probs=163.3
Q ss_pred cCCCCCCccccccccceEEEEeC--CC--cEEEEEEecCCCC--CcchHHHHHHHHHHhccCCCcccceeeeEecCCcce
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ--DG--TVVAVKRLKDGNA--IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERL 372 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 372 (517)
++|+..+.||+|+||.||+|+.. ++ ..||||+++.... ....++|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45778899999999999999853 22 3789999865432 2234579999999999999999999999976 4678
Q ss_pred EEEecCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCC
Q 010149 373 LVYPYMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDH 451 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~ 451 (517)
+||||+++|++.+++.. ...+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999999999987764 45799999999999999999999998 999999999999999999999999999998755
Q ss_pred CCCce--eeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 452 CDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 452 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
..... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 43332 233458889999999999999999999999999999998 899997543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=340.32 Aligned_cols=205 Identities=26% Similarity=0.373 Sum_probs=164.6
Q ss_pred HhcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC-
Q 010149 297 ATSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT- 368 (517)
Q Consensus 297 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~- 368 (517)
..++|++.+.||+|+||.||+|+.. +++.||||+++..........+.+|...+.++ +|+|||++++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3467888999999999999999853 34689999997655544556788888877766 689999999998765
Q ss_pred CcceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
...++||||+++|+|.++++.. ..+++..+..++.||++||.|||++ +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeE
Confidence 4578999999999999998632 3489999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC-CCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~-~P~~~~~ 504 (517)
++++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999876543332 334456999999999999999999999999999999999975 5676443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=336.20 Aligned_cols=197 Identities=33% Similarity=0.497 Sum_probs=169.5
Q ss_pred CCccccccccceEEEEeCCC----cEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEec-CCcceEEEecC
Q 010149 304 KNLVGKGGFGNVYKGYLQDG----TVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMT-TTERLLVYPYM 378 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~ 378 (517)
.++||+|+||+||+|++.++ ..||||+++.........+|.+|++++++++|||||+++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996532 36899999765555455789999999999999999999999875 45789999999
Q ss_pred cCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc--
Q 010149 379 SNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH-- 455 (517)
Q Consensus 379 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~-- 455 (517)
++|+|.+++.. ....++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999998874 44678899999999999999999999 9999999999999999999999999999876543222
Q ss_pred -eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 456 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 456 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
......||+.|+|||.+....++.++||||||+++|||+||+.||...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 223346899999999999999999999999999999999998888654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=340.90 Aligned_cols=200 Identities=30% Similarity=0.446 Sum_probs=168.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCc--EEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGT--VVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lv 374 (517)
++|+..+.||+|+||+||+|+++ +|. .||||+++........++|.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56778899999999999999975 343 57888886555445566899999999998 799999999999999999999
Q ss_pred EecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCe
Q 010149 375 YPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEA 438 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 438 (517)
|||+++|+|.++++.. ..+++..+..++.||++||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998643 5789999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCC-CcCcC
Q 010149 439 VVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLR-ALEFG 503 (517)
Q Consensus 439 ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~-P~~~~ 503 (517)
||+|||+++...... ......||..|+|||.+....++.++|||||||++|||++|.. ||...
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 999999998654221 2223458999999999999999999999999999999999765 56543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=335.48 Aligned_cols=202 Identities=23% Similarity=0.342 Sum_probs=170.7
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....++.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999996 57999999999654322 235678999999999999999999999999999999999
Q ss_pred cCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCc
Q 010149 377 YMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSH 455 (517)
Q Consensus 377 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~ 455 (517)
|+.++.+..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.|+...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 998654443333 355799999999999999999999999 99999999999999999999999999998765432 2
Q ss_pred eeeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 456 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 456 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 333456999999999876655 5789999999999999999999997543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-42 Score=333.81 Aligned_cols=201 Identities=23% Similarity=0.333 Sum_probs=175.1
Q ss_pred cCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEec
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYPY 377 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 377 (517)
++|+..+.||+|+||+||+|+.++|+.||||+++.... .....++.+|+.++++++|||||++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999999999999999975532 23356799999999999999999999999999999999999
Q ss_pred CcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCcee
Q 010149 378 MSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHVT 457 (517)
Q Consensus 378 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~ 457 (517)
+.++.+..+....+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+....... ...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 99988888888788899999999999999999999998 99999999999999999999999999998765432 223
Q ss_pred eeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 458 TAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 458 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
....|++.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 34458999999999865 45689999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=334.13 Aligned_cols=200 Identities=24% Similarity=0.370 Sum_probs=171.8
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCc-----chHHHHHHHHHHhccC--CCcccceeeeEecCC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIG-----GEIQFQTEVEMISLAV--HRNLLRLIGFCMTTT 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~ 369 (517)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ...++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357888999999999999999964 78999999986432211 1234678999999886 999999999999999
Q ss_pred cceEEEecCcC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCCeEEccccccc
Q 010149 370 ERLLVYPYMSN-GSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-YYEAVVGDFGLAK 447 (517)
Q Consensus 370 ~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DFGla~ 447 (517)
..++||||+.+ +++.+++.....+++..++.++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 99999999975 68888888778899999999999999999999999 9999999999999985 4799999999998
Q ss_pred ccCCCCCceeeeccccccccCccccccCCC-CcccceehhhHHHHHHHhCCCCcCcC
Q 010149 448 LLDHCDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 448 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||+..
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 75432 2345679999999999987665 67799999999999999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=336.12 Aligned_cols=201 Identities=28% Similarity=0.406 Sum_probs=176.0
Q ss_pred hcCCCCCCccccccccceEEEEe------CCCcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecCCc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL------QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTTTE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 370 (517)
.++|+..+.||+|+||.||+|++ .+++.||||+++.........+|.+|+.+++++ +|||||+++|++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35777889999999999999985 246789999998665555566799999999998 69999999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 371 RLLVYPYMSNGSVASRLKAKP------------------SLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
.++||||+++|+|.+++.... .+++..+..++.||++||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999986432 589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCCc-eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcC
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALE 501 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~ 501 (517)
+.++.+|++|||+++........ ......||+.|+|||.+....++.++|||||||++|||+|+..|+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999977654333 3345679999999999999999999999999999999999555543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=333.67 Aligned_cols=204 Identities=31% Similarity=0.435 Sum_probs=171.4
Q ss_pred hcCCCCCCccccccccceEEEEeCC--------CcEEEEEEecCCCCCcchHHHHHHHHHHhcc-CCCcccceeeeEecC
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLA-VHRNLLRLIGFCMTT 368 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 368 (517)
.++|.+.+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3567788999999999999998532 3479999997765555556788898888887 899999999999999
Q ss_pred CcceEEEecCcCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE
Q 010149 369 TERLLVYPYMSNGSVASRLKAK----------------PSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILL 432 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl 432 (517)
...++||||+++|+|.+++... ..+++.+++.++.||++||+|||++ +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 9999999999999999999643 3589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEcccccccccCCCCC-ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHh-CCCCcCcCc
Q 010149 433 DEYYEAVVGDFGLAKLLDHCDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIS-GLRALEFGK 504 (517)
Q Consensus 433 ~~~~~~ki~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~ellt-G~~P~~~~~ 504 (517)
+.++.+||+|||+++....... .......|++.|+|||.+.++.|+.++|||||||++|||+| |+.||....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999987654332 23344568999999999999999999999999999999998 678886544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=333.26 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=162.0
Q ss_pred CCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHH--HHHHHHhccCCCcccceeeeEecCC----cceE
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQ--TEVEMISLAVHRNLLRLIGFCMTTT----ERLL 373 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~l 373 (517)
+|...+.||+|+||.||+|+++ |+.||||+++... ..++. .|+..+..++|||||+++|++...+ ..++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4556788999999999999974 8899999986432 23333 4455556789999999999998654 4689
Q ss_pred EEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 374 VYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQ-----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 374 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
||||+++|+|.+++++. .++|..+..++.|++.||+|+|+. .+++|+||||||+|||+++++.+||+|||+++.
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999999865 689999999999999999999973 134999999999999999999999999999987
Q ss_pred cCCCCCc---eeeeccccccccCccccccC------CCCcccceehhhHHHHHHHhCCCCcCc
Q 010149 449 LDHCDSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELISGLRALEF 502 (517)
Q Consensus 449 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~S~Gvil~elltG~~P~~~ 502 (517)
....... ......||+.|+|||++... .++.++|||||||++|||+||..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 6543322 22345699999999998654 267799999999999999999988754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=333.42 Aligned_cols=203 Identities=25% Similarity=0.411 Sum_probs=175.6
Q ss_pred hcCCCCCCccccccccceEEEEeC------CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCCcc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ------DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTER 371 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 371 (517)
.++|...+.||+|+||+||+|.+. ++..||||+++..........|.+|++++++++|||||+++|++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467788899999999999999863 35789999997655444556799999999999999999999999999999
Q ss_pred eEEEecCcCCChhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEc
Q 010149 372 LLVYPYMSNGSVASRLKA----------KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVG 441 (517)
Q Consensus 372 ~lv~e~~~~gsL~~~l~~----------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 441 (517)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 999999999999998862 13579999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCce-eeeccccccccCccccccCCCCcccceehhhHHHHHHHhCC-CCcCcC
Q 010149 442 DFGLAKLLDHCDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGL-RALEFG 503 (517)
Q Consensus 442 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~-~P~~~~ 503 (517)
|||+|+.+....... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 999998765433222 23335899999999999999999999999999999999985 666543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=329.76 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=168.3
Q ss_pred hcCCCCCCccccccccceEEEEe-CC-CcEEEEEEecCCCCC-cchHHHHHHHHHHhcc---CCCcccceeeeEec----
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QD-GTVVAVKRLKDGNAI-GGEIQFQTEVEMISLA---VHRNLLRLIGFCMT---- 367 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~---- 367 (517)
.++|++.+.||+|+||+||+|+. ++ ++.||||+++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 667999998643322 2233566777776655 79999999999853
Q ss_pred -CCcceEEEecCcCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccc
Q 010149 368 -TTERLLVYPYMSNGSVASRLK-AKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGL 445 (517)
Q Consensus 368 -~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGl 445 (517)
....+++|||++++.+..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 245689999999887764443 456789999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 446 AKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 446 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 986543 223345669999999999999999999999999999999999999997654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=330.00 Aligned_cols=203 Identities=22% Similarity=0.323 Sum_probs=169.6
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC----cce
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT----ERL 372 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~ 372 (517)
+++|.+.+.||+|+||+||+|+. .+|+.||||+++........+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999985 5899999999976554444567899999999999999999999997653 235
Q ss_pred EEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCC
Q 010149 373 LVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 373 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~ 452 (517)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 566677799999999765 699999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCc--eeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 221 2234569999999999854 567889999999999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=329.45 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=176.9
Q ss_pred cCCCCCCccccccccceEEEEeC----CCcEEEEEEecCCCC---CcchHHHHHHHHHHhccCC-CcccceeeeEecCCc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ----DGTVVAVKRLKDGNA---IGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTE 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~ 370 (517)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ......+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999842 488999999864321 1224567899999999976 899999999999999
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.+++|||+.+|+|.+++.....+.+.....++.||+.||.|+|++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999999888889999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCceeeeccccccccCccccccC--CCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
...........|++.|+|||.+... .++.++||||+||++|||+||+.||.....
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~ 237 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 237 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5444444556799999999998654 468899999999999999999999976543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=324.12 Aligned_cols=203 Identities=27% Similarity=0.389 Sum_probs=170.3
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCC-CcchHHHHHHHHHHhccCCCcccceeeeEecC--------
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNA-IGGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-------- 368 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-------- 368 (517)
++|++.+.||+|+||+||+|+. ++|+.||||++..... .....++.+|++++++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788899999999999999996 4799999999865433 23346788999999999999999999988653
Q ss_pred CcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 369 TERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 369 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
...++||||++++.+.........+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 45789999999988877777777899999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC---ceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDS---HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
...... .......||+.|+|||.+... .++.++||||+||++|||++|+.||+...
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 653221 122334699999999998654 68999999999999999999999997543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=316.97 Aligned_cols=201 Identities=23% Similarity=0.322 Sum_probs=177.3
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999996 47899999999755433 335678999999999999999999999999999999999
Q ss_pred cCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccCCCCCce
Q 010149 377 YMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLDHCDSHV 456 (517)
Q Consensus 377 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~ 456 (517)
++.++++..++...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 999999999888888999999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred eeeccccccccCccccccCC-CCcccceehhhHHHHHHHhCCCCcCcC
Q 010149 457 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELISGLRALEFG 503 (517)
Q Consensus 457 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~S~Gvil~elltG~~P~~~~ 503 (517)
.....+++.|+|||.+.... ++.++||||+||++|||++|+.||..+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 33345788999999887654 689999999999999999999997543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-39 Score=316.55 Aligned_cols=200 Identities=19% Similarity=0.236 Sum_probs=171.7
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCC-CcccceeeeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVH-RNLLRLIGFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e 376 (517)
++|.+.+.||+|+||+||+|+.. +|+.||||+++.... ..++.+|++.++.++| +|++.+++++......++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57888999999999999999954 689999999865432 2346788888888865 899999999999999999999
Q ss_pred cCcCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-----CCCeEEcccccccccC
Q 010149 377 YMSNGSVASRLKA-KPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDE-----YYEAVVGDFGLAKLLD 450 (517)
Q Consensus 377 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DFGla~~~~ 450 (517)
|+ +++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 6799988875 34799999999999999999999999 9999999999999974 5789999999998764
Q ss_pred CCCC------ceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCcc
Q 010149 451 HCDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGKT 505 (517)
Q Consensus 451 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~~ 505 (517)
.... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 3321 123345799999999999999999999999999999999999999975443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=324.11 Aligned_cols=195 Identities=27% Similarity=0.351 Sum_probs=163.0
Q ss_pred CCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcccceeeeEecCC------cce
Q 010149 300 NFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ERL 372 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------~~~ 372 (517)
+|...++||+|+||+||+|+.. +|+.||||+++.... .+.+|++++++++||||+++++++.... ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4677889999999999999965 699999999965432 2247999999999999999999986432 357
Q ss_pred EEEecCcCCChhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccc
Q 010149 373 LVYPYMSNGSVASRL---KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKL 448 (517)
Q Consensus 373 lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~ 448 (517)
+||||++++.+.... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999999876443332 3566799999999999999999999998 999999999999999775 899999999987
Q ss_pred cCCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 449 LDHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 449 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
..... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 65432 2234569999999998764 578999999999999999999999997554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-39 Score=319.65 Aligned_cols=194 Identities=20% Similarity=0.273 Sum_probs=168.0
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecC--CcceEE
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTT--TERLLV 374 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~lv 374 (517)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ...++.+|+++++.++ ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999996 47899999999643 2457889999999985 99999999998754 457899
Q ss_pred EecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-CeEEcccccccccCCCC
Q 010149 375 YPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYY-EAVVGDFGLAKLLDHCD 453 (517)
Q Consensus 375 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DFGla~~~~~~~ 453 (517)
|||+++++|.... +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+......
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999998764 3689999999999999999999999 999999999999998655 68999999998765432
Q ss_pred CceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 454 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 454 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
......||+.|+|||.+.+. .++.++||||+||+++||++|+.||..+.
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 23445689999999998765 47999999999999999999999997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=321.52 Aligned_cols=198 Identities=25% Similarity=0.346 Sum_probs=164.1
Q ss_pred hcCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecCC------
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTTT------ 369 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 369 (517)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467888999999999999999964 6999999999754332 22446889999999999999999999997654
Q ss_pred cceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEccccccccc
Q 010149 370 ERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLL 449 (517)
Q Consensus 370 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~ 449 (517)
..++||||+ +.+|....+. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 468999999 4577776654 4699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeeccccccccCcccccc-CCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 450 DHCDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 450 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 172 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 172 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 532 234569999999999865 457899999999999999999999997653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-39 Score=312.88 Aligned_cols=199 Identities=21% Similarity=0.237 Sum_probs=165.3
Q ss_pred cCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCccccee-eeEecCCcceEEEe
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNLLRLI-GFCMTTTERLLVYP 376 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~-~~~~~~~~~~lv~e 376 (517)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ..++..|+++++.++|+|++..+ ++..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4688899999999999999996 4689999999865432 23578899999999877766555 45567778889999
Q ss_pred cCcCCChhhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc---CCCCeEEcccccccccCCC
Q 010149 377 YMSNGSVASRL-KAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLD---EYYEAVVGDFGLAKLLDHC 452 (517)
Q Consensus 377 ~~~~gsL~~~l-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DFGla~~~~~~ 452 (517)
|+.+ ++.+.+ .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9955 555554 4566899999999999999999999999 999999999999985 4557999999999977543
Q ss_pred CCc------eeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 453 DSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 453 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 321 2234569999999999999999999999999999999999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-38 Score=313.93 Aligned_cols=199 Identities=24% Similarity=0.346 Sum_probs=166.9
Q ss_pred hcCCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC-----Cc
Q 010149 298 TSNFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT-----TE 370 (517)
Q Consensus 298 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 370 (517)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46789999999999999999995 57999999999754332 2334688999999999999999999998643 34
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.+++++|+.+|+|.+++..+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 56778888999999998654 699999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCceeeeccccccccCccccccC-CCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
. ......|++.|+|||...+. .++.++||||+||++|||++|+.||...+
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 2 23345699999999987654 56889999999999999999999997544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-38 Score=312.51 Aligned_cols=198 Identities=22% Similarity=0.262 Sum_probs=159.8
Q ss_pred cCCCCCCccccccccceEEEEeC-CCcEEEEEEecCCCCC-cchHHHHHHHHHHhccCCCcccceeeeEecC------Cc
Q 010149 299 SNFSSKNLVGKGGFGNVYKGYLQ-DGTVVAVKRLKDGNAI-GGEIQFQTEVEMISLAVHRNLLRLIGFCMTT------TE 370 (517)
Q Consensus 299 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~~ 370 (517)
++|.+.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999965 6999999999754332 2234688999999999999999999999643 56
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccccccccC
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFGLAKLLD 450 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~~~ 450 (517)
.++||||+.++.+ +.+. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 7899999977544 4443 3589999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 451 HCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 451 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
.. .......||+.|+|||.+.+..++.++||||+||+++||++|+.||...+
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 32 23344569999999999999999999999999999999999999997543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=5.2e-33 Score=278.72 Aligned_cols=196 Identities=21% Similarity=0.232 Sum_probs=155.7
Q ss_pred CCCCCCccccccccceEEEEe-CCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-----------CCcccceeeeEec
Q 010149 300 NFSSKNLVGKGGFGNVYKGYL-QDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-----------HRNLLRLIGFCMT 367 (517)
Q Consensus 300 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~~~~~ 367 (517)
+|++.+.||+|+||+||+|+. .+|+.||||+++... .....+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 488899999999999999996 479999999997432 22346778888887764 5789999998865
Q ss_pred C--CcceEEEecCcCCChhhh---hhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCC----
Q 010149 368 T--TERLLVYPYMSNGSVASR---LKAKPSLDWATRKRIALGAARGLLYLHE-QCDPKIIHRDVKAANILLDEYYE---- 437 (517)
Q Consensus 368 ~--~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~---- 437 (517)
. ...+++++++..+..... ......+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 3 445566666554432222 2245678999999999999999999998 5 8999999999999986653
Q ss_pred --eEEcccccccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHHHHHHHhCCCCcCcCc
Q 010149 438 --AVVGDFGLAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELISGLRALEFGK 504 (517)
Q Consensus 438 --~ki~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvil~elltG~~P~~~~~ 504 (517)
++++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||....
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 899999999865432 234569999999999999999999999999999999999999997543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=1.7e-28 Score=240.55 Aligned_cols=171 Identities=32% Similarity=0.545 Sum_probs=155.2
Q ss_pred CCchHHHHHHHHHHHhCCCCCCCCCCCCCCCCCCc--eeeeEEeCC----CCEEEEecCCCCCcc--cccccccCCCCCc
Q 010149 27 KGVNYEVQALMGIKDSLHDPHDVLNNWDENSVDPC--SWALVTCSD----GLVTGLGAPSQNLSG--TLSSSIGNLTNLQ 98 (517)
Q Consensus 27 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~~~c--~w~gv~C~~----~~v~~l~l~~~~l~~--~~~~~~~~l~~L~ 98 (517)
.|.++|++||++||+++.||. .+++|... +||| .|.||+|+. .||++|+|+++++.| .+|+++++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 478999999999999999886 68999864 5999 599999984 379999999999998 5889999999999
Q ss_pred EEeccc-CccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCC
Q 010149 99 LVLLQN-NNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177 (517)
Q Consensus 99 ~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 177 (517)
+|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+++|+.+++++|++.+.+|..+.+++.|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999996 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCc------CcccccCCccc
Q 010149 178 NLSGPVPSFHA------KTFNITGNSLI 199 (517)
Q Consensus 178 ~l~~~~p~~~~------~~~~l~~N~~~ 199 (517)
.++|.+|..+. +.+++++|.+.
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred cccccccccccccccccccccccccccc
Confidence 99999997654 44566777663
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.3e-24 Score=195.19 Aligned_cols=169 Identities=13% Similarity=0.102 Sum_probs=119.7
Q ss_pred CCCCccccccccceEEEEeCCCcEEEEEEecCCCCC----c-------------chHHHHHHHHHHhccCCCcccceeee
Q 010149 302 SSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAI----G-------------GEIQFQTEVEMISLAVHRNLLRLIGF 364 (517)
Q Consensus 302 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~-------------~~~~~~~Ei~~l~~l~H~nIv~l~~~ 364 (517)
.+.+.||+|+||+||+|+..+|+.||||+++..... . .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356789999999999999888999999987532110 0 01234567888889999999888765
Q ss_pred EecCCcceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCCeEEcccc
Q 010149 365 CMTTTERLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQCDPKIIHRDVKAANILLDEYYEAVVGDFG 444 (517)
Q Consensus 365 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DFG 444 (517)
. ..+++|||++++.+.+ ++......++.|+++++.|||++ +|+||||||+|||++++ .++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence 3 3479999998865533 33445678999999999999999 99999999999999975 48999999
Q ss_pred cccccCCCCCceeeeccccccccCccccccCCCCcccceehhhHH
Q 010149 445 LAKLLDHCDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 489 (517)
Q Consensus 445 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S~Gvi 489 (517)
.|........... ...+...+ .|.+ ..+|..++|+||..--
T Consensus 148 ~a~~~~~~~~~~~--l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREI--LERDVRNI-ITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHH--HHHHHHHH-HHHH-HHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHH--HHHHHHHH-HHHH-cCCCCCcccHHHHHHH
Confidence 9976543221100 00000000 1122 3567889999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=3.9e-19 Score=160.35 Aligned_cols=143 Identities=21% Similarity=0.292 Sum_probs=115.9
Q ss_pred ceeeeEEeCC-----------CCEEEEecCCCCCcccc-cccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeec
Q 010149 61 CSWALVTCSD-----------GLVTGLGAPSQNLSGTL-SSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 61 c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 128 (517)
|.|..|.|++ ..++.|+|++|.|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 7899999973 35888999999998655 56678899999999999999988888888999999999999
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCC
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG 203 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~ 203 (517)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.... +...+..|.+.|..+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 999977777888999999999999999977778888999999999999998865543221 445566677777654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=8.8e-18 Score=151.34 Aligned_cols=127 Identities=23% Similarity=0.347 Sum_probs=113.6
Q ss_pred EEEecCCCCCcccccccccCCCCCcEEecccCccCCCC-CCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcc
Q 010149 74 TGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHI-PTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 74 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 152 (517)
+.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 46899999998 6777663 78999999999998755 56689999999999999999988999999999999999999
Q ss_pred cccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 153 NSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 153 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
|+|++..|..|.++++|+.|+|++|+|++.+|..|. +.++|++|++.|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999977788899999999999999999998887765 788999999988764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.64 E-value=3.1e-17 Score=159.47 Aligned_cols=134 Identities=28% Similarity=0.486 Sum_probs=102.6
Q ss_pred CCEEEEecCC-CCCcccccccccCCCCCcEEecccCccCCC------------------------CCCcccccCcccEEE
Q 010149 71 GLVTGLGAPS-QNLSGTLSSSIGNLTNLQLVLLQNNNISGH------------------------IPTEIGKLSKLLTLD 125 (517)
Q Consensus 71 ~~v~~l~l~~-~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~------------------------~p~~~~~l~~L~~L~ 125 (517)
..++.|+|++ |+++|.+|+.|++|++|++|+|++|++.+. +|..+.++++|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 4688899986 789999999999999999999988887743 445566666666666
Q ss_pred eecCCCCCCCCccC------------------------------------------------------------------
Q 010149 126 LSNNFFTGPIPSTV------------------------------------------------------------------ 139 (517)
Q Consensus 126 l~~N~l~~~~p~~~------------------------------------------------------------------ 139 (517)
+++|.++|.+|..+
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 66666655444322
Q ss_pred -----CCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCCC
Q 010149 140 -----SHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 204 (517)
Q Consensus 140 -----~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~~ 204 (517)
..+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|.... +.+++++|+.+|+.+.
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred cccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence 1245677888889999988999999999999999999999988887522 5678899998888654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=9.2e-16 Score=145.28 Aligned_cols=130 Identities=25% Similarity=0.245 Sum_probs=85.7
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccC-----------------------CCCCCcccccCcccEEEeec
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNIS-----------------------GHIPTEIGKLSKLLTLDLSN 128 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~-----------------------~~~p~~~~~l~~L~~L~l~~ 128 (517)
+++.|+|++|+|+. +| .++.+++|++|+|++|+++ +..+..+..+.+|+.|++++
T Consensus 56 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~ 133 (266)
T d1p9ag_ 56 RLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133 (266)
T ss_dssp TCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred cccccccccccccc-cc-cccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccc
Confidence 45666666666553 22 2345555555555555555 33333344444445555555
Q ss_pred CCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccccCCC
Q 010149 129 NFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLICATG 203 (517)
Q Consensus 129 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~ 203 (517)
|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+..++..+. +.++|+||++.|+|.
T Consensus 134 n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 555544455566788888999999999977777888899999999999999843333333 678899999999874
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=2.5e-16 Score=150.75 Aligned_cols=133 Identities=23% Similarity=0.252 Sum_probs=119.9
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|++++|++....+..+...++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.+++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 46888999999998888888999999999999999999777778899999999999999999877888999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccccCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLICATG 203 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~c~~~ 203 (517)
++|++++..|..|..+++|++|++++|++++.+|..+. +.+++++|++.|.|+
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 99999988899999999999999999999988776553 788999999999875
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=1.7e-15 Score=125.57 Aligned_cols=103 Identities=26% Similarity=0.326 Sum_probs=88.7
Q ss_pred EEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccc
Q 010149 75 GLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNS 154 (517)
Q Consensus 75 ~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 154 (517)
.|+|++|+++ .++ .++.+++|++|++++|+|+ .+|+.++.+++|+.|++++|+|+ .+| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 5899999998 444 4899999999999999998 67888999999999999999999 455 58999999999999999
Q ss_pred cCCCC-CCCcccCCCcceEeccCCCCCCC
Q 010149 155 LTGAI-PPSLSNMSQLAFLDLSYNNLSGP 182 (517)
Q Consensus 155 l~~~~-p~~~~~l~~L~~l~l~~N~l~~~ 182 (517)
|+... ...+..+++|+.|++++|+++..
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 98432 24688899999999999999853
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.9e-14 Score=136.13 Aligned_cols=126 Identities=25% Similarity=0.233 Sum_probs=104.4
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.|+|++|.|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ ..|..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 36899999999999888889999999999999999998 555 4678999999999999999 56778889999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----~~~~l~~N~~~ 199 (517)
++|++.+..+..+..+.+|+.|++++|.+++.++..+. +.+++++|.+.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 99988876677777777888888888887766555443 55677777664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.1e-14 Score=117.87 Aligned_cols=100 Identities=24% Similarity=0.374 Sum_probs=85.8
Q ss_pred cEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCC
Q 010149 98 QLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYN 177 (517)
Q Consensus 98 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 177 (517)
|.|+|++|+++ .+| .+.++++|++|+|++|+|+ .+|+.+..+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 68999999999 666 4999999999999999999 78889999999999999999999 555 5999999999999999
Q ss_pred CCCCCCC-CCCc-----CcccccCCccccCC
Q 010149 178 NLSGPVP-SFHA-----KTFNITGNSLICAT 202 (517)
Q Consensus 178 ~l~~~~p-~~~~-----~~~~l~~N~~~c~~ 202 (517)
+|+.... ..+. +.+++++|++....
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 9996543 2222 67899999985443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.1e-14 Score=139.17 Aligned_cols=132 Identities=21% Similarity=0.215 Sum_probs=117.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..+..+++++|+++++.+..|..+++|+.|+|++|++++..|..|.++++|+.|++++|++++..|..|..+++|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 46899999999999888889999999999999999999888889999999999999999999989999999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCC----CcCcccccCCccccCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF----HAKTFNITGNSLICAT 202 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~----~~~~~~l~~N~~~c~~ 202 (517)
++|++++..|..|..+++|++|+|++|++.+..+.. +.+.+....+.+.|..
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~ 264 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred cccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCC
Confidence 999999888889999999999999999999876532 1255556667777753
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=5.8e-14 Score=121.22 Aligned_cols=109 Identities=18% Similarity=0.165 Sum_probs=88.1
Q ss_pred CceeeeEEeCCCCEEEEecCCCCCcccccccccCCCCCcEEecccC-ccCCCCCCcccccCcccEEEeecCCCCCCCCcc
Q 010149 60 PCSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNN-NISGHIPTEIGKLSKLLTLDLSNNFFTGPIPST 138 (517)
Q Consensus 60 ~c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 138 (517)
|+.+.+|+|+ ++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..
T Consensus 7 c~~~~~l~c~----------~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~ 75 (156)
T d2ifga3 7 PHGSSGLRCT----------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (156)
T ss_dssp CSSSSCEECC----------SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred cCCCCeEEec----------CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccc
Confidence 3456677775 34443 45677888999999999766 588666677999999999999999999777888
Q ss_pred CCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCC
Q 010149 139 VSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 139 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
|..+++|++|+|++|+|+ .+|.......+|+.|+|++|++.
T Consensus 76 f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp GGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 999999999999999999 66665555567999999999886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=6.1e-14 Score=121.07 Aligned_cols=112 Identities=16% Similarity=0.153 Sum_probs=96.2
Q ss_pred cCCCCCcEEecccCccCCCCCCcccccCcccEEEeecC-CCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcc
Q 010149 92 GNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN-FFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLA 170 (517)
Q Consensus 92 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 170 (517)
......+.++.+++.+. ..|..+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34455677999999998 67888999999999999866 58865567899999999999999999977788899999999
Q ss_pred eEeccCCCCCCCCCCCCc----CcccccCCccccCCCC
Q 010149 171 FLDLSYNNLSGPVPSFHA----KTFNITGNSLICATGA 204 (517)
Q Consensus 171 ~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~c~~~~ 204 (517)
+|+|++|+|+..++..+. +.++|++|++.|++..
T Consensus 84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred ceeccCCCCcccChhhhccccccccccCCCcccCCchH
Confidence 999999999977666654 6889999999998753
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=2.8e-14 Score=124.06 Aligned_cols=106 Identities=21% Similarity=0.214 Sum_probs=71.6
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
++.+|+|++|+|+. ++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|+
T Consensus 19 ~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 56677777777764 3555566777777777777777 343 46777777777777777774333344567777777777
Q ss_pred ccccCCCCC--CCcccCCCcceEeccCCCCCC
Q 010149 152 NNSLTGAIP--PSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 152 ~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~ 181 (517)
+|+|+ .++ ..+..+++|++|++++|+++.
T Consensus 96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 96 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccccc-ccccccccccccccchhhcCCCcccc
Confidence 77776 333 356677777777777777763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.41 E-value=2e-13 Score=131.43 Aligned_cols=72 Identities=32% Similarity=0.415 Sum_probs=65.4
Q ss_pred ceeeeEEeCC-----------CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecC
Q 010149 61 CSWALVTCSD-----------GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNN 129 (517)
Q Consensus 61 c~w~gv~C~~-----------~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 129 (517)
|.|.+|.|++ ..++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|++++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 7899999974 35788999999999777778999999999999999999888889999999999999999
Q ss_pred CCC
Q 010149 130 FFT 132 (517)
Q Consensus 130 ~l~ 132 (517)
+++
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.39 E-value=2.8e-13 Score=130.43 Aligned_cols=128 Identities=20% Similarity=0.242 Sum_probs=110.5
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
..++.+++++|++. .+|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..|..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 46888999999987 455443 689999999999999999999999999999999999999888889999999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc-----------CcccccCCccccCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA-----------KTFNITGNSLICAT 202 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-----------~~~~l~~N~~~c~~ 202 (517)
++|+|+ .+|..+.++++|+.|+|++|+|+......+. +.++|++|++.+..
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~ 288 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCc
Confidence 999999 7899999999999999999999965433321 56789999987653
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.4e-13 Score=119.59 Aligned_cols=108 Identities=19% Similarity=0.117 Sum_probs=89.2
Q ss_pred ccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCC
Q 010149 89 SSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQ 168 (517)
Q Consensus 89 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 168 (517)
+.+.+...|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .+..+++|++|+|++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 44678889999999999999 67877788999999999999999 554 5899999999999999999544445678999
Q ss_pred cceEeccCCCCCCCCC-CCC-----cCcccccCCccc
Q 010149 169 LAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLI 199 (517)
Q Consensus 169 L~~l~l~~N~l~~~~p-~~~-----~~~~~l~~N~~~ 199 (517)
|+.|++++|+|+.... ..+ .+.+++++|++.
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCccc
Confidence 9999999999985322 122 267889999873
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.23 E-value=8.4e-12 Score=112.06 Aligned_cols=102 Identities=29% Similarity=0.443 Sum_probs=49.2
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
+++.|+|++|.+++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+... ..+..+++|+.|+++
T Consensus 63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~ 136 (199)
T d2omxa2 63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELS 136 (199)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECC
T ss_pred CcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhh
Confidence 44455555555543322 445555555555555544 222 244555555555555554421 234445555555555
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCC
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 181 (517)
+|++. .+| .+..+++|+.|++++|++++
T Consensus 137 ~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 137 SNTIS-DIS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp SSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred hhhhc-ccc-cccccccccccccccccccC
Confidence 55554 222 34455555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=1.3e-11 Score=110.74 Aligned_cols=120 Identities=27% Similarity=0.398 Sum_probs=99.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+++++++.. ++ .+..+++|++|+|++|++++. + .++++++|++|++++|.+. .+| .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCc-c-cccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 478899999999984 33 488999999999999999964 4 3999999999999999998 455 4889999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCCc----CcccccCCccc
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFHA----KTFNITGNSLI 199 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~l~~N~~~ 199 (517)
++|.+... ..+..+++|+.|++++|+++.. |.... +.+++.+|.+.
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc-cccccccccccccccccccc
Confidence 99999843 3588999999999999999853 32211 67888888764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.16 E-value=2.3e-11 Score=110.16 Aligned_cols=119 Identities=29% Similarity=0.399 Sum_probs=69.1
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
+++.|+|++|.+++.. .++++++|++|++++|+++ .+| .+.++++|+.|++++|.+. .+ ..+..+++|+.++++
T Consensus 69 ~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence 5666666666665432 2456666666666666666 334 3566666666666666655 22 245556666666666
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCC-C--cCcccccCCcc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF-H--AKTFNITGNSL 198 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~--~~~~~l~~N~~ 198 (517)
+|.+++ +..+..+++|+.+++++|++++..|-. + .+.+++++|.+
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred cccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCC
Confidence 666653 234556667777777777776543311 1 15566766665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=2.5e-11 Score=109.84 Aligned_cols=120 Identities=22% Similarity=0.310 Sum_probs=100.4
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhc
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLN 151 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 151 (517)
.++.|++++++++... .+..+++|++|+|++|++++ ++ .++.+++|++|++++|+|+ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 6889999999998543 38899999999999999996 44 4789999999999999999 455 58899999999999
Q ss_pred ccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC---cCcccccCCccc
Q 010149 152 NNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGNSLI 199 (517)
Q Consensus 152 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N~~~ 199 (517)
+|.+. .+ ..+..+++|+.+++++|.+++..+... .+.+++++|.+.
T Consensus 121 ~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 121 HNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp TSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred ccccc-cc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 99997 44 468899999999999999986443222 277888888874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.12 E-value=2.7e-11 Score=119.66 Aligned_cols=122 Identities=29% Similarity=0.383 Sum_probs=77.3
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCC--------------
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-------------- 136 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-------------- 136 (517)
.+++.|++++|.++.. +.+..+++|+.|++++|.+++..| +..+++|+.|++++|++++..|
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 3566677777766542 345666667777777776664332 5666666666666666553211
Q ss_pred ------ccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC----cCcccccCCccc
Q 010149 137 ------STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH----AKTFNITGNSLI 199 (517)
Q Consensus 137 ------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~----~~~~~l~~N~~~ 199 (517)
..+..+++|+.|++++|++++. + .+..+++|+.|++++|+|++ +|..- .+.+++++|++.
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCC
T ss_pred cccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCC
Confidence 2245566778888888888854 2 37778888888888888875 33211 166778888764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.11 E-value=2.1e-13 Score=122.61 Aligned_cols=111 Identities=20% Similarity=0.315 Sum_probs=80.1
Q ss_pred cccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCccc
Q 010149 86 TLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSN 165 (517)
Q Consensus 86 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 165 (517)
.++.++..|++|++|+|++|+|+ .++ .+.+|++|+.|+|++|+|+ .+|.....+++|+.|++++|+|+ .++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccc
Confidence 44566778888888888888888 455 4788888888888888887 56665566677888888888887 343 4777
Q ss_pred CCCcceEeccCCCCCCCCC-CCC-----cCcccccCCccccC
Q 010149 166 MSQLAFLDLSYNNLSGPVP-SFH-----AKTFNITGNSLICA 201 (517)
Q Consensus 166 l~~L~~l~l~~N~l~~~~p-~~~-----~~~~~l~~N~~~c~ 201 (517)
+++|+.|++++|+|+.... ..+ .+.+++++|++.+.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 8888888888888874321 111 26778888877443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.10 E-value=2.7e-13 Score=121.90 Aligned_cols=109 Identities=25% Similarity=0.268 Sum_probs=93.7
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. + +.+..+++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEE
T ss_pred cccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccccccccc
Confidence 478999999999984 44 5899999999999999998 678766777899999999999994 4 35888999999999
Q ss_pred cccccCCCCC--CCcccCCCcceEeccCCCCCCCCCC
Q 010149 151 NNNSLTGAIP--PSLSNMSQLAFLDLSYNNLSGPVPS 185 (517)
Q Consensus 151 ~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~~~p~ 185 (517)
++|+|+ .++ ..+..+++|+.|+|++|+++...+.
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccchhc-cccccccccCCCccceeecCCCccccCccc
Confidence 999998 444 4688999999999999999865554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.4e-10 Score=107.02 Aligned_cols=108 Identities=19% Similarity=0.291 Sum_probs=52.4
Q ss_pred ceeeeEEeCCCCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCC-ccC
Q 010149 61 CSWALVTCSDGLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-STV 139 (517)
Q Consensus 61 c~w~gv~C~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~ 139 (517)
|....|.|.+ .+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|
T Consensus 8 C~~~~i~c~~----------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f 74 (242)
T d1xwdc1 8 CSNRVFLCQE----------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74 (242)
T ss_dssp ECSSEEEEES----------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSE
T ss_pred CcCCEEEEeC----------CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccc
Confidence 5566777753 2233 3333321 345555555555553333345555555555555555543322 234
Q ss_pred CCCccchhhhhc-ccccCCCCCCCcccCCCcceEeccCCCCCC
Q 010149 140 SHLETLQYLRLN-NNSLTGAIPPSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 140 ~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 181 (517)
..++.+++|.+. .|++....+..|..+++|+.|++++|.++.
T Consensus 75 ~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp ESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhcc
Confidence 455555555443 244444444445555555555555555543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.97 E-value=1.8e-10 Score=113.56 Aligned_cols=118 Identities=25% Similarity=0.344 Sum_probs=98.9
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|+++++.+++..+ +..++.++.+++++|.+++ + ..+..+++++.|+|++|++++. + .+..+++|+.|+|
T Consensus 263 ~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCCc--ccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEEC
Confidence 478999999999986543 7889999999999999995 3 3588999999999999999964 3 3889999999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCCCCC---cCcccccCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSFH---AKTFNITGN 196 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~l~~N 196 (517)
++|+|+ .+| .+.++++|++|++++|+|++.+|-.. .+.+++++|
T Consensus 337 ~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 999998 455 69999999999999999998766221 166778776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.91 E-value=9.6e-10 Score=100.38 Aligned_cols=123 Identities=25% Similarity=0.386 Sum_probs=67.9
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCC--------------
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIP-------------- 136 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-------------- 136 (517)
.+++.|++++|.+++..| +..+++|++|++++|.++ .++ .+..+++|+.|++++|...+..+
T Consensus 63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchh
Confidence 356666666666654433 556666666666666665 333 35566666666666655442211
Q ss_pred ------ccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCCCC---CcCcccccCCccc
Q 010149 137 ------STVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVPSF---HAKTFNITGNSLI 199 (517)
Q Consensus 137 ------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~l~~N~~~ 199 (517)
..+..+++|+.|++++|++++. ..+.++++|+.|+|++|++++..+-. ..+.+++++|++.
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred hhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCC
Confidence 1123445566666666666532 23666677777777777776533211 1155666666653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.83 E-value=2.8e-09 Score=103.25 Aligned_cols=100 Identities=25% Similarity=0.331 Sum_probs=82.6
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRL 150 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 150 (517)
.+++.|||++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36788999999998 57753 578999999999999 788654 57899999999998 55532 146999999
Q ss_pred cccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 151 NNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 151 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
++|+++ .+|. ++.+++|+.|++++|.++..++
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred cccccc-cccc-hhhhccceeecccccccccccc
Confidence 999999 6775 6889999999999999986554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.81 E-value=2.6e-09 Score=97.37 Aligned_cols=107 Identities=21% Similarity=0.348 Sum_probs=75.5
Q ss_pred CEEEEecCCCCCcccccccccCCCCCcEEecccCccCCC--------------------CCCcccccCcccEEEeecCCC
Q 010149 72 LVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGH--------------------IPTEIGKLSKLLTLDLSNNFF 131 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--------------------~p~~~~~l~~L~~L~l~~N~l 131 (517)
.++.+++++|.++. ++ .+..+++|+.|++++|...+. ....+.++++|+.|++++|.+
T Consensus 86 ~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~ 163 (227)
T d1h6ua2 86 KITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQV 163 (227)
T ss_dssp SCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhcccccccccccccccc
Confidence 45555555555542 22 345555555555555544421 112367788899999999999
Q ss_pred CCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEeccCCCCCCCCC
Q 010149 132 TGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 132 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
++. ..+.++++|+.|+|++|++++ +| .+.++++|++|+|++|+|++..|
T Consensus 164 ~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 164 SDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp CCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG
T ss_pred ccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc
Confidence 843 348899999999999999994 54 48899999999999999997554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.80 E-value=2.8e-09 Score=98.07 Aligned_cols=129 Identities=14% Similarity=0.142 Sum_probs=101.2
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEecccCccCCCCC-CcccccCcccEEEeec-CCCCCCCCccCCCCccchhh
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIP-TEIGKLSKLLTLDLSN-NFFTGPIPSTVSHLETLQYL 148 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L 148 (517)
..++.|+|++|.++...+..|.++++|++|+|++|.+...+| ..|.+++++++|++.. |++....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 368999999999987667789999999999999999986554 5688999999999874 78887778889999999999
Q ss_pred hhcccccCCCCC-CCcccCCCcceEeccCCCCCCCCCCCCc------CcccccCCccc
Q 010149 149 RLNNNSLTGAIP-PSLSNMSQLAFLDLSYNNLSGPVPSFHA------KTFNITGNSLI 199 (517)
Q Consensus 149 ~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~~~------~~~~l~~N~~~ 199 (517)
++++|+++...+ ..+..+..|..+..+++.+....+..+. ..+++.+|.+.
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 999999984322 2345566777778888888765444432 34567777663
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.43 E-value=2.7e-07 Score=88.80 Aligned_cols=93 Identities=27% Similarity=0.314 Sum_probs=72.3
Q ss_pred CCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCCCCccCCCCccchhhhhcccccCCCCCCCcccCCCcceEec
Q 010149 95 TNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGPIPSTVSHLETLQYLRLNNNSLTGAIPPSLSNMSQLAFLDL 174 (517)
Q Consensus 95 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 174 (517)
.+|+.|||++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 47899999999998 68864 578999999999999 788765 46788899999998 55532 146999999
Q ss_pred cCCCCCCCCCCCCc---CcccccCCccc
Q 010149 175 SYNNLSGPVPSFHA---KTFNITGNSLI 199 (517)
Q Consensus 175 ~~N~l~~~~p~~~~---~~~~l~~N~~~ 199 (517)
++|.++..++.... +.+++++|.+.
T Consensus 106 ~~n~l~~lp~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLEKLPELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCSSCCCCTTCTTCCEEECCSSCCS
T ss_pred cccccccccchhhhccceeecccccccc
Confidence 99999964432211 67788887764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=1.2e-06 Score=80.89 Aligned_cols=150 Identities=13% Similarity=0.083 Sum_probs=98.7
Q ss_pred HHHHHHhcCCCCCCccccccccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccC-CCcccceeeeEecCCc
Q 010149 292 KELQSATSNFSSKNLVGKGGFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAV-HRNLLRLIGFCMTTTE 370 (517)
Q Consensus 292 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 370 (517)
.++...-+.|...+..+.++.+.||+...+ ++.+.+|+...... .....+.+|...+..+. +--+.+++.+...++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 345555556665555444455789988754 56677888754322 12334677888776653 3235677788777888
Q ss_pred ceEEEecCcCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 010149 371 RLLVYPYMSNGSVASRLKAKPSLDWATRKRIALGAARGLLYLHEQC---------------------------------- 416 (517)
Q Consensus 371 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~~~---------------------------------- 416 (517)
.++||+++++.++.+..... .....++.++++.++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 89999999998876544321 112334556666666666420
Q ss_pred ----------------------CCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 417 ----------------------DPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 417 ----------------------~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877777999998864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=4.8e-09 Score=90.25 Aligned_cols=64 Identities=27% Similarity=0.260 Sum_probs=28.6
Q ss_pred cCCCCCcEEecccCccCCC--CCCcccccCcccEEEeecCCCCCCCCc-cCCCCccchhhhhcccccC
Q 010149 92 GNLTNLQLVLLQNNNISGH--IPTEIGKLSKLLTLDLSNNFFTGPIPS-TVSHLETLQYLRLNNNSLT 156 (517)
Q Consensus 92 ~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~ 156 (517)
..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+. +++ .......|+.|+|++|.+.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcC
Confidence 3445555555555555522 12233445555555555555552 221 1122233455555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=4.5e-09 Score=90.44 Aligned_cols=104 Identities=20% Similarity=0.143 Sum_probs=72.9
Q ss_pred EEecCCCCCcccccccccCCCCCcEEecccCccCCCCCCcccccCcccEEEeecCCCCCC--CCccCCCCccchhhhhcc
Q 010149 75 GLGAPSQNLSGTLSSSIGNLTNLQLVLLQNNNISGHIPTEIGKLSKLLTLDLSNNFFTGP--IPSTVSHLETLQYLRLNN 152 (517)
Q Consensus 75 ~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~ 152 (517)
.|++++.... +.+..+..+..|+..+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++
T Consensus 26 ~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~ 100 (162)
T d1koha1 26 ALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100 (162)
T ss_dssp CBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTT
T ss_pred eeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccccc
Confidence 3555554322 23455556666666666554 4555556799999999999999953 234567789999999999
Q ss_pred cccCCCCCC-CcccCCCcceEeccCCCCCCCCC
Q 010149 153 NSLTGAIPP-SLSNMSQLAFLDLSYNNLSGPVP 184 (517)
Q Consensus 153 N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~p 184 (517)
|+|+ .+++ ......+|+.|++++|++++...
T Consensus 101 N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 101 NELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp SCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred Cccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 9999 4443 33344678999999999987654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=6e-09 Score=104.55 Aligned_cols=110 Identities=25% Similarity=0.282 Sum_probs=85.8
Q ss_pred CEEEEecCCCCCcccc-cccccCCCCCcEEecccCccCC----CCCCcccccCcccEEEeecCCCCCC----CCccCC-C
Q 010149 72 LVTGLGAPSQNLSGTL-SSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPSTVS-H 141 (517)
Q Consensus 72 ~v~~l~l~~~~l~~~~-~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~-~ 141 (517)
++++||++.+++++.. ...+..+++|+.|+|++|.++. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5899999999998642 4456678999999999999872 3445577899999999999998621 222332 2
Q ss_pred CccchhhhhcccccCCC----CCCCcccCCCcceEeccCCCCCC
Q 010149 142 LETLQYLRLNNNSLTGA----IPPSLSNMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 142 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~ 181 (517)
.++|+.|+|++|+++.. ++..+..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999743 45667889999999999999874
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.09 E-value=2.7e-08 Score=96.48 Aligned_cols=65 Identities=25% Similarity=0.280 Sum_probs=30.0
Q ss_pred cCCCCCcEEecccCccCCC-----CCCcccccCcccEEEeecCCCCCC----CCccCCCCccchhhhhcccccC
Q 010149 92 GNLTNLQLVLLQNNNISGH-----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLT 156 (517)
Q Consensus 92 ~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 156 (517)
...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|+
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 3444555555555554411 222344455555555555554311 2233344455555555555554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=6.4e-06 Score=75.38 Aligned_cols=130 Identities=18% Similarity=0.098 Sum_probs=84.8
Q ss_pred cccccc-cceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCC--cccceeeeEecCCcceEEEecCcCCCh
Q 010149 307 VGKGGF-GNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHR--NLLRLIGFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 307 lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~~~~lv~e~~~~gsL 383 (517)
+..|.. +.||+...+++..+.+|...... ...+..|.+.++.+... -+.+++++..+.+..++||+|+++.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444544 57899988888888999875443 22456777777665332 256678887888888999999988655
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------------
Q 010149 384 ASRLKAKPSLDWATRKRIALGAARGLLYLHE------------------------------------------------- 414 (517)
Q Consensus 384 ~~~l~~~~~l~~~~~~~i~~~i~~~L~yLH~------------------------------------------------- 414 (517)
.+.. ... ...+.++++.|.-||+
T Consensus 94 ~~~~-----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 94 LSSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp TTSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred cccc-----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 3311 111 1112233333333332
Q ss_pred --c----CCCCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 415 --Q----CDPKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 415 --~----~~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
. ..+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122479999999999999877778999998864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.99 E-value=1.3e-07 Score=91.46 Aligned_cols=111 Identities=21% Similarity=0.284 Sum_probs=83.9
Q ss_pred CCEEEEecCCCCCccc-----ccccccCCCCCcEEecccCccCCC----CCCcccccCcccEEEeecCCCCCCCCcc---
Q 010149 71 GLVTGLGAPSQNLSGT-----LSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGPIPST--- 138 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~--- 138 (517)
..++.|+|++|.+... +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-...
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 5789999999998642 456688899999999999998632 4456778999999999999998532222
Q ss_pred -CC--CCccchhhhhcccccCCC----CCCCcc-cCCCcceEeccCCCCCC
Q 010149 139 -VS--HLETLQYLRLNNNSLTGA----IPPSLS-NMSQLAFLDLSYNNLSG 181 (517)
Q Consensus 139 -~~--~l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~l~l~~N~l~~ 181 (517)
+. ..+.|++|+|++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 22 236799999999998732 223332 56789999999999974
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=3.9e-07 Score=85.57 Aligned_cols=126 Identities=21% Similarity=0.205 Sum_probs=82.1
Q ss_pred CCEEEEecCCCCCcccccccccCCCCCcEEeccc-CccCCC-CCCcccccCcccEEEeecC-CCCC--------------
Q 010149 71 GLVTGLGAPSQNLSGTLSSSIGNLTNLQLVLLQN-NNISGH-IPTEIGKLSKLLTLDLSNN-FFTG-------------- 133 (517)
Q Consensus 71 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~-------------- 133 (517)
.+++.|+|+++.+....+..++.+++|++|+|++ +.++.. +..-..++++|++|+|+++ .++.
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 3677778888777777777777778888888877 355421 1112345677777777763 2220
Q ss_pred -------C--------CCccCCCCccchhhhhccc-ccCCCCCCCcccCCCcceEeccC-CCCCCCCCCCCc-----Ccc
Q 010149 134 -------P--------IPSTVSHLETLQYLRLNNN-SLTGAIPPSLSNMSQLAFLDLSY-NNLSGPVPSFHA-----KTF 191 (517)
Q Consensus 134 -------~--------~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~p~~~~-----~~~ 191 (517)
. +..-+.++++|++|+|++| .+++..+..+.++++|++|+|++ +.+++.....+. +.+
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEE
Confidence 0 0011134688999999986 57777778899999999999999 467754433332 456
Q ss_pred cccCC
Q 010149 192 NITGN 196 (517)
Q Consensus 192 ~l~~N 196 (517)
++.|+
T Consensus 231 ~l~~~ 235 (284)
T d2astb2 231 QVFGI 235 (284)
T ss_dssp ECTTS
T ss_pred eeeCC
Confidence 66554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.86 E-value=3.6e-05 Score=75.21 Aligned_cols=77 Identities=16% Similarity=0.060 Sum_probs=47.3
Q ss_pred CCccccccccceEEEEeCC-CcEEEEEEecCCC------CCcchHHHHHHHHHHhccC-C--CcccceeeeEecCCcceE
Q 010149 304 KNLVGKGGFGNVYKGYLQD-GTVVAVKRLKDGN------AIGGEIQFQTEVEMISLAV-H--RNLLRLIGFCMTTTERLL 373 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~------~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~~~~~~l 373 (517)
.+.||.|....||+....+ ++.++||.-.... ......+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 6789999754211 1112234456777776552 2 234445443 5567789
Q ss_pred EEecCcCCC
Q 010149 374 VYPYMSNGS 382 (517)
Q Consensus 374 v~e~~~~gs 382 (517)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.68 E-value=4.6e-07 Score=90.34 Aligned_cols=129 Identities=16% Similarity=0.134 Sum_probs=89.8
Q ss_pred CCCEEEEecCCCCCccccccc----c-cCCCCCcEEecccCccCCCCCC----cccccCcccEEEeecCCCCCC----CC
Q 010149 70 DGLVTGLGAPSQNLSGTLSSS----I-GNLTNLQLVLLQNNNISGHIPT----EIGKLSKLLTLDLSNNFFTGP----IP 136 (517)
Q Consensus 70 ~~~v~~l~l~~~~l~~~~~~~----~-~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~----~p 136 (517)
...+..+++++|.+...-... + .....|+.+++++|.++..-.. .+...++|++|+|++|+|++. ++
T Consensus 282 ~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~ 361 (460)
T d1z7xw1 282 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361 (460)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred cccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhh
Confidence 457888999999986432222 1 2346899999999998854222 234566899999999998742 33
Q ss_pred ccCC-CCccchhhhhcccccCC----CCCCCcccCCCcceEeccCCCCCCCCC----------CCCcCcccccCCcc
Q 010149 137 STVS-HLETLQYLRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNLSGPVP----------SFHAKTFNITGNSL 198 (517)
Q Consensus 137 ~~~~-~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~~p----------~~~~~~~~l~~N~~ 198 (517)
..+. ..+.|++|+|++|+|+. .++..+..+++|++|+|++|+|+.... ....+.+++.+|.+
T Consensus 362 ~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred hhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 3343 45679999999999974 244556778999999999999974221 12236677777766
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.62 E-value=2.2e-06 Score=73.42 Aligned_cols=108 Identities=15% Similarity=0.175 Sum_probs=64.3
Q ss_pred CCEEEEecCCC-CCccc----ccccccCCCCCcEEecccCccCC----CCCCcccccCcccEEEeecCCCCCC----CCc
Q 010149 71 GLVTGLGAPSQ-NLSGT----LSSSIGNLTNLQLVLLQNNNISG----HIPTEIGKLSKLLTLDLSNNFFTGP----IPS 137 (517)
Q Consensus 71 ~~v~~l~l~~~-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 137 (517)
..+++|+|+++ .+... +-..+...++|+.|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 46788888764 34322 33456677778888888887762 2223344567788888888887732 122
Q ss_pred cCCCCccchhhhhcccccCCC-------CCCCcccCCCcceEeccCCC
Q 010149 138 TVSHLETLQYLRLNNNSLTGA-------IPPSLSNMSQLAFLDLSYNN 178 (517)
Q Consensus 138 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~l~l~~N~ 178 (517)
.+...++|++|+|++|++... +...+...+.|+.|+++.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 345556677777777655421 22233345666666665543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.61 E-value=4.9e-06 Score=77.78 Aligned_cols=107 Identities=16% Similarity=0.179 Sum_probs=80.6
Q ss_pred CCEEEEecCCCC-Ccc-cccccccC-CCCCcEEecccC--ccCC-CCCCcccccCcccEEEeecC-CCCCCCCccCCCCc
Q 010149 71 GLVTGLGAPSQN-LSG-TLSSSIGN-LTNLQLVLLQNN--NISG-HIPTEIGKLSKLLTLDLSNN-FFTGPIPSTVSHLE 143 (517)
Q Consensus 71 ~~v~~l~l~~~~-l~~-~~~~~~~~-l~~L~~L~l~~N--~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~ 143 (517)
.++++|+++++. ++. .+...+.. .++|+.|++++. .++. .+.....++++|++|+|++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 479999999864 432 22333333 478999999864 3442 12333467899999999986 57877778899999
Q ss_pred cchhhhhcc-cccCCCCCCCcccCCCcceEeccCC
Q 010149 144 TLQYLRLNN-NSLTGAIPPSLSNMSQLAFLDLSYN 177 (517)
Q Consensus 144 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~N 177 (517)
+|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 999999999 5787666677889999999999887
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.0019 Score=60.82 Aligned_cols=134 Identities=15% Similarity=0.114 Sum_probs=76.7
Q ss_pred cccceEEEEeCCCcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcc-----ccee--eeEecCCcceEEEecCcCCCh
Q 010149 311 GFGNVYKGYLQDGTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-----LRLI--GFCMTTTERLLVYPYMSNGSV 383 (517)
Q Consensus 311 ~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~l~--~~~~~~~~~~lv~e~~~~gsL 383 (517)
..-.||++..++|..+++|+.+.... ...++..|.+.+..+....+ +..- .........+.++++++|..+
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 34689999999999999999865422 34567788887766532222 1111 122344566788999876332
Q ss_pred h-----hh------h---h----c-----CCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCC
Q 010149 384 A-----SR------L---K----A-----KPSLDWA-------------------TRKRIALGAARGLLYLHE----QCD 417 (517)
Q Consensus 384 ~-----~~------l---~----~-----~~~l~~~-------------------~~~~i~~~i~~~L~yLH~----~~~ 417 (517)
. .. + + . ....++. ....+...+.+.++.+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 00 0 1 0 0111111 111122222223333322 234
Q ss_pred CCeEecCCCCCceEEcCCCCeEEcccccccc
Q 010149 418 PKIIHRDVKAANILLDEYYEAVVGDFGLAKL 448 (517)
Q Consensus 418 ~~ivH~Dlk~~NILl~~~~~~ki~DFGla~~ 448 (517)
.+++|+|+.+.|||++++ ..++||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 578999999999999753 46899998864
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.10 E-value=1.4e-05 Score=68.17 Aligned_cols=89 Identities=16% Similarity=0.155 Sum_probs=64.9
Q ss_pred cCCCCCcEEecccC-ccCCC----CCCcccccCcccEEEeecCCCCCC----CCccCCCCccchhhhhcccccCCC----
Q 010149 92 GNLTNLQLVLLQNN-NISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPSTVSHLETLQYLRLNNNSLTGA---- 158 (517)
Q Consensus 92 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---- 158 (517)
.+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|+.|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45689999999974 56521 223466778899999999998732 223445568899999999998842
Q ss_pred CCCCcccCCCcceEeccCCCCC
Q 010149 159 IPPSLSNMSQLAFLDLSYNNLS 180 (517)
Q Consensus 159 ~p~~~~~l~~L~~l~l~~N~l~ 180 (517)
+-..+...++|++|+|++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 2235666788999999998766
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.74 E-value=2.6e-05 Score=66.29 Aligned_cols=109 Identities=11% Similarity=0.159 Sum_probs=72.0
Q ss_pred CCEEEEecCC-CCCccc----ccccccCCCCCcEEecccCccCCC----CCCcccccCcccEEEeecCCCCCC----CCc
Q 010149 71 GLVTGLGAPS-QNLSGT----LSSSIGNLTNLQLVLLQNNNISGH----IPTEIGKLSKLLTLDLSNNFFTGP----IPS 137 (517)
Q Consensus 71 ~~v~~l~l~~-~~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~ 137 (517)
..++.|+|++ ++++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.+... +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4688888887 445422 345566788899999999988732 223355678899999998887632 224
Q ss_pred cCCCCccchh--hhhcccccCC----CCCCCcccCCCcceEeccCCCC
Q 010149 138 TVSHLETLQY--LRLNNNSLTG----AIPPSLSNMSQLAFLDLSYNNL 179 (517)
Q Consensus 138 ~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l 179 (517)
.+...++|+. |++++|++.. .+...+...++|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 4556677775 4455677753 2334556778888888876654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.35 E-value=0.016 Score=53.58 Aligned_cols=31 Identities=23% Similarity=0.173 Sum_probs=27.8
Q ss_pred CCCeEecCCCCCceEEcCCCCeEEccccccc
Q 010149 417 DPKIIHRDVKAANILLDEYYEAVVGDFGLAK 447 (517)
Q Consensus 417 ~~~ivH~Dlk~~NILl~~~~~~ki~DFGla~ 447 (517)
..+++|+|+.+.||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4589999999999999988877899999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.35 E-value=0.0043 Score=59.95 Aligned_cols=73 Identities=15% Similarity=0.161 Sum_probs=48.0
Q ss_pred CCccccccccceEEEEeCC--------CcEEEEEEecCCCCCcchHHHHHHHHHHhccCCCcc-cceeeeEecCCcceEE
Q 010149 304 KNLVGKGGFGNVYKGYLQD--------GTVVAVKRLKDGNAIGGEIQFQTEVEMISLAVHRNL-LRLIGFCMTTTERLLV 374 (517)
Q Consensus 304 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lv 374 (517)
.+.|+.|-.-.+|++..++ ...|.+++.- .. .......+|..+++.+.-.++ .++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 3567888899999988654 3456666654 22 223455678888887743344 467776643 689
Q ss_pred EecCcCCCh
Q 010149 375 YPYMSNGSV 383 (517)
Q Consensus 375 ~e~~~~gsL 383 (517)
+||+++.++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.29 E-value=0.00016 Score=61.25 Aligned_cols=95 Identities=20% Similarity=0.231 Sum_probs=63.6
Q ss_pred cccccccCCCCCcEEeccc-CccCCC----CCCcccccCcccEEEeecCCCCCCCC----ccCCCCccchhhhhcccccC
Q 010149 86 TLSSSIGNLTNLQLVLLQN-NNISGH----IPTEIGKLSKLLTLDLSNNFFTGPIP----STVSHLETLQYLRLNNNSLT 156 (517)
Q Consensus 86 ~~~~~~~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~ 156 (517)
.+.....+.+.|++|+|++ |.++.. +-..+...++|+.|+|++|.++...- ..+...++|+.|++++|.++
T Consensus 8 ~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 8 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3444456778999999997 567521 22345578899999999999874321 23445678888899888876
Q ss_pred CC----CCCCcccCCCcceEec--cCCCCC
Q 010149 157 GA----IPPSLSNMSQLAFLDL--SYNNLS 180 (517)
Q Consensus 157 ~~----~p~~~~~l~~L~~l~l--~~N~l~ 180 (517)
.. +-..+...++|+.++| ++|.+.
T Consensus 88 ~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 88 GSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred chhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 32 2345667788887555 456664
|